Citrus Sinensis ID: 044608
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | 2.2.26 [Sep-21-2011] | |||||||
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | no | no | 0.745 | 0.677 | 0.579 | 1e-111 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | no | 0.695 | 0.669 | 0.556 | 1e-100 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.681 | 0.456 | 0.541 | 1e-96 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.681 | 0.456 | 0.534 | 6e-96 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.681 | 0.455 | 0.527 | 4e-95 | |
| P43294 | 443 | Serine/threonine-protein | no | no | 0.678 | 0.638 | 0.549 | 4e-95 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.681 | 0.451 | 0.541 | 1e-93 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.681 | 0.451 | 0.541 | 2e-93 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.681 | 0.449 | 0.527 | 4e-93 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.678 | 0.558 | 0.519 | 1e-89 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 402 bits (1032), Expect = e-111, Method: Compositional matrix adjust.
Identities = 183/316 (57%), Positives = 233/316 (73%), Gaps = 5/316 (1%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
MD++ KE+G G FG V++A ++ GE VA+K++K++Y S+E+C++LREVK LR++NH
Sbjct: 1 MDRFKMIKEVGDGTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKLKE+I+ N+ LY + E MECNLYQLM +DR K FSE E++ W FQ+FQ L+YMHQ
Sbjct: 61 NIVKLKEVIRENDILYFIMEYMECNLYQLM--KDRVKPFSEAEVRNWCFQIFQALAYMHQ 118
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
G+FHRDLKPENLLVS+ +IK+ADFGLARE+ S PPYT YV +RWYRAPE+LLQS +Y S
Sbjct: 119 RGYFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYDS 178
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
DMWAMGAIMAEL T PLFPG SEAD++ KIC V+GSP SW GL A +K+QFP
Sbjct: 179 AVDMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQFP 238
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
Q+ L+ +M S S +A+ L SLCSWDP KRP AAE LQH FF+ C + PP +RS
Sbjct: 239 QVSGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVPPTVRSKAG 298
Query: 300 VATTTANQPAAATRGM 315
V T P +G+
Sbjct: 299 VLPKTP--PCVGVKGV 312
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (941), Expect = e-100, Method: Compositional matrix adjust.
Identities = 162/291 (55%), Positives = 217/291 (74%), Gaps = 1/291 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y +E+G G G VF+A++ T E VA+K++K+++ WE+C++LREVK L+KLNH
Sbjct: 1 MERYKVIREIGDGTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+ N+ L+ +FE MECNLY ++ R + FSE EI+ ++ Q+ QGL+YMH N
Sbjct: 61 NIVKLKEVTMENHELFFIFENMECNLYDVIRER-QAAFSEEEIRNFMVQILQGLAYMHNN 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV+ G +KIADFGLARE+ S PPYT+YV +RWYRAPE+LLQS Y+
Sbjct: 120 GYFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYTPA 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWA+GAI+AELFT PLFPG SE DQ+YKIC VLG+P W +G+ R+ + F Q
Sbjct: 180 IDMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNFFQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
+P NL L+P+A+ +AI L + LCSWDP +RPTA ++LQHPFF + P
Sbjct: 240 IPPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVP 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (906), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 155/286 (54%), Positives = 221/286 (77%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ K+LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY VFE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+TF PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 153/286 (53%), Positives = 221/286 (77%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+TF PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 348 bits (894), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 151/286 (52%), Positives = 219/286 (76%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+ PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 156/284 (54%), Positives = 212/284 (74%), Gaps = 1/284 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M +Y +ELG G G V++A + T E VA+K++K+++ WE+C+NLREVK LRKLNH
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+I+KLKE+++ +N L+ +FECM+ NLY +M R+R FSE EI++++ Q+ QGL++MH+N
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERP-FSEGEIRSFMSQMLQGLAHMHKN 127
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV+ I+KIADFGLARE+ S PPYT YV +RWYRAPE+LLQS LY+
Sbjct: 128 GYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPA 187
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWA+GAI+AEL+ PLFPG SE DQ+YKIC VLG P ++ + +R + +
Sbjct: 188 VDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTE 247
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
P+ ++ L+P+A+ +AI L LCSWDP KRPTA EAL HPFF
Sbjct: 248 FPQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFF 291
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 155/286 (54%), Positives = 217/286 (75%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ K+LG G +G V +GE +AIK++K+++ SWE+C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ N+ LY +FE M+ NLYQL+ R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERN-KLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRDLKPENLL + ++KIADFGLAREI+S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G IMAE++T PLFPGASE D ++KIC VLG+P W +G + + A+ + +P
Sbjct: 180 PIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFLWP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L L WDP KRPTA++AL++P+F+
Sbjct: 240 QCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQ 285
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 155/286 (54%), Positives = 217/286 (75%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ K+LG G +G V +GE +AIK++K+++ SWE+C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ N+ LY +FE M+ NLYQL+ R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NIVKLKEVIRENDHLYFIFEYMKENLYQLIKERN-KLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRDLKPENLL + ++KIADFGLAREI+S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G IMAE++T PLFPGASE D ++KIC VLG+P W +G + + A+ + +P
Sbjct: 180 PIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFIWP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L L WDP KRPTA++AL++P+F+
Sbjct: 240 QCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQ 285
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 151/286 (52%), Positives = 218/286 (76%), Gaps = 2/286 (0%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE +AIK++K+++ SWE+C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTIRQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N+VKLKE+I+ N+ LY +FE M+ NLYQL+ R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVVKLKEVIRENDHLYFIFEYMKENLYQLIKERN-KLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRDLKPENLL + ++KIADFGLAREI+S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G IMAE++T PLFPGASE D ++KIC VLG+P W +G + + A+ +++P
Sbjct: 180 PIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFRWP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +A+ L + WDP KRPTA++AL++P+F+
Sbjct: 240 QCVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQ 285
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 150/289 (51%), Positives = 212/289 (73%), Gaps = 6/289 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M+KY K++G GA+G V +A D TGE VAIK +K++++ W++C+ LRE+K L+KL H
Sbjct: 1 MEKYQFIKQVGDGAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLKHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKL E+I + L+ VFE +E NLY+ + +DR KL E I+ ++Q+ Q L +MH
Sbjct: 61 NIVKLLEIILERDELFFVFEYLENNLYE--SIKDRTKLLPETTIRNIIYQILQALHFMHT 118
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
NGFFHRDLKPEN+++ +KIADFGLAREI+S PP+T+Y+ +RWYRAPE+LL+ Y++
Sbjct: 119 NGFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNA 178
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+GAIMAEL++ P+FPG+SE DQ++KIC ++GSPT +W DG++ A ++ + FP
Sbjct: 179 PIDIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFP 238
Query: 240 --QLPRAN-LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q P N LS L+P+A+QDAI L L +DP KRPT +ALQH +FK
Sbjct: 239 NVQPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFK 287
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| 255557681 | 455 | mak, putative [Ricinus communis] gi|2235 | 0.985 | 0.903 | 0.555 | 1e-136 | |
| 224074450 | 453 | predicted protein [Populus trichocarpa] | 0.964 | 0.887 | 0.551 | 1e-136 | |
| 356531493 | 455 | PREDICTED: cyclin-dependent kinase F-4-l | 0.976 | 0.894 | 0.559 | 1e-136 | |
| 356496445 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.973 | 0.902 | 0.569 | 1e-135 | |
| 357484657 | 449 | Serine/threonine protein kinase ICK [Med | 0.978 | 0.908 | 0.567 | 1e-135 | |
| 359474639 | 452 | PREDICTED: cyclin-dependent kinase F-4-l | 0.978 | 0.902 | 0.549 | 1e-131 | |
| 356558874 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.978 | 0.906 | 0.562 | 1e-130 | |
| 449456767 | 449 | PREDICTED: cyclin-dependent kinase F-4-l | 0.971 | 0.902 | 0.527 | 1e-129 | |
| 18415242 | 461 | putative serine/threonine protein kinase | 0.959 | 0.867 | 0.525 | 1e-129 | |
| 356559079 | 414 | PREDICTED: cyclin-dependent kinase F-4-l | 0.901 | 0.908 | 0.594 | 1e-128 |
| >gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 492 bits (1267), Expect = e-136, Method: Compositional matrix adjust.
Identities = 251/452 (55%), Positives = 313/452 (69%), Gaps = 41/452 (9%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ +GE VAIK++K++Y +WE+C+NLREVK LR++NH
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYTWEECVNLREVKSLRRMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKLKE+I+ N+ LY VFE M+CNLYQL+ +DR KLF E E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMDCNLYQLI--KDRVKLFPEAEVRNWCFQVFQGLAYMHQ 118
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
G+FHRDLKPENLLV++GIIKIADFGLAREI S PPYT YV +RWYRAPE+LLQS LYSS
Sbjct: 119 RGYFHRDLKPENLLVTKGIIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYLYSS 178
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K DMWAMGAIMAELFT PLFPG SEAD++YKIC ++GSPT DSWADGL ARAI YQFP
Sbjct: 179 KVDMWAMGAIMAELFTLRPLFPGTSEADEIYKICNIIGSPTKDSWADGLNLARAINYQFP 238
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
Q LSAL+PSAS+DA++L +SLCSWDPSKRP+A EALQHPFF+ CFY PP +RS
Sbjct: 239 QFGGVQLSALIPSASEDAVNLIKSLCSWDPSKRPSAGEALQHPFFQSCFYVPPTLRSR-- 296
Query: 300 VATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSP-----LDLIKQ 354
A T P+A + L+Q+ ++ + A + ++ LS LDL+ Q
Sbjct: 297 -APVTRTPPSAGAKCTLEQQYARRPTGPLSNSKVSPAYMSPKLNASLSTGVQRKLDLVNQ 355
Query: 355 VQQK-------SVKQPKYSPAAEKKSPTS-INK-----------DKIAQLNL-------- 387
+ S KQ KY P K PT+ INK DK A + +
Sbjct: 356 DASRNDKSFRSSTKQQKYRPPGRKSPPTNIINKSRAARGVSDTADKFASMAVGSNRHSGL 415
Query: 388 ---PHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
P MK GVQW AESG++FLRP+ + GR
Sbjct: 416 QQRPPPMKAGVQWAAESGDMFLRPSHQFQAGR 447
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074450|ref|XP_002304373.1| predicted protein [Populus trichocarpa] gi|222841805|gb|EEE79352.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1262), Expect = e-136, Method: Compositional matrix adjust.
Identities = 253/459 (55%), Positives = 312/459 (67%), Gaps = 57/459 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ +GE VAIK++K++Y SWE+C+NLREVK LRK+NH
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKL+E+I+ N+ LY VFE MECNLYQL R+ KLFSE E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLREVIRENDILYFVFEYMECNLYQLTKDRE-KLFSEAEVRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLVS+ IIKIADFGLARE+ S PPYT YV +RWYRAPE+LLQS LYSSK
Sbjct: 120 GYFHRDLKPENLLVSKSIIKIADFGLAREVNSQPPYTEYVSTRWYRAPEVLLQSYLYSSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELFT PLFPG SEAD++YKIC V+GSPT D+WADGL ARAI YQFPQ
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGTSEADEIYKICSVIGSPTTDTWADGLNLARAINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
+L L+PSAS+DAI+L +SLCSWDP RP+AA+ALQHPFF+ CFY PP +R A+
Sbjct: 240 FAGVHLPTLIPSASEDAINLIKSLCSWDPCTRPSAADALQHPFFQSCFYVPPSLRPRAAI 299
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKL-SP----------- 348
T A +A T+G L +QQ G + A SNS++ SP
Sbjct: 300 TRTPA---SAGTKGGL-------EQQCGRNLPG--ALSNSKLTNSFPSPKLHASLSTGVQ 347
Query: 349 --LDLIKQVQQ------KSVKQPKYSPAAEKKSPTSINK-----------DKIAQLNL-- 387
LD++ Q + KS +P+Y P +KSPT ++K DK A + +
Sbjct: 348 RKLDMVNQDSRKPDKSLKSSTKPRYQPPG-RKSPTFMSKGRVARGASETADKFASMTIAS 406
Query: 388 ----------PHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
P MK GVQW ESG +FLRPTQ GR
Sbjct: 407 RRQSLGQQPKPPTMKAGVQWTGESGGMFLRPTQQFPHGR 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531493|ref|XP_003534312.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 255/456 (55%), Positives = 314/456 (68%), Gaps = 49/456 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ TGE VAIK++K++Y SWE+C+NLREVK LRK+NH
Sbjct: 1 MERYKLIKEIGDGTFGTVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ ++ LY VFE MECNLYQLM R+ KLFSE E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLMKDRE-KLFSEAEVRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV++ IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS +Y+SK
Sbjct: 120 GYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYMYTSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELF+ PLFPGASEAD++YKICGV+G+PT +SWADGL+ AR I YQFPQ
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
L +LSAL+PSAS DAISL SLCSWDP KRPTA+EALQHPFF+ CFY PP +R+ AV
Sbjct: 240 LAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNR-AV 298
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSP---------LDL 351
A T P A TRG L Q Q+ ++ GA + +++ S M KL P LD+
Sbjct: 299 ARTP---PPAGTRGALDQ--QEVKRYSGALPTSKLSNNFSSM--KLHPPLASGVQRKLDM 351
Query: 352 IKQVQQKSVK-----QPKYSPAAEKKSPTSINKDK------------------------- 381
+ Q K+ K +PKY + SPTS++K +
Sbjct: 352 VNQDGIKNEKPVRTTKPKYRQPGKDSSPTSMSKGRSVRGVSETAEKLRNLSVTNRRQSSI 411
Query: 382 -IAQLNLPHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
I Q P MK G W +ESGN L P Q + GR
Sbjct: 412 GIGQPRPPPPMKAGGNWISESGNFILGPAQQISTGR 447
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496445|ref|XP_003517078.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 258/453 (56%), Positives = 316/453 (69%), Gaps = 47/453 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ TGE VAIK++K++Y SWE+C+NLREVK LRK+NH
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ ++ LY VFE MECNLYQLM R+ KLFSE E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLMKDRE-KLFSEGEVRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV++ IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS LY+SK
Sbjct: 120 GYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYLYTSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELF+ PLFPGASEAD++YKICGV+G+PT +SWADGL+ AR I YQFPQ
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
L +LSAL+PSAS DAISL SLCSWDP KRPTA+EALQHPFF+ CFY PP +R+ AV
Sbjct: 240 LAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNR-AV 298
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSP---------LDL 351
A T P A TRG L Q Q ++ GA + +++ S M KL P LD+
Sbjct: 299 ARTP---PPAGTRGALDQ--QGVKRYSGALPTSKLSNNFSSM--KLHPPLASGVQRKLDM 351
Query: 352 IKQVQQKSVK-----QPKYSPAAEKKSPTSINK-----------DKIAQLNL-------- 387
+ Q K+ K +PKY K SPTS+NK +K+ L++
Sbjct: 352 VNQDGIKNEKPMRTTKPKYRQPG-KDSPTSMNKGRSVRGVSETAEKLGNLSVSSRRQSMG 410
Query: 388 ----PHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
P MK G W +ESGN L P Q + GR
Sbjct: 411 QPRPPPPMKAGGNWISESGNFILGPAQQIPTGR 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 255/449 (56%), Positives = 311/449 (69%), Gaps = 41/449 (9%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A + TGE VAIK++K++Y SWE+C+NLREVK LRK+NH
Sbjct: 1 MERYKIIKEVGDGTFGSVWRAISKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ ++ LY VFE MECNLYQLM R+ KLFSE EI+ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRESDILYFVFEYMECNLYQLMKDRE-KLFSEGEIRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV++ +IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS +YSSK
Sbjct: 120 GYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYIYSSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELF+ PLFPGASEAD++YKICGV+G+PT DSWADGL+ AR I YQFPQ
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLARDINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
L NLSAL+PSAS AISL +SLCSWDP KRPTA+EALQHPFF+ CFY PP +RS AV
Sbjct: 240 LAGVNLSALIPSASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRSR-AV 298
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQ-----MVGKLSPLDLIKQ- 354
A T P A TRG L Q Q ++ GA + + S G LD++ Q
Sbjct: 299 ARTP---PPAGTRGALDQ--QGVKRYPGALHSSKPTNYFSSPKVQPSSGVQRKLDMVNQE 353
Query: 355 -----VQQKSVKQPKYSPAAEKKSPTSINK-----------DKIAQLNL----------- 387
K+ Q KY K+SPTS+ K +++A +++
Sbjct: 354 GIKNEKSMKTTTQSKYRHPG-KESPTSVIKGRTIHGISETAERLANMSIGNRRQSMGQPR 412
Query: 388 PHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
P MK GV W++ES N LRP + GR
Sbjct: 413 PPPMKAGVNWSSESPNFMLRPAPQIPTGR 441
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474639|ref|XP_002265359.2| PREDICTED: cyclin-dependent kinase F-4-like [Vitis vinifera] gi|296088459|emb|CBI37450.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1218), Expect = e-131, Method: Compositional matrix adjust.
Identities = 248/451 (54%), Positives = 310/451 (68%), Gaps = 43/451 (9%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
MDKY+ KE+G G FG V++A ++ TGE VAIK++K++Y SWE+CLNLREVK LRK+NH
Sbjct: 1 MDKYTIIKEVGDGTFGSVWRAINKQTGEVVAIKKMKRKYYSWEECLNLREVKSLRKMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKL+E+ + N+ LY VFE MECNLYQLM +DR KLFSE E++ W FQVFQGL+YMH+
Sbjct: 61 NIVKLREVFRENDILYFVFEYMECNLYQLM--KDRLKLFSETEVRNWCFQVFQGLAYMHR 118
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
G+FHRDLKPENLLV++ +IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS Y S
Sbjct: 119 RGYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSSTYGS 178
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
DMWAMGAIMAELFT PLFPG+SEAD++YKIC V+GSPT +SWA+GL+ A AI YQFP
Sbjct: 179 AVDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVMGSPTWNSWAEGLKLANAINYQFP 238
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
Q +LS L+PSAS+DAISL SLCSWDP KRPTA EALQHPFF+ CFY PP +R A
Sbjct: 239 QFSSIHLSVLIPSASEDAISLITSLCSWDPCKRPTALEALQHPFFQSCFYVPPSLRPRTA 298
Query: 300 VATTTANQPAAATRGMLKQR--RQQQQQQQGARMCADEASSNSQ---MVGKLSPLDLIKQ 354
V T P+ T+G L Q+ R+ + ++ ++ +S+ + G L++ Q
Sbjct: 299 VTRTP---PSGETKGALDQKSGRRYSRATSNSKPTSNYSSAKPHAAFVTGVQRKLEMNNQ 355
Query: 355 VQQK-------SVKQPKYSPAAEKKSPTSINKD-----------KIAQL----------- 385
K S KQP+Y P A + SPTSI D K+A +
Sbjct: 356 DVYKNDKSLKSSPKQPRYRPPA-RNSPTSIYADRTKREVSDAAEKLANMTVGSGRNGMRQ 414
Query: 386 NLPHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
+LP MK G W+ +S + FL +Q L PGR
Sbjct: 415 SLPAPMKAG-GWHGQSDS-FLGRSQELRPGR 443
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558874|ref|XP_003547727.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1208), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/450 (56%), Positives = 308/450 (68%), Gaps = 42/450 (9%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ +GE VAIK++K++Y SWE+C+NLREVK LRK+NH+
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ + L LVFE ME NLYQLM R+ KLFSE E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRECDTLCLVFEYMEYNLYQLMKNRE-KLFSENEVRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV++ +IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS LYSSK
Sbjct: 120 GYFHRDLKPENLLVTKDVIKIADFGLAREISSLPPYTEYVSTRWYRAPEVLLQSHLYSSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELFT PLFPG+SEAD++YKIC VLGSPT +SWADGL+ AR I YQFPQ
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVLGSPTTESWADGLKLARDINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
L +LS L+PS S DAISL SLCSWDP KRPTAAE LQHPFF+ CFY PP +R T AV
Sbjct: 240 LAGVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEVLQHPFFQSCFYIPPSLR-TRAV 298
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGA----RMCADEASSNSQ---MVGKLSPLDLIK 353
T P+A TRG L R ++ GA ++ + S Q G LD+
Sbjct: 299 ---TRTPPSAGTRGSLD--RLGLKRYSGALPNTKITNNFTSPKVQASIASGVQRKLDMAN 353
Query: 354 QVQQKSVKQPKYSPAAE-----KKSPTSINKDKIAQ---------LNL------------ 387
+ KS K K + ++ K SPTSINK + A+ +N+
Sbjct: 354 EDGIKSKKSLKTTQQSKYRLPGKGSPTSINKGRTARGVSETAEKLVNMSIGTRRLSLGQT 413
Query: 388 -PHMMKTGVQWNAESGNLFLRPTQNLEPGR 416
P MK GV W +ESGNL LR Q + R
Sbjct: 414 RPPPMKAGVNWISESGNL-LRSGQQIPTER 442
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456767|ref|XP_004146120.1| PREDICTED: cyclin-dependent kinase F-4-like [Cucumis sativus] gi|449520459|ref|XP_004167251.1| PREDICTED: cyclin-dependent kinase F-4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1205), Expect = e-129, Method: Compositional matrix adjust.
Identities = 233/442 (52%), Positives = 301/442 (68%), Gaps = 37/442 (8%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
KE+G G FG V++A ++ TGE VAIK++K++Y +WE+C+NLREVK LRK+NH NIVKLK
Sbjct: 3 IKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYTWEECVNLREVKSLRKMNHPNIVKLK 62
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
E+I+ NN LY VFE MECNLYQLM ++ KLFSE E++ W FQVFQGL+YMHQ G+FHRD
Sbjct: 63 EVIRENNILYFVFEYMECNLYQLMKDKE-KLFSEAEVRNWCFQVFQGLAYMHQRGYFHRD 121
Query: 127 LKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAM 186
LKPENLLV++ +IK+ADFGLARE + PPYT YV +RWYRAPE+LLQS LY K DMWAM
Sbjct: 122 LKPENLLVAKDLIKLADFGLARETSAMPPYTEYVSTRWYRAPEVLLQSYLYGPKVDMWAM 181
Query: 187 GAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANL 246
GAIMAELFT PLFPGASE DQ+YKIC +LG+PTMD+W+ GL AR I YQFPQ +L
Sbjct: 182 GAIMAELFTLRPLFPGASETDQIYKICNILGTPTMDTWSGGLCLARNINYQFPQFNGVHL 241
Query: 247 SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTTAN 306
S ++PSAS DA++L SLCSWDPSKRPTA EALQHPFF+ C+Y PP +R+ P + T
Sbjct: 242 SVVIPSASDDAVNLIASLCSWDPSKRPTAMEALQHPFFQSCYYVPPSLRARPPITRTP-- 299
Query: 307 QPAAATRGMLKQRRQQQQ--QQQGARMCADEASSNSQMV---GKLSPLDLIKQ------- 354
P+A T+ +L+Q+ ++ +R+ + +S + G LDL+ Q
Sbjct: 300 -PSAGTKDVLEQQTAKKYPVALSDSRIGGNFSSPKLPALLSTGVQRKLDLMNQDLNKNDK 358
Query: 355 VQQKSVKQPKYSPAAEKKSPTSINK-----------DKIAQLN----------LPHMMKT 393
+ +V+Q KY P SI K +K+A + LP MK
Sbjct: 359 TMKSTVRQQKYRPPVRNSPTNSIYKGNNVRGVSDTGEKLANMTIAPRKPTIGQLPRPMKA 418
Query: 394 GVQWNAESGNLFLRPTQNLEPG 415
GV+W++ S +L +RP Q + G
Sbjct: 419 GVRWSSSSSDLLIRPAQEFQTG 440
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18415242|ref|NP_567574.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|13430556|gb|AAK25900.1|AF360190_1 putative kinase [Arabidopsis thaliana] gi|14532760|gb|AAK64081.1| putative kinase [Arabidopsis thaliana] gi|332658741|gb|AEE84141.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1203), Expect = e-129, Method: Compositional matrix adjust.
Identities = 241/459 (52%), Positives = 303/459 (66%), Gaps = 59/459 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
MD+Y KE+G G FG V++A ++ TGE VAIK++K++Y SW++C+NLREVK LR++NH
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ N+ LY VFE MECNLYQLM R +KLF+E +IK W FQVFQGLSYMHQ
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR-QKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLVS+ IIKIADFGLARE+ S PP+T YV +RWYRAPE+LLQS +Y+SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAEL + P+FPGASEAD++YKIC V+G+PT ++W +GL A I YQFPQ
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
LP LS+LMPSAS+DAI+L E LCSWDPS RPTAAE LQHPFF+ CFY PP +R P+V
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKPSV 299
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSP---------LDL 351
A T P RG + Q ++ A+ NS + K + LD+
Sbjct: 300 ARTP---PPVGPRGSF----EHQSVKRYPVSLANAKPFNSYVSPKSNAAFGSGVQRKLDM 352
Query: 352 IKQVQQK-------SVKQPKYSPAAEKKSPT-SINK------------DKIAQLNL---- 387
+ Q + SV+ KY P +K P S+NK DK+A + +
Sbjct: 353 VNQDGTRNTKPVRSSVRDSKYRPPGKKSPPAASLNKNRVTRSSVSETADKLANMTIGATG 412
Query: 388 ----------------PHMMKTGVQWNAESGNLFLRPTQ 410
P MK G W E+ ++FLRPTQ
Sbjct: 413 SRRHSVSVVGQHQQLKPPPMKAG--WVGETRDMFLRPTQ 449
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356559079|ref|XP_003547829.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-128, Method: Compositional matrix adjust.
Identities = 236/397 (59%), Positives = 290/397 (73%), Gaps = 21/397 (5%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y KE+G G FG V++A ++ +GE VAIK++K++Y SWE+C+NLREVK LRK+NH+
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ + L LVFE ME NLYQL+ R+ KLFSE E++ W FQVFQGL+YMHQ
Sbjct: 61 NIVKLKEVIRECDTLCLVFEYMEYNLYQLVKNRE-KLFSENEVRNWCFQVFQGLAYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV++G+IKIADFGLAREI S PPYT YV +RWYRAPE+LLQS LYSSK
Sbjct: 120 GYFHRDLKPENLLVTKGVIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSHLYSSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAELFT PLFPG+SEAD++YKIC V+GSPT +SWADGL+ AR I YQFPQ
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVIGSPTTESWADGLKLARDINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
L +LS L+PS S DAISL SLCSWDP KRPTAAEALQHPFF+ CFY PP +R T AV
Sbjct: 240 LASVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEALQHPFFQSCFYIPPSLR-TRAV 298
Query: 301 ATTTANQPAAATRGMLKQRRQQQQQQQGA-------------RMCADEASSNSQMVGKLS 347
T P+A TRG L RQ ++ GA ++ A AS + + +
Sbjct: 299 TRTP---PSAGTRGSLD--RQGLKRYSGALPNTKITNNFSSPKLQASIASGVQRKLDMAN 353
Query: 348 PLDLIKQVQQKSVKQPKYSPAAEKKSPTSINKDKIAQ 384
+ + K+ +Q KY K SPTSINK + A+
Sbjct: 354 EDGIKSKKSLKTTQQSKYRLPG-KGSPTSINKGRTAR 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.705 | 0.633 | 0.681 | 4.7e-116 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.702 | 0.587 | 0.655 | 3e-112 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.681 | 0.456 | 0.541 | 8.6e-88 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.681 | 0.456 | 0.534 | 2.3e-87 | |
| UNIPROTKB|P20793 | 622 | Mak "Serine/threonine-protein | 0.681 | 0.456 | 0.534 | 2.3e-87 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.681 | 0.455 | 0.534 | 2.9e-87 | |
| UNIPROTKB|Q6DCJ4 | 648 | mak "Mak-prov protein" [Xenopu | 0.681 | 0.438 | 0.545 | 4.7e-87 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.681 | 0.455 | 0.531 | 1.3e-86 | |
| UNIPROTKB|Q2YDJ7 | 382 | MAK "Uncharacterized protein" | 0.681 | 0.743 | 0.531 | 1.3e-86 | |
| TAIR|locus:2123221 | 444 | MHK [Arabidopsis thaliana (tax | 0.700 | 0.657 | 0.538 | 1.3e-86 |
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 4.7e-116, Sum P(2) = 4.7e-116
Identities = 201/295 (68%), Positives = 244/295 (82%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
MD+Y KE+G G FG V++A ++ TGE VAIK++K++Y SW++C+NLREVK LR++NH
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKLKE+I+ N+ LY VFE MECNLYQLM R +KLF+E +IK W FQVFQGLSYMHQ
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLMKDR-QKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLVS+ IIKIADFGLARE+ S PP+T YV +RWYRAPE+LLQS +Y+SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWAMGAIMAEL + P+FPGASEAD++YKIC V+G+PT ++W +GL A I YQFPQ
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
LP LS+LMPSAS+DAI+L E LCSWDPS RPTAAE LQHPFF+ CFY PP +R
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLR 294
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 194/296 (65%), Positives = 238/296 (80%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ KE+G G FG V++A ++ T E VAIK +K++Y SWE+C+NLREVK L ++NH
Sbjct: 1 MERYTLLKEVGDGTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMNHP 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKLKE+I+ N+ LY VFE MECNLYQLM +DR K F+E +I+ W FQVFQGLSYMHQ
Sbjct: 61 NIVKLKEVIRENDILYFVFEYMECNLYQLM--KDRPKHFAESDIRNWCFQVFQGLSYMHQ 118
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
G+FHRDLKPENLLVS+ +IKIAD GLAREI S PPYT YV +RWYRAPE+LLQS +Y+S
Sbjct: 119 RGYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTS 178
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K DMWAMGAIMAEL + PLFPGASEAD++YKIC V+GSPT ++W +GL A I YQFP
Sbjct: 179 KVDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFP 238
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
Q P +LS++MP AS DA++L E LCSWDP RPT AEALQHPFF+ C+Y PP +R
Sbjct: 239 QFPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPSLR 294
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
Identities = 155/286 (54%), Positives = 221/286 (77%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ K+LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY VFE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+TF PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 873 (312.4 bits), Expect = 2.3e-87, P = 2.3e-87
Identities = 153/286 (53%), Positives = 221/286 (77%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+TF PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 873 (312.4 bits), Expect = 2.3e-87, P = 2.3e-87
Identities = 153/286 (53%), Positives = 221/286 (77%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+TF PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 153/286 (53%), Positives = 220/286 (76%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S +YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+T PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + SWDP KRPTA++AL+HP+F+
Sbjct: 240 QCAPINLKTLIPNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|Q6DCJ4 mak "Mak-prov protein" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 156/286 (54%), Positives = 218/286 (76%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ K+LG G +G V +GE VAIK +K+++ SWE+C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMKQLGDGTYGSVIMGRSNESGELVAIKRMKRKFYSWEECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N+VKLKE+I+ N+ LY VFE M+ NLYQLM R+ KL E I+ ++Q+ QGL+++H++
Sbjct: 61 NVVKLKEVIRENDHLYFVFEYMKENLYQLMKDRN-KLLPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + +IKIADFGL RE++S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELIKIADFGLVRELRSQPPYTDYVSTRWYRAPEVLLRSSSYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+T PLFPG SE DQ++KIC VLG+P + W +G + A ++ ++FP
Sbjct: 180 PIDLWAVGSIMAELYTLRPLFPGTSEVDQIFKICQVLGTPKKNDWPEGYQLAASMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS+DA++L WDP KRPTA++AL+HP+F+
Sbjct: 240 QCIPINLKTLIPNASEDALNLMRDTMQWDPKKRPTASQALRHPYFQ 285
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 152/286 (53%), Positives = 219/286 (76%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+T PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 152/286 (53%), Positives = 219/286 (76%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M++Y+ ++LG G +G V +GE VAIK +K+++ SW++C+NLREVK L+KLNH+
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLNHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
N++KLKE+I+ N+ LY +FE M+ NLYQLM R+ KLF E I+ ++Q+ QGL+++H++
Sbjct: 61 NVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN-KLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GFFHRDLKPENLL-VSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GFFHRD+KPENLL + ++KIADFGLARE++S PPYT+YV +RWYRAPE+LL+S YSS
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSS 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA+G+IMAEL+T PLFPG SE D+++KIC VLG+P W +G + A ++ ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q NL L+P+AS +AI L + +WDP KRPTA++AL+HP+F+
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| TAIR|locus:2123221 MHK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 159/295 (53%), Positives = 215/295 (72%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M +Y +ELG G G V++A + T E VA+K++K+++ WE+C+NLREVK LRKLNH
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLNHP 68
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+I+KLKE+++ +N L+ +FECM+ NLY +M R+R FSE EI++++ Q+ QGL++MH+N
Sbjct: 69 HIIKLKEIVREHNELFFIFECMDHNLYHIMKERERP-FSEGEIRSFMSQMLQGLAHMHKN 127
Query: 121 GFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
G+FHRDLKPENLLV+ I+KIADFGLARE+ S PPYT YV +RWYRAPE+LLQS LY+
Sbjct: 128 GYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPA 187
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
DMWA+GAI+AEL+ PLFPG SE DQ+YKIC VLG P ++ + +R + +
Sbjct: 188 VDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTE 247
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA--PPH 293
P+ ++ L+P+A+ +AI L LCSWDP KRPTA EAL HPFF A P H
Sbjct: 248 FPQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQASYPIH 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 417 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-166 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-114 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-112 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-99 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-98 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-96 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-93 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-91 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-91 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-85 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-83 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-83 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-83 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-80 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-78 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-78 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-77 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-76 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-75 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-75 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-75 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-74 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-73 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-71 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-70 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-69 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-68 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-66 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-65 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-65 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-64 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-64 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-64 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-64 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-63 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-63 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-61 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-60 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-59 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-59 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-58 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-57 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-55 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-55 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-53 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-53 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-53 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-51 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-49 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-47 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-45 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-42 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-42 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-41 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-38 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-38 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-38 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-37 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-37 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-37 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-35 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-35 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-33 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-32 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-29 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-26 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-26 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-24 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-22 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-21 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| TIGR01982 | 437 | TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 467 bits (1203), Expect = e-166
Identities = 168/283 (59%), Positives = 218/283 (77%), Gaps = 2/283 (0%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNI 62
Y K+LG G FG V+ A ++ TGE VAIK++K+++ SWE+C+NLREVK LRKLN H NI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
VKLKE+ + N+ LY VFE ME NLYQLM R K FSE I++ ++Q+ QGL+++H++GF
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 123 FHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
FHRDLKPENLLVS ++KIADFGLAREI+S PPYT+YV +RWYRAPEILL+S YSS
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D+WA+G IMAEL+T PLFPG+SE DQ+YKIC VLG+PT W +G + A + ++FPQ
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+L L+P+AS +AI L + + WDP KRPTA++ALQHP+F
Sbjct: 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-114
Identities = 119/286 (41%), Positives = 181/286 (63%), Gaps = 9/286 (3%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED---CLNLREVKCLRKLNHS 60
Y ++LG G +G V++A D+ TGE VA+K+++ E+ LRE+ L++L H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHP 58
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIVKL ++I +LYLVFE + +L + + R L S IK+ ++Q+ +GL+Y H +
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPL-SPNLIKSIMYQLLRGLAYCHSH 117
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSELYS 178
HRDLKP+N+L++ G++K+ADFGLAR YT+ V + WYRAPEILL S+ YS
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+ D+W++G I AE+ T PLFPG SE DQ++KI +LG+PT +SW G+ + K F
Sbjct: 178 TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP-GVTKLPDYKPTF 236
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
P+ P +L ++P + I L + ++P+KR +A EAL+HP+F
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 328 bits (844), Expect = e-112
Identities = 131/284 (46%), Positives = 187/284 (65%), Gaps = 4/284 (1%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNI 62
Y ++G G +G V++A D+ TGE VAIK++K R+ S LRE+K L++LNH NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+KL ++ ++ LYLVFE M+ +LY+L+ R ++ E IK++L+Q+ QGL++ H +G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRDLKPENLL++ G++K+ADFGLAR S PYT+YV +RWYRAPE+LL + YS+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D+W++G I AEL + PLFPG SE DQ++KI LG+P + W AR K+ FP+
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
L L P+AS A+ L + +DP KR TA +AL HP+F
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 296 bits (760), Expect = 6e-99
Identities = 120/278 (43%), Positives = 179/278 (64%), Gaps = 5/278 (1%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKEL 68
+G G F V +A TG+ AIK +K+ + S E NLRE++ LR+L+ H NI++L E+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 69 I--QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ + RL LVFE M+ NLY+L+ R ++ E +K++++Q+ + L +MH+NG FHRD
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRD 125
Query: 127 LKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAM 186
+KPEN+L+ I+K+ADFG R I S PPYT Y+ +RWYRAPE LL Y K D+WA+
Sbjct: 126 IKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV 185
Query: 187 GAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANL 246
G + E+ + PLFPG +E DQ+ KI VLG+P + R++R + Y FP L
Sbjct: 186 GCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYNFPSKKGTGL 244
Query: 247 SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
L+P+AS + + L + L ++DP +R TA +AL+HP+F
Sbjct: 245 RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 294 bits (755), Expect = 1e-98
Identities = 106/279 (37%), Positives = 152/279 (54%), Gaps = 31/279 (11%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
++LG G+FG+V+ A D+ TG+ VAIK +K++ + LRE+K L+KL H NIV+L +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ ++ ++LYLV E E +L+ L+ + R SE E + +L Q+ L Y+H G HRD
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRD 122
Query: 127 LKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWA 185
LKPEN+L+ G +K+ADFGLAR++ G T +VG+ Y APE+LL Y D+W+
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG-YGKAVDIWS 181
Query: 186 MGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRAN 245
+G I+ EL T P FPG + +++K G P
Sbjct: 182 LGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPP--------------------- 219
Query: 246 LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
S +A L L DP KR TA EALQHPFF
Sbjct: 220 ----EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 287 bits (738), Expect = 5e-96
Identities = 111/281 (39%), Positives = 159/281 (56%), Gaps = 29/281 (10%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLK 66
++LG G+FG V++A + TG+ VA+K LK+R S +D RE++ LR+L+H NIV+L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 67 ELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ ++ + LYLV E E +L+ + SE E K Q+ +GL Y+H NG HR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 126 DLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADM 183
DLKPEN+L+ + G++KIADFGLA++ +KS T +VG+ WY APE+LL Y K D+
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W++G I+ EL T P F G + DQ+ I +LG P
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK----------------- 225
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
S S++A L + + DPSKRPTA E LQHP+F
Sbjct: 226 ------WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 6e-93
Identities = 113/290 (38%), Positives = 175/290 (60%), Gaps = 11/290 (3%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLN---LREVKCLRKLN 58
+Y K+LG G + V++A D+ TG VAIK++K +D +N LRE+K L++L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYM 117
H NI+ L ++ + + + LVFE ME +L +++ +D+ + + +IK+++ +GL Y+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVI--KDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGP-PYTNYVGSRWYRAPEILLQSE 175
H N HRDLKP NLL+ S G++K+ADFGLAR S T+ V +RWYRAPE+L +
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y DMW++G I AEL P PG S+ DQ+ KI LG+PT ++W ++
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
++ P L + P+AS DA+ L + L + +P+KR TA +AL+HP+F
Sbjct: 239 FKP--FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 278 bits (713), Expect = 3e-91
Identities = 117/296 (39%), Positives = 169/296 (57%), Gaps = 16/296 (5%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+Y K +G GA+G V A D+ TG VAIK++ + D LRE+K LR L H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 62 IVKLKELIQNN-----NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
I+ L ++++ N +Y+V E ME +L++++ + + ++ I+ +L+Q+ +GL Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYFLYQILRGLKY 118
Query: 117 MHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY----TNYVGSRWYRAPEIL 171
+H HRDLKP N+LV+ +KI DFGLAR + T YV +RWYRAPE+L
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
L S Y+ D+W++G I AEL T PLFPG DQ+ I VLG+P+ + +
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED-LKFITSE 237
Query: 232 RAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+A Y P+ P+ LS L P AS +AI L E + +DP KR TA EAL HP+
Sbjct: 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 3e-91
Identities = 106/287 (36%), Positives = 174/287 (60%), Gaps = 14/287 (4%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC----LNLREVKCLRKLNHSNIV 63
++G G +G+V++A ++ TGE VA+K+++ E +RE+K L+KL H NIV
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 64 KLKELIQNNNR--LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+LKE++ + + +Y+VFE M+ +L L+ + + K F+E +IK ++ Q+ +GL Y+H NG
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQYLHSNG 120
Query: 122 FFHRDLKPENLLVS-QGIIKIADFGLAREI--KSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRD+K N+L++ G++K+ADFGLAR ++ YTN V + WYR PE+LL + Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+ DMW++G I+AELF P+F G++E +Q+ KI + GSPT ++W + +
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 239 PQLPRANLSALMPSA-SQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ + L A+ L + L + DP KR +A +ALQH +F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 1e-85
Identities = 115/289 (39%), Positives = 170/289 (58%), Gaps = 11/289 (3%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKLNH 59
+Y +G GA G VF+A D TGE VA+K++ R E + LRE+K L+ H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALR--RLEGGIPNQALREIKALQACQH 58
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+VKL ++ + + LV E M +L +++ +R L E ++K+++ + +G++YMH
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPL-PEAQVKSYMRMLLKGVAYMHA 117
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYTNYVGSRWYRAPEILLQSEL 176
NG HRDLKP NLL+S G++KIADFGLAR Y++ V +RWYRAPE+L +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-ARAIK 235
Y D+WA+G I AEL PLFPG ++ +Q+ + LG+P ++W GL K
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP-GLTSLPDYNK 236
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP+ L + P AS +A+ L + L +DPSKR +AAEAL+HP+F
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 2e-83
Identities = 121/289 (41%), Positives = 177/289 (61%), Gaps = 13/289 (4%)
Query: 7 FKELGR---GAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSNI 62
+++L R G +G V++A D+ TGE VA+K+LK ++ +LRE+ L KL H NI
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 63 VKLKELI--QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
V +KE++ N +++Y+V E +E +L LM ++ F + E+K + Q+ G++++H N
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEHDLKSLME-TMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSELYS 178
HRDLK NLL++ +GI+KI DFGLARE S PYT V + WYRAPE+LL ++ YS
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY-Q 237
+ DMW++G I AEL T PLFPG SE DQ+ KI +LG+PT W G + K
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP-GFSELPGAKKKT 244
Query: 238 FPQLPRANLSALMP--SASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
F + P L P S S + L L ++DP+KR +A +AL+HP+F
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 2e-83
Identities = 120/288 (41%), Positives = 183/288 (63%), Gaps = 12/288 (4%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKLNHS 60
Y +++G G +G V++A D+ TGE VA+K K R + ++ + +RE+ L++LNH
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK--KIRLETEDEGVPSTAIREISLLKELNHP 58
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV+L +++ + N+LYLVFE ++ +L + M + P IK++L+Q+ QG++Y H +
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSEL 176
HRDLKP+NLL+ +G +K+ADFGLAR G P YT+ V + WYRAPEILL S
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
YS+ D+W++G I AE+ PLFPG SE DQ+++I LG+P D W G+ K
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP-GVTSLPDYKP 235
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP+ R +LS ++P+ +D + L + +DP+KR +A ALQHP+F
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 5e-83
Identities = 117/290 (40%), Positives = 163/290 (56%), Gaps = 9/290 (3%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNH 59
+KY +G GA+G V + ++ TGE VAIK+ K+ ED LREVK LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRH 59
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV LKE + RLYLVFE +E L +L+ A L ++++++Q+ Q ++Y H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGL-PPDAVRSYIWQLLQAIAYCHS 118
Query: 120 NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPEILLQSEL 176
+ HRD+KPEN+LVS+ G++K+ DFG AR +++ P P T+YV +RWYRAPE+L+
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y D+WA+G IMAEL PLFPG S+ DQ+Y I LG R
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 237 QFP-QLPRANLSALMPSA-SQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP +L P S A+ ++ DP +R T E LQHP+F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 1e-80
Identities = 121/316 (38%), Positives = 177/316 (56%), Gaps = 46/316 (14%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL---------KQRYASWEDCLNLREVKC 53
KY ++LG+GA+G V++A D T E VA+K++ QR RE+
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR--------TFREIMF 59
Query: 54 LRKL-NHSNIVKLKELI--QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQV 110
L++L +H NIVKL +I +N+ +YLVFE ME +L+ ++ A + + + ++Q+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA---NILEDVHKRYIMYQL 116
Query: 111 FQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAR------EIKSGPPYTNYVGSR 163
+ L Y+H HRDLKP N+L+ S +K+ADFGLAR E P T+YV +R
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
WYRAPEILL S Y+ DMW++G I+ E+ PLFPG S +Q+ KI V+G P+ +
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE- 235
Query: 224 WADGLRQARAIKYQF--------PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA 275
+IK F P PR L L+P AS DA+ L + L ++P+KR TA
Sbjct: 236 ------DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289
Query: 276 AEALQHPFFKRCFYAP 291
EAL+HP+ + F+ P
Sbjct: 290 EEALEHPYVAQ-FHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 1e-78
Identities = 107/288 (37%), Positives = 167/288 (57%), Gaps = 18/288 (6%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKL---NHSNI 62
E+G GA+G V++A D +TG VA+K+++ + E+ + LRE+ L++L H NI
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNI 63
Query: 63 VKLKELIQNNNR-----LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
V+L ++ L LVFE ++ +L ++ + IK + Q+ +G+ ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H + HRDLKP+N+LV+ G +KIADFGLAR T+ V + WYRAPE+LLQS
Sbjct: 124 HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS- 182
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y++ DMW++G I AELF PLF G SEADQ+ KI V+G P+ + W R +
Sbjct: 183 YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP---RNVSLPRS 239
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP + + +P ++ + L + + +++P KR +A EALQHP+F
Sbjct: 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 2e-78
Identities = 119/283 (42%), Positives = 176/283 (62%), Gaps = 10/283 (3%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+++G G +G V++A ++ TGE VA+K+++ + E + +RE+ L++LNH NIVKL
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKL 64
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
++I N+LYLVFE + +L + M A P IK++LFQ+ QGL++ H + HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 126 DLKPENLLV-SQGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKA 181
DLKP+NLL+ ++G IK+ADFGLAR G P YT+ V + WYRAPEILL + YS+
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D+W++G I AE+ T LFPG SE DQ+++I LG+P W G+ K FP+
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSLPDYKPSFPKW 241
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
R + S ++P +D L + +DP+KR +A AL HPFF
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-77
Identities = 110/299 (36%), Positives = 167/299 (55%), Gaps = 26/299 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCL-NLREVKCLRK 56
+Y +G GA+G V A + TG VAIK++ Q + C LRE+K LR+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF-----CQRTLREIKILRR 59
Query: 57 LNHSNIVKLKELIQ-----NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
H NI+ + ++I+ + N +Y+V E ME +LY+L+ + S I+ +L+Q+
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLYQIL 116
Query: 112 QGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY----TNYVGSRWYR 166
+GL Y+H HRDLKP NLL++ +KI DFGLAR + T YV +RWYR
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
APEI+L S+ Y+ D+W++G I+AE+ + PLFPG Q+ I GVLG+P+ + +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL-N 235
Query: 227 GLRQARAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ RA Y P P+ + L P+A A+ L + + +++P KR T EAL HP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-76
Identities = 110/286 (38%), Positives = 170/286 (59%), Gaps = 8/286 (2%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
+ ++LG G + V++ + TGE VA+KE+ +RE+ +++L H NIV
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L ++I N+L LVFE M+ +L + M R +K++ +Q+ +G+++ H+N
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYS 178
HRDLKP+NLL+++ G +K+ADFGLAR G P ++N V + WYRAP++LL S YS
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+ D+W++G IMAE+ T PLFPG + DQ+ KI ++G+PT +W G+ Q K F
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPEYKPTF 238
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
P+ P +L L P A I L L +P R +A +ALQHP+F
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 2e-75
Identities = 114/299 (38%), Positives = 181/299 (60%), Gaps = 25/299 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED----CLNLREVKCLRK 56
MD+Y +++G G +G V++A D T E +A+K+++ ED +RE+ L++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMA-----ARDRKLFSEPEIKAWLFQVF 111
+ H NIV+L++++ + RLYLVFE ++ +L + M A++ +L IK +L+Q+
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL-----IKTYLYQIL 112
Query: 112 QGLSYMHQNGFFHRDLKPENLLV--SQGIIKIADFGLAREIKSGPP---YTNYVGSRWYR 166
+G++Y H + HRDLKP+NLL+ +K+ADFGLAR G P +T+ V + WYR
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYR 170
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
APEILL S YS+ D+W++G I AE+ PLFPG SE D+++KI +LG+P ++W
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP- 229
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
G+ K FP+ P +L+ ++P+ + L + DPSKR TA AL+H +FK
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 4e-75
Identities = 104/298 (34%), Positives = 163/298 (54%), Gaps = 16/298 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC-LNLREVKCLRKLNHS 60
+Y + +G GA+G V A D +G+ VAIK++ + LRE+K LR H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 61 NIVKLKELIQNNNRL----YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
NI+ ++++++ Y+V + ME +L+ ++ + +E I+ +L+Q+ +GL Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHII--HSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-----YTNYVGSRWYRAPEI 170
+H HRDLKP NLLV++ ++I DFG+AR + S P T YV +RWYRAPE+
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
LL Y++ DMW++G I AE+ LFPG + Q+ I VLGSP+ + + +
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE-VLNRIGS 241
Query: 231 ARAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
R KY P+ S + P AS +A+ L + +DP +R T +ALQHPF +
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 8e-75
Identities = 120/311 (38%), Positives = 176/311 (56%), Gaps = 18/311 (5%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHSN 61
KY K +GRGA+G V A + T E VAIK++ + + D LRE+K LR L+H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 62 IVKLKELIQNNNR-----LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
++ +K+++ +R +Y+V+E M+ +L+Q++ R + S+ + +L+Q+ +GL Y
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQII--RSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 117 MHQNGFFHRDLKPENLLVSQGI-IKIADFGLAR-EIKSGPPYTNYVGSRWYRAPEILLQS 174
+H HRDLKP NLL++ +KI DFGLAR + G T YV +RWYRAPE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y++ D+W++G I AEL PLFPG Q+ I +LGSP+ + +R +A
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS-EEDLGFIRNEKAR 242
Query: 235 KY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
+Y P PR + + L P A+ AI L E + +DPSKR T EAL HP+ A
Sbjct: 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL-----ASL 297
Query: 293 HIRSTPAVATT 303
H S V T
Sbjct: 298 HDPSDEPVCQT 308
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 1e-74
Identities = 113/283 (39%), Positives = 158/283 (55%), Gaps = 10/283 (3%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKLNHSNIVKLK 66
+G G +G V++A D +GE VA+K K R + D + +LRE+ L L H NIV+LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK--KVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 67 ELIQNN--NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
E++ + ++LV E E +L L+ FSE ++K + Q+ +GL Y+H+N H
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP-FSESQVKCLMLQLLRGLQYLHENFIIH 131
Query: 125 RDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNYVGSRWYRAPEILLQSELYSSKAD 182
RDLK NLL++ G +KIADFGLAR P T V + WYRAPE+LL Y++ D
Sbjct: 132 RDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAID 191
Query: 183 MWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
MWA+G I+AEL PL PG SE +Q+ I +LG+P W K+ P+ P
Sbjct: 192 MWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQP 251
Query: 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
NL P S+ + L L +DP KR TA EAL+ +FK
Sbjct: 252 YNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-73
Identities = 112/290 (38%), Positives = 184/290 (63%), Gaps = 13/290 (4%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKLNH 59
Y+ +++G G +G V++ ++ TG+ VA+K K R S E+ + +RE+ L++L H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK--KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPE-IKAWLFQVFQGLSYMH 118
NIV L++++ +RLYL+FE + +L + + + + + + E +K++L+Q+ QG+ + H
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQS 174
HRDLKP+NLL+ ++G+IK+ADFGLAR G P YT+ V + WYRAPE+LL S
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
YS+ D+W++G I AE+ T PLF G SE DQ+++I +LG+PT D W G+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP-GVTSLPDY 235
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
K FP+ + +L + + + +D + L E + +DP+KR +A +AL HP+F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 6e-71
Identities = 109/307 (35%), Positives = 164/307 (53%), Gaps = 31/307 (10%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKLNHS 60
Y +LG G FG V++A TG VA+K++ +D LRE+K L+KL H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHP 67
Query: 61 NIVKLKELI--------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
N+V L ++ + +Y+V M+ +L L+ KL +E +IK ++ Q+ +
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL-TESQIKCYMLQLLE 126
Query: 113 GLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP------------YTNY 159
G++Y+H+N HRD+K N+L+ QGI+KIADFGLAR PP YTN
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSP 219
V +RWYR PE+LL Y++ D+W +G + AE+FT P+ G S+ DQ++ I + G+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 220 TMDSW--ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE 277
T ++W L + F PR L + + L L S DP KR TA++
Sbjct: 247 TEETWPGWRSLPGCEG-VHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304
Query: 278 ALQHPFF 284
AL+HP+F
Sbjct: 305 ALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 2e-70
Identities = 114/301 (37%), Positives = 182/301 (60%), Gaps = 25/301 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKLN 58
D Y +++G G +G+V++A D++TG+ VA+K K R E+ + LRE+ L+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLS 58
Query: 59 HSN-IVKL---KELIQNNNR--LYLVFECMECNLYQLMAARDRKL---FSEPEIKAWLFQ 109
S IV+L + + + N + LYLVFE ++ +L + M + R IK++++Q
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLV--SQGIIKIADFGLARE----IKSGPPYTNYVGSR 163
+ +G+++ H++G HRDLKP+NLLV +G++KIAD GL R +KS YT+ + +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS---YTHEIVTL 175
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
WYRAPE+LL S YS+ D+W++G I AE+ PLFPG SE Q+ I +LG+PT
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
W G+ + R ++FPQ +LS +P S + + L + + +DP+KR +A AL HP+
Sbjct: 236 WP-GVSKLRDW-HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 284 F 284
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 5e-69
Identities = 112/290 (38%), Positives = 166/290 (57%), Gaps = 8/290 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
++ Y +LG G++ V++ + TG+ VA+KE++ + +RE L+ L H+
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV L ++I L LVFE ++ +L Q M L S ++ +LFQ+ +GL+Y HQ
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGL-SMHNVRLFLFQLLRGLAYCHQR 122
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSELY 177
HRDLKP+NLL+S +G +K+ADFGLAR KS P Y+N V + WYR P++LL S Y
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSWADGLRQARAIKY 236
S+ DMW +G I E+ T PLFPG+++ DQ++KI VLG+PT ++W Y
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241
Query: 237 QFPQLPRANLSALMPSASQ--DAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP P L P + L ++P KR +AAEA++HP+F
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 3e-68
Identities = 104/318 (32%), Positives = 155/318 (48%), Gaps = 40/318 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLN 58
+ G +GRG +GRV++A + G+ AIK+ K + RE+ LR+L
Sbjct: 3 EIEGC--IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 59 HSNIVKLKELIQNNN--RLYLVFECMECNLYQLM---AARDRKLFSEPEIKAWLFQVFQG 113
H N+V L E+ + +YL+F+ E +L+Q++ R +K+ L+Q+ G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 114 LSYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKS--GPPYT--NYVGSRW 164
+ Y+H N HRDLKP N+LV +G++KI D GLAR + P V + W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 165 YRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKICGV 215
YRAPE+LL + Y+ D+WA+G I AEL T P+F G DQ+ +I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 216 LGSPTMDSWAD---------GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCS 266
LG+PT W D ++ + Y L + P + L L
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS--QGFDLLRKLLE 298
Query: 267 WDPSKRPTAAEALQHPFF 284
+DP+KR TA EAL+HP+F
Sbjct: 299 YDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 109/298 (36%), Positives = 164/298 (55%), Gaps = 24/298 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
D+Y +G GA+G+V AFD TG VAIK+L + + S RE++ L+ ++H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 61 NIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L +++ +YLV M +L ++ + +KL S+ I+ ++Q+ +GL
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKL-SDDHIQFLVYQILRGL 131
Query: 115 SYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRDLKP N+ V++ +KI DFGLAR T YV +RWYRAPEI+L
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLN 189
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT------MDSWADG 227
Y+ D+W++G IMAEL T LFPG+ DQ+ +I ++G+P + S +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES-- 247
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
AR PQ+P+ + + A+ AI L E + DP KR TAAEAL HP+
Sbjct: 248 ---ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 86/188 (45%), Positives = 118/188 (62%), Gaps = 5/188 (2%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
LG G FG V+ A D+ TG+ VAIK +K+ +S LRE++ L+KLNH NIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 70 QNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLK 128
++ N LYLV E E +L L+ + KL SE EI L Q+ +GL Y+H NG HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKL-SEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 129 PENLLVS--QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADMWA 185
PEN+L+ G +K+ADFGL++ + S VG+ Y APE+LL YS K+D+W+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 186 MGAIMAEL 193
+G I+ EL
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 1e-65
Identities = 113/292 (38%), Positives = 168/292 (57%), Gaps = 21/292 (7%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVKLKEL 68
+G+G++G V A D HTGE VAIK++ + D LRE+K LR L H +IV++K +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 69 IQNNNR-----LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+ +R +Y+VFE ME +L+Q++ A D + + +L+Q+ + L Y+H F
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVF 125
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAR-EIKSGPP---YTNYVGSRWYRAPEILLQSEL-- 176
HRDLKP+N+L + +KI DFGLAR P +T+YV +RWYRAPE L S
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSK 184
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y+ D+W++G I AE+ T PLFPG + Q+ I +LG+P+ ++ +R +A +Y
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET-ISRVRNEKARRY 243
Query: 237 ---QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ P S P+A A+ L E L ++DP RPTA EAL P+FK
Sbjct: 244 LSSMRKKQPVP-FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 3e-65
Identities = 109/292 (37%), Positives = 166/292 (56%), Gaps = 19/292 (6%)
Query: 8 KELGRGAFGRVFQAFDEHT--GEAVAIKELKQRYASWEDCLN-LREVKCLRKL-NHSNIV 63
KELG+GA+G V A + T E VAIK++ ++ LRE+K LR H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 64 KLKEL----IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
L ++ N N LYL E ME +L+Q++ R + ++ +++++Q+ GL Y+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILCGLKYIHS 123
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGP----PY-TNYVGSRWYRAPEILLQ 173
HRDLKP NLLV + +KI DFGLAR P + T YV +RWYRAPEI+L
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
+ Y+ D+W++G I+AEL P+F G DQ+ +I VLG+P ++ + + +A
Sbjct: 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR-IGSPKA 242
Query: 234 IKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
Y P +P+ ++ P+A+ A+ L E L ++DP+KR + EAL+HP+
Sbjct: 243 QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 5e-65
Identities = 105/293 (35%), Positives = 164/293 (55%), Gaps = 17/293 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
+KY ++G G++G VF+ + TG+ VAIK ++ ED LRE++ L++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQ 56
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
L H N+V L E+ + +L+LVFE + + + R + E IK ++Q Q +++
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNF 115
Query: 117 MHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQ 173
H++ HRD+KPEN+L++ QG IK+ DFG AR I +GP YT+YV +RWYRAPE+L+
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS--PTMDSWADGLRQA 231
Y D+WA+G + AEL T PL+PG S+ DQ+Y I LG P +
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ + P+ R L + P+ S A+S + DP++R + E L+HP+F
Sbjct: 235 KGLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 2e-64
Identities = 110/309 (35%), Positives = 170/309 (55%), Gaps = 37/309 (11%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLN------------LREVKCL 54
LG G +G+V +A+D TG+ VAIK++K ++ LRE+K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 55 RKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
++ H NI+ L ++ + + LV + M +L +++ + R +E ++K L Q+ GL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--LTESQVKCILLQILNGL 132
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAR---------------EIKSGPPYTN 158
+ +H+ F HRDL P N+ + S+GI KIADFGLAR ++ T+
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218
V + WYRAPE+L+ +E Y DMW++G I AEL T PLFPG +E DQ+ +I +LG+
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252
Query: 219 PTMDSWADGLRQARAIKYQFPQLPRA--NLSALMPSASQDAISLFESLCSWDPSKRPTAA 276
P D+W QA+ + PR +L + P+AS DAI L +SL +P +R +A
Sbjct: 253 PNEDNWP----QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308
Query: 277 EALQHPFFK 285
EAL+H +FK
Sbjct: 309 EALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 3e-64
Identities = 106/300 (35%), Positives = 153/300 (51%), Gaps = 18/300 (6%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKE-LKQRYASWEDCLNLREVKCLRKLNHS 60
KY ++G+G FG VF+A + T + VA+K+ L + LRE+K L+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 61 NIVKLKELI------QNNNR--LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
N+V L E+ N + YLVFE E +L L++ ++ K F+ EIK + +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMKMLLN 130
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAR-----EIKSGPPYTNYVGSRWYR 166
GL Y+H+N HRD+K N+L+++ GI+K+ADFGLAR + YTN V + WYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
PE+LL Y DMW G IMAE++T P+ G +E Q+ I + GS T + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 227 GLRQARAIKYQFP--QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ K + P Q + A+ L + L DP+KR A AL H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 6e-64
Identities = 108/289 (37%), Positives = 163/289 (56%), Gaps = 9/289 (3%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
++ Y +LG G + VF+ + T VA+KE++ + C +REV L+ L H+
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMH 118
NIV L ++I L LVFE ++ +L Q + D L S +K ++FQ+ +GLSY H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 119 QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSE 175
+ HRDLKP+NLL+++ G +K+ADFGLAR KS P Y+N V + WYR P++LL S
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
YS+ DMW +G I+ E+ T P+FPG++ ++++ I +LG+PT ++W
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
Y FPQ L P D I L SL ++ R +A AL+H +F
Sbjct: 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 9e-64
Identities = 104/293 (35%), Positives = 169/293 (57%), Gaps = 20/293 (6%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED------CLNLREVKCLRK 56
KY +++G G +G VF+A + T E VA+K + +D LRE+ L++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKE 55
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
L H NIV+L +++ ++ +L LVFE + +L + + + + +K+++FQ+ +GL++
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILL 172
H + HRDLKP+NLL+++ G +K+ADFGLAR G P Y+ V + WYR P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLF 172
Query: 173 QSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
++LYS+ DMW+ G I AEL PLFPG DQ+ +I +LG+PT +SW G+ +
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP-GVSKL 231
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
K +L ++P + L ++L +P +R +A EALQHP+F
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 103/298 (34%), Positives = 163/298 (54%), Gaps = 27/298 (9%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC----LNLREVKCLRKL 57
+KY +G G++G V + + TG+ VAIK+ S +D + +RE++ L++L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQL 57
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H N+V L E+ + RLYLVFE ++ + + L E ++ +LFQ+ +G+ +
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGIEFC 116
Query: 118 HQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSE 175
H + HRD+KPEN+LVSQ G++K+ DFG AR + + G YT+YV +RWYRAPE+L+
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y D+WA+G ++ E+ T PLFPG S+ DQ+Y I LG+ + + + I
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL--------IPRHQEIF 228
Query: 236 YQFP-----QLPRA----NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ P +LP L P S + L + DP RP++++ L H FF
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 6e-63
Identities = 114/313 (36%), Positives = 171/313 (54%), Gaps = 47/313 (15%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKL 57
+DK+ ++G G +G+V++A D+ TGE VA+K K R + ++ +RE+K LR+L
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKILRQL 63
Query: 58 NHSNIVKLKELI----------QNNNRLYLVFECMECNLYQLMAARDRKL--FSEPEIKA 105
NH NIV LKE++ ++ YLVFE M+ +L L+ + L FSE IK+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKS 120
Query: 106 WLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR--EIKSGPPYTNYVGS 162
++ Q+ +GL+Y H+ F HRD+K N+L++ +G IK+ADFGLAR + PYTN V +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222
WYR PE+LL E Y D+W+ G I+ ELFT P+F E Q+ I + GSP
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 223 SWADGLR------------QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS 270
W D ++ R ++ +F +P A+ L + + + DPS
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPT------------PALDLLDHMLTLDPS 288
Query: 271 KRPTAAEALQHPF 283
KR TA EAL P+
Sbjct: 289 KRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 1e-61
Identities = 111/312 (35%), Positives = 169/312 (54%), Gaps = 24/312 (7%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
++Y + +G GAFG V A D+ TG+ VAIK++ + +++ RE+K L+ L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 61 NIVKLKEL-IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPE-IKAWLFQVFQGLSYMH 118
NI+ L ++ I +Y V E + +L++L+ +R E + I+ +L+Q+ +GL Y+H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPL----EKQFIQYFLYQILRGLKYVH 125
Query: 119 QNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
G HRDLKP N+L+++ +KI DFGLAR P T YV +R+YRAPEI+L + Y
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD-----SWADGLRQAR 232
+ D+W+ G I AE+ PLFPG +Q I +LG+P D + LR +
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
++ P+ S +A AI L E + +DP KR +AAEAL HP+ AP
Sbjct: 244 SL----PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL-----APY 294
Query: 293 HIRSTPAVATTT 304
H + VA
Sbjct: 295 HDPTDEPVAEEK 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 6e-61
Identities = 91/287 (31%), Positives = 138/287 (48%), Gaps = 42/287 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKL 65
+ LGRG+FG V+ A D+ TGE +A+K ++ S E + L RE++ L L H NIV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREIRILSSLQHPNIVRY 64
Query: 66 K--ELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
E + N L + E + +L L+ + EP I+ + Q+ +GL+Y+H NG
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN---YVGSRWYRAPEILLQSELYS 178
HRD+K N+LV G++K+ADFG A+ + G+ ++ APE++ E Y
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YG 181
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWADGLRQARAIKYQ 237
AD+W++G + E+ T P + +YKI G G P
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI-GSSGEP------------------ 222
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
P++P S++A DP KRPTA E LQHPF
Sbjct: 223 -PEIP--------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 106/287 (36%), Positives = 163/287 (56%), Gaps = 5/287 (1%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
++ Y +LG G + V++ + T VA+KE++ + C +REV L+ L H+
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV L ++I L LVFE ++ +L Q + + +K +LFQ+ +GL+Y H+
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 121 GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSELY 177
HRDLKP+NLL+++ G +K+ADFGLAR KS P Y+N V + WYR P+ILL S Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S++ DMW +G I E+ T PLFPG++ +Q++ I +LG+PT ++W L Y
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+P+ L P D L L ++ KR +A EA++HP+F
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 1e-59
Identities = 106/289 (36%), Positives = 168/289 (58%), Gaps = 7/289 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M+ Y ++LG G + VF+ + T VA+KE++ + C +REV L+ L H+
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV L +++ + L LVFE ++ +L Q M + S +K +L+Q+ +GL+Y H+
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 121 GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSELY 177
HRDLKP+NLL+++ G +K+ADFGLAR KS P Y+N V + WYR P++LL S Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK-Y 236
S++ DMW +G I E+ + PLFPG++ D+++ I +LG+PT ++W G+ K Y
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP-GISSNDEFKNY 241
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
FP+ L P + I L ++ KR +A EA++H +F+
Sbjct: 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 2e-59
Identities = 109/292 (37%), Positives = 157/292 (53%), Gaps = 17/292 (5%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+Y+ K++G GA+G V A D+ TGE VAIK+L + + S RE+ L+ + H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 62 IVKLKEL------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
++ L ++ YLV M+ +L ++M SE +++ ++Q+ GL
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP----LSEDKVQYLVYQMLCGLK 131
Query: 116 YMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
Y+H G HRDLKP NL V++ +KI DFGLAR + T YV +RWYRAPE++L
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNW 189
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y+ D+W++G IMAE+ T LF G DQ+ +I V G P + L A
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-PEFVQKLEDKAAK 248
Query: 235 KY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
Y P+ PR + S L P AS A+ L E + D KR TA EAL+HP+F
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 1e-58
Identities = 99/311 (31%), Positives = 154/311 (49%), Gaps = 38/311 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN----LREVKCLRKLN 58
+Y + LG G+ G VF A D + VA+K++ D + LRE+K +R+L+
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRLD 60
Query: 59 HSNIVKLKELIQNNNR--------------LYLVFECMECNLYQLMAARDRKLFSEPEIK 104
H NIVK+ E++ + +Y+V E ME +L ++ ++ SE +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL---EQGPLSEEHAR 117
Query: 105 AWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG--IIKIADFGLAREIKSGPPYTNY--- 159
+++Q+ +GL Y+H HRDLKP N+ ++ ++KI DFGLAR + + Y
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 160 -VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218
+ ++WYR+P +LL Y+ DMWA G I AE+ T PLF GA E +QM I L S
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI---LES 234
Query: 219 PTMDSWADGLRQARAIKYQFPQ---LPRANLSALMPSASQDAISLFESLCSWDPSKRPTA 275
+ D I PR L L+P + +A+ E + +++P R TA
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
Query: 276 AEALQHPFFKR 286
EAL HP+
Sbjct: 295 EEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 2e-57
Identities = 111/296 (37%), Positives = 170/296 (57%), Gaps = 20/296 (6%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKLN 58
D+Y K++G GA+G V A D TG VAIK+L + + S + RE++ L+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMK 72
Query: 59 HSNIVKLKELIQNNNRL------YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
H N++ L ++ + L YLV M +L +LM + KL SE I+ ++Q+ +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM--KHEKL-SEDRIQFLVYQMLK 129
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
GL Y+H G HRDLKP NL V++ +KI DFGLAR+ S T YV +RWYRAPE++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVI 187
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
L Y+ D+W++G IMAE+ T PLF G DQ+ +I V G+P+ + + L+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSE 246
Query: 232 RAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
A Y + P+ + + +L+P+A+ A+++ E + D R TAAEAL HP+F+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-55
Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 36/288 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
KY K++G+G+FG+V+ + G+ +KE+ S ++ + L EVK L+KLNH N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMH 118
I+K E + +L +V E + +L Q + + + K F E +I W Q+ L Y+H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 119 QNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
HRD+KP+N L S G++K+ DFG+++ + S VG+ +Y +PE+ Q++
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL-CQNKP 179
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y+ K+D+W++G ++ EL T F G + + KI +K
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---------------------LKG 218
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
Q+P +P S + +L SL DP +RP+ A+ LQ PF
Sbjct: 219 QYPPIP--------SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 8e-55
Identities = 115/295 (38%), Positives = 165/295 (55%), Gaps = 20/295 (6%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL---REVKCLRKL-- 57
+Y E+G GA+G V++A D H+G VA+K + R + ED L L REV L++L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEA 58
Query: 58 -NHSNIVKLKEL-----IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
+H NIV+L ++ ++ LVFE ++ +L + IK + Q
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
+GL ++H N HRDLKPEN+LV S G +K+ADFGLAR T V + WYRAPE+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
LLQS Y++ DMW++G I AE+F PLF G SEADQ+ KI ++G P D W +
Sbjct: 179 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237
Query: 231 ARAIKYQF-PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
R F P+ PR + +++P + L + +++P KR +A ALQHPFF
Sbjct: 238 PRG---AFSPRGPRP-VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 100/292 (34%), Positives = 160/292 (54%), Gaps = 14/292 (4%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
++Y +G GA+G V A+D + VA+K+L + + S RE++ L+ + H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 61 NIVKLKEL------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ I+N N +YLV M +L ++ + S+ ++ ++Q+ +GL
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK---LSDEHVQFLIYQLLRGL 131
Query: 115 SYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRDLKP N+ V++ ++I DFGLAR+ + T YV +RWYRAPEI+L
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLN 189
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD-GLRQAR 232
Y+ D+W++G IMAEL LFPG DQ+ +I V+G+P+ + AR
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
P +P+ +L + A+ AI L E + D KR +A+EAL HP+F
Sbjct: 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-53
Identities = 86/283 (30%), Positives = 126/283 (44%), Gaps = 41/283 (14%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLKE 67
LG+G+FG+V + TG+ A+K LK++ + L E L ++NH IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 68 LIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q +LYLV E L+ + FSE + + ++ L Y+H G +RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 127 LKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADMW 184
LKPEN+L+ + G IK+ DFGLA+E+ S TN + G+ Y APE+LL Y D W
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWW 177
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
++G ++ E+ T P F ++Y I + P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRK-EIY---------------------EKILKDPLRFP-- 213
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAAEA---LQHPFF 284
S +A L L DP+KR + A HPFF
Sbjct: 214 ------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (459), Expect = 2e-53
Identities = 100/292 (34%), Positives = 156/292 (53%), Gaps = 14/292 (4%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC-LNLREVKCLRKLNHS 60
++Y +G GA+G V AFD TG VA+K+L + + S RE++ L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 61 NIVKLKEL------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ ++ N +YLV M +L ++ + ++ ++ ++Q+ +GL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 133
Query: 115 SYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H HRDLKP NL V++ +KI DFGLAR + T YV +RWYRAPEI+L
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 191
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD-GLRQAR 232
Y+ D+W++G IMAEL T LFPG DQ+ I ++G+P + AR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
Q+P+ N + + A+ A+ L E + D KR TAA+AL H +F
Sbjct: 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 103/289 (35%), Positives = 159/289 (55%), Gaps = 8/289 (2%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHS 60
+K+ +G GA+G V + + T E VAIK+ K + E LRE+K LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV+LKE + +LYLVFE +E N+ +L+ + E +++++++Q+ + + + H+N
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKN 119
Query: 121 GFFHRDLKPENLLVSQG-IIKIADFGLAREIKSG--PPYTNYVGSRWYRAPEILLQSELY 177
HRD+KPENLL+S ++K+ DFG AR + G YT YV +RWYR+PE+LL + Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-Y 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
DMW++G I+ EL PLFPG SE DQ++ I VLG + R +
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238
Query: 238 FPQL--PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
FP + P++ + S + L ++L +P+ R + L HP F
Sbjct: 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 3e-51
Identities = 95/305 (31%), Positives = 136/305 (44%), Gaps = 42/305 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNH-SNIVK 64
++LG G+FG V+ A D VA+K L ++ S E LRE++ L LNH NIVK
Sbjct: 6 RKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 65 LKELIQNNNRLYLVFE-CMECNLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYMHQNGF 122
L + Q+ LYLV E +L L+ RK SE E L Q+ L Y+H G
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI 122
Query: 123 FHRDLKPENLLVSQ--GIIKIADFGLAREIKSG-------PPYTNYVGSRWYRAPEILLQ 173
HRD+KPEN+L+ + ++K+ DFGLA+ + + VG+ Y APE+LL
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 174 SEL--YSSKADMWAMGAIMAELFTFCPLFPG---ASEADQMYKICGVLGSPTMDSWADGL 228
L SS +D+W++G + EL T P F G +S Q KI L +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT---------- 232
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288
P L + S+ A L + L + DP R +++ L H
Sbjct: 233 ----------PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282
Query: 289 YAPPH 293
Sbjct: 283 LKESD 287
|
Length = 384 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 3e-51
Identities = 99/287 (34%), Positives = 157/287 (54%), Gaps = 13/287 (4%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVKLK 66
+ +G GAFG V+ D G+ VA+K++ + + C RE+K L H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 67 ELIQNNN-----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+++Q + +Y+V E M+ +L++++ + S +K +L+Q+ +GL Y+H G
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQP--LSSDHVKVFLYQILRGLKYLHSAG 123
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAR--EIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRD+KP NLLV S ++KI DFGLAR E T V +++YRAPEIL+ S Y+
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
S D+W++G I AEL LF S Q+ I +LG+P++++ ARA +
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 239 PQLP--RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P P L L A+ +A+ L + +DP KR +AA+AL HP+
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-49
Identities = 102/288 (35%), Positives = 151/288 (52%), Gaps = 10/288 (3%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
Y ++LG G++ V++ G+ VA+K + + +RE L+ L H+NIV
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L ++I L VFE M +L Q M L ++ ++FQ+ +GL+Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-NVRLFMFQLLRGLAYIHGQHIL 125
Query: 124 HRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPEILLQSELYSSK 180
HRDLKP+NLL+S G +K+ADFGLAR KS P Y++ V + WYR P++LL + YSS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSWADGLRQARAIKYQ-F 238
D+W G I E+ P FPG S+ +Q+ KI VLG PT D+W G+ + K + F
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP-GVSKLPNYKPEWF 243
Query: 239 PQLPRANLSALMPSASQ--DAISLFESLCSWDPSKRPTAAEALQHPFF 284
L + S+ A L + P R +A +AL HP+F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 82/283 (28%), Positives = 144/283 (50%), Gaps = 42/283 (14%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKEL---KQRYASWEDCLNLREVKCLRKLNHSNIVKL 65
+GRGAFG V++ + TG+ VAIK++ K + + + + E+ L+ L H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ--EIDLLKNLKHPNIVKY 64
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
I+ ++ LY++ E E +L Q++ F E + +++QV QGL+Y+H+ G H
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 125 RDLKPENLLVSQ-GIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELYSSKAD 182
RD+K N+L ++ G++K+ADFG+A ++ + VG+ ++ APE++ S S+ +D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASD 181
Query: 183 MWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
+W++G + EL T P + + +++I + P LP
Sbjct: 182 IWSLGCTVIELLTGNPPYYDLNPMAALFRIV---------------------QDDHPPLP 220
Query: 243 RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFF 284
+S + F C DP+ RPTA + L+HP+
Sbjct: 221 -EGISP--------ELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 44/289 (15%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
+ +++G+G FG V++A + TG+ VAIK +K + E + E++ L+K H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK--IINEIQILKKCKHPN 58
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IVK + L++V E +L L+ + ++ +E +I ++ +GL Y+H N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN 117
Query: 121 GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
G HRD+K N+L++ G +K+ DFGL+ ++ VG+ ++ APE++ + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDY 176
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY--- 236
KAD+W++G EL A+ P + +A+
Sbjct: 177 KADIWSLGITAIEL------------AEGKP--------PYSELPPM-----KALFKIAT 211
Query: 237 -QFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPF 283
P L P D F C +P KRPTA + L+HPF
Sbjct: 212 NGPPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-49
Identities = 105/295 (35%), Positives = 159/295 (53%), Gaps = 19/295 (6%)
Query: 3 KYSGFKELGRGAFGRVFQAFD-EHTGEAVAIKELKQRYASWEDCLNL---REVKCLRKLN 58
+Y E+G GA+G+VF+A D ++ G VA+K + R + E+ + L REV LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLE 59
Query: 59 ---HSNIVKLKEL-----IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQV 110
H N+V+L ++ +L LVFE ++ +L + IK +FQ+
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 111 FQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+GL ++H + HRDLKP+N+LV S G IK+ADFGLAR T+ V + WYRAPE
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+LLQS Y++ D+W++G I AE+F PLF G+S+ DQ+ KI V+G P + W +
Sbjct: 180 VLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
R F + + + L +++P+KR +A AL HP+F
Sbjct: 239 LPRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 106/289 (36%), Positives = 149/289 (51%), Gaps = 8/289 (2%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D Y ++LG G++ V++ + G+ VA+K ++ + +RE L+ L H+N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IV L ++I L LVFE + +L Q M L E +K +LFQ+ +GLSY+HQ
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE-NVKLFLFQLLRGLSYIHQRY 123
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSELYS 178
HRDLKP+NLL+S G +K+ADFGLAR KS P Y+N V + WYR P++LL S YS
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASE-ADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ DMW +G I E+ FPG + DQ+ +I VLG+P D+W +
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242
Query: 238 FPQLPRANLSALMPSAS--QDAISLFESLCSWDPSKRPTAAEALQHPFF 284
F NL S A L L P R +A AL H +F
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 108/330 (32%), Positives = 156/330 (47%), Gaps = 53/330 (16%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----------KQRYASWEDCLNLREVK 52
+Y K +G GA G V A+D TG+ VAIK+L K+ Y RE+
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY---------RELV 67
Query: 53 CLRKLNHSNIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAW 106
++ +NH NI+ L ++ ++ +YLV E M+ NL Q++ L E +
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHE-RMSYL 123
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
L+Q+ G+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+Y
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
RAPE++L Y D+W++G IM E+ LFPG DQ KI LG+P+ D +
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS-DEFM 241
Query: 226 DGL-------------RQARAIKYQFPQ--LPRANLSALMPSASQDAISLFESLCSWDPS 270
L + + FP P + S ASQ A L + DP
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQ-ARDLLSKMLVIDPE 300
Query: 271 KRPTAAEALQHPFFKRCF-----YAPPHIR 295
KR + +ALQHP+ + APP
Sbjct: 301 KRISVDDALQHPYINVWYDPSEVEAPPPAP 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 102/308 (33%), Positives = 162/308 (52%), Gaps = 28/308 (9%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQ--RYASWEDCLNLREVKCLRKLNHSNIVKLK- 66
+G G+FG V++A T E VAIK++ Q +Y + RE+ ++ LNH NI+ LK
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHINIIFLKD 126
Query: 67 ----ELIQNNNR---LYLVFECMECNLYQLMAARDRKLFSEPE--IKAWLFQVFQGLSYM 117
E + N + L +V E + +++ M R + P +K + +Q+ + L+Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 118 HQNGFFHRDLKPENLLVSQGI--IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
H HRDLKP+NLL+ +K+ DFG A+ + +G +Y+ SR+YRAPE++L +
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y++ D+W++G I+AE+ P+F G S DQ+ +I VLG+PT D + IK
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306
Query: 236 YQFPQLPRANLSALMPSAS-QDAISLFESLCSWDPSKRPTAAEALQHPFFKR----CFYA 290
FP + +L + P + DAI+ ++P KR EAL PFF C
Sbjct: 307 --FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKL 364
Query: 291 PPHIRSTP 298
P +I P
Sbjct: 365 PKYIDKLP 372
|
Length = 440 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-45
Identities = 86/308 (27%), Positives = 126/308 (40%), Gaps = 63/308 (20%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN-HSNIV 63
K +G G+F V A ++ T + AIK L +R E + E + L +LN H I+
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
KL Q+ LY V E L Q + R E + + ++ L Y+H G
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLHSKGI 123
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAR----------------EIKSGPPY-----TNYV 160
HRDLKPEN+L+ + IKI DFG A+ I S ++V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT 220
G+ Y +PE+L + +D+WA+G I+ ++ T P F G++E Y
Sbjct: 184 GTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT-------- 230
Query: 221 MDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA----A 276
++ ++Y FP P+ DA L E L DP R
Sbjct: 231 -------FQKILKLEYSFP-----------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYD 272
Query: 277 EALQHPFF 284
E HPFF
Sbjct: 273 ELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 6e-43
Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 43/284 (15%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNI 62
K+LG GAFG V++ + VA+K LK+ AS + LRE + +RKL+H NI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE-DASEQQIEEFLREARIMRKLDHPNI 63
Query: 63 VKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
VKL + L +V E M +L + K S ++ ++ Q+ +G+ Y+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 122 FFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS---RWYRAPEILLQSELY 177
F HRDL N LV + ++KI+DFGL+R++ Y G RW APE L + + +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEGK-F 181
Query: 178 SSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+SK+D+W+ G ++ E+FT +PG S A+ + + G R
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------------KKGYR------- 222
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
LP+ P+ + L + DP RPT +E ++
Sbjct: 223 ----LPK------PPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 90/288 (31%), Positives = 133/288 (46%), Gaps = 40/288 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
K LG+G+ G V++ + TG+ A+K++ LRE+K LR +VK
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHR 125
+ +V E M+ +L L+ + EP + Q+ +GL Y+H HR
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 126 DLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADM 183
D+KP NLL+ S+G +KIADFG+++ +++ N +VG+ Y +PE +Q E YS AD+
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADI 183
Query: 184 WAMGAIMAELFT-FCPLFP--GASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
W++G + E P P S + M IC G P P
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICD--GPP-------------------PS 222
Query: 241 LPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
LP S + F S C DP KRP+AAE LQHPF K+
Sbjct: 223 LPAEE-------FSPEFRD-FISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 46/285 (16%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K+LG GAFG V++ VA+K LK+ + + LRE + +RKL+H N+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 64 KLKELIQNNNRLYLVFECME---CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
KL + LY+V E ME Y L R + S ++ ++ Q+ +G+ Y+
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSY-LRKNRPK--LSLSDLLSFALQIARGMEYLESK 121
Query: 121 GFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS---RWYRAPEILLQSEL 176
F HRDL N LV + ++KI+DFGL+R++ Y G RW APE L + +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEGK- 179
Query: 177 YSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
++SK+D+W+ G ++ E+FT +PG S + + + +G R
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------------KNGYR------ 221
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
LP+ P+ + L + DP RPT +E ++
Sbjct: 222 -----LPQ------PPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 7e-42
Identities = 86/283 (30%), Positives = 129/283 (45%), Gaps = 47/283 (16%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K+LG GAFG V++ E T VA+K LK+ + E L E ++KL+H NIV
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L + LY+V E M +L + KL + ++ Q+ +G+ Y+ F
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESKNF 123
Query: 123 FHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
HRDL N LV+ ++KI+DFGL+R+I Y G +W APE L + +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLKDGK-F 181
Query: 178 SSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+SK+D+W+ G ++ E+FT +PG S + + + DG R R
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL------------EDGYRLPR---- 225
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSW--DPSKRPTAAE 277
P+ L LM C W DP RPT +E
Sbjct: 226 --PENCPDELYELM------------LQC-WAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 47/292 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLKE 67
+ +GA+GRVF A + TG+ AIK +K+ ++ ++ L E L + +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 68 LIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q LYLV E + +L L+ + E + ++ ++ L Y+H NG HRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 127 LKPENLLV-SQGIIKIADFGLA------REIKSGPPYTN---YVGSRWYRAPEILLQSEL 176
LKP+N+L+ S G +K+ DFGL+ R+I VG+ Y APE++L +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL-GQG 177
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+S D W++G I+ E P F G + + I K
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL-------------------NGKI 218
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA---EALQHPFFK 285
++P+ S +AI L L DP KR A E HPFFK
Sbjct: 219 EWPED---------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 99/318 (31%), Positives = 149/318 (46%), Gaps = 26/318 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
+ +Y K +G GA G V AFD G VA+K+L + + + RE+ L+ +NH
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 60 SNIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI+ L ++ ++ +YLV E M+ NL Q++ + L+Q+ G
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME----LDHERMSYLLYQMLCG 135
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y D+W++G IM EL +F G DQ K+ LG+P+ + R
Sbjct: 196 GMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 233 AIKYQFPQLPRANLSALMPS------------ASQDAISLFESLCSWDPSKRPTAAEALQ 280
PQ P + L P + A L + DP KR + EAL+
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 281 HPFFKRCFYAPPHIRSTP 298
HP+ +Y P + P
Sbjct: 315 HPYI-TVWYDPAEAEAPP 331
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-39
Identities = 101/318 (31%), Positives = 154/318 (48%), Gaps = 26/318 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
+ +Y K +G GA G V A+D VAIK+L + + + RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60 SNIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI+ L ++ ++ +YLV E M+ NL Q++ + L+Q+ G
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 131
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT---MDSWADGLR 229
Y D+W++G IM E+ LFPG DQ K+ LG+P M +R
Sbjct: 192 GMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 230 Q--ARAIKYQFPQLPRANLSALMPSASQ-------DAISLFESLCSWDPSKRPTAAEALQ 280
KY P+ +L P+ S+ A L + DP+KR + EALQ
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 281 HPFFKRCFYAPPHIRSTP 298
HP+ +Y P + + P
Sbjct: 311 HPYIN-VWYDPAEVEAPP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKE--LKQRYASWEDCLNL--REVKCLRKLNHSNIVKL 65
LG G+FG V++ + G+ A+KE L + ++ + +E+ L KL H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ + LY+ E + +L +L+ + F EP I+ + Q+ GL Y+H H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 125 RDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADM 183
RD+K N+LV + G++K+ADFG+A+++ ++ GS ++ APE++ Q Y AD+
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W++G + E+ T P + ++KI G +LP
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRS-------------------KELP- 221
Query: 244 ANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPF 283
+P D F C DPS RPTAAE L+HPF
Sbjct: 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 6e-39
Identities = 102/320 (31%), Positives = 167/320 (52%), Gaps = 43/320 (13%)
Query: 3 KYSGFKELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+Y G K +GRG +G V++A D + A+K+++ S C RE+ LR+L H
Sbjct: 3 EYEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC---REIALLRELKHP 58
Query: 61 NIVKLKE--LIQNNNRLYLVFECMECNLYQLM-----AARDRKLFSEPE--IKAWLFQVF 111
N++ L++ L ++ +++L+F+ E +L+ ++ + ++K P +K+ L+Q+
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-----SQGIIKIADFGLAREIKSG-PPYTNY---VGS 162
G+ Y+H N HRDLKP N+LV +G +KIAD G AR S P + V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKIC 213
WYRAPE+LL + Y+ D+WA+G I AEL T P+F E DQ+ +I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 214 GVLGSPTMDSWAD--GLRQARAIKYQFPQLPRANLSALMPSASQDAIS-------LFESL 264
V+G P W D + + ++ F + AN S+L+ + + L + L
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYAN-SSLIKYMEKHKVKPDSKVFLLLQKL 297
Query: 265 CSWDPSKRPTAAEALQHPFF 284
+ DP+KR T+ +ALQ P+F
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ Y +++G GA G V++A D TG+ VAIK+++ R + E L + E+ ++ H N
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE--LIINEILIMKDCKHPN 76
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IV + + L++V E M+ + ++ +EP+I +V QGL Y+H
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSS 179
HRD+K +N+L+S+ G +K+ADFG A ++ N VG+ ++ APE++ + + Y
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGP 195
Query: 180 KADMWAMGAI---MAE----LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
K D+W++G + MAE PL A ++ I
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPL-----RA--LFLI--------TTKGI------- 233
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
P L S + DP KRP+A E LQHPF K+
Sbjct: 234 ------PPLKNPE------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 40/282 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW---EDCLNLREVKCLRKLNHSNIVK 64
K+LG+G++G V++ + A+KE+ S ED +N E++ L +NH NI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN--EIRILASVNHPNIIS 63
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNG 121
KE + N+L +V E +L + ++ R RKL E EI Q+ +GL +H+
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 122 FFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRDLK N+L+ ++KI D G+++ +K T +G+ Y APE+ + YS K
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEV-WKGRPYSYK 181
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
+D+W++G ++ E+ TF P F S D YK+ ++P
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------KYPP 220
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282
+P SQD + S+ P RP + L P
Sbjct: 221 IPPIY--------SQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 86/283 (30%), Positives = 138/283 (48%), Gaps = 45/283 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSNIVKLKEL 68
LG G++G V++A + TG+ VAIK + ED + +E+ L++ + IVK
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 69 IQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
N L++V E C ++ +M ++ L +E EI A L+Q +GL Y+H N HRD+
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKTL-TEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 128 KPENLLVSQ-GIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADMWA 185
K N+L+++ G K+ADFG++ ++ N +G+ ++ APE++ + Y++KAD+W+
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWS 184
Query: 186 MG--AI-MAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
+G AI MAE P + RAI + P P
Sbjct: 185 LGITAIEMAEGKP--PYS--------------------------DIHPMRAI-FMIPNKP 215
Query: 243 RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFF 284
LS P + F C DP +RP+A + LQHPF
Sbjct: 216 PPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 83/294 (28%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSN 61
Y + +G+G+FG V + + G+ + KE+ + ++ L EV LR+L H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 62 IVKL--KELIQNNNRLYLVFE-CMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGLSY 116
IV+ + + ++N LY+V E C +L QL+ ++RK E I L Q+ L
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 117 MH-----QNGFFHRDLKPENL-LVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPE 169
H N HRDLKP N+ L + +K+ DFGLA+ + + YVG+ +Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
L Y K+D+W++G ++ EL P F ++ KI +G
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK------------EG-- 225
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+F ++P S + + +S+ + DP KRP+ E LQ P
Sbjct: 226 -------KFRRIP--------YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 92/295 (31%), Positives = 127/295 (43%), Gaps = 58/295 (19%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIK--------ELKQRYASWEDCLNLREVKCLRKLN 58
K LG G+FGRV + +G+ A+K +LKQ E LN E + L+ +
Sbjct: 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV----EHVLN--EKRILQSIR 59
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H +V L Q+++ LYLV E L+ + R F EP + + QV L Y+
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYL 117
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H +RDLKPENLL+ S G IKI DFG A+ +K YT G+ Y APEI + S+
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT-LCGTPEYLAPEI-ILSKG 174
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADGLRQARAIK 235
Y D WA+G ++ E+ P F Q+Y KI K
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKIL-------------------EGK 214
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+FP S DA L +L D +KR + HP+F
Sbjct: 215 VRFP-----------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 9e-38
Identities = 100/319 (31%), Positives = 159/319 (49%), Gaps = 41/319 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+Y G K +GRG +G V++A D A+K+++ S C RE+ LR+L H
Sbjct: 3 EYEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELKHP 58
Query: 61 NIVKLKE--LIQNNNRLYLVFECMECNLYQLM-----AARDRKLFSEPE--IKAWLFQVF 111
N++ L++ L + +++L+F+ E +L+ ++ + ++K P +K+ L+Q+
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-----SQGIIKIADFGLAREIKSG-PPYTNY---VGS 162
G+ Y+H N HRDLKP N+LV +G +KIAD G AR S P + V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKIC 213
WYRAPE+LL + Y+ D+WA+G I AEL T P+F E DQ+ +I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 214 GVLGSPTMDSWAD--GLRQARAIKYQFPQLPRANLSAL------MPSASQDAISLFESLC 265
V+G P W D + + + F + N S + A L + L
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298
Query: 266 SWDPSKRPTAAEALQHPFF 284
+ DP KR T+ +A+Q P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 83/294 (28%), Positives = 137/294 (46%), Gaps = 54/294 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLR----EVKCLRKLNHSNI 62
++G G FG+V+ A + TGE +A+KE++ Q D ++ E+K L L H N+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLKHPNL 61
Query: 63 VKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
VK + + ++Y+ E C L +L ++ E I+ + Q+ +GL+Y+H +G
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEEL--LEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 122 FFHRDLKPEN-LLVSQGIIKIADFGLAREIKS-----GPPYTNYVGSRWYRAPEILLQSE 175
HRD+KP N L G+IK+ DFG A ++K+ G + G+ Y APE++ +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 176 L--YSSKADMWAMGAIMAELFTFCPLFPGASEADQ----MYKICGVLGSPTMDSWADGLR 229
+ AD+W++G ++ E+ T + SE D M+ + G
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVG--AGHK---------- 224
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P +P + S + + DP KRPTA+E LQHPF
Sbjct: 225 ---------PPIPDSL------QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 83/289 (28%), Positives = 127/289 (43%), Gaps = 48/289 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLKE 67
LG G FGRV + A+K +K+R+ E + L + NH IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 68 LIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y++ E C+ L+ ++ RDR LF E + ++ V Y+H G +RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118
Query: 127 LKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWA 185
LKPENLL+ S G +K+ DFG A+++KSG + G+ Y APEI+L Y D W+
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWS 177
Query: 186 MGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI-----KYQFPQ 240
+G ++ EL T P F G + D M +I I K +FP
Sbjct: 178 LGILLYELLTGRPPF-GEDDEDPM-EIY------------------NDILKGNGKLEFPN 217
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFF 284
+ A L + L +P +R + +H +F
Sbjct: 218 Y-----------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 9e-37
Identities = 99/319 (31%), Positives = 149/319 (46%), Gaps = 28/319 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
+ +Y K +G GA G V A+D VAIK+L + + + RE+ ++ +NH
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 60 SNIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI+ L ++ ++ +Y+V E M+ NL Q++ + L+Q+ G
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 138
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y D+W++G IM E+ LFPG DQ K+ LG+P + R
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 233 AIKYQFPQLPRANLSALMP-------------SASQDAISLFESLCSWDPSKRPTAAEAL 279
P+ + L P ASQ A L + D SKR + EAL
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ-ARDLLSKMLVIDASKRISVDEAL 316
Query: 280 QHPFFKRCFYAPPHIRSTP 298
QHP+ +Y P + P
Sbjct: 317 QHPYIN-VWYDPSEAEAPP 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 87/290 (30%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-------KQRYASWEDCLNLREVKCLRK 56
Y + LG+GAFG V KE+ K+R D LN E+ L
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERR----DALN--EIVILSL 55
Query: 57 LNHSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
L H NI+ ++N L + E LY + + +LF E + +LFQ+ +S
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 116 YMHQNGFFHRDLKPENL-LVSQGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQ 173
Y+H+ G HRD+K N+ L G+IK+ DFG+++ + S VG+ +Y +PE L Q
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQ 174
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ K+D+WA+G ++ EL T F + + + KI V G ++ +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--VQG-----NYTPVVSV--- 224
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
Y S + ISL SL DP KRPTA E L P
Sbjct: 225 --Y-----------------SSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 89/295 (30%), Positives = 131/295 (44%), Gaps = 40/295 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNH 59
D Y + +G GA V+ A E VAIK +L++ S ++ +EV+ + + NH
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCNH 58
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYM 117
N+VK + L+LV + +L +M + R E I L +V +GL Y+
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 118 HQNGFFHRDLKPENLLVSQ-GIIKIADFGLA------REIKSGPPYTNYVGSRWYRAPEI 170
H NG HRD+K N+L+ + G +KIADFG++ + T +VG+ + APE+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEV 177
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ Q Y KAD+W+ G EL T + K P M L+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPY---------SKY------PPMKVLMLTLQN 222
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFF 284
P L + + I SLC DPSKRPTA E L+H FF
Sbjct: 223 D------PPSLETGADYKKYSKSFRKMI----SLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ ++ + +G+G+FG V++A D+ T + VAIK + A E +E++ L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I K ++L+++ E C + L+ E I L +V GL Y+H+
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE 117
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYS 178
G HRD+K N+L+S +G +K+ADFG++ ++ S N +VG+ ++ APE++ QS Y
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YD 176
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI-KYQ 237
KAD+W++G EL G P + S +R I K
Sbjct: 177 EKADIWSLGITAIELAK---------------------GEPPL-SDLHPMRVLFLIPKNN 214
Query: 238 FPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P L S F SLC + DP +RP+A E L+H F K+
Sbjct: 215 PPSLEGNKFS--------KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 86/290 (29%), Positives = 136/290 (46%), Gaps = 54/290 (18%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNI 62
K+LG GAFG V++ D T VA+K LK+ AS E+ + L+E + ++KL H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKT-TEVAVKTLKE-DASEEERKDFLKEARVMKKLGHPNV 58
Query: 63 VKLKELIQNNNRLYLVFECMEC-NL-------YQLMAARDRKLFSEPEIKAWLFQVFQGL 114
V+L + LYLV E ME +L + + ++ S ++ ++ Q+ +G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 115 SYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPE 169
Y+ F HRDL N LV ++KI+DFGL+R++ Y G RW APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APE 177
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKICGVLGSPTMDSWADG 227
L+ +++SK+D+W+ G ++ E+FT P +PG S + + + G
Sbjct: 178 -SLKDGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLR------------KG 223
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE 277
R + P+ L LM S DP RPT +E
Sbjct: 224 YRLPK------PEYCPDELYELM-----------LSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-35
Identities = 90/298 (30%), Positives = 139/298 (46%), Gaps = 57/298 (19%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCLNLREVKCLRKLNH 59
++ +E+G G+FG V+ A D T E VAIK++ KQ W+D + +EV+ L++L H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQLRH 74
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARD-----RKLFSEPEIKAWLFQVFQGL 114
N ++ K + +LV E Y L +A D +K E EI A QGL
Sbjct: 75 PNTIEYKGCYLREHTAWLVME------YCLGSASDILEVHKKPLQEVEIAAICHGALQGL 128
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
+Y+H + HRD+K N+L+++ G +K+ADFG A + S P ++VG+ ++ APE++L
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVS--PANSFVGTPYWMAPEVILA 185
Query: 174 SE--LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS--WADGLR 229
+ Y K D+W++G EL P + +Y I SPT+ S W+D R
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSNDWSDYFR 244
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKR 286
F C P RP++ E L+H F R
Sbjct: 245 N------------------------------FVDSCLQKIPQDRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 96/293 (32%), Positives = 138/293 (47%), Gaps = 49/293 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+G+G +GRV+ A + TGE +A+K EL A D VK LR S I LK+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR----SEIETLKD 64
Query: 68 LIQNNNRLYLVFECMECNLYQLM----------AARDRKLFSEPEIKAWLFQVFQGLSYM 117
L N YL FE E L + R F E ++ + QV +GL+Y+
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYV-----GSRWYRAPEIL 171
H G HRDLK +NLLV GI KI+DFG+++ KS Y N GS ++ APE++
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 172 -LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
S+ YS+K D+W++G ++ E+F + M+K LG+ R
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK----LGN---------KRS 229
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
A P +P + + S A+ + + +P RPTA E LQHPF
Sbjct: 230 A-------PPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 85/291 (29%), Positives = 145/291 (49%), Gaps = 49/291 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKEL---------KQRYASWEDCLNLREVKCLRKLNHS 60
+G G+FG V+ + +GE +A+K++ K R S D L RE+ L++L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA-REIALLKELQHE 66
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV+ + + L + E + + + F E ++ ++ Q+ +GL+Y+H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREI-------KSGPPYTNYVGSRWYRAPEILL 172
G HRD+K N+LV ++G IKI+DFG+++++ K+ + GS ++ APE++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Q+ Y+ KAD+W++G ++ E+ T FP ++ ++KI G SP + S
Sbjct: 186 QT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPS--------- 234
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ S +AI E D +KRPTAAE L+HPF
Sbjct: 235 -------------------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 35/287 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
+Y K++G G+FG+++ A + E IKE+ + E + +EV L K+ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IV Q N RL++V E C +L + + + LFSE +I +W Q+ GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 121 GFFHRDLKPENLLVSQG--IIKIADFGLAREIKSGPPYTNY-VGSRWYRAPEILLQSELY 177
HRD+K +N+ +S+ + K+ DFG+AR++ VG+ +Y +PEI Q+ Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPY 179
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
++K D+W++G ++ EL T F G + + KIC
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC------------------------ 215
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ + + P+ S+D SL L P RP+ L+ PF
Sbjct: 216 -----QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
KY K++G G+FG+ + G+ IKE+ + + E + +EV L + H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IV+ +E + N LY+V + C +LY+ + A+ LF E +I W Q+ L ++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 121 GFFHRDLKPENL-LVSQGIIKIADFGLAREIKSGPPYTNY-VGSRWYRAPEILLQSELYS 178
HRD+K +N+ L G IK+ DFG+AR + S +G+ +Y +PEI ++ Y+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CENRPYN 179
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+K+D+WA+G ++ E+ T F + + + KI I+ +
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---------------------IRGSY 218
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P + S D +L L +P RP+ L+ F
Sbjct: 219 PPVS--------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-32
Identities = 90/297 (30%), Positives = 142/297 (47%), Gaps = 55/297 (18%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCLNLREVKCLRKLNH 59
+ G E+G G+FG V+ A + HT E VA+K++ KQ W+D + +EVK L++L H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII--KEVKFLQQLKH 80
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARD-----RKLFSEPEIKAWLFQVFQGL 114
N ++ K + +LV E Y L +A D +K E EI A QGL
Sbjct: 81 PNTIEYKGCYLKEHTAWLVME------YCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
+Y+H + HRD+K N+L+++ G +K+ADFG A + P ++VG+ ++ APE++L
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILA 191
Query: 174 SE--LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS--WADGLR 229
+ Y K D+W++G EL P + +Y I SPT+ S W D R
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDSFR 250
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ Y ++P+ +RP +AE L+H F +R
Sbjct: 251 --GFVDYCLQKIPQ---------------------------ERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
KY + +GRGAFG V + + V IK++ ++ E E + L+ L+H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I++ E + L +V E L + + R L E I + Q+ L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 121 GFFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRDLK +N+L+ + ++KI DFG+++ + S VG+ Y +PE L + + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKPYN 179
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
K+D+WA+G ++ EL + F A+ + KI +P D ++ LRQ
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ-------- 231
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282
L S+ + DPSKRP ++ + P
Sbjct: 232 ---------------------LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 83/282 (29%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
ELG G G V + TG+ +A+K ++ LRE+ L K N IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFHRD 126
NN + + E M+ + + E + V +GL+Y+H ++ HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 127 LKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWA 185
+KP N+LV S+G IK+ DFG++ ++ + T +VG+ Y APE +Q YS K+D+W+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWS 184
Query: 186 MGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRAN 245
+G + EL T FP E D I +L + P+LP
Sbjct: 185 LGLSLIELAT--GRFPYPPENDPPDGIFELL--------------QYIVNEPPPRLPSGK 228
Query: 246 LSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKR 286
S F +LC DP +RP+ E L+HPF K+
Sbjct: 229 FSPDF--------QDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 31/203 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
KELG G FG V H G+ VAIK +++ S +D + E K + KL+H N+
Sbjct: 10 KELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE--EAKVMMKLSHPNL 61
Query: 63 VKLKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLF----QVFQGLSY 116
V+L + +++V E M C L + R KL +E WL V + + Y
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGC-LLNYLRERKGKLGTE-----WLLDMCSDVCEAMEY 115
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILL 172
+ NGF HRDL N LV ++K++DFGLAR + YT+ G+++ + PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQGTKFPVKWAPPEVFD 174
Query: 173 QSELYSSKADMWAMGAIMAELFT 195
S +SSK+D+W+ G +M E+F+
Sbjct: 175 YSR-FSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 83/307 (27%), Positives = 134/307 (43%), Gaps = 72/307 (23%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK----ELKQRYASWEDCLNLREVKCLRKL 57
+ Y + +G G +G V++A D TGE VAIK E + + +E+ L++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ-----QEISMLKEC 57
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMEC-------NLYQLMAARDRKLFSEPEIKAWLFQV 110
H NIV ++L++ ME ++YQ+ R SE +I +
Sbjct: 58 RHPNIVAYFGSYLRRDKLWI---VMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRET 110
Query: 111 FQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAP 168
+GL+Y+H+ G HRD+K N LL G +K+ADFG++ ++ + ++G+ ++ AP
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 169 EILLQSEL--YSSKADMWAMG--AI-MAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
E+ Y K D+WA+G AI +AEL P+F
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP--PMF----------------------- 205
Query: 224 WADGLRQARAI------KYQFPQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAA 276
L RA+ + P+L + S + + + DP KRPTA
Sbjct: 206 ---DLHPMRALFLISKSNFPPPKLKDKEKWSPVF-------HDFIKKCLTKDPKKRPTAT 255
Query: 277 EALQHPF 283
+ LQHPF
Sbjct: 256 KLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 80/249 (32%), Positives = 132/249 (53%), Gaps = 6/249 (2%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
+Y+ + +G G+FGR ++ + A+KE++ +S + +E L K+ H NI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 63 VKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
V KE + + LY+V E C +L Q + + KLF E I W Q+ G+ ++H+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQSELYSS 179
HRD+K +N+ ++Q G +K+ DFG AR + S Y YVG+ +Y PEI ++ Y++
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI-WENMPYNN 179
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K+D+W++G I+ EL T F S + + K+C P ++ LR IK F
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRS--LIKQMFK 237
Query: 240 QLPRANLSA 248
+ PR+ SA
Sbjct: 238 RNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-31
Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 52/288 (18%)
Query: 11 GRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLN-LREVKCLRKLNHSNIVKLKEL 68
G+GAFG+V T + A+K + KQ+ N L E + L++LNH +V L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 69 IQNNNRLYLVFECMECNLYQLMAARD-------RKLFSEPEIKAWLFQVFQGLSYMHQNG 121
Q+ +YLV + L+ D + FSE ++K W+ ++ L Y+H G
Sbjct: 69 FQDEENMYLVVD--------LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRD+KP+N+L+ QG + I DF +A ++ T+ G+ Y APE+ L + YS
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQGYSVA 179
Query: 181 ADMWAMGAIMAE-LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D W++G E L P + G S + D +R +
Sbjct: 180 VDWWSLGVTAYECLRGKRP-YRGHSR-----------------TIRDQIRAKQETA---- 217
Query: 240 QLPRANLSALMPSA-SQDAISLFESLCSWDPSKR--PTAAEALQHPFF 284
L P+ S +AI L DP KR + HP+F
Sbjct: 218 -------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 56/295 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKL----NH 59
K LG+G+FG+V A + T E A+K LK+ + L +V+C R L H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKK-----DVILQDDDVECTMTEKRVLALAGKH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ +L Q +RL+ V E N LM R + F EP + + ++ GL ++
Sbjct: 56 PFLTQLHSCFQTKDRLFFVME--YVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFL 112
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSE 175
H+ G +RDLK +N+L+ S+G IKIADFG+ +E I G + + G+ Y APEI L +
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI-LSYQ 171
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y D WA+G ++ E+ F G E D+++ ++I
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELF---------------------QSIL 209
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL-QHPFFK 285
+ PR S++A S+ +S + +P KR PT + + HPFF+
Sbjct: 210 EDEVRYPR--------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 90/362 (24%), Positives = 151/362 (41%), Gaps = 67/362 (18%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLK 66
++G+G +G+VF A + TGE VA+K +K+ + + L E L +VKL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 67 ELIQNNNRLYLV--------FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
Q++ LYL F + NL L SE + ++ ++F+ + +H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVL---------SEDHARFYMAEMFEAVDALH 118
Query: 119 QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
+ G+ HRDLKPEN L+ G IK+ DFGL++ I + Y N VGS Y APE+ L+ +
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEV-LRGKG 174
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y D W++G ++ E P F G++ ++W + ++
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGST---------------PNETWENLKYWKETLQR 219
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ-HPFFKRCFYA----- 290
PR NLS D + DPS+R + E ++ HPFFK +
Sbjct: 220 PVYDDPRFNLS--------DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELREL 271
Query: 291 -PPHIRSTPAVATTT-------ANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQM 342
PP + P + + + K ++++ + + +
Sbjct: 272 KPPFV---PELESEIDTGYFDDFENEDDMAK--YKDVHEKKKAAGKGGANGRDPGNRRKF 326
Query: 343 VG 344
VG
Sbjct: 327 VG 328
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 87/292 (29%), Positives = 128/292 (43%), Gaps = 52/292 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHS-----N 61
K + +GAFG V+ A TG+ AIK LK+ S N + VK R +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 62 IVKLKELIQNNNRLYLVFECM---EC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ KL Q+ + LYLV E + +C +L + + E K ++ +V G+ +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-----LPEDWAKQYIAEVVLGVEDL 113
Query: 118 HQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
HQ G HRD+KPENLL+ Q G +K+ DFGL+R +VG+ Y APE +L
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGVG- 169
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+D W++G ++ E P F A D + + + L R I
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPF-HAETPDAV--------------FDNILS--RRI-- 210
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA---AEALQHPFFK 285
+P+ S +A+ L L DP+KR A E HPFFK
Sbjct: 211 NWPE--EVK-----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 90/319 (28%), Positives = 138/319 (43%), Gaps = 77/319 (24%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK----LNHSN-- 61
K +GRGAFG V+ D+ TG+ A+K L++ D + ++ +R L ++
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-----SDMIKRNQIAHVRAERDILADADSP 61
Query: 62 -IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
IVKL Q+ LYLV E M +L L+ +D F E + ++ ++ L +H+
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVLALDSVHK 119
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSG-----------------------PP 155
GF HRD+KP+N+L+ + G IK+ADFGL +++
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 156 YTNY-------VGSRWYRAPEILLQSELYSSKADMWAMGAIMAE-LFTFCPLFPGASEAD 207
+ VG+ Y APE+L + Y + D W++G I+ E L+ F P + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 208 QMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW 267
KI +W + LR FP P S +AI L L
Sbjct: 239 YN-KII---------NWKESLR--------FPPDPP---------VSPEAIDLICRLLC- 270
Query: 268 DPSKRPTAAE-ALQHPFFK 285
DP R + E HPFFK
Sbjct: 271 DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 55/297 (18%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCLNLREVKCLRKLNH 59
++ +E+G G+FG V+ A D T E VAIK++ KQ W+D + +EVK L+++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVKFLQRIKH 84
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARD-----RKLFSEPEIKAWLFQVFQGL 114
N ++ K + +LV E Y L +A D +K E EI A QGL
Sbjct: 85 PNSIEYKGCYLREHTAWLVME------YCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
+Y+H + HRD+K N+L+++ G +K+ADFG A P ++VG+ ++ APE++L
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILA 195
Query: 174 SE--LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS--WADGLR 229
+ Y K D+W++G EL P + +Y I SPT+ S W+D R
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFR 254
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ +S P RPT+ E L+H F R
Sbjct: 255 -----------------------------NFVDSCLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 50/288 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKEL--------KQRYASWEDCLNLREVKCLRKLNH 59
K++G+G F V++A G VA+K++ K R +DCL +E+ L++L+H
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDCL--KEIDLLKQLDH 61
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLM--AARDRKLFSEPEIKAWLFQVFQGLSY 116
N++K NN L +V E + +L +++ + ++L E I + Q+ L +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 117 MHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQS 174
MH HRD+KP N+ ++ G++K+ D GL R S + VG+ +Y +PE +
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHE 180
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQM--YKICGVLGSPTMDSWADGLRQAR 232
Y+ K+D+W++G ++ E+ F G D+M Y +C +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLC-----------------KK 219
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
K +P LP + S + L + DP KRP + LQ
Sbjct: 220 IEKCDYPPLPADHYSEELR-------DLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 66/279 (23%), Positives = 128/279 (45%), Gaps = 38/279 (13%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKLNHSNIVKLK 66
+G+G+FG VF+ + A+K++ + E+ ++ E + L KL+ S I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID--EARVLAKLDSSYIIRYY 65
Query: 67 ELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
E + +L +V E +L++L+ + + E ++ + Q+ GL+++H HR
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 126 DLKPENLLVSQGI-IKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADM 183
D+K NL + +KI D G+A+ + + N VG+ +Y +PE L + + Y+ K+D+
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDV 184
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
WA+G ++ E T F ++ + KI I+ FP + +
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKI---------------------IRGVFPPVSQ 223
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282
SQ L + + D +RP + L++P
Sbjct: 224 M--------YSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQ----RYASWEDCLNLREVKCLRKLNHSNIV 63
+ LG+G+FG V+ D+ +K LK+ E +E + L KL+H IV
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 64 KLKELIQNNNRLYLVFE-C----MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
K + ++ E C ++C L +L K SE ++ W Q+ G+ YMH
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 119 QNGFFHRDLKPENLLVSQGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELY 177
Q HRDLK +N+ + ++KI DFG++R + S T + G+ +Y +PE L+ + Y
Sbjct: 124 QRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-LKHQGY 182
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
SK+D+W++G I+ E+ F G + + +I + PT
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI---VEGPT----------------- 222
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P LP L S+ +S+ + DPS RP+AAE L++PF
Sbjct: 223 -PSLPETYSRQLN--------SIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 81/293 (27%), Positives = 133/293 (45%), Gaps = 53/293 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC----LRKLNHSNIV 63
K LG+GAFGRV+ +D TG +A+K++ S E + ++C L+ L H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 64 KLKELIQNNNRLYLVFECM-------ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+ ++++ L + E M + Y + +E + + Q+ +G+ Y
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--------TETVTRKYTRQILEGVEY 119
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIK----SGPPYTNYVGSRWYRAPEIL 171
+H N HRD+K N+L S G +K+ DFG ++ ++ SG + G+ ++ +PE++
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
E Y KAD+W++G + E+ T P P A E + M I + PT
Sbjct: 180 S-GEGYGRKADVWSVGCTVVEMLTEKP--PWA-EFEAMAAIFKIATQPTN---------- 225
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
PQLP S DA + + KRP+A E L+H F
Sbjct: 226 -------PQLP--------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 85/288 (29%), Positives = 140/288 (48%), Gaps = 42/288 (14%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
ELG GAFG+V++A + TG A K ++ + ED + E+ L + H NIV L E
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED--FMVEIDILSECKHPNIVGLYE 69
Query: 68 LIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
N+L+++ E C L +M +R L +EP+I+ Q+ + L+++H + HRD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGL-TEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 127 LKPENLLVSQ-GIIKIADFGL-AREIKSGPPYTNYVGSRWYRAPEILL----QSELYSSK 180
LK N+L++ G +K+ADFG+ A+ + ++G+ ++ APE++ + Y K
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS--PTMDSWADGLRQARAIKYQF 238
AD+W++G + EL + P E + M + +L S PT+D
Sbjct: 189 ADIWSLGITLIEL---AQMEPPHHELNPMRVLLKILKSEPPTLDQ--------------- 230
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
P ++ + + S DP RPTAAE L+HPF
Sbjct: 231 PSKWSSSFNDFLKSCLVK-----------DPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 85/293 (29%), Positives = 129/293 (44%), Gaps = 55/293 (18%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR----------KLNH 59
LGRG FG+V A + TGE AIK LK+ D + EV+ L H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKK-----GDIIARDEVESLMCEKRIFETANSERH 61
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+V L Q + + V E LM +FSEP + V GL Y+H+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELY 177
N +RDLK +NLL+ +G +KIADFGL +E + G + + G+ + APE+L ++ Y
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-Y 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ D W +G ++ E+ FPG E ++++ +I
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFD---------------------SIVND 216
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFK 285
+ PR LS +AIS+ L +P +R AE ++ PFF+
Sbjct: 217 EVRYPR-FLSR-------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 21/215 (9%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEA-VAIKEL-----------KQRYASWEDCLNLREV 51
Y+ + LG GAFG V++ ++ G+ +A+KE+ ++R S D ++ EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS--EV 59
Query: 52 KCLRK-LNHSNIVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRK--LFSEPEIKAWL 107
+++ L H NIV+ + N+RLY+V + +E L + + K F+E I
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 108 FQVFQGLSYMHQNGFF-HRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRWY 165
Q+ L Y+H+ HRDL P N+++ + + I DFGLA++ + T+ VG+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLF 200
PEI+ ++E Y KAD+WA G I+ ++ T P F
Sbjct: 180 SCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 77/240 (32%), Positives = 122/240 (50%), Gaps = 26/240 (10%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCLNLREVKCLRKLNH 59
+S +E+G G+FG V+ A D E VAIK++ KQ W+D + +EV+ L+KL H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLRH 74
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARD-----RKLFSEPEIKAWLFQVFQGL 114
N ++ + + +LV E Y L +A D +K E EI A QGL
Sbjct: 75 PNTIQYRGCYLREHTAWLVME------YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
+Y+H + HRD+K N+L+S+ G++K+ DFG A + P +VG+ ++ APE++L
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILA 185
Query: 174 SE--LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS--WADGLR 229
+ Y K D+W++G EL P + +Y I SP + S W++ R
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFR 244
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 85/284 (29%), Positives = 134/284 (47%), Gaps = 42/284 (14%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK-LKEL 68
LG+G +G V+ A D T +AIKE+ +R + + L+ E+ L H NIV+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH-EEIALHSYLKHRNIVQYLGSD 74
Query: 69 IQNNNRLYLVFECMECNLYQLMAARDRKLFS-EPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+N + + +L L+ ++ L E I + Q+ +GL Y+H N HRD+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 128 KPENLLVS--QGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQSEL-YSSKADM 183
K +N+LV+ G++KI+DFG ++ + P T + G+ Y APE++ + Y + AD+
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF----P 239
W++G + E+ T P F LG P QA K P
Sbjct: 195 WSLGCTIVEMATGKPPFIE-------------LGEP----------QAAMFKVGMFKIHP 231
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
++P + LSA A + FE DP KR +A + LQ PF
Sbjct: 232 EIPES-LSA---EAKNFILRCFEP----DPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 46/290 (15%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLK 66
ELG GAFG+V++A ++ TG A K ++ + E+ L + E++ L NH IVKL
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLL 75
Query: 67 ELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ +L+++ E C + +M DR L +EP+I+ Q+ + L Y+H HR
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 126 DLKPENLLVSQ-GIIKIADFGL-AREIKSGPPYTNYVGSRWYRAPEILLQSEL----YSS 179
DLK N+L++ G IK+ADFG+ A+ +K+ +++G+ ++ APE+++ + Y
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS--PTMDSWADGLRQARAIKYQ 237
KAD+W++G + E+ + P E + M + + S PT+
Sbjct: 195 KADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPPTLSQ-------------- 237
Query: 238 FPQLPRANLSALMPSA-SQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
PS S + ++ P RP+AA+ L+HPF
Sbjct: 238 -------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 85/286 (29%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIVKL 65
K LG+G FG+V ++ TG+ A+K LK+ A E L E + L+ H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
K Q ++RL V E +R+R +FSE + + ++ L Y+H +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 126 DLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADM 183
DLK ENL++ + G IKI DFGL +E I G + G+ Y APE+L ++ Y D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 178
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W +G +M E+ +CG L P + D + I + + PR
Sbjct: 179 WGLGVVMYEM------------------MCGRL--PFYNQ--DHEKLFELILMEEIRFPR 216
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFF 284
+ S +A SL L DP +R A E ++H FF
Sbjct: 217 --------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 92/340 (27%), Positives = 131/340 (38%), Gaps = 91/340 (26%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKEL---------KQRYASWEDCLNLREVKCLRKLN 58
K LG+G GRVF + TG+ A+K L K + E +E+ L L+
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE-----QEI--LATLD 59
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H + L Q L LV + C L++L+ + K SE + + +V L Y+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 118 HQNGFFHRDLKPENLLVSQ-GIIKIADFGLA---------------------------RE 149
H G +RDLKPEN+L+ + G I ++DF L+ E
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 150 IKSGPPYTN---YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAE-LFTFCPLFPGASE 205
S P +VG+ Y APE+ + + + S D W +G ++ E L+ P F G++
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTTP-FKGSNR 237
Query: 206 ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC 265
+ I L FP P S A L L
Sbjct: 238 DETFSNI---LKKEVT----------------FPG---------SPPVSSSARDLIRKLL 269
Query: 266 SWDPSKR----PTAAEALQHPFFK-------RCFYAPPHI 294
DPSKR AAE QHPFF+ R PP I
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH-TTPPII 308
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 72/200 (36%), Positives = 108/200 (54%), Gaps = 25/200 (12%)
Query: 8 KELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
KELG G FG V H G+ VAIK + + S ED + E K + KL+H +
Sbjct: 10 KELGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFI--EEAKVMMKLSHPKL 61
Query: 63 VKLKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQ-VFQGLSYMHQ 119
V+L + LY+V E ME C L L R R+ ++ + Q V +G+ Y+ +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 120 NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSE 175
N F HRDL N LVS G++K++DFG+ R + YT+ G+++ + PE+ S+
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 176 LYSSKADMWAMGAIMAELFT 195
YSSK+D+W+ G +M E+FT
Sbjct: 178 -YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 10 LGRGAFGRVFQ--AFDE---HTGEA-VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
LG GAFG V++ A D +G VA+K L++ E L+E + NH NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 64 KLKELIQNNNRLYLVFECMECN--LYQLMAARDRK----LFSEPEIKAWLFQVFQGLSYM 117
KL + N Y++ E ME L L AR + L + E+ V +G Y+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 118 HQNGFFHRDLKPENLLVSQG------IIKIADFGLAREIKSGPPY----TNYVGSRWYRA 167
Q F HRDL N LVS+ ++KI DFGLAR+I Y + RW A
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-A 181
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTF 196
PE LL +++++D+W+ G +M E+ T
Sbjct: 182 PESLLDG-KFTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 59/192 (30%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+E+G G FG V+ + + VAIK +++ S ED + E + + KL+H +V+L
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI--EEAQVMMKLSHPKLVQLYG 66
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ + + LVFE ME R FS+ + V +G++Y+ + HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 128 KPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKADM 183
N LV + ++K++DFG+ R + YT+ G+++ + +PE+ S+ YSSK+D+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDV 184
Query: 184 WAMGAIMAELFT 195
W+ G +M E+F+
Sbjct: 185 WSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 75/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED----CLNLR-EVKCLRKLNHSNI 62
++LG GAF +QA D TG +A+K++ + + LR E++ + +LNH +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+++ ++ L E M + F E I + Q+ +GLSY+H+N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLL-SKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 123 FHRDLKPENLLV-SQG-IIKIADFGLAREIKS-----GPPYTNYVGSRWYRAPEILLQSE 175
HRD+K NLL+ S G ++IADFG A + + G +G+ + APE+L + E
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-RGE 183
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQ---MYKICGVLGSPTMDSWADGLRQAR 232
Y D+W++G ++ E+ T P + ++ ++KI +P++
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE--------- 234
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
L P + E P RP + E L+HP F+
Sbjct: 235 ---------------HLSPGLRDVTLRCLEL----QPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
F ++G G+ G V A D+ TG VA+K++ R + L EV +R H NIV++
Sbjct: 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-FNEVVIMRDYQHPNIVEMY 82
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ L++V E +E + R +E +I V + LS++H G HRD
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRD 140
Query: 127 LKPEN-LLVSQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
+K ++ LL S G +K++DFG ++ K P + VG+ ++ APE ++ Y ++ D+W
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-VISRLPYGTEVDIW 199
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
++G ++ E+ P + M +I D+ L+ + P+L
Sbjct: 200 SLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKLKNLHKVS---PRLR-- 246
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
S + + DP++R TAAE L HPF +
Sbjct: 247 --------------SFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 47/292 (16%)
Query: 8 KELGRGAFGRVFQAFDEH---TGEAVAIKELKQR--YASWEDCLNLR-EVKCLRKLNHSN 61
K LG+G +G+VFQ TG+ A+K LK+ + +D + + E L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRK-LFSEPEIKAWLFQVFQGLSYMHQN 120
IV L Q +LYL+ E + +L +R+ +F E +L ++ L ++HQ
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 121 GFFHRDLKPEN-LLVSQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYS 178
G +RDLKPEN LL +QG +K+ DFGL +E I G + G+ Y APEIL++S +
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HG 178
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
D W++GA+M ++ T P F + + KI
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------------------------- 213
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFK 285
+ L+ L P + +A L + L +PS R P A +Q HPFF+
Sbjct: 214 ----KGKLN-LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWE-DCLNLREVKCLRKLNHSNIVKLKE 67
LG+G FG V + TG+ A K+L K+R + + + L E K L K++ IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 68 LIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+ + L LV M + ++Y + F E + Q+ GL ++HQ
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV----GEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
+RDLKPEN+L+ G ++I+D GLA E+K G G+ Y APE+ LQ E+Y
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV-LQGEVYDFSV 175
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D +A+G + E+ + R K + +L
Sbjct: 176 DWFALGCTLYEMIA-----------------------------GRSPFRQRKEKVEKEEL 206
Query: 242 PRANLS---ALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
R L S +A L E+L DP KR +A E +HP FK
Sbjct: 207 KRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 85/291 (29%), Positives = 138/291 (47%), Gaps = 37/291 (12%)
Query: 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
F ++G G+ G V A ++HTG+ VA+K++ R + L EV +R +H N+V
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYHHENVVD 83
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ + L++V E +E + R +E +I V + LSY+H G H
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIH 141
Query: 125 RDLKPEN-LLVSQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSEL-YSSKA 181
RD+K ++ LL S G IK++DFG ++ K P + VG+ ++ APE++ S L Y ++
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI--SRLPYGTEV 199
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D+W++G ++ E+ P + P L+ R I+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPPY---------------FNEPP-------LQAMRRIRDNLP-- 235
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
PR S + S + + L + +PS+R TA E LQHPF K PP
Sbjct: 236 PRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFLK--LAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS--- 60
Y + +GRGA+G V++ TG VA+K + + REV L +L S
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI K RL+++ E ++ LM A +E I + +V L Y+H+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYIHK 119
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNYVGSRWYRAPEILLQSELY 177
G HRD+K N+LV+ G +K+ DFG+A + + +VG+ ++ APE++ + + Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI--- 234
+KAD+W++G + E+ T G+P + RA+
Sbjct: 180 DTKADIWSLGITIYEMAT---------------------GNPPY----SDVDAFRAMMLI 214
Query: 235 -KYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFK 285
K + P+L S L+ ++ F + C +P +R +A E L+ + K
Sbjct: 215 PKSKPPRLEDNGYSKLL----RE----FVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 59/189 (31%), Positives = 104/189 (55%), Gaps = 9/189 (4%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
+G+G FG V ++ G+ VA+K LK ++ L E + L H N+V+L ++
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLK-DDSTAAQAF-LAEASVMTTLRHPNLVQLLGVV 69
Query: 70 QNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLK 128
N LY+V E M +L + +R R + + + + V +G+ Y+ + F HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 129 PENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMG 187
N+LVS + K++DFGLA+E G + + +W APE L + + +S+K+D+W+ G
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKW-TAPEALREKK-FSTKSDVWSFG 186
Query: 188 AIMAELFTF 196
++ E+++F
Sbjct: 187 ILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 8 KELGRGAFGRV----FQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG G FG+V + ++TGE VA+K LK +E++ LR L H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 64 KLKELIQNN--NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
K K + + N + L+ E + + R++ + + + Q+ +G+ Y+
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSR-----WYRAPEILLQSE 175
+ HRDL N+LV S+ +KI DFGL + I++ Y WY APE L+QS+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSK 188
Query: 176 LYSSKADMWAMGAIMAELFTFC 197
Y + +D+W+ G + EL T+C
Sbjct: 189 FYIA-SDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 15/208 (7%)
Query: 8 KELGRGAFGRVFQA-FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
++LG G FG V+ ++ T VA+K LK S E L +E + ++KL H +V+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFL--QEAQIMKKLRHDKLVQLY 67
Query: 67 ELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ +Y+V E M +L + + + K P++ Q+ +G++Y+ + HR
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127
Query: 126 DLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKA 181
DL N+LV + + KIADFGLAR I+ YT G+++ + APE ++ K+
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAANYGR-FTIKS 185
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEAD 207
D+W+ G ++ E+ T+ P +PG + +
Sbjct: 186 DVWSFGILLTEIVTYGRVP-YPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 76/285 (26%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNI 62
Y + +G+G++G V G+ IK+L R AS E +E + L +L H NI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 63 VKLKELIQNNN-RLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
V +E + + LY+V C +LY + + KL E ++ W Q+ L Y+H+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 121 GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY-TNYVGSRWYRAPEILLQSELYS 178
HRDLK +N+ +++ IIK+ D G+AR +++ + +G+ +Y +PE L ++ Y+
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYN 180
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
K+D+WA+G + E+ T F +Y+I I+ +
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI---------------------IEGKL 219
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P +P+ S + L ++ S P KRP+ L+ P+
Sbjct: 220 PPMPK--------DYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLN 58
K+LG G FG+V ++TGE VA+K L Q + +E RE++ LR L+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE-----REIEILRTLD 64
Query: 59 HSNIVKLKELI--QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
H NIVK K + L L+ E + + R R + + + Q+ +G+ Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAR--EIKSGPPYTNYVGS---RWYRAPEI 170
+ + HRDL N+LV S+ ++KI+DFGLA+ Y G WY APE
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFC 197
L S+ +SS +D+W+ G + ELFT+
Sbjct: 184 LRTSK-FSSASDVWSFGVTLYELFTYG 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKL----NH 59
K LG+G+FG+V A + T E AIK LK+ +D +V C R L H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD-----DVDCTMTEKRILALAAKH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ L Q +RL+ V E + R RK F EP + + +V L ++H+
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHR 114
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELY 177
+G +RDLK +N+L+ ++G K+ADFG+ +E I +G T + G+ Y APEIL + E Y
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-Y 173
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEAD 207
D WA+G +M E+ P F +E D
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 5e-24
Identities = 67/189 (35%), Positives = 106/189 (56%), Gaps = 11/189 (5%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
+G G FG V Q E+TG+ VA+K +K + L E + KL+H N+V+L +I
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 70 QNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLK 128
+N LY+V E M + NL + R R L S ++ + V +G+ Y+ HRDL
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 129 PENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMG 187
N+LVS+ G+ K++DFGLAR G + + +W APE L + +SSK+D+W+ G
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVD-NSKLPVKW-TAPEALKHKK-FSSKSDVWSYG 184
Query: 188 AIMAELFTF 196
++ E+F++
Sbjct: 185 VLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-24
Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 36/283 (12%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++ + +G+G+FG VF+ D T + VAIK + A E +E+ L + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
K +L+++ E + + L+ A F E +I L ++ +GL Y+H
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKK 122
Query: 123 FHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSK 180
HRD+K N+L+S QG +K+ADFG+A ++ N +VG+ ++ APE++ QS Y SK
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSK 181
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
AD+W++G EL P P D + R +
Sbjct: 182 ADIWSLGITAIELAKGEP--------------------PNSD-----MHPMRVLFL---- 212
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+P+ N L S+ ++ + DPS RPTA E L+H F
Sbjct: 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL 68
+LG G +G V++ + VA+K LK+ E+ L +E ++++ H N+V+L +
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL--KEAAVMKEIKHPNLVQLLGV 70
Query: 69 IQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
Y++ E M NL + +R+ + + Q+ + Y+ + F HRDL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 128 KPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKADM 183
N LV + ++K+ADFGL+R + G YT + G+++ + APE L ++ +S K+D+
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDV 188
Query: 184 WAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
WA G ++ E+ T+ +PG + Q+Y + G R R
Sbjct: 189 WAFGVLLWEIATYGMSPYPGI-DLSQVY-----------ELLEKGYRMERP--------- 227
Query: 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAE---ALQHPF 283
L + W+PS RP+ AE A + F
Sbjct: 228 --------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 62/208 (29%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLR----EVKCLRKLNHSNIV 63
++LG G FG V++ ++ VAIK LK +D L + EV+ L++L H +++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR-VAIKILKS-----DDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 64 KLKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
L + +Y++ E ME +L + + + ++ + QV +G++Y+ +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 123 FHRDLKPENLLVSQGII-KIADFGLAREIKSGPPYTNY---VGSRWYRAPEILLQSELYS 178
HRDL N+LV + ++ K+ADFGLAR IK Y + + +W APE +S
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKW-TAPEAASHGT-FS 182
Query: 179 SKADMWAMGAIMAELFTF--CPLFPGAS 204
+K+D+W+ G ++ E+FT+ P +PG +
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVP-YPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 42/305 (13%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
Y+ K L G+ GRVF A + V +K + Q+ + L E L+ +NH +++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK-IGQKGTT------LIEAMLLQNVNHPSVI 120
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLF--QVFQGLSYMHQNG 121
++K+ + + +V +LY + R R L P +A + Q+ +GL Y+H
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL---PIDQALIIEKQILEGLRYLHAQR 177
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRD+K EN+ + + I D G A+ P + G+ APE+L + + Y+SK
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK-YNSK 236
Query: 181 ADMWAMGAIMAELFTF----------CPLFPGASEADQMYKICGVLG--------SPTMD 222
AD+W+ G ++ E+ + P S + KI L P
Sbjct: 237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296
Query: 223 SWADGLRQARAIKY---QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279
+ A + ++P R NL D L + ++D + RP+A E L
Sbjct: 297 LVRGFIEYASLERQPYTRYPCFQRVNL-------PIDGEFLVHKMLTFDAAMRPSAEEIL 349
Query: 280 QHPFF 284
+P F
Sbjct: 350 NYPMF 354
|
Length = 357 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 45/287 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKLNHSNIVKLK 66
+G GA G V++ TG A+K + Y + ED + RE++ LR +NH N+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +N + ++ E M+ + + E + Q+ G++Y+H+ HRD
Sbjct: 139 DMFDHNGEIQVLLEFMDGG-----SLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRD 193
Query: 127 LKPENLLV-SQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEIL---LQSELYSSKA 181
+KP NLL+ S +KIADFG++R + ++ P + VG+ Y +PE + L Y A
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA 253
Query: 182 -DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D+W++G + E + F + D +C + S Q P+
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS------------------QPPE 295
Query: 241 LPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKR 286
P +AS++ F S C +P+KR +A + LQHPF R
Sbjct: 296 AP--------ATASREFRH-FISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 65/199 (32%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLK 66
ELG GAFG+V++A ++ TG A K + + E+ L + E+ L +H NIVKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLL 68
Query: 67 ELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ N L+++ E C + +M +R L +EP+I+ Q + L+Y+H+N HR
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPL-TEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 126 DLKPENLLVS-QGIIKIADFGL-AREIKSGPPYTNYVGSRWYRAPEILL----QSELYSS 179
DLK N+L + G IK+ADFG+ A+ ++ +++G+ ++ APE+++ + Y
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 180 KADMWAMGAIMAELFTFCP 198
KAD+W++G + E+ P
Sbjct: 188 KADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 63/307 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
+ + +G G +G+V++A + TG+ VAIK + E+ E LRK NH
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK--EEYNILRKYSNHP 63
Query: 61 NIVK------LKELIQNNNRLYLVFECME-C------NLYQLMAARDRKLFSEPEIKAWL 107
NI K N+++L+LV ME C +L + + + ++L E I L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLV---MELCGGGSVTDLVKGLRKKGKRL-KEEWIAYIL 119
Query: 108 FQVFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWY 165
+ +GL+Y+H+N HRD+K +N LL +K+ DFG++ ++ S N ++G+ ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 166 RAPEILLQSE----LYSSKADMWAMG--AI-MAELFTFCPLFPGASEADQMYKICGVLGS 218
APE++ E Y +++D+W++G AI +A+ G
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELAD------------------------GK 215
Query: 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSA--SQDAISLFESLCSWDPSKRPTAA 276
P + D + RA+ F ++PR L S+ + +RP
Sbjct: 216 PPL---CD-MHPMRAL---F-KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFME 267
Query: 277 EALQHPF 283
E L+HPF
Sbjct: 268 ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 85/279 (30%), Positives = 133/279 (47%), Gaps = 43/279 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGE-AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
KELG G FG V + + G+ VAIK +K+ S ++ + E K + KL+H +V+L
Sbjct: 10 KELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIE--EAKVMMKLSHEKLVQLY 65
Query: 67 ELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ +Y+V E M C L L R F ++ V +G++Y+ F H
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 125 RDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSK 180
RDL N LV QG +K++DFGL+R + YT+ VGS++ + PE+LL S+ +SSK
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSK-FSSK 181
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
+D+WA G +M E+++ Y+ S T++ + GLR R P
Sbjct: 182 SDVWAFGVLMWEVYSL---------GKMPYERFN--NSETVEKVSQGLRLYR------PH 224
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279
L + A+M S + +RPT + L
Sbjct: 225 LASEKVYAIMYSCWHEK-----------AEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-23
Identities = 72/283 (25%), Positives = 133/283 (46%), Gaps = 33/283 (11%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
+ ++G G+ G V A ++H+G VA+K + R + L EV +R H N+V++
Sbjct: 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL-FNEVVIMRDYQHQNVVEMY 84
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ L+++ E ++ + ++ R +E +I V Q L Y+H G HRD
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 127 LKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
+K +++L++ G +K++DFG +I K P + VG+ ++ APE++ ++ Y ++ D+W
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIW 201
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
++G ++ E+ P + S M ++ DS L+ A I P L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDSPPPKLKNAHKIS---PVLR-- 248
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
E + + +P +R TA E L HPF +
Sbjct: 249 --------------DFLERMLTREPQERATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 84/290 (28%), Positives = 137/290 (47%), Gaps = 47/290 (16%)
Query: 8 KELGRGAFGRVF---QAFDEHTGEAVAIKELKQRYASWEDCLNLR-EVKCLRKLNHSNIV 63
K LG+G+FG+VF + G+ A+K LK+ D + + E L ++NH IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
KL Q +LYL+ + + +L+ ++ +F+E ++K +L ++ L ++H G
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
+RDLKPEN+L+ + G IK+ DFGL++E I ++ G+ Y APE+ + ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQS 178
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
AD W+ G +M E+ T F G + M I
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI---------------------------- 210
Query: 241 LPRANLSALMPS-ASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFF 284
+A L MP S +A SL +L +P+ R P E ++ HPFF
Sbjct: 211 -LKAKLG--MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-23
Identities = 63/211 (29%), Positives = 113/211 (53%), Gaps = 11/211 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
++LG G FG V++ +T VA+K LK +D L E + ++KL H +++L
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFL--AEAQIMKKLRHPKLIQLYA 68
Query: 68 LIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ +Y+V E M+ +L + + + P++ QV G++Y+ + HRD
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD 128
Query: 127 LKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKAD 182
L N+LV + I K+ADFGLAR IK Y G+++ + APE L + +S K+D
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNR-FSIKSD 186
Query: 183 MWAMGAIMAELFTFCPL-FPGASEADQMYKI 212
+W+ G ++ E+ T+ + +PG + A+ + ++
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 5e-23
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNHSN 61
++ +++G+G+FG VF+ D T + VAIK +L++ ED +E+ L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ K + +L+++ E + + + E +I L ++ +GL Y+H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSS 179
HRD+K N+L+S+ G +K+ADFG+A ++ N +VG+ ++ APE++ QS Y S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDS 180
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
KAD+W++G EL G P + +K F
Sbjct: 181 KADIWSLGITAIEL---------------------AKGEPPHS-------ELHPMKVLF- 211
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+P+ N L + S+ E+ + +PS RPTA E L+H F R
Sbjct: 212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-23
Identities = 85/286 (29%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIVKL 65
K LG+G FG+V ++ +G+ A+K LK+ A E L E + L+ H + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
K Q +RL V E + +R+R +FSE + + ++ L Y+H +R
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 126 DLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADM 183
DLK ENL++ + G IKI DFGL +E I + G+ Y APE+L ++ Y D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDW 178
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W +G +M E+ +CG L P + D + I + + PR
Sbjct: 179 WGLGVVMYEM------------------MCGRL--PFYNQ--DHEKLFELILMEDIKFPR 216
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFF 284
+ S DA SL L DP+KR A E ++H FF
Sbjct: 217 --------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 53/292 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK--------CLRKLNH 59
K +G+G+FG+V A + G+ A+K L++ + L +E K L+ + H
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQK-----KAILKKKEQKHIMAERNVLLKNVKH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMH 118
+V L Q ++LY V + + N +L R + F EP + + ++ L Y+H
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYV--NGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSEL 176
+RDLKPEN+L+ SQG + + DFGL +E I+ + + G+ Y APE+L +
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP- 172
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y D W +GA++ E+ P F A +MY +L P LR
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EMYD--NILNKP--------LR------- 214
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ----HPFF 284
L P+ S A L E L D +KR A + H FF
Sbjct: 215 ------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 8 KELGRGAFGRVFQA-FDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
KELG G FG V + + +G+ VA+K LKQ + + LRE + +L+H IV+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 65 LKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L + + L LV E L + + + R+ ++K QV G++Y+ F
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 124 HRDLKPEN-LLVSQGIIKIADFGLAREIKSGPP-YTNYVGSRW---YRAPEILLQSELYS 178
HRDL N LLV++ KI+DFG++R + +G Y RW + APE + + +S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FS 176
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
SK+D+W+ G + E F++ + Y + G+ + G R R
Sbjct: 177 SKSDVWSYGVTLWEAFSY---------GAKPYG--EMKGAEVIAMLESGERLPR------ 219
Query: 239 PQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRCFY 289
P+ + ++M C + P RPT +E F+R
Sbjct: 220 PEECPQEIYSIM------------LSCWKYRPEDRPTFSEL--ESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 106/422 (25%), Positives = 179/422 (42%), Gaps = 79/422 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLR 55
+++Y K++G G FG VF + T E A++ + LK+R E + EV +R
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----EKSQLVIEVNVMR 67
Query: 56 KLNHSNIVKLKELIQN--NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL---FQV 110
+L H NIV+ + N N +LY++ E + + K+F + E A + Q+
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 111 FQGLSYMHQ-----NG--FFHRDLKPENLLVSQGI------------------IKIADFG 145
L+Y H NG HRDLKP+N+ +S GI KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 146 LAREIKSGPPYTNYVGSRWYRAPEILL-QSELYSSKADMWAMGAIMAELFTFCPLFPGAS 204
L++ I + VG+ +Y +PE+LL +++ Y K+DMWA+G I+ EL + F A+
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
Query: 205 EADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESL 264
Q+ L++ P LP + S++ L ++L
Sbjct: 248 NFSQLIS---------------ELKRG-------PDLP-------IKGKSKELNILIKNL 278
Query: 265 CSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQ 324
+ +RP+A + L + K P V AA G + RR +
Sbjct: 279 LNLSAKERPSALQCLGYQIIKNV---------GPPVGAAGGGAGVAAAPGAVVARRNPSK 329
Query: 325 QQQGARMCADEASSNSQMVG-KLSPLDLIKQVQQKSVKQPKYSPAAEKKSPTSINKDKIA 383
+ G ++ A E + +++ +SP LI Q ++ + S A+ + + N I
Sbjct: 330 EHPGLQLAAMEKAKHAEAANYGISPNTLINQRNEEQHGRRSSSCASRQSANNVTNITSIT 389
Query: 384 QL 385
+
Sbjct: 390 SV 391
|
Length = 1021 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 62/208 (29%), Positives = 115/208 (55%), Gaps = 11/208 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
K+LG G FG V+ + + VA+K LK S + L E ++ L H +V+L
Sbjct: 12 KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFL--EEANLMKTLQHDKLVRLYA 68
Query: 68 LIQNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y++ E M + +L + + + P++ + Q+ +G++Y+ + + HRD
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 127 LKPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKAD 182
L+ N+LVS+ ++ KIADFGLAR I+ YT G+++ + APE + ++ K+D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEA-INFGSFTIKSD 186
Query: 183 MWAMGAIMAELFTFCPL-FPGASEADQM 209
+W+ G ++ E+ T+ + +PG S +D M
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK--------CLRKLNH 59
K +G+G+FG+V A + G+ A+K L+++ LN +E K L+ + H
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-----LNRKEQKHIMAERNVLLKNVKH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+V L Q +LY V + + R+R F EP + + ++ L Y+H
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS-FPEPRARFYAAEIASALGYLHS 114
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELY 177
+RDLKPEN+L+ SQG + + DFGL +E I T + G+ Y APE+ ++ + Y
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPY 173
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ D W +GA++ E+ P F + +MY +L P +
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYD--NILHKPLV---------------- 214
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL----QHPFFK 285
L P AS A S+ E L D +R A E +HPFF+
Sbjct: 215 -----------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 51/284 (17%)
Query: 8 KELGRGAFGRVFQAFD---EHTGEA--VAIKELKQRYASWEDCLNLREVKCLRKL-NHSN 61
K LG GAFG+V +A + VA+K LK S E + E+K + L NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IV L + ++ E C +L + + + ++ ++ +QV +G++++
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 121 GFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYV--GS-----RWYRAPEILL 172
HRDL N+L++ G I+KI DFGLAR+I + +NYV G+ +W APE +
Sbjct: 161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWM-APESIF 216
Query: 173 QSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+Y+ ++D+W+ G ++ E+F+ P +PG + YK+ +G R
Sbjct: 217 NC-VYTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYKLI-----------KEGYRM 263
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT 274
A+ A + + ++ DP KRPT
Sbjct: 264 AQPE-----------------HAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 55/299 (18%)
Query: 8 KELGRGAFGRVF---QAFDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLNH 59
+ LG GA+G+VF + G+ A+K LK Q+ + E R+V L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV--LEAVRR 63
Query: 60 SN-IVKLKELIQNNNRLYLVFEC-----MECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
+V L Q + +L+L+ + + +LYQ R+ F+E E++ ++ ++
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ------REHFTESEVRVYIAEIVLA 117
Query: 114 LSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYT--NYVGSRWYRAPEI 170
L ++HQ G +RD+K EN LL S+G + + DFGL++E + ++ G+ Y APE+
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 171 LLQSELYSSKA-DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+ KA D W++G + EL T F E + +I
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI----------------- 220
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFK 285
+R I P P + S +A + L DP KR A E HPFF+
Sbjct: 221 -SRRILKSKPPFP--------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 46/289 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC----LRKLNHSNIV 63
K LGRGAFG V+ +D TG +A+K++ S E + ++C L+ L H IV
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 64 KLKELIQN--NNRLYLVFECMECNLY--QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ +++ +L + E M QL A +E + + Q+ QG+SY+H
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS 124
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIK----SGPPYTNYVGSRWYRAPEILLQS 174
N HRD+K N+L S G +K+ DFG ++ I+ SG + G+ ++ +PE+ +
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV-ISG 183
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
E Y KAD+W++ + E+ T P + +E + M I + PT
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK------------- 227
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P LP + A +D + + + +RPTA L+HPF
Sbjct: 228 ----PMLPDG-----VSDACRD---FLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-22
Identities = 87/287 (30%), Positives = 129/287 (44%), Gaps = 42/287 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR--YASWEDCLNLREVKCLRKLNHSNIVKL 65
K LG+G FG+V ++ TG A+K LK+ A E L E + L+ H + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFH 124
K Q ++RL V E +R+R +FSE + + ++ L Y+H + +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 125 RDLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKAD 182
RDLK ENL++ + G IKI DFGL +E IK G + G+ Y APE+L ++ Y D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVD 178
Query: 183 MWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
W +G +M E+ +CG L P + D + I + + P
Sbjct: 179 WWGLGVVMYEM------------------MCGRL--PFYNQ--DHEKLFELILMEEIRFP 216
Query: 243 RANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFF 284
R + S +A SL L DP +R A E +QH FF
Sbjct: 217 R--------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 6e-22
Identities = 69/275 (25%), Positives = 131/275 (47%), Gaps = 38/275 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELK----QRYASWEDCLNLREVKCLRKLNHSNIV 63
K++GRG F V++A G VA+K+++ + DC+ +E+ L++LNH N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVI 65
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMA--ARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K +N L +V E + +L +++ + ++L E + + Q+ L +MH
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQSELYS 178
HRD+KP N+ ++ G++K+ D GL R S + VG+ +Y +PE + ++ Y+
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YN 184
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
K+D+W++G ++ E+ F G + +Y +C + + +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLC-----------------KKIEQCDY 225
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRP 273
P LP + S++ L + DP KRP
Sbjct: 226 PPLPSDHY-------SEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-22
Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 55/293 (18%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKL----NHSN 61
LG+G+FG+V A + +G A+K LK+ +D +V+C R L NH
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD-----DVECTMTEKRILSLARNHPF 57
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ +L Q +RL+ V E + + R+ F E + + ++ L ++H G
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKG 116
Query: 122 FFHRDLKPENLLVS-QGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
+RDLK +N+L+ +G K+ADFG+ +E I +G + + G+ Y APEI LQ LY
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEMLYGP 175
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D WAMG ++ E+ F +E D I
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------------------------- 209
Query: 240 QLPRANLSALMPS-ASQDAISLFESLCSWDPSKRPTAAE------ALQHPFFK 285
N + P+ SQDA+ + ++ + +P+ R + L+HPFFK
Sbjct: 210 -----NDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 8e-22
Identities = 80/300 (26%), Positives = 138/300 (46%), Gaps = 36/300 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
KY+ F+++G+GA G V+ A D TG+ VAIK++ + ++ L + E+ +R+ + NI
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKNPNI 78
Query: 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
V + + L++V E + L E +I A + Q L ++H N
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 123 FHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRD+K +N+L+ G +K+ DFG +I + VG+ ++ APE++ + + Y K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 195
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D+W++G + E+ P + + +Y I G+P + Q P+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPEL---------------QNPE 239
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
LSA+ + + D +R +A E LQHPF K A P TP +
Sbjct: 240 ----RLSAVFRDFLNRCLEM-------DVDRRGSAKELLQHPFLK---LAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 75/303 (24%), Positives = 120/303 (39%), Gaps = 30/303 (9%)
Query: 9 ELGRGAFGR--VFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSNIVKL 65
+G+ V A + T VA+K++ S ED L +E+ R+L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 66 KELIQNNNRLYLVFECME---CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
++ LY+V M C L+ + E I L V L Y+H GF
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLARE-IKSG----PPYTNYVGS----RWYRAPEILL 172
HR +K ++L+S G + ++ + IK G + S W +PE+L
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQ 181
Query: 173 QSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQMY--KICGVLGSPTMDSWADGLR 229
Q+ Y+ K+D++++G EL F A QM K+ G + +D L
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPCL-LDKSTYPLY 239
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAIS-----LFESLCSWDPSKRPTAAEALQHPFF 284
+ + + N + S E DP RP+A++ L H FF
Sbjct: 240 EDSMSQSRSS-NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
Query: 285 KRC 287
K+C
Sbjct: 299 KQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 66/222 (29%), Positives = 110/222 (49%), Gaps = 30/222 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQA----FDEHTGE-AVAIKELKQRYASWEDCLNL-REVKCLR 55
D+ + K LG GAFG+V +A D VA+K LK A+ +D +L E++ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMK 70
Query: 56 KL-NHSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARD--------------RKLFS 99
+ H NI+ L + LY+V E NL + AR + +
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 100 EPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTN 158
+ ++ ++ +QV +G+ ++ HRDL N+LV++ ++KIADFGLAR+I Y
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 159 YVGSR----WYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
R W APE L +Y+ ++D+W+ G ++ E+FT
Sbjct: 191 TTNGRLPVKWM-APEALF-DRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 57/198 (28%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
K +G G FG V + + G+ VAIK LK + + L E + + +H NI++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 65 LKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L+ ++ + + ++ E ME +L + + D K F+ ++ L + G+ Y+ + +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 124 HRDLKPENLLVSQGII-KIADFGLAREIK-SGPPYTNYVGS---RWYRAPEILLQSELYS 178
HRDL N+LV+ ++ K++DFGL+R ++ S YT G RW APE + ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA-IAYRKFT 186
Query: 179 SKADMWAMGAIMAELFTF 196
S +D+W+ G +M E+ ++
Sbjct: 187 SASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 81/303 (26%), Positives = 136/303 (44%), Gaps = 38/303 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
KY+ F+++G+GA G V+ A D TG+ VAIK++ Q+ E +N E+ +R+ H N
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN--EILVMRENKHPN 77
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IV + + L++V E + L E +I A + Q L ++H N
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 122 FFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELYSS 179
HRD+K +N+L+ G +K+ DFG +I + VG+ ++ APE++ + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGP 194
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K D+W++G + E+ P + + +Y I G+P +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP-----------------ELQ 236
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
+ + + +D ++ D KR +A E LQHPF K A P TP
Sbjct: 237 NPEK------LSAIFRDFLN---RCLEMDVEKRGSAKELLQHPFLK---IAKPLSSLTPL 284
Query: 300 VAT 302
+A
Sbjct: 285 IAA 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
F ++G G+ G V A + +G+ VA+K++ R + L EV +R H N+V++
Sbjct: 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMY 83
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ L++V E +E + R +E +I A V + LS +H G HRD
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 127 LKPENLLVSQ-GIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSEL-YSSKADM 183
+K +++L++ G +K++DFG ++ K P + VG+ ++ APE++ S L Y + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI--SRLPYGPEVDI 199
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W++G ++ E+ P + P L+ + I+ P P+
Sbjct: 200 WSLGIMVIEMVDGEPPY---------------FNEPP-------LKAMKMIRDNLP--PK 235
Query: 244 -ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
NL + PS + L DP++R TAAE L+HPF + PP
Sbjct: 236 LKNLHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFLAKA--GPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 56/294 (19%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKLNHSN---- 61
LG+G+FG+V A + T E AIK LK+ +D +V+C R L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD-----DVECTMVEKRVLALPGKPPF 62
Query: 62 IVKLKELIQNNNRLYLVFECMECN--LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ +L Q +RLY V E + +Y + F EP + ++ GL ++H
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHS 119
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQSELY 177
G +RDLK +N+++ ++G IKIADFG+ +E G T + G+ Y APEI+ + Y
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPY 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
D WA G ++ E+ P F G E D++++ +I
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQ---------------------SIMEH 216
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFKR 286
P+ S S++A+S+ + L + P+KR PT ++ H FF+R
Sbjct: 217 NVSYPK--------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 38/301 (12%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSN 61
KY+ ++++G+GA G VF A D TG+ VAIK++ Q+ E +N E+ +++L + N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN--EILVMKELKNPN 77
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IV + + L++V E + L E +I A + Q L ++H N
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 122 FFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELYSS 179
HRD+K +N+L+ G +K+ DFG +I + VG+ ++ APE++ + + Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 194
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K D+W++G + E+ P + + +Y I G+P + Q P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPEL---------------QNP 238
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
+ LS + + + D KR +A E LQHPF K A P TP
Sbjct: 239 E----KLSPIFRDFLNRCLEM-------DVEKRGSAKELLQHPFLK---LAKPLSSLTPL 284
Query: 300 V 300
+
Sbjct: 285 I 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 45/289 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQR--YASWEDCLNLREVKCLRKLNHSN---IVK 64
+G+G FG+V+Q + T A+K L ++ A E + E L + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
LK Q ++ LYLV + M L+ + R FSE K ++ ++ L ++H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKA 181
+RDLKPEN+L+ + G I + DFGL++ + TN + G+ Y APE+LL + Y+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 182 DMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D W++G ++ E+ + P + A + QMY R I + +
Sbjct: 179 DFWSLGVLVFEMCCGWSPFY--AEDTQQMY---------------------RNIAFGKVR 215
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQHPFFK 285
P+ LS + + L + +P R A E +HPFF
Sbjct: 216 FPKNVLSD-------EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 3e-21
Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 36/301 (11%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
KY+ F+++G+GA G V+ A D TG+ VAI+++ + ++ L + E+ +R+ + NI
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNI 79
Query: 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
V + + L++V E + L E +I A + Q L ++H N
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 123 FHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELYSSK 180
HRD+K +N+L+ G +K+ DFG +I + VG+ ++ APE++ + + Y K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPK 196
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D+W++G + E+ P + + +Y I G+P + Q P+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPEL---------------QNPE 240
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAV 300
LSA+ + + D KR +A E LQH F K A P TP +
Sbjct: 241 ----KLSAIFRDFLNRCLDM-------DVEKRGSAKELLQHQFLK---IAKPLSSLTPLI 286
Query: 301 A 301
A
Sbjct: 287 A 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK-CLRKLNHSNIVKLKE 67
ELGRGA+G V + TG +A+K ++ S E L ++ +R ++ V
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 68 LIQNNNRLYLVFECMECNLYQLMA-ARDRKLF-SEPEIKAWLFQVFQGLSYMHQN-GFFH 124
+ +++ E M+ +L + D+ L E + + + L Y+H H
Sbjct: 68 ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127
Query: 125 RDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL---LQSELYSSK 180
RD+KP N+L++ G +K+ DFG++ + T G + Y APE + L + Y K
Sbjct: 128 RDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVK 187
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR-AIKYQFP 239
+D+W++G M EL T FP DSW +Q + ++ P
Sbjct: 188 SDVWSLGITMIELATG--RFP-------------------YDSWKTPFQQLKQVVEEPSP 226
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
QLP S QD ++ + +RP E LQHPFF+
Sbjct: 227 QLPAEKFSPEF----QDFVN---KCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 31/210 (14%)
Query: 8 KELGRGAFGRV----FQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG+G FG V + ++TGE VA+K+L+ A RE++ L+ L H NIV
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE-REIEILKSLQHDNIV 68
Query: 64 KLKELI----QNNNRL---YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
K K + + N RL YL + + L + R+ ++ + Q+ +G+ Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-----QKHRERLDHRKLLLYASQICKGMEY 123
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSR--------WYRA 167
+ + HRDL N+LV S+ +KI DFGL + + P Y R WY A
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKVREPGESPIFWY-A 179
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFC 197
PE L +S+ +S +D+W+ G ++ ELFT+
Sbjct: 180 PESLTESK-FSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK-------CLRKLNHSNI 62
LG G+FGRV A + TGE AIK LK+R + L +++V+ L +L+H I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILMELSHPFI 80
Query: 63 VKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
V + Q+ NR+Y + E + L+ + R F K + ++ Y+H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKD 138
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
+RDLKPENLL+ ++G +K+ DFG A+++ +T G+ Y APE+ +QS+ +
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFT-LCGTPEYLAPEV-IQSKGHGKA 195
Query: 181 ADMWAMGAIMAELFTFCPLF 200
D W MG ++ E P F
Sbjct: 196 VDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 45/222 (20%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN------LREVKCLRK 56
+ELG GAFG+VF E+ E VA+K LK E N RE + L
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLK------ETASNDARKDFEREAELLTN 64
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECME---CNLYQLMAARD-RKLFSEPEIKAWL----- 107
H NIVK + + +VFE ME N + D L S L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 108 ----FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNY--V 160
Q+ G+ Y+ F HRDL N LV ++KI DFG++R++ + T+Y V
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYYRV 180
Query: 161 GS------RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
G RW PE ++ + +++++D+W+ G ++ E+FT+
Sbjct: 181 GGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 54/195 (27%), Positives = 109/195 (55%), Gaps = 12/195 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELK----QRYASWEDCLNLREVKCLRKLNHSNIV 63
K++GRG F V++A + VA+K+++ + +DC+ +E+ L++LNH N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV--KEIDLLKQLNHPNVI 65
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMA--ARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K + +N L +V E + +L Q++ + ++L E + + Q+ + +MH
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT-NYVGSRWYRAPEILLQSELYS 178
HRD+KP N+ ++ G++K+ D GL R S + VG+ +Y +PE + ++ Y+
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YN 184
Query: 179 SKADMWAMGAIMAEL 193
K+D+W++G ++ E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 50/290 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL---RKL-----NH 59
K LG+G+FG+V A + T E AIK LK+ +D +V+C R++ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD-----DVECTMVERRVLALAWEH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLM-AARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+ L Q L+ V E + N LM + F E + + ++ GL ++H
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYL--NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 119 QNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
+ G +RDLK +N+L+ G IKIADFG+ +E +G + + G+ Y APEI L+ +
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQK 172
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y+ D W+ G ++ E+ F G E D+++ +I
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFD---------------------SILN 210
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-PTAAEALQHPFFK 285
P PR S++A L DP+KR + QHPFF+
Sbjct: 211 DRPHFPR--------WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 38/287 (13%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNHSN 61
++ + +G+G+FG V++ D T E VAIK +L++ ED +E+ L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI--QQEITVLSQCDSPY 63
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
I + +L+++ E + + E I L ++ +GL Y+H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGG--SALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 122 FFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSS 179
HRD+K N+L+S QG +K+ADFG+A ++ N +VG+ ++ APE++ QS Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDF 180
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
KAD+W++G EL P P D L R +
Sbjct: 181 KADIWSLGITAIELAKGEP--------------------PNSD-----LHPMRVLFL--- 212
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+P+ + L S+ E+ + DP RPTA E L+H F R
Sbjct: 213 -IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 7e-21
Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 46/289 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC----LRKLNHSNIV 63
K LG+GAFGRV+ +D TG +A K+++ S E + ++C L+ L H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 64 KLKELIQNNNR--LYLVFECMECNLY--QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ +++ L + E M QL A +E + + Q+ +G+SY+H
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS 124
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIK----SGPPYTNYVGSRWYRAPEILLQS 174
N HRD+K N+L S G +K+ DFG ++ ++ SG + G+ ++ +PE+ +
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV-ISG 183
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
E Y KAD+W++G + E+ T P + +E + M I + PT
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN------------- 227
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
PQL PS + F + RP+A E L+HPF
Sbjct: 228 ----PQL---------PSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 82/286 (28%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIVKL 65
K LG+G FG+V ++ TG A+K L++ A E + E + L+ H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
K Q ++RL V E +R+R +F+E + + ++ L Y+H +R
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 126 DLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADM 183
D+K ENL++ + G IKI DFGL +E I G + G+ Y APE+L ++ Y D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 178
Query: 184 WAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
W +G +M E+ +CG L P + D R I + + PR
Sbjct: 179 WGLGVVMYEM------------------MCGRL--PFYNQ--DHERLFELILMEEIRFPR 216
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFF 284
+ S +A SL L DP +R A E ++H FF
Sbjct: 217 --------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 50/295 (16%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKEL-----KQRYASWEDCLNLREVKCLRKLNHSN 61
++ LG+G FG V TG+ A K+L K+R + + L E + L K+N
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKQILEKVNSRF 61
Query: 62 IVKLKELIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+V L + + L LV M + ++Y + F E + ++ GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCGLED 117
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+H+ +RDLKPEN+L+ G I+I+D GLA EI G VG+ Y APE+ +++E
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV-VKNE 176
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y+ D W +G ++ E+ G S Q R+ + +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIE------GKSPFRQ--------------------RKEKVKR 210
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+ + + + S+ A S+ L + DP R A E HPFF+
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 91/343 (26%), Positives = 145/343 (42%), Gaps = 88/343 (25%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKL----NHS 60
K +GRGAFG V + TG A+K+L++ + L + V+ R + ++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-----SEMLEKEQVAHVRAERDILAEADNP 61
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+VKL Q+ N LYL+ E + ++ L+ +D F+E E + ++ + + +H+
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK 119
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGL------------AREIKSGPPYTNY------- 159
G+ HRD+KP+NLL+ ++G IK++DFGL R + P
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 160 --------------------VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL 199
VG+ Y APE+ LQ+ Y+ + D W++G IM E+ P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP 238
Query: 200 FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAIS 259
F + + KI +W + L QFP LS +A
Sbjct: 239 FCSDNPQETYRKII---------NWKETL--------QFP--DEVPLSP-------EAKD 272
Query: 260 LFESLCSWDPSKR---PTAAEALQHPFFKRCFYAPPHIRSTPA 299
L + LC + +R E HPFFK + HIR PA
Sbjct: 273 LIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE--HIRERPA 312
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 59/190 (31%), Positives = 103/190 (54%), Gaps = 11/190 (5%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
+G+G FG V ++ G VA+K +K + L E + +L HSN+V+L +I
Sbjct: 14 IGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 70 -QNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ LY+V E M + +L + +R R + + + V + + Y+ N F HRDL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128
Query: 128 KPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAM 186
N+LVS+ + K++DFGL +E S T + +W APE L+ + +S+K+D+W+
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKW-TAPEA-LREKKFSTKSDVWSF 185
Query: 187 GAIMAELFTF 196
G ++ E+++F
Sbjct: 186 GILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 64/207 (30%), Positives = 115/207 (55%), Gaps = 14/207 (6%)
Query: 8 KELGRGAFGRVFQA-FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
K+LG G FG V+ A +++HT VA+K +K S E L E ++ L H +VKL
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA--EANVMKTLQHDKLVKLH 67
Query: 67 ELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
++ +Y++ E M +L + + + P++ + Q+ +G++++ Q + HR
Sbjct: 68 AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 126 DLKPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKA 181
DL+ N+LVS ++ KIADFGLAR I+ YT G+++ + APE + ++ K+
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFGS-FTIKS 184
Query: 182 DMWAMGAIMAELFTFCPL-FPGASEAD 207
D+W+ G ++ E+ T+ + +PG S +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 84/299 (28%), Positives = 140/299 (46%), Gaps = 49/299 (16%)
Query: 7 FKELGRGAFGRVF---QAFDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLN 58
K LG GA+G+VF + +G+ A+K LK Q+ + E R+V L +
Sbjct: 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIR 62
Query: 59 HSN-IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
S +V L Q + +L+L+ + + L+ ++ R+R F E E++ + ++ L +
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEH 120
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY--VGSRWYRAPEILLQ 173
+H+ G +RD+K EN+L+ S G + + DFGL++E Y G+ Y AP+I+
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 174 SELYSSKA-DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ KA D W+MG +M EL T F E + +I +R
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI------------------SR 222
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL-QHPFFKR 286
I P P+ +SAL A + + L DP KR P+ A+ + +HPFF++
Sbjct: 223 RILKSEPPYPQ-EMSAL-------AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 45/288 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKEL----KQRYASWEDCLNLRE-VKCLRKLNHSNIVK 64
LG+GA+G V+ + G+ +A+K++ A+ ++ L+E V L+ L H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDR-KLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
++N + + E + + + +R EP + Q+ G++Y+H N
Sbjct: 67 YLGTCLDDNTISIFMEFVPGG--SISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 124 HRDLKPEN-LLVSQGIIKIADFGLAREI---KSGPPYTNYV----GSRWYRAPEILLQSE 175
HRD+K N +L+ GIIK+ DFG AR + ++N + G+ ++ APE++ +S
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y K+D+W++G + E+ T P M+ I G
Sbjct: 185 -YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAHRGL---------------- 226
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P+LP S S AI S + D +RP+A + L+H F
Sbjct: 227 --MPRLPD--------SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLK 66
ELG+G +G V++ TG +A+KE+ R E N + E+ L K IV
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 67 ELIQNNNRLYLVFECMEC----NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM-HQNG 121
+Y+ E M+ LY A + E ++ + V +GL ++ ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKEEHN 123
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL-----LQSE 175
HRD+KP N+LV G +K+ DFG++ + + TN +G + Y APE + Q+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQNP 182
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEAD---QMYKICGVLGSPTMDSWADGLRQAR 232
Y+ ++D+W++G + E+ +P + A+ Q+ I G P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP------------- 227
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
P LP S DA + P++RPT A+ L+HP+ +
Sbjct: 228 ------PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 46/289 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC----LRKLNHSNIV 63
K LG+GAFGRV+ +D TG +A+K+++ S E + ++C L+ L H IV
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 64 K----LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ L++ ++ +++ QL + +E + + Q+ +G+SY+H
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIK----SGPPYTNYVGSRWYRAPEILLQS 174
N HRD+K N+L S G +K+ DFG ++ ++ SG + G+ ++ +PE+ +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV-ISG 183
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
E Y KAD+W++G + E+ T P + +E + M I + PT
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------------- 227
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
P LP P S + + + RP+A E L+H F
Sbjct: 228 ----PVLP--------PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 8 KELGRGAFGRV----FQAFDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLN 58
+ LG G FG+V + ++ TGE VA+K LK Q + W+ +E+ L+ L
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-----KEINILKTLY 64
Query: 59 HSNIVKLKELI--QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
H NIVK K Q L L+ E + L L + + ++ + Q+ +G++Y
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSR-------WYRAP 168
+H + HRDL N+L+ + ++KI DFGLA+ + G Y Y WY A
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFWY-AV 179
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFC 197
E L +++ + +D+W+ G + EL T C
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELLTHC 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 82/293 (27%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLKE 67
LG+G FG V TG+ A K+L ++ + E + L K++ IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 68 LIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
Q L LV M ++Y + + F EP + Q+ GL ++HQ
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNV--DEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 123 FHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSK 180
+RDLKPEN LL + G ++I+D GLA E+K G T Y G+ + APE LLQ E Y
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE-LLQGEEYDFS 177
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D +A+G + E+ A G +AR K + +
Sbjct: 178 VDYFALGVTLYEMIA-----------------------------ARGPFRARGEKVENKE 208
Query: 241 LPRANLSALMPSA---SQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
L + L+ + S + S E+L + DP KR HP F+
Sbjct: 209 LKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 36/243 (14%)
Query: 8 KELGRGAFGRV-----FQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHS 60
+ELG GAFG+V + + +VAIK LK+ ++ +E + + L H
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAELMSDLQHP 68
Query: 61 NIVKLKELIQNNNRLYLVFECME-CNLYQLMAARD--------------RKLFSEPEIKA 105
NIV L + ++FE + +L++ + + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 106 WLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGS-- 162
Q+ G+ Y+ + F HRDL N LV +G+ +KI+DFGL+R+I S Y S
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 163 --RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKI--CGVL 216
RW PE +L + +++++D+W+ G ++ E+F++ P + G S + + I +L
Sbjct: 189 PVRWM-PPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEMIRSRQLL 245
Query: 217 GSP 219
P
Sbjct: 246 PCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRY----ASWEDCLNLREVKCLRKLNHSNIV 63
K +G+G+FG+V A + G A+K L+++ + R V L+ L H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L Q +LY V + + R+R F EP + + +V + Y+H
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC-FLEPRARFYAAEVASAIGYLHSLNII 118
Query: 124 HRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
+RDLKPEN+L+ SQG + + DFGL +E ++ + + G+ Y APE+ L+ E Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-LRKEPYDRTV 177
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSP 219
D W +GA++ E+ P F + + QMY +L P
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY-SRDVSQMYD--NILHKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 8 KELGRGAFGRVFQA-------FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+++G+GAFGRVFQA ++ T VA+K LK+ ++ RE + + +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 61 NIVKLKELIQNNNRLYLVFECME----------CNLYQLMAAR-----------DRKLFS 99
NIVKL + + L+FE M + + + S
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 100 EPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPY-- 156
E QV G++Y+ + F HRDL N LV + ++KIADFGL+R I S Y
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 157 --TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+ + RW PE + + Y++++D+WA G ++ E+F++
Sbjct: 189 SENDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSY 228
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 89/315 (28%), Positives = 137/315 (43%), Gaps = 54/315 (17%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+G+G+FG+V Q T A+K +++ + + E L E L ++N IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRK-LFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q+ +LYLV + N +L R+ F + + ++ L +H+ +RD
Sbjct: 61 SFQSPEKLYLVLAFI--NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYSSKADMW 184
LKPEN+L+ QG I + DFGL + TN + G+ Y APE+LL Y+ D W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAVDWW 177
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
+G ++ E+ T P F ++MY+ +L P + DG
Sbjct: 178 TLGVLLYEMLTGLPPFYD-ENVNEMYR--KILQEPLR--FPDGFD--------------- 217
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFF-----KRCF---YAPPH 293
+DA L L S DP++R A E HPFF K+ PP
Sbjct: 218 ----------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267
Query: 294 IRSTPAVATT--TAN 306
PAV++ T+N
Sbjct: 268 ---KPAVSSAIDTSN 279
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 62/189 (32%), Positives = 97/189 (51%), Gaps = 7/189 (3%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKE 67
LG+G FG V ++TG+ A K+L ++ + + + L E + L K+N IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 68 LIQNNNRLYLVFECMECN--LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
++ L LV M Y + +R L E + + Q+ G+ ++H +R
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-RVIHYSAQITCGILHLHSMDIVYR 119
Query: 126 DLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
D+KPEN+L+ QG +++D GLA E+K G T G+ Y APEIL + E YS D +
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPVDWF 178
Query: 185 AMGAIMAEL 193
AMG + E+
Sbjct: 179 AMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 83/289 (28%), Positives = 139/289 (48%), Gaps = 38/289 (13%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK---CLRKLNHSNIVKLK 66
+GRG++ +V + T A+K +K+ + ++ ++ + + + NH +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLF--QVFQGLSYMHQNGFFH 124
Q +RL+ V E + R RKL PE A + ++ L+Y+H+ G +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---PEEHARFYSAEISLALNYLHERGIIY 119
Query: 125 RDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKAD 182
RDLK +N+L+ S+G IK+ D+G+ +E ++ G + + G+ Y APEI L+ E Y D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI-LRGEDYGFSVD 178
Query: 183 MWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
WA+G +M E+ G S D I G +P ++ D L Q I + ++P
Sbjct: 179 WWALGVLMFEMMA------GRSPFD----IVGSSDNPDQNT-EDYLFQ--VILEKQIRIP 225
Query: 243 RANLSALMPSASQDAISLFESLCSWDPSKR----PTA--AEALQHPFFK 285
R S S A S+ +S + DP +R P A+ HPFF+
Sbjct: 226 R--------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 1 MDKYSGFKELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCL 54
+K + +ELG+G+FG V++ VAIK + + AS + + L E +
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVM 63
Query: 55 RKLNHSNIVKLKELIQNNNRLYLVFECMECN-----LYQLMA-ARDRKLFSEP---EIKA 105
++ N ++V+L ++ +V E M L A + P +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 106 WLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY----- 159
++ G++Y+ F HRDL N +V++ +KI DFG+ R+I T+Y
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY----ETDYYRKGG 179
Query: 160 ---VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211
+ RW APE L+ ++++K+D+W+ G ++ E+ T A+Q Y+
Sbjct: 180 KGLLPVRWM-APES-LKDGVFTTKSDVWSFGVVLWEMATL---------AEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-19
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 44/295 (14%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSN 61
+ ++ LG+G FG V TG+ A K L+++ + + L E + L K+N
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 62 IVKLKELIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+V L + + L LV M + ++Y + F E + ++ GL
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLED 117
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+H+ +RDLKPEN+L+ G I+I+D GLA +I G VG+ Y APE+ L ++
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV-LNNQ 176
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y+ D W +G ++ E+ F G R+ + +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG--------------------------RKEKVKR 210
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+ + S++A S+ + L + DP +R A E +HPFF+
Sbjct: 211 EEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLR-------EVKCL 54
D K +G G FGRV D + A+K + + + L+ E + L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVL 55
Query: 55 RKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
++++H I++L + LY++ E + R+ FS + ++ L
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYV-PGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 115 SYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H +RDLKPEN+L+ +G IK+ DFG A+++ +T G+ Y APE+ +Q
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT-LCGTPEYLAPEV-IQ 171
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLF 200
S+ ++ D WA+G ++ E+ P F
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 85/301 (28%), Positives = 143/301 (47%), Gaps = 52/301 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D + + +G+G +G+VF+ ++ G A+K L + E+ E L+ L +H
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHP 75
Query: 61 NIVKL-----KELIQNNNRLYLVFECMECN------LYQLMAARDRKLFSEPEIKAWLFQ 109
N+VK K+ ++N ++L+LV E CN L + R ++ EP I L +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLEL--CNGGSVTDLVKGFLKRGERM-EEPIIAYILHE 132
Query: 110 VFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNY-VGSRWYRA 167
GL ++H N HRD+K N LL ++G +K+ DFG++ ++ S N VG+ ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 168 PEIL-LQSEL---YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
PE++ + +L Y ++ D+W++G EL D G P +
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL------------GD---------GDPPL-- 229
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHP 282
AD L RA+ ++ P+ P L P + + F C + D KRPT ++ LQH
Sbjct: 230 -AD-LHPMRAL-FKIPRNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284
Query: 283 F 283
F
Sbjct: 285 F 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 26/222 (11%)
Query: 8 KELGRGAFGRVFQA-FDEHTGE--AVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNI 62
K+LG G+FG V + + G+ VA+K LK S D ++ L+E + L+H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENL 58
Query: 63 VKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLF--QVFQGLSYMHQ 119
++L ++ + L +V E +L + R L + Q+ G+ Y+
Sbjct: 59 IRLYGVVLTH-PLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYR------APEILL 172
F HRDL N+L+ S +KI DFGL R + + YV + APE L
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAWCAPES-L 172
Query: 173 QSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKI 212
++ +S +D+W G + E+FT+ P + G S + + KI
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP-WAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
K+LG G FG V+ + VAIK LKQ S L E +++L H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 68 LIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y++ E ME +L + + + ++ Q+ +G++++ + + HRD
Sbjct: 69 VV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 127 LKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKAD 182
L+ N+LVS+ + KIADFGLAR I+ YT G+++ + APE + ++ K+D
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA-INYGTFTIKSD 185
Query: 183 MWAMGAIMAELFTFCPL-FPG 202
+W+ G ++ E+ T+ + +PG
Sbjct: 186 VWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVK 64
++ LG+G FG V TG+ A K+L+++ + + L E + L K+N +V
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 65 LKELIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
L + + L LV M + ++Y + A F E + ++ GL +HQ
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLEDLHQ 120
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
+RDLKPEN+L+ G I+I+D GLA + G VG+ Y APE+ +++E Y+
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNERYT 179
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
D WA+G ++ E+ G S Q R+ + + +
Sbjct: 180 FSPDWWALGCLLYEMIA------GQSPFQQ--------------------RKKKIKREEV 213
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFKR 286
+L + S DA SL + L DP +R A E +HP FK+
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 8 KELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K LG GAFG V++ GE VAIK L++ + + L E + ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 64 KLKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+L I ++++ L+ + M C L + +D + W Q+ +G+SY+ +
Sbjct: 73 RLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSEL 176
HRDL N+LV + +KI DFGLA+ + + G +W A E +L
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILHRI- 187
Query: 177 YSSKADMWAMGAIMAELFTF 196
Y+ K+D+W+ G + EL TF
Sbjct: 188 YTHKSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 8 KELGRGAFGRVFQAFDE--HTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIV 63
ELG G FG V + + + + VA+K LK + +D L LRE +++L++ IV
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDEL-LREANVMQQLDNPYIV 59
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
++ + + + LV E E +++ + +E I + QV G+ Y+ + F
Sbjct: 60 RMIGICEAES-WMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFV 117
Query: 124 HRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNYVGS-----RWYRAPEILLQSELY 177
HRDL N LLV+Q KI+DFGL++ + + Y +WY APE + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APEC-MNYYKF 175
Query: 178 SSKADMWAMGAIMAELFTF 196
SSK+D+W+ G +M E F++
Sbjct: 176 SSKSDVWSFGVLMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 39/244 (15%)
Query: 50 EVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAW 106
E+ CL +H IVK + +++++L L+ E + N ++ F E E+
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENL-LVSQGIIKIADFGLAREIKSGPPY---TNYVGS 162
+Q+ L +H HRDLK N+ L+ GIIK+ DFG +++ +++ G+
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222
+Y APE L + + YS KADMW++G I+ EL T F G S+ + M
Sbjct: 235 PYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM------------- 280
Query: 223 SWADGLRQARAIKYQ-FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+Q KY FP + + AL+ + L S +P+ RPT + L
Sbjct: 281 ------QQVLYGKYDPFPCPVSSGMKALL-----------DPLLSKNPALRPTTQQLLHT 323
Query: 282 PFFK 285
F K
Sbjct: 324 EFLK 327
|
Length = 478 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-19
Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 11/193 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
K+LG G FG V+ + VA+K LK S E L E + ++KL H +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE--EAQIMKKLRHDKLVQLYA 68
Query: 68 LIQNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ + +Y+V E M + +L + + + P + QV G++Y+ + + HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127
Query: 127 LKPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKAD 182
L+ N+LV G++ KIADFGLAR I+ YT G+++ + APE L ++ K+D
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKSD 185
Query: 183 MWAMGAIMAELFT 195
+W+ G ++ EL T
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 10/209 (4%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRY----ASWEDCLNLREVKCLRKLNHSNIV 63
K +G+G+FG+V A + + A+K L+++ + ++ R V L+ + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L Q ++LY V + + R+R F EP + + ++ L Y+H
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 124 HRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
+RDLKPEN+L+ SQG I + DFGL +E I+ + + G+ Y APE+ L + Y
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-LHKQPYDRTV 177
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMY 210
D W +GA++ E+ P F + A +MY
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTA-EMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 66/214 (30%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 4 YSGFKE---LGRGAFGRVF----QAFDEHTGEA-VAIKELKQRYASWEDCLN--LREVKC 53
S +E LGRG FG VF + +E GE V +K L++ E+ + RE+
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDM 61
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAA---RDRKLFSEP----EIKA 105
RKL+H N+V+L L + Y++ E + +L Q + A +D KL P + A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 106 WLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGP--PYTN-YVG 161
Q+ G+ ++ F HRDL N LV SQ +K++ L++++ + N +
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFT 195
RW APE + + + +S+K+D+W+ G +M E+FT
Sbjct: 182 LRWL-APEAVQEDD-FSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 49/291 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL--REVKCLRKLNHSNIVKLKE 67
+GRG FG V ++ TG+ A+K +K+ ++ ++ E L N I +L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q+ + LYLV E +L L+ R F E + +L ++ + +HQ G+ HRD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 127 LKPENLLVSQ-GIIKIADFGLA------REIKSGPPYTNYVGSRWYRAPEILL-----QS 174
+KPEN+L+ + G IK+ADFG A + + S P VG+ Y APE+L
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAPEVLTTMNGDGK 183
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y + D W++G I E+ F + A I + R +
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI---------------MNFQRFL 228
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESL-CSWDPSKRPTAAEALQHPFF 284
K FP+ P+ S D + L +SL C +R HPFF
Sbjct: 229 K--FPEDPK---------VSSDFLDLIQSLLCG--QKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 9e-19
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 9 ELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
ELG GAFG+VF A E VA+K LK+ S RE + L L H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTVLQHQHIV 70
Query: 64 KLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSE-----------PEIKAWLFQ 109
+ + L +VFE M + N + D K+ + ++ A Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS------ 162
+ G+ Y+ F HRDL N LV QG ++KI DFG++R+I S Y VG
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPI 188
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
RW IL + +++++D+W+ G ++ E+FT+
Sbjct: 189 RWMPPESILYRK--FTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL--NLREVKCLRKLNHSN-IVKLK 66
LG+G+FG+V A + T E AIK LK+ +D + + E + L + + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q +RLY V E + + K F EP+ + ++ GL ++H+ G +RD
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 127 LKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
LK +N+++ S+G IKIADFG+ +E + G + G+ Y APEI + + Y D W
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI-IAYQPYGKSVDWW 185
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
A G ++ E+ P F G E D++++ +I P+
Sbjct: 186 AYGVLLYEMLAGQPPFDGEDE-DELFQ---------------------SIMEHNVSYPK- 222
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL-QHPFFKR 286
S S++A+S+ + L + PSKR P + +H FF+R
Sbjct: 223 -------SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 52/291 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKLN----H 59
K LG+G+FG+VF A + T + AIK LK+ +D +V+C R L+ H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD-----DVECTMVEKRVLSLAWEH 55
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN--LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ L Q L+ V E + ++ + + F P + ++ GL ++
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFL 112
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSE 175
H G +RDLK +N+L+ + G IKIADFG+ +E G T + G+ Y APEILL +
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-GQ 171
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y++ D W+ G ++ E+ F G E + I MD+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDN------------ 212
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-PTAAEALQHPFFK 285
P PR +++A + L +P +R + QHPFF+
Sbjct: 213 ---PCYPRW--------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL----RKLNHSN---- 61
LG+G+FG+V A + T E AIK LK+ +D +V+C R L S
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD-----DVECTMVEKRVLALSGKPPF 62
Query: 62 IVKLKELIQNNNRLYLVFECMECN--LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+ +L Q +RLY V E + +YQ+ F EP + ++ GL ++H
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHS 119
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELY 177
G +RDLK +N+++ S+G IKIADFG+ +E + G + G+ Y APEI + + Y
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQPY 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211
D WA G ++ E+ F G E D++++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 62/192 (32%), Positives = 105/192 (54%), Gaps = 11/192 (5%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL 68
+LG+G FG V+ T VAIK LK S E L +E + ++KL H +V+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLRHEKLVQLYAV 69
Query: 69 IQNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ + +Y+V E M + +L + K P++ Q+ G++Y+ + + HRDL
Sbjct: 70 V-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 128 KPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKADM 183
+ N+LV + ++ K+ADFGLAR I+ YT G+++ + APE L ++ K+D+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKSDV 186
Query: 184 WAMGAIMAELFT 195
W+ G ++ EL T
Sbjct: 187 WSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREV-KCLRKLNHSN--IVK 64
K LG+G+FG+V A + GE A+K LK+ +D + V K + L N +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 65 LKELIQNNNRLYLVFECMECNLYQLM-AARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L Q L+ V E + N LM +D+ F + ++ GL ++H G
Sbjct: 61 LYCTFQTKEHLFFVMEFL--NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 124 HRDLKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
+RDLK +N+++ + G IKIADFG+ +E + + + G+ Y APEI LQ Y+
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI-LQGLKYTFSV 177
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D W+ G ++ E+ F G E D++++ +I+ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDE-DELFE---------------------SIRVDTPHY 215
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ-HPFFK 285
PR ++++ + E L DP++R ++ HPFFK
Sbjct: 216 PRW--------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 68/253 (26%), Positives = 103/253 (40%), Gaps = 60/253 (23%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQ--RYASWEDCLNLREVKCLRKLNHS 60
+ LG GAFG V++ + VA+K L + D L E + K NH
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM--EALIMSKFNHQ 69
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLF--------SEPEIKAWL----- 107
NIV+L + +++ E LMA D K F P
Sbjct: 70 NIVRLIGVSFERLPRFILLE--------LMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 108 -FQVFQGLSYMHQNGFFHRDLKPEN-LLVSQG---IIKIADFGLAREIKSGPPYTNYVGS 162
V +G Y+ +N F HRD+ N LL +G + KIADFG+AR+I +
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI---------YRA 172
Query: 163 RWYR------------APEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGAS--EAD 207
+YR PE L +++SK D+W+ G ++ E+F+ + +PG + E
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 208 QMYKICGVLGSPT 220
+ G L P
Sbjct: 232 EFVTGGGRLDPPK 244
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 8 KELGRGAFGRVFQAFDEH-TGEA----VAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
K LG G FG+V +A G A VA+K LK+ +S E L E L+++NH ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 63 VKLKELIQNNNRLYLVFEC---------------MECNLYQLMAARDRKLFSEPEIKA-- 105
+KL + L L+ E + + R+ P+ +A
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 106 ------WLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT- 157
+ +Q+ +G+ Y+ + HRDL N+LV++G +KI+DFGL+R++ Y
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 158 ---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+ +W A E L +Y++++D+W+ G ++ E+ T
Sbjct: 186 RSKGRIPVKWM-AIESLF-DHIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 10 LGRGAFGRVFQAFDEHTGEA---VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
+G G FG V + + G+ VAIK LK Y + L E + + +H NI+ L+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 67 ELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
++ + + ++ E ME L + D + F+ ++ L + G+ Y+ + + HR
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLSEMNYVHR 130
Query: 126 DLKPENLLVSQGII-KIADFGLAR---EIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
DL N+LV+ ++ K++DFGL+R + S P YT+ +G RW APE + +
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEA-IAYRKF 188
Query: 178 SSKADMWAMGAIMAELFTF 196
+S +D+W+ G +M E+ ++
Sbjct: 189 TSASDVWSYGIVMWEVMSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 87/301 (28%), Positives = 133/301 (44%), Gaps = 56/301 (18%)
Query: 7 FKELGRGAFGRVF---QAFDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLN 58
K LG GA+G+VF + TG+ A+K L+ Q+ + E R V L +
Sbjct: 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LEHVR 62
Query: 59 HSN-IVKLKELIQNNNRLYLVFEC-----MECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
S +V L Q +L+L+ + M +LYQ R FSE E++ + ++
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ------RDNFSEDEVRFYSGEIIL 116
Query: 113 GLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY--VGSRWYRAPE 169
L ++H+ G +RD+K EN+L+ S+G + + DFGL++E S Y G+ Y APE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
I+ + D W++G ++ EL T F E + ++
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----------------- 219
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFF 284
+R I P P S + P A QD L L DP KR P A ++ HPFF
Sbjct: 220 -SRRILKCDPPFP----SFIGPEA-QD---LLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
Query: 285 K 285
K
Sbjct: 271 K 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-18
Identities = 63/192 (32%), Positives = 104/192 (54%), Gaps = 11/192 (5%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL 68
+LG+G FG V+ T + VAIK LK E L +E + ++KL H +V L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFL--QEAQIMKKLRHDKLVPLYAV 69
Query: 69 IQNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ + +Y+V E M + +L + D K P++ Q+ G++Y+ + + HRDL
Sbjct: 70 V-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 128 KPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELYSSKADM 183
+ N+LV ++ KIADFGLAR I+ YT G+++ + APE L ++ K+D+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKSDV 186
Query: 184 WAMGAIMAELFT 195
W+ G ++ EL T
Sbjct: 187 WSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 89/341 (26%), Positives = 142/341 (41%), Gaps = 75/341 (21%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLR-EVKCLRKLNH 59
D + K +GRGAFG V + TG A+K L K E ++R E L + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+ +VK+ Q+ LYL+ E + ++ L+ +D SE + ++ + + +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIH 118
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLA------------REIKSGPP----YTNY-- 159
Q GF HRD+KP+NLL+ ++G +K++DFGL R + PP + N
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 160 ------------------VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFP 201
VG+ Y APE+ +Q+ Y+ D W++G IM E+ P F
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 202 GASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLF 261
+ + K+ +W + L P++P S+ A L
Sbjct: 238 SETPQETYRKVM---------NWKETLVFP-------PEVP----------ISEKAKDLI 271
Query: 262 ESLCSWDPSKR---PTAAEALQHPFFKRCFYAPPHIRSTPA 299
C+ D R E HPFF+ + HIR PA
Sbjct: 272 LRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG--HIRERPA 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 42/291 (14%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-----NHSNIVK 64
+GRG++ +V + T A+K +K+ + ++ ++ V+ + + NH +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE--DIDWVQTEKHVFETASNHPFLVG 60
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLF--QVFQGLSYMHQNGF 122
L Q +RL+ V E + R RKL PE A + ++ L+++H+ G
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKL---PEEHARFYSAEISLALNFLHERGI 117
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSK 180
+RDLK +N+L+ ++G IK+ D+G+ +E I+ G + + G+ Y APEI L+ E Y
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-LRGEDYGFS 176
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
D WA+G +M E+ G S D I G+ +P ++ D L Q I + +
Sbjct: 177 VDWWALGVLMFEMMA------GRSPFD----IVGMSDNPDQNT-EDYLFQ--VILEKQIR 223
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKR------PTAAEALQHPFFK 285
+PR S S A S+ + + DP +R + HPFF+
Sbjct: 224 IPR--------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
K +G G FG VF+ + G AVAIK LK Y + L E + + +H NI++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 65 LKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L+ ++ ++ E ME L + + D + FS ++ L + G+ Y+ +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGP--PYTNYVGS---RWYRAPEILLQSELY 177
HRDL N+LV S K++DFGL+R ++ P YT G RW APE + + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEAIAYRK-F 187
Query: 178 SSKADMWAMGAIMAELFTF 196
+S +D+W+ G +M E+ +F
Sbjct: 188 TSASDVWSFGIVMWEVMSF 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSN---IVK 64
+GRG FG V+ TG+ A+K L ++ + + L L E L ++ + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 65 LKELIQNNNRLYLVFECMECN--LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+ ++L + + M Y L +FSE E++ + ++ GL +MH
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKA 181
+RDLKP N+L+ + G ++I+D GLA + P+ + VG+ Y APE+L + Y S A
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSA 177
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D +++G ++ +L G S Q D R +L
Sbjct: 178 DWFSLGCMLFKLLR------GHSPFRQHKT-------------KDKHEIDRMTLTMAVEL 218
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
P S S + SL E L D ++R A E +HPFF+
Sbjct: 219 PD--------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVK 64
++ LG+G FG V TG+ A K+L+++ + + L E + L K+N +V
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 65 LKELIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
L + + L LV M + ++Y + F E + ++ GL + +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNM----GNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
+RDLKPEN+L+ +G I+I+D GLA +I G VG+ Y APE+ + +E Y+
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV-INNEKYT 179
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
D W +G ++ E+ G S + R+ R + +
Sbjct: 180 FSPDWWGLGCLIYEMIQ------GQSPFRK--------------------RKERVKREEV 213
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+ + + S+DA S+ L + +P +R AA QHP FK
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 59/294 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ +G G +G V++A + +TGE AIK +K + +E+ ++ HSNIV
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-QEIIMMKDCKHSNIVAYFG 73
Query: 68 LIQNNNRLYLVFECME-C------NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
++L++ CME C ++Y + SE +I + QGL Y+H
Sbjct: 74 SYLRRDKLWI---CMEFCGGGSLQDIYHVTGP-----LSESQIAYVSRETLQGLYYLHSK 125
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNYVGSRWYRAPEI--LLQSEL 176
G HRD+K N+L++ G +K+ADFG++ +I + +++G+ ++ APE+ + +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y+ D+WA+G EL P P D L RA
Sbjct: 186 YNQLCDIWAVGITAIELAELQP--------------------PMFD-----LHPMRA--- 217
Query: 237 QFPQLPRANLSALMPSASQDAISLFESL-------CSWDPSKRPTAAEALQHPF 283
L S P +D + S + +P KRPTA + LQHPF
Sbjct: 218 ----LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL--KE 67
LG GA G V + ++TG A+K + LRE++ + IVK
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 68 LIQNNNRLYLVFECMEC----NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L ++++ + + E E ++Y+ + R ++ E + V +GLSY+H
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI-GEKVLGKIAESVLKGLSYLHSRKII 127
Query: 124 HRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKAD 182
HRD+KP N+L++ +G +K+ DFG++ E+ + T + G+ +Y APE +Q + YS +D
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE-RIQGKPYSITSD 185
Query: 183 MWAMGAIMAELFTFCPLFPGASEADQMYKICGVLG------SPTM-DSWADGLRQARAIK 235
+W++G + E+ FP E + +L +P + D +G++ + K
Sbjct: 186 VWSLGLTLLEVAQNR--FPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK 243
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFK 285
F C DP++RPT + L+HP+ K
Sbjct: 244 D------------------------FIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 45/223 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIK--------ELKQRYASWEDCLNLREVKCLRKLNH 59
+++G+G FG V++ + E VA+K +LK+++ L+E + L++ +H
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKF--------LQEAEILKQYDH 51
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARD-----RKLFSEPEIKAWLFQVFQ-- 112
NIVKL + +Y+V E L+ RK + +K L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVME--------LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAA 103
Query: 113 -GLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSR-----WY 165
G+ Y+ HRDL N LV + ++KI+DFG++RE + G YT G + W
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKW- 161
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEA 206
APE L Y+S++D+W+ G ++ E F+ P +PG S
Sbjct: 162 TAPEALNYGR-YTSESDVWSYGILLWETFSLGDTP-YPGMSNQ 202
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 52/303 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D + + +G+G +G+V++ ++ G A+K L E+ E L+ L NH
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE--AEYNILQSLPNHP 79
Query: 61 NIVKLKELIQNNNR-----LYLVFECMECN------LYQLMAARDRKLFSEPEIKAWLFQ 109
N+VK + ++ L+LV E CN L + + ++L E I L+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLEL--CNGGSVTELVKGLLICGQRL-DEAMISYILYG 136
Query: 110 VFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNY-VGSRWYRA 167
GL ++H N HRD+K N LL ++G +K+ DFG++ ++ S N VG+ ++ A
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196
Query: 168 PEILLQSELYSS----KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
PE++ + Y + D+W++G EL P ++KI
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI----------- 245
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW-DPSKRPTAAEALQHP 282
P+ P L L P + + F S C D RP+ L+HP
Sbjct: 246 ---------------PRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288
Query: 283 FFK 285
F K
Sbjct: 289 FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 81/292 (27%), Positives = 126/292 (43%), Gaps = 46/292 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLR-EVKCLRKLNHSNIVKLKEL 68
LG GA G V A GE A+K + S D + EV CL + +IVK E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 69 I--------QNNNRLYLVFECMEC-NLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYM 117
+N + LV + +L Q + +R + + F E E QV + ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159
Query: 118 HQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIK---SGPPYTNYVGSRWYRAPEILLQ 173
H HRD+K N LL S G++K+ DFG ++ S + G+ +Y APEI +
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
YS KADM+++G ++ EL T F G + + M+K
Sbjct: 220 KP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK---------------------T 257
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ ++ LP PS S + + +L S DP +RP++++ L P K
Sbjct: 258 LAGRYDPLP--------PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 77/312 (24%), Positives = 126/312 (40%), Gaps = 59/312 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIK----ELKQRYASWEDCLN--LREVKCLRKLNHSN 61
ELG G G V + +G +A K E+K N +RE+K L + N
Sbjct: 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECNSPY 60
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN- 120
IV ++ + + E M+ + + ++ E + V +GL+Y+ +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREKH 119
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRD+KP N+LV S+G IK+ DFG++ + I S ++VG+R Y +PE LQ Y+
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE-RLQGTHYT 176
Query: 179 SKADMWAMGAIMAELFT------------FCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
++D+W++G + E+ +F + + + DS
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS--- 233
Query: 227 GLRQARAIKYQF-----------PQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+ AI F P+LP S D F C +P +R
Sbjct: 234 --PRPMAI---FELLDYIVNEPPPKLPSGAFS--------DEFQDFVDKCLKKNPKERAD 280
Query: 275 AAEALQHPFFKR 286
E +HPF KR
Sbjct: 281 LKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 8 KELGRGAFGRVFQA--------FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-- 57
K LG G FG+V +A + T VA+K LK A+ +D +L L KL
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTV-TVAVKMLKDN-ATDKDLADLISEMELMKLIG 75
Query: 58 NHSNIVKLKELIQNNNRLYLVFECM-ECNLYQLMAAR--------------DRKLFSEPE 102
H NI+ L + LY++ E + NL + + AR + S +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 103 IKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVG 161
+ + +QV +G+ Y+ HRDL N+LV++ ++KIADFGLAR + Y
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 162 SRW---YRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
R + APE L +Y+ ++D+W+ G +M E+FT
Sbjct: 196 GRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
+ELG GAFG+VF A E VA+K LK + + RE + L L H +I
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHI 69
Query: 63 VKLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAWLFQ---------V 110
VK + + L +VFE M + N + D L +E A L Q +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 111 FQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT----NYVGSRWY 165
G+ Y+ F HRDL N LV + ++KI DFG++R++ S Y + RW
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTF 196
I+ + +++++D+W++G ++ E+FT+
Sbjct: 190 PPESIMYRK--FTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
K +G G FG V + G+ VAIK LK Y + L E + + +H NI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
L+ ++ + + +V E ME + F+ ++ L + G+ Y+ G+ H
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 125 RDLKPENLLVSQGII-KIADFGLAREIKSGP--PYTNYVGS---RWYRAPEILLQSELYS 178
RDL N+LV+ ++ K++DFGL+R ++ P YT G RW APE + ++
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEA-IAYRKFT 187
Query: 179 SKADMWAMGAIMAELFTF 196
S +D+W+ G +M E+ ++
Sbjct: 188 SASDVWSYGIVMWEVMSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
Y + +G G +G V++A + HTGE A+K +K + L +E+ +++ H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIV 69
Query: 64 KLKELIQNNNRLYLVFECME-C------NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+ +L++ CME C ++Y + SE +I + QGL+Y
Sbjct: 70 AYFGSYLSREKLWI---CMEYCGGGSLQDIYHVTGP-----LSELQIAYVCRETLQGLAY 121
Query: 117 MHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSG-PPYTNYVGSRWYRAPEI--LL 172
+H G HRD+K N LL G +K+ADFG+A +I + +++G+ ++ APE+ +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
++ Y+ D+WA+G EL L P D L R
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL--------------------AELQPPMFD-----LHPMR 216
Query: 233 AI----KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
A+ K F Q P+ S + + + SL +P KRPTA L H F
Sbjct: 217 ALFLMSKSNF-QPPKLKDKTKWSSTFHNFVKI--SLTK-NPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 40/207 (19%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE-- 67
+GRG FG V+ TG+ A+K CL+ + +K + + L E
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK-----------CLDKKRIK----MKQGETLALNERI 46
Query: 68 ---LIQNNNRLYLVFECME---------CNLYQLMAARD-------RKLFSEPEIKAWLF 108
L+ + ++V CM C + LM D +FSE E++ +
Sbjct: 47 MLSLVSTGDCPFIV--CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRA 167
++ GL +MH +RDLKP N+L+ + G ++I+D GLA + P+ + VG+ Y A
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMA 163
Query: 168 PEILLQSELYSSKADMWAMGAIMAELF 194
PE+L + Y S AD +++G ++ +L
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEA-----VAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
+ELG GAFG+VF A + VA+K LK + RE + L L H +I
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHEHI 69
Query: 63 VKLKELIQNNNRLYLVFECME-CNLYQLMAA-----------RDRKLFSEPEIKAWLF-- 108
VK + + + L +VFE M+ +L + + A + R+ E + L
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 109 -QVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS---- 162
Q+ G+ Y+ F HRDL N LV ++KI DFG++R++ S Y VG
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VGGHTML 187
Query: 163 --RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
RW I+ + +++++D+W+ G I+ E+FT+
Sbjct: 188 PIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAF-----DEHTGEAV--AIKELKQRYASWEDCLNL-REVKC 53
DK + K LG G FG+V A + EAV A+K LK A+ +D +L E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 73
Query: 54 LRKL-NHSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARD----------RKLFSEP 101
++ + H NI+ L + LY++ E + NL + + AR ++ E
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 102 ----EIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPY 156
++ + +QV +G+ Y+ HRDL N+LV++ ++KIADFGLAR++ + Y
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 157 TNYVGSRW---YRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
R + APE L +Y+ ++D+W+ G +M E+FT
Sbjct: 194 KKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK----L 57
D + K +GRGAFG V ++TG+ A+K L + WE L E C R+ L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK----WE-MLKRAETACFREERDVL 55
Query: 58 NHSN---IVKLKELIQNNNRLYLVFEC-MECNLYQLMAARDRKLFSEPEIKA--WLFQVF 111
+ + I L Q+ N LYLV + + +L L++ + +L PE A +L ++
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARFYLAEMV 112
Query: 112 QGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFG-LAREIKSGPPYTNY-VGSRWYRAP 168
+ +HQ G+ HRD+KP+N+L+ G I++ADFG R + G +N VG+ Y +P
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 169 EILLQSE----LYSSKADMWAMGAIMAELF 194
EIL E Y + D W++G M E+
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 56/189 (29%), Positives = 97/189 (51%), Gaps = 7/189 (3%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSN--IVKLK 66
+GRG++ +V + + A+K +K+ ED ++ K + + SN +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
Q +RL+LV E + R RKL E + + ++ L+++H+ G +RD
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKL-PEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 127 LKPENLLVSQ-GIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
LK +N+L+ G IK+ D+G+ +E + G + + G+ Y APEI L+ E Y D W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI-LRGEEYGFSVDWW 180
Query: 185 AMGAIMAEL 193
A+G +M E+
Sbjct: 181 ALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 87/296 (29%), Positives = 127/296 (42%), Gaps = 60/296 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVA---IKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
E+G G FG+V + H G + A +KEL+ E L L+EV+ R+LNH N+++
Sbjct: 1 DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQ----------VFQGL 114
+ LV E C L L L S + A + Q V GL
Sbjct: 60 CLGQCIESIPYLLVLEF--CPLGDLKNY----LRSNRGMVAQMAQKDVLQRMACEVASGL 113
Query: 115 SYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN----YVGSRWYRAPE 169
++HQ F H DL N L + +KI D+GLA E Y V RW APE
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APE 172
Query: 170 IL--LQSELY----SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
++ +L + K+++W++G M ELFT ADQ Y P + S
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---------AADQPY--------PDL-S 214
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESL--CSWDPSKRPTAAE 277
L+Q ++ Q +LP+ L + + + +E + C DP RPTA E
Sbjct: 215 DEQVLKQ--VVREQDIKLPKPQLD--LKYSDR----WYEVMQFCWLDPETRPTAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 86/344 (25%), Positives = 143/344 (41%), Gaps = 81/344 (23%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR------ 55
+ + K +GRGAFG V + TG A+K L++ D L +V +R
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK-----ADMLEKEQVGHIRAERDIL 55
Query: 56 -KLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
+ + +VK+ Q+ LYL+ E + ++ L+ +D +E E + ++ +
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLA 113
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY------------- 159
+ +HQ GF HRD+KP+NLL+ S+G +K++DFGL +K Y
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 160 -----------------------VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
VG+ Y APE+ +Q+ Y+ D W++G IM E+
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232
Query: 197 CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQD 256
P F + + K+ +W + L FP P +S ++D
Sbjct: 233 YPPFCSETPQETYKKVM---------NWKETL--------IFP--PEVPIS----EKAKD 269
Query: 257 AISLFESLCSWDPSKRPTAAEALQ-HPFFKRCFYAPPHIRSTPA 299
I F C W+ E ++ +PFF+ + HIR PA
Sbjct: 270 LILRF--CCEWEHRIGAPGVEEIKTNPFFEGVDWE--HIRERPA 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 26 TGEAVAIKELK-------QRYASWEDCLNLREVKCLRKLNHSNIVKL-KELIQNNNRLYL 77
TG VAIK L+ + A + RE +L H NIV L L+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFR-----RETALCARLYHPNIVALLDSGEAPPGLLFA 56
Query: 78 VFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ 136
VFE + L +++AA E + QV L+ H G HRDLKP+N++VSQ
Sbjct: 57 VFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 137 GII----KIADFGL------AREI--KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
+ K+ DFG+ R+ + T +G+ Y APE L+ E + +D++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYK 211
A G I E T + GAS A+ +Y+
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 32/286 (11%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKLKE 67
E+GRGAFG V + + +G +A+K ++ E L ++ + + + IVK
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 68 LIQNNNRLYLVFECMEC---NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFF 123
+ ++ E M+ Y+ + + + E + + L+Y+ +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 124 HRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL--YSSK 180
HRD+KP N+L+ + G IK+ DFG++ ++ T G R Y APE + S Y +
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVR 190
Query: 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240
+D+W++G + E+ T G P +S D L Q +K P
Sbjct: 191 SDVWSLGITLYEVAT------------------GKFPYPKWNSVFDQLTQ--VVKGDPPI 230
Query: 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
L N S S ++ D SKRP E L+HPF K
Sbjct: 231 LS--NSEEREFSPS--FVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 33/233 (14%)
Query: 7 FKE-LGRGAFGRV-------FQAF-----DEHTGEA--VAIKELKQRYASWEDCLNLREV 51
KE LG G FG V F E G+ VA+K L+ L+E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 52 KCLRKLNHSNIVKLKELIQNNNRLYLVFECME-CNLYQLMAARD-RKLFSEP------EI 103
K + +L + NI++L + +++ L ++ E ME +L Q ++ R+ F+ I
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 104 KAWLF---QVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY--- 156
L+ Q+ G+ Y+ F HRDL N LV IKIADFG++R + SG Y
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 157 -TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ 208
+ RW ILL +++ +D+WA G + E+FT C P + +D+
Sbjct: 189 GRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTG---------EAVAIKELKQRYASWEDCLNL-REVKCLRKL 57
K LG G FG+V A E G VA+K LK A+ +D +L E++ ++ +
Sbjct: 24 KPLGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMI 80
Query: 58 -NHSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAAR--------------DRKLFSEP 101
H NI+ L + LY++ E + NL + + AR + S
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 102 EIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYV 160
++ + +QV +G+ Y+ HRDL N+LV++ ++KIADFGLAR+I Y
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 161 GSRW---YRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
R + APE L +Y+ ++D+W+ G ++ E+FT
Sbjct: 201 NGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 89/353 (25%), Positives = 137/353 (38%), Gaps = 87/353 (24%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK-LNHS 60
+ + K +G+GAFG V + TG+ A+K L + +D L VK R L S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD--QLAHVKAERDVLAES 58
Query: 61 N---IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ +V L Q+ LYL+ E + M + FSE + ++ + + +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAV 117
Query: 118 HQNGFFHRDLKPENLLVSQ-GIIKIADFGLA---------------REIKSGPPYTNY-- 159
H+ GF HRD+KP+N+L+ + G IK++DFGL+ + KS +
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 160 -------------------------------VGSRWYRAPEILLQSELYSSKADMWAMGA 188
VG+ Y APEI LQ + Y + D W++GA
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236
Query: 189 IMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSA 248
IM E P F + + KI +W + L FP +LS
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKII---------NWRETL--------YFPD--DIHLSV 277
Query: 249 LMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFYAPPHIRSTPA 299
+A L L + ++ R A E HPFF+ + IR A
Sbjct: 278 -------EAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWD--TIRQIRA 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 46/240 (19%)
Query: 7 FKE-LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN------------------ 47
FKE LG G FG V H EA +++ + S + N
Sbjct: 9 FKEKLGEGQFGEV------HLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62
Query: 48 ----LREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME-CNLYQLM---------AAR 93
L+E+K + +L NI++L + ++ L ++ E ME +L Q +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 94 DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKS 152
D S + Q+ G+ Y+ F HRDL N LV + IKIADFG++R + S
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 153 GPPYT----NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ 208
G Y + RW ILL +++ +D+WA G + E+ T C P + +D+
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 81/312 (25%), Positives = 129/312 (41%), Gaps = 57/312 (18%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
+S + GA G F D T E V IK QR + E LR +NH +I+
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA-GQRGGT------ATEAHILRAINHPSII 146
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+LK N L+ + +LY +AA+ + +I A V + + Y+H+N
Sbjct: 147 QLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRII 204
Query: 124 HRDLKPENLLVSQ-GIIKIADFGLA---REIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
HRD+K EN+ ++ G + + DFG A +I + Y + G+ APE LL + Y
Sbjct: 205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPE-LLARDPYGP 262
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI----- 234
D+W+ G + LF A+ D +++ G +D D RQ + I
Sbjct: 263 AVDIWSAGIV---------LFEMATCHDSLFEKDG------LDGDCDSDRQIKLIIRRSG 307
Query: 235 --KYQFPQLPRANL----------SALMPSASQDAISLFE----------SLCSWDPSKR 272
+FP +ANL S+ P + +L+E + ++D R
Sbjct: 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367
Query: 273 PTAAEALQHPFF 284
P+A L F
Sbjct: 368 PSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 3 KYSGF---KELGRGAFGRVFQA-FDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRK 56
KY F + LG G+FGRV A + VAIK ++ + ++ E K L
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+NH V L ++ + LYLV E + + R+++ F + Q+ Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEY 146
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ +RDLKPENLL+ + G IK+ DFG A+ + + YT G+ Y APEILL
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILLNVG 204
Query: 176 LYSSKADMWAMGAIMAELFTFCPLF 200
+ AD W +G + E+ CP F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 30/306 (9%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D + ELG G G VF+ + +G +A K + +RE++ L + N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ- 119
IV ++ + + E M+ +L Q++ R E + V +GL+Y+ +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 122
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
+ HRD+KP N+LV S+G IK+ DFG++ ++ ++VG+R Y +PE LQ YS
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE-RLQGTHYS 180
Query: 179 SKADMWAMGAIMAEL----FTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
++D+W+MG + E+ + P P A E + M+ C V G P +
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFG-CPVEGDPAESETSPR------- 230
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESL---CSWDPSKRPTAAEALQ-HPFFKRCFYA 290
P+ P LS+ P S+ +++FE L + P K P+ + F +C
Sbjct: 231 ----PRPPGRPLSSYGPD-SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285
Query: 291 PPHIRS 296
P R+
Sbjct: 286 NPAERA 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 72/288 (25%), Positives = 132/288 (45%), Gaps = 44/288 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKL-KE 67
+G G +G+V++ TG+ AIK + E+ +E+ L+K +H NI
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNIATYYGA 71
Query: 68 LIQNN-----NRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
I+ N ++L+LV E C ++ L+ E I ++ +GLS++HQ+
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 122 FFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSE---- 175
HRD+K +N+L+++ +K+ DFG++ ++ N ++G+ ++ APE++ E
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 191
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y K+D+W++G E+ P P D + RA+
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAP--------------------PLCD-----MHPMRAL- 225
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ P+ P L + S+ S ES + S+RPT + ++HPF
Sbjct: 226 FLIPRNPAPRLKS--KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 80/328 (24%), Positives = 132/328 (40%), Gaps = 61/328 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQ-AFDEHTGEAVAIKELKQRYASWEDCLNL----------- 48
+ + +L GAFG++F A T EA A + + C L
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 49 -----REVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEP-- 101
E+ L +LNH NI+K++E++++ Y++ + + +LY M P
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 102 -EIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR--EIKSGPPYT 157
+ +A + Q+ + Y+H HRD+K EN+ ++ G I + DFG A E +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT--FCPLFPGASE-ADQMYKICG 214
+VG+ +PEI L + Y D+W+ G I+ ++ + FCP+ G + Q+ KI
Sbjct: 327 GWVGTVATNSPEI-LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI-- 383
Query: 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISL-------------- 260
+ +FP P L + SA D
Sbjct: 384 -------------IDSLSVCDEEFPD-PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPAD 429
Query: 261 FE----SLCSWDPSKRPTAAEALQHPFF 284
FE + ++D RP AAE L P F
Sbjct: 430 FEYPLVKMLTFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 54/295 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIK--------ELKQRYASWEDCLNLREVKCLRKLNH 59
+LG G G V + TG +A K ++++ LRE++ + +
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--------LRELQIMHECRS 62
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL-FQVFQGLSYMH 118
IV N N + + E M+C + + + EI + V +GL+Y++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI--PVEILGKIAVAVVEGLTYLY 120
Query: 119 -QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
+ HRD+KP N+LV S+G IK+ DFG++ E+ + T +VG+ Y +PE +Q
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPE-RIQGGK 178
Query: 177 YSSKADMWAMGAIMAEL------FTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
Y+ K+D+W++G + EL F F + + D M G+L D L+Q
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDG-QDDPM----GIL---------DLLQQ 224
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW-DPSKRPTAAEALQHPFF 284
++ P+LP ++ + F C DP++RPT + P F
Sbjct: 225 --IVQEPPPRLPSSDFPEDL--------RDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 10 LGRGAFGRVFQA-FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL 68
LG+G FG VF+ + T VA+K K+ L E + L++ +H NIVKL +
Sbjct: 3 LGKGNFGEVFKGTLKDKT--PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 69 IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLK 128
+Y+V E + + + + ++ + G++Y+ HRDL
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 129 PENLLVSQG-IIKIADFGLAREIKSGPPYTN---YVGSRWYRAPEILLQSELYSSKADMW 184
N LV + ++KI+DFG++R+ G ++ + +W APE L YSS++D+W
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPEALNYGR-YSSESDVW 178
Query: 185 AMGAIMAELFTF--CPLFPGAS 204
+ G ++ E F+ CP +PG +
Sbjct: 179 SYGILLWETFSLGVCP-YPGMT 199
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ +GRG FG VF VA+K ++ L+E + L++ +H NIV+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ +Y+V E ++ + + E+ + G+ Y+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 128 KPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRW----YRAPEILLQSELYSSKAD 182
N LV++ ++KI+DFG++RE + G Y + G + + APE L YSS++D
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPEALNYGR-YSSESD 178
Query: 183 MWAMGAIMAELFTF 196
+W+ G ++ E F+
Sbjct: 179 VWSFGILLWEAFSL 192
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 57/296 (19%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS-NIVK-LK 66
E+G G G+V++ + TG +A+K++++ E+ L ++ + K + IVK
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKL-------FSEPEIKAWLFQVFQGLSYMHQ 119
I +++ VF CME M+ KL E + + + L Y+ +
Sbjct: 82 YFITDSD----VFICMEL-----MSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 120 N-GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL- 176
G HRD+KP N+L+ + G +K+ DFG++ + T G Y APE + +
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 177 --YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG----VLGSPTMDSWADGLRQ 230
Y +AD+W++G + EL T FP YK C VL
Sbjct: 193 PKYDIRADVWSLGISLVELAT--GQFP--------YKNCKTEFEVL-------------- 228
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ ++ + P LP S D S + + D KRP E LQHPF +R
Sbjct: 229 TKILQEEPPSLPPNE------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 60/220 (27%), Positives = 115/220 (52%), Gaps = 39/220 (17%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKL 57
+ELG AFG++++ +H + VAIK LK Q++ ++ +E + +L
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDH-AQLVAIKTLKDINNPQQWGEFQ-----QEASLMAEL 64
Query: 58 NHSNIVKLKELIQNNNRLYLVFECM-ECNLYQLMAAR----DRKLFSEPE--IKAWL--- 107
+H NIV L ++ + ++FE + + +L++ + R D S+ + +K+ L
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 108 ------FQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY---- 156
Q+ G+ Y+ + F H+DL N+L+ + + +KI+D GL+REI S Y
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+ + RW PE ++ + +SS +D+W+ G ++ E+F+F
Sbjct: 185 KSLLPIRWM-PPEAIMYGK-FSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 9e-15
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 9 ELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
ELG G FG V + + + VAIK LK +RE + + +L++ IV++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 67 ELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ + L LV E L + ++ + ++ + + QV G+ Y+ F HR
Sbjct: 62 GVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVS-NVVELMHQVSMGMKYLEGKNFVHR 119
Query: 126 DLKPEN-LLVSQGIIKIADFGLAREIKSGPP-YTNYVGSRW---YRAPEILLQSELYSSK 180
DL N LLV+Q KI+DFGL++ + + Y +W + APE + + +SS+
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSR 178
Query: 181 ADMWAMGAIMAELFTF 196
+D+W+ G M E F++
Sbjct: 179 SDVWSYGITMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 34/260 (13%)
Query: 50 EVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQ 109
E + LR+L+H ++ L ++ LV +LY + AR R L ++ A Q
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPL-GLAQVTAVARQ 268
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFG---LAREIKSGPPYTNYVGSRWY 165
+ + Y+H G HRD+K EN+LV+ I + DFG AR S P + G+
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
APE+ L + Y+ D+W+ G ++ E AS D+ P
Sbjct: 329 NAPEV-LAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER--------RPYDAQIL 379
Query: 226 DGLRQARAIKYQFPQLPRANLSALM---------PSASQDAISLFESL--------C--- 265
+RQA+ +FPQ + L + P+ ++ A + + L C
Sbjct: 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRAL 439
Query: 266 SWDPSKRPTAAEALQHPFFK 285
++D ++RP+AAE L+ P F+
Sbjct: 440 TFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 10 LGRGAFGRVFQA-FDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
+G G FG V+Q + E AVA+K K + L+E +R+ +H +IVKL
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 67 ELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+I N +++V E L + L I + +Q+ L+Y+ F HR
Sbjct: 74 GVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLIL-YSYQLSTALAYLESKRFVHR 131
Query: 126 DLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS---RWYRAPEILLQSELYSSKA 181
D+ N+LV S +K+ DFGL+R ++ Y G +W APE + ++S +
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APES-INFRRFTSAS 189
Query: 182 DMWAMGAIMAELFTF 196
D+W G M E+
Sbjct: 190 DVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK-----ELKQRYAS---WEDCLNLREVKC 53
+ + K +GRGAFG V + + + A+K E+ +R S WE+ R++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RDI-- 96
Query: 54 LRKLNHSN---IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQ 109
+ H+N IV+L Q++ LY+V E M +L LM+ D E + + +
Sbjct: 97 ---MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAE 150
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLA-REIKSGPPYT-NYVGSRWYR 166
V L +H GF HRD+KP+N+L+ G +K+ADFG + +G VG+ Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 167 APEILL---QSELYSSKADMWAMGAIMAEL 193
+PE+L Y + D W++G + E+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 8 KELGRGAFGRVF--QAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65
KE+G G FG+V + +T V +KEL+ + E L E + R L HSN+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 66 KELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPE---IKAWLFQVFQGLSYMHQNG 121
LV E C +L + + + P+ ++ ++ GL ++H+N
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 122 FFHRDLKPENLLVSQGI-IKIADFGLA----REIKSGPPYTNYVGSRWYRAPEIL--LQS 174
F H DL N L++ + +KI D+GL+ +E P +V RW APE++ +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHG 179
Query: 175 ELY----SSKADMWAMGAIMAELFTF 196
L + ++++W++G + ELF
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 10 LGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVKL 65
LG+G FG V +A ++ + + VA+K LK S D LRE C+++ +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 66 KELI---QNNNRL---YLVFECM---ECNLYQLMAARDRKLFSEPE--IKAWLFQVFQGL 114
+ + RL ++ M + + + LM+ + F+ P + ++ + G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 115 SYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSR----WYRAPE 169
Y+ F HRDL N ++++ + + +ADFGL+++I SG Y S+ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 170 ILLQSELYSSKADMWAMGAIMAELFT 195
L +Y++ +D+WA G M E+ T
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-- 59
D + K +GRGAFG V +HT A+K L + WE L E C R+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK----WE-MLKRAETACFREERNVL 55
Query: 60 -----SNIVKLKELIQNNNRLYLVFEC-MECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
I L Q+ N LYLV + + +L L++ + +L E + ++ ++
Sbjct: 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLA 114
Query: 114 LSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNY-VGSRWYRAPEI 170
+ +HQ + HRD+KP+N+L+ G I++ADFG ++ + G ++ VG+ Y +PEI
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 171 LLQSE----LYSSKADMWAMGAIMAELF 194
L E Y + D W++G M E+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 82/334 (24%), Positives = 129/334 (38%), Gaps = 91/334 (27%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLRE---VKCLRKL----NHS 60
K +G GAFG V T A+K L++ D L + VK R + ++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKA-----DVLMRNQAAHVKAERDILAEADNE 61
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRK-LFSEPEIKAWLFQVFQGLSYMHQ 119
+VKL Q+ + LY V + + +M+ R +F E + ++ ++ + +H+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGG--DMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119
Query: 120 NGFFHRDLKPENLLVSQ-GIIKIADFGL-----------------------------ARE 149
GF HRD+KP+N+L+ + G IK+ DFGL E
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 150 IKSGPPYT---------------NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF 194
I + VG+ Y APE+LL++ Y+ D W++G I+ E+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEML 238
Query: 195 TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSAS 254
P F + A+ K+ +W L P +A L S
Sbjct: 239 VGQPPFLADTPAETQLKVI---------NWETTLH--------IP--SQAKL-------S 272
Query: 255 QDAISLFESLCSWDPSKR---PTAAEALQHPFFK 285
++A L LC R A E HPFFK
Sbjct: 273 REASDLILRLCC-GAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 64/234 (27%), Positives = 116/234 (49%), Gaps = 32/234 (13%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEA--VAIKELKQRYASWEDCLNL-REVKCLRKL-N 58
K LG G FG+V A + + VA+K LK A+ +D +L E++ ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGK 76
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAAR--------------DRKLFSEPEI 103
H NI+ L + LY++ E + NL + + AR + + ++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 104 KAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGS 162
+ +QV +G+ Y+ HRDL N+LV++ ++KIADFGLAR++ + Y
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 163 RW---YRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKI 212
R + APE L +Y+ ++D+W+ G ++ E+FT +PG ++++K+
Sbjct: 197 RLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK-----ELKQRYAS---WEDCLNLREVKC 53
+ Y K +GRGAFG V + T + A+K E+ +R S WE+ R++
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
N +V+L Q++ LY+V E M +L LM+ D E + + +V
Sbjct: 99 FA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVL 153
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI-KSGPPYTNY-VGSRWYRAPE 169
L +H GF HRD+KP+N+L+ + G +K+ADFG ++ K G + VG+ Y +PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 170 ILLQSE----LYSSKADMWAMGAIMAELF 194
+ L+S+ Y + D W++G + E+
Sbjct: 214 V-LKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK-----LNHSN 61
K +GRGAFG V ++ + A+K L + WE L E C R+ +N N
Sbjct: 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNK----WE-MLKRAETACFREERDVLVNGDN 60
Query: 62 --IVKLKELIQNNNRLYLVFEC-MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
I L Q+ N LYLV + + +L L++ + +L E + +L ++ + +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYLAEMVIAIDSVH 119
Query: 119 QNGFFHRDLKPENLLVS-QGIIKIADFG-LAREIKSGPPYTNY-VGSRWYRAPEILLQSE 175
Q + HRD+KP+N+L+ G I++ADFG + ++ G ++ VG+ Y +PEIL E
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 176 ----LYSSKADMWAMGAIMAELF 194
Y + D W++G M E+
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 16/150 (10%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRK---LNHSN 61
K + RGAFG+V+ ++ + A+K +K+ D +N + +V+ R L+ S
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKK-----ADMINKNMVHQVQAERDALALSKSP 64
Query: 62 -IVKLKELIQNNNRLYLVFECM-ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
IV L +Q+ N +YLV E + ++ L+ F E ++ +V L Y+H+
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR 122
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAR 148
+G HRDLKP+N+L+S +G IK+ DFGL++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 83/346 (23%), Positives = 135/346 (39%), Gaps = 102/346 (29%)
Query: 8 KELGRGAFGRVFQA--FDEHTG---EAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSN 61
K LG GAFG+V +A F VA+K LK+ + E + E+K L + NH N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 62 IVK-LKELIQNNNRLYLVFE-CMECNLYQLM----------------------------- 90
+V L + N L ++ E C NL +
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 91 ------AARDRKLFSE----------PEIKA---WL------------FQVFQGLSYMHQ 119
A + LFS P + W FQV +G+ ++
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 120 NGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSE 175
HRDL N+L+S+ ++KI DFGLAR+I P Y +R + APE + +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF-DK 251
Query: 176 LYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+Y++++D+W+ G ++ E+F+ +PG ++ + DG R RA
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-----------RLKDGTRM-RAP 299
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ P++ R L+ DP +RPT + ++
Sbjct: 300 ENATPEIYRIMLACW----------------QGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 10 LGRGAFGRVFQAFDEHTGEAV--AIKELKQRYASWEDCLNLR-EVKCLRKLN-HSNIVKL 65
+G G FG+V +A + G + AIK +K+ YAS +D + E++ L KL H NI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 66 KELIQNNNRLYLVFE---------------CMECNLYQLMAARDRKLFSEPEIKAWLFQV 110
++ LYL E +E + +A S ++ + V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 111 FQGLSYMHQNGFFHRDLKPENLLVSQGII-KIADFGLAREIKSGPPYT-NYVGSRWYRAP 168
+G+ Y+ Q F HRDL N+LV + + KIADFGL+R + T + RW
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 193
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTF 196
L +Y++ +D+W+ G ++ E+ +
Sbjct: 194 S--LNYSVYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 8 KELGRGAFGRV---------------FQAFDEHTGEA-VAIKELKQRYASWEDCLNLREV 51
++LG G FG V F D VA+K L+ + L+EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 52 KCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWL--- 107
K L +L+ NI +L + + L ++ E ME +L Q + + L
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 108 ------FQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYV 160
Q+ G+ Y+ F HRDL N LV + IKIADFG++R + S Y
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS-DYYRVQ 189
Query: 161 GS-----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC 197
G RW +LL +++K+D+WA G + E+ T C
Sbjct: 190 GRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLC 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 30/196 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIK--------ELKQRYASWEDCLNLREVKCLRKLNHSN 61
LG G G V++A+ T +A+K EL+++ S E++ L K +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS--------ELEILYKCDSPY 60
Query: 62 IVKLKELIQNNNRLYLVFECME---CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
I+ NR+ + E M+ ++Y+ + E + V +GL+Y+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIP--------EHVLGRIAVAVVKGLTYLW 112
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
HRD+KP N+LV ++G +K+ DFG++ ++ + T YVG+ Y APE + E Y
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPERIS-GEQY 170
Query: 178 SSKADMWAMGAIMAEL 193
+D+W++G EL
Sbjct: 171 GIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKL--- 65
+G G +G+V++ TG+ AIK + E+ E+ L+K +H NI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK--LEINMLKKYSHHRNIATYYGA 81
Query: 66 ---KELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
K ++++L+LV E C ++ L+ E I ++ +GL+++H +
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 122 FFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSE---- 175
HRD+K +N+L+++ +K+ DFG++ ++ N ++G+ ++ APE++ E
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y ++D+W++G E+ P P D + RA+
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAP--------------------PLCD-----MHPMRAL- 235
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ P+ P L + S+ I E + RP+ + L+HPF
Sbjct: 236 FLIPRNPPPKLKS--KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 38/181 (20%)
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRW-- 164
FQV +G+ ++ HRDL N+L+S+ ++KI DFGLAR+I P Y +R
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 165 -YRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMD 222
+ APE + +Y+ ++D+W+ G ++ E+F+ +PG ++ C L T
Sbjct: 246 KWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRRLKEGT-- 299
Query: 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW--DPSKRPTAAEALQ 280
+ RA Y P++ + L W +PS+RPT +E ++
Sbjct: 300 -------RMRAPDYTTPEMYQTMLDC------------------WHGEPSQRPTFSELVE 334
Query: 281 H 281
H
Sbjct: 335 H 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 19/229 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D + ELG G G V + + +G +A K + +RE++ L + N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ- 119
IV ++ + + E M+ +L Q++ ++ K E + V +GL+Y+ +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
+ HRD+KP N+LV S+G IK+ DFG++ ++ ++VG+R Y +PE LQ YS
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE-RLQGTHYS 180
Query: 179 SKADMWAMGAIMAEL----FTFCPLFPGASEADQMYKICGVLGSPTMDS 223
++D+W+MG + EL + P P A E + ++ G P +D
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF------GRPVVDG 221
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 57/193 (29%), Positives = 79/193 (40%), Gaps = 50/193 (25%)
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY------------- 159
L Y+H G HRDLKP+NLL+ S G IK+ DFGL++ I TN
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTTNLYEGHIEKDTREFL 172
Query: 160 ----VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGV 215
G+ Y APE++L+ + Y D WAMG I+ E C F G + + ++
Sbjct: 173 DKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231
Query: 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR--- 272
W +G +P+ +QD IS L +P +R
Sbjct: 232 -----DIEWPEG-------------------DEALPADAQDLIS---RLLRQNPLERLGT 264
Query: 273 PTAAEALQHPFFK 285
A E QH FF
Sbjct: 265 GGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK-----ELKQRYAS---WEDCLNLREVKC 53
+ Y K +GRGAFG V + + + A+K E+ +R S WE+ R++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMA 98
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
N +V+L Q++ LY+V E M +L LM+ D E K + +V
Sbjct: 99 FA--NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVL 153
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI-KSGPPYTNY-VGSRWYRAPE 169
L +H G HRD+KP+N+L+ + G +K+ADFG ++ ++G + VG+ Y +PE
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213
Query: 170 ILLQSE----LYSSKADMWAMGAIMAELF 194
+ L+S+ Y + D W++G + E+
Sbjct: 214 V-LKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 2 DKYSGFKELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
+K + +ELG+G+FG V++ + VAIK + + + E L E +++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECM-----ECNLYQLMAARDRKLFSEPEIKAWLFQ-- 109
N ++V+L ++ ++ E M + L L + P + Q
Sbjct: 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 110 --VFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY----TNYVGS 162
+ G++Y++ N F HRDL N +V++ +KI DFG+ R+I Y +
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
RW +PE L+ ++++ +D+W+ G ++ E+ T
Sbjct: 186 RWM-SPES-LKDGVFTTYSDVWSFGVVLWEIATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 10 LGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
LG G FG + + + + VAI L+ + + L E L + +HSNIV+L+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+I N + +V E M + ++ L + G+ Y+ + G+ H+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132
Query: 127 LKPENLLVSQGII-KIADFGLAREIKSGPPYTNYVGSR--WYRAPEILLQSELYSSKADM 183
L +LV+ ++ KI+ F +E KS YT G + APE +Q +SS +D+
Sbjct: 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA-IQYHHFSSASDV 191
Query: 184 WAMGAIMAELFTF 196
W+ G +M E+ ++
Sbjct: 192 WSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 8 KELGRGAFGRVFQA--FDEHTGE---AVAIKELKQRYASWEDCLNLREV----KCLR-KL 57
+ELG FG+V++ F GE AVAIK LK + LRE +R +L
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-----GPLREEFKHEAMMRSRL 65
Query: 58 NHSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAAR-----------DRKLFSEPEIKA 105
H NIV L ++ L ++F C +L++ + R D+ + S E
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 106 WLF---QVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY----T 157
++ Q+ G+ ++ + H+DL N+LV + +KI+D GL RE+ + Y
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+ + RW +PE ++ + +S +D+W+ G ++ E+F++
Sbjct: 186 SLLPIRWM-SPEAIMYGK-FSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 42/242 (17%)
Query: 7 FKE-LGRGAFGRVFQA--------------FDEHTGEA--VAIKELKQRYASWEDCLNLR 49
FKE LG G FG V F+ G VA+K L+ L+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 50 EVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAAR--DRK---------- 96
EVK L +L NI++L + + + L ++ E ME +L Q +++ D K
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 97 -----LFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREI 150
S + Q+ G+ Y+ F HRDL N LV + + IKIADFG++R +
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 151 KSGPPY----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA 206
+G Y + RW A E +L + +++ +D+WA G + E+ C P
Sbjct: 189 YAGDYYRIQGRAVLPIRWM-AWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELT 246
Query: 207 DQ 208
D+
Sbjct: 247 DE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 10 LGRGAFGRVFQAFDEHTGEAV--AIKELKQRYASWEDCLNLR-EVKCLRKL-NHSNIVKL 65
+G G FG+V +A + G + AIK LK+ +AS D + E++ L KL +H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEP---------------EIKAWLFQ 109
+N LY+ E NL + + R L ++P ++ +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVSQGII-KIADFGLAR-EIKSGPPYTNYVGSRWYRA 167
V G+ Y+ + F HRDL N+LV + + KIADFGL+R E + RW
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAI 187
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTF 196
L +Y++K+D+W+ G ++ E+ +
Sbjct: 188 ES--LNYSVYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 35/101 (34%), Positives = 60/101 (59%), Gaps = 10/101 (9%)
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRW-- 164
FQV +G+ ++ HRDL N+L+S+ ++KI DFGLAR+I P Y +R
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 165 -YRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS 204
+ APE + ++Y++++D+W+ G ++ E+F+ GAS
Sbjct: 240 KWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSL-----GAS 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 40/115 (34%), Positives = 68/115 (59%), Gaps = 16/115 (13%)
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYV--GS-- 162
+QV +G+S++ HRDL N+L++ G I KI DFGLAR+I++ +NYV G+
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVKGNAR 277
Query: 163 ---RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
+W APE + +Y+ ++D+W+ G ++ E+F+ P +PG + YK+
Sbjct: 278 LPVKWM-APESIFNC-VYTFESDVWSYGILLWEIFSLGSSP-YPGMPVDSKFYKM 329
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 35/107 (32%), Positives = 65/107 (60%), Gaps = 8/107 (7%)
Query: 102 EIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPY---- 156
++ ++ +QV +G+ ++ HRDL N+L++QG I+KI DFGLAR+I Y
Sbjct: 238 DLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPG 202
+ ++ +W APE + + LY++ +D+W+ G ++ E+F+ +PG
Sbjct: 298 STFLPVKWM-APESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 33/108 (30%), Positives = 61/108 (56%), Gaps = 7/108 (6%)
Query: 94 DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKS 152
+ S ++ + +QV G+ ++ HRDL N+L+ +G ++KI DFGLAR+I
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 153 GPPY----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
Y + ++ +W APE + + LY++ +D+W+ G ++ E+FT
Sbjct: 292 DSNYISKGSTFLPLKWM-APESIFNN-LYTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 10 LGRGAFGRVFQAFDEHTGEAV--AIKELKQRYASWEDCLNLR-EVKCLRKL-NHSNIVKL 65
+G G FG+V +A + G + AIK +K+ YAS +D + E++ L KL +H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEP---------------EIKAWLFQ 109
++ LYL E NL + + R L ++P ++ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVSQGII-KIADFGLAR-EIKSGPPYTNYVGSRWYRA 167
V +G+ Y+ Q F HRDL N+LV + + KIADFGL+R + + RW
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 180
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTF 196
L +Y++ +D+W+ G ++ E+ +
Sbjct: 181 ES--LNYSVYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 10 LGRGAFGRVFQA--FDEHTGEA-VAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVKL 65
+G+G FG V+ D + A+K L R E+ L+E ++ +H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 66 KELIQNNNRLYLVF--ECMECNLYQLMAARDRKLFSEPEIKAWL---FQVFQGLSYMHQN 120
+ + LV +L + R P +K + QV +G+ Y+
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 121 GFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT--NYVGSR----WYRAPEILLQ 173
F HRDL N ++ + +K+ADFGLAR+I Y+ N+ G++ W A E L Q
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM-ALESL-Q 175
Query: 174 SELYSSKADMWAMGAIMAELFT 195
++ +++K+D+W+ G ++ EL T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLN 58
++ K LG GAFG V++ GE VAIKEL++ + + L E + ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 59 HSNIVKLKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+ ++ +L + + + L+ + M C L + +D + W Q+ +G++Y
Sbjct: 68 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNY 124
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAR----EIKSGPPYTNYVGSRWYRAPEIL 171
+ + HRDL N+LV + +KI DFGLA+ + K V +W IL
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 172 LQSELYSSKADMWAMGAIMAELFTF 196
+ Y+ ++D+W+ G + EL TF
Sbjct: 185 HRI--YTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
M +Y + +G+G G V+ A+D VA+K++++ + LRE K L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 59 HSNIVKLKELIQNNNRLYLVFECMEC-NLYQLM-AARDRKLFSEP-----EIKAWL---F 108
H IV + + + + +Y +E L L+ + ++ S+ + A+L
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK-------------SGP 154
++ + Y+H G HRDLKP+N+L+ G + I D+G A K
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 155 PYTNY------VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT 195
Y++ VG+ Y APE LL S D++A+G I+ ++ T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAV----AIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K LG GAFG V++ GE V AIK L + + + E + ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 64 KLKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+L + + + LV + M C L + +D + W Q+ +G+ Y+ +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRW---YRAPEILLQSELY 177
HRDL N+LV S +KI DFGLAR ++ N G + + A E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC-IHYRKF 188
Query: 178 SSKADMWAMGAIMAELFTF 196
+ ++D+W+ G + EL TF
Sbjct: 189 THQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIV 63
K LG G FG V + D+ + VA+K +K ++ + L E C++ +H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 64 KL------KELIQNNNRLYLVFECMECN------LYQLMAARDRKLFSEPEIKAWLFQVF 111
KL +Q + ++ M+ LY + KL + +K ++ +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FMVDIA 123
Query: 112 QGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPE- 169
G+ Y+ F HRDL N ++ + + + +ADFGL+++I SG Y R + P
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ---GRIAKMPVK 180
Query: 170 -ILLQS---ELYSSKADMWAMGAIMAELFT 195
I ++S +Y+SK+D+WA G M E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 2 DKYSGFKELGRGAFGRVFQ--AFDEHTGEA---VAIKELKQRYASWEDCLNLREVKCLRK 56
+K + +ELG+G+FG V++ A D GEA VA+K + + + E L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLF-------SE-------PE 102
++V+L ++ +V E LMA D K + +E P
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVME--------LMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 103 IKAWL---FQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPY-- 156
++ + ++ G++Y++ F HRDL N +V+ +KI DFG+ R+I Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 157 --TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+ RW APE L+ ++++ +DMW+ G ++ E+ +
Sbjct: 178 GGKGLLPVRWM-APES-LKDGVFTTSSDMWSFGVVLWEITSL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 10 LGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65
LG GAFG V++ GE VAIK L++ + + L E + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 66 KELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+ + + LV + M C L + +DR ++ W Q+ +G+SY+ +
Sbjct: 75 LGICLTST-VQLVTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY------VGSRWYRAPEILLQSEL 176
HRDL N+LV S +KI DFGLAR + T Y V +W IL +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDE--TEYHADGGKVPIKWMALESILHRR-- 187
Query: 177 YSSKADMWAMGAIMAELFTF 196
++ ++D+W+ G + EL TF
Sbjct: 188 FTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 52/209 (24%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 8 KELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVK 64
K LG G FG V + + + VA+K +K + + + L E C+++ +H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 65 LKEL-IQNNNR-------LYLVF----ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
L + +Q + L F + LY + + L ++ +K ++ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIAS 123
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPE-- 169
G+ Y+ F HRDL N ++++ + + +ADFGL+++I +G Y R + P
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ---GRIAKMPVKW 180
Query: 170 ILLQS---ELYSSKADMWAMGAIMAELFT 195
I ++S +Y++K+D+W+ G M E+ T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 85/340 (25%), Positives = 137/340 (40%), Gaps = 62/340 (18%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN------IV 63
LG G FG+V +A+D E A+K ++ D E++ + K+ ++ ++
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK--IEIQFMEKVRQADPADRFPLM 194
Query: 64 KLKELIQNNN-RLYLVF-ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN- 120
K++ QN + +V + C L +M FS + +FQ L Y H
Sbjct: 195 KIQRYFQNETGHMCIVMPKYGPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTEL 251
Query: 121 GFFHRDLKPENLLVSQG-----------------IIKIADFG-LAREIKSGPPYTNYVGS 162
H DLKPEN+L+ ++I D G E S T V +
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS---RTAIVST 308
Query: 163 RWYRAPEILLQ-SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221
R YR+PE++L +YS+ DMW+MG I+ EL+T L+ + ++ + LG
Sbjct: 309 RHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366
Query: 222 DSWAD--GLRQARAIKYQFPQL-----PRANLSALMPSASQDAIS------LFESLCSWD 268
+ WA G +AR + QL P+ ++ I L L +D
Sbjct: 367 E-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425
Query: 269 PSKRPTAAEALQHP----FFKRCFYAPPH------IRSTP 298
KR A + HP ++ C P + +R TP
Sbjct: 426 RQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPTP 465
|
Length = 467 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 38/115 (33%), Positives = 65/115 (56%), Gaps = 16/115 (13%)
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYV--GS-- 162
QV QG+ ++ HRD+ N+L++ G + KI DFGLAR+I + +NYV G+
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNYVVKGNAR 275
Query: 163 ---RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
+W APE + +Y+ ++D+W+ G ++ E+F+ P +PG + YK+
Sbjct: 276 LPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGKSP-YPGILVNSKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREV-------KCLRKLNHS 60
K LG GAFG V A T A+K L+++ D LN +V L + ++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKK-----DVLNRNQVAHVKAERDILAEADNE 61
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+VKL Q+ + LY V + + + R ++F E + ++ ++ + +H+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKM 120
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
GF HRD+KP+N+L+ G IK+ DFGL +G +T+ S++Y+ + Q + S
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLC----TGFRWTH--NSKYYQKGSHIRQDSMEPS 174
Query: 180 KADMW 184
D+W
Sbjct: 175 --DLW 177
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 62/261 (23%), Positives = 108/261 (41%), Gaps = 42/261 (16%)
Query: 49 REVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLF 108
RE+ L+ ++H I+ L + + + +V +C+L+ + DR P +A
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV---DRS-GPLPLEQAITI 190
Query: 109 Q--VFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS---GPPYTNYVGS 162
Q + + L+Y+H G HRD+K EN+ + + + DFG A ++ + P + G+
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAE-LFTFCPLF----PGASEADQMYKICGVL- 216
+PE LL + Y +K D+W+ G ++ E LF +S Q+ I +
Sbjct: 251 LETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS--QLRSIIRCMQ 307
Query: 217 ---------GSPTM----DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFES 263
GS + +A LR Y P + R D L
Sbjct: 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPP----YTIPPVIRKY------GMHMDVEYLIAK 357
Query: 264 LCSWDPSKRPTAAEALQHPFF 284
+ ++D RP+A + L P F
Sbjct: 358 MLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 88/359 (24%), Positives = 138/359 (38%), Gaps = 92/359 (25%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL---NLREVKCLRKL----NHS 60
K LG GAFG V A T A+K L+++ D L + VK R + ++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKK-----DVLLRNQVAHVKAERDILAEADNE 61
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V+L Q+ + LY V + + + R +F E + ++ ++ + +H+
Sbjct: 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKM 120
Query: 121 GFFHRDLKPENLLVSQ-GIIKIADFGL---------AREIKSG---------------PP 155
GF HRD+KP+N+L+ + G IK+ DFGL ++ +SG P
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 156 YTNYVGSRW------------------------YRAPEILLQSELYSSKADMWAMGAIMA 191
G R Y APE+LL++ Y+ D W++G I+
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILY 239
Query: 192 ELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMP 251
E+ P F + + K+ +W L P P+A LS P
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVI---------NWQTSL--------HIP--PQAKLS---P 277
Query: 252 SASQDAISLFESLCSW--DPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTTANQP 308
AS L LC D + A E HPFFK ++ +R A P
Sbjct: 278 EAS----DLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS-SDLRQQSAPYIPKITHP 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 45/213 (21%)
Query: 13 GAFGRVFQAF--DEHTG--EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL 68
G FGR+F DE G E V +K +K + + L L+E L L+H NI
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI------ 70
Query: 69 IQNNNRLYLVFECMECN-----LYQLMAARDRKLF---------------SEPEIKAWLF 108
L ++ C+E LY M + KLF S ++
Sbjct: 71 ------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYR- 166
Q+ G+SY+H+ G H+D+ N ++ + +KI D L+R++ P + +G R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLF--PMDYHCLGDNENRP 182
Query: 167 ----APEILLQSELYSSKADMWAMGAIMAELFT 195
A E L ++ YSS +D+W+ G ++ EL T
Sbjct: 183 VKWMALESL-VNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 46/231 (19%)
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
N+V L + I + + ++LV + E L+ ++ E +K W ++ L +H+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHR 103
Query: 120 NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
G RDL P N+L+ G I++ F E++ Y APE+ SE +
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE--DSCDGEAVENMYCAPEVGGISEE-T 160
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
D W++GAI+ EL T G ++ G+
Sbjct: 161 EACDWWSLGAILFELLT---------------------GKTLVECHPSGIN--THTTLNI 197
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA-----LQHPFF 284
P+ S++A SL + L ++P++R A A HPFF
Sbjct: 198 PEW-----------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
++ N +KL + L+ + ++ +L+ L+ + SE E+K + Q+ + L+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALND 124
Query: 117 MHQNGFFHRDLKPENLLVSQGI--IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
+H++ H D+K EN+L + I + D+GL + I G P Y G+ Y +PE +
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GTPSC-YDGTLDYFSPEKIK-G 180
Query: 175 ELYSSKADMWAMGAIMAELFT 195
Y D WA+G + EL T
Sbjct: 181 HNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 32/291 (10%)
Query: 26 TGEAVAIKELKQRYASWEDCLNLR-EVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84
TGE V ++ + + E L+ E+ + NH NIV + +N L++V M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 85 -NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-------- 135
+ L+ SE I L V + L Y+H G+ HR +K ++L+S
Sbjct: 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
Query: 136 --QGIIKIADFGL-AREIKSGPPYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMA 191
+ + + + G R + P Y+ V + +PE+L Q+ + Y +K+D++++G
Sbjct: 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITAC 201
Query: 192 ELFT-FCPLFPGASEADQMYKICGVLG---------------SPTMDSWADGLRQARAIK 235
EL P + + K+ G + P+ GL ++ +
Sbjct: 202 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVS 261
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
P ++ + S E +P RP+A+ L H FFK+
Sbjct: 262 TPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 49/317 (15%)
Query: 9 ELGRG--AFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK-------LNH 59
E+GRG V+ A TG V + R E+C +K L+ H
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTV-----RITDLENC-TEEHLKALQNEVVLSHFFRH 58
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
NI+ + + L+++ M + L+ + SE I LF +GL+Y+H
Sbjct: 59 PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 119 QNGFFHRDLKPENLLVS-QGIIKIADFG-LAREIKSG---------PPYTNYVGSRWYRA 167
QNG+ HR++K ++L+S G++ ++ L +++G P ++ V W +
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV-LPWL-S 176
Query: 168 PEILLQS-ELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWA 225
PE+L Q Y+ K+D++++G EL T P + K+ G SP +D
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP-LDITT 235
Query: 226 DGLRQARAIKYQF-------PQLPRANLSALMPSA----------SQDAISLFESLCSWD 268
++R Q + A ++ M S S +L E D
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295
Query: 269 PSKRPTAAEALQHPFFK 285
P KRP+A+ L H FFK
Sbjct: 296 PEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVA---IKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+E+G G FG+V + + +T VA +KELK +S E L++ R L H NI++
Sbjct: 1 QEIGNGWFGKVLLS-EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 65 -LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEI---KAWLFQVFQGLSYMHQN 120
L + ++ L LVFE E + ++++ ++ + ++ G+++MH++
Sbjct: 60 CLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118
Query: 121 GFFHRDLKPEN-LLVSQGIIKIADFGLA----REIKSGPPYTNYVGSRWYRAPEIL--LQ 173
F H DL N L S +K+ D+G+ +E V RW APE++
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFH 177
Query: 174 SELYSSK----ADMWAMGAIMAELF 194
L +++ +++WA+G + ELF
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK----CLRKLNHSNIV 63
K LG G FG V + G+++ I + +E+ + L+H+ IV
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+L + + L LV + + R + W Q+ +G+ Y+ ++
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 124 HRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSEL 176
HR+L N LL S I++IADFG+A + P Y S +W IL
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYFYSEHKTPIKWMALESILFGR-- 187
Query: 177 YSSKADMWAMGAIMAELFTF 196
Y+ ++D+W+ G + E+ ++
Sbjct: 188 YTHQSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 103 IKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVG 161
IK + QV GL +H+ G HRD+KPENLLV+ G +KI DFG A ++ +G + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 162 --SRWYRAPEILLQSELYSSKADMWAMGAIMA 191
Y PE L+ + +A AM A+++
Sbjct: 371 MLDPRYSPPEELVMPQSC-PRAPAPAMAALLS 401
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 38/195 (19%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K+LG GAFG V++A +K+ + Y + E +N R + +
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE-YGAVEIWMNERVRRACPNSCADFVY 196
Query: 64 KLKELIQNNNR--LYLV--FECMECNLYQLMAARD------RKLFSEPE----------- 102
E + + +LV +E E L LM +++ L + +
Sbjct: 197 GFLEPVSSKKEDEYWLVWRYEG-ESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENK 255
Query: 103 -IKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNY 159
I+ + Q+ L +H G HRD+KP+N++ S+ G KI D G A +++ G NY
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INY 312
Query: 160 VGSRW-----YRAPE 169
+ + Y APE
Sbjct: 313 IPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 69/296 (23%), Positives = 112/296 (37%), Gaps = 72/296 (24%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
+ RG G ++ G +KE+ + + E+ + KL H NIVKL L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEIND-----VNSIPSSEIADMGKLQHPNIVKLIGLC 752
Query: 70 QNNNRLYLVFECMEC-NLYQLMAA----RDRKLFSEPEIKAWLFQVFQGLSYMHQN---G 121
++ YL+ E +E NL +++ R RK+ + + L ++H
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI---------AIGIAKALRFLHCRCSPA 803
Query: 122 FFHRDLKPENLLVSQGIIKIADFGLAREIKSGPP------YTNYVGSRWYRAPEILLQSE 175
+L PE + II D ++ P ++ S Y APE +
Sbjct: 804 VVVGNLSPEKI-----IIDGKD---EPHLRLSLPGLLCTDTKCFISSA-YVAPETRETKD 854
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT-----------MDSW 224
+ + K+D++ G I+ EL T G S AD + GV GS +D W
Sbjct: 855 I-TEKSDIYGFGLILIELLT------GKSPADAEF---GVHGSIVEWARYCYSDCHLDMW 904
Query: 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
D + Q + NL AL +A+ DP+ RP A + L+
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNL-ALHCTAT-------------DPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 8/64 (12%)
Query: 91 AARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE 149
A DRK +E ++A+L Q+ + +GFFH D P N+LV S G I + DFG+
Sbjct: 262 AGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314
Query: 150 IKSG 153
+
Sbjct: 315 LDPK 318
|
Length = 517 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 45/193 (23%), Positives = 97/193 (50%), Gaps = 18/193 (9%)
Query: 27 GEAVAIKELKQRYASWEDCLNL--REVKCLRKLNHSNIVKLK----ELIQNNNRLYLVFE 80
+ V I+ K+ + + +++ E+K LR+++ +NI+K+ +++ + RL L+ E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 81 -CMECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ- 136
C L + L +D ++ ++ +GL +++ +++L + LV++
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDM---AIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN 159
Query: 137 GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELF 194
+KI GL + I S PP+ N V Y + ++L SE Y+ K D++++G ++ E+F
Sbjct: 160 YKLKIICHGLEK-ILSSPPFKN-VNFMVYFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIF 216
Query: 195 TFCPLFPGASEAD 207
T F + +
Sbjct: 217 TGKIPFENLTTKE 229
|
Length = 283 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 13/32 (40%), Positives = 18/32 (56%)
Query: 117 MHQNGFFHRDLKPENLLVSQGIIKIADFGLAR 148
+H+ G H DL N+++S G I DFGL
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 14/32 (43%), Positives = 19/32 (59%)
Query: 117 MHQNGFFHRDLKPENLLVSQGIIKIADFGLAR 148
+H G H DL N+++S G I + DFGLA
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 8/57 (14%)
Query: 91 AARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGL 146
A DRK +E +++L QV + +GFFH DL P N+ V G I DFG+
Sbjct: 254 AGLDRKALAENLARSFLNQVLR-------DGFFHADLHPGNIFVLKDGKIIALDFGI 303
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 11/32 (34%), Positives = 18/32 (56%)
Query: 117 MHQNGFFHRDLKPENLLVSQGIIKIADFGLAR 148
+H+ G H DL N++V + + DFGL +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 6/64 (9%)
Query: 8 KELGRGAFGRVFQ--AFD---EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSN 61
K LGRGAFG+V Q AF + VA+K LK+ + E + E+K L + +H N
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLN 72
Query: 62 IVKL 65
+V L
Sbjct: 73 VVNL 76
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ- 112
+R+++H +IV L + + +V E +E L R + + P W F+V +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP----WKFKVAKQ 113
Query: 113 ---GLSYMHQNGFFHRDLKPENLLVS-QGI-------IKIADFGLAREIKSGPPYTNYVG 161
LSY+ H ++ +N+L++ +GI IK++D G+ + S +
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI- 172
Query: 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-----PLFPGA-SEADQMYKICGV 215
W APE + S+ S AD W+ G + E+ C PL +E ++ Y+ +
Sbjct: 173 -PWI-APECVEDSKNLSIAADKWSFGTTLWEI---CYNGEIPLKDKTLAEKERFYEGQCM 227
Query: 216 LGSPTMDSWADGLRQ 230
L +P+ AD +
Sbjct: 228 LVTPSCKELADLMTH 242
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.55 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.38 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.13 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.82 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.79 | |
| PLN02236 | 344 | choline kinase | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.67 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.55 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.21 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.61 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.28 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.01 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.69 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.26 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.25 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.63 |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-74 Score=549.40 Aligned_cols=290 Identities=59% Similarity=1.084 Sum_probs=281.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCC-EEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNN-RLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~~lv 78 (417)
|++|.++++||.|+||.||+|..+.+|+.||||.++++...++++..+||++.|++|+ |||||++.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 6899999999999999999999999999999999999999999999999999999999 999999999999888 99999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||||+++|++++..+ ++.|+|+.++.|+.||++||+|+|.+|++||||||||||+. ...|||+|||+|+.+.+.++++
T Consensus 89 fE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT 167 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT 167 (538)
T ss_pred HHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc
Confidence 999999999999988 58899999999999999999999999999999999999998 7899999999999999999999
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.++.|+||+|||+|++...|+.++|||++|||++|+.+.++.|+|.++.|++++||+++|+|..+.|..+....+.+.+.
T Consensus 168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 291 (417)
+|...+..+..+.+..+.++.+||.+||.|||++||||+|+|+||||+......
T Consensus 248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~ 301 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG 301 (538)
T ss_pred CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence 999999999999999999999999999999999999999999999999765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-63 Score=443.12 Aligned_cols=283 Identities=43% Similarity=0.752 Sum_probs=255.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|...++||+|.||.||+|++..||+.||||.|+..... .-....+|||+.|+.++|+||+.++++|...+.+.||+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57999999999999999999999999999999999865332 22344579999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-Cc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-YT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-~~ 157 (417)
|||+.+|...+..+ ...++..+++.|+.+++.||+|||+++|+||||||+|+||+ +|.+||+|||+|+.+.+... .+
T Consensus 81 Efm~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred EeccccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99998888776654 47799999999999999999999999999999999999996 69999999999998876433 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+-|.||+|||.+.+.+.|+..+||||.|||++||+-|.|.|+|.++.|++..|+..+|+|..+.|.+.........+.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 45889999999999999999999999999999999999999999999999999999999999999999998888777776
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+......+++..|.++.||+.+||..||.+|+|+.|+|+|+||+.
T Consensus 240 --~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 240 --QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred --cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 23344555588999999999999999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-64 Score=450.73 Aligned_cols=285 Identities=33% Similarity=0.618 Sum_probs=250.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
||+|+.+.++|+|+||.||+|+++.||+.||||.+.....+.. ..-.+||+++|++|+|||+|.++++|.....+++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 8999999999999999999999999999999999876544322 333479999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~ 157 (417)
||++...++.+.... ..+++..++.|++|++.|+.|||+++++|||||||||||+ +|.+||||||+|+.+. ++..++
T Consensus 81 E~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 81 EYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 999999998887665 4589999999999999999999999999999999999997 5899999999999887 778899
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.++.|+||+|||.+.++..|+..+||||+||++.||++|.+.|++.++.|+++.|...+|.-...-..-+..........
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 99999999999999998889999999999999999999999999999999999999999976544332222222233334
Q ss_pred CCCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+|... ...+...+|.+|.-+.||+.+||..||.+|+|.+|+|.|+||..
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 55442 45667778899999999999999999999999999999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-62 Score=469.19 Aligned_cols=283 Identities=39% Similarity=0.696 Sum_probs=249.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 78 (417)
+.|+.+++||+|+||.||+|++..||+.||+|.+........ .....|||.||++|+||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 679999999999999999999999999999999986543222 23346999999999999999999988765 789999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC--CC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG--PP 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~--~~ 155 (417)
||||+.+|..++.. ..-.|++.+|++||+||++||+|||++||+|||||..||||++ |.+||+|||+|+.+... ..
T Consensus 197 FeYMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred EecccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 99999998877754 3356999999999999999999999999999999999999975 89999999999976543 45
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
++..+-|.||+|||+|++...|+.++|+||+||||.||+.|++.|++.++.+++.+|+..+|+|..+.|. ..+......
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~ 354 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATI 354 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccc
Confidence 7888999999999999999999999999999999999999999999999999999999999999999998 444443333
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+.-.......+.+.+..++..+.+|+..||+.||.+|.||.++|+|+||..
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 433333456666777889999999999999999999999999999999943
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-63 Score=462.82 Aligned_cols=258 Identities=35% Similarity=0.570 Sum_probs=220.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh------hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE------DCLNLREVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
|.|.+.+.||+|+||.|.+|.++.||+.||||+++++..... .....+|+++|++|+|||||+++++|+..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 578999999999999999999999999999999987654431 12235899999999999999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC----cEEEeeccccccc
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG----IIKIADFGLAREI 150 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~----~vkL~DFg~a~~~ 150 (417)
|+||||++|| |++.+..+ +.+.|...+.+++|++.||.|||++||+||||||+|||++++ .+||+|||+|+..
T Consensus 252 YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999876 66666654 558999999999999999999999999999999999999643 5999999999999
Q ss_pred cCCCCCccccCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCccchHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEAD-QMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~ 227 (417)
+...-+.+.||||.|.|||++... ..+..++||||||||||.+|+|.+||.+..... ....|.
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~-------------- 395 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL-------------- 395 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh--------------
Confidence 888889999999999999999643 345669999999999999999999998775444 333332
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...|.|- +..+..+|+++.+||.+||..||++|||++|+|+||||+..
T Consensus 396 -----~G~y~f~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 396 -----KGRYAFG-------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred -----cCccccc-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 2233332 23456789999999999999999999999999999999863
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-61 Score=441.71 Aligned_cols=286 Identities=41% Similarity=0.686 Sum_probs=258.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEE--eCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQ--NNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l 77 (417)
++.|+.+..|++|+||.||+|+++.|++.||+|.++...... -....+|||.+|.+++|||||.+.++.. +-+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 468999999999999999999999999999999998654111 1122379999999999999999999875 4567999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~ 155 (417)
|||||+.++...+.... ..|.+.+++.++.|++.||+|||.++|+||||||+|+|++ .|.+||+|||+|+.+++. ..
T Consensus 155 VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 99999999888776654 5699999999999999999999999999999999999996 499999999999998775 55
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
++..+-|.||+|||+|++...|+.++||||+|||+.||+++.|.|+|.++.+++.+|+..+|+|+...|+..........
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 78889999999999999999999999999999999999999999999999999999999999999999999877776667
Q ss_pred ccCCCCCcccccccCCCCC--HhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSAS--QDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..|+..+...+...++..+ +...+|+..+|..||.+|.||+|+|+|.||.+.
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 8889888888887777665 999999999999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-60 Score=462.55 Aligned_cols=254 Identities=35% Similarity=0.569 Sum_probs=227.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|+..+.||+|+|+.||.+++..+|+.||+|++.+.... .......+||+|.+.|+|||||+++++|+|.+++|||+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 599999999999999999999999999999999865332 223445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
+|..+.+..+.++ ++.++|.+++.|++||+.||.|||+++|+|||||..|+|++++ +|||+|||+|+.+... ....+
T Consensus 99 LC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 99 LCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred ecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 9998877777764 4779999999999999999999999999999999999999876 8999999999988854 67788
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.||||.|.||||+.+.. ++..+||||+|||||-||+|+|||...+-.+.+.+|.. .+|.+
T Consensus 178 lCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------------~~Y~~ 237 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------------NEYSM 237 (592)
T ss_pred ecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------------cCccc
Confidence 99999999999997555 89999999999999999999999999998888888853 35555
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
|. .+|.+|+|||.+||+.||.+|||+++||.|+||+..+
T Consensus 238 P~-----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 238 PS-----------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred cc-----------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 53 5799999999999999999999999999999996654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-59 Score=431.14 Aligned_cols=260 Identities=34% Similarity=0.521 Sum_probs=226.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+++.+.|++.||+|++++...... .....+|..+|.+++||+||+++..|++++.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 689999999999999999999999999999999987654433 344568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc-cCCCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~-~~~~~~~ 157 (417)
||+.||-+....++. +.|+|+.++.|+..|+.||.|||++||+||||||||||++ +|+|+|+|||+|+.. ..+....
T Consensus 105 d~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 105 DYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred eccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 999987555555544 5699999999999999999999999999999999999997 599999999999854 4456667
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
++|||+.|||||++.+.. |+.++|+||||+++|||++|.+||.+.+....+.+|...
T Consensus 184 tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---------------------- 240 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---------------------- 240 (357)
T ss_pred cccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----------------------
Confidence 789999999999998775 999999999999999999999999999999888888531
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC----CHHHHHcCccccccccCCC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP----TAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~~~~~~ 292 (417)
.+.....-.|.++++||+++|..||++|. .++++-+||||....|...
T Consensus 241 -------k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 241 -------KLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred -------cCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 01122233799999999999999999995 7999999999998766543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-59 Score=431.76 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=222.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-EEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-RLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E 80 (417)
++.+.++.||+|..|+||+|+|+.|++.+|+|+|..........++.+|++++++++|||||++|++|.++. .++|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 356788999999999999999999999999999976666666777889999999999999999999999999 5999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+|+.++.+.... +.++|.....++.+|++||.|||+ .+|+||||||+|||++ +|.|||||||.+..+.+. ...+
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~t 236 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANT 236 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccc
Confidence 99999888887765 568999999999999999999995 9999999999999995 699999999999988776 6688
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA-----SEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
++||..|||||.+.+.. |+.++||||||+.++||++|+.||... ...+.+..|+
T Consensus 237 fvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-------------------- 295 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-------------------- 295 (364)
T ss_pred ccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh--------------------
Confidence 99999999999997665 999999999999999999999999875 2333333333
Q ss_pred hhccCCCCCcccccccCC-CCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 234 IKYQFPQLPRANLSALMP-SASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...| ..++. .+|+++++||..||++||.+|+|+.|+|+|||+++.
T Consensus 296 --~~pp-------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 296 --DEPP-------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred --cCCC-------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 1111 12223 389999999999999999999999999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-59 Score=429.56 Aligned_cols=283 Identities=40% Similarity=0.694 Sum_probs=250.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe-----CCEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN-----NNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~ 76 (417)
+|..++.||+|+||.|+.|.++.+|+.||||.+........ ..+.+||+++|+.++|+||+.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 56668999999999999999999999999999985544333 3455799999999999999999999865 46799
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC---
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS--- 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~--- 152 (417)
+|+|+|+.+|...+... ..+++..++.++.||+.||.|+|+.||+||||||.|+|++ +..+||||||+|+...+
T Consensus 103 iV~elMetDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EehhHHhhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999988887777654 3489999999999999999999999999999999999996 56899999999998864
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH-HHH
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL-RQA 231 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~-~~~ 231 (417)
...++.++.|.||+|||+++....|+.++||||+||||+||++|++.|+|.+..+++..|...+|+|..+.+.... ...
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 5557889999999999999888889999999999999999999999999999999999999999999877765543 233
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+......|..++..++..++++++++.||+.+||..||.+|+|++|+|+||||...
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 44555688889999999999999999999999999999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-58 Score=425.08 Aligned_cols=286 Identities=40% Similarity=0.759 Sum_probs=254.6
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCC-eeeeceEEEeCC-----
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSN-IVKLKELIQNNN----- 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~----- 73 (417)
|+.|+.+++||+|+||+||+|+++.+|+.||+|+++.... +.-....++|+.+|+.|+|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3568999999999999999999999999999999986544 222334479999999999999 999999998877
Q ss_pred -EEEEEEeccCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 74 -RLYLVFECMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 74 -~~~lv~E~~~~~l~~~~~~~~~--~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
.+++||||++-++...+..... ..++...++.+++||+.||+|||++||+||||||+||||++ |.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 8999999999999888876553 35788999999999999999999999999999999999975 8999999999997
Q ss_pred cc-CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 150 IK-SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 150 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
+. +...++..++|.||+|||++++...|+..+||||+|||++||+++.+.|++.++.+++.+|...+|+|+.+.|+...
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 76 44557788999999999999999889999999999999999999999999999999999999999999999999877
Q ss_pred HHHhhhhccCCCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....... .|+... ...+....+..++++.+|+.+||+.||.+|.||+.+|.||||...
T Consensus 250 ~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 250 SLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 6554333 566665 667778888888999999999999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=438.13 Aligned_cols=256 Identities=35% Similarity=0.564 Sum_probs=227.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhh--hHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL--NLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|.+++.||+|+|++|++|+++.+++.||||++.+++.-.+... +.+|-.+|.+| +||.|++|+..|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 589999999999999999999999999999999988766544432 35799999999 899999999999999999999
Q ss_pred EeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-
Q 044608 79 FECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 79 ~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~- 155 (417)
+||+.+ +|++++.+. +.|+|..++.|+.+|+.||+|||++|||||||||||||++ ++++||+|||.|..+.....
T Consensus 153 Le~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999975 577777655 4599999999999999999999999999999999999997 58999999999987643211
Q ss_pred -------------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 156 -------------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 156 -------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
..+++||..|++||+|.... .++.+|||+||||||.|+.|.+||.+.++.-.+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-------- 301 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-------- 301 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--------
Confidence 25689999999999986554 89999999999999999999999999999999999974
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 290 (417)
+.|.|| +++++++.|||+++|..||.+|+|+.+|.+||||..+.|.
T Consensus 302 -----------l~y~fp-----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 302 -----------LDYEFP-----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred -----------hcccCC-----------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 356655 4678999999999999999999999999999999988664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-56 Score=431.87 Aligned_cols=271 Identities=31% Similarity=0.494 Sum_probs=229.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||.||+|+.+.||+.||+|++++..--.. ......|-.+|...++|+||++|..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 5899999999999999999999999999999999987543222 12235799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccC-----
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS----- 152 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~----- 152 (417)
|||++||....++.+. ..|+|..++.|+.+++.|++.||+.|++||||||+|+||+. |++||+|||||..+..
T Consensus 220 MEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999988666666555 56999999999999999999999999999999999999984 9999999999964321
Q ss_pred -------------------CC-----C-------------------CccccCCccccCchhhhccCCCCchhhHHHHHHH
Q 044608 153 -------------------GP-----P-------------------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAI 189 (417)
Q Consensus 153 -------------------~~-----~-------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 189 (417)
.. . ....+|||.|+||||+.+.. |+..+|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHH
Confidence 00 0 01358999999999998877 9999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCC
Q 044608 190 MAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDP 269 (417)
Q Consensus 190 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 269 (417)
+||||.|.|||.+++..+...+|.. |.. ...+|.. ...|++|+|||.+||+ ||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~n---------wr~--------~l~fP~~---------~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVN---------WRE--------TLKFPEE---------VDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHH---------Hhh--------hccCCCc---------CcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999864 322 2334432 2467999999999999 99
Q ss_pred CCCC---CHHHHHcCccccccccCCCCCCCCCCC
Q 044608 270 SKRP---TAAEALQHPFFKRCFYAPPHIRSTPAV 300 (417)
Q Consensus 270 ~~Rp---ta~elL~hp~f~~~~~~~~~~~~~~~~ 300 (417)
++|. +++||.+||||+.+.|........|.+
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfv 464 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFV 464 (550)
T ss_pred HHhcCcccHHHHhcCCccccCCcchhhcCCCCCC
Confidence 9996 499999999999998876655554443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-56 Score=415.22 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=223.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++.++||.|+||+||+|+++.++..||||.|.+..... .......|+++|+.++|||||.+++++++.+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999998765333 3344468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-------CcEEEeeccccccccC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-------GIIKIADFGLAREIKS 152 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-------~~vkL~DFg~a~~~~~ 152 (417)
|||+|+.+..++.+. +.++|..++.++.||+.||++||+++|+||||||+||||+. -.+||+|||+|+.+.+
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 999977666655554 45999999999999999999999999999999999999963 2489999999999998
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+.||+|.|||||++...+ |+.|+|+||+|+|+|+|++|.+||...+..+....+..
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k------------------ 228 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK------------------ 228 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc------------------
Confidence 88889999999999999996554 99999999999999999999999999998888765421
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..... .......+....+|+..+|..||..|.+..+-+.|+++...
T Consensus 229 -~~~~~--------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 229 -GNEIV--------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred -ccccc--------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 11111 12223467788899999999999999999999999998653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=400.66 Aligned_cols=256 Identities=36% Similarity=0.574 Sum_probs=226.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|.|++.++||+|.|+.||++.+..||+.+|+|+++....... ...+.+|+.|-+.|+|||||++++.+......|+|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 579999999999999999999999999999999975543332 3344689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-C---CcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-Q---GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~---~~vkL~DFg~a~~~~~~~~ 155 (417)
+|+|+ +...+..+ ..++|..+..+++||++||.|||.+||+|||+||+|+|+. + .-+||+|||+|..+.++..
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99876 66666665 4589999999999999999999999999999999999993 2 3599999999999988777
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+|||.|||||++.... |+..+|||+.|||||.|+.|++||.+++..+.+..|.. ..
T Consensus 169 ~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~-------------------g~ 228 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA-------------------GA 228 (355)
T ss_pred cccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-------------------cc
Confidence 88889999999999997666 99999999999999999999999999998888888763 34
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
|.++. ..++.+|+++++||++||..||.+|.|+.|+|+|||+.+
T Consensus 229 yd~~~-------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 229 YDYPS-------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred cCCCC-------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 44442 356789999999999999999999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-56 Score=399.19 Aligned_cols=260 Identities=31% Similarity=0.504 Sum_probs=226.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||.|+||.|.+++++.+|..||+|++++...-.- .....+|..+|+.+.||+++++++.|.+.+++|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4789999999999999999999999999999999986543221 12235799999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|||.+|+ +..++.+. +.|+|..++.|+.||+.||+|||+++|++|||||||||++ +|.+||+|||+|+.+... .
T Consensus 123 meyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 9999877 55554433 4599999999999999999999999999999999999997 599999999999987655 4
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
-+.||||.|+|||++.... |+.++|+|||||++|||+.|.+||.+.+...++.+|++. ++
T Consensus 199 ~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-------------------~v 258 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-------------------KV 258 (355)
T ss_pred EEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------------cc
Confidence 6779999999999996555 999999999999999999999999999999999999743 34
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCC-----CCHHHHHcCccccccccCCCCCC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFKRCFYAPPHIR 295 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R-----pta~elL~hp~f~~~~~~~~~~~ 295 (417)
.|| ..+|++++|||+++|+.|-.+| ....+|..||||+...|.....+
T Consensus 259 ~fP-----------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 259 KFP-----------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred cCC-----------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 444 3579999999999999999999 45889999999999877665444
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-56 Score=412.55 Aligned_cols=279 Identities=39% Similarity=0.682 Sum_probs=244.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--C---EEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--N---RLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~---~~~l 77 (417)
.|.-.+.+|.|+||.||+|....+++.||||.+-.+... .-+|+++|++++|||||++..+|... . ++.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 377789999999999999999999999999998654322 23799999999999999999988632 2 4568
Q ss_pred EEeccCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCC
Q 044608 78 VFECMECNLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~ 153 (417)
|||||+.++.+.+... .+..++.-.++-|+.||++||.|||+.||+||||||+|||++ .|.+||||||+|+.+..+
T Consensus 100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 9999999998887642 345689999999999999999999999999999999999997 388999999999999988
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.+..++..|++|+|||.+.+...|+.++||||.|||+.||+-|++.|+|.+..+++..|+..+|.|+.+...... ...
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn--~~y 257 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN--PNY 257 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC--ccc
Confidence 888889999999999999999999999999999999999999999999999999999999999999988765432 222
Q ss_pred hhccCCCCCcccccc-cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 234 IKYQFPQLPRANLSA-LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
....+|......+.. +....++++.+|+.++|..+|++|.|+.|+|.||||....
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 355667776666655 6678899999999999999999999999999999998643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=410.91 Aligned_cols=283 Identities=37% Similarity=0.671 Sum_probs=243.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|++|+++++||.|+||.||+|+++.+++.||+|+++............+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 68999999999999999999999999999999999755433333445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+++++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 84 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 84 YLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 99998877765443 4579999999999999999999999999999999999996 588999999999765432 23345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|...........+.+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 67899999999987666689999999999999999999999999999999999999999999998887655544444555
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+...........+..+.++++||++||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 5543334444556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=420.13 Aligned_cols=254 Identities=34% Similarity=0.536 Sum_probs=222.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC----hhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS----WEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||+|+.|.+..+|+.||+|++.++... .....+.+|+.+++.+. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 5899999999999999999999999999999988764222 12233458999999999 999999999999999999
Q ss_pred EEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccc-cC
Q 044608 77 LVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREI-KS 152 (417)
Q Consensus 77 lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~-~~ 152 (417)
+||||+.| +|++.+.. .+.+.|.+++.+|+||++|++|||++||+||||||||||++. +.+||+|||++... ..
T Consensus 97 ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred EEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 99999987 57777766 356999999999999999999999999999999999999975 68999999999988 46
Q ss_pred CCCCccccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....+.|||+.|+|||++.+.. +-+.++||||+||+||.|++|+.||...+......+|..
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~----------------- 237 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK----------------- 237 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------
Confidence 67788999999999999998766 557899999999999999999999999887777776542
Q ss_pred hhhhccCCCCCcccccccCCCC-CHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSA-SQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+.+| ..+ |+++++||++||..||.+|+|+.+++.||||+..
T Consensus 238 --~~~~~p-----------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 238 --GEFKIP-----------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred --CCccCC-----------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 234333 234 9999999999999999999999999999999973
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=426.37 Aligned_cols=260 Identities=32% Similarity=0.467 Sum_probs=230.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccc--cChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY--ASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.-|++.+.||.|+.|.|.+|+|..||+..|||+|.+.. .+.....+.+||-+|+.+.||||+++|+++++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45899999999999999999999999999999998652 2222344568999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.|| |++++..+ +.++|.+++.+++||+.|+.|||..+|+||||||+|+|++. +.|||+|||+|..-..+....
T Consensus 92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999865 67766655 45999999999999999999999999999999999999974 679999999999888888889
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+.||+|.|.|||++.+..+.+.++||||+|||||.||+|+.||.+.+-...+.+++. ..|+
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-------------------G~f~ 230 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-------------------GVFE 230 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------------Cccc
Confidence 999999999999999999889999999999999999999999998888777777753 3444
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCCC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPH 293 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 293 (417)
.| ..+|.++++||++||..||++|.|.+||++|||++.+...+..
T Consensus 231 MP-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 231 MP-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred CC-----------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 44 3689999999999999999999999999999999987554433
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=429.55 Aligned_cols=280 Identities=37% Similarity=0.644 Sum_probs=232.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-C-----CCeeeeceEEEeCCEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-H-----SNIVKLKELIQNNNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~~~~~ 76 (417)
+|++++.||+|+||.|-+|.+..|++.||||+++.+.... .+...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~--~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL--RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH--HHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 6999999999999999999999999999999998764332 23357999999997 4 38999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC---CcEEEeeccccccccCC
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSG 153 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~---~~vkL~DFg~a~~~~~~ 153 (417)
||+|.++.+|++++..+....|+...++.++.||+.||.+||+.||||+|||||||||.+ ..|||+|||+|+.....
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999999999999999998888999999999999999999999999999999999999953 57999999999865433
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.+ +++-+++|+|||++++.. |+.+.||||||||++||++|.++|+|.++.|++..|++++|.|+..-...+.+....
T Consensus 345 -vy-tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 345 -VY-TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred -ce-eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 23 789999999999999887 999999999999999999999999999999999999999998876543332222111
Q ss_pred hhc--cCCCC------------------------------CcccccccCC-CCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 234 IKY--QFPQL------------------------------PRANLSALMP-SASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 234 ~~~--~~~~~------------------------------~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+.. .++.. ....+..... .-...+.|||.+||.+||.+|+|+.++|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111 00000 0111111112 22345799999999999999999999999
Q ss_pred Ccccccc
Q 044608 281 HPFFKRC 287 (417)
Q Consensus 281 hp~f~~~ 287 (417)
||||...
T Consensus 502 Hpfl~~~ 508 (586)
T KOG0667|consen 502 HPFLTGT 508 (586)
T ss_pred Ccccccc
Confidence 9999853
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=424.51 Aligned_cols=262 Identities=31% Similarity=0.480 Sum_probs=226.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 77 (417)
+++|.++++||+|+||+|+++..+.+++.||||++++...-..+ .....|..|+...+ ||.++.++.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 57899999999999999999999999999999999987543322 22357888888875 9999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
||||+.|+.+.. ......|+|..++.|+..|+.||+|||++||+|||||.+|||+| +|++||+|||+++..- .+..
T Consensus 447 vmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 447 VMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 999999887322 23336699999999999999999999999999999999999997 6999999999998654 5566
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.+++||||.|+|||++.+.. |+.++|+|||||+|||||.|.+||+++++++....|.. .+
T Consensus 525 TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-------------------d~ 584 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-------------------DE 584 (694)
T ss_pred cccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------------CC
Confidence 78899999999999997766 99999999999999999999999999999999988852 11
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCCCCC
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYAPPHIR 295 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~~~~~ 295 (417)
..++-.+|.|+.+++++||.+||++|.. +++|.+||||....|.....+
T Consensus 585 -----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r 638 (694)
T KOG0694|consen 585 -----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNR 638 (694)
T ss_pred -----------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhc
Confidence 1233468999999999999999999965 689999999998876544433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-54 Score=413.85 Aligned_cols=254 Identities=31% Similarity=0.525 Sum_probs=223.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+..... +.....+|++|+++|+|||||.+++.|+...++|+|.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 799999999999999999999999999999999998765443 4445568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-Cc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-~~ 157 (417)
||+.|+|...+... +.++|+.++.++.+++.||.|||+++|+|||+||.|||++. |.+|+||||+|+....... .+
T Consensus 81 e~a~g~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 81 EYAVGDLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhhhhHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 99999777666543 45999999999999999999999999999999999999975 7899999999997765433 45
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...|||.|||||++.+. .|+..+|+||||||+|||++|+|||...+-.+....|.+-
T Consensus 159 sikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---------------------- 215 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---------------------- 215 (808)
T ss_pred eccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC----------------------
Confidence 66899999999998754 4999999999999999999999999988877777766420
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
- ...+..+|.++++||..+|.+||.+|.|..+++.|||+++.
T Consensus 216 ~--------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 216 P--------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred C--------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 0 11223689999999999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-55 Score=389.11 Aligned_cols=243 Identities=28% Similarity=0.482 Sum_probs=207.2
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeece-EEEe-CCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKE-LIQN-NNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~-~~~~~lv~ 79 (417)
+|+|.++||+|+||+||++++..+|+.+|.|.++-...+. +......|+.+|++|+|||||++++ .|.. +.-++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 5999999999999999999999999999999998544433 3344578999999999999999998 4544 44499999
Q ss_pred eccCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccCCCCCeeeeC-CcEEEeecccccccc
Q 044608 80 ECMECNLYQLMAAR---DRKLFSEPEIKAWLFQVFQGLSYMHQ--NG--FFHRDLKPENLLVSQ-GIIKIADFGLAREIK 151 (417)
Q Consensus 80 E~~~~~l~~~~~~~---~~~~l~e~~i~~i~~qi~~aL~~LH~--~g--i~HrDLKp~NILl~~-~~vkL~DFg~a~~~~ 151 (417)
|||++|.+..++++ .++.++|..+|.++.|++.||.+||+ .. |+||||||.||+|+. |.|||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99987766666543 45679999999999999999999999 44 999999999999974 899999999999887
Q ss_pred CCCC-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 152 SGPP-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 152 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
+... ..+++|||+||+||++.... |+.++||||+||++|||+..++||.+.+-.+...+|+..
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--------------- 243 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--------------- 243 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC---------------
Confidence 7654 35689999999999997766 999999999999999999999999999888877777632
Q ss_pred HhhhhccCCCCCcccccccC-CCCCHhHHHHHHHhcccCCCCCCCH
Q 044608 231 ARAIKYQFPQLPRANLSALM-PSASQDAISLFESLCSWDPSKRPTA 275 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta 275 (417)
.+ +.++ ..+|.++..||..|+..||+.||+.
T Consensus 244 ------d~--------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 244 ------DY--------PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ------CC--------CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 11 1122 3478999999999999999999996
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=400.68 Aligned_cols=286 Identities=35% Similarity=0.577 Sum_probs=230.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.++|++++.||+|+||.||+|.++.+|+.||+|++.............+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 37899999999999999999999999999999999765433333445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~ 158 (417)
|+.+++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 99999888876543 5589999999999999999999999999999999999996 58899999999875432 223345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.+....|.............
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 6789999999998766668999999999999999999999998764 456677777777888777776543221111111
Q ss_pred CCCCCcccccccC--CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALM--PSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.......+...+ ...+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 1111111111111 1356889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=413.53 Aligned_cols=254 Identities=30% Similarity=0.538 Sum_probs=225.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
..|...++||+|+.|.||.|+...+++.||||++..+.... ...+++|+.+|+.++|+|||++++.|...+.+|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 46889999999999999999999999999999998765443 44567999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
|+|+.+.++.... .++|.+|+.+++.+++||+|||.+||+|||||.+|||++ +|.+||+|||++..+... ....+.
T Consensus 352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 9998887777654 499999999999999999999999999999999999996 689999999999877654 467788
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+|||+|||||++.... |++++||||||+++.||+-|.+||-.++....++.|.. .|.|...
T Consensus 430 VGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk----------------- 490 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK----------------- 490 (550)
T ss_pred cCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-----------------
Confidence 9999999999996655 99999999999999999999999999998888888753 2333322
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....+|++++||+.+||+.|+++|+||.|||+||||+.
T Consensus 491 ---------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ---------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ---------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 23568999999999999999999999999999999964
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=383.29 Aligned_cols=258 Identities=33% Similarity=0.528 Sum_probs=222.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh---hh----hhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW---ED----CLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~---~~----~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|+-.+.||.|..++|.+|.++.+|..+|+|+|....... .. .....|+.||+++ .||||+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46888899999999999999999999999999986322211 11 1224799999998 6999999999999999
Q ss_pred EEEEEEeccC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccccc
Q 044608 74 RLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK 151 (417)
Q Consensus 74 ~~~lv~E~~~-~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~ 151 (417)
.+++|+|.|. |.|++.+.+. -.++|.+.+.+++||++|++|||.++|+||||||+|||+++ -++||+|||+|+.+.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999986 5677777655 45999999999999999999999999999999999999976 579999999999999
Q ss_pred CCCCCccccCCccccCchhhh-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILL-----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
.+......||||+|+|||.+. +...|+..+|+|++|||||-|+.|++||......-++..|++.
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG----------- 243 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG----------- 243 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc-----------
Confidence 999999999999999999984 3356899999999999999999999999888777777777643
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+|+|.. ..+.++|.+++|||++||+.||.+|.|++|+|+||||...
T Consensus 244 --------kyqF~s-------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 244 --------KYQFRS-------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred --------ccccCC-------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 344432 2335678999999999999999999999999999999654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=398.21 Aligned_cols=286 Identities=35% Similarity=0.673 Sum_probs=244.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|++|.++++||+|+||.||+|+++.+++.||+|.++............+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 68999999999999999999999999999999999755433333445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 85 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 85 YLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 99998887766543 4589999999999999999999999999999999999996 578999999998754332 22334
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...........+.+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 57899999999987666689999999999999999999999999999999999999999999888877655444444555
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+......+....+.++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 5544444444556789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=392.07 Aligned_cols=269 Identities=29% Similarity=0.419 Sum_probs=228.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||.|.-|+||+|+.+.++..+|+|++.+....... .+...|.+||..++||.++.+|..|+..+..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 5789999999999999999999999999999999876544322 23357999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee-eCCcEEEeeccccccccC-----
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS----- 152 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl-~~~~vkL~DFg~a~~~~~----- 152 (417)
|||.|+ |..+..++..+.|+|+.++.|+..|+.||+|||-.|||+|||||||||| ++|+|-|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999876 5555666677899999999999999999999999999999999999999 579999999999853210
Q ss_pred ------------------------------C----------------------CCCccccCCccccCchhhhccCCCCch
Q 044608 153 ------------------------------G----------------------PPYTNYVGSRWYRAPEILLQSELYSSK 180 (417)
Q Consensus 153 ------------------------------~----------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~ 180 (417)
. .....++||-.|+|||++.+.. .+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCch
Confidence 0 0013468999999999998766 8999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHH
Q 044608 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISL 260 (417)
Q Consensus 181 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 260 (417)
+|+|+|||++|||+.|..||.|.+..+++.+|+.. ...||.. +.+|..++||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-------------------~l~Fp~~---------~~vs~~akDL 367 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-------------------PLKFPEE---------PEVSSAAKDL 367 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-------------------CCcCCCC---------CcchhHHHHH
Confidence 99999999999999999999999999999988631 2223332 3678999999
Q ss_pred HHHhcccCCCCCCC----HHHHHcCccccccccCCCCCCCCCC
Q 044608 261 FESLCSWDPSKRPT----AAEALQHPFFKRCFYAPPHIRSTPA 299 (417)
Q Consensus 261 i~~~L~~dP~~Rpt----a~elL~hp~f~~~~~~~~~~~~~~~ 299 (417)
|+++|.+||.+|.. |.||.+||||+.+.|.-......|.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 99999999999998 9999999999999987544433333
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=403.45 Aligned_cols=256 Identities=38% Similarity=0.599 Sum_probs=225.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 78 (417)
+.|++.++||+|.||.||+|+++.||+.+|+|++.+...... .....+|+.+|++|. |||||.++++|++...+|+|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 479999999999999999999999999999999987655332 245568999999998 99999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---C--CcEEEeeccccccccC
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---Q--GIIKIADFGLAREIKS 152 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~--~~vkL~DFg~a~~~~~ 152 (417)
||++.|+ |++.+... .++|..+..++.||+.++.|||+.||+||||||||+|+. + +.+|++|||+|.....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999865 66666655 299999999999999999999999999999999999993 2 4799999999998888
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
+......|||++|+|||++.... |+..+||||+||++|.|++|.+||.+.++......|...
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----------------- 253 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----------------- 253 (382)
T ss_pred CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----------------
Confidence 77788999999999999996544 999999999999999999999999999988888777532
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++.|+ ...++.+|..+++||++||..||.+|+|+.++|+|||++..
T Consensus 254 --~~~f~-------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 254 --DFDFT-------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred --CCCCC-------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 22222 34456789999999999999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=352.59 Aligned_cols=284 Identities=35% Similarity=0.643 Sum_probs=249.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|.+|...++||+|.||+||+|+++.+++.||+|.++.+..+. -....++|+-+|+.|+|.|||+++++..++..+-+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 678999999999999999999999999999999997654332 2334579999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~ 157 (417)
|||+.++......-+ +.++.+.++.++.|++.||.|||+.++.||||||+|+||+ +|.+||+|||+++.++-.. -++
T Consensus 81 e~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 999988887776655 5689999999999999999999999999999999999996 6899999999999876543 244
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
..+-|.||++|.++.+.+.|+.+.|+||.|||+.|+. .|++.|++.+..+++.+|+..+|.++.+.|...........|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 5678999999999999999999999999999999998 588999999999999999999999999999987665544333
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..- .....++.+.|.++...+||+.++|..+|..|.+|+++|+||||..
T Consensus 240 p~y-pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIY-PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCc-cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 211 1244567788899999999999999999999999999999999976
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=388.10 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=227.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh--hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC--LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.+|++.+.||+|+||+|.+|.+...|+.||||.|++.....+.. .+.+||+||+.|+||||+.+|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999998776554433 3468999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||..++ |++++..+. .++|.+++.+++||.+|+.|||.++++|||||.+|||++ ++.+||+|||++..+....-.+
T Consensus 133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 998754 777776654 499999999999999999999999999999999999997 4789999999999998888889
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
++||+|.|.+||++.+..+-++.+|.|||||+||-|..|..||.|.+....+..|. ...|.
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------------------~GaYr 271 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------------------RGAYR 271 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------------------ccccc
Confidence 99999999999999888888999999999999999999999999998777766653 33443
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 291 (417)
-| .-+.++.-||+.||..||++|.|++++-.|-|.+.....+
T Consensus 272 EP------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~ 313 (668)
T KOG0611|consen 272 EP------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMP 313 (668)
T ss_pred CC------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheeecccccc
Confidence 33 3456899999999999999999999999999998765443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=391.40 Aligned_cols=256 Identities=32% Similarity=0.525 Sum_probs=210.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--EEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN--RLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E 80 (417)
+|...+.||+|+||.||++.+..+|+.+|+|.+....... .....+|+.+|++|+|||||++++...... .++++||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 5788999999999999999999999999999987653222 333468999999999999999999754444 6999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccC----CC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKS----GP 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~----~~ 154 (417)
|+.++.+..+..+.+..++|+.++.+.+||++||.|||++||+||||||+|||++. +.+||+|||++..... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99987776666665447999999999999999999999999999999999999976 6999999999987663 12
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
......||+.|||||++..+...+.++|||||||++.||+||.+||... ...+.+.+|..
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~------------------- 237 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR------------------- 237 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-------------------
Confidence 2345789999999999975433345999999999999999999999873 33333333311
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......++..+|.++++||.+||..||++||||+++|+|||.+..
T Consensus 238 ---------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 238 ---------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 001124556789999999999999999999999999999999764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=408.44 Aligned_cols=279 Identities=33% Similarity=0.567 Sum_probs=232.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--------C
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--------N 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------~ 73 (417)
++|++++.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||++++++|... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 479999999999999999999999999999998864321 224799999999999999999887432 2
Q ss_pred EEEEEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeecccccc
Q 044608 74 RLYLVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLARE 149 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~ 149 (417)
.+++||||+.+++.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+.
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 5779999999988776653 23456899999999999999999999999999999999999963 4699999999987
Q ss_pred ccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
+.........+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+.++...+|.+..+.+.....
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 76655556678999999999987766689999999999999999999999999999999999999999887766543211
Q ss_pred HHhhhhccCCCCCccccccc-CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 230 QARAIKYQFPQLPRANLSAL-MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......++......+... ....+.++++||.+||..||.+|+|+.|+|+||||...
T Consensus 301 --~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 301 --NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred --hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 112233444433334333 33578999999999999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=386.29 Aligned_cols=267 Identities=28% Similarity=0.396 Sum_probs=220.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++..+||.|..++||+|++..+++.||||+++.+....+...+.+|+..++.++||||++++..|..++.+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 68999999999999999999999999999999998765555545567899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CC----
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GP---- 154 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~---- 154 (417)
|.|| +++.+...-...++|..|+.++++++.||.|||++|.+|||||+.||||+ +|.|||+|||.+..+.. +.
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9876 55555555556699999999999999999999999999999999999995 69999999998765432 21
Q ss_pred CCccccCCccccCchhh-hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 155 PYTNYVGSRWYRAPEIL-LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.+++++||++|||||++ .+...|+.|+||||||++..||.+|..||....+...+-.-. -+.|+.-. ..
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~-t~------- 255 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLL-TS------- 255 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcc-cc-------
Confidence 13677999999999995 445669999999999999999999999999888776554322 12221000 00
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
. .-......++..++.+|..||+.||.+||||+++|+|+||+...
T Consensus 256 ---------~-~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 256 ---------G-LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ---------c-CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 0 00011234567899999999999999999999999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=386.37 Aligned_cols=281 Identities=36% Similarity=0.650 Sum_probs=227.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|+++.+++.||+|++....... ......+|+++++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 58999999999999999999999999999999997543322 22344689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CCCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~~~ 157 (417)
|+.++++..+.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... ....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99999888776543 5689999999999999999999999999999999999996 478999999999876432 2234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+....+....+.+.............
T Consensus 160 ~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 567999999999987655 8999999999999999999999999998888888887777766554443322211111111
Q ss_pred CCCC--CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQL--PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
++.. ...........+|.++.+||++||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1111 0111122334578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=386.86 Aligned_cols=279 Identities=36% Similarity=0.637 Sum_probs=230.5
Q ss_pred CCceecceecccCceEEEEEEECC-CCcEEEEEEecccccChh-hhhhHHHHHHHHhc---CCCCeeeeceEEE-----e
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYASWE-DCLNLREVKCLRKL---NHSNIVKLKELIQ-----N 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~ 71 (417)
++|++++.||+|+||.||+|.+.. +|+.||+|.++....... .....+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999865 578899999875433221 22334677777665 6999999999885 3
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
...+++||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4568999999999888887765555689999999999999999999999999999999999996 588999999999876
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
..........||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+....+.+....|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 6555555668999999999986654 899999999999999999999999999999999999988888877777654332
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.. ..+.......+....+.++.++++||.+||+.||++|||+.|+|+||||
T Consensus 240 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cc---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 21 1222233344455667789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=388.05 Aligned_cols=286 Identities=36% Similarity=0.662 Sum_probs=242.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+++|++.++||.|+||.||+|.++.+++.||+|.+.............+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999998755433333445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+++++...+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... .....
T Consensus 85 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 85 YLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred ccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 99988877766543 4589999999999999999999999999999999999996 478999999998754332 22334
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.+....|...........+.+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 56799999999987766688999999999999999999999999999999999999999988888877655444444444
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+......+....+.+++++++||.+||+.||.+|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 4443333444556789999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=373.52 Aligned_cols=288 Identities=34% Similarity=0.626 Sum_probs=233.5
Q ss_pred CCceecceecccCceEEEEEEECCCCc----EEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~ 75 (417)
+.|+++++||+|+||.||+|..+.++. .||||.++.... +.-.....||+.+++.|+||||+.+..+|.. ...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 579999999999999999997666543 789999975522 1222333589999999999999999999877 7889
Q ss_pred EEEEeccCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-C----CcEEEeecccc
Q 044608 76 YLVFECMECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-Q----GIIKIADFGLA 147 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~----~~vkL~DFg~a 147 (417)
++++||.+.+|+..+.-.. .+.++...++.++.||+.|+.|||++.|+||||||.|||+. + |.|||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999999999998876432 24689999999999999999999999999999999999994 3 78999999999
Q ss_pred ccccCC----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHH
Q 044608 148 REIKSG----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS---------EADQMYKICG 214 (417)
Q Consensus 148 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i~~ 214 (417)
+.+.+. ......+-|.||+|||.+++...|+.++|+|++|||+.||++..|.|.+.. ..+++.+|++
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 987643 223456789999999999999999999999999999999999999998764 3588999999
Q ss_pred hhCCCCccchHHHHHHHhh--hhccCCCCCcc-----cccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 215 VLGSPTMDSWADGLRQARA--IKYQFPQLPRA-----NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++|.|+.+.|++..+.... ....|+..... .+-.....-++.+.+|+.+||..||-+|.|++++|+|+||.+.
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 9999999999986544332 00111111111 1112223345669999999999999999999999999999875
Q ss_pred cc
Q 044608 288 FY 289 (417)
Q Consensus 288 ~~ 289 (417)
..
T Consensus 344 ~l 345 (438)
T KOG0666|consen 344 PL 345 (438)
T ss_pred CC
Confidence 43
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=364.34 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=224.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+|+|++.+.||+|.||.||+|+.+.++..||+|++.+..... ...+..+|++|.+.|+||||+++|++|.+...+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 589999999999999999999999999999999997654322 223446899999999999999999999999999999
Q ss_pred EeccC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~-~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
+||.. |.++..+.....+.++|...+.|+.|++.||.|||.++|+||||||+|+|++ +|.+||+|||.+.... ....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR 179 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR 179 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence 99986 5688888766667799999999999999999999999999999999999995 7999999999987654 4455
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+.+.+|.. .++
T Consensus 180 ~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-------------------~~~ 239 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-------------------VDL 239 (281)
T ss_pred eeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-------------------ccc
Confidence 7789999999999986655 89999999999999999999999999998888888753 233
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+| ..+|.++.|||.+||..+|.+|.+..|++.|||...
T Consensus 240 ~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 KFP-----------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cCC-----------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 333 468999999999999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=391.52 Aligned_cols=261 Identities=33% Similarity=0.492 Sum_probs=217.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-------------hhhhhHHHHHHHHhcCCCCeeeece
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-------------EDCLNLREVKCLRKLNHSNIVKLKE 67 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-------------~~~~~~~E~~~l~~l~hpnIv~l~~ 67 (417)
+++|+++++||+|.||+|.+|++..+++.||||++.+..... ......+||.+|++|.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 579999999999999999999999999999999996532111 1123458999999999999999999
Q ss_pred EEEeC--CEEEEEEeccCCCHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEee
Q 044608 68 LIQNN--NRLYLVFECMECNLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIAD 143 (417)
Q Consensus 68 ~~~~~--~~~~lv~E~~~~~l~~~~~~~~~~~-l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~D 143 (417)
+..+. +.+|||+|||..+-..+.- ..+. +++.+++.|+++++.||+|||.+||+||||||.|+||+ +|+|||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 98764 6899999999877555432 2234 89999999999999999999999999999999999995 59999999
Q ss_pred ccccccccC------CCCCccccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 144 FGLAREIKS------GPPYTNYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 144 Fg~a~~~~~------~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
||.+..+.. ...+...+|||.|+|||.+.+. ...+.+.||||+||+||-|+.|..||-++...+.+.+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 999986632 2224457999999999998762 3457789999999999999999999999999999999863
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 291 (417)
. ...||.. +.+.++++|||.+||.+||++|.|..+|..|||.......+
T Consensus 334 ~-------------------pL~fP~~---------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 334 D-------------------PLEFPEN---------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred C-------------------cccCCCc---------ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 2 2223322 35689999999999999999999999999999998754333
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=391.06 Aligned_cols=282 Identities=33% Similarity=0.545 Sum_probs=228.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCC------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNN------ 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 73 (417)
+++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999997543332 2334468999999999999999999986543
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCcCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 579999999998877653 2378999999999999999999999999999999999996 58999999999986655
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....++..++.+....+........
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred CccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 55556678999999999986654 89999999999999999999999999998888888888888877655444332222
Q ss_pred hhhccCCCCCccccc------------ccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLS------------ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+......+. ......+.++++||.+||+.||++|||+.|+|+||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 221111111111111 1122357889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=381.65 Aligned_cols=278 Identities=38% Similarity=0.651 Sum_probs=230.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhc---CCCCeeeeceEEEe-----CC
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKL---NHSNIVKLKELIQN-----NN 73 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~ 73 (417)
+|++.+.||+|+||.||+|.++.+|+.||+|.++....... .....+|+.+++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875432211 12234677766655 79999999998864 35
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+++||||+.+++...+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 68999999998888877665545689999999999999999999999999999999999996 58899999999987765
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|.......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP- 238 (288)
T ss_pred cccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc-
Confidence 55555668899999999987655 8999999999999999999999999999999999999888887777775432211
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...+.......+....+.++.++.+||.+||+.||++|||+.|+|.||||
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 --RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred --ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11222333444556667889999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=388.16 Aligned_cols=283 Identities=37% Similarity=0.648 Sum_probs=227.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (417)
+|++.+.||+|+||.||+|+++.+|+.||||++...... .......+|++++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999998754322 2223456899999999999999999988543 3589
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~- 154 (417)
+||||+++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 81 lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELMESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCCCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999998887776543 3589999999999999999999999999999999999996 4789999999997543221
Q ss_pred ---CCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ---PYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....|.+....+......
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 22456899999999998542 45899999999999999999999999999988888888888887766654432211
Q ss_pred H-hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 A-RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ..............+....+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 1 00111111222233444556788999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=387.75 Aligned_cols=257 Identities=32% Similarity=0.531 Sum_probs=231.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
-|.+.+.||+|.|+.|.+|+|..||+.||||+|.+... +.....++.|+..|+.++|||||++|++......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 38888999999999999999999999999999976433 33344557899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCCCCCcc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
-++ ++++++++.. ..+.|+.++.|+.||+.|+.|||+..+||||||||||.+- -|-|||.|||++..+..+...++
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 876 6888888766 5689999999999999999999999999999999999884 38999999999999999999999
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.||+..|.|||+|+++.+..+++||||||||||-|.+|++||...++.+.+-.|+.. +|..
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-------------------KYtv 238 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-------------------KYTV 238 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-------------------cccC
Confidence 999999999999999997789999999999999999999999999999998888643 4444
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 290 (417)
| ..+|.+++|||..||..||.+|.|.+||..|+|++.....
T Consensus 239 P-----------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 239 P-----------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred c-----------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 4 3579999999999999999999999999999999986543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=387.88 Aligned_cols=282 Identities=32% Similarity=0.525 Sum_probs=227.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeC------C
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNN------N 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 73 (417)
+++|++.+.||+|+||.||+|.+..+++.||||++....... ......+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999999999999999997643322 233456899999999999999999987543 4
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 6799999999988876642 378999999999999999999999999999999999996 57899999999987665
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...++...++.+..+.+........
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 55556678999999999987654 89999999999999999999999999999999999988888876554443322222
Q ss_pred hhhccCCCCCccc------------ccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRAN------------LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+...... ........+.++++||.+||+.||.+|||++|+|+||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 2111111111100 111122346789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=391.89 Aligned_cols=283 Identities=34% Similarity=0.591 Sum_probs=233.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-----EEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNN-----RLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 76 (417)
+|++++.||+|+||.||+|.+..+|+.||||.+....... ......+|+++++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5899999999999999999999999999999987543322 2234568999999999999999999998776 899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC--
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-- 153 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-- 153 (417)
+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 81 lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999998888776543 45899999999999999999999999999999999999964 78999999999765432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.......+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+.+..|...+|.+..+.+.........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 22345578999999999977666899999999999999999999999999999999999999999888766554433322
Q ss_pred hhccCCCCCc--ccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 234 IKYQFPQLPR--ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 234 ~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+..++ ..+.......++++.+||.+||+.||++|||+.|+|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 2222221111 11112345678999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=364.59 Aligned_cols=315 Identities=29% Similarity=0.406 Sum_probs=239.4
Q ss_pred CCceecc-eecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEe----CCEE
Q 044608 2 DKYSGFK-ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQN----NNRL 75 (417)
Q Consensus 2 ~~Y~~~~-~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~ 75 (417)
|+|.+-. +||-|-.|+|..|.++.||+.+|+|++...- ...+|+++.-.. .|||||.++++|++ -..+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 6777765 6999999999999999999999999986431 123788876665 69999999999875 3578
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccc
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREI 150 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~ 150 (417)
.+|||+|+|+ |+..+..+....|+|.++..|++||..|+.|||+.+|.||||||||+|.+. ..+||+|||+|+.-
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 8999999876 777888887788999999999999999999999999999999999999953 46999999999987
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.....+.+.|-||+|.|||++. .+.|+..+|+||+|||+|.|++|.+||........- .+..+.
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---------------pgMk~r 278 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------------PGMKRR 278 (400)
T ss_pred CCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---------------hhHHhH
Confidence 7777788889999999999984 455999999999999999999999999876532110 112223
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCCCCCCCCCCCCCCCCCchh
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTTANQPAA 310 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (417)
+....|.||.. .+..+|++++|+|++||..+|.+|.|+++++.|||+......|.....+.... ..
T Consensus 279 I~~gqy~FP~p-------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l-------~~ 344 (400)
T KOG0604|consen 279 IRTGQYEFPEP-------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRML-------KE 344 (400)
T ss_pred hhccCccCCCh-------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhc-------ch
Confidence 34556777652 33567999999999999999999999999999999987544332211111110 01
Q ss_pred hhhhHHHHHHHHHHHHhcccccccccccCccccCCCCccchhhh
Q 044608 311 ATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSPLDLIKQ 354 (417)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (417)
+... ... .|+......+.|+.......-+..+..++.-+..+
T Consensus 345 a~e~-w~d-vqeem~~~lA~mrv~~~~v~ik~l~~~nn~Ll~kr 386 (400)
T KOG0604|consen 345 AVEA-WDD-VQEEMTETLATMRVDPLQVQIKPLGSSNNPLLRKR 386 (400)
T ss_pred hhhh-hHH-HHHHHHHHHHhcccCcceeEEeeccccCcHHHHHH
Confidence 1111 111 33444556677766666555555555555444443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=379.26 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=212.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 6899999999999999999999999999999998754221 12233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+.++.+....... +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 999865444433333 4589999999999999999999999999999999999996 578999999999866432 234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------------~~-- 215 (291)
T cd05612 158 LCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------------KL-- 215 (291)
T ss_pred ccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------Cc--
Confidence 57999999999986554 899999999999999999999999988876666555321 11
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccC
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYA 290 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 290 (417)
.+...++.++++||++||+.||.+|++ ++|+++||||+...+.
T Consensus 216 ---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 216 ---------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 122346889999999999999999995 9999999999875443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=385.59 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=212.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|+++.+|+.||+|++...... .......+|+.++++++||||+++++++.+++.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999999754321 1223346899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.++.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--F 173 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--c
Confidence 9999876444433333 4589999999999999999999999999999999999996 5889999999998664332 3
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ...
T Consensus 174 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-------------------~~~ 233 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-------------------RLK 233 (329)
T ss_pred eecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------CcC
Confidence 468999999999986554 799999999999999999999999888776666554310 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 287 (417)
+...++.++.+||.+||+.||.+|++ ++++++||||...
T Consensus 234 -----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 234 -----------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 12346889999999999999999987 7999999999874
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=387.35 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=210.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|.++.+++.||+|++.+..... ......+|+.++.+++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999997543211 1223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.|+.+..+..+. +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999876554444333 4589999999999999999999999999999999999996 5899999999987543211
Q ss_pred --------------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 044608 155 --------------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPG 202 (417)
Q Consensus 155 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 202 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 012458999999999987655 89999999999999999999999999
Q ss_pred CCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCC---CCCCHHHHH
Q 044608 203 ASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS---KRPTAAEAL 279 (417)
Q Consensus 203 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpta~elL 279 (417)
.+..+...++..... ...+|. ...+|+++++||.+||. +|. .||+++|++
T Consensus 239 ~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 239 ETPQETYKKVMNWKE-----------------TLIFPP---------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCHHHHHHHHHcCcC-----------------cccCCC---------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 888777766642110 111111 12478999999999886 454 458999999
Q ss_pred cCcccccccc
Q 044608 280 QHPFFKRCFY 289 (417)
Q Consensus 280 ~hp~f~~~~~ 289 (417)
+||||+...+
T Consensus 292 ~hp~f~~~~~ 301 (363)
T cd05628 292 TNPFFEGVDW 301 (363)
T ss_pred CCCCCCCCCH
Confidence 9999987644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=384.98 Aligned_cols=282 Identities=33% Similarity=0.530 Sum_probs=226.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------C
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------N 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 73 (417)
+++|++++.||+|+||.||+|.+..+++.||+|.+........ .....+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4789999999999999999999999999999999976543322 23446899999999999999999998643 3
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+|+||||+++++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 579999999998877664 2378999999999999999999999999999999999996 57899999999987665
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...++.+..+.+........
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred ccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 55556678999999999986654 89999999999999999999999999998888888888888776554433221111
Q ss_pred hhhccCCCCC------------cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLP------------RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+... ...........+.++++||.+||..||++|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 1111111100 000111223356789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=374.45 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=212.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|++.+.||+|+||.||+|.+..+|+.||+|.+....... ......+|+.++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999987543221 22334689999999999999999999999999999999
Q ss_pred ccCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.++.+. .+.......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99876554 44333334689999999999999999999999999999999999996 47899999999987655555556
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 161 ~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--------------------- 218 (285)
T cd05631 161 RVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--------------------- 218 (285)
T ss_pred CCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh---------------------
Confidence 78999999999997554 89999999999999999999999987664333222211100
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCF 288 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 288 (417)
.....+...++.++.+||++||+.||.+|+| ++++++||||....
T Consensus 219 -----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 219 -----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0011233467899999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=382.98 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=208.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.||+|+||.||+|.++.+|+.||+|+++..... .......+|+.++++++||||+++++++.+.+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999764321 22234468999999999999999999999999999999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCCc
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSR 163 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt~ 163 (417)
.+....... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.... ........+||+
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 554444333 4689999999999999999999999999999999999996 5789999999987532 233344568999
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+... ..
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------~~------- 212 (323)
T cd05571 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EI------- 212 (323)
T ss_pred cccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------CC-------
Confidence 999999986554 899999999999999999999999887766555544210 11
Q ss_pred ccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 244 ANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 244 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.+...+++++.+||.+||..||++|| ++.++++||||....+
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 12245789999999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=359.47 Aligned_cols=264 Identities=33% Similarity=0.557 Sum_probs=216.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCCC-
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMECN- 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~~- 85 (417)
+.||+|+|+.|-.|.+..+|..||||+|.+. ......+.+||++++..+ .|+||++++++|+++..+|||||-|.|+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4699999999999999999999999999887 455566778999999999 5999999999999999999999998765
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccC--------C
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKS--------G 153 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~--------~ 153 (417)
++..+.++ +.|+|.++..++++|+.||+|||.+||.||||||+|||..+ .-||||||.+.....- .
T Consensus 163 lLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 163 LLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 77777665 45999999999999999999999999999999999999954 3499999999865432 2
Q ss_pred CCCccccCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhCCCCccchHH
Q 044608 154 PPYTNYVGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK---ICGVLGSPTMDSWAD 226 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~~~ 226 (417)
+...+.+|+..|||||+.. +...|+.++|.||||||||.||+|.+||.|.-..+--.. .|..+. ..
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ-------~~ 313 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ-------NK 313 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-------HH
Confidence 3355679999999999962 345699999999999999999999999987653221000 000000 01
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+..+....|.||+.. +..+|.+++|||+.+|..|+..|.++.++++|||++.+.
T Consensus 314 LFesIQEGkYeFPdkd-------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKD-------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHhccCCcCChhh-------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 2233445567777533 356799999999999999999999999999999999864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.96 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=215.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|++..+++.||+|+++...... ......+|++++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997653221 2233468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 999876555555443 4589999999999999999999999999999999999996 57899999999986544 3345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+..... ....
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------~~~~ 219 (333)
T cd05600 158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-----------------TLQR 219 (333)
T ss_pred cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-----------------cccC
Confidence 6899999999998766 489999999999999999999999998887776655532100 0011
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
+.. ......++.++.+||.+||..+|.+|||++++++||||....
T Consensus 220 ~~~-----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 220 PVY-----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred CCC-----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 110 011135789999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=385.75 Aligned_cols=275 Identities=25% Similarity=0.341 Sum_probs=214.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|++..+++.||+|.... ....+|++++++|+||||++++++|..+...++|||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 579999999999999999999999999999997542 1235899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~~~~ 158 (417)
+.++++..+... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...... .....
T Consensus 165 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 165 YKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 988888777654 3489999999999999999999999999999999999996 488999999999753321 23345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA-------SEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.+||+.|+|||++.+.. ++.++|||||||++|||++|..||... .....+..+....|.+..+...+.....
T Consensus 243 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 68999999999986654 899999999999999999999776432 2345667777777765433211111000
Q ss_pred hhh-----hccCCC-CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 232 RAI-----KYQFPQ-LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 232 ~~~-----~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... ...... .....+. ....++.++.+||.+||+.||++|||++|+|+||||+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000 000000 0000111 112356789999999999999999999999999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=384.59 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=227.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE-EEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR-LYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv 78 (417)
|++|+.++.+|+|+||.+++++++..++.|++|.|..... +.+......|+.+++++.|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 6899999999999999999999999999999999985543 3333455689999999999999999999988887 9999
Q ss_pred EeccCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-C
Q 044608 79 FECMECNLY-QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-P 155 (417)
Q Consensus 79 ~E~~~~~l~-~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~ 155 (417)
|+|++|+.+ +.+.+..+..|+|+.+..|+.|++.||.|||+++|+|||||+.||+++ ++.|||+|||+|+.+.+.. .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999998754 455555557899999999999999999999999999999999999996 4789999999999988776 6
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
..+.+|||.|+.||++.+.. |+.|+|||||||++|||++-+++|.+.+-.....+|+....
T Consensus 163 a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~------------------ 223 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY------------------ 223 (426)
T ss_pred hheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC------------------
Confidence 67889999999999986655 99999999999999999999999999999999999875432
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+...+|.+++.||+.||..+|+.||++.++|.+|.++.
T Consensus 224 -----------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 224 -----------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 2344567999999999999999999999999999998874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=367.47 Aligned_cols=279 Identities=43% Similarity=0.838 Sum_probs=236.4
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeC--CEEEEEEe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNN--NRLYLVFE 80 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~E 80 (417)
|+++++||+|+||.||+|.+..+++.||+|.++............+|+.++.++. ||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999999876544434444467999999985 99999999999987 89999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCCCcccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYV 160 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~~~~~~ 160 (417)
|+.+++++.+..+. ..+++..++.++.||+.||.|||++|++||||||+||+++++.+||+|||++.............
T Consensus 81 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~ 159 (282)
T cd07831 81 LMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYI 159 (282)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCC
Confidence 99998888776543 46899999999999999999999999999999999999988999999999998776655556667
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
++..|+|||++.....++.++|||||||++|+|++|.+||.+.+..+....+....+.+... |...........+.++.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE-VLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH-HHHhhcccccccccCcc
Confidence 89999999987666667899999999999999999999999999888888888877766543 33333333334445555
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.....+....+.++.++.+||.+||+.||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 44445555567789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=380.50 Aligned_cols=281 Identities=35% Similarity=0.658 Sum_probs=228.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++++.||+|+||.||+|.+..+++.||+|.+....... ......+|+++++.++||||++++++|... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 68999999999999999999999999999999987543322 223345899999999999999999988643 45
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|++||++++++...+. . ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 95 ~~~~~~~~~~~l~~~~~-~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-C--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred EEEEeecCCCCHHHHHh-c--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 79999999777765543 2 3489999999999999999999999999999999999996 578999999999865432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH-h
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA-R 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~ 232 (417)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+....... .
T Consensus 172 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred --cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 3456899999999999775568999999999999999999999999999888888888888777655443321111 1
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+..+...+.......++.+.+||.+||..||++|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 1111233333444455556778899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.22 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=211.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|++..+|+.||||++...... .......+|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 5899999999999999999999999999999999754221 12223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.++.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999877555544433 4589999999999999999999999999999999999996 5889999999987543211
Q ss_pred -----------------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 044608 155 -----------------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL 199 (417)
Q Consensus 155 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p 199 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCC
Confidence 111347999999999986554 89999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC---HH
Q 044608 200 FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT---AA 276 (417)
Q Consensus 200 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~ 276 (417)
|.+.+..+....+.... ....++. ...+++++.+||.+||. ||.+|++ ++
T Consensus 239 f~~~~~~~~~~~i~~~~-----------------~~~~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 239 FCSDNPQETYRKIINWK-----------------ETLQFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCHHHHHHHHHcCC-----------------CccCCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 99888776665553210 0111111 12468999999999997 9999998 99
Q ss_pred HHHcCcccccccc
Q 044608 277 EALQHPFFKRCFY 289 (417)
Q Consensus 277 elL~hp~f~~~~~ 289 (417)
|+|+||||+...+
T Consensus 292 ~ll~h~~~~~~~~ 304 (364)
T cd05599 292 EIKSHPFFKGVDW 304 (364)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999987543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=373.98 Aligned_cols=275 Identities=32% Similarity=0.589 Sum_probs=215.3
Q ss_pred cceecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~ 82 (417)
.++||+|+||.||+|+++ .+++.||+|.+...... ....+|+.++++++||||++++++|.+ ...+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999976 46789999998754322 234589999999999999999999854 46789999999
Q ss_pred CCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-----CCcEEEeeccccccc
Q 044608 83 ECNLYQLMAARD-------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREI 150 (417)
Q Consensus 83 ~~~l~~~~~~~~-------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-----~~~vkL~DFg~a~~~ 150 (417)
++++...+.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 998887765321 12589999999999999999999999999999999999993 257999999999866
Q ss_pred cCC----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhhC
Q 044608 151 KSG----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKICGVLG 217 (417)
Q Consensus 151 ~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~g 217 (417)
... ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+... .+.+..+....|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 432 2234568899999999997766689999999999999999999999976543 466778888889
Q ss_pred CCCccchHHHHHHHhhhhc-------cCCCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 218 SPTMDSWADGLRQARAIKY-------QFPQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.+....|............ .+.... ...........+.++.+||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888888764322111000 000000 000111122456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=366.84 Aligned_cols=281 Identities=37% Similarity=0.718 Sum_probs=233.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++++.||+|++|.||+|.+..+++.||+|.+....... ......+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5999999999999999999999999999999987543222 123345799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 82 MECNLYQLMAARD-RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~-~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
+.+++.+.+.... ...+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 9988877765433 25689999999999999999999999999999999999996 588999999998765432 22234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..+++.|+|||++.+...++.++|+|||||++|+|++|++||.+....+....+....+.+....|....... .....+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP-DYKNTF 239 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH-HHHhhc
Confidence 4678999999998766667899999999999999999999999999888888888888887777775533322 222333
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+......+......+++++.+||.+||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 3333444445556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=365.95 Aligned_cols=258 Identities=32% Similarity=0.487 Sum_probs=224.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh--hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC--LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++|+.++.||+|.||+|-+|+.+.+|+.||||++++...-.... ..+.|-++|+..+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 789999999999999999999999999999999998775433332 236799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccc-ccCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLARE-IKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~-~~~~~~~ 156 (417)
|||..|+-+..-..+. +.|+|+..+.|...|++||.|||+++|++||||.+|+|++ +|+|||+|||+++. +..+...
T Consensus 247 MeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 9999887444433333 5699999999999999999999999999999999999997 59999999999974 4456677
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.++||||.|+|||++.... |+.++|+|.+||++|||++|+.||...+....+..|.. ...
T Consensus 326 kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~-------------------ed~ 385 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM-------------------EDL 385 (516)
T ss_pred ccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------------------hhc
Confidence 8899999999999996554 99999999999999999999999999888877777642 122
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYA 290 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 290 (417)
.| +..+|++++.|+..+|.+||.+|.. |.|+.+|+||..+.|.
T Consensus 386 kF-----------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 386 KF-----------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred cC-----------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 33 3468999999999999999999964 8999999999987664
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=367.91 Aligned_cols=283 Identities=38% Similarity=0.676 Sum_probs=233.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+++|++.+.||.|++|.||+|.++.+++.||+|.+.............+|+++++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999998754433223344689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+.+++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 99988777665443 4689999999999999999999999999999999999996 478999999998754321 22233
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+....+....+.+..+.|.............
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 4578899999998765568999999999999999999999998776 567777788888888888777765544444444
Q ss_pred CCCCCcccccccCCCCC--HhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSAS--QDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
++......+....+.++ .++.++|.+||+.||++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 43333333444444556 899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=381.02 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=212.1
Q ss_pred CCCceecceecccCceEEEEEEECCCC-cEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||.||+|.++.++ ..||+|++...... .......+|+.+++.++||||+++++++.+++.+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999876655 78999998654221 122334589999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--T 185 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--c
Confidence 99999776444444333 4589999999999999999999999999999999999996 588999999999866432 2
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+.......+... ..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 245 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-------------------II 245 (340)
T ss_pred ceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-------------------CC
Confidence 4568999999999986654 899999999999999999999999988776666555321 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
.+.+.+++++.+||++||+.||++|+ |++++++||||.+..+.
T Consensus 246 -----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 246 -----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 12245788999999999999999995 89999999999875443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=382.28 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=222.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
.|..+++||+|+||.||+|.+..+++.||||++.......+...+..|+.+|.+++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 58888999999999999999999999999999998877777777789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-Ccccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-YTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-~~~~~ 160 (417)
+|+....+.+.. ..+.|.++..++++++.||.|||..+.+|||||+.|||+. +|.+||+|||.+..+..... ..+++
T Consensus 94 ~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred cCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 988665555543 4459999999999999999999999999999999999996 48999999999987765433 37889
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
|||+||||||+.+.. |+.++||||||+++|||++|.||+....+.. ..+.+|+
T Consensus 173 GTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmr--------------------------vlflIpk 225 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMR--------------------------VLFLIPK 225 (467)
T ss_pred ccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcce--------------------------EEEeccC
Confidence 999999999998544 9999999999999999999999998766522 2444555
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..++.+.. .+|+.+++||..||.+||+.||||.++|+|+|++.
T Consensus 226 ~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 SAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 55544443 78999999999999999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=372.23 Aligned_cols=286 Identities=38% Similarity=0.655 Sum_probs=237.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (417)
+++|++.+.||+|+||.||+|.++.+|+.||+|.++....... .....+|+.++++++|+||+++++++.+. +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 5789999999999999999999999999999999875432221 22335799999999999999999998755 57899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~ 155 (417)
||||+++++.+.+.... ..+++.+++.++.||+.||.|||++|++||||||+||++++ +.+||+|||++...... ..
T Consensus 86 v~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 99999988777765433 56899999999999999999999999999999999999964 78999999999876543 23
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....|...........
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 33445688999999987766689999999999999999999999999999999999999999888877766544333333
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+..+..+...+.......++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 3333333333444445579999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=383.77 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=208.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
..|++++.||+|+||+||+|+++.+++.||+|++...... .......+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3699999999999999999999999999999999754322 12234468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.|+.+..+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 81 DYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999876554444333 4589999999999999999999999999999999999996 5899999999975431100
Q ss_pred --------------------------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHH
Q 044608 155 --------------------------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIM 190 (417)
Q Consensus 155 --------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 190 (417)
.....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence 012457999999999987654 89999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccC--
Q 044608 191 AELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWD-- 268 (417)
Q Consensus 191 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d-- 268 (417)
|||++|.+||...+..+....+..... ...+| ....+++++.+||.+||..+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~---------~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWEN-----------------TLHIP---------PQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcccc-----------------ccCCC---------CCCCCCHHHHHHHHHHccCccc
Confidence 999999999998877665555431100 00111 11247899999999977554
Q ss_pred CCCCCCHHHHHcCcccccccc
Q 044608 269 PSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 269 P~~Rpta~elL~hp~f~~~~~ 289 (417)
+..|+|++|+++||||+...+
T Consensus 293 ~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 293 RLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ccCCCCHHHHhcCcccCCCCh
Confidence 445999999999999987644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=385.67 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=208.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|.++.+|+.||||++.+.... .......+|+++++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 6899999999999999999999999999999998654221 12233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.|+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999766444444333 4589999999999999999999999999999999999996 5889999999986332100
Q ss_pred --------------------------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHH
Q 044608 155 --------------------------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIM 190 (417)
Q Consensus 155 --------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 190 (417)
.....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhh
Confidence 001247999999999986554 89999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCC
Q 044608 191 AELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS 270 (417)
Q Consensus 191 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 270 (417)
|||++|.+||.+.+..+.+..+..... ...+|. ...++.++.+||.+||. +|.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRE-----------------TLYFPD---------DIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCC-----------------ccCCCC---------CCCCCHHHHHHHHHHhc-CHh
Confidence 999999999998887776665542100 011111 12468999999999998 777
Q ss_pred CC---CCHHHHHcCcccccccc
Q 044608 271 KR---PTAAEALQHPFFKRCFY 289 (417)
Q Consensus 271 ~R---pta~elL~hp~f~~~~~ 289 (417)
+| +|+.|+++||||....+
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=366.63 Aligned_cols=279 Identities=35% Similarity=0.660 Sum_probs=230.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||+|+||.||+|+++.+|+.||+|.+........ .....+|+.++++++||||+++++++.+.+.+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 69999999999999999999999999999999875432211 22345799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... ......
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 9998887766543 5589999999999999999999999999999999999996 578999999999865432 223445
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+...++.+....|.......... .+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 237 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK--PY 237 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc--cc
Confidence 7789999999987766689999999999999999998766 67777788888888888888777776543322221 11
Q ss_pred CCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+... ...+....+.+++++.+||.+||..||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1111 122244556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=384.79 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=209.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.+|+++++||+|+||.||+|+++.+++.||+|++.+.... .......+|+.++++++||||++++++|.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999754321 12233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG----- 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~----- 153 (417)
||+.++.+..+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 81 DYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999876444444333 4589999999999999999999999999999999999996 589999999997532100
Q ss_pred -------------------------------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHH
Q 044608 154 -------------------------------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIM 190 (417)
Q Consensus 154 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 190 (417)
......+||+.|+|||++.+.. |+.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence 0012357999999999987655 89999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCC
Q 044608 191 AELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS 270 (417)
Q Consensus 191 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 270 (417)
|||++|.+||.+.+..+....+..... ...+| ....+++++.+||.+|+ .||.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p---------~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQT-----------------SLHIP---------PQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCC-----------------CcCCC---------CcccCCHHHHHHHHHHc-cCHh
Confidence 999999999998887666555532100 01111 12357899999999987 5999
Q ss_pred CCCC---HHHHHcCcccccccc
Q 044608 271 KRPT---AAEALQHPFFKRCFY 289 (417)
Q Consensus 271 ~Rpt---a~elL~hp~f~~~~~ 289 (417)
+|++ ++|+++||||+...+
T Consensus 292 ~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 292 DRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HcCCCCCHHHHhcCCCcCCcCh
Confidence 9987 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=376.04 Aligned_cols=250 Identities=30% Similarity=0.463 Sum_probs=207.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.||+|+||.||+|.++.+|+.||+|++.+.... .......+|+.+++.++||||+++++++.+.+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999999764322 22234468999999999999999999999999999999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCCc
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSR 163 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt~ 163 (417)
.+....... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||+
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 554444333 4589999999999999999999999999999999999996 58899999999875332 23344568999
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.. ...
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-------------------~~~------- 212 (328)
T cd05593 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------EDI------- 212 (328)
T ss_pred CccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------------------CCc-------
Confidence 999999986554 89999999999999999999999988776655544321 011
Q ss_pred ccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 244 ANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 244 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.+...++.++.+||.+||..||++|+ |+.|+++||||....+
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 213 ----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred ----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 12345789999999999999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=365.02 Aligned_cols=287 Identities=37% Similarity=0.705 Sum_probs=237.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|++|++.+.||+|++|.||+|.++.+|+.||+|.+....... ......+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999986543221 1233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCC-CCC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSG-PPY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~-~~~ 156 (417)
||+++++...+.......+++..++.++.||+.||+|||++|++|+||+|+||++++ +.+||+|||++...... ...
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 999988888776655445789999999999999999999999999999999999973 46999999999765432 223
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+....+...++....+.+....|......... ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY-KS 239 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh-hh
Confidence 44577899999999876666899999999999999999999999999888888888888888877777643322211 22
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.++...........+.+++++.++|.+||+.||++|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 2333333344455677899999999999999999999999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=388.46 Aligned_cols=278 Identities=24% Similarity=0.390 Sum_probs=213.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC------CCeeeeceEEEeC-CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH------SNIVKLKELIQNN-NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~-~~ 74 (417)
++|+++++||+|+||+||+|.+..+++.||||+++.... .......|+.+++.+.| .+|++++++|..+ .+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 579999999999999999999999999999999964321 11222457777777654 4589999988764 57
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeC-C---------------
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ-G--------------- 137 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~-~--------------- 137 (417)
+|+|||++++++++.+... ..+++..++.++.||+.||+|||+ .||+||||||+|||++. +
T Consensus 207 ~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8999999988888877654 458999999999999999999998 59999999999999964 2
Q ss_pred -cEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 044608 138 -IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL 216 (417)
Q Consensus 138 -~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 216 (417)
.+||+|||++.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+...+
T Consensus 285 ~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 285 CRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred ceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999886432 2334678999999999997665 8999999999999999999999999999999998888888
Q ss_pred CCCCccchHHHHH------HHhhhhccCCCCCcccccccC-------CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 217 GSPTMDSWADGLR------QARAIKYQFPQLPRANLSALM-------PSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 217 g~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~-------~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
|..... |..... .........+......+..+. ...++.+.|||.+||++||.+|||++|+|+|||
T Consensus 362 g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 362 GRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred CCCCHH-HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 876543 322100 000000000000000000000 012567899999999999999999999999999
Q ss_pred cccc
Q 044608 284 FKRC 287 (417)
Q Consensus 284 f~~~ 287 (417)
|++.
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 9874
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=363.70 Aligned_cols=282 Identities=39% Similarity=0.712 Sum_probs=238.2
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|++..... ........+|+.+++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999876543 22234456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~~ 158 (417)
+++++.+.+.... ..+++.+++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++....... ....
T Consensus 81 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 MPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9556666554433 5689999999999999999999999999999999999997 4789999999998765433 2445
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|+..|+|||++.+...++.++|||||||++|+|++|.++|.+..+.+....+...++.+....|.............+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 67899999999987666679999999999999999999999999999999999999888888877776544333333444
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
+......+....+..+.++.+||.+||..||++|||++++|+||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 44444445556677889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=374.20 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=208.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.||+|+||.||+|.++.+|+.||+|+++..... .......+|+++++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 5799999999999999999999999999764321 22233457999999999999999999999999999999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCCc
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGSR 163 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt~ 163 (417)
.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||+
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 555444433 4589999999999999999999999999999999999996 4789999999987532 223334568999
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------~~------- 212 (323)
T cd05595 160 EYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EI------- 212 (323)
T ss_pred CcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------CC-------
Confidence 999999986554 899999999999999999999999887766655554310 11
Q ss_pred ccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 244 ANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 244 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.+...+++++.+||.+||..||++|+ ++.++++|+||.+..+
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 12245789999999999999999998 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.48 Aligned_cols=273 Identities=24% Similarity=0.360 Sum_probs=213.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|++..+|..||+|.+.............+|++++++++||||+++++++.+.+.+++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 78999999999999999999999999999999997654333334567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
++++.+..+.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||++...... .....
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 162 (331)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccC
Confidence 9886555555443 4589999999999999999999986 699999999999996 578999999998765432 23456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccc----hH----------
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS----WA---------- 225 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~----~~---------- 225 (417)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+ +.+..+. +.
T Consensus 163 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 163 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred CCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCccccCccccccc
Confidence 7999999999987654 899999999999999999999999877654433222 2111100 00
Q ss_pred --------------HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 --------------DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
........+....+ . ......+++++++||.+||.+||++|||++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPP----P--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCC----c--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000000000000 0 00112478899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=379.73 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=214.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999999753211 11223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~ 156 (417)
||+.|+.+..+.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 123 Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 123 EYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 999877555555443 489999999999999999999999999999999999996 5899999999998664332 23
Q ss_pred ccccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 157 TNYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+..|.....
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------- 264 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---------------- 264 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----------------
Confidence 456899999999998643 2478999999999999999999999999887776666542100
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCccccccccC
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 290 (417)
...+|. ...+|.++++||.+||..+|.+ |+|++|+++||||+...+.
T Consensus 265 -~~~~~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 265 -SLTFPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred -cCCCCC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 011111 1247899999999999999998 9999999999999875443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=379.12 Aligned_cols=260 Identities=32% Similarity=0.506 Sum_probs=214.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|++..+|+.||||+++..... .......+|++++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 5899999999999999999999999999999999754322 12233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999765444444333 5689999999999999999999999999999999999996 5789999999998655433
Q ss_pred --------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 044608 155 --------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ 208 (417)
Q Consensus 155 --------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 208 (417)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 23456799999999998765 489999999999999999999999998887766
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-HHHHHcCcccccc
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-AAEALQHPFFKRC 287 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~elL~hp~f~~~ 287 (417)
..++..... ...+|. ...+++++.+||.+||. ||.+|++ ++|+|+||||+..
T Consensus 239 ~~~i~~~~~-----------------~~~~p~---------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 239 YNKIINWKE-----------------SLRFPP---------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHhccCC-----------------cccCCC---------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 665542100 111111 12368999999999998 9999999 9999999999876
Q ss_pred ccC
Q 044608 288 FYA 290 (417)
Q Consensus 288 ~~~ 290 (417)
.+.
T Consensus 292 ~~~ 294 (350)
T cd05573 292 DWE 294 (350)
T ss_pred CHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=371.17 Aligned_cols=246 Identities=30% Similarity=0.448 Sum_probs=204.7
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||+|+||.||+|++..+++.||+|++..... ........+|+.++++++||||+++++++.+.+.+|+||||+.++.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999999999999999975422 12223446899999999999999999999999999999999987655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCCccc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWY 165 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt~~y 165 (417)
....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||+.|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 4444333 4589999999999999999999999999999999999996 58899999999875432 2333456899999
Q ss_pred cCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCccc
Q 044608 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRAN 245 (417)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (417)
+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 160 ~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-------------------~---------- 209 (312)
T cd05585 160 LAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-------------------P---------- 209 (312)
T ss_pred CCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-------------------C----------
Confidence 9999987654 899999999999999999999999988766655544310 0
Q ss_pred ccccCCCCCHhHHHHHHHhcccCCCCCC---CHHHHHcCcccccc
Q 044608 246 LSALMPSASQDAISLFESLCSWDPSKRP---TAAEALQHPFFKRC 287 (417)
Q Consensus 246 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~ 287 (417)
..+...+++++.+||.+||..||.+|| ++.|+|+||||...
T Consensus 210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 112345789999999999999999997 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=382.45 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=209.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.+|++++.||+|+||.||+|+++.+++.||+|++.+..... ......+|+.++++++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987542211 1223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG----- 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~----- 153 (417)
||+.++.+..+.... +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999876554444433 4589999999999999999999999999999999999996 588999999997533100
Q ss_pred ---------------------------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH
Q 044608 154 ---------------------------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF 194 (417)
Q Consensus 154 ---------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell 194 (417)
......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell 238 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEML 238 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehh
Confidence 0012357999999999986554 899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-
Q 044608 195 TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP- 273 (417)
Q Consensus 195 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 273 (417)
+|..||.+.+..+....+.... ....++ ....+++++.+||.+|+ .||.+|+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~-----------------~~~~~~---------~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWE-----------------TTLHIP---------SQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccC-----------------ccccCC---------CCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 9999999888776655543110 001111 12357899999999987 5999999
Q ss_pred --CHHHHHcCccccccc
Q 044608 274 --TAAEALQHPFFKRCF 288 (417)
Q Consensus 274 --ta~elL~hp~f~~~~ 288 (417)
|+.|+++||||+...
T Consensus 292 ~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 292 KNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCHHHHhCCCCcCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=376.25 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=215.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||+||+|.++.+|+.||+|+++..... .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 5899999999999999999999999999999999865331 12233457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~ 156 (417)
||++++.+..+..+....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99987655555544445699999999999999999999999999999999999996 48999999999987654322 2
Q ss_pred ccccCCccccCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 157 TNYVGSRWYRAPEILLQ-----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
...+||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-------------- 226 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-------------- 226 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 33479999999999863 34578999999999999999999999998887776666542100
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
...+| ..+.++.++.+||.+||. ||.+|||++++++||||....+
T Consensus 227 ---~~~~~---------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 227 ---FLKFP---------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ---ccCCC---------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 01111 123578999999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=377.10 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=211.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999998753221 12233458999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~ 156 (417)
||+.++.+..+.... .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|....... ..
T Consensus 123 Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 123 EYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 999876555544433 489999999999999999999999999999999999996 4899999999998764332 23
Q ss_pred ccccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 157 TNYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..|.....
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 264 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---------------- 264 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----------------
Confidence 456899999999998643 2378899999999999999999999998887777666543111
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCccccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCF 288 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~ 288 (417)
...+|. ...++..+++||.+||..++.+ |+|++|+++||||+...
T Consensus 265 -~~~~p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 265 -SLNFPE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred -ccCCCC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 011111 1246899999999999865544 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=361.64 Aligned_cols=281 Identities=41% Similarity=0.738 Sum_probs=235.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++++.||.|+||.||+|++..+|+.||||.+........ .....+|++++++++||||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999999999999999875433222 23446899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.+++...+.......+++..++.++.||+.||+|||++|++|+||+|+||+++ ++.+||+|||++...... ......
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 988877777655556689999999999999999999999999999999999996 578999999998765433 223344
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.+++.|+|||++.+...++.++|||||||++|+|++|..||.+.++.+...++....+.+....|...... ......++
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL-PDYKPSFP 239 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH-HHHHhhcc
Confidence 67899999998876665789999999999999999999999999999999999888888876666543332 22233445
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...........+.++.++.+||.+||+.||++|||++++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 444444555567789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.58 Aligned_cols=252 Identities=31% Similarity=0.471 Sum_probs=208.0
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHH---HHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKC---LRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~---l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++++.||+|+||.||+|.++.+|+.||||+++..... .......+|+++ ++.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999754321 112233455554 4567899999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~ 156 (417)
|||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999988766554433 4589999999999999999999999999999999999996 58899999999875432 2334
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-------------------~~ 218 (324)
T cd05589 159 STFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-------------------EV 218 (324)
T ss_pred cccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC
Confidence 4568999999999986654 899999999999999999999999988877766555321 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 288 (417)
.+...++.++.+||.+||+.||.+|| ++.++++||||....
T Consensus 219 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 219 -----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 12235789999999999999999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=370.46 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=210.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCC-CeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHS-NIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~ 79 (417)
+|++++.||+|+||.||+|.++.+++.||+|++.+... .........|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 59999999999999999999999999999999976432 12223345789999999765 5889999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~ 157 (417)
||+.++.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 999876554444333 4589999999999999999999999999999999999996 5789999999987532 223334
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... ..
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------------~~- 218 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------------NV- 218 (324)
T ss_pred eecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------CC-
Confidence 568999999999987655 899999999999999999999999988877766655321 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHcCcccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA-----AEALQHPFFKRCFY 289 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~~~ 289 (417)
.+...++.++.+||.+||..||.+|+++ +++++||||....+
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 219 ----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1223578999999999999999999986 89999999987644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=362.83 Aligned_cols=283 Identities=42% Similarity=0.731 Sum_probs=234.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (417)
+++|++.+.||.|.||.||+|.+..+++.||+|.++....... .....+|+.++++++||||+++++++... +.+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999999999999999975433211 12345799999999999999999998877 89999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~ 155 (417)
||||+.+++.+.+.... ..+++..++.++.||+.||.|||++|++|+||||+|||+++ +.+||+|||++...... ..
T Consensus 84 v~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 99999987777665433 46899999999999999999999999999999999999974 78999999999876554 33
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||...+..+.+.++...++.+....|...........
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 44557889999999987665578999999999999999999999999999999999999999888888876543332222
Q ss_pred ccCCCCCcccccccCCC--CCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 236 YQFPQLPRANLSALMPS--ASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..........+....+. +++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 22222222223333344 48999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=369.34 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=206.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.+++.||+|++.+... .........|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999975432 11223345788888876 699999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 6555444433 4589999999999999999999999999999999999996 5789999999987532 23334456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-------------------~~------ 213 (320)
T cd05590 160 PDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------------------EV------ 213 (320)
T ss_pred ccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------CC------
Confidence 9999999986544 899999999999999999999999998877766655311 00
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH------HHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA------AEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~~~ 289 (417)
.+...++.++.+||++||+.||++|+|+ +++++||||+...+
T Consensus 214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 1223578999999999999999999998 99999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.50 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=211.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|.++.+++.||+|+++..... .......+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999999753221 12223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---- 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---- 154 (417)
||+.|+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999876554444333 4589999999999999999999999999999999999996 5899999999987543210
Q ss_pred --------------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 044608 155 --------------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPG 202 (417)
Q Consensus 155 --------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 202 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCC
Confidence 012457999999999987655 89999999999999999999999998
Q ss_pred CCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC---CHHHHH
Q 044608 203 ASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP---TAAEAL 279 (417)
Q Consensus 203 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~elL 279 (417)
.+..+....+.... ....+|. ...++.++++||.+|+. ||.+|+ +++|++
T Consensus 239 ~~~~~~~~~i~~~~-----------------~~~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 239 ETPQETYRKVMNWK-----------------ETLVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCHHHHHHHHHcCC-----------------CceecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 88777666654210 0111111 12368999999999875 999998 589999
Q ss_pred cCccccccccCC
Q 044608 280 QHPFFKRCFYAP 291 (417)
Q Consensus 280 ~hp~f~~~~~~~ 291 (417)
+||||....|..
T Consensus 292 ~hp~f~~~~~~~ 303 (360)
T cd05627 292 SHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCCCCHHH
Confidence 999999865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=374.10 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=206.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||.||+|.+..+|+.||||++...........+.+|+++++.++|+||+++++++.+++.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 57889999999999999999999999999999997554433344557899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++.+.. ....++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..+... ......
T Consensus 154 ~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 154 MDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred CCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 99875532 134678889999999999999999999999999999999964 78999999999866533 223456
Q ss_pred cCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
+||..|+|||++.. ...++.++|||||||++|||++|..||......+....+... .
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-------------------~ 289 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-------------------C 289 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------------------h
Confidence 89999999998742 233567899999999999999999999744322221111110 0
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... .......++.++.+||.+||..||++|||+.|+|+||||...
T Consensus 290 ~~~-------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 290 MSQ-------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ccC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000 011234678999999999999999999999999999999875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=368.07 Aligned_cols=263 Identities=27% Similarity=0.382 Sum_probs=211.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||++.++.+++.||+|++.+... ........+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999975321 112223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~ 156 (417)
||+.++.+..+..+....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+..... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99977655444444345689999999999999999999999999999999999996 58899999999876544322 2
Q ss_pred ccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~--------------- 225 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------------- 225 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 23579999999999863 24478899999999999999999999998877776665532100
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~ 289 (417)
... +....+.++.++++||++||..++++ |++++++++||||....+
T Consensus 226 --~~~--------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 226 --HFQ--------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred --ccc--------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 011 11222457899999999999765544 789999999999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=359.22 Aligned_cols=281 Identities=60% Similarity=1.081 Sum_probs=249.0
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
|.+.+.||+|+||+||+|+...+++.||||.+.............+|+..+++++ ||||+++++++.+++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7899999999999999999999999999999876655444445568999999999 999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccccC
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVG 161 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~g 161 (417)
++++++.+.......+++..+..++.||+.+|.|||++|++|+||+|+||++++ +.++|+|||++.............+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS 160 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCC
Confidence 888888777654456899999999999999999999999999999999999975 8899999999987766555566788
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
+..|+|||++.+...++.++|+||||+++++|++|.+||...+..+.+.+++..++.+....|.+.........+.++..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07830 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240 (283)
T ss_pred cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence 99999999986666689999999999999999999999999999999999999999999888988877777777766666
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.........+..+.++.+||++||+.||++|||++|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 5555566666678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.72 Aligned_cols=250 Identities=31% Similarity=0.467 Sum_probs=207.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.||+|+||.||+|.+..+|+.||+|++....... ......+|+++++.++||||+++++++.+.+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997643221 2233467999999999999999999999999999999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
.+.....+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 555544433 458999999999999999999997 7999999999999996 5789999999987533 23334456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-------------------~~------ 213 (325)
T cd05594 160 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------EI------ 213 (325)
T ss_pred cccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------CC------
Confidence 9999999986654 899999999999999999999999887766655544210 11
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.+...+++++.+||.+||+.||++|+ ++.++++||||....+
T Consensus 214 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 214 -----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 12245789999999999999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=357.85 Aligned_cols=281 Identities=38% Similarity=0.721 Sum_probs=236.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
+|++.++||.|++|.||+|++..+|+.||||+++............+|+.++++++||||+++++++.+.+.+++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 69999999999999999999999999999999976544333344568999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 83 ECNLYQLMAARD-RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 83 ~~~l~~~~~~~~-~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
.+++.+.+.... ...+++..+..++.||+.||.|||++|++||||||+||+++ ++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE 160 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence 988877765433 24589999999999999999999999999999999999996 478999999999765432 223345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.++..|++||++.+...++.++|+|||||++|+|++|.+||.+.+..+....+....+.+....|.... ........++
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTFP 239 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCchhccccc
Confidence 678999999998766668999999999999999999999999999888888888888888887776554 2233333444
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.........+.+..+.++.++|.+||+.||.+|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 444444455566789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=360.46 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=212.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|++.+.||+|+||+||++.+..+++.||+|++........ .....+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999975432221 2234579999999999999999999999999999999
Q ss_pred ccCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.++.+. .+.......+++..+..++.||+.||.|||++||+||||||+||++++ +.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99876554 443333356899999999999999999999999999999999999965 7899999999987655544455
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+.......+...+. .
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~------------------~-- 219 (285)
T cd05605 161 RVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK------------------E-- 219 (285)
T ss_pred ccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh------------------h--
Confidence 68999999999986554 89999999999999999999999988765444333321110 0
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCF 288 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 288 (417)
....+...++..+.+||.+||..||++|| |++++++||||....
T Consensus 220 ------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 220 ------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred ------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 00112345789999999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=366.75 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=203.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.+|+.||+|+++.... .........|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 579999999999999999999999999976432 11223335677887764 899999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 6544444333 4589999999999999999999999999999999999996 47899999999875322 2334556899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.. ..
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~----------------------~~---- 212 (316)
T cd05620 160 PDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV----------------------DT---- 212 (316)
T ss_pred cCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------CC----
Confidence 9999999987654 89999999999999999999999988877655544321 00
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH-HHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA-AEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~elL~hp~f~~~~~ 289 (417)
..+...++.++.+||.+||..||++|+|+ +++++||||....+
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 213 ----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 11223478999999999999999999997 58899999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=367.17 Aligned_cols=251 Identities=31% Similarity=0.471 Sum_probs=207.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.+++.||+|++...... ........|.+++..+ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999764322 1222345788888876 799999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 6554444333 4589999999999999999999999999999999999996 58899999999875432 2334456799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... ..
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------------------~~------ 213 (321)
T cd05591 160 PDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------------------DV------ 213 (321)
T ss_pred ccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------CC------
Confidence 9999999986554 899999999999999999999999998887777665421 01
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC-------CHHHHHcCccccccccC
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP-------TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-------ta~elL~hp~f~~~~~~ 290 (417)
.....++.++.+||.+||+.||++|+ +++++++||||....+.
T Consensus 214 -----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 214 -----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 11234689999999999999999999 99999999999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=358.15 Aligned_cols=282 Identities=37% Similarity=0.694 Sum_probs=232.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCE-----
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLN-HSNIVKLKELIQNNNR----- 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~----- 74 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ......+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 68999999999999999999999999999999987543322 1233467999999995 6999999999887665
Q ss_pred EEEEEeccCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeecccccc
Q 044608 75 LYLVFECMECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLARE 149 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~ 149 (417)
+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 89999999998887776543 235899999999999999999999999999999999999974 6899999999876
Q ss_pred ccCC-CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 150 IKSG-PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 150 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
+... .......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+...++....+.+....|....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5332 223344678999999998766668999999999999999999999999999888888888888888777776544
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
....... ++...........+.++.++.+||.+||..||.+|||++|+|.||||+
T Consensus 241 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHE--FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhh--cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 4333222 233333344455567899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=366.71 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=210.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|++++.||+|+||.||+|.++.+++.||+|++.+..... .......|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999997643221 122335678888777 5899999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~ 157 (417)
||+.++.+....... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 999866444443333 4589999999999999999999999999999999999996 57899999999875432 23344
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+... ..
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~- 218 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------------NV- 218 (323)
T ss_pred cCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC-
Confidence 568999999999987655 899999999999999999999999998877776665421 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
.+...++.++.+||.+||+.||.+|++ ..++++||||....+
T Consensus 219 ----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 219 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 122357899999999999999999998 489999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.23 Aligned_cols=275 Identities=33% Similarity=0.600 Sum_probs=213.5
Q ss_pred cceecccCceEEEEEEECC--CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE--eCCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFDEH--TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ--NNNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lv~E~~ 82 (417)
..+||+|+||.||+|.++. ++..||+|.+...... ....+|++++++++||||+++++++. ....+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS---MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc---HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3589999999999998654 6689999998754322 23458999999999999999999885 456789999999
Q ss_pred CCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-----CCcEEEeeccccccc
Q 044608 83 ECNLYQLMAARD-------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREI 150 (417)
Q Consensus 83 ~~~l~~~~~~~~-------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-----~~~vkL~DFg~a~~~ 150 (417)
++++++.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||++...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 998887765321 23488999999999999999999999999999999999993 358999999999866
Q ss_pred cCCC----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhhC
Q 044608 151 KSGP----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKICGVLG 217 (417)
Q Consensus 151 ~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~g 217 (417)
.... .....+||+.|+|||++.+...++.++|||||||++|||++|.+||....+ .+.+..+...+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 4322 234567899999999987766689999999999999999999999976543 356677888888
Q ss_pred CCCccchHHHHHHHhhhhcc--C--CCCCccc----ccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 218 SPTMDSWADGLRQARAIKYQ--F--PQLPRAN----LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.+....|.+........... + ....... ........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88888887643221110000 0 0000000 111123456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.16 Aligned_cols=282 Identities=34% Similarity=0.579 Sum_probs=224.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+|+.+++.++|+||+++++++.+++..|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 67999999999999999999999999999999987654333333456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++++..+.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... ......
T Consensus 85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 85 MHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred ccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 9988888776543 4578899999999999999999999999999999999996 588999999998754322 223445
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+ ..+.+..+....|.+....|.............+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 679999999998665557889999999999999999999997665 3466666767777766665554433222222222
Q ss_pred CCCCcccccccCC--CCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMP--SASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+......+..... ..+.++.+||.+||..||.+|||+.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2211111211111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=380.91 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=221.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|.|+|+..||.|+||+||+|.++.++-..|.|+|.... ..+....+-||+||..++||+||++++.|..++.++|+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45789999999999999999999999999999997653 33445566799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~ 159 (417)
|+||-.+.++-.-...++|++|..+++|++.||.|||+++|+|||||..|||++ +|.|+|+|||.+..... .....++
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 999988887766667899999999999999999999999999999999999996 79999999998764433 3445678
Q ss_pred cCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
+|||+|||||++. .+..|++++||||||++|.||..+.||....+....+-+|..-
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-------------------- 250 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-------------------- 250 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--------------------
Confidence 9999999999973 4566999999999999999999999999888887777666321
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.-| .-.-+...|..+.||+.+||.+||..||+++++|+||||++.
T Consensus 251 -ePP------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 251 -EPP------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -CCC------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 101 111123467889999999999999999999999999999863
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.70 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=211.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|+++.+++.||+|++.+.... .......+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998653221 12223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~ 156 (417)
||+.|+.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 999876555555443 489999999999999999999999999999999999996 5899999999998664322 23
Q ss_pred ccccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 157 TNYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+......+|.....
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 264 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------------- 264 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 456899999999998643 2378999999999999999999999999887776666542110
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~ 289 (417)
...+| ..+.++.++++||.+||..++.+ |++++|+++|+||++..+
T Consensus 265 -~~~~~---------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 265 -SLTFP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -cccCC---------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 01111 12357999999999999844443 789999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=364.69 Aligned_cols=250 Identities=29% Similarity=0.440 Sum_probs=203.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.+..+++.||+|+++..... ........|..++..+ +||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764321 1122334577777654 899999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 6555444433 4589999999999999999999999999999999999996 57899999999975433 2333456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------------~---- 212 (316)
T cd05592 160 PDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND----------------------R---- 212 (316)
T ss_pred ccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------------------C----
Confidence 9999999987655 899999999999999999999999988876665554210 0
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH-HHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA-AEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~elL~hp~f~~~~~ 289 (417)
..+...++.++.+||.+||+.||++|+++ .++++||||....+
T Consensus 213 ----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 ----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 11224578999999999999999999986 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=353.87 Aligned_cols=281 Identities=35% Similarity=0.647 Sum_probs=223.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|+|++.+.||+|+||.||+|.++.+|+.||+|++....... ......+|+++++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 68999999999999999999999999999999986543221 12234589999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~ 158 (417)
|++++++..+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99999888776544 4589999999999999999999999999999999999996 5889999999998765443 3344
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh-hcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI-KYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~-~~~ 237 (417)
..++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+....+....+....... ......... ...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ-QIFSTNQFFKGLS 238 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh-hhccccccccccc
Confidence 578899999999876566899999999999999999999999998888877777655544322110 000000000 000
Q ss_pred CCC-CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQ-LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.+. ..........+.++.++.+||.+||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 111 11112233456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.98 Aligned_cols=263 Identities=26% Similarity=0.369 Sum_probs=212.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|+++++||+|+||.||+++++.+++.||+|++.+.... .......+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999998653211 11222457899999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~ 156 (417)
||+.++.+..+..+....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99976644444444335689999999999999999999999999999999999996 57899999999876543222 2
Q ss_pred ccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...+||+.|+|||++.. ...++.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------- 224 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK---------------- 224 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC----------------
Confidence 34579999999999862 3458899999999999999999999999888777766654210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCcccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~ 289 (417)
....+ ......++.++++||++||..++.+ |+|++|+++||||....+
T Consensus 225 -~~~~~--------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 225 -ERFQF--------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred -ccccC--------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 00111 1222457899999999999765554 689999999999987544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=363.77 Aligned_cols=285 Identities=37% Similarity=0.654 Sum_probs=229.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+|+.++++++||||+++++++... ..+|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 68999999999999999999999999999999986433333333456799999999999999999987644 3589
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~- 154 (417)
+|+||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus 85 lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 85 IVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 9999999887766532 35899999999999999999999999999999999999964 789999999987654322
Q ss_pred ---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 ---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++.+..+.+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 12345789999999998665568999999999999999999999999988888888888888877666654332211
Q ss_pred hh-hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 232 RA-IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
.. .....+......+....+..+.++.+||.+||+.||++|||+.|+++||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 11 00111222222333445677999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=348.43 Aligned_cols=284 Identities=37% Similarity=0.639 Sum_probs=235.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--------C
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQN--------N 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 72 (417)
..|+...+||+|.||.||+|+++.+|+.||+|++..... +.-....++|+++|..|+|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 468888999999999999999999999999997643211 1111234799999999999999999988743 2
Q ss_pred CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccccc
Q 044608 73 NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK 151 (417)
Q Consensus 73 ~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~ 151 (417)
..+|+||++|+.+|...+.... ..|+..+|+.++.+++.||.|+|++.|+|||+|++|+||+. |.+||+|||+++.+.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 3589999999988887776543 45899999999999999999999999999999999999985 899999999997664
Q ss_pred CC-----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 152 SG-----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 152 ~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
.. ..++..+-|.||++||.+++.+.|+++.|||..|||+.||+++.+.|.++++..++..|...+|+.+.+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 32 3356677899999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhhhccCCCCCcccccccCC-----CCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMP-----SASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.....-.-....+..+....+.+.. .-.+++.||+.+||..||.+|++++++|+|.||..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 7655443333333232222222211 12568999999999999999999999999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=399.09 Aligned_cols=268 Identities=28% Similarity=0.390 Sum_probs=224.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|+|++.||+|+||.|.+++++.|++.||+|++++-.-- .+...+..|-.+|..-+.+-|++++..|+|+.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 6899999999999999999999999999999999762111 11222346888999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CC
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PP 155 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~ 155 (417)
||+.|| ++.++. +.. .++|+.++.|+..|+.||+.||+.|+|||||||+||||+ .|+|||+|||.+-.+... ..
T Consensus 155 dY~pGGDlltLlS-k~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLS-KFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred ecccCchHHHHHh-hcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 999776 555554 443 699999999999999999999999999999999999998 599999999998776633 33
Q ss_pred CccccCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 YTNYVGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
....+|||.|.+||+|. +...|+..+|+||+||++|||+.|..||..++-.+++.+|+..
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------------- 296 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------------- 296 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------------
Confidence 56679999999999984 2246999999999999999999999999999999999999854
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC---HHHHHcCccccccccCCCCCCCCC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT---AAEALQHPFFKRCFYAPPHIRSTP 298 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~~~~~~~~~~ 298 (417)
.-.+.||.. ..+|.++++||+++++ +|+.|.. ++++..||||.+..|........|
T Consensus 297 -k~~l~FP~~---------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 297 -KESLSFPDE---------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred -hhhcCCCcc---------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 113344421 2489999999999998 7999988 999999999999888544333333
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=367.54 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=205.0
Q ss_pred CceecceecccCceEEEEEEEC---CCCcEEEEEEecccccC---hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
+|++++.||+|+||.||+|++. .+|+.||+|++.+.... .......+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999764 47899999999754221 1122345799999999 599999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
|+||||+.++ +.+.+..+ ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999876 44554433 4589999999999999999999999999999999999996 579999999999865332
Q ss_pred --CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 154 --PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......+||+.|+|||++.+...++.++|||||||++|||++|..||...........+... .
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---------------~ 223 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR---------------I 223 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH---------------H
Confidence 22334689999999999876555789999999999999999999999754322111111100 0
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.... ..+...+++++.+||.+||..||++|| +++++++||||+...+
T Consensus 224 ~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 224 LKCD-----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred hcCC-----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0000 112345789999999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=366.42 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=200.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.+++.||+|++++...... .....+|+.++..+ +||||++++++|.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999999999999999986533222 22345799999998 799999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc-cCCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~-~~~~~~~~~~gt 162 (417)
+.+.....+. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++... .........+||
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 6544443333 4589999999999999999999999999999999999996 578999999998753 233344567899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|+|||||++|+|++|..||......+. +................
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~------- 221 (329)
T cd05588 160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQNTEDYLFQVILEKQ------- 221 (329)
T ss_pred ccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCccccccccc----------ccccchHHHHHHHHcCC-------
Confidence 9999999986654 89999999999999999999999964221100 00000000000000001
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCC------HHHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPT------AAEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~~ 288 (417)
..+...++.++.+||.+||+.||.+|+| ++++++||||....
T Consensus 222 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 222 ----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 1123457899999999999999999987 79999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.60 Aligned_cols=249 Identities=34% Similarity=0.534 Sum_probs=205.5
Q ss_pred cceecccCceEEEEEEEC---CCCcEEEEEEecccccC---hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 7 FKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++.||+|+||.||+|.+. .+++.||+|+++..... .......+|+.+++.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 478999999999999864 47899999999754221 112233579999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~ 158 (417)
|+.++.+.....+. +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 99876555544443 4589999999999999999999999999999999999996 58999999999875432 233345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+....+..+... .
T Consensus 160 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------------~--- 216 (323)
T cd05584 160 FCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------------K--- 216 (323)
T ss_pred cCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------C---
Confidence 68999999999986654 789999999999999999999999988776665554311 0
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 287 (417)
..+.+.+++++.+||.+||..||++|| +++++++||||...
T Consensus 217 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 --------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 112345789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=369.17 Aligned_cols=276 Identities=25% Similarity=0.425 Sum_probs=208.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++||||+++++++......|+|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3699999999999999999999999999999975432 224699999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYV 160 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~ 160 (417)
+.++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.............
T Consensus 139 ~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 9998888876543 5689999999999999999999999999999999999996 4789999999997544444445567
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH---------HHHHHHHHHhhCCCCccchHH-HHH
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASE---------ADQMYKICGVLGSPTMDSWAD-GLR 229 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~-~~~ 229 (417)
||+.|+|||++.+.. ++.++|||||||++|||+++ .++|..... ...+..+...++........+ ...
T Consensus 218 gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 999999999987655 89999999999999999985 445544321 223344444443322111000 000
Q ss_pred H-HhhhhccCCC-CCcccc-cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 230 Q-ARAIKYQFPQ-LPRANL-SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 230 ~-~~~~~~~~~~-~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. .....+.... .+.... ......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 0000000000 000000 0111256788999999999999999999999999999975
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.19 Aligned_cols=249 Identities=30% Similarity=0.470 Sum_probs=203.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHH-HHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVK-CLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||+||+|+++.+|+.||+|++...... .......+|.. +++.++||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 11223344544 56789999999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+.....+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 6554444433 4689999999999999999999999999999999999996 57899999999875422 2334456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------------------- 211 (323)
T cd05575 160 PEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--------------------------- 211 (323)
T ss_pred hhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---------------------------
Confidence 9999999986654 899999999999999999999999988776666555311
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~~ 288 (417)
.....+.++.++.+||.+||+.||.+||++ .|+++||||....
T Consensus 212 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 212 ---PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 011234678999999999999999999997 6999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=355.94 Aligned_cols=282 Identities=39% Similarity=0.710 Sum_probs=231.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC----hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS----WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ........|+++++.++|+||+++++++.+++.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999754332 1122335799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~ 156 (417)
|||+.+++.+.+.... ..+++..++.++.||++||.|||++||+|+||||+||+++ ++.++|+|||++...... ...
T Consensus 81 ~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred EcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999666666554332 3689999999999999999999999999999999999996 588999999999876543 233
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....+++.|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+.++...++.+....|............
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 44467889999999876666899999999999999999999999999988888888888887777666654333222111
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...............+.++.+||.+||..||++|||+.|+|+|+||++.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 240 --KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred --cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 1112233344556778999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=355.36 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=203.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||+|+||+||+|.++.+|+.||+|.+......... .....|+.+++.++||||+++++++...+.+|+||||+.++.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998754322211 2335799999999999999999999999999999999987755
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCccccCC
Q 044608 88 QLMAAR---DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNYVGS 162 (417)
Q Consensus 88 ~~~~~~---~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~~gt 162 (417)
...... ....+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||++..+.... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 544321 2346899999999999999999999999999999999999964 789999999997665432 23345799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+.... ..
T Consensus 161 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------~~--- 215 (280)
T cd05608 161 PGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---------------------LN--- 215 (280)
T ss_pred cCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---------------------cc---
Confidence 9999999997655 8999999999999999999999998754322211111000 00
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
....+...++.++.+|+.+||+.||++|| |++++++||||+...+.
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 216 --DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred --cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 00122345789999999999999999999 89999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=362.89 Aligned_cols=249 Identities=30% Similarity=0.475 Sum_probs=205.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||+||+|.++.+++.||+|++++.... .......+|..+++.+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999864321 1222335788899888 699999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
+.+.....+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 6555444433 4589999999999999999999999999999999999996 5789999999987532 22333456799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-------------------~~------ 213 (318)
T cd05570 160 PDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-------------------EV------ 213 (318)
T ss_pred ccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------CC------
Confidence 9999999986654 899999999999999999999999888766655544210 11
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA-----AEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~~ 288 (417)
.+...++.++.+||.+||..||.+|||+ .++++||||+...
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 214 -----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred -----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1123578999999999999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=363.97 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=212.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|+|++++.||+|+||.||+++++.+++.||+|++.+... ........+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 689999999999999999999999999999999875321 112223357899999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC--
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY-- 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~-- 156 (417)
||+.|+.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99987655555444335689999999999999999999999999999999999996 578999999999766543222
Q ss_pred ccccCCccccCchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEILLQS----ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---------------- 224 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE---------------- 224 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC----------------
Confidence 335799999999998642 347889999999999999999999999887776665553210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCccccccccC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 290 (417)
.... +......++.++.+||.+||..++.+ |++++++++||||....+.
T Consensus 225 -~~~~--------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 225 -ERFQ--------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred -Cccc--------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 0011 11223457899999999999876655 5799999999999875443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=361.37 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=203.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHh-cCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRK-LNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||+||+|.+..+++.||+|+++.... .........|..++.. ++||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 579999999999999999999999999976532 1222334567788876 4899999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 6544444332 4589999999999999999999999999999999999996 57899999999875432 2233456799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.. ..+
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~----------------------~~~--- 213 (316)
T cd05619 160 PDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----------------------DNP--- 213 (316)
T ss_pred ccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------CCC---
Confidence 9999999986554 89999999999999999999999988876665544321 000
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHH-HHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAA-EALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~~~ 289 (417)
.+...++.++.+||.+||+.||++|+++. ++++||||....+
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 214 -----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 11234788999999999999999999996 9999999987644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=360.26 Aligned_cols=277 Identities=23% Similarity=0.360 Sum_probs=210.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||.||+|.+..++..+|+|.+.............+|+++++.++||||++++++|.+.+.+|+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 68999999999999999999999999999999987654333334556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.++.+..+.... +.+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++..+... .....
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 162 (333)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccC
Confidence 9876555444433 4589999999999999999999985 799999999999996 478999999998765332 22345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhCCCCccchH-------------
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG-VLGSPTMDSWA------------- 225 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~g~~~~~~~~------------- 225 (417)
+||..|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+.. ..+.+......
T Consensus 163 ~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 163 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 7999999999986554 89999999999999999999999987665433222110 01111000000
Q ss_pred --------HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 --------DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
............ .... .....++.++++||.+||+.||++|||++|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 242 GPDSRPPMAIFELLDYIVNE----PPPK--LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cccccccccHHHHHHHHhcC----CCcc--CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000000000 0000 0012367899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=362.97 Aligned_cols=281 Identities=33% Similarity=0.559 Sum_probs=223.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++++.||+|+||.||+|.+..+|+.||+|.+.+...... .....+|+.++++++||||++++++|... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 689999999999999999999999999999999875433222 23345899999999999999999988643 35
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+.+++.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 96 ~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 96 VYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 799999999888876643 289999999999999999999999999999999999996 578999999999876655
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...++...+|.+..+.+.........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 4445567899999999987654 899999999999999999999999999988888888888888765433221111111
Q ss_pred hhccCCCCCccccccc-------------CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 234 IKYQFPQLPRANLSAL-------------MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+......+... ....+.++.+||.+||+.||++|||+.|+|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 1100110000000010 12346679999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=352.08 Aligned_cols=280 Identities=41% Similarity=0.769 Sum_probs=233.1
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
|+++++||.|++|.||+|.++.+|..||+|++........ .....+|+++++.++||||+++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 7899999999999999999999999999999875432221 223457999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~~ 160 (417)
++++.+.+.......+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 160 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence 88777776654434689999999999999999999999999999999999996 578999999999765422 2223446
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+...++....+.+....|....... .....++.
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP-DYKPTFPK 239 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch-hhhhhccc
Confidence 78999999988665557899999999999999999999999999888888888888888777765543322 22223444
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..........+.++.++.+||.+||+.||++|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 44444455667889999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=356.57 Aligned_cols=283 Identities=37% Similarity=0.616 Sum_probs=222.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN------ 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 73 (417)
+++|++.++||+|+||.||+|.+..+++.||+|.+........ .....+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 5789999999999999999999999999999999865432221 223357999999999999999999986543
Q ss_pred --EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 74 --RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 74 --~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
..|+||||+.+++.+.+.... ..+++.+++.++.||+.||.|||++|++|+||||+||++++ +.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 459999999988877765433 45899999999999999999999999999999999999974 78999999999765
Q ss_pred cCCC-----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KSGP-----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.... ......++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.+.......+....|....+.|.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 4321 12345678899999998766557899999999999999999999999988888777777777776665554
Q ss_pred HHHHHHhhhhccCCCCCcccccc-c-CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSA-L-MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+...........++......... + ....+..+.+||.+||..||++|||++|+|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 43222111112222211111111 0 11246789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.54 Aligned_cols=249 Identities=30% Similarity=0.486 Sum_probs=203.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHH-HHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVK-CLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||+||+|.++.+|+.||+|++.+.... ........|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 5799999999999999999999999999754321 12223344544 57789999999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 6554444433 4589999999999999999999999999999999999996 58899999999875432 2334456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--------------------------- 211 (325)
T cd05604 160 PEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--------------------------- 211 (325)
T ss_pred hhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---------------------------
Confidence 9999999986654 899999999999999999999999988776665554310
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~~ 288 (417)
.....+..+.++.++|.+||..||.+||++ .++++||||....
T Consensus 212 ---~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 212 ---PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ---CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 011234678999999999999999999986 5999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=361.33 Aligned_cols=247 Identities=28% Similarity=0.381 Sum_probs=205.5
Q ss_pred ceecceecccCceEEEEEEECCCCcE-EEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC-EEEEEEe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEA-VAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN-RLYLVFE 80 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~-vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E 80 (417)
..+.+.||.|+||+||+|.. .|.. ||+|++........ ...+.+|+.+|.+|+|||||+|++++.++. .++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 45566799999999999954 4666 99999986544333 345568999999999999999999999887 7999999
Q ss_pred ccCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCCeeeeC-C-cEEEeeccccccccCC-CC
Q 044608 81 CMECNLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNG-FFHRDLKPENLLVSQ-G-IIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~l~e~~i~~i~~qi~~aL~~LH~~g-i~HrDLKp~NILl~~-~-~vkL~DFg~a~~~~~~-~~ 155 (417)
|+.++.+..+... ....++...+..|+.||+.|+.|||+++ ||||||||+|||++. + ++||+|||+++..... ..
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9998877766655 3577999999999999999999999999 999999999999986 4 8999999999876654 44
Q ss_pred CccccCCccccCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQ-SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.+...||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........++....
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~----------------- 263 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL----------------- 263 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence 555799999999999974 34599999999999999999999999999988666665542111
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.| .+.....+.+..||.+|+..||.+||+..+++.
T Consensus 264 ---Rp--------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 264 ---RP--------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---CC--------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11 112237889999999999999999999999964
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=361.93 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=200.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.+++.||+|++++..... ......+|+.++.++ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998653222 222345788888776 899999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 7555444433 4589999999999999999999999999999999999996 5789999999987532 23334456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||......+. +................
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~i~~~~------- 221 (329)
T cd05618 160 PNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQ------- 221 (329)
T ss_pred ccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCC----------cccccHHHHHHHHhcCC-------
Confidence 9999999987654 89999999999999999999999953211000 00000000000000001
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCC------HHHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPT------AAEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~ 289 (417)
..++..++.++.+||.+||+.||++|+| ++++++||||+...+
T Consensus 222 ----~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 222 ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 1133467899999999999999999998 589999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.53 Aligned_cols=249 Identities=31% Similarity=0.519 Sum_probs=205.6
Q ss_pred cceecccCceEEEEEEE---CCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFD---EHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
++.||+|+||.||++.+ ..+|+.||+|++....... ......+|++++++++||||+++++++.+++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46899999999999876 4578999999997643322 2233457999999999999999999999999999999999
Q ss_pred CCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 83 ECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 83 ~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
.++ +.+.+. +. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ......
T Consensus 81 ~~~~L~~~l~-~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLS-KE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHH-Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 765 444443 33 4589999999999999999999999999999999999996 578999999998765443 333456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... ..
T Consensus 159 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-------------------~~--- 215 (318)
T cd05582 159 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-------------------KL--- 215 (318)
T ss_pred cCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-------------------CC---
Confidence 8999999999986544 799999999999999999999999988776666555321 11
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCF 288 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 288 (417)
.+...+++++.+||++||+.||++||| ++++++||||....
T Consensus 216 --------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 216 --------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 122357899999999999999999999 78899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.22 Aligned_cols=275 Identities=20% Similarity=0.368 Sum_probs=214.0
Q ss_pred CCceecceecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.+|++++.||+|+||.||+|... .++..||+|.+.... ...+|++++++|+||||++++++|.....+|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 36999999999999999999754 356789999886432 2247999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC---C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP---P 155 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~---~ 155 (417)
|++.++++..+.. ...+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..+.... .
T Consensus 166 e~~~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 166 PKYKCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hhcCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 9999988887733 356899999999999999999999999999999999999964 789999999997654332 2
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhhCCCCccchHH----HH
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS---EADQMYKICGVLGSPTMDSWAD----GL 228 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~----~~ 228 (417)
....+||+.|+|||++.... |+.++|||||||++|||++|..||.+.. ..+.+..+...++....+.... ..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 23467999999999986554 8999999999999999999999997654 3455666666655433321111 11
Q ss_pred HHHhhhhccCCCCCccccccc--CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLPRANLSAL--MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..... +.....+...+... ...++.++.+||++||..||++|||+.|+|.||||.+.
T Consensus 323 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 323 KHFKQ--YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHh--hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 11111 11111111111111 12467889999999999999999999999999999874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=355.99 Aligned_cols=283 Identities=36% Similarity=0.640 Sum_probs=227.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeC-------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNN------- 72 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------- 72 (417)
+++|++.++||+|+||.||+|.++.+++.||+|.+....... ......+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999999999999999986543221 122346899999999999999999987543
Q ss_pred -CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 73 -NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 73 -~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
..+|+||||+.+++...+... ...+++..++.++.||++||.|||++||+|+||||+|||++ ++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 357999999998887776543 34689999999999999999999999999999999999996 478999999999755
Q ss_pred cCCC------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Q 044608 151 KSGP------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 151 ~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
.... ..+...|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3321 1233467889999999876666899999999999999999999999999999988898888888
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+....|.....................+......+++++.+||.+||..||++|||+.|++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 777766553322221111111111222333445677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.77 Aligned_cols=250 Identities=29% Similarity=0.464 Sum_probs=204.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHH-HHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREV-KCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|+++.+++.||+|++....... ......+|. .+++.++||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999997543211 122223443 457889999999999999999999999999988
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 7555544443 4589999999999999999999999999999999999996 57899999999875432 2334556899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+... .
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------------------~------- 212 (325)
T cd05602 160 PEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------------------P------- 212 (325)
T ss_pred ccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------C-------
Confidence 9999999986654 899999999999999999999999988877666555321 0
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHH----HHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAA----EALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~----elL~hp~f~~~~~ 289 (417)
..+.+.++.++.+||.+||+.||.+|+++. ++++|+||....+
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 112356789999999999999999999876 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=350.64 Aligned_cols=280 Identities=47% Similarity=0.849 Sum_probs=242.5
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
|++.+.||.|++|.||+|.+..+|+.+++|.+...... .......+|++++++++||||+++++++.+++.+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 78899999999999999999999999999998765433 22334468999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~~ 160 (417)
++++...+.... ..+++..+..++.||+.||.|||++||+|+||||+||++++ +.++|+|||.+....... ......
T Consensus 81 ~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 988877776544 56899999999999999999999999999999999999975 789999999997765543 334457
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+.++...++.+....|.............++.
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 88999999998766468999999999999999999999999999999999999888888887777776655556666666
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..........+.++.++.+||.+||..||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 55555566667789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.27 Aligned_cols=251 Identities=28% Similarity=0.469 Sum_probs=218.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNL 86 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l 86 (417)
+.||.|.||+||-|+++++|+.||||+|.+..... .+....+|+.||+++.||.||.+--.|+..+.+++|||-+.|+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 67999999999999999999999999998665443 34444579999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCCCCccccCC
Q 044608 87 YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 87 ~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
++-+.....+.++|...+.++.||+.||.|||-+||+|+||||||||+.. -++||||||+|+.++...-..+.+||
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT 729 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT 729 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence 99999888889999999999999999999999999999999999999954 36999999999999887777788999
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
|.|+|||++.+.. |+.+.||||+|||+|.-++|..||....+ +...|. ...+.+|..+
T Consensus 730 PAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQ-------------------NAaFMyPp~P 787 (888)
T KOG4236|consen 730 PAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQ-------------------NAAFMYPPNP 787 (888)
T ss_pred ccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhh-------------------ccccccCCCc
Confidence 9999999997655 99999999999999999999999954432 222221 2244444433
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+ ..+|++++|||..+|+..-.+|.|++..|.|||+++.
T Consensus 788 W-------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 788 W-------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred h-------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 2 3578999999999999999999999999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=360.68 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=203.0
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHH-HHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREV-KCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|++..+|+.||+|++.+.... .......+|. .+++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 1222233444 467889999999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
+.+.....+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 6554444333 4589999999999999999999999999999999999996 5899999999987532 22333456899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....+... .
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------------------~------- 212 (321)
T cd05603 160 PEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-------------------P------- 212 (321)
T ss_pred cccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-------------------C-------
Confidence 9999999986554 899999999999999999999999988766655544310 0
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCcccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFFKRCFY 289 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~~~ 289 (417)
..+.+..+.++.++|.+||+.||.+|+++ .|+++|+||....+
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 ----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 12234578899999999999999999875 59999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.26 Aligned_cols=282 Identities=34% Similarity=0.653 Sum_probs=224.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.++.+++.||+|.+....... ......+|+++++.++||||+++++++.+++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 68999999999999999999999999999999986543332 22334589999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|++++++..+.... ..+++.+++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++..+... .....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99998887766544 3489999999999999999999999999999999999996 478999999998765433 33345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+....+......-..............
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 67899999999987656678999999999999999999999999888888888776665432211000000000000111
Q ss_pred CCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+... ........+.++.++.+||.+||..||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111 112223456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=361.44 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=223.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++.|...++||+|+||.||-|+.+.||+-||+|.+.++...... ...++|..+|.+++.+.||.+-..|++.+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788899999999999999999999999999998765444332 3446899999999999999999999999999999
Q ss_pred EeccCCCHHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC
Q 044608 79 FECMECNLYQL-MAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~-~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~ 156 (417)
|..|+|+.+.. +.......|+|..+..|+.+|+.||++||+.+||+|||||+|||+|+ |+|.|+|+|+|..+..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999876655 44444457999999999999999999999999999999999999976 99999999999999999888
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||.+|||||++.+.. |+.+.|+|||||++|||+.|+.||....+..--..+- +...
T Consensus 344 ~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---------------rr~~---- 403 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---------------RRTL---- 403 (591)
T ss_pred ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---------------HHHh----
Confidence 8889999999999997666 9999999999999999999999998766433222221 1111
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
.....+...+|+++++|.+.+|.+||.+|. +++++.+||||+...|.
T Consensus 404 -------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 404 -------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 111234467899999999999999999995 47899999999987654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.39 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=209.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.... ........|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 588999999999999999999999999999999764321 12233457888888886 577889999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||+.++.+....... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 999876554444333 4589999999999999999999999999999999999996 578999999998754322 2234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+... ..
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------------~~- 218 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------------NV- 218 (323)
T ss_pred CccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC-
Confidence 567999999999986554 899999999999999999999999988877666655421 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
.+...++.++.+|+.+||+.||.+|++ .+++++||||....+
T Consensus 219 ----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 219 ----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 122457899999999999999999997 589999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=364.16 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=202.2
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc---CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL---NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
||+|+||+||+|+++.+|+.||+|++.+..... .......|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999996543221 112234577777665 699999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~~gt 162 (417)
+.+....... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......+||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 6544444333 4589999999999999999999999999999999999996 57899999999875432 3334567899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ...++
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~~--- 217 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-------------------KVRFP--- 217 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------CCCCC---
Confidence 99999999876656899999999999999999999999888766655544210 11111
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC----CHHHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP----TAAEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~~ 288 (417)
...+++++.+||.+||+.||.+|| ++.++++||||....
T Consensus 218 -------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 -------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred -------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 123689999999999999999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.41 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=202.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||+|+||.||++.++.+|+.||+|.+....... .......|++++++++||||++++++++++..+|+||||+.|+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999999999999999987533221 122334699999999999999999999999999999999987644
Q ss_pred -HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCccc
Q 044608 88 -QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWY 165 (417)
Q Consensus 88 -~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y 165 (417)
..+.......+++..+..++.||+.||+|||++||+||||||+|||++ ++.++|+|||++.............||+.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 444444444589999999999999999999999999999999999996 478999999999876655444556799999
Q ss_pred cCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCccc
Q 044608 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRAN 245 (417)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (417)
+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+... .....
T Consensus 161 ~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~-------- 214 (277)
T cd05607 161 MAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR-----------------TLEDE-------- 214 (277)
T ss_pred cCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-----------------hhccc--------
Confidence 9999987665 899999999999999999999999765432211111100 00000
Q ss_pred ccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCcccccccc
Q 044608 246 LSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFFKRCFY 289 (417)
Q Consensus 246 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~~~ 289 (417)
.......++.++.+||.+||+.||++|||+ ++++.|+||+...+
T Consensus 215 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 215 VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 001113578999999999999999999999 77889999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=369.85 Aligned_cols=274 Identities=24% Similarity=0.352 Sum_probs=208.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
..|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|++|+|||||++++++..++..++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 369999999999999999999999999999996432 1235799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC---CCc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP---PYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~---~~~ 157 (417)
+.++++..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++.+.... ...
T Consensus 242 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 9988888776543 46899999999999999999999999999999999999964 789999999997654321 122
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCC------HHHHHHHHHHhhCCCCcc--c-----
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGAS------EADQMYKICGVLGSPTMD--S----- 223 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~------~~~~~~~i~~~~g~~~~~--~----- 223 (417)
..+||+.|+|||++.+.. ++.++|||||||++|||++|..+ |.... ..+.+.++....+..... .
T Consensus 321 ~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred ccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 457999999999997655 89999999999999999998754 43321 123444444432221110 0
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+...... .......+......+..+ ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 400 l~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRH-RAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHh-hhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000100 000111111111122221 246789999999999999999999999999999974
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=351.35 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=218.7
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
|.++++||+|+||.||+|+|+.+|..+|||.+.-.. +...+++|+.++++++.|+||++|+.|.....+|||||||+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 678999999999999999999999999999987542 34556789999999999999999999999999999999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee-eCCcEEEeeccccccccCC-CCCccccC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSG-PPYTNYVG 161 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl-~~~~vkL~DFg~a~~~~~~-~~~~~~~g 161 (417)
.+...++.+..++.++|.++..+++.-+.||+|||...-+|||||..|||+ ++|..||+|||.|..+.+. ...++.+|
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcccc
Confidence 888888887777899999999999999999999999999999999999999 5799999999999876543 44577899
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
||.|||||++..-. |+.++||||||++..||..|++||.+-.+...+ +..|..
T Consensus 192 TPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------------FMIPT~ 244 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------------FMIPTK 244 (502)
T ss_pred CcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccccee--------------------------EeccCC
Confidence 99999999997665 999999999999999999999999776543322 223333
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+++.+. .+...|.++.|||++||.+.|++|-||.++++|||.++.
T Consensus 245 PPPTF~-KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 245 PPPTFK-KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCCCCC-ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 332222 223468899999999999999999999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=357.75 Aligned_cols=282 Identities=38% Similarity=0.653 Sum_probs=231.8
Q ss_pred CCceec-ceecccCceEEEEEEECCCCcEEEEEEecccccChh-------------hhhhHHHHHHHHhcCCCCeeeece
Q 044608 2 DKYSGF-KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-------------DCLNLREVKCLRKLNHSNIVKLKE 67 (417)
Q Consensus 2 ~~Y~~~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-------------~~~~~~E~~~l~~l~hpnIv~l~~ 67 (417)
++|..+ +.||.|+||.||+|.++.+++.||+|.+........ .....+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 578755 679999999999999999999999999865432211 012458999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 68 ~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
++..++.+|+||||+.+++.+.+... ..+++..+..++.||+.||.|||++||+|+||+|+||+++ ++.+||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999998888776543 4589999999999999999999999999999999999996 47899999999
Q ss_pred cccccC---------------CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 044608 147 AREIKS---------------GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211 (417)
Q Consensus 147 a~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 211 (417)
+..... ........+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 876541 11223345788999999987666679999999999999999999999999999999999
Q ss_pred HHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 212 ICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 212 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+....+.+....|...........+ ............+..+.++.+||.+||+.||++|||++|+|.||||+..
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHhCCCchhhCcchhhccccccc--CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 9999998888777765432222111 1112233344556778999999999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=345.97 Aligned_cols=256 Identities=36% Similarity=0.623 Sum_probs=209.1
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh-hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC-LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~-~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
|++++.||+|+||+||+|.+..+++.||+|++.......... ...+|+.++++++||||+++++++.+...+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999998765443332 2356999999999999999999999999999999999
Q ss_pred CC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc-cCCCCCccc
Q 044608 83 EC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNY 159 (417)
Q Consensus 83 ~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~-~~~~~~~~~ 159 (417)
.+ ++.+.+... ..+++..+..++.||+.||.+||++||+|+||||+||+++ ++.++|+|||++... .........
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 98 455555423 4589999999999999999999999999999999999997 588999999999753 333445567
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.++..|+|||++.....++.++|+||||+++|+|++|..||......+....+........ .....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~ 224 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL--------------PSSSQ 224 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH--------------HHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc--------------ccccc
Confidence 8999999999986355589999999999999999999999998854444444432211100 00000
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.....+.++.+||.+||+.||++|||+.++++||||
T Consensus 225 ---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=359.15 Aligned_cols=284 Identities=39% Similarity=0.685 Sum_probs=229.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 75 (417)
++|.+.+.||+|+||.||+|.+..+|+.||||.+...... .......+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5899999999999999999999999999999998754322 2223446899999999999999999988654 358
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~- 153 (417)
|+||||+++++.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 999999998887776543 4589999999999999999999999999999999999996 578999999999866443
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH-Hh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-AR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~ 232 (417)
.......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+....|.+..+.|...... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 23345678999999999876555899999999999999999999999998888888888888888776655321110 01
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+...........+.+++++.+||.+||+.||++|||++|+|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 1111122222333344556789999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.36 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=201.4
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||+||+|.++.+++.||+|++.+..... ......+|+.++.++ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998653322 222345789999888 699999999999999999999999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCCccccCC
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPYTNYVGS 162 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~~~~~gt 162 (417)
+.+....... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ........+||
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 6554444333 4589999999999999999999999999999999999996 5889999999987532 23334567899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE------ADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .+....+. ....
T Consensus 160 ~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------------~~~~- 219 (327)
T cd05617 160 PNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------------------LEKP- 219 (327)
T ss_pred cccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------------------HhCC-
Confidence 9999999986554 89999999999999999999999964321 11111111 0000
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC------HHHHHcCcccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT------AAEALQHPFFKRCFY 289 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~ 289 (417)
..+...++.++.+||.+||..||.+|++ ++++++||||....+
T Consensus 220 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 220 ----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 1123457899999999999999999998 579999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=347.74 Aligned_cols=282 Identities=40% Similarity=0.695 Sum_probs=225.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+..+++.||+|.++....... .....+|+++++.++|+||+++++++.+.+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 589999999999999999999999999999999875433222 2345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
|++++++..+..+. ..+++.+++.++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 99998887766544 4589999999999999999999999999999999999996 5789999999998765543 445
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+....+...++......+.............
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 57889999999999776468999999999999999999999999988888877777666654433222111111000111
Q ss_pred CCCCC-ccccc-ccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLP-RANLS-ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~-~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
++... ...+. .+...++.++.+||++||..||++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 11111 00111 1223358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=349.08 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=208.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|++.+.||+|+||.||+|.+..+++.||+|.+........ .....+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999875432222 2234579999999999999999999999999999999
Q ss_pred ccCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLY-QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~-~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.++.+ +.+.......+++..+..++.|++.||.|||++||+||||||+||++++ +.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 9987644 4444433346899999999999999999999999999999999999964 7899999999976655444455
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..||..|+|||++.+.. ++.++|+|||||++|+|++|..||................ ....
T Consensus 161 ~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~---------------~~~~--- 221 (285)
T cd05630 161 RVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---------------KEVQ--- 221 (285)
T ss_pred CCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh---------------hhhh---
Confidence 68999999999986655 8999999999999999999999998654321111110000 0000
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 287 (417)
..+...+++++.+||.+||+.||++||| ++|+++||||++.
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 --------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred --------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 1123457889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=351.92 Aligned_cols=282 Identities=37% Similarity=0.646 Sum_probs=222.1
Q ss_pred CceecceecccCceEEEEEEECC--CCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEH--TGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 76 (417)
+|++.++||+|+||.||+|.++. +++.||+|.+..... ........+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 899999999976321 11122345799999999999999999999988 8899
Q ss_pred EEEeccCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-----CCcEEEeeccccc
Q 044608 77 LVFECMECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAR 148 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-----~~~vkL~DFg~a~ 148 (417)
+||||+++++++.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999999988887765332 23689999999999999999999999999999999999995 4789999999998
Q ss_pred cccCCCC----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHh
Q 044608 149 EIKSGPP----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA---------DQMYKICGV 215 (417)
Q Consensus 149 ~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~~~ 215 (417)
....... ....++++.|+|||++.+...++.++|||||||++|+|++|.+||.+.... +.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543221 234578999999999877666899999999999999999999999876543 456677777
Q ss_pred hCCCCccchHHHHHHHhhhhc----cCCCCCcccccc---cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 216 LGSPTMDSWADGLRQARAIKY----QFPQLPRANLSA---LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
++.+....|............ .........+.. .....+.++.++|.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 787777666543333221110 000001011111 112578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=372.99 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=209.8
Q ss_pred CceecceecccCceEEEEEEECCC-CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHT-GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~-g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ........+|+.+++.++|||||++++++..++.+|+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 499999999999999999998887 7889999775432 22223445799999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC---
Q 044608 82 MECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--- 154 (417)
Q Consensus 82 ~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--- 154 (417)
+.++ |.+.+... ....+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 9865 44444322 234689999999999999999999999999999999999997 5889999999998765432
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~------------------- 286 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG------------------- 286 (478)
T ss_pred cccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 234567999999999986554 899999999999999999999999988777666655321
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. .......++.++.+||.+||..||++|||++++|.|+|++.
T Consensus 287 ~----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 287 K----------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred C----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 0 01122357889999999999999999999999999999975
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=356.86 Aligned_cols=284 Identities=36% Similarity=0.676 Sum_probs=230.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEE----eCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQ----NNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .......+|+.+++.++||||+++++++. ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5899999999999999999999999999999998764322 12233457999999999999999999876 345789
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~- 154 (417)
+||||+.+++.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 85 lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999988777666433 4489999999999999999999999999999999999996 4789999999987654321
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.....+|+..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....|.+....+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1234578999999999866555899999999999999999999999999988888888888888776654432211
Q ss_pred H-hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 A-RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ......++......+....+..+.++.+||.+||+.||++|||++++++||||.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 1 11111233333444455567789999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=350.06 Aligned_cols=283 Identities=39% Similarity=0.660 Sum_probs=226.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNN------ 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 73 (417)
+++|++.+.||+|+||.||+|.++.+|+.||+|.++..... .......+|+++++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999999999999999998754322 12233457999999999999999999987654
Q ss_pred ----EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccc
Q 044608 74 ----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAR 148 (417)
Q Consensus 74 ----~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~ 148 (417)
.+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+|+||||+||++++ +.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 89999999999887776544 345899999999999999999999999999999999999975 789999999998
Q ss_pred cccCCC--CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 149 EIKSGP--PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 149 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
...... ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 664332 223345688899999986655578999999999999999999999999988888888888888877766654
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...................+......++..+.+||.+||..||++|||+++++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3221111000000001112222334578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.82 Aligned_cols=268 Identities=31% Similarity=0.473 Sum_probs=218.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ......+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 58999999999999999999999999999999997654332 2234468999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC---
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--- 154 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--- 154 (417)
||+.++ +.+.+.......+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 998775 55544433345689999999999999999999999999999999999996 5799999999987543211
Q ss_pred ---------------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 044608 155 ---------------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEAD 207 (417)
Q Consensus 155 ---------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 207 (417)
.....+||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 112347899999999986654 7999999999999999999999998887766
Q ss_pred HHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC----HHHHHcCcc
Q 044608 208 QMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT----AAEALQHPF 283 (417)
Q Consensus 208 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~elL~hp~ 283 (417)
.+..+... ...++. ...++.++.+||.+||..||++||| ++|+|+|||
T Consensus 240 ~~~~~~~~-------------------~~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 240 TFSNILKK-------------------EVTFPG---------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHhcC-------------------CccCCC---------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 65554310 001110 1226899999999999999999999 999999999
Q ss_pred ccccccCCCCCCCCC
Q 044608 284 FKRCFYAPPHIRSTP 298 (417)
Q Consensus 284 f~~~~~~~~~~~~~~ 298 (417)
|+...+........|
T Consensus 292 ~~~~~~~~~~~~~~~ 306 (316)
T cd05574 292 FRGVNWALIRHTTPP 306 (316)
T ss_pred hhcCChhhcccCCCC
Confidence 998766555544433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.26 Aligned_cols=284 Identities=40% Similarity=0.700 Sum_probs=235.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-----EEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-----RLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 76 (417)
+|++.+.||.|+||.||+|++..+|+.||||.+..... ........+|+.+++.++||||+++++++.+.. .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999876542 222334568999999999999999999988775 889
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~- 154 (417)
+||||+.+++.+.+... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELMETDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchhhhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999998776666433 3689999999999999999999999999999999999996 5799999999998765543
Q ss_pred ---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH-H
Q 044608 155 ---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-Q 230 (417)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~ 230 (417)
......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+..+.|..... .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 245567899999999987664689999999999999999999999999999999999999888887766542111 1
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
........+......+....+.++.++.+||.+||++||++|||++++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1111112333334455566677899999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=345.85 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=212.3
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|+..+.||+|+||+||+|.+..+++.||+|.+........ .....+|+++++.++|+||+.+++++.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999875432222 2234679999999999999999999999999999999
Q ss_pred ccCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.++.+. .+.......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99876554 44433334689999999999999999999999999999999999996 47899999999976654444455
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+.......
T Consensus 161 ~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~------------------- 220 (285)
T cd05632 161 RVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET------------------- 220 (285)
T ss_pred CCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-------------------
Confidence 68999999999986554 8999999999999999999999998876654444332111000
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 287 (417)
...+...++.++.+|+.+||+.||++||| +++++.|+||...
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 221 -------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 01123457889999999999999999999 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.37 Aligned_cols=280 Identities=38% Similarity=0.696 Sum_probs=227.9
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEEEEe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYLVFE 80 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 80 (417)
|++.++||.|+||.||+|.+..+|+.+|+|.+...... .......+|+++++.++||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78999999999999999999999999999999865422 2223446899999999999999999999988 89999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
|+++++...+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++....... ..+
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 99987777665442 4689999999999999999999999999999999999997 5789999999998765443 234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...++..|+|||.+.+...++.++|||||||++|+|++|..||...+..+.+..+....+.+....|.............
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 45678899999987665558999999999999999999999999999888888888888888777775533221111111
Q ss_pred CCCCCcccccccCCC-CCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPS-ASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
........+...... .+.++.++|.+||+.||++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 111111122223334 38999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=372.07 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=210.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNN------- 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------- 73 (417)
++|.+.+.||+|+||+||+|.+..+|+.||||++....... ......+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 68999999999999999999999999999999997654332 2334568999999999999999998775332
Q ss_pred -EEEEEEeccCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 74 -RLYLVFECMECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 74 -~~~lv~E~~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
.+++||||+.++ |.+.+..+ ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 478999999865 55554432 234689999999999999999999999999999999999996 5789999999997
Q ss_pred cccCC---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 149 EIKSG---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 149 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.+... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~---------- 260 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG---------- 260 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----------
Confidence 65432 2234568999999999986654 899999999999999999999999988776665554311
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....+.+.+++++.+||.+||+.||.+|||+.++++|||++..
T Consensus 261 -------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 -------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 0112335678999999999999999999999999999998753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=340.00 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=207.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh----hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE----DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+.|++.+.||+|++|.||+|.+..+++.||+|.+........ .....+|++++++++||||+++++++.+++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 689999999999999999999999999999999875432211 1234579999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~- 155 (417)
||||+.++.+....... ..+++..++.++.||+.||.|||++||+|+||+|+||++++ +.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999876544444333 45899999999999999999999999999999999999975 7899999999876543211
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------------- 222 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ----------------- 222 (263)
T ss_pred cccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----------------
Confidence 13456889999999987655 899999999999999999999999876655444333210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.....+...++.++.+||.+||..||.+|||+.|+|+|+||
T Consensus 223 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 -----------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -----------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 00112334578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=354.89 Aligned_cols=282 Identities=34% Similarity=0.585 Sum_probs=218.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC---------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--------- 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------- 72 (417)
.+|++.+.||.|+||.||+|.++.+|+.||+|.+...... ......+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 5899999999999999999999999999999998654332 223446899999999999999999876543
Q ss_pred -----CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeecc
Q 044608 73 -----NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFG 145 (417)
Q Consensus 73 -----~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg 145 (417)
..+|+||||+.+++.+.+.. ..+++..++.++.||++||.|||++||+||||||+||+++ ++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35899999999877665532 3489999999999999999999999999999999999996 3468999999
Q ss_pred ccccccCCC----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 146 LAREIKSGP----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 146 ~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
++..+.... ......|+..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 997653321 1223467899999998866566889999999999999999999999988887777766554433332
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+..........................+.++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 222222111111111001111222334456789999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.07 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=211.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.|+++++||.|+||.||+|.+..+++.|++|.+.... ........+|+++++.++||||+++++++..++.+|+||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 57999999999999999999999999999999987542 22233446799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++.+..+.......+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++...... ......
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 170 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF 170 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence 998876665544445689999999999999999999999999999999999996 588999999998754332 223455
Q ss_pred cCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.+++.|+|||++.. ...++.++|+|||||++|+|++|.+||...+......++...
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------- 230 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-------------------- 230 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--------------------
Confidence 78999999998852 334688999999999999999999999876654443332110
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
..+ .......++.++.+||.+||..||++|||++|+++||||.....
T Consensus 231 -~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 231 -EPP------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred -CCc------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 01112356889999999999999999999999999999986533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=382.15 Aligned_cols=258 Identities=30% Similarity=0.467 Sum_probs=208.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (417)
+++|++++.||+|+||+||+|.++.+++.||+|++...... .....+..|+.+++.|+|||||+++++|.+ ...+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 47899999999999999999999999999999998754332 233445689999999999999999998854 467999
Q ss_pred EEeccCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccCCCCCeeeeC-----------
Q 044608 78 VFECMECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQN-------GFFHRDLKPENLLVSQ----------- 136 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~-------gi~HrDLKp~NILl~~----------- 136 (417)
||||+.++ |...+... ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999875 54444432 124689999999999999999999984 4999999999999953
Q ss_pred -------CcEEEeeccccccccCCCCCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 044608 137 -------GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ 208 (417)
Q Consensus 137 -------~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 208 (417)
+.+||+|||++..+.........+||+.|+|||++.+. ..++.++||||||||||+|++|..||........
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 24899999999876555445566899999999998643 4478999999999999999999999987655443
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+..+... .+. ...+..+.++.+||..||..||.+|||+.|+|.|+||+..
T Consensus 252 li~~lk~----------------------~p~-------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LISELKR----------------------GPD-------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhc----------------------CCC-------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 3322110 010 0113468899999999999999999999999999999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=344.04 Aligned_cols=279 Identities=42% Similarity=0.772 Sum_probs=237.7
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
|++.+.||+|.||.||+|.+..+++.||+|++....... .......|+.++++++||||+++++++.+.+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 788999999999999999999999999999998654221 1233457999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~~ 160 (417)
++++.+.+.... ..+++..+..++.||+.||.|||++||+|+||+|+||++++ +.++|+|||++....... ......
T Consensus 81 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 DMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred CcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 988777766543 45899999999999999999999999999999999999975 889999999998664432 334456
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++...++.+....|....... .....++.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPK 238 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccccc
Confidence 78899999998766468999999999999999999999999999999999999999988888887665443 34445555
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..........+.++.++.++|.+||..||++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 55555556667789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=352.85 Aligned_cols=281 Identities=22% Similarity=0.301 Sum_probs=205.5
Q ss_pred eecceeccc--CceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 5 SGFKELGRG--AFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 5 ~~~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+++++||+| +|++||++.++.+|+.||+|.+........ .....+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 467899999 678999999999999999999976543322 23345799999999999999999999999999999999
Q ss_pred cCCCHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-C----
Q 044608 82 MECNLYQLMA-ARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-P---- 154 (417)
Q Consensus 82 ~~~~l~~~~~-~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~---- 154 (417)
+.++.+..+. ......+++..++.++.||+.||+|||++||+||||||+|||++ ++.++++||+.+...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9876555444 33344589999999999999999999999999999999999996 478999999865433211 0
Q ss_pred ---CCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCc--c------
Q 044608 155 ---PYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM--D------ 222 (417)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~--~------ 222 (417)
......++..|+|||++.+. ..++.++|||||||++|+|++|..||.............. +.... +
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhh
Confidence 01223567889999998653 3489999999999999999999999987665544333221 11000 0
Q ss_pred -c---------hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 223 -S---------WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 223 -~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. +..............+.............+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0 0000000000000000001111122334568899999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=355.34 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=195.4
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeC-CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNN-NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-~~ 74 (417)
++|++.++||+|+||.||+|.+ ..+++.||+|+++............+|+.++..+ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 6899999999999999999975 3456789999997654444444567899999999 899999999988754 46
Q ss_pred EEEEEeccCCCHHHHHHHhc------------------------------------------------------------
Q 044608 75 LYLVFECMECNLYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~------------------------------------------------------------ 94 (417)
+++||||+.++.+..+....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 89999999876444433221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---CccccCCccccCch
Q 044608 95 -RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPE 169 (417)
Q Consensus 95 -~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE 169 (417)
...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... .....+++.|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 12477889999999999999999999999999999999997 57899999999986543221 22345678899999
Q ss_pred hhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccc
Q 044608 170 ILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSA 248 (417)
Q Consensus 170 ~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (417)
++.+.. ++.++|||||||++|||++ |..||.+....+.+...... + .. ..
T Consensus 247 ~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~-------------------~~--------~~ 297 (338)
T cd05102 247 SIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-G-------------------TR--------MR 297 (338)
T ss_pred HhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-C-------------------CC--------CC
Confidence 986554 8999999999999999997 99999876543333222110 0 00 01
Q ss_pred cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 249 LMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 249 ~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.....++++.+||.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=351.08 Aligned_cols=280 Identities=28% Similarity=0.499 Sum_probs=223.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC--CC----eeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH--SN----IVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h--pn----Iv~l~~~~~~~~~~ 75 (417)
++|++++.+|+|+||.|-.|.+..++..||||+++.-..- ....+-|+++|.++++ |+ +|.+.++|.-.++.
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5899999999999999999999999999999999754222 2233469999999942 33 78888999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----------C--------
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----------G-------- 137 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----------~-------- 137 (417)
|||+|.++-++++.+..++...|+.+.++.+..||+++++|||+++++|-||||||||+.+ .
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 9999999889999999888888999999999999999999999999999999999999821 1
Q ss_pred ---cEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 138 ---IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 138 ---~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
.|+|+|||.|+..... .++.+.|..|+|||++++-. ++..+||||+||||+||++|...|++..+.+.+..+..
T Consensus 247 ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred CCcceEEEecCCcceeccC--cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 3899999999864333 36778999999999999877 99999999999999999999999999999998877777
Q ss_pred hhCCCCccchHHHHH--HHhhhhccCCCCCcc-----------cccccCCCCC---HhHHHHHHHhcccCCCCCCCHHHH
Q 044608 215 VLGSPTMDSWADGLR--QARAIKYQFPQLPRA-----------NLSALMPSAS---QDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~s---~~~~~li~~~L~~dP~~Rpta~el 278 (417)
++|..+..-...... .......+.++.... .+..+....+ .++.|||++||..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 888655443322210 001111122221111 1111111222 258999999999999999999999
Q ss_pred HcCccccc
Q 044608 279 LQHPFFKR 286 (417)
Q Consensus 279 L~hp~f~~ 286 (417)
|.||||..
T Consensus 404 L~HpFF~~ 411 (415)
T KOG0671|consen 404 LSHPFFAR 411 (415)
T ss_pred hcCHHhhc
Confidence 99999975
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=343.85 Aligned_cols=258 Identities=30% Similarity=0.452 Sum_probs=211.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|+|++++.||.|+||.||+|.+..+++.||+|++..... .......+|++++++++||||+++++++.+...+|+||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 689999999999999999999999999999999875422 2223445799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
++++.+..+.......+++..++.++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++...... ......
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccccee
Confidence 998766666655445699999999999999999999999999999999999996 588999999998755432 223445
Q ss_pred cCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.|++.|+|||++.. ...++.++|+|||||++|+|++|.+||.+.+....+..+...
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 223 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-------------------- 223 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--------------------
Confidence 78999999999852 234678999999999999999999999887665544433210
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+. ......++.++.+||.+||..||.+|||++++|+||||...
T Consensus 224 -~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 224 -EPPT------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -CCCC------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0000 01123568899999999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=345.76 Aligned_cols=277 Identities=23% Similarity=0.350 Sum_probs=210.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||++.+..+|+.||+|.+.............+|++++++++||||++++++|.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 58999999999999999999999999999999987653333334456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
++++.+..+..+. ..+++..+..++.||+.||.|||+ .+++|+||||+|||++ ++.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF 158 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cccC
Confidence 9876555554443 558999999999999999999998 5999999999999996 4789999999987653322 2456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC--------------ccchH
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT--------------MDSWA 225 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~--------------~~~~~ 225 (417)
+|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+........ ...+.
T Consensus 159 ~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 8899999999986544 89999999999999999999999987664333222211000000 00000
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..........-..+ ..+ -...++.++.+||.+||..||++|||+.|+++||||.+.
T Consensus 238 ~~~~~~~~~~~~~~----~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPP----PKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCC----ccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00011110000000 000 011368899999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=356.40 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=200.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecc-cccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQ-RYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|+++++||.|+.++||+++.-.. ..||+|.+.. ........-...|+.+|.+| .|.+||++|++-..++.+|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 699999999999999999976544 4566665543 33333334456899999999 49999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCC---Cc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPP---YT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~---~~ 157 (417)
|-+++|-..+.++. ...+.-.++.|..|++.|+.++|+.||||.||||.|+|+-+|.+||+|||.|..+..... ..
T Consensus 441 ~Gd~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 441 CGDIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred cccccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeec
Confidence 98888887776654 334445899999999999999999999999999999999999999999999987765422 34
Q ss_pred cccCCccccCchhhhccC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 158 NYVGSRWYRAPEILLQSE----------LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..... .+.++. .+..|.
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~-aI~~P~------- 589 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLH-AITDPN------- 589 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHH-hhcCCC-------
Confidence 579999999999985432 256789999999999999999999965431 111111 111110
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....||..+. ..++.++++.||.+||.+|||+.|+|+|||++.
T Consensus 590 ------~~Iefp~~~~----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 590 ------HEIEFPDIPE----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ------ccccccCCCC----------chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1123333221 124999999999999999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=325.43 Aligned_cols=278 Identities=28% Similarity=0.561 Sum_probs=230.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeC--CEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNN--NRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~l 77 (417)
.|+|++++++|+|.|++||.|++..+++.++||+++.- ....+.||+++|+.|. ||||++++++..+. ....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 37899999999999999999999999999999998753 2334568999999996 99999999998765 45789
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~~~ 155 (417)
|+||++...+..+.. .++.-+++.++.+|+.||+|||+.||+|||+||.|++|+. ..++|+|+|+|..+..+..
T Consensus 113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999999877766653 3788999999999999999999999999999999999974 5799999999999999888
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh-
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA- 233 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~- 233 (417)
.+-.+.+.+|-.||.+..-..|+.+.|+|||||+|+.|++.+ |.|.|.+..|++-+|..++|+.....+..-....-.
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 888899999999999988888999999999999999999986 557899999999999999998666554432211100
Q ss_pred -hhccCCCCCcccccccCC-----CCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 234 -IKYQFPQLPRANLSALMP-----SASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 234 -~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
............+..+.+ -+++++.|||.++|..|..+|+||.|++.||||..
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000011111222222222 25799999999999999999999999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=361.79 Aligned_cols=252 Identities=33% Similarity=0.521 Sum_probs=215.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccc--ccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQR--YASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|.-+++||.|+||-||.|++..+.+.||||.+.-. .......+++.|+..|++|+|||+|.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366788999999999999999999999999998622 233445677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
||-|+-.+.+.. ..+++.|-+|..|+.+.+.||.|||+.+.||||||..|||+++ |.|||+|||.|.... +.+++
T Consensus 107 YClGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsF 182 (948)
T KOG0577|consen 107 YCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSF 182 (948)
T ss_pred HHhccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhcc
Confidence 998876555443 4477999999999999999999999999999999999999976 899999999997654 34678
Q ss_pred cCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+|||+||||||++ ....|+-++||||||++..||.-.+||.-..+....++-|... .+|++
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtL---------------- 245 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTL---------------- 245 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCC----------------
Confidence 9999999999985 3345999999999999999999999998888877777776421 11111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. .+..|..+++|+..||.+-|.+|||++++|.|+|...
T Consensus 246 ----q-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 246 ----Q-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----C-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1 2345788999999999999999999999999999875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.40 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=207.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHH-HHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-LRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.++.+|+.||||.++.............|+.+ ++.++||||+++++++...+.+|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5899999999999999999999999999999999865444344444556665 666799999999999999999999999
Q ss_pred ccCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 81 CMECNLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|+++++.+.+... ....+++..++.++.||+.||.|||++ +++||||||+|||++ ++.+||+|||++.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9998877666542 234689999999999999999999998 999999999999996 578999999999876544333
Q ss_pred ccccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
+...|+..|+|||++.+. ..++.++|+|||||++|+|++|..||.... ..+.+..+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 222 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE------------------ 222 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh------------------
Confidence 445789999999988542 336889999999999999999999996432 2222222210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+.. ....+|.++.+||.+||..||++|||+.++++||||...
T Consensus 223 ---~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 223 ---EPSPQL-------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ---cCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000000 012468899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=340.36 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=211.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||.|+||.||+|.+..+++.||+|.+.............+|+++++.++||||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 58999999999999999999999999999999987654333334456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++.+....... .+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++...... ......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 9876555444432 589999999999999999999999999999999999996 578999999999876543 233456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|++.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+... ..+
T Consensus 159 ~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---------------------~~~ 216 (274)
T cd06609 159 VGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---------------------NPP 216 (274)
T ss_pred cCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------------CCC
Confidence 7899999999987655 899999999999999999999999776644433322110 000
Q ss_pred CCCcccccccCCC-CCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPS-ASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..... ++.++.++|.+||..||++|||++++++||||++.
T Consensus 217 --------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 --------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred --------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 11112 68899999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.72 Aligned_cols=284 Identities=38% Similarity=0.650 Sum_probs=226.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|.+.+.||+|+||.||+|.+..+|+.||+|++........ .....+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 689999999999999999999999999999999875432221 22346899999999999999999998754 35
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+|+||+..++.... ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 95 ~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 95 FYLVMPYMQTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred EEEEecccccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 6999999987654432 23589999999999999999999999999999999999996 58899999999876432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH-h
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA-R 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~ 232 (417)
......+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+....|.+....+....... .
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 23345789999999998765558999999999999999999999999988888888888776655543322211110 1
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 291 (417)
......+......+....+..+.++.+||.+||+.||++|||++|+|.||||.......
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 11112233344455556677899999999999999999999999999999998865433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.63 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=210.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
-|++.++||+|+||.||+|.+..++..+++|.+..... .......+|+++++.++||||+++++++...+..|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 47899999999999999999999999999999865422 22334467999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~~ 160 (417)
.++.+..+..+....+++..+..++.||+.||.|||+.|++||||||+|||++ ++.+||+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 98877665544445689999999999999999999999999999999999996 578999999998755332 2234457
Q ss_pred CCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 161 GSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 161 gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
|+..|+|||++. ....++.++|+|||||++|+|++|.+||...+..+....+....
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------------- 224 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-------------------- 224 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--------------------
Confidence 899999999974 23347789999999999999999999998877655554442110
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+. ......++.++.+||.+||+.||++|||++++++||||+..
T Consensus 225 -~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 225 -PPT------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -CCC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 000 01123467899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.31 Aligned_cols=252 Identities=29% Similarity=0.537 Sum_probs=206.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E 80 (417)
+|++++.||+|++|.||++.++.+++.||+|.+....... ......+|++++++++||||+++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999987543322 22334679999999999999999998864 456899999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CCCc
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
|+.++ +.+.+.......+++.+++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||++...... ....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99865 555555444456899999999999999999999999999999999999974 78999999999766433 2234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---------------------~ 218 (257)
T cd08223 161 TLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG---------------------K 218 (257)
T ss_pred cccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------------C
Confidence 457899999999986554 889999999999999999999999877665554443210 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+......+++++.+||.+||+.||++|||+.++++||||
T Consensus 219 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 --------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011224578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=341.19 Aligned_cols=277 Identities=38% Similarity=0.696 Sum_probs=224.3
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhc---CCCCeeeeceEEEeCCE-----
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKL---NHSNIVKLKELIQNNNR----- 74 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----- 74 (417)
|++.+.||+|+||.||+|.++.+++.||+|.++....... .....+|+.+++++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433221 22334677777665 69999999999988776
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
++++|||+.+++.+.+.......+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 9999999998877766554444689999999999999999999999999999999999996 478999999999877655
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.......++..|+|||++.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....|.......
T Consensus 161 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-- 237 (287)
T ss_pred cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc--
Confidence 5445567899999999987655 8999999999999999999999999999999998888777665554443321111
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...++...........+.++.++.+||.+||+.||.+|||++|+++||||
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 -RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred -hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11112222233344455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=360.85 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=221.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
..|.+.+.||+|.|++|.+|++..||..||||.|++...+... ....+|++++..|+|||||+++.+.+....+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 4699999999999999999999999999999999876555443 224689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCc-EEEeeccccccccCCCCCcc
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGI-IKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~-vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.++ +.+++.. . +.+.+..++.++.|+++|++|||+++|+|||||.+||||+.+. +||+|||++..+.......+
T Consensus 136 ya~~ge~~~yl~~-~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 136 YASGGELFDYLVK-H-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred eccCchhHHHHHh-c-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence 98765 5555544 3 3477899999999999999999999999999999999998765 99999999999998888899
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.||++.|.|||++.+..+.++.+|+||+|+++|-|++|..||.+.+-.+.-.+.. ..++..
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl-------------------~gk~rI 274 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL-------------------RGKYRI 274 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe-------------------eeeecc
Confidence 9999999999999988888999999999999999999999999876544332221 122222
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
| --+|.++.+||+++|..+|.+|++.+++..|.|......
T Consensus 275 p-----------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 275 P-----------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred c-----------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 2 247899999999999999999999999999999976543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.33 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=206.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+..+++.||+|.+.............+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 57999999999999999999999999999999987654333334456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYV 160 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~ 160 (417)
++++.+... ..+++..+..++.||+.||.|||++||+|+||||+|||++ ++.++|+|||++....... ....+
T Consensus 81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYV 154 (279)
T ss_pred CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccCCC
Confidence 998876543 2378999999999999999999999999999999999996 5789999999997654432 34468
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
||..|+|||++.+.. ++.++|+|||||++|+|++|..||......+... .+....... .....+.
T Consensus 155 ~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~------------~~~~~~~~~--~~~~~~~ 219 (279)
T cd06619 155 GTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL------------MPLQLLQCI--VDEDPPV 219 (279)
T ss_pred CChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhccccccc------------chHHHHHHH--hccCCCC
Confidence 999999999986654 8999999999999999999999996532211000 000000000 0000000
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......++++.+||.+||+.||++|||++|+++||||+..
T Consensus 220 -------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 220 -------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred -------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0123467899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.35 Aligned_cols=259 Identities=24% Similarity=0.432 Sum_probs=210.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|+|++++.||+|+||.||+|++..+|+.||+|.+.............+|++++++++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 68999999999999999999999999999999987653333334556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 82 MECNLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
+.++.+..+.... ...+++..+..++.||+.||.|||+ .||+|+||||+||++++ +.+||+|||++..+.... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-cc
Confidence 9987666555442 2368999999999999999999997 59999999999999964 789999999997654332 23
Q ss_pred cccCCccccCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 158 NYVGSRWYRAPEILLQSE-----LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...+++.|+|||++.+.. .++.++|+|||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------- 223 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV---------------- 223 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh----------------
Confidence 457889999999985432 35889999999999999999999997654433322221110
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ....+.+.++.++.+||.+||..||++|||++++++||||...
T Consensus 224 ---~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 224 ---DG-------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ---hc-------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 00 0112334578999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=335.58 Aligned_cols=259 Identities=30% Similarity=0.421 Sum_probs=212.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||.|+||.||+|.+..++..+|+|++.............+|+++++.++|+||+++++.+...+.+|+|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 68999999999999999999999999999999997654444445567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC---
Q 044608 82 MECNLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 82 ~~~~l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--- 155 (417)
+.++.+..+.... ...+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9877555554432 245899999999999999999999999999999999999974 7899999999876554322
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
....+|+..|+|||++.....++.++|+|||||++|+|++|..||...+......++...
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 222 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------------------ 222 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC------------------
Confidence 234578999999999876646899999999999999999999999877665544443211
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..+. .........+++++.+||.+||..||++|||+.++++||||
T Consensus 223 ---~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 223 ---DPPS---LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---CCCC---cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000 00001124678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.29 Aligned_cols=254 Identities=32% Similarity=0.474 Sum_probs=211.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||++.+..+++.||+|++...... .......+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 5899999999999999999999999999999998754321 12233468999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.++ +.+.+.. . ..+++..+..++.||+.||.|||++|++|+||+|.|||++ ++.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~-~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRK-S-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHH-c-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence 999655 5554443 3 4589999999999999999999999999999999999996 578999999999876544 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~-- 214 (290)
T cd05580 157 TLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-------------------K-- 214 (290)
T ss_pred CCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------C--
Confidence 557899999999986554 789999999999999999999999887755544443210 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
..+...++..+.++|.+||..||.+|+ +++|+++||||+...+.
T Consensus 215 ---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 215 ---------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ---------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 012234688999999999999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=351.00 Aligned_cols=281 Identities=38% Similarity=0.689 Sum_probs=226.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNR------ 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------ 74 (417)
++|++.+.||+|+||.||+|++..+++.||+|++....... ......+|+.+++.++||||+++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 68999999999999999999999999999999987543222 22334589999999999999999998876554
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+|+||+++++.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 899999998777766543 3589999999999999999999999999999999999996 478999999999865433
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH-Hh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-AR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~ 232 (417)
.....++..|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.+....|...... ..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 345578999999999866555889999999999999999999999999888888888887776554333221110 01
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+......+.......+.++.+||.+||+.||++|||+.||++||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 1111122222333344455679999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=348.51 Aligned_cols=284 Identities=39% Similarity=0.701 Sum_probs=228.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhc-CCCCeeeeceEEEeC--CEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKL-NHSNIVKLKELIQNN--NRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~l 77 (417)
++|++.+.||+|+||.||+|.+..+|+.+|+|.+....... ......+|+.+++++ +||||+++++++... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 68999999999999999999999999999999886543222 223345799999999 999999999998653 46899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-- 154 (417)
||||+.+++...+... .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 87 v~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 87 VFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9999998777665432 588999999999999999999999999999999999996 4789999999997654322
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......||+.|+|||++.+...++.++|+|||||++|+|++|.+||.+....+...++....+.+....|......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 2334678999999999876666889999999999999999999999999999998888888877665554432211
Q ss_pred Hhh-hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 231 ARA-IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
... +....+...........+.++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 111 1111222223334455566899999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=347.65 Aligned_cols=281 Identities=38% Similarity=0.677 Sum_probs=223.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCC------E
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNN------R 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~ 74 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 68999999999999999999999999999999986543222 2233468999999999999999999987653 4
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+++||||+++++...+. . ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~~-~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 95 FYLVMPFMGTDLGKLMK-H--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred EEEEEecCCCCHHHHHh-c--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 68999999666655543 2 3589999999999999999999999999999999999996 578999999999765432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh-
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR- 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~- 232 (417)
.....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......++...+....+ |...+....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (343)
T cd07880 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSEDA 248 (343)
T ss_pred --ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HHHhhcchhH
Confidence 2345779999999998764558899999999999999999999999988888887777665554332 222221111
Q ss_pred -hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 233 -AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
......+......+....+.++.++.++|.+||+.||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11112233333344455677899999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=346.05 Aligned_cols=283 Identities=37% Similarity=0.648 Sum_probs=227.1
Q ss_pred CceecceecccCceEEEEEEECCC--CcEEEEEEecccccCh-hhhhhHHHHHHHHhc-CCCCeeeeceEEEe----CCE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHT--GEAVAIKELKQRYASW-EDCLNLREVKCLRKL-NHSNIVKLKELIQN----NNR 74 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~--g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~ 74 (417)
+|++.+.||+|+||.||++.+..+ +..||+|.+....... ......+|+.+++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 9999999987543222 123446799999999 59999999987532 356
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+++||+++++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+...
T Consensus 81 ~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8999999998887776543 4589999999999999999999999999999999999996 478999999999765432
Q ss_pred C-----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 154 P-----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 154 ~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.+..+.+....
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 12345789999999998765568999999999999999999999999999999999999988887765544322
Q ss_pred HHHh-hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQAR-AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.... .........+...+....+..+.++.+||.+||+.||++|||+.|++.||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 2110 0111122222333444556778999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=333.59 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=209.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|++..++..|++|.+..... .....+|++++++++||||+++++++.+...+|+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 689999999999999999999999999999999875432 34456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
+.++.+..+.......+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 988766665554446689999999999999999999999999999999999996 5789999999998765433 23345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|+..|+|||++.+.. ++.++|||||||++|+|++|..||......+....+...
T Consensus 160 ~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------------ 214 (256)
T cd06612 160 IGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK------------------------ 214 (256)
T ss_pred cCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC------------------------
Confidence 6889999999986554 899999999999999999999999876654433222100
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.. ........++.++.+||.+||+.||++|||+.|+|+||||
T Consensus 215 --~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 --PP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --CC-CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 0011123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=326.93 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=217.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++.+++..||.|+.|.||+++.+.+|..+|||.+.+....++..++++.+.++.+. ++|+||+.+++|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 35567889999999999999999999999999999877777777788888887766 49999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
+|.. ..+.+.++..+.++|..+-.+...++.||.||.++ ||+|||+||+|||+++ |.|||||||.+..+.++...+.
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence 8863 34444455557799999999999999999999976 8999999999999986 9999999999998888877788
Q ss_pred ccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 159 YVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 159 ~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
..|.+.|||||.+. ....|+..+|+||||+.++||.||..||.+.+ +.+.+-+|..
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------------------- 309 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------------------- 309 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---------------------
Confidence 89999999999984 23458999999999999999999999999864 5566665542
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..| ..-....++|+++++|+..||.+|+.+||...++|+|||+..
T Consensus 310 -~eP-----P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 310 -EEP-----PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred -cCC-----CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 111 111112348999999999999999999999999999999975
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=333.22 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=210.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..+++.+++|++...... ......+|+++++.++||||+++++++.+.+.+|++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 6899999999999999999999999999999999765433 234456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+.......+++..++.++.|++.||.|||++||+|+||||+||++++ +.+||+|||++....... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 9987766666554456899999999999999999999999999999999999974 789999999987665432 23455
Q ss_pred cCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+.......+... .+.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-------------------~~~ 222 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-------------------NFP 222 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCC
Confidence 789999999998544 24788999999999999999999999887765554433210 000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.+ .......++.++.+||.+||..||..|||+.+++.|+|
T Consensus 223 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 PP------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred Cc------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 00112345788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=368.53 Aligned_cols=281 Identities=24% Similarity=0.381 Sum_probs=202.2
Q ss_pred CCceecceecccCceEEEEEEECCCC-cEEEEEEe--------------cccc--cChhhhhhHHHHHHHHhcCCCCeee
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKEL--------------KQRY--ASWEDCLNLREVKCLRKLNHSNIVK 64 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i--------------~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~ 64 (417)
++|+++++||+|+||+||+|..+... +.+++|.+ .+.. .........+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 68999999999999999998765432 22232211 1110 1111223458999999999999999
Q ss_pred eceEEEeCCEEEEEEeccCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEE
Q 044608 65 LKELIQNNNRLYLVFECMECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIK 140 (417)
Q Consensus 65 l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vk 140 (417)
+++++.+.+..|+|+|++.++++..+.... ........++.++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999988888765432 12244677889999999999999999999999999999996 58899
Q ss_pred EeeccccccccCCCC--CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCC--CHHHHHHHHHHh
Q 044608 141 IADFGLAREIKSGPP--YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGA--SEADQMYKICGV 215 (417)
Q Consensus 141 L~DFg~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~--~~~~~~~~i~~~ 215 (417)
|+|||++..+..... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..+ |.+. .....+.++...
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999987654322 23468999999999987655 89999999999999999998754 4332 344555555554
Q ss_pred hCCCCccchHH----HHHHHhhhhccCCCCCccccccc--CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 216 LGSPTMDSWAD----GLRQARAIKYQFPQLPRANLSAL--MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 216 ~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++....+ +.+ .........+. .. ...+..+ ...++.++.++|.+||++||.+|||+.|+|+||||...
T Consensus 387 ~~~~~~~-~p~~~~~~~~~i~~~~~~--~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 387 LSVCDEE-FPDPPCKLFDYIDSAEID--HA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccChhh-cCCcHHHHHHHhhhhhcc--cC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 4432211 111 11111111111 00 0111111 12367789999999999999999999999999999764
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=340.48 Aligned_cols=255 Identities=28% Similarity=0.506 Sum_probs=212.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|++++.||.|+||.||+|.+..+|+.||+|.+...... ......+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4699999999999999999999999999999998754332 233446899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-Cccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-YTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-~~~~ 159 (417)
+.++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........ ....
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9887766665443 489999999999999999999999999999999999996 57899999999876544322 2345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....+... +. +
T Consensus 176 ~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~--------------------~ 233 (296)
T cd06655 176 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT--------------------P 233 (296)
T ss_pred CCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC--------------------c
Confidence 7899999999986544 789999999999999999999999888766554443210 00 0
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.......+++.+.+||.+||..||++|||+.++++||||+.+
T Consensus 234 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 234 ------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 011123578899999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.64 Aligned_cols=281 Identities=35% Similarity=0.643 Sum_probs=222.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 78999999999999999999999999999999997543222 223446899999999999999999988643 34
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
.|++++++++++.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 97 ~~lv~~~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 97 VYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred EEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 789999987776655432 3489999999999999999999999999999999999996 47899999999876433
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH-h
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA-R 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~ 232 (417)
......|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.+....+....... .
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 23455789999999998765558999999999999999999999999888888777777766665444332221110 0
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+..+...+.......++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 1111122223333344444678999999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.10 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=209.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|.+.+.||+|+||.||+|.++.+++.|++|.+..... ........+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58999999999999999999999999999999875432 23334456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-Ccc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YTN 158 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-~~~ 158 (417)
+.++ +.+.+.......+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..+..... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9765 555454443456899999999999999999999999999999999999975 8899999999886654322 234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.. ..+
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~ 218 (256)
T cd08529 161 IVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---------------------GVF 218 (256)
T ss_pred cccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------------CCC
Confidence 57899999999986655 88999999999999999999999988876555544321 111
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+ .....++.++.++|.+||+.||++||++.++++|||+
T Consensus 219 ~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 P--------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred C--------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 1 1112467899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=337.04 Aligned_cols=254 Identities=30% Similarity=0.439 Sum_probs=209.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||.|+||.||+|.++.+++.||+|.+.............+|++++++++||||+++++++...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 57999999999999999999999999999999988765444445567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.+..+..+.......+++..+..++.||+.||.|||+ .|++|+||||+||++++ +.++|+|||.+.......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-F 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc-c
Confidence 99665555555443668999999999999999999999 99999999999999975 789999999987654332222 6
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-----EADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.++..|+|||.+.+. .++.++|+|||||++|+|++|..||.... ..+.+..+.
T Consensus 160 ~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 217 (265)
T cd06605 160 VGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV--------------------- 217 (265)
T ss_pred cCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh---------------------
Confidence 789999999998655 48999999999999999999999996542 111111111
Q ss_pred hccCCCCCcccccccCCC-CCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 235 KYQFPQLPRANLSALMPS-ASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....+ ..... ++.++.+||.+||..||++|||+.+++.||||+.
T Consensus 218 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 218 NEPPP--------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred cCCCC--------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00000 11111 6889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.96 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=209.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|++++.||+|+||.||+|.+..++..||+|.+....... .....+|+.+++.++||||+++++.+.++...|+||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 58999999999999999999999999999999987644332 33456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
+.++.+..+... ..+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .....
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 987655555443 3479999999999999999999999999999999999996 4789999999987654322 22345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......+....+... + .+
T Consensus 177 ~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~--------------------~~ 234 (296)
T cd06654 177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G--------------------TP 234 (296)
T ss_pred cCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-C--------------------CC
Confidence 7899999999986544 789999999999999999999999877654443322100 0 00
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ......++..+.+||.+||..||++|||+.|+++||||...
T Consensus 235 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 235 E------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred C------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0 01123567899999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=335.21 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------~~ 74 (417)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......|+.+++++ +||||+++++++... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 469999999999999999999999999999999875432 223446799999998 799999999998753 46
Q ss_pred EEEEEeccCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccC
Q 044608 75 LYLVFECMECNLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~-~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~ 152 (417)
+|+||||+.++.+..+... ....+++..+..++.||+.||.|||++||+|+||||+||++++ +.+||+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 8999999987644444433 3356899999999999999999999999999999999999964 7899999999976543
Q ss_pred C-CCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 153 G-PPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
. .......|++.|+|||++.+ ...++.++|+|||||++|+|++|..||...........+..
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~------------- 230 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 230 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-------------
Confidence 2 22345678999999999853 23478899999999999999999999976654433332210
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...+ ......++.++.+||.+||..||.+|||+.|+++||||
T Consensus 231 --------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 --------NPAP-------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------CCCC-------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 01123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.60 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=210.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... ........+|+++++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999875432 22334456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCCCCCcc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
+.++ +.+.+.......+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9875 555554444455899999999999999999999999999999999999964 4589999999987765544455
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~----------------------- 216 (256)
T cd08220 161 VVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG----------------------- 216 (256)
T ss_pred cccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----------------------
Confidence 67899999999986544 789999999999999999999999887665554443210
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
........++.++.++|.+||..||++|||+.|+++||||
T Consensus 217 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 ------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0111223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.42 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|+..+.||+|+||.||++.+..+|+.||+|.+.............+|+.++.++. ||||+++++++.+++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 578889999999999999999999999999999876544444445578999999996 9999999999999999999999
Q ss_pred ccCCCHHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 81 CMECNLYQLM---AARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~l~~~~---~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.+++.+.. .......+++..+..++.|++.||+|||+. |++||||||+||+++ ++.+||+|||++..+.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 9987654432 223335689999999999999999999975 999999999999996 57899999999987655444
Q ss_pred CccccCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 156 YTNYVGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.....|++.|+|||++.+. ..++.++|||||||++|+|++|..||..... ....+.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~---------------- 225 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK---------------- 225 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC----------------
Confidence 4555789999999998665 3589999999999999999999999976542 1111111100
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...+.. .......++.++.+||.+||+.||++|||++++++||||+.
T Consensus 226 --~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 226 --GDPPIL----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred --CCCCcC----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000110 01112357899999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.23 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=204.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 579999999999999999999999999999999875432 2223345799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
++++.+..+.... +.+++.+++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++...... ......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 9876555544433 4589999999999999999999999999999999999996 578999999998765432 223445
Q ss_pred cCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|+..|+|||++. ....++.++|+|||||++|+|++|..||...........+... ...
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-------------------~~~ 227 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-------------------NFQ 227 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-------------------CCC
Confidence 7999999999974 2334788999999999999999999998765543332222100 000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.+ .+. ....++..+.+||.+||..||++|||++++++|||
T Consensus 228 ~~-----~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 228 PP-----KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CC-----ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00 001 11246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.08 Aligned_cols=255 Identities=28% Similarity=0.486 Sum_probs=208.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|++++.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++||||+++++++...+.+|+||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5899999999999999999999999999999998754332 233446899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+... ..+++.++..++.|++.||.|||+.|++||||||+|||++ ++.++|+|||++....... .....
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence 987766655543 3479999999999999999999999999999999999996 5789999999987654332 22345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+.. .+ .+
T Consensus 176 ~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~--------------------~~ 233 (297)
T cd06656 176 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--------------------TP 233 (297)
T ss_pred cCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC--------------------CC
Confidence 7899999999986544 78999999999999999999999977654333221110 00 00
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.......++..+.+||.+||..||++|||++++++||||+..
T Consensus 234 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 234 ------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 011123567889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.47 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=210.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||++.+..+++.||+|.+...... .......+|+++++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999998754321 12234458999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG----- 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~----- 153 (417)
||++|+.+..+.... +.+++..+..++.|++.||.|||++|++||||||+||++++ +.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999886665555444 45899999999999999999999999999999999999964 78999999988631100
Q ss_pred -----------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 154 -----------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 154 -----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
.......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~------- 231 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD------- 231 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------
Confidence 0112346788999999986654 899999999999999999999999887766555444321
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC---HHHHHcCccccccccCC
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT---AAEALQHPFFKRCFYAP 291 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~~~ 291 (417)
....+ .....++.++.+||.+||+.||++||| +.++|+||||....+..
T Consensus 232 ------------~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 232 ------------DIEWP--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred ------------ccCCC--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 00111 111247889999999999999999998 89999999998765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=327.90 Aligned_cols=252 Identities=32% Similarity=0.533 Sum_probs=211.3
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++++.||.|+||.||.+++..+++.+++|.+...... .......+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999998754332 2233446899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCcc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTN 158 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~ 158 (417)
+.++ +.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.+||+|||++....... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9865 555554443456899999999999999999999999999999999999964 789999999997664433 3345
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+...
T Consensus 161 ~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~----------------------- 216 (256)
T cd08221 161 VVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG----------------------- 216 (256)
T ss_pred cCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 67899999999986655 789999999999999999999999887776666554310
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
......+.++.++.++|.+||..||.+|||+.++|+|+|+
T Consensus 217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 217 ------NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0111124578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=331.55 Aligned_cols=251 Identities=31% Similarity=0.547 Sum_probs=205.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--------hhhhHHHHHHHHhcCCCCeeeeceEEEeCCE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--------DCLNLREVKCLRKLNHSNIVKLKELIQNNNR 74 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 74 (417)
+|.+.+.||+|+||.||+|.+..+++.||+|.+........ .....+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 58899999999999999999999999999998865432211 1233579999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~ 153 (417)
.++||||+.++.+..+.... ..+++..+..++.|++.||+|||++|++||||+|+||++++ +.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999876555554443 45899999999999999999999999999999999999964 78999999998766421
Q ss_pred C-------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 154 P-------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 154 ~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
. ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------------ 226 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------------
Confidence 1 112346889999999986554 78999999999999999999999987765544433211
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
... ......++.++.+||.+||+.||.+|||+.|+++||||
T Consensus 227 ---------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 ---------NAS--------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------cCC--------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001 12224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=329.40 Aligned_cols=249 Identities=31% Similarity=0.530 Sum_probs=207.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
+|++.+.||+|+||.||++.+..+++.||+|.++............+|+.+++.++||||+++++++.+.+.+|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 69999999999999999999999999999999875433333444568999999999999999999999999999999999
Q ss_pred CCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 83 ECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 83 ~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
.++ +.+.+.......+++..+..++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++....... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 765 55555544445689999999999999999999999999999999999996 5789999999997664432 23346
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+...
T Consensus 161 ~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~------------------------ 215 (255)
T cd08219 161 VGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG------------------------ 215 (255)
T ss_pred cCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC------------------------
Confidence 7899999999986554 899999999999999999999999887765554443210
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++.++.+||.+||+.||++|||+.+++.-
T Consensus 216 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 -----SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111223567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=366.94 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=204.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceE-EE---e---CCE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKEL-IQ---N---NNR 74 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~-~~---~---~~~ 74 (417)
+++|.+.|.+|+|+.||+|.+...|..||+|++-.. .+.......+||++|++|+ |+|||.+++. .. . .-.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 568899999999999999999998899999998765 3334455578999999996 9999999993 22 1 135
Q ss_pred EEEEEeccC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 75 LYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 75 ~~lv~E~~~-~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
++|+||||. |+|.+.+..+....|+|.+|..|+.|+++|+.+||... |+|||||-|||||+ +|.+||||||.|+..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 789999999 58999998877777999999999999999999999998 99999999999996 588999999998743
Q ss_pred cCCCCC----------ccccCCccccCchhh--hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Q 044608 151 KSGPPY----------TNYVGSRWYRAPEIL--LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 151 ~~~~~~----------~~~~gt~~y~aPE~l--~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
-..... -...-|+.|+|||++ ..+...+.|+|||+|||+||.||+...||+......++
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl--------- 267 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL--------- 267 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE---------
Confidence 222210 012469999999997 34555899999999999999999999999776432221
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
...|.||.. +.+|..+++||+.||+.||++||++.+++.+-+
T Consensus 268 --------------ng~Y~~P~~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 268 --------------NGNYSFPPF---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred --------------eccccCCCC---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 346777753 568999999999999999999999999986544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.47 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+|+.++++++||||+++++++...+.+|+||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 5799999999999999999999999999999998754322 222345799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..+.... .....
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 9876555544433 4589999999999999999999999999999999999996 4789999999998664322 23445
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|++.|+|||.+.. ...++.++|+|||||++|+|++|..||......+....+.. ..+.
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-------------------~~~~ 227 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-------------------SNFQ 227 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-------------------CCCC
Confidence 78999999998742 33367899999999999999999999965543332221110 0001
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.+. . .....++.++.+||++||+.||++|||++++|+|+|
T Consensus 228 ~~~-----~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 228 PPK-----L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCC-----C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 010 0 112346889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.79 Aligned_cols=252 Identities=30% Similarity=0.552 Sum_probs=209.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||+|+||.||++.+..+|+.||+|.+..... ........+|+.++++++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 69999999999999999999999999999999875432 22333456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-Ccc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-YTN 158 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-~~~ 158 (417)
+.++ +.+.+.......+++..+..++.||+.||.|||++|++|+||+|+|||++ ++.++|+|||++........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9764 55555443334579999999999999999999999999999999999996 47899999999976644322 234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..|++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+... .+
T Consensus 161 ~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~---------------------~~ 218 (256)
T cd08218 161 CIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG---------------------SY 218 (256)
T ss_pred ccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC---------------------CC
Confidence 56889999999986554 789999999999999999999999877766665544311 01
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.......+.++.++|.+||+.||.+|||+.++++||||
T Consensus 219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 --------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 11223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=330.64 Aligned_cols=252 Identities=28% Similarity=0.459 Sum_probs=204.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+....... ......+|+++++.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 578999999987543221 11234579999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC----
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS---- 152 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~---- 152 (417)
||||+.++.+..+..+. ..+++..++.++.||+.||+|||+.||+|+||+|+||+++ ++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999887665555443 4589999999999999999999999999999999999996 58899999999875432
Q ss_pred ---CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 153 ---GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 153 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
........|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 223 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-------------- 223 (265)
T ss_pred ccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc--------------
Confidence 11223457899999999986554 889999999999999999999999876654443332210
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.. ........++.++.+||.+||..||++|||+.|+|+||||
T Consensus 224 -----~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 224 -----RG--------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----cC--------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 0112234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.59 Aligned_cols=261 Identities=27% Similarity=0.477 Sum_probs=226.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.+.+++..||-|+||.|=++........+|+|++++...-. ....+..|-.+|..+..|+||++|..|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 46778899999999999999776666679999998764432 3334468999999999999999999999999999999
Q ss_pred e-ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 E-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E-~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
| |++|.++..+..+ +.|++..++.|+..+++|++|||++||++|||||||++++ +|-+||.|||+|+.+.++....
T Consensus 500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 9 5667787776654 5599999999999999999999999999999999999997 5899999999999999999999
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
++||||.|+|||++++.. .+.++|.||||+++|||++|.+||.+.++...+..|...+. ...
T Consensus 578 TFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----------------~i~ 639 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----------------KIE 639 (732)
T ss_pred eecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------------hhh
Confidence 999999999999998766 79999999999999999999999999999999888875321 112
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCCC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYAPPH 293 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~~~ 293 (417)
+ +..++..+.+||++++..+|.+|.. +.||-+|.||....|.-..
T Consensus 640 ~-----------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 640 F-----------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred c-----------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 2 2357889999999999999999976 9999999999887665433
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.26 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=209.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
..|+.++.||.|+||.||+|.+..++..||+|++.............+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 36889999999999999999999999999999987654444444556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+... ..+++..+..++.|++.||+|||++|++|+||+|+||++++ +.++|+|||++....... .....
T Consensus 84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 987655554443 34899999999999999999999999999999999999974 789999999997654432 22345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.++..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+..
T Consensus 162 ~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------------------------- 215 (277)
T cd06640 162 VGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------------------------- 215 (277)
T ss_pred cCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-------------------------
Confidence 6889999999986554 79999999999999999999999987665444332210
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+...++.++.+||.+||..||++|||+.++++|+||...
T Consensus 216 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 216 ----NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00011223467889999999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=356.99 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=210.3
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHHH
Q 044608 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQ 88 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~~ 88 (417)
+||+|+||+||.|+++.|...+|||.|..+... ...-...||.+.+.|.|.|||++++.+..++.+-|.||-++||.+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 599999999999999999999999999765432 2222347999999999999999999999999999999999998888
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCCCCC-ccccCCc
Q 044608 89 LMAARDRKLF--SEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPY-TNYVGSR 163 (417)
Q Consensus 89 ~~~~~~~~~l--~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~~~~-~~~~gt~ 163 (417)
.+.+..-+++ .|+.+..|.+||++||.|||++.|||||||-+||||+ .|.+||+|||-++.+..-.++ .++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 8777766777 8999999999999999999999999999999999996 499999999999887665444 4678999
Q ss_pred cccCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 164 WYRAPEILLQ-SELYSSKADMWAMGAIMAELFTFCPLFPGASEAD-QMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 164 ~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
.|||||++.+ ...|+.++|||||||++.||.||+|||....... .+.++ ..|.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---------------------GmyK---- 795 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---------------------GMYK---- 795 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---------------------ccee----
Confidence 9999999954 3569999999999999999999999996543322 22221 0111
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....++..+|.+++.||.+|+.+||.+||+|.++|++||++..
T Consensus 796 ---vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 796 ---VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0122345679999999999999999999999999999999865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=331.39 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=203.0
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.++ ..+..||+|.++............+|+.++++++||||+++++++..++.+|+|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 47999999999999999999765 456789999998654444444557899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||++++.+..+.......+++..++.++.||+.||+|||++|++||||||+|||++ ++.+||+|||.+..........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence 999998877766555445689999999999999999999999999999999999996 4789999999876543222111
Q ss_pred --cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 158 --NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 158 --~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------------------ 225 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------------ 225 (266)
T ss_pred ccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------------
Confidence 234567899999986654 8999999999999999775 999999887776655542110
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. .....++..+.+++.+||+.||++|||++++++
T Consensus 226 --~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 --RL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --CC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 00 112456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=339.58 Aligned_cols=280 Identities=36% Similarity=0.636 Sum_probs=223.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 79 (417)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.+..... ......+|+++++.++||||++++++|.. .+..|+||
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 68999999999999999999999999999999886543222 22344589999999999999999999865 56789999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+++++...+. . ..+++..+..++.||++||.|||++||+||||+|.|||+++ +.+||+|||++..... ....
T Consensus 90 e~~~~~L~~~~~-~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~ 164 (328)
T cd07856 90 ELLGTDLHRLLT-S--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG 164 (328)
T ss_pred ehhccCHHHHHh-c--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence 999877665543 2 34789999999999999999999999999999999999964 7899999999875432 2244
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh--c
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK--Y 236 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~ 236 (417)
..++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.........+...+|.+..+.+...... .... .
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 243 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE-NTLRFVQ 243 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch-hhHHHHh
Confidence 578899999998866556899999999999999999999999998887777777777777664443322111 1111 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+...........+.++.++.++|.+||+.||++|||+++++.||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 112222223344556788999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=331.43 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=208.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.... .......+|++++++++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 599999999999999999999999999999999754322 223345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.++.+....... ..+++..+..++.||++||.|||++|++|+||+|+||+++ ++.++|+|||++............
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99877555555443 4689999999999999999999999999999999999996 478999999999876655444556
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE--ADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...+. .+.+.... ..
T Consensus 160 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~- 216 (258)
T cd05578 160 SGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---------------------ET- 216 (258)
T ss_pred CCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh---------------------cc-
Confidence 7899999999986555 89999999999999999999999987764 22211110 00
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH--HHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA--AEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta--~elL~hp~f 284 (417)
......+..+.++.++|.+||..||.+|||+ +|+++||||
T Consensus 217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0112234567999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=336.91 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=196.7
Q ss_pred CCceecceecccCceEEEEEEECC----------------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeee
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH----------------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 65 (417)
++|++.++||+|+||.||+|.+.. ++..||+|++.............+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 589999999999999999997532 3457999998765433333455689999999999999999
Q ss_pred ceEEEeCCEEEEEEeccCCC-HHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Q 044608 66 KELIQNNNRLYLVFECMECN-LYQLMAARD-----------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127 (417)
Q Consensus 66 ~~~~~~~~~~~lv~E~~~~~-l~~~~~~~~-----------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDL 127 (417)
++++.+.+..++||||+.++ +.+.+.... ...+++..+..++.||+.||.|||++||+||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 99999999999999999775 444443221 123677889999999999999999999999999
Q ss_pred CCCCeeeeC-CcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 044608 128 KPENLLVSQ-GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT--FCPLFP 201 (417)
Q Consensus 128 Kp~NILl~~-~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~ 201 (417)
||+|||+++ +.+||+|||++..+..... .....++..|+|||++.... ++.++|||||||++|+|++ +..||.
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999975 7899999999986543321 22345678899999986655 8999999999999999987 567887
Q ss_pred CCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 202 GASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 202 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
..+..+.+..+....... . ........+.++..+.+||.+||+.||++|||+.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~---------------~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQ---------------G-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred cCCHHHHHHHHHHHhhhc---------------c-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 776655554432211000 0 0000112245678999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=331.63 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=209.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 78 (417)
..|++++.||+|+||.||+|.+..+++.||+|.+.............+|+.+++.+. ||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 368999999999999999999999999999999876544434444568999999996 99999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~ 156 (417)
|||+.++.+..+... ..+++..+..++.||+.||.|||++||+|+||+|+||+++ ++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999988766555543 3589999999999999999999999999999999999997 5789999999998665432 23
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+.. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---------------------~ 217 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---------------------S 217 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---------------------C
Confidence 4457899999999987666678999999999999999999999987654433221100 0
Q ss_pred cCCCCCcccccccCC-CCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMP-SASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+ .+.. .++.++.+||.+||..||++|||+.|+++|+||++.
T Consensus 218 ~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 KPP--------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCC--------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 000 1111 267899999999999999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=333.28 Aligned_cols=253 Identities=22% Similarity=0.398 Sum_probs=202.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEE------eCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQ------NNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~------~~~~ 74 (417)
+.|++.+.||.|+||.||+|.+..+++.||+|++..... .......|+.+++++ +||||+++++++. ..+.
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 479999999999999999999999999999999865322 223345789999998 7999999999985 3568
Q ss_pred EEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 75 LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
+|++|||+.++ +.+.+.......+++..++.++.||+.||.|||++||+|+||||+||+++ ++.++|+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 89999999875 44444433345588999999999999999999999999999999999996 47899999999876543
Q ss_pred C-CCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 153 G-PPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
. .......|++.|+|||++.. ...++.++|+|||||++|+|++|..||...........+...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------ 241 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------------ 241 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC------------
Confidence 2 22344678999999999853 234788999999999999999999999776544333222100
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.........++.++.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ----------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 ----------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00011123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=337.51 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=208.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.|++++.||+|+||.||+|.+..+++.||+|.+.............+|++++++++||||+++++++..++.+|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45888999999999999999999999999999987554333344556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++..+.... .....
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 987755555433 4589999999999999999999999999999999999996 4789999999997655432 12334
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+..
T Consensus 162 ~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------------------------- 215 (277)
T cd06642 162 VGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK------------------------- 215 (277)
T ss_pred cCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-------------------------
Confidence 6889999999986554 89999999999999999999999976554333222100
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.........++.++.+||.+||..||++|||+.++++||||...
T Consensus 216 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 216 ----NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 00011223467899999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=337.74 Aligned_cols=255 Identities=28% Similarity=0.509 Sum_probs=208.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.|.....||+|+||.||++.+..++..||||.+..... .......+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 346667889999999999999999999999999865432 2233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++.+..+... ..+++.++..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++...... ......
T Consensus 101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 998776666543 3489999999999999999999999999999999999997 478999999998755332 222345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|+..|+|||.+.+.. ++.++|+|||||++|||++|..||...+..+.+..+.... +
T Consensus 179 ~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----------------------~ 235 (292)
T cd06658 179 VGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL----------------------P 235 (292)
T ss_pred ecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------------C
Confidence 7899999999986544 8999999999999999999999998776655444332110 0
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ......++.++.+||.+||..||.+|||++|+++||||...
T Consensus 236 ~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 236 PR-----VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred Cc-----cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 00 00112468899999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=325.37 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=208.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC---h-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS---W-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~---~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+|+..+.||+|+||+||+|.+..+++.|++|.+...... . ......+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999989999999998653321 1 223345899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.++.+..+..+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999876555555443 4589999999999999999999999999999999999996 5789999999988765544445
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...|+..|+|||.+.....++.++|+|||||++|+|++|..||......+....+...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------------------- 217 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS---------------------- 217 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc----------------------
Confidence 6678999999999854444789999999999999999999999776644433332100
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.....+.+.+++++.+||.+||+.||.+|||+.++|+|||+
T Consensus 218 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01122334578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=333.98 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=208.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||+||++.+..+|+.||+|++.............+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 68999999999999999999999999999999987654333344556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.++.+..+.... +.+++..++.++.+++.||.|||+ .|++||||||+||++++ +.++|+|||++....... ....
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~~ 162 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTF 162 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCcc
Confidence 9987666655443 458999999999999999999997 59999999999999964 789999999987543322 2345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+|+..|+|||++.+. .++.++|+|||||++|+|++|..||......+.... ....+.+.. .......+
T Consensus 163 ~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~ 230 (284)
T cd06620 163 VGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DPMGILDLL---QQIVQEPP 230 (284)
T ss_pred ccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hhhHHHHHH---HHHhhccC
Confidence 789999999998655 489999999999999999999999987654311000 000000000 00000000
Q ss_pred CCCcccccccC-CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALM-PSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+. ..++.++.+||.+||+.||++|||+.|+++|+||.+
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 -------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0011 126788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=326.27 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=206.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 79 (417)
+|++++.||.|+||.||+|.+..+|..||+|.+....... ......+|+++++.++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 6999999999999999999999999999999987543332 33345689999999999999999998753 45789999
Q ss_pred eccCCCHH-HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 80 ECMECNLY-QLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMH-----QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 80 E~~~~~l~-~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH-----~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
||+.++.+ +.+... ....+++..++.++.||+.||.||| +.+++|+||||+||++++ +.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99987544 444332 1356899999999999999999999 999999999999999975 88999999999877
Q ss_pred cCCCC-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 151 KSGPP-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 151 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
..... .....|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 224 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--------------- 224 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc---------------
Confidence 65443 34567899999999986655 88999999999999999999999988775444333211
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
. ....+....+.++.+|+.+||+.||++|||+.++|+|||+
T Consensus 225 ------~--------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 ------G--------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------C--------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0 0112234578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.69 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=203.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeC-----CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNN-----NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-----~~~ 75 (417)
++|++.+.||+|+||.||+|.+..+++.+|+|++..... ......+|+.+++++ +||||+++++++... +.+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 679999999999999999999999999999999865322 223345799999999 899999999998653 468
Q ss_pred EEEEeccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc
Q 044608 76 YLVFECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK 151 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~ 151 (417)
|+||||+.++.+..+.. .....+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 99999998765544332 1235689999999999999999999999999999999999996 4789999999987654
Q ss_pred CCC-CCccccCCccccCchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 152 SGP-PYTNYVGSRWYRAPEILLQSE----LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 152 ~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
... ......|+..|+|||++.... .++.++|||||||++|+|++|.+||......+.+..+...
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~----------- 248 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN----------- 248 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC-----------
Confidence 332 223457899999999975432 2678999999999999999999999877655544433210
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
..+. .......+.++.+||.+||+.||++|||+.|+++||||+
T Consensus 249 ----------~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 ----------PPPT------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ----------CCCC------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0000 001134567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=327.92 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=200.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC----hhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS----WEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (417)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998644221 112234579999999999999999999875 4678
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~- 153 (417)
+++|||+.++.+....... ..+++..++.++.||+.||.|||++||+|+||||+||++++ +.+||+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999876444443333 34899999999999999999999999999999999999964 78999999998755321
Q ss_pred ---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 ---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.......++..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-------------- 225 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-------------- 225 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--------------
Confidence 1123356889999999986544 8899999999999999999999998765444433321100
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
....+...+++.+.+|| +||..||++|||++|+++||||+
T Consensus 226 --------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 --------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00112234678899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=351.46 Aligned_cols=268 Identities=27% Similarity=0.482 Sum_probs=216.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh--hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC--LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
-|..++.||-|+||+|.+++...|...||+|.+.+...-.... -...|-.||..-+.+-||+||..|+|.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4788999999999999999999999999999997654332222 12469999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc--------
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-------- 151 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-------- 151 (417)
|+.|+....+..+. +.|.|+.++.|+..|..|+++.|..|+|||||||+||||| +|+|||.||||++.+.
T Consensus 710 YIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred ccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99876444443333 5699999999999999999999999999999999999998 6999999999997542
Q ss_pred -CCCC----------------------------------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC
Q 044608 152 -SGPP----------------------------------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196 (417)
Q Consensus 152 -~~~~----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g 196 (417)
++.. ....+||+.|+|||+|.... |+..+|+||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhC
Confidence 0000 02357999999999997766 89999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC--
Q 044608 197 CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-- 274 (417)
Q Consensus 197 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-- 274 (417)
++||.+....+..++|. +|...+. + .+...+|.|+.+||.++++ +++.|..
T Consensus 868 ~~pf~~~tp~~tq~kv~---------nw~~~l~--------~---------~~~~~ls~e~~~li~kLc~-sad~RLGkn 920 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVI---------NWRNFLH--------I---------PYQGNLSKEALDLIQKLCC-SADSRLGKN 920 (1034)
T ss_pred CCCccCCCCCcceeeee---------ehhhccc--------c---------ccccccCHHHHHHHHHHhc-Chhhhhccc
Confidence 99999988777666553 4544321 1 1224689999999999876 7888864
Q ss_pred -HHHHHcCccccccccCCCCCCCCCC
Q 044608 275 -AAEALQHPFFKRCFYAPPHIRSTPA 299 (417)
Q Consensus 275 -a~elL~hp~f~~~~~~~~~~~~~~~ 299 (417)
++|+..||||+...+.......++.
T Consensus 921 g~d~vKaHpfFkgIDfsslRkq~ApY 946 (1034)
T KOG0608|consen 921 GADQVKAHPFFKGIDFSSLRKQRAPY 946 (1034)
T ss_pred chhhhhcCccccccchHhhhhccCCc
Confidence 7889999999987665543333333
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=328.95 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=205.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+|+..+.||+|+||.||++.+..+++.||+|++....... ......+|+++++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5899999999999999999999999999999987543211 12334679999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-cEEEeeccccccccCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-IIKIADFGLAREIKSGP- 154 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-~vkL~DFg~a~~~~~~~- 154 (417)
||||+.++.+..+..+. ..+++..+..++.||+.||.|||++|++|+||||+||+++. + .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999887665555443 45899999999999999999999999999999999999964 4 59999999987664321
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 224 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-------------- 224 (268)
T ss_pred cCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh--------------
Confidence 122356889999999986544 8999999999999999999999997554332222221100
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
. ........+.+++++.++|.+||..||++|||+.|+++||||+
T Consensus 225 -----~------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 -----S------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -----c------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0001122345789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=329.84 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=204.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC------E
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN------R 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~------~ 74 (417)
++|++.+.||+|+||.||+|.++.+++.|++|++..... ......+|+.+++++ +||||+++++++.+.. .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 689999999999999999999999999999999875433 233456899999999 7999999999997644 5
Q ss_pred EEEEEeccCCCHHHHHHHh-c--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 75 LYLVFECMECNLYQLMAAR-D--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~-~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
+|+||||++++.+..+... . ...+++..++.++.|++.||.|||++|++|+||+|+||+++ ++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 8999999987655444332 2 35689999999999999999999999999999999999996 578999999998765
Q ss_pred cCC-CCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KSG-PPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
... .......|+..|+|||++.. ...++.++|||||||++|+|++|.+||...........+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 233 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---------- 233 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc----------
Confidence 432 22344578999999998743 234788999999999999999999999876554444333210
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
..+. + .....++.++.+||.+||..||++|||+.|+++|||+
T Consensus 234 -----------~~~~-----~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 -----------PPPT-----L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----------CCCC-----C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0000 0 0112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=332.58 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=203.9
Q ss_pred CCCceecceecccCceEEEEEEECCCC-----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTG-----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
+++|++.+.||+|+||.||+|.+...+ ..||+|.++............+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999876655 689999987554333334456899999999999999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcE
Q 044608 76 YLVFECMECN-LYQLMAARDR--------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GII 139 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~--------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~v 139 (417)
|++|||+.++ +.+.+..... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 9999999765 5555543211 45788999999999999999999999999999999999965 689
Q ss_pred EEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 044608 140 KIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 140 kL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 215 (417)
||+|||++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997654322 123446788999999986655 8999999999999999998 99999888776665554311
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++.++.+|+.+||+.||.+|||+.|++++
T Consensus 243 -----------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 243 -----------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -----------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=335.44 Aligned_cols=255 Identities=25% Similarity=0.468 Sum_probs=210.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
-|+....||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 356677899999999999999999999999998654322 2334568999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~~ 160 (417)
+++.+..+... ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++..+... ......+
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 88766665544 3489999999999999999999999999999999999996 578999999998755432 2234567
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......+.+..+...
T Consensus 179 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------------------- 232 (297)
T cd06659 179 GTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS------------------------- 232 (297)
T ss_pred cCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------------
Confidence 899999999986655 899999999999999999999999877765554433210
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
..........++.++.++|.+||+.||++|||++++++||||.++.
T Consensus 233 --~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 233 --PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred --CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0000112245788999999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.91 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=202.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC----hhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS----WEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NR 74 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 74 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+|+.++++++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 46899999999999999999999999999999988643211 1122345799999999999999999998763 57
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~ 153 (417)
++++|||+.++.+.....+. ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 88999999876555444433 44799999999999999999999999999999999999964 78999999998765321
Q ss_pred ----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 154 ----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 154 ----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
.......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+. ..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~---------- 225 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP---------- 225 (265)
T ss_pred cccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC----------
Confidence 1233456899999999986644 8999999999999999999999998765444433221 000
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
. .....+.++..+.++|.+||. +|++|||++|+++|||+.
T Consensus 226 -------~--------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 -------T--------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -------C--------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 011234567889999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.03 Aligned_cols=251 Identities=29% Similarity=0.417 Sum_probs=196.3
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHH---HhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCL---RKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
.||+|+||.||++.+..+++.||+|.+........ .....+|..++ ...+||||+.+++++..++.+|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999875433211 22223444433 34579999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
++.+....... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++....... .....||
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence 77665544433 4589999999999999999999999999999999999996 5789999999987654332 2345799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.. .....
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~-------------------~~~~~---- 214 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------------MTLTV---- 214 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH-------------------HhhcC----
Confidence 99999999865555899999999999999999999999764321111 0100 00000
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 288 (417)
-..+.+.++.++.+||.+||..||++|+ |+.|+++||||+...
T Consensus 215 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 215 ---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0123346789999999999999999999 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=331.27 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=200.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEE-----eCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQ-----NNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+|+.+++.+ +||||+++++++. +++.+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 689999999999999999999999999999998764322 123345799999999 7999999999873 45679
Q ss_pred EEEEeccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccccc
Q 044608 76 YLVFECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK 151 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~ 151 (417)
|+||||++++.+..+.. .....+++..++.++.|++.||.|||+++|+||||||+||++++ +.+||+|||++....
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999998765544332 12345899999999999999999999999999999999999964 789999999987654
Q ss_pred CCC-CCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 152 SGP-PYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 152 ~~~-~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
... ......|++.|+|||++.. ...++.++|||||||++|+|++|..||........+..+..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------------ 243 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR------------ 243 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc------------
Confidence 322 2334578999999999743 23478899999999999999999999987655443322110
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...+. ......++.++.+||.+||+.||++|||+.|+|+|+||
T Consensus 244 ---------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 ---------NPPPT------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------cCCCc------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00000 01112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.65 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=209.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4799999999999999999999999999999998643222 22234568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+.|++.+.+.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++ ++.+||+|||++...... ..
T Consensus 95 e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 999988877765433 4589999999999999999999999999999999999996 478999999998754332 34
Q ss_pred ccCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 159 YVGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
..+++.|+|||++.+ ...++.++||||||+++|+|++|.+||.+.+.......+...
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--------------------- 229 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------------------- 229 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---------------------
Confidence 578899999998742 345889999999999999999999999877665554433210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+.. .....+.++.+||.+||+.||++|||+.+++.||||..
T Consensus 230 ~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 230 DSPTL-------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CCCCC-------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 01235788999999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.03 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=196.9
Q ss_pred CCceecceecccCceEEEEEEECCCC-----cEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-----EAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|++..+| ..||+|+++............+|+.+++.+ +||||+++++++...+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 57999999999999999999865443 579999997654443444556899999999 899999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhc------------------------------------------------------------
Q 044608 76 YLVFECMECN-LYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~------------------------------------------------------------ 94 (417)
|+||||+.++ +.+.+....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999765 544443211
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC---ccccCC
Q 044608 95 --------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY---TNYVGS 162 (417)
Q Consensus 95 --------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~---~~~~gt 162 (417)
...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++........ ....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 124788899999999999999999999999999999999975 67999999999765433221 123356
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
..|+|||++.+.. ++.++|||||||++|+|++ |..||...........+... .+..
T Consensus 278 ~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~-------------------~~~~--- 334 (374)
T cd05106 278 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR-------------------GYQM--- 334 (374)
T ss_pred cceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-------------------ccCc---
Confidence 6799999986554 8999999999999999997 99999876554433333210 0000
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.....+++++.++|.+||+.||++|||+.++++
T Consensus 335 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.29 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=208.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
-|++++.||.|+||.||+|.+..+++.||+|.+.............+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47889999999999999999999999999999875443333344567999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~~ 160 (417)
+++.+..+... ..+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++..+.... ......
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 88765555543 34899999999999999999999999999999999999964 789999999987654432 223457
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
|+..|+|||.+.+.. .+.++|+|||||++|+|++|..||...........+..
T Consensus 163 ~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------------- 215 (277)
T cd06641 163 GTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-------------------------- 215 (277)
T ss_pred CCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--------------------------
Confidence 899999999986544 78899999999999999999999977665443333210
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+...++.++.++|.+||..||.+||++.++++||||.+.
T Consensus 216 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ---NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00111234568899999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.86 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=203.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||.|+||.||+|.+..+++.||+|++...... .......+|+++++.++||||+++++++.+++.+|+||||+.++.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999754332 2233456899999999999999999999999999999999987655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCcccc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYR 166 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~ 166 (417)
.....+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++.............|++.|+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 5444433 4589999999999999999999999999999999999996 5789999999998776544444567899999
Q ss_pred CchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcc
Q 044608 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS--EADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244 (417)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (417)
+||.+.+.. ++.++|+|||||++|+|++|..||.... ..+....+... .
T Consensus 160 ~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~ 210 (262)
T cd05572 160 APEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG----------------------------N 210 (262)
T ss_pred ChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc----------------------------C
Confidence 999986544 8999999999999999999999998776 33333333210 0
Q ss_pred cccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccc
Q 044608 245 NLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRC 287 (417)
Q Consensus 245 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 287 (417)
....+....+.++.+||.+||+.||++|+| ++|+++||||++.
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 001122345789999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=324.85 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=210.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|++|.||+|.+..+++.|++|++.............+|+..+.+++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 57999999999999999999999999999999987664433344556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC-cc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY-TN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~-~~ 158 (417)
++++.+..+.... ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++ ++.++|+|||++......... ..
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9966555554443 558999999999999999999999 9999999999999996 578999999999876543332 25
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS---EADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
..++..|+|||.+... .++.++|+||||+++|+|++|..||.... ..+....+..
T Consensus 160 ~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------------- 217 (264)
T cd06623 160 FVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD--------------------- 217 (264)
T ss_pred eeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---------------------
Confidence 5789999999998655 58999999999999999999999997764 2222222210
Q ss_pred ccCCCCCcccccccCCC-CCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPS-ASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......... ++..+.++|.+||..+|++|||+.|+++||||+..
T Consensus 218 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 218 --------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred --------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 000112223 78899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.07 Aligned_cols=252 Identities=32% Similarity=0.584 Sum_probs=207.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|.+.+.||+|+||.||+|.++.+|..||+|.+...... .+.....+|+++++.++|+||+++++.+.+.+.+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 699999999999999999999999999999998754222 2233446899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC--cEEEeeccccccccCCCC-Cc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG--IIKIADFGLAREIKSGPP-YT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~--~vkL~DFg~a~~~~~~~~-~~ 157 (417)
+.++ +.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++++ .+||+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 9765 5555544443458999999999999999999999999999999999999753 479999999976654322 23
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 161 ~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------------- 217 (257)
T cd08225 161 TCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG---------------------- 217 (257)
T ss_pred ccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----------------------
Confidence 346899999999886554 889999999999999999999999877655544433210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
......+.++.++.++|.+||..||++|||+.|+++||||
T Consensus 218 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 218 -------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0112235678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.85 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=223.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhh--hHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL--NLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
.+|..+.+||+|+||+|.+|..+.|.+.||||+++++..-..... .+.|-++|... +-|.+++++.+|+..+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468899999999999999999999999999999987654322211 14678888777 468999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc-cCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~-~~~~~~ 156 (417)
|||+.|+.+.+-+++- +.|.|..+..|+..|+-||-|||++||++||||.+||+++ +|+|||+|||+++.- ..+...
T Consensus 429 MEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 9999988666655554 4589999999999999999999999999999999999996 699999999999743 345556
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.++||||.|+|||++.-.. |+.++|+||+||+||||+.|.+||.++++.+....|... +
T Consensus 508 kTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------------n- 566 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------------N- 566 (683)
T ss_pred eeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------------c-
Confidence 7899999999999986554 999999999999999999999999999999999888642 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCCCCCCC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYAPPHIRS 296 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~~~~~~ 296 (417)
..++.++|.++.++...+|.+.|.+|.. -.++-.||||....|...+.+.
T Consensus 567 ----------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~e 621 (683)
T KOG0696|consen 567 ----------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERRE 621 (683)
T ss_pred ----------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhcc
Confidence 2334578999999999999999999965 4788999999988776554443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.73 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=199.4
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHH---HHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLRE---VKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E---~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
.||+|+||.||+|.+..+++.||+|.+........ ......| +..++..+||||+++++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999875432211 1112233 344555689999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
|+.+....... ..+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..+.... ....+|+
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 77665555443 5689999999999999999999999999999999999996 5789999999987654332 2345799
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
..|+|||++.+...++.++||||+||++|+|++|..||.+....+..... . ......
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~---------------~~~~~~------- 215 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R---------------MTLTMA------- 215 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-H---------------HhhccC-------
Confidence 99999999875545899999999999999999999999776322111100 0 000000
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccCCC
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~~~ 292 (417)
..+....|.++.+||.+||..||.+|+ |+.++++||||....+...
T Consensus 216 ----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 216 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred ----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 112234689999999999999999999 9999999999988655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=344.83 Aligned_cols=251 Identities=29% Similarity=0.452 Sum_probs=197.6
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+ ..++..||+|+++............+|+.+++.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999964 3467789999997554444444567899999999 899999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhc------------------------------------------------------------
Q 044608 76 YLVFECMECN-LYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~------------------------------------------------------------ 94 (417)
|+||||+.++ |.+.+....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999865 544443221
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC---c
Q 044608 95 -------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY---T 157 (417)
Q Consensus 95 -------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~---~ 157 (417)
...+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......... .
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 124788899999999999999999999999999999999975 67999999999866443221 2
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|||||||++|||++ |..||..........++... .+
T Consensus 275 ~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-------------------~~ 334 (375)
T cd05104 275 NARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-------------------GY 334 (375)
T ss_pred CCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh-------------------Cc
Confidence 234566799999986554 8999999999999999997 89999876654443332210 00
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ......+.++.+||.+||+.||++|||+.|+++.
T Consensus 335 ~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 RM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred cC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.84 Aligned_cols=252 Identities=30% Similarity=0.398 Sum_probs=202.8
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||+|+||+||+|.+..+|+.||+|.+...... .......+|+++++.++||||+++++++...+.+|+||||++++.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998754321 1222335799999999999999999999999999999999987644
Q ss_pred H-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccccCCccc
Q 044608 88 Q-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWY 165 (417)
Q Consensus 88 ~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~gt~~y 165 (417)
. .+.......+++..+..++.||+.||.|||++|++|+||+|+||++++ +.+||+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 4 444434346899999999999999999999999999999999999965 78999999998866544444456788999
Q ss_pred cCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCccc
Q 044608 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRAN 245 (417)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (417)
+|||++.+.. ++.++|+|||||++|+|++|..||...........+... ... .
T Consensus 161 ~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~-------~ 213 (277)
T cd05577 161 MAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------------TLE-------M 213 (277)
T ss_pred CCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-------------------ccc-------c
Confidence 9999987655 899999999999999999999999776542221111100 000 0
Q ss_pred ccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 044608 246 LSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCF 288 (417)
Q Consensus 246 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 288 (417)
.....+.+++++.+||.+||+.||++|| |+.++++||||....
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 1122345689999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=325.90 Aligned_cols=257 Identities=29% Similarity=0.472 Sum_probs=204.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh---------hhhhHHHHHHHHhcCCCCeeeeceEEEeCC
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE---------DCLNLREVKCLRKLNHSNIVKLKELIQNNN 73 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 73 (417)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++....... .....+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68999999999999999999999999999998864221111 112347999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+++||||+.++.+.....+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999876555444443 4689999999999999999999999999999999999996 57899999999876543
Q ss_pred C---CCCccccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 153 G---PPYTNYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 153 ~---~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
. .......|+..|+|||++.... .++.++|+||||+++|+|++|..||......+....+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 228 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR------------ 228 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc------------
Confidence 2 1123456889999999986543 47899999999999999999999997655444333221100
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
....+ .....+.++.++.+||.+||..||++|||++++|+||||
T Consensus 229 -----~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 -----SAPPI-------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -----cCCcC-------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00000 112334578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=349.56 Aligned_cols=241 Identities=28% Similarity=0.484 Sum_probs=201.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+.|++...+|.|+|+.|..+.+..+++.+++|++.+.... ..+|+.++... +||||+++++++.++.+.|+|||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5789999999999999999999999999999999876222 23577666655 79999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
.+.|+.+...+... ..+. .++..|+++|+.|+.|||++|++||||||+|||++ .|+++|+|||.++..... +.+
T Consensus 397 ~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDT 472 (612)
T ss_pred hccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcc
Confidence 99887444333322 2233 78889999999999999999999999999999993 588999999999877655 444
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|-|..|.|||++.... |+.++||||||++||+||+|+.||...... +.+.+| +.+.
T Consensus 473 p~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~----------------- 530 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPK----------------- 530 (612)
T ss_pred cchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCc-----------------
Confidence 57789999999997544 999999999999999999999999887665 333332 1111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+...+|.+++|||++||+.||.+|+|+.+++.||||
T Consensus 531 -----------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 -----------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 114689999999999999999999999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=340.65 Aligned_cols=242 Identities=31% Similarity=0.508 Sum_probs=202.0
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
+.++++||+|.||+||.|.... ...||+|.++..... ....++|+++|++|+|+|||++++++..++.+|||||||.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 4678899999999999996543 237999999865333 3445689999999999999999999999889999999997
Q ss_pred C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcccc-
Q 044608 84 C-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYV- 160 (417)
Q Consensus 84 ~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~- 160 (417)
. +|++.+....+..+...+...++.||++|++||+++++|||||-..||||++ ..+||+|||+|+...++. ++...
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~ 363 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEG 363 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCC
Confidence 5 5777776656678999999999999999999999999999999999999975 679999999999544332 22222
Q ss_pred --CCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 161 --GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 161 --gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
-..-|.|||.+.... ++.++|||||||+|+||+| |+.||++.+..+.+..+.+ .|.
T Consensus 364 ~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~--------------------GyR 422 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER--------------------GYR 422 (468)
T ss_pred CCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc--------------------cCc
Confidence 244599999997766 8999999999999999997 7999999999998887743 222
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
.| .++.+++++.+++..|+..+|++|||.+.+.
T Consensus 423 lp---------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 423 LP---------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CC---------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 22 2356899999999999999999999998664
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=326.30 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=203.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 79 (417)
|+|++.+.||.|++|.||+|.+..+++.||+|.+.............+|++++++++||||++++++|.+ .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 6899999999999999999999999999999998765443334455789999999999999999998865 44789999
Q ss_pred eccCCCHHHHH-HH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 80 ECMECNLYQLM-AA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 80 E~~~~~l~~~~-~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
||++++.+..+ .. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99987644433 22 2234589999999999999999999999999999999999996 47899999999875543222
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhhCCCCccchHHHHHH
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE-----ADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||..... .+....+..
T Consensus 161 -~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 222 (287)
T cd06621 161 -GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---------------- 222 (287)
T ss_pred -ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----------------
Confidence 2456788999999986544 89999999999999999999999976632 111111100
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+.... ........++++.+||.+||..||.+|||+.|+++||||++.
T Consensus 223 -----~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 223 -----MPNPELKD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -----CCchhhcc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00000000 000001246789999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=327.42 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=201.9
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++. .+..||+|.+.............+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 589999999999999999997653 355899998875543333334568999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAARD--------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~--------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
+||||+.++ |.+.+.... ...++...+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 999999765 444443321 12346678899999999999999999999999999999996 47899999999
Q ss_pred cccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
++....... .....++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+....+....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~------- 237 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG------- 237 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence 876543221 12234567899999986554 8999999999999999998 78999887766655443210
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc------Ccccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ------HPFFKRC 287 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~------hp~f~~~ 287 (417)
.. .......++++.++|.+||+.||++|||+.++++ ||||...
T Consensus 238 --------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 --------------GY--------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred --------------CC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 00 0112245789999999999999999999999986 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=319.96 Aligned_cols=252 Identities=33% Similarity=0.578 Sum_probs=209.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||.|+||.||++.+..++..||+|++...... .......+|+++++.++|||++++++.+...+.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 699999999999999999999999999999999765432 2334456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CC
Q 044608 82 MECN-LYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PY 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~ 156 (417)
++++ +.+.+.... ...+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9875 444444332 366899999999999999999999999999999999999975 889999999998665443 23
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 218 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--------------------- 218 (258)
T ss_pred cceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC---------------------
Confidence 4457899999999886554 889999999999999999999999877655444333210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
....+...++.++.++|.+||..||++|||+.|+|+||||
T Consensus 219 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 219 --------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0112233578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=321.19 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=194.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
+.||+|+||.||+|.++.+|+.||+|.+.............+|+++++.++||||+++++++.+.+.+|+||||+.++.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999999999999999887554433344567899999999999999999999999999999999987655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc---cccCCc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT---NYVGSR 163 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~---~~~gt~ 163 (417)
..........+++..++.++.|++.||.|||++||+||||||+|||+++ +.+||+|||++.......... ...++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 5554444456899999999999999999999999999999999999974 789999999987654321111 112245
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
.|+|||.+.+.. ++.++|+|||||++|+|++ |..||......+....+... .+
T Consensus 161 ~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~----------------------~~--- 214 (252)
T cd05084 161 KWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----------------------VR--- 214 (252)
T ss_pred eecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC----------------------CC---
Confidence 699999986554 8999999999999999997 89999776655443332110 00
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......+.++.+||.+||+.||++|||+.++++
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 ----LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=323.19 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=199.4
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
......||+|+||.||+|++..++..||+|.+...... ......+|+.+++.++|+||+++++++..++.+++||||+.
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 33456899999999999999999999999988754322 23345689999999999999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCC-CCCcc
Q 044608 84 CNLYQLMAARDRKLF--SEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l--~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
++.+..........+ ++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++...... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 765555444332345 8889999999999999999999999999999999996 468999999998765432 22334
Q ss_pred ccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 159 YVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
..|++.|+|||++.+. ..++.++|+||||+++|+|++|.+||........ ...+. ..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--------------------~~- 227 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--------------------MF- 227 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--------------------hh-
Confidence 4689999999998543 3478999999999999999999999965432211 11100 00
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.....+...+++++.+||.+||+.+|++|||+.|++.||||
T Consensus 228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.39 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=204.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc----ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA----SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+|.+.++||+|+||.||++.+..++..+++|+++.... ..+.....+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 69999999999999999999988888787877654221 12223345789999999999999999999999999999
Q ss_pred EeccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCC-C
Q 044608 79 FECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSG-P 154 (417)
Q Consensus 79 ~E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~-~ 154 (417)
|||+.++.+..+.. .....+++..++.++.|++.||.|||++|++|+||||+||+++++.+||+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 99998765554432 2235689999999999999999999999999999999999999999999999998765433 2
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.........+..
T Consensus 161 ~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-------------------- 219 (260)
T cd08222 161 LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-------------------- 219 (260)
T ss_pred cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--------------------
Confidence 233456899999999885444 78899999999999999999999987665544443321
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
... ......++.++.++|.+||..||++|||+.|+++||||
T Consensus 220 -~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 -GPT--------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -CCC--------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001 11224568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.09 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=208.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||++.+..+++.||+|.+...... ......+|+.+++.++||||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 5899999999999999999999999999999998643322 233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
+.++.+..+... ..+++.++..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... .....
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 987765555543 34789999999999999999999999999999999999964 789999999887554332 23345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.|++.|+|||.+.... ++.++|+|||||++|+|++|..||...+..+....+.. .+ .+
T Consensus 176 ~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~--------------------~~ 233 (293)
T cd06647 176 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--------------------TP 233 (293)
T ss_pred cCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CC--------------------CC
Confidence 7899999999986554 78999999999999999999999987765443322110 00 00
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
. ......++.++.+||.+||..||++|||+++++.|+||+.+.
T Consensus 234 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 234 E------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred C------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0 011234678899999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=320.31 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=205.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|.+.+.||+|+||.||+|.+..+++.||+|.++..... .......+|+++++.++|+||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999999765443 2334456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-----
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP----- 155 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~----- 155 (417)
+.++.+..+.... ..+++..++.++.|++.||.|||++||+|+||+|+||++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9877666655443 45899999999999999999999999999999999999965 7899999999987654322
Q ss_pred CccccCCccccCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 YTNYVGSRWYRAPEILLQSE--LYSSKADMWAMGAIMAELFTFCPLFPGASE-ADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....++..|+|||++.+.. .++.++|||||||++|+|++|..||..... ......+.. +.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~-------------- 223 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GH-------------- 223 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CC--------------
Confidence 12356889999999985432 378899999999999999999999976532 222222210 00
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...+| ....++.++.+||.+||+.||.+|||+.|++.|||+
T Consensus 224 --~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 224 --KPPIP---------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --CCCCC---------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00011 112358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=325.25 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=200.9
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.............+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 478999999999999999999887 788999998875544444445678999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAARDR-----KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~-----~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~ 146 (417)
+||||+.++ +.+.+..... ..+++..+..++.||+.||.|||++|++||||||+|||+++ + .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 999999765 4444433221 25899999999999999999999999999999999999964 2 599999999
Q ss_pred cccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
+........ ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+... +
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~----- 238 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-G----- 238 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C-----
Confidence 986633221 11223456799999986655 8999999999999999996 99999887766554433210 0
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ......++.++.++|.+||+.||++|||+.++++|
T Consensus 239 ------------~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 ------------R-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ------------c-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 01124568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=325.90 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=201.5
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|.+.+.||+|+||.||+|.+.. +++.||+|.++............+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 579999999999999999998753 467899999876544433445568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEe
Q 044608 77 LVFECMECNLYQLMAARD-------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIA 142 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~-------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~ 142 (417)
+||||+.++.+....... ...+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 999999876554444322 13478899999999999999999999999999999999996 5889999
Q ss_pred eccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCC
Q 044608 143 DFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 143 DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--- 240 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--- 240 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---
Confidence 9999976533221 22345678899999986655 8999999999999999998 99999887766655444210
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........++.++.+||.+||+.||++|||+.|+++
T Consensus 241 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 --------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=325.52 Aligned_cols=254 Identities=27% Similarity=0.495 Sum_probs=207.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
+|...+.||+|++|.||++.+..+++.+++|++...... ......+|+.+++.++||||+++++++...+..|+++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 466678999999999999999999999999998643322 2334568999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCcccc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNYV 160 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~~ 160 (417)
.++.+..+... ..+++..+..++.||+.||.|||++||+||||+|+||+++ ++.++|+|||++....... ......
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 87655555544 3489999999999999999999999999999999999997 4789999999887554322 223457
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+... ..+.
T Consensus 177 ~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---------------------~~~~ 234 (285)
T cd06648 177 GTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---------------------LPPK 234 (285)
T ss_pred CCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------------CCCC
Confidence 899999999986554 899999999999999999999999877665554443211 0000
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......++.++.+||.+||+.||++|||+.++++||||.++
T Consensus 235 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 235 ------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred ------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 01123467899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=328.22 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=206.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++.+.||+|+||.||+|.+..+++.||+|.++............+|+.++.++ +||||+++++++.+...+|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 478999999999999999999999999999999997654433344455677767666 5999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.+.+...+.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++ ++.+||+|||++..+.......
T Consensus 94 e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~ 172 (296)
T cd06618 94 ELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172 (296)
T ss_pred eccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence 999876666554433 468999999999999999999997 5999999999999996 4789999999998765544444
Q ss_pred cccCCccccCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 158 NYVGSRWYRAPEILLQS---ELYSSKADMWAMGAIMAELFTFCPLFPGASE-ADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...++..|+|||.+.+. ..++.++|||||||++|+|++|..||..... .+.+..+...
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------ 234 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE------------------ 234 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC------------------
Confidence 55688899999998543 2378899999999999999999999976432 2222222110
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+.. .....++.++.+||.+||..||.+|||++++++|+||..
T Consensus 235 ---~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 235 ---EPPSL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ---CCCCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 00000 001146789999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=322.93 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=194.4
Q ss_pred CCceeccee--cccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKEL--GRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~L--G~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +||||++++++|...+.+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 467787776 99999999999999999999999987543221 133333323 799999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-cEEEeeccccccccCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-IIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.++.+..+.... ..+++.+++.++.||+.||.|||+.|++||||||+||+++. + .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 9999765444444333 36899999999999999999999999999999999999965 4 7999999998765433
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......+........ . .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~-~- 223 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK-----------------R-Q- 223 (267)
T ss_pred ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH-----------------h-h-
Confidence 2346899999999986555 899999999999999999999999865433211110000 0 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-HHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-AAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~elL~hp~f~~ 286 (417)
. ......+..++.+.+||.+||+.||.+|++ ++|+|+||||++
T Consensus 224 ~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 224 Q-------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred c-------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0 001122367999999999999999999996 599999999963
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.42 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=208.3
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|...++||+|+||.||+|.+..+|+.|++|.+....... ......+|+++++.++|||++++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 4667788999999999999999999999999986543221 12234679999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.+++++.+.... ..+++.++..++.||+.||.|||++|++|+||+|+||+++ ++.+||+|||++.... .....
T Consensus 102 ~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~ 177 (313)
T cd06633 102 YCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF 177 (313)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence 99988877765443 5689999999999999999999999999999999999996 4789999999986432 23456
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|+..|+|||++.. ...++.++|+|||||++|+|++|.+||...+.......+... .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---------------------~ 236 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------------D 236 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------------C
Confidence 78999999999742 344788999999999999999999999887765555544210 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+. ...+.++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 237 ~~~-------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 237 SPT-------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CCC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 111 1123467789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=324.91 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=200.4
Q ss_pred CCCceecceecccCceEEEEEEE----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFD----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
+++|++.+.||+|+||.||+|.+ ..++..||+|.+.............+|+.+++.++||||+++++++...+..|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46899999999999999999985 34567899999975443333344568999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcE
Q 044608 77 LVFECMECN-LYQLMAARD---------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GII 139 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~---------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~v 139 (417)
+||||+.++ +.+.+..+. ...+++..+..++.||+.||.|||++|++||||||+|||+++ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 999999865 444443221 124788999999999999999999999999999999999975 679
Q ss_pred EEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 044608 140 KIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 140 kL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 215 (417)
||+|||+++...... ......++..|+|||++.+.. ++.++|+|||||++|||++ |.+||.+.+..+....+...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998654322 123345677899999986554 8999999999999999998 99999887765554443210
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........+++++.++|.+||+.||++||++.+++++
T Consensus 243 -----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 243 -----------------------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -----------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0011223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=325.26 Aligned_cols=240 Identities=20% Similarity=0.236 Sum_probs=194.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEe----CCEEEEEEec
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQN----NNRLYLVFEC 81 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 81 (417)
..||+|++|.||+|.. +|+.||+|.++....... .....+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999975 789999999976433221 1234589999999999999999999876 4578999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.++.+..+.... ..+++.....++.|++.||.|||+. +++||||||+|||++ ++.+||+|||++....... ...
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN 180 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence 9987555555443 4589999999999999999999984 999999999999997 5789999999988654322 245
Q ss_pred cCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
+||..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+..... .
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-------------------~- 240 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN-------------------S- 240 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-------------------C-
Confidence 789999999998652 3489999999999999999999999998877666555432110 0
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......++++.+||.+||+.||++|||++|+++
T Consensus 241 --------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 --------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0112256889999999999999999999999985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=330.59 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=197.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcE--EEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~--vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++.+.||+|+||.||+|.++.++.. +|+|.+.............+|++++.++ +||||+++++++.+.+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999999888764 5777766433333334456899999999 89999999999999999999
Q ss_pred EEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEE
Q 044608 78 VFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKI 141 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL 141 (417)
||||+.++ +.+.+.... ...+++..++.++.||+.||+|||++|++||||||+|||++ ++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 99999765 555544321 13578999999999999999999999999999999999996 578999
Q ss_pred eeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCC
Q 044608 142 ADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPT 220 (417)
Q Consensus 142 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~ 220 (417)
+|||++.............++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------ 238 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 238 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc------
Confidence 9999986433222222223466799999885544 8999999999999999998 9999987766554433210
Q ss_pred ccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 221 MDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+. .......+.++.+||.+||+.||++|||++++|++
T Consensus 239 --------------~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 --------------GYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --------------CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00112467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.92 Aligned_cols=252 Identities=29% Similarity=0.505 Sum_probs=208.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
+|++.+.||+|++|.||++.+..+++.+++|++..... .......+|+++++.++||||+++++++...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58999999999999999999999999999999976543 23344568999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccC
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVG 161 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~g 161 (417)
+++.+..+.......+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||.+.............+
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 96655555544435689999999999999999999999999999999999997 47899999999987665443455678
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.. ...+..
T Consensus 160 ~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~~~~ 217 (253)
T cd05122 160 TPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------------NGPPGL 217 (253)
T ss_pred CCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---------------------cCCCCc
Confidence 99999999986554 78999999999999999999999987754444333211 000000
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.....++.++.++|.+||+.||++|||+.|+|+|||
T Consensus 218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 001124789999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=324.16 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=198.0
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++. ++..||+|.+.............+|+.+++.++||||+++++++.+++..+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 589999999999999999998642 457899999865433233334568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 77 LVFECMECNLYQLMAARDR---------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~---------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
+||||+.++.+..+..... ..++...+..++.|++.||.|||++|++|+||||+|||++ ++.++|+|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 9999998765544443321 2356788999999999999999999999999999999997 57899999999
Q ss_pred cccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
+........ .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~------- 237 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG------- 237 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 875543221 12235578899999986544 8999999999999999998 78999887766555443210
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. .......+.++.+||.+||+.||++|||+.|++++
T Consensus 238 --------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 --------------GL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --------------Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 11123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=336.30 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=195.4
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEe-CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQN-NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (417)
++|++.+.||+|+||.||+|.+. .+++.||+|+++............+|+.++.++ +||||+++++++.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 58999999999999999999743 345889999987544333333456899999999 89999999998764 467
Q ss_pred EEEEEeccCCCHHH-HHHHhc-----------------------------------------------------------
Q 044608 75 LYLVFECMECNLYQ-LMAARD----------------------------------------------------------- 94 (417)
Q Consensus 75 ~~lv~E~~~~~l~~-~~~~~~----------------------------------------------------------- 94 (417)
++++|||+.++.+. .+....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999876444 443211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC---CCccccCCccccCchh
Q 044608 95 RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---PYTNYVGSRWYRAPEI 170 (417)
Q Consensus 95 ~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~ 170 (417)
...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.... ......++..|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 12578899999999999999999999999999999999997 5789999999998654322 1223456778999999
Q ss_pred hhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCccccccc
Q 044608 171 LLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSAL 249 (417)
Q Consensus 171 l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (417)
+.+.. ++.++|||||||++|||++ |..||.+....+.+...... ... ...
T Consensus 247 ~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------------~~~--------~~~ 297 (337)
T cd05054 247 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE--------------------GTR--------MRA 297 (337)
T ss_pred hcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc--------------------cCC--------CCC
Confidence 87655 8999999999999999998 99999875543333222110 000 011
Q ss_pred CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 250 MPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 250 ~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
....++++.+++.+||+.+|++|||+.|+++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=326.58 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.++||+|+||.||+|.+..+ +..||+|+++............+|+.++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 5789999999999999999987543 57899999975543322334567999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEE
Q 044608 77 LVFECMECNLYQLMAAR---------------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIK 140 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~---------------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vk 140 (417)
+++||+.++.+..+... ....+++..+..++.|++.||.|||++||+||||||+|||+++ +.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999886644443321 1234788899999999999999999999999999999999964 6899
Q ss_pred EeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 044608 141 IADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVL 216 (417)
Q Consensus 141 L~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 216 (417)
|+|||+++....... .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~- 242 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR- 242 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999876543221 23345678999999986655 8999999999999999998 88999888776665554321
Q ss_pred CCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 217 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++.++.+|+.+||+.||.+|||++++++.
T Consensus 243 ----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 243 ----------------------------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0011234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=319.86 Aligned_cols=251 Identities=30% Similarity=0.445 Sum_probs=199.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHH-HHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKC-LRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
++.||+|+||.||+|.+..+|+.||+|++.+...... ......|..+ ...++||||+++++++...+.+|+||||+.
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 3679999999999999999999999999875422111 1122344444 445589999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccccCC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
++.+..+.... ..+++..+..++.||+.||.|||++|++|+||+|+||++++ +.+||+|||++..... .....|+
T Consensus 81 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 81 GGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCC
Confidence 77665555443 45899999999999999999999999999999999999964 7899999999875433 2345688
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+... ...++
T Consensus 157 ~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~--- 213 (260)
T cd05611 157 PDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-------------------RINWP--- 213 (260)
T ss_pred cCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------ccCCC---
Confidence 9999999987655 899999999999999999999999887766555443211 00011
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCC---HHHHHcCccccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPT---AAEALQHPFFKRCF 288 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~ 288 (417)
......++.++.++|.+||+.||++||| ++|+|.||||.+..
T Consensus 214 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 214 ----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 1122357899999999999999999995 58999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=326.80 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=197.6
Q ss_pred CCceecceecccCceEEEEEEECCCCc--EEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|..+.++. .+++|.++............+|++++.++ +||||+++++++.+.+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 789999999999999999999887775 47888877433333334456899999999 799999999999999999999
Q ss_pred EeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEe
Q 044608 79 FECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIA 142 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~ 142 (417)
|||+.++ +.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 9998765 555554321 12478999999999999999999999999999999999996 4789999
Q ss_pred eccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 143 DFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 143 DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
|||++..............+..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~------ 234 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 234 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC------
Confidence 999986433221222223355799999986544 8999999999999999997 99999887766655443210
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+. ......++.++.+||.+||..||.+|||++++++.
T Consensus 235 --------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 --------------YR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------CC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123578899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.25 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=202.4
Q ss_pred CCceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||+||+|.++.+ ...||+|.++............+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999988654 4589999987655444444556899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-CC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-PY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-~~ 156 (417)
|||+.++.+..+.......+++..+..++.|++.||.|||++||+|+||||+|||+++ +.++|+|||++....... ..
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999876555554444456899999999999999999999999999999999999975 789999999998765211 11
Q ss_pred --ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 157 --TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 157 --~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||......+....+...
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------------ 224 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG------------------ 224 (266)
T ss_pred eccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC------------------
Confidence 1223467899999986544 8999999999999999997 99999877666555444210
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+..+ .....+.++.+|+.+||+.||++|||++|++++
T Consensus 225 --~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 --YRLP---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred --CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0001 113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=308.49 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=197.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-----CCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN-----NNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~ 76 (417)
+||.+.+.||+|+|+-||++.+..+++.||+|++.... ..+....++|++..++++||||++++++... ....|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 58999999999999999999999999999999998765 2334555799999999999999999987533 34589
Q ss_pred EEEeccC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 77 LVFECME-CNLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 77 lv~E~~~-~~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
|+++|.. |++++.+... .+..++|.++..|+.+|++||++||+.. ++||||||.|||+++ +.++|.|||+++..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999764 6687776543 3447999999999999999999999999 999999999999976 89999999999754
Q ss_pred cCCCC----------CccccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Q 044608 151 KSGPP----------YTNYVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 151 ~~~~~----------~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
.-... ...-..|..|+|||.+. .....+.++|||||||+||.|+.|..||... ...-|+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgS 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGGS 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCCe
Confidence 31111 11224588899999873 2334789999999999999999999999432 110011
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
-.... ....+.+|.. ..+|+.+.+||+.||+.||.+|||+.+++.+
T Consensus 251 laLAv--------~n~q~s~P~~---------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAV--------QNAQISIPNS---------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEee--------eccccccCCC---------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000 0112333332 2389999999999999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.63 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=200.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-C-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-S-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|+++.+++.||||.+..... . .......+|+++++.++||||+++++++.+.+.+++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 5799999999999999999999999999999998864322 2 2223346899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 79 FECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 79 ~E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|||++++.+..+.. .....+++..+..++.||+.||.|||++|++|+||||+|||++ ++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99998764443332 1234589999999999999999999999999999999999996 4789999999988665432
Q ss_pred C-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 P-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE--ADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
. .....|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... .+....+ ...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~--------------- 223 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQC--------------- 223 (267)
T ss_pred HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcC---------------
Confidence 1 23457899999999986655 78999999999999999999999865432 1222111 100
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.++.. .....+.++.+||.+||..||++|||+.++++.
T Consensus 224 -----~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 224 -----DYPPL-------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----CCCCC-------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 01110 112457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.29 Aligned_cols=246 Identities=30% Similarity=0.376 Sum_probs=198.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||++..+. +..+|+|.+...... .....+|+.++++++||||+++++++.+.+.+++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 579999999999999999998654 567999988654332 23456799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC--cc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY--TN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~--~~ 158 (417)
+.++.+..........+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||+++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9866444444333345899999999999999999999999999999999999964 78999999998765432221 12
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||++.+.. ++.++|+|||||++|+|++ |..||...+..+....+....
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~--------------------- 218 (256)
T cd05114 161 AKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF--------------------- 218 (256)
T ss_pred CCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---------------------
Confidence 23456799999986544 8999999999999999999 899998887776666553210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+ ......+.++.+||.+||..||++|||++++++
T Consensus 219 ~~--------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 RL--------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CC--------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 011235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.54 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=196.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcE----EEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEA----VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
.+|++.+.||+|+||.||+|.+..+++. ||+|+++............+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5799999999999999999998776664 8999987544333344556899999999999999999998765 4678
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~ 155 (417)
++||+.++ +.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++..+.....
T Consensus 86 v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 86 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 99988765 5554443 3355899999999999999999999999999999999999965 7899999999987654332
Q ss_pred C---ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 Y---TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
. ....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.. .++..
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~---------------- 226 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEK---------------- 226 (316)
T ss_pred ceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhC----------------
Confidence 2 2223467899999986554 8999999999999999997 99999877654432 22210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... ...+..+.++.++|.+||..||++|||+.+++.+
T Consensus 227 ---~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ---GERL---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---CCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001 1123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=363.32 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=201.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC---------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--------- 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------- 72 (417)
++|+.++.||+|+||.||+|+++-+|..||||+|...........+++|++.|.+|+|||||++|..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 57899999999999999999999999999999998776444445567999999999999999886543100
Q ss_pred --------------------------------------------------------------------------------
Q 044608 73 -------------------------------------------------------------------------------- 72 (417)
Q Consensus 73 -------------------------------------------------------------------------------- 72 (417)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 044608 73 ------------------------------NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122 (417)
Q Consensus 73 ------------------------------~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi 122 (417)
..+||-||||+..++..+..++...-.....|.++++|++||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 01799999999999999887764221478999999999999999999999
Q ss_pred ccccCCCCCeeee-CCcEEEeecccccccc-------------------CCCCCccccCCccccCchhhhccC--CCCch
Q 044608 123 FHRDLKPENLLVS-QGIIKIADFGLAREIK-------------------SGPPYTNYVGSRWYRAPEILLQSE--LYSSK 180 (417)
Q Consensus 123 ~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~ 180 (417)
+||||||.||+++ ++.|||+|||+|+... +....+..+||..|+|||++.+.. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 9999999999997 4789999999998621 112456789999999999986555 59999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHH
Q 044608 181 ADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISL 260 (417)
Q Consensus 181 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 260 (417)
+||||||+||+||+. ||....+.... +. ..+ ...+|.. ..++..--+.-..+
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~i--L~----------------~LR--~g~iP~~-----~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASI--LT----------------NLR--KGSIPEP-----ADFFDPEHPEEASL 850 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHH--HH----------------hcc--cCCCCCC-----cccccccchHHHHH
Confidence 999999999999986 57654432211 11 111 1111111 22333344567899
Q ss_pred HHHhcccCCCCCCCHHHHHcCcccc
Q 044608 261 FESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 261 i~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
|+.||+.||.+||||.|+|++.||.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhccCCC
Confidence 9999999999999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=329.27 Aligned_cols=279 Identities=22% Similarity=0.274 Sum_probs=198.6
Q ss_pred eeccc--CceEEEEEEECCCCcEEEEEEecccc-cChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 9 ELGRG--AFGRVFQAFDEHTGEAVAIKELKQRY-ASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 9 ~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+||+| ++|.||.+++..+++.||+|++.... .........+|+++++.++||||+++++++.+.+..|++|||+.++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34444 44566666768899999999997653 2233344568999999999999999999999999999999999876
Q ss_pred HHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--------
Q 044608 86 LYQLMAA-RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-------- 155 (417)
Q Consensus 86 l~~~~~~-~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-------- 155 (417)
.+..+.. .....+++..++.++.||+.||.|||++||+||||||+||++++ +.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 5554443 33456899999999999999999999999999999999999974 8999999998865432211
Q ss_pred CccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCcc--chHHHHHHHh
Q 044608 156 YTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD--SWADGLRQAR 232 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~--~~~~~~~~~~ 232 (417)
.....++..|+|||++... ..++.++|+||+||++|+|++|..||...................... .+........
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 2334578889999998653 347899999999999999999999998776544332221110000000 0000000000
Q ss_pred hh--hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AI--KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ....+.............++.++.+||.+||..||++|||++++|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00 00000000111112223456789999999999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.99 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=200.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|.+.+.||+|+||.||+|.++.+++.||+|.+..... ......+|+++++.++||||+++++++...+.++++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 368899999999999999999999999999999875422 233456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC--c
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY--T 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~--~ 157 (417)
+.++ +.+.+.......+++..++.++.|++.||.|||++|++||||||+|||++ ++.+||+|||++......... .
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9765 55555444445689999999999999999999999999999999999996 478999999999876543221 1
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+... +
T Consensus 164 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--------------------~ 222 (263)
T cd05052 164 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG--------------------Y 222 (263)
T ss_pred CCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------------------C
Confidence 223456799999886554 8999999999999999998 99999887765554443210 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......++.++.+||.+||+.||++|||+.++++
T Consensus 223 ~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 R---------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred C---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 0122457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.02 Aligned_cols=251 Identities=30% Similarity=0.515 Sum_probs=207.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.++||+|+||.||++.++.+++.||+|.+...... .......+|+++++.++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 699999999999999999999999999999998754322 2233446899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 82 MECNLYQLMAAR---DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~~---~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
+.+..+.....+ ....+++..++.++.|++.||.|||++|++|+||+|+||++++ +.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 977644443322 1245899999999999999999999999999999999999975 78999999999876554 333
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.. ..
T Consensus 160 ~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~ 217 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------------------GK 217 (256)
T ss_pred cccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------CC
Confidence 457899999999986544 78999999999999999999999988776554433321 01
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+ .......+.++.++|.+||..||++|||+.|+++||++
T Consensus 218 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 Y--------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred C--------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 1 11223568899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=313.47 Aligned_cols=251 Identities=30% Similarity=0.544 Sum_probs=209.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|++.+.||+|++|.||++.+..+++.||+|.+...... .......+|++++++++|||++++++++.+.+.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 699999999999999999999999999999999765432 2233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-Cccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-~~~~ 159 (417)
++++.+..+.... ..+++..++.++.|++.||.|||++||+|+||||+||++++ +.++|+|||++........ ....
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9876555555444 45899999999999999999999999999999999999975 7899999999987654432 2345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.. ...
T Consensus 160 ~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------~~~- 216 (254)
T cd06627 160 VGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---------------------DDH- 216 (254)
T ss_pred ccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------------cCC-
Confidence 7899999999986554 88999999999999999999999987665444333210 001
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
......++.++.++|.+||..||++|||+.+++.||||
T Consensus 217 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 -------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 12234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.43 Aligned_cols=254 Identities=27% Similarity=0.480 Sum_probs=207.5
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
|+...+||+|+||.||++.++.+|+.||+|.+.... ........+|+.+++.++||||+++++++...+..|+||||+.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 344568999999999999999999999999886432 2233445689999999999999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccccC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNYVG 161 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~~g 161 (417)
++.+..+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ......|
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 8766666543 3489999999999999999999999999999999999997 4789999999987554322 2334578
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+....+....+... .+.
T Consensus 179 ~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~----------------------~~~- 234 (292)
T cd06657 179 TPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------------------LPP- 234 (292)
T ss_pred CccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh----------------------CCc-
Confidence 99999999886544 789999999999999999999999887665544333210 000
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+ .....++.++.++|.+||..||.+|||+.++|+||||....
T Consensus 235 ---~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 ---KL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ---cc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00 11235688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=325.81 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=208.3
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|...+.||+|+||.||+|.+..+|..||+|.+....... ......+|+++++.++|||++++++++.+.+..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4788899999999999999999999999999987542221 22345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.|++.+.+... ...+++.++..++.||+.||.|||++||+||||+|+||+++ ++.+||+|||++..... ....
T Consensus 106 ~~~g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~ 181 (317)
T cd06635 106 YCLGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSF 181 (317)
T ss_pred CCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccc
Confidence 9998877766543 35589999999999999999999999999999999999996 47899999999875433 2345
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|++.|+|||++.. ...++.++|+|||||++|+|++|.+||...........+....
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--------------------- 240 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------------------- 240 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc---------------------
Confidence 78999999999742 3447899999999999999999999998776655554443110
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+. .....++..+.+||.+||+.||.+|||+.++++|+|+...
T Consensus 241 ~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 241 SPT-------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CCC-------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 000 0112467889999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.86 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=203.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc----ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA----SWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 75 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ........+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998753221 12223445799999999999999999998764 568
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~- 153 (417)
+++|||+.++.+....... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999876554444333 3489999999999999999999999999999999999996 478999999999765421
Q ss_pred ---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 ---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.......|+..|+|||++.+.. ++.++|+|||||++|+|++|.+||...........+.. .+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~----------- 225 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QP----------- 225 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CC-----------
Confidence 1223457899999999986654 78999999999999999999999987655544433321 00
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
....+.+.+++++.++|.+||. +|.+|||+.+++.|||.
T Consensus 226 --------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 --------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0112345688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.70 Aligned_cols=249 Identities=32% Similarity=0.484 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
||.|+||.||+|.+..+|+.|++|++...... .......+|++++++++||||+++++.+..+..+|++|||+.++.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 69999999999999999999999998755332 1223446799999999999999999999999999999999987655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC---------CCc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP---------PYT 157 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~---------~~~ 157 (417)
..+..+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 5555443 3589999999999999999999999999999999999996 4789999999987543321 223
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...++..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+.. ....
T Consensus 160 ~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~~~ 219 (265)
T cd05579 160 RIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-------------------GKIE 219 (265)
T ss_pred CcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------CCcC
Confidence 456889999999986655 88999999999999999999999988776665544421 0111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH---HHHHcCccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA---AEALQHPFFKRCF 288 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta---~elL~hp~f~~~~ 288 (417)
++. ...++.++.+||.+||+.||.+|||+ .++|+||||++..
T Consensus 220 ~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 220 WPE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred CCc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 111 01248899999999999999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=322.46 Aligned_cols=250 Identities=33% Similarity=0.523 Sum_probs=207.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 78 (417)
++|.+.+.||+|+||.||+|.+..+|+.||+|++...... .......+|+++++++. ||||+++++++.+.+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5899999999999999999999999999999998764322 22334468999999998 99999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-- 154 (417)
|||+.++ +.+.+. .. ..+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~-~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIR-KY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHH-Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999655 555444 33 3589999999999999999999999999999999999996 4889999999987654322
Q ss_pred -------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 044608 155 -------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 155 -------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 215 (417)
......|+..|+|||++.... ++.++|+|||||++++|++|..||...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~- 236 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK- 236 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-
Confidence 123346789999999986544 88999999999999999999999988775544443321
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCccc
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFF 284 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f 284 (417)
..+ .+...+++++.+||.+||+.||++|||+ +++|+||||
T Consensus 237 ------------------~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 ------------------LEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ------------------cCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 111 1224568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.54 Aligned_cols=252 Identities=30% Similarity=0.479 Sum_probs=206.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|...+.||+|+||.||+|+++.+++.||+|.+..... ........+|+++++.++|+|++++++++.+.+..|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 57888999999999999999999999999999864321 1222344589999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.|++.+.+.... ..+++..+..++.|++.||.|||++|++||||||+|||+++ +.+||+|||++...... ...
T Consensus 96 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 171 (308)
T cd06634 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXF 171 (308)
T ss_pred ccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccc
Confidence 99888776665433 55899999999999999999999999999999999999964 78999999998765432 345
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.|++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------------------~ 230 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------------E 230 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc---------------------C
Confidence 78999999999752 234788999999999999999999999776655444333210 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+. .....++..+.+||.+||..+|++|||++++++|||+..
T Consensus 231 ~~~-------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 SPA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCC-------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 010 112356788999999999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.03 Aligned_cols=278 Identities=23% Similarity=0.309 Sum_probs=200.6
Q ss_pred cceeccc--CceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 7 FKELGRG--AFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 7 ~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
..+||+| +||+||+|.+..+|+.||+|++......... ....+|+.+++.++||||++++++|..++.+|+||||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 4567777 9999999999999999999998754433322 344579999999999999999999999999999999998
Q ss_pred CC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-C-----
Q 044608 84 CN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-P----- 155 (417)
Q Consensus 84 ~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~----- 155 (417)
++ +.+.+.......+++..+..++.||+.||+|||++||+||||||+|||++ ++.++++||+.+....... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 65 55444443334589999999999999999999999999999999999996 5789999998654322110 0
Q ss_pred --CccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH-----H
Q 044608 156 --YTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD-----G 227 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~-----~ 227 (417)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||...........+... +....|.. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 239 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG---PPYSPLDITTFPCE 239 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC---CCCCCccccccchh
Confidence 0112346679999998654 34789999999999999999999999887665544433221 11111100 0
Q ss_pred HHHHhhhhccCC--------------CCCcccc-cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 228 LRQARAIKYQFP--------------QLPRANL-SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 228 ~~~~~~~~~~~~--------------~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..........+. ......+ ......++.++.+||++||+.||++|||++|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 000000000000 0000000 01123467889999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.45 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=200.2
Q ss_pred CCceecceecccCceEEEEEEECCCC-----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++..+ ..||+|.+.............+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 68999999999999999999876544 7899999875543333444568999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAARD--------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~--------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
+||||+.++ |.+.+.... ...+++..+..++.||+.||.|||++|++||||||+|||++ ++.+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 999999755 554443321 12367889999999999999999999999999999999996 58899999999
Q ss_pred cccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
++.+.... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~------- 237 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG------- 237 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-------
Confidence 87654332 123345678899999986554 8999999999999999998 99999887766655443210
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ........+.++.+||.+||+.||++|||+.++++
T Consensus 238 --------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 --------------G--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --------------C--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 01112345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.71 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=200.1
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||++.++.. ...+|+|.+.............+|+++++++ +||||+++++++...+.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 5799999999999999999987644 3789999987654444344456899999999 899999999999999999
Q ss_pred EEEEeccCCCHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcE
Q 044608 76 YLVFECMECNLYQLMAAR---------------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGII 139 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~---------------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~v 139 (417)
+++|||+.++.+..+... ....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 999999876544444322 234689999999999999999999999999999999999996 4789
Q ss_pred EEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 044608 140 KIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 140 kL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 215 (417)
||+|||++..+..... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986654321 12233467799999885544 8999999999999999997 99999887766554443210
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. . .......+.++.+||.+||..||++|||+.|++++
T Consensus 251 --------------------~-~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 251 --------------------Y-R--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred --------------------C-c--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 0 0 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.43 Aligned_cols=147 Identities=30% Similarity=0.455 Sum_probs=127.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++|.++++||+|+||.||+|.+..+++.||||+++...... ......+|+.++..++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999997543221 123445799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
|||+.|+.+..+.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999765444444333 4589999999999999999999999999999999999996 4899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=312.80 Aligned_cols=252 Identities=33% Similarity=0.540 Sum_probs=207.9
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 79 (417)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... .......+|++++++++||||+++++.+.+. +.+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 589999999999999999999999999999998765432 2233446899999999999999999999988 8999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC---
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--- 155 (417)
||+.++.+..+.... ..+++..++.++.|++.||.|||++|++|+||+|+||++++ +.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999766555555444 26899999999999999999999999999999999999975 8899999999987765543
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE-ADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 217 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG--------------------- 217 (260)
T ss_pred ccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc---------------------
Confidence 44567899999999986555 89999999999999999999999987662 11111110
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
. ......+....+.++.+||.+||..||++|||+.|+++||||
T Consensus 218 -~------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 -S------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -c------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0 011112334558999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=319.92 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=196.5
Q ss_pred CCceecceecccCceEEEEEEECCCCc----EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||.||+|.+..+|+ .||+|++.............+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 579999999999999999999877776 48999987654444445556899999999999999999998754 4778
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~ 155 (417)
+|||+.++ +.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++.......
T Consensus 86 ~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 86 VTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99998765 5555443 3356899999999999999999999999999999999999964 7899999999986643322
Q ss_pred C---ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 Y---TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ~---~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
. ....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||......+....+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----------------- 226 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK----------------- 226 (279)
T ss_pred eeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----------------
Confidence 1 1223467899999986554 8999999999999999998 8999977665444332211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... ....+..+.++.++|.+||..||++|||+.+++.
T Consensus 227 ----~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 ----GER--------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----CCc--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0112356889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=356.14 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=198.6
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++|+++++||+|+||.||+|.+..+|+.||+|++....... ......+|++++++++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999999997643322 223456899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccc
Q 044608 79 FECMECNLYQLMAARD----------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLA 147 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~----------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a 147 (417)
|||++|+.+..+..+. ...++...+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999876554443321 12345677889999999999999999999999999999996 488999999999
Q ss_pred ccccCC-------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 044608 148 REIKSG-------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ 208 (417)
Q Consensus 148 ~~~~~~-------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 208 (417)
...... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||......+.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765211 0112357999999999986655 89999999999999999999999977544332
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
..... ...+. .. .....+++.+.+++.+||..||++|++..+.|.+
T Consensus 240 ~~~~~----------------------i~~P~----~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDV----------------------ILSPI----EV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh----------------------ccChh----hc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21100 00000 00 0113567899999999999999999887666644
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.56 Aligned_cols=256 Identities=25% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCceecceecccCceEEEEEEECCCC----------------cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeee
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG----------------EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g----------------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 65 (417)
++|+++++||+|+||.||+|.+..++ ..||+|.+.............+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 58999999999999999999876644 56899998865444334455689999999999999999
Q ss_pred ceEEEeCCEEEEEEeccCCCHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee
Q 044608 66 KELIQNNNRLYLVFECMECNLYQLMAARDR----------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS 135 (417)
Q Consensus 66 ~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~----------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~ 135 (417)
++++.+++.++++|||+.++.+..+..... ..+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 999999999999999997654444433321 2589999999999999999999999999999999999996
Q ss_pred C-CcEEEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q 044608 136 Q-GIIKIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT--FCPLFPGASEADQM 209 (417)
Q Consensus 136 ~-~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~ 209 (417)
+ +.++|+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ +..||...+..+.+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 5 789999999987654332 123345678899999986654 8999999999999999998 67888776665554
Q ss_pred HHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 210 YKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 210 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..+....... .........+.++.++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 244 ENAGHFFRDD----------------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHhccccc----------------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 4432211000 000001122456789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.97 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=197.9
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|.+.+.||+|+||+||++.+. .++..+|+|.+.... ........+|++++++++||||+++++++...+.++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 47899999999999999999752 345679999887542 222334568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEee
Q 044608 77 LVFECMECNLYQLMAARDR------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIAD 143 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~D 143 (417)
+||||+.++.+..+..... ..+++..+..++.||+.||+|||++|++||||||+|||++ ++.+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 9999998664444433221 2489999999999999999999999999999999999996 47899999
Q ss_pred ccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCC
Q 044608 144 FGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSP 219 (417)
Q Consensus 144 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~ 219 (417)
||++........ .....++..|+|||++.+. .++.++|+|||||++|+|++ |.+||......+....+...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~---- 238 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---- 238 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----
Confidence 999976543221 2234457789999998654 48999999999999999998 99999888776655554311
Q ss_pred CccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 220 TMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. .......+.++.+||.+||+.||.+|||+.|++.
T Consensus 239 -----------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 -----------------RV--------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -----------------Cc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0112346789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.80 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=209.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.|++.+.||+|+||.||+|.+..++..|++|++..... ......+|+++++.++|+||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 578999999999999999999998999999999976433 233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+.......+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++....... .....
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 996555544444323689999999999999999999999999999999999997 5789999999987554322 22344
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+... ..+
T Consensus 177 ~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~ 234 (286)
T cd06614 177 VGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---------------------GIP 234 (286)
T ss_pred cCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------------CCC
Confidence 6789999999986554 899999999999999999999999887765554443210 000
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ......++.++.+||.+||+.||.+|||+.++|+|+||.+
T Consensus 235 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 235 P------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred C------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0 0111236789999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.43 Aligned_cols=247 Identities=28% Similarity=0.374 Sum_probs=198.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.... +..+|+|.+...... .....+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 579999999999999999997654 456999998754332 23456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC--cc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY--TN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~--~~ 158 (417)
+.++.+..+.......+++..++.++.||+.||.|||++|++|+||||+|||++ ++.+||+|||++......... ..
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 987655544444334689999999999999999999999999999999999996 478999999998765433211 12
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 161 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 219 (256)
T cd05113 161 SKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-------------------- 219 (256)
T ss_pred CccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC--------------------
Confidence 23456799999986554 8999999999999999998 9999988776665554432100
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......+..+.+++.+||+.||++|||+.+++++
T Consensus 220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 220 ---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 00112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=313.98 Aligned_cols=244 Identities=30% Similarity=0.483 Sum_probs=201.0
Q ss_pred ceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.+... +..||+|.+.............+|+++++.++|+||+++++++.+...+++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 5799999999999998866 8999999998665443344556899999999999999999999999999999999965
Q ss_pred C-HHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-
Q 044608 85 N-LYQLMAARD-------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 85 ~-l~~~~~~~~-------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~- 154 (417)
+ +.+.+.... ...+++..++.++.||+.||.|||++|++|+||||+||++++ +.+||+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 5 555444331 356899999999999999999999999999999999999975 899999999998765432
Q ss_pred --CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 --PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------- 223 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------------- 223 (262)
T ss_pred cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 23345678899999998655 48999999999999999999 69999988766655544210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++.++.++|.+||..||.+|||+.|++++
T Consensus 224 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.76 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=196.4
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 75 (417)
++|++++.||+|+||.||+|.+... +..||+|++.............+|++++.+++ ||||+++++++.+.+.+
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 5788999999999999999986433 35799999976544444445678999999996 99999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhc------------------------------------------------------------
Q 044608 76 YLVFECMECN-LYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~------------------------------------------------------------ 94 (417)
|+||||+.++ |.+.+..+.
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999765 444443221
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcE
Q 044608 95 ----------------------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GII 139 (417)
Q Consensus 95 ----------------------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~v 139 (417)
...+++..+..++.||+.||.|||++||+||||||+|||+++ +.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 124788889999999999999999999999999999999975 679
Q ss_pred EEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 044608 140 KIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 140 kL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~ 215 (417)
||+|||++..+..... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+........
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999986543222 22345678899999986554 8999999999999999997 99999876544333322110
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... ......++.++.+||.+||+.||++|||+.++.+
T Consensus 356 -------------------~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 356 -------------------GYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred -------------------CCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 000 0112356889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.88 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=200.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||.||+|.+. .+..||+|.+..... ......+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 68999999999999999999864 566799998865332 233456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Cc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.+ ++.+.+.......+++..+..++.||+.||.|||++|++||||||+||++++ +.+||+|||++........ ..
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 975 4665555544566899999999999999999999999999999999999975 7899999999986643221 12
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.... ++.++|||||||++|+|++ |..||......+....+... +
T Consensus 163 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--------------------~ 221 (261)
T cd05072 163 GAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG--------------------Y 221 (261)
T ss_pred CCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 234567899999986554 8899999999999999998 99999887766655544211 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. .....++.++.+||.+||..||++|||++++++
T Consensus 222 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 RM---------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.46 Aligned_cols=278 Identities=35% Similarity=0.544 Sum_probs=229.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
.||.-++.+|.|+- .|..|.|.-++..||+|.+........ ..+..+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 37888899999999 888899999999999998865533322 23345899999999999999999999643 45
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+|||+|+.++-..+.- .++-..+..++.|++.|++|||+.||+||||||+||++. +..+||+|||+|+.-...
T Consensus 96 ~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 799999999998877762 267789999999999999999999999999999999995 688999999999876666
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
-.++.++.|++|+|||++.+.. |...+||||+||++.||+.|+..|+|....++..+|.+.+|++......+.....+.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 6778899999999999998877 999999999999999999999999999999999999999999987766554332222
Q ss_pred hhc------------cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 234 IKY------------QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 234 ~~~------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
.-. .||...........+.-+..+.||+.+||..||++|.+++++|+||||+
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111 1222222222222233456799999999999999999999999999998
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=323.53 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=198.2
Q ss_pred CCceecceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|.+.+.||+|+||.||+|.+.. ++..+|+|.++............+|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998643 23579999998654443444556899999999 7999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|+||||+.++ +.+.+..+. ...++..++..++.||+.||+|||++|++||||||+|||++ ++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 999999999865 555554332 12478899999999999999999999999999999999996 57
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++........ .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 899999999876543221 11223456899999986554 8999999999999999998 899998776555444332
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. . ........+.++.+||.+||..+|++|||+.+++++
T Consensus 257 ~~--------------------~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 EG--------------------H---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cC--------------------C---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 10 0 011223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=322.21 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=199.3
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|.+.+.||+|+||.||+|.+ ..++..||+|.++............+|+.+++++ +||||+++++++...+.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4789999999999999999975 3356689999987654333334456899999999 799999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~ 153 (417)
|+||||+.++ +.+.+.......+++.++..++.||+.||.|||++||+|+||||+|||+++ +.+||+|||++......
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 9999999865 555544433344899999999999999999999999999999999999975 67999999999865433
Q ss_pred CC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 154 PP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 154 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
.. .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+...+....
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-------------- 259 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-------------- 259 (302)
T ss_pred CceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc--------------
Confidence 21 12234578899999986655 8999999999999999998 99999887655544333210
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... .......+.++.+||.+||..||++|||+.|+++
T Consensus 260 -----~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 -----GYR---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -----CCc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 0112346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=315.95 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=200.6
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.++.++. .+|+|.++............+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 479999999999999999998875554 79999987654433344556899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC-
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY- 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~- 156 (417)
|||+.++.+..........+++.++..++.||+.||.|||++|++||||||+|||++ ++.++|+|||++.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 999987655555444445689999999999999999999999999999999999996 478999999999866543221
Q ss_pred ---ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 ---TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ---~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||...+..+....+...
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~----------------- 225 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG----------------- 225 (267)
T ss_pred eecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----------------
Confidence 1122356899999986544 8999999999999999886 99999887766555444211
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+..+ ....+++++.+|+.+||+.+|++|||+.++++
T Consensus 226 ---~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 ---YRLP---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---CcCC---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0011 12346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=338.66 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=203.1
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEeccccc---ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE--EEEEEe
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA---SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR--LYLVFE 80 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~E 80 (417)
...+||+|+|-+||+|.|..+|..||--.++.+.. .....+...|+.+|+.|+|||||++|+++.+... +.+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34579999999999999999999999776653322 2223455689999999999999999999987655 889999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC--CcEEEeeccccccccCCCCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~~~~ 156 (417)
.+.+|.+..+.++. +.++...++.|++||+.||.|||++. |+|||||.+||+|+. |.|||+|+|+|+.......
T Consensus 124 L~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a- 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA- 201 (632)
T ss_pred cccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence 99887666666555 45899999999999999999999995 999999999999964 8899999999997654433
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK-ICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
...+|||.|||||++. +.|+..+||||||+.|+||+|+.+||.-.....++|+ +.+...
T Consensus 202 ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK------------------ 261 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK------------------ 261 (632)
T ss_pred ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC------------------
Confidence 4479999999999885 4499999999999999999999999976665555544 432211
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+..+. .--.+++++||.+||.. .++|+|+.|+|+||||...
T Consensus 262 -------P~sl~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 262 -------PAALS---KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -------HHHhh---ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11111 12368999999999999 9999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=321.06 Aligned_cols=256 Identities=25% Similarity=0.322 Sum_probs=198.4
Q ss_pred CCceecceecccCceEEEEEEECCCC--------------cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeece
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG--------------EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g--------------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 67 (417)
++|++.+.||+|+||.||+|.+..++ ..||+|.++............+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 48999999999999999999875432 3599999876544333445568999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC
Q 044608 68 LIQNNNRLYLVFECMECNLYQLMAARDR-----------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ 136 (417)
Q Consensus 68 ~~~~~~~~~lv~E~~~~~l~~~~~~~~~-----------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~ 136 (417)
++...+..++||||+.++.+..+..... ..+++..+..++.||+.||.|||++|++||||||+||++++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 9999999999999998765444433211 23688899999999999999999999999999999999964
Q ss_pred -CcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHH
Q 044608 137 -GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT--FCPLFPGASEADQMY 210 (417)
Q Consensus 137 -~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~ 210 (417)
+.+||+|||++..+..... .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||...+..+.+.
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 6899999999976543321 12234577899999987655 8999999999999999988 678888877666554
Q ss_pred HHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 211 KICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 211 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+....... .. .......+..++.+.+||.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~--------------~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 244 NTGEFFRNQ--------------GR--------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHhhhhc--------------cc--------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 443211000 00 0001122346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=316.12 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=201.3
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
.+|++.+.||+|+||.||+|.++.+++ .||+|.+.............+|+.+++.++||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 579999999999999999999887765 69999987654333344556899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||+.++.+..+.......+++.+++.++.|++.||.|||++|++|+||||+||++++ +.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999887666555544456899999999999999999999999999999999999964 6899999999876543221
Q ss_pred -Ccccc---CCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 156 -YTNYV---GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 156 -~~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
..... .+..|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+....+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~--------------- 227 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD--------------- 227 (269)
T ss_pred ccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 11111 245799999986554 8999999999999999886 99999887766555444210
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+..+ ....++.++.+++.+||..||++|||++++++
T Consensus 228 -----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -----YRLP---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----CcCC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 12346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.08 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=201.5
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|+..+.||+|+||.||+|.++.++. .+|+|.++.............|++++++++||||+++++++.+.+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 478999999999999999999877665 79999987654443344556899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC-
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY- 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~- 156 (417)
|||+.++.+..........+++..+..++.|++.||+|||++|++|+||||+||++++ +.+||+|||++.........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999887666555544456899999999999999999999999999999999999964 78999999998765433211
Q ss_pred -c--cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 -T--NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 -~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
. ....+..|+|||++.+.. ++.++|+|||||++|+|++ |..||...+..+....+....
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---------------- 227 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---------------- 227 (268)
T ss_pred eeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC----------------
Confidence 1 112345799999986554 8999999999999999997 999998877666555543110
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..+ .....+.++.+|+.+||..||++||++.++++
T Consensus 228 ----~~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 ----RLP---------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=313.20 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.+|++.+.||+|+||.||+|.++ ++..+|+|.+...... .....+|+++++.++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46899999999999999999876 4668999998654332 23346799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc--c
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT--N 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~--~ 158 (417)
+.++.+..........+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||+++...+..... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 977644444333334689999999999999999999999999999999999996 5789999999987654332211 1
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...+..+....+...
T Consensus 161 ~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------------- 217 (256)
T cd05059 161 TKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---------------------- 217 (256)
T ss_pred CCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC----------------------
Confidence 12345799999986654 8999999999999999998 89999887766555443211
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
++ .......+.++.+++.+||..+|++|||+.|+++.
T Consensus 218 ~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 218 YR-------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred Cc-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=315.55 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=199.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.++.+|+.||+|.+...... .......+|+.+++.++||||+++++++...+.++++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 57899999999999999999999999999999988653221 1223446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 79 FECMECNLYQLMAAR---DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~---~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|||+.++.+..+... ....+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999987644443322 234589999999999999999999999999999999999996 4789999999987654432
Q ss_pred C-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 P-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA--DQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
. .....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... +....+.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 221 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------------------ 221 (267)
T ss_pred cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh------------------
Confidence 2 23457899999999986554 789999999999999999999999765432 1111110
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....+.. ....++.++.+||.+||..||++|||+.+|++
T Consensus 222 ---~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 222 ---QCDYPPL-------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---cCCCCCC-------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0011110 11246889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.50 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=202.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||.|+||.||+|.+.. +..+|+|++...... ......+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 479999999999999999999888 889999998765331 233456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-Ccc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YTN 158 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-~~~ 158 (417)
+++ ++.+.+.......+++..++.++.||+.||.|||++||+|+||||+||++++ +.+||+|||++........ ...
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 976 4555555444456899999999999999999999999999999999999964 7899999999976643321 223
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+... +.
T Consensus 164 ~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------~~ 222 (261)
T cd05148 164 KKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG--------------------YR 222 (261)
T ss_pred CCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC--------------------Cc
Confidence 3456789999998654 48999999999999999998 89999888766666554311 00
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......++++.++|.+||..||++|||+.++++
T Consensus 223 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 ---------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.69 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=197.6
Q ss_pred CCceecceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|.+.+.||+|+||.||+|.+.. .+..+|+|.++............+|+.+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 579999999999999999997642 34579999987654433344456899999999 6999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|++|||+.++ +.+.+.... ...+++..+..++.||+.||.|||++|++||||||+|||++ ++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999876 444443321 13478899999999999999999999999999999999997 57
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999986543221 1222345679999998654 48999999999999999999 899998877666555442
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. ........++.++.+||.+||..||++|||+.|+++
T Consensus 251 ~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 EG-----------------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cC-----------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10 001122456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=318.12 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=198.3
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.+.. ++..||+|++.............+|+.++++++||||+++++++.++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 589999999999999999998753 678999999876543333344567999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee
Q 044608 77 LVFECMECN-LYQLMAARD--------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS 135 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~--------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~ 135 (417)
+||||+.++ +.+.+.... ...+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 999999865 544443221 12478889999999999999999999999999999999995
Q ss_pred -CCcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 044608 136 -QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMY 210 (417)
Q Consensus 136 -~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 210 (417)
++.++|+|||++..+..... .....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 57899999999876543221 12234466799999986554 8999999999999999997 888998777666554
Q ss_pred HHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 211 KICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 211 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+... .........+.++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 244 YVRDG-----------------------------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHhcC-----------------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 43210 001112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.24 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=194.8
Q ss_pred ceecceecccCceEEEEEEECC---CCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCE-----
Q 044608 4 YSGFKELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNR----- 74 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 74 (417)
|.+.+.||+|+||.||+|.... ++..||+|.++....... .....+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 347899999876433322 2344689999999999999999998765443
Q ss_pred -EEEEEeccCCCHHHHHH-Hh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccc
Q 044608 75 -LYLVFECMECNLYQLMA-AR----DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLA 147 (417)
Q Consensus 75 -~~lv~E~~~~~l~~~~~-~~----~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a 147 (417)
.+++|||+.++.+..+. .. ....+++..+..++.||+.||.|||++|++||||||+||++++ +.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999876544433 22 1235899999999999999999999999999999999999965 68999999999
Q ss_pred ccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccc
Q 044608 148 REIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 148 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 223 (417)
+....... .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------- 231 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-------- 231 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 86543321 112235678999999854 448999999999999999999 89999887766554443210
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .......++.++.++|.+||+.||++|||+.|++++
T Consensus 232 -------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 -------------N--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -------------C--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 011224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=367.52 Aligned_cols=255 Identities=29% Similarity=0.501 Sum_probs=215.0
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++.....||.|.||.||.|.+..||+..|+|-|+....... .....+|+.++..|+|||+|++|++-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45566789999999999999999999999999875544321 12335899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-----C
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-----P 155 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-----~ 155 (417)
|+++.+..+.... +..+|...+.|..|++.||.|||+.|||||||||+|||++ +|.+|++|||.|..+.... .
T Consensus 1316 C~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred hccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999888887765 4578888999999999999999999999999999999996 5899999999998776542 2
Q ss_pred CccccCCccccCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 YTNYVGSRWYRAPEILLQSE--LYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....||+.|||||++.+.. ..+.+.||||||||+.||+||+.||... +++.+++.+-.
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------------ 1456 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------------ 1456 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------------
Confidence 45678999999999997543 4577899999999999999999999654 45666665531
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+.++..+|++..|||.+||..||..|.|+.|+|+|.|-+.+
T Consensus 1457 -----------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1457 -----------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 11223344689999999999999999999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=345.71 Aligned_cols=201 Identities=30% Similarity=0.474 Sum_probs=175.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC------CEEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN------NRLYL 77 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~l 77 (417)
+...+.||+|+||.||+++++.+|+.||||.++............+|+++|++|+|||||++.++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 456788999999999999999999999999998765444455556899999999999999999986543 35689
Q ss_pred EEeccCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCc--EEEeeccccccc
Q 044608 78 VFECMECNLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGI--IKIADFGLAREI 150 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~--vkL~DFg~a~~~ 150 (417)
|||||.|+.+..+..+ +...++|.++..++.++..||.|||++||+||||||+||++- +|+ .||+|||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999998866665543 235699999999999999999999999999999999999994 243 799999999999
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS 204 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 204 (417)
+++..+++.+||+.|.+||++...+.|+..+|.|||||++|+++||..||....
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999999999999999999998755669999999999999999999999986543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=333.96 Aligned_cols=281 Identities=30% Similarity=0.492 Sum_probs=224.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC------CCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH------SNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~~~~ 75 (417)
++|.+....|+|-|++|.+|.+..-|..||||+|.....-. ..-++|+++|++|+. -|+++++..|...+++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 48999999999999999999999999999999998653221 112589999999963 4899999999999999
Q ss_pred EEEEeccCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccC
Q 044608 76 YLVFECMECNLYQLMAARD-RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKS 152 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~-~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~ 152 (417)
|||||-+.-+|.+.+.+.. ...|....++.|+.|++.||..|...||+|.||||+|||+++ +.+||||||.|.....
T Consensus 510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 9999999989888887654 235888999999999999999999999999999999999975 5699999999986654
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH--HH
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL--RQ 230 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~--~~ 230 (417)
. ..+.+.-+.+|+|||++++-. |+...|+||+||.||||.||+..|+|.+..+++...+.+-|..+..-...+. .+
T Consensus 590 n-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 590 N-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred c-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 4 356667789999999999877 9999999999999999999999999999999999999888876554332211 11
Q ss_pred Hhhh--hc---cCCCCCc-------------ccccccC----------CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 231 ARAI--KY---QFPQLPR-------------ANLSALM----------PSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 231 ~~~~--~~---~~~~~~~-------------~~~~~~~----------~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
.... ++ ....+.. ..+...+ +.+-..+.+||.+||..||++|.|..++|+||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 0000 00 0111100 1111000 11223589999999999999999999999999
Q ss_pred cccc
Q 044608 283 FFKR 286 (417)
Q Consensus 283 ~f~~ 286 (417)
||+.
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9975
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=318.32 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=203.1
Q ss_pred CceecceecccCceEEEEEEEC---CCCcEEEEEEecccccC---hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
+|++.+.||+|+||.||+|.+. .+|+.||+|++...... .......+|+++++.+ +|+||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998753221 1122335799999999 599999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||+.++.+....... ..+++..+..++.||+.||.|||++|++||||||+|||++ ++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999876444433333 4589999999999999999999999999999999999996 5789999999997654422
Q ss_pred --CCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 --PYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......|+..|+|||.+... ..++.++|+|||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------------- 224 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--------------- 224 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---------------
Confidence 22345789999999998643 246789999999999999999999996543222222211100
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.... ..+...+++.+.+||.+||+.||++|+ ++++++.||||+...+
T Consensus 225 ---~~~~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 225 ---LKSE--------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ---hccC--------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0000 112235788999999999999999997 8999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.05 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=195.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||.||+|.+. .+..+|+|.+....... ....+|+.++++++||||+++++++. .+..|++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH--HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 68999999999999999999765 56679999987644332 33568999999999999999999875 4568999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Cc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.++ +.+.+.......+++..++.++.||+.||.|||++||+||||||+||++++ +.++|+|||++..+..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 9765 555554433455899999999999999999999999999999999999975 6899999999976543321 12
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------~ 220 (260)
T cd05070 162 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG--------------------Y 220 (260)
T ss_pred CCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 234566799999986554 8999999999999999999 89999887766655544210 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......+.++.+||.+||..||++|||++++++
T Consensus 221 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 R---------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred C---------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 0112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.53 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=191.1
Q ss_pred eecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCH
Q 044608 9 ELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNL 86 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l 86 (417)
.||+|+||.||+|.+. ..+..||+|++.............+|+.++++++||||++++++++. ..+++||||+.++.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 5899999999999765 44567999998765433333445689999999999999999998864 57899999998765
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC----CccccC
Q 044608 87 YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP----YTNYVG 161 (417)
Q Consensus 87 ~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~----~~~~~g 161 (417)
+..+.......+++..+..++.||+.||.|||++|++||||||+|||+++ +.+||+|||++........ .....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 55555444456899999999999999999999999999999999999965 6899999999976543322 111233
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQ 240 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (417)
+..|+|||++.... ++.++|||||||++|+|++ |..||......+....+.... .
T Consensus 161 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------~----- 216 (257)
T cd05115 161 PLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK------------------R----- 216 (257)
T ss_pred CcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------------C-----
Confidence 57899999986544 8999999999999999996 999998887766554442110 0
Q ss_pred CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 241 LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 241 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....+..++++.+||.+||..||++|||+.++++
T Consensus 217 ------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122456899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.11 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=191.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcE----EEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEA----VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||+||+|....+|+. +++|.+..............|+..+.+++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 5899999999999999999998887774 67777653322222233456888899999999999999875 455788
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~- 154 (417)
++||+.++ +.+.+. .....+++..+..++.||+.||.|||++|++||||||+|||+++ +.+||+|||+++......
T Consensus 86 i~e~~~~gsL~~~l~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 86 VTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEeCCCCcHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99998755 555544 33456899999999999999999999999999999999999975 689999999997654322
Q ss_pred --CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 --PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.........+..
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----------------- 226 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK----------------- 226 (279)
T ss_pred ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----------------
Confidence 223445677899999986554 8999999999999999998 9999988765443222210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
...+ ......+.++.+++.+|+..||++|||+.|+++
T Consensus 227 ----~~~~--------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 ----GERL--------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----CCcC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 011224678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=310.55 Aligned_cols=251 Identities=28% Similarity=0.505 Sum_probs=199.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-C-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-S-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++.... . .......+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4789999999999999999999999999999999864322 2 2234456899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 79 FECMECN-LYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|||+.++ +...+.. .....+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999875 4444432 1234589999999999999999999999999999999999996 5889999999987654332
Q ss_pred -CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 -PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE--ADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||..... .+....+.
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 221 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------------------ 221 (267)
T ss_pred cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh------------------
Confidence 223457899999999986554 89999999999999999999999965431 11111110
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
...++..+ ...++.++.++|.+||..||++|||+.++++
T Consensus 222 ---~~~~~~~~-------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 222 ---KCDYPPLP-------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---cCCCCCCC-------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00011100 1256789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.64 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=197.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. +++.||+|.++..... .....+|+.++++++||||+++++++...+.+|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc--HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 57999999999999999999865 4578999998754322 33456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc--
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT-- 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~-- 157 (417)
+.+ ++.+.+.......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 954 566555544435689999999999999999999999999999999999996 4789999999998765322111
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....+..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.........+... +
T Consensus 163 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------------~ 221 (261)
T cd05068 163 GAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG--------------------Y 221 (261)
T ss_pred CCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 112245799999886544 8999999999999999999 99999887766655444211 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......+.++.+++.+||+.||++|||+.++++
T Consensus 222 ~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 R---------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred C---------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 0112346789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.88 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=199.1
Q ss_pred CCceecceecccCceEEEEEEEC-------CCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-------HTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|.+.+.||+|+||.||+|++. ..+..||+|.+.............+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 57999999999999999999753 234579999987654343444556899999999 8999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|+||||+.++ +.+.+.... ...++...+..++.||+.||.|||++||+||||||+|||++ ++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 999999999875 444444321 12477888999999999999999999999999999999996 47
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 899999999986643221 22334567899999986554 8999999999999999998 789998877666555442
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... . ......++.++.+||.+||..+|.+|||+.|+++.
T Consensus 254 ~~~--------------------~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 254 EGH--------------------R---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCC--------------------c---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 100 0 01123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.19 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=195.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||.||+|.+..++ .||+|++....... ....+|+++++.++||||+++++++. .+..|+||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~--~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCH--HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 57999999999999999999887654 59999987643322 34468999999999999999999875 4568999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Cc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.++ +.+.+.......+++..+..++.|++.||.|||++|++||||||+||++++ +.+||+|||.+..+..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 9865 555554433345799999999999999999999999999999999999965 7899999999976543322 12
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+....+....+... .
T Consensus 162 ~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~--------------------~ 220 (262)
T cd05071 162 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------------------Y 220 (262)
T ss_pred CCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC--------------------C
Confidence 234567899999886555 8999999999999999999 89999887766555443210 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......++.++.+||.+||+.||++|||+.++++
T Consensus 221 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 R---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 0112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=313.72 Aligned_cols=280 Identities=31% Similarity=0.567 Sum_probs=229.9
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC-----EEEEE
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN-----RLYLV 78 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv 78 (417)
+-.+.||-|+||.||.+.+..+|+.||+|.+..-..... ....++|+++|.-++|.|++..+++.+-.+ .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 445789999999999999999999999999865433322 234579999999999999999998876543 46788
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC--CC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG--PP 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~--~~ 155 (417)
.|.|..+|-..+..- ..++.+.++-+++||++||.|||+.||.||||||.|+|++. -.+||||||+++..+.. ..
T Consensus 136 TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 888887776655432 45899999999999999999999999999999999999964 57899999999876543 44
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
++..+-|.+|+|||++.+.+.|+.++||||+|||+.||+..+..|...++.+++..|...+|+|..+.......-++...
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 56678899999999999999999999999999999999999999999999999999999999999998776655554443
Q ss_pred ccCCCCCccccccc-----CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSAL-----MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..-+... +.++-+ ......++.+++.+||..||++|.+.++++.|+++.+.
T Consensus 294 LR~~~k~-Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLRA-PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCCC-CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 3322221 111111 12344579999999999999999999999999998764
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.77 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=198.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||.|+||.||+|.. .|+.||+|.+..... ......+|+.+++.++|+||+++++++.+.+..|+||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 5799999999999999999975 488999999976543 334456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.+ ++.+.+.......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++........ ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~ 159 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SG 159 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cC
Confidence 986 555555444434689999999999999999999999999999999999996 47899999999987643222 33
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.++..|+|||.+.... ++.++|+|||||++|+|++ |..||...+..+....+... +
T Consensus 160 ~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------------~ 216 (256)
T cd05039 160 KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------------Y 216 (256)
T ss_pred CCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------------C
Confidence 4566799999986554 8899999999999999997 99999887765544333210 0
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......+++++.+||.+||..||++|||++|+++
T Consensus 217 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 R-------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred C-------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=325.55 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=213.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccc--ccChhhhh----hHHHHHHHHhcCCCCeeeeceEEE-eCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQR--YASWEDCL----NLREVKCLRKLNHSNIVKLKELIQ-NNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~--~~~~~~~~----~~~E~~~l~~l~hpnIv~l~~~~~-~~~~ 74 (417)
++|-++..||+|+|+.||+|.+....+.||+|+-... ..+..... ..+|..|.+.|+||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5899999999999999999999999999999975433 22222221 248999999999999999999996 6778
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCCCCeeeeC----CcEEEeeccccc
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN--GFFHRDLKPENLLVSQ----GIIKIADFGLAR 148 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~--gi~HrDLKp~NILl~~----~~vkL~DFg~a~ 148 (417)
+|-|+|||+|+.++.+.+.. +.++|.+++.|+.||+.||.||... -|+|-||||.|||+.+ |.|||.|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999998888766 6799999999999999999999977 5999999999999954 569999999999
Q ss_pred cccCCC--------CCccccCCccccCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhC
Q 044608 149 EIKSGP--------PYTNYVGSRWYRAPEILLQ---SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLG 217 (417)
Q Consensus 149 ~~~~~~--------~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g 217 (417)
..+... ......||.||++||.+.- ....+.++||||+|||+|.++.|+.||..+.....+-...
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN---- 697 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN---- 697 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh----
Confidence 775432 1345789999999998742 3457899999999999999999999997765332221110
Q ss_pred CCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 218 SPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...++...+||.. |.+|.++++||++||++.-++|..+.++-.||+|..
T Consensus 698 -----------TIlkAtEVqFP~K---------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 -----------TILKATEVQFPPK---------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred -----------chhcceeccCCCC---------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1122344556543 568999999999999999999999999999999975
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=310.38 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=190.9
Q ss_pred ceecccCceEEEEEEE--CCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFD--EHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~--~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++||+|+||.||+|.. +.+++.+|+|+++....... .....+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 4699999999999964 56788999999875433322 233467999999999999999999875 4567899999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC----Cccc
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP----YTNY 159 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~----~~~~ 159 (417)
+.+..+.... ..+++..+..++.||+.||.|||++||+||||||.||++++ +.+||+|||++........ ....
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 80 GPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 6554444333 45899999999999999999999999999999999999975 6799999999986644322 1223
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.++..|+|||.+... .++.++|+|||||++|||++ |..||.+.+..+....+... ..
T Consensus 159 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~---------------------~~ 216 (257)
T cd05116 159 KWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG---------------------ER 216 (257)
T ss_pred CCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---------------------CC
Confidence 446789999988544 48899999999999999998 99999888776655544210 00
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
......+++++.+||.+||+.||++|||+++|.+
T Consensus 217 --------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 --------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1122457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.29 Aligned_cols=247 Identities=30% Similarity=0.435 Sum_probs=200.0
Q ss_pred ceecceecccCceEEEEEEECCCC----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTG----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++.+.||.|+||.||+|.+..++ ..||+|++..............|+.+++.++|+||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998876 8999999976544333445568999999999999999999999999999999
Q ss_pred eccCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 80 ECMECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.++.+. .+.......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999875444 444333222899999999999999999999999999999999999975 679999999998665442222
Q ss_pred --cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 158 --NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 158 --~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+...
T Consensus 161 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~------------------- 220 (258)
T smart00219 161 KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG------------------- 220 (258)
T ss_pred cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 1236789999999844 448999999999999999998 89999887766655544210
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ........+.++.+++.+||..||++|||+.|+++
T Consensus 221 --~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 --Y--------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --C--------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0 01112347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=307.75 Aligned_cols=243 Identities=24% Similarity=0.411 Sum_probs=194.4
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
+.||+|+||.||+|... ++..||+|.++............+|+++++.++||||+++++++.+.+..++||||+.++.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999854 68899999987654433334456899999999999999999999999999999999987655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC--ccccCCcc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY--TNYVGSRW 164 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~--~~~~gt~~ 164 (417)
..........+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||++......... ....++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 5444444456899999999999999999999999999999999999964 78999999998754332211 12234567
Q ss_pred ccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 165 YRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
|+|||++.... ++.++|||||||++|+|++ |..||.+.........+... .
T Consensus 160 y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~----------------------~----- 211 (250)
T cd05085 160 WTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG----------------------Y----- 211 (250)
T ss_pred ccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC----------------------C-----
Confidence 99999986544 8999999999999999998 99999887766554443210 0
Q ss_pred ccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 244 ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 244 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......++.++.+|+.+||+.||++|||+.|+++.
T Consensus 212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 001223568899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.43 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=193.4
Q ss_pred ceecceecccCceEEEEEEECCCCc--EEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
|.+.+.||+|+||.||+|.+..++. .+|+|.++....... .....+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999999887775 699998876533322 33446799999999999999999976432 35
Q ss_pred EEEEEeccCCC-HHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 75 LYLVFECMECN-LYQLMAAR----DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~----~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
.+++|||+.++ +...+... ....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999865 44444321 223478999999999999999999999999999999999996 4789999999998
Q ss_pred cccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 149 EIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 149 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
....... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--------- 230 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--------- 230 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------
Confidence 7644321 12234677899999986554 8999999999999999999 89999887665544433210
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 231 ------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 231 ------------N--------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------C--------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 001224567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=315.81 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=196.2
Q ss_pred CceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.............+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58999999999999999998753 2357999988765433333445689999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee
Q 044608 78 VFECMECNLYQLMAARD-----------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV 134 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~-----------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl 134 (417)
+|||+.++.+..+.... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999866554443221 1247889999999999999999999999999999999999
Q ss_pred e-CCcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 044608 135 S-QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQM 209 (417)
Q Consensus 135 ~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~ 209 (417)
+ ++.+||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 6 47899999999976533221 12334567899999886544 8999999999999999998 99999887765544
Q ss_pred HHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 210 YKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 210 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..+... +.. .....++.++.+||.+||+.||++|||++|+++
T Consensus 240 ~~~~~~--------------------~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTG--------------------YRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCC--------------------CCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 332110 000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.96 Aligned_cols=243 Identities=26% Similarity=0.432 Sum_probs=195.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEE-EeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI-QNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~ 79 (417)
+++|++.+.||+|+||.||++.. .|..||+|.+.... ......+|+.+++.++|+||+++++++ ...+..|++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46899999999999999999965 47889999986432 123346899999999999999999975 4567799999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.++ +.+.+..+....+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++....... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence 999864 55555544444589999999999999999999999999999999999996 5789999999987654332 2
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+...
T Consensus 158 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------- 215 (256)
T cd05082 158 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------- 215 (256)
T ss_pred CCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------------------
Confidence 334567899999986544 8999999999999999997 99999877655544443210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+ ....+.+++.+.+||.+||+.||++|||+.++++
T Consensus 216 -~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 -YK-------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -CC-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 1122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=319.60 Aligned_cols=281 Identities=31% Similarity=0.473 Sum_probs=208.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----C---CCeeeeceEEE---
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----H---SNIVKLKELIQ--- 70 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l~~~~~--- 70 (417)
.||.++++||.|.|++||+|.|..+.+.||+|+.+....- ....+.||++|+++. | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY--tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY--TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH--HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4899999999999999999999999999999999754221 223368999999983 3 36999999996
Q ss_pred -eCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeCCc----------
Q 044608 71 -NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQGI---------- 138 (417)
Q Consensus 71 -~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~~~---------- 138 (417)
++.++|+|+|+++.+|+.++.....+.++...++.|++||+.||.|||.. ||+|-||||+|||+.-+.
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a 235 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA 235 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence 46699999999999999999998888899999999999999999999965 999999999999972110
Q ss_pred --------------------------------------------------------------------------------
Q 044608 139 -------------------------------------------------------------------------------- 138 (417)
Q Consensus 139 -------------------------------------------------------------------------------- 138 (417)
T Consensus 236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~ 315 (590)
T KOG1290|consen 236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST 315 (590)
T ss_pred ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence
Q ss_pred -----------------------------------------------------------------------------EEE
Q 044608 139 -----------------------------------------------------------------------------IKI 141 (417)
Q Consensus 139 -----------------------------------------------------------------------------vkL 141 (417)
|||
T Consensus 316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI 395 (590)
T KOG1290|consen 316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI 395 (590)
T ss_pred hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence 011
Q ss_pred eeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHHh
Q 044608 142 ADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA------SEADQMYKICGV 215 (417)
Q Consensus 142 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~------~~~~~~~~i~~~ 215 (417)
+|||-|+.+. ..++.-+.|..|+||||+++.. |++.+||||++|+++||+||..+|... .+++.+..|++.
T Consensus 396 aDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL 472 (590)
T KOG1290|consen 396 ADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL 472 (590)
T ss_pred eeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence 1111111000 0011123467799999999887 999999999999999999999999643 368899999999
Q ss_pred hCCCCccc------hHHHHHHHhhhhccCCCCCccccccc-------CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 216 LGSPTMDS------WADGLRQARAIKYQFPQLPRANLSAL-------MPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 216 ~g~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
+|..+..- +.+++.....+.. +.......+..+ ...-..++.|||.-||+.+|++|+||.++|+||
T Consensus 473 LG~iPr~ia~~Gk~SRdFFnr~G~Lrh-I~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP 551 (590)
T KOG1290|consen 473 LGKIPRKIALGGKYSRDFFNRRGELRH-IRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP 551 (590)
T ss_pred HhhccHHHHhcCcchHhhhccccceec-ccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence 99865442 2222211111111 001111111110 011234689999999999999999999999999
Q ss_pred cccccc
Q 044608 283 FFKRCF 288 (417)
Q Consensus 283 ~f~~~~ 288 (417)
|++...
T Consensus 552 wLn~~~ 557 (590)
T KOG1290|consen 552 WLNPVA 557 (590)
T ss_pred cccCCC
Confidence 998753
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.54 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=193.0
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEe-CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQN-NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (417)
++|++.+.||+|+||.||+|.+ ..+++.||||+++............+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 6899999999999999999984 3567899999997654433334556899999999 68999999998764 456
Q ss_pred EEEEEeccCCCHHHHHHHhc------------------------------------------------------------
Q 044608 75 LYLVFECMECNLYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~------------------------------------------------------------ 94 (417)
+++||||++++.+..+....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999876444433221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---CccccCCcc
Q 044608 95 ------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP---YTNYVGSRW 164 (417)
Q Consensus 95 ------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~ 164 (417)
...++...+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ .....++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 12367788899999999999999999999999999999996 57899999999876533221 122345677
Q ss_pred ccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 165 YRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
|+|||++.+.. ++.++|||||||++|+|++ |..||.+............. ...
T Consensus 247 y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------------~~~----- 300 (343)
T cd05103 247 WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------------------GTR----- 300 (343)
T ss_pred eECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc--------------------cCC-----
Confidence 99999986554 8999999999999999997 99999775433222221100 000
Q ss_pred ccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 244 ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 244 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......++++.+++.+||..||++|||+.|+++|
T Consensus 301 ---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.31 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=196.8
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
.+|.+.++||+|+||.||+|... .++..+|+|.+.... ........+|+++++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 47889999999999999999743 356789999886532 222334568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEE
Q 044608 77 LVFECMECNLYQLMAARDR--------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKI 141 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~--------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL 141 (417)
++|||+.++.+..+..... ..+++..+..++.||+.||+|||++|++||||||+|||+++ +.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 9999998664444433321 24789999999999999999999999999999999999964 78999
Q ss_pred eeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhC
Q 044608 142 ADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLG 217 (417)
Q Consensus 142 ~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 217 (417)
+|||++........ .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 241 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR- 241 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-
Confidence 99999875533221 12334578899999986655 8999999999999999998 999998777666554432100
Q ss_pred CCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 218 SPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......+++.+.+||.+||+.||.+|||+.|+++
T Consensus 242 -----------------~-----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 -----------------E-----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -----------------c-----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0112356789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.19 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=196.1
Q ss_pred CCceecceecccCceEEEEEEECC----------------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeee
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH----------------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~----------------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 65 (417)
++|++.+.||+|+||.||+|.+.. ++..||+|++.............+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999985432 3457999998765433333455689999999999999999
Q ss_pred ceEEEeCCEEEEEEeccCCC-HHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee
Q 044608 66 KELIQNNNRLYLVFECMECN-LYQLMAARD---------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS 135 (417)
Q Consensus 66 ~~~~~~~~~~~lv~E~~~~~-l~~~~~~~~---------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~ 135 (417)
++++.+.+..++||||+.++ +.+.+.... ...+++..+..++.||+.||+|||++|++|+||||+|||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 99999999999999999765 544444321 12367789999999999999999999999999999999996
Q ss_pred -CCcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHH
Q 044608 136 -QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT--FCPLFPGASEADQM 209 (417)
Q Consensus 136 -~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~ 209 (417)
++.++|+|||++..+..... .....++..|+|||+..+.. ++.++|+|||||++|||++ |..||...+..+..
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 47899999999986543321 12234467899999886654 8999999999999999998 77899877665544
Q ss_pred HHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 210 YKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 210 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
......... .. ........+.++..+.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~---------------~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 244 ENTGEFFRD---------------QG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHhh---------------cc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332111000 00 00000112346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.57 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=196.6
Q ss_pred CceecceecccCceEEEEEEE----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFD----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 76 (417)
-|++++.||+|+||.||+|.. +.++..||+|.++............+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 378999999999999999973 5678899999987543333334456899999999999999999998775 6789
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~ 155 (417)
+||||+.|+.+..+.......+++..+..++.||+.||.|||++|++||||||+||++++ +.+||+|||++..+.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 999999877665555444446899999999999999999999999999999999999964 7899999999986654322
Q ss_pred ----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccc-hHHHHHH
Q 044608 156 ----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS-WADGLRQ 230 (417)
Q Consensus 156 ----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~-~~~~~~~ 230 (417)
.....++..|+|||++.+.. ++.++|||||||++|+|++++.|+..... ... ...+...... +......
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccccHHHHHHH
Confidence 12345677899999986654 89999999999999999998876533211 111 1111111110 1111000
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... ........++.++.+||.+||+.||++|||+.+++++
T Consensus 239 ---~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 ---LEEG-------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ---HHcC-------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000 0011234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=310.43 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=212.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
.+-+..||.|+||+|++..++.+|+.+|+|.|+....+.+..+.+.|.+...+- ++||||++|+....++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 445678999999999999999999999999999877777777778888876655 7999999999999999999999999
Q ss_pred CCCHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 83 ECNLYQL---MAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 83 ~~~l~~~---~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
+-++-.+ ........++|+.+-.+....+.||+||... .|+|||+||+|||++. |.|||||||.+..+.++...+
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 8764433 3333445689999999999999999999965 8999999999999985 999999999998887776666
Q ss_pred cccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.-.|...|||||.+.... .|+-++|+||||++|||+.||..|+.+-+. .+..++.+ .+
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~V-------------------v~ 284 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQV-------------------VI 284 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHH-------------------Hc
Confidence 778999999999985443 389999999999999999999999966432 33333322 22
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..|..- ....-.-.+|..++.||.-||.+|-..||...+++++||+...
T Consensus 285 gdpp~l--~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 285 GDPPIL--LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CCCCee--cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 211110 0111113478999999999999999999999999999999764
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=311.97 Aligned_cols=243 Identities=27% Similarity=0.374 Sum_probs=190.0
Q ss_pred ceecccCceEEEEEEECCCCc--EEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~--~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|+||.||+|.++.++. .+++|.++............+|++++.++ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988876 46888887543333334456899999999 899999999999999999999999976
Q ss_pred C-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 85 N-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 85 ~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
+ +.+.+.... ...+++..+..++.|++.||+|||++|++||||||+|||++ ++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 5 555544321 12478999999999999999999999999999999999996 5789999999986
Q ss_pred cccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 149 EIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 149 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
.............+..|+|||++... .++.++|+|||||++|||++ |..||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~------------- 226 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------------- 226 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-------------
Confidence 43322112222346679999998554 48999999999999999997 9999987765554443311
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+. .......+.++.+|+.+||..||.+|||+.++++
T Consensus 227 -------~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -------GYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------CCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 0112346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=314.02 Aligned_cols=246 Identities=32% Similarity=0.484 Sum_probs=194.3
Q ss_pred eecceecccCceEEEEEEEC----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 5 SGFKELGRGAFGRVFQAFDE----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++.+.||.|.||.||+|... ..+..|+||.++............+|++.+++++||||+++++++...+.+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999887 35678999999664443345566789999999999999999999998888999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--- 155 (417)
|+.++ |.+.+.......+++..+..|+.||+.||.|||+++++|+||++.|||++ ++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99854 66666655356689999999999999999999999999999999999997 57899999999987632211
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+...|+|||.+.... ++.++||||||+++|||++ |..||...+..+....+...
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~------------------- 221 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG------------------- 221 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-------------------
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc-------------------
Confidence 22345678899999987665 8999999999999999999 78999888777766555211
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........++..+.++|.+||..||++|||+.++++
T Consensus 222 ----------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ----------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 001122357889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=312.26 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=198.4
Q ss_pred CCceecceecccCceEEEEEEECCCCc----EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+.||+|+||.||+|.++.+|+ .+|+|.+.............+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 579999999999999999999877765 5899988765443333455689999999999999999999887 78899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
||||+.++.+..........+++..+..++.||+.||+|||++|++||||||+|||++ ++.+||+|||++..+......
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 9999976644444444445689999999999999999999999999999999999996 578999999999866543221
Q ss_pred c---cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 T---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~---~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
. ...++..|+|||.+.... ++.++|+|||||++|||++ |..||.+....+....+...
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------- 227 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG----------------- 227 (279)
T ss_pred eecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-----------------
Confidence 1 122356799999885444 8999999999999999998 99999887766655444210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ........+.++.+++.+||..||.+|||+.++++
T Consensus 228 ---~---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 228 ---E---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---C---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00112346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.72 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=198.0
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 75 (417)
++|.+.+.||+|+||.||+|++. .+++.||+|+++............+|+++|.++. ||||+++++++...+.+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888899999999999999853 4567899999986544433345568999999997 99999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhc------------------------------------------------------------
Q 044608 76 YLVFECMECN-LYQLMAARD------------------------------------------------------------ 94 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~------------------------------------------------------------ 94 (417)
++||||+.++ |.+.+....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999865 544443221
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C
Q 044608 95 ------------------------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G 137 (417)
Q Consensus 95 ------------------------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~ 137 (417)
...+++..+..++.||+.||.|||++||+||||||+|||+++ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 123677788999999999999999999999999999999975 6
Q ss_pred cEEEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||......+......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 89999999998653322 122346788999999986554 8999999999999999998 899998766555433322
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ... ......++.++.+||.+||..||++|||++|+++.
T Consensus 356 ~~-------------------~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 356 KR-------------------GYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred Hc-------------------CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 000 01223568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.32 Aligned_cols=239 Identities=21% Similarity=0.293 Sum_probs=188.1
Q ss_pred ceecccCceEEEEEEECC------------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 8 KELGRGAFGRVFQAFDEH------------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~------------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
+.||+|+||.||+|.... ....+++|++...... ......+|+.+++.++||||+++++++.+....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD-ISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh-HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999997432 2235888987654322 223445789999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-------cEEEeecccc
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-------IIKIADFGLA 147 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-------~vkL~DFg~a 147 (417)
++||||++++.++.+..+....+++..++.++.||+.||+|||++||+||||||+|||+++ + .+|++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999988777766655566899999999999999999999999999999999999963 2 2899999998
Q ss_pred ccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 148 REIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 148 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
...... ....++..|+|||++.....++.++|||||||++|+|+ .|..||......+... +..
T Consensus 160 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~------------ 223 (262)
T cd05077 160 ITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE------------ 223 (262)
T ss_pred ccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh------------
Confidence 755332 23467889999999865566899999999999999998 5888887654332211 100
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
..+ ......+.++.+||.+||+.||++|||+.+|+++
T Consensus 224 ---------~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 224 ---------GQC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------cCc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 0112345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.96 Aligned_cols=261 Identities=24% Similarity=0.432 Sum_probs=214.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh--hhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC--LNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~--~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+.+|.++++||+|+|++|.+++++.|.+.||+|++++......+. -...|..+...- +||.+|-++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999999999999999998765443221 123576676665 79999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccc-ccCCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLARE-IKSGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~-~~~~~~ 155 (417)
|.||++|+.+..-.++. ..++|+.++.|...|+.||.|||++||++||||.+|+|++ +|++||.|+|+++. +..+..
T Consensus 329 vieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99999987665555544 4489999999999999999999999999999999999996 69999999999874 556777
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPG-------ASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
.+++||||.|.|||++.+.. |++++|+|+|||+++||+.|+.||.- .+.++.+..+.
T Consensus 408 tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------------- 471 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------------- 471 (593)
T ss_pred cccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH---------------
Confidence 88999999999999997766 99999999999999999999999952 22233332221
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC------HHHHHcCccccccccCCC
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT------AAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~~~~ 292 (417)
+..+ ..++.++|-.+..+++..|++||.+|.. ..++..|+||....|...
T Consensus 472 -----lekq---------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 472 -----LEKQ---------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred -----hhhc---------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence 0111 1223467888999999999999999954 789999999997766543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.60 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=198.4
Q ss_pred CCceecceecccCceEEEEEEECCC-------CcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-------GEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
.+|++.+.||+|+||.||+|.+... +..||+|.++............+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3699999999999999999986432 2379999887654343344556899999999 7999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|++|||+.++ +.+.+..+. ...++...+..++.||+.||.|||++||+||||||+|||++ ++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 999999999765 444444321 12367788999999999999999999999999999999996 57
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 899999999986544321 12233456799999986554 8999999999999999998 899998887666554442
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
.. . ........+.++.+||.+||..+|++|||+.|++++-
T Consensus 251 ~~--------------------~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 251 EG--------------------H---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred cC--------------------C---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 10 0 0011235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.69 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=196.9
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+...... ......+|++++++++||||+++++++.+.+.++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 46899999999999999999754 34567999988654322 2233468999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEE
Q 044608 77 LVFECMECNLYQLMAARD---------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIK 140 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~---------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vk 140 (417)
+||||+.++.+....... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 999999766544444321 13478999999999999999999999999999999999996 47899
Q ss_pred EeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 044608 141 IADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVL 216 (417)
Q Consensus 141 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 216 (417)
|+|||++....... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 241 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG- 241 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC-
Confidence 99999997654322 123345688999999986554 8999999999999999998 99999887766554433210
Q ss_pred CCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 217 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ........+.++.+||.+||+.||++|||+.++++
T Consensus 242 --------------------~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 --------------------R--------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred --------------------C--------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 0 01112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=306.46 Aligned_cols=242 Identities=35% Similarity=0.546 Sum_probs=199.8
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC-CH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NL 86 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~-~l 86 (417)
||.|+||.||++.+..+++.||+|++....... ......+|+++++.++||||+++++.+++++.+|+||||+.+ ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999999999999999987654322 223446799999999999999999999999999999999955 45
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CCCccccCCcc
Q 044608 87 YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PPYTNYVGSRW 164 (417)
Q Consensus 87 ~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~~~~~~gt~~ 164 (417)
.+.+.. . ..+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++...... .......++..
T Consensus 81 ~~~l~~-~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSK-E-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 555543 3 35899999999999999999999999999999999999964 78999999998766543 23445678999
Q ss_pred ccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcc
Q 044608 165 YRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244 (417)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (417)
|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+.. ..
T Consensus 159 ~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~--------- 209 (250)
T cd05123 159 YLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------------------DP--------- 209 (250)
T ss_pred ccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------------------CC---------
Confidence 99999986554 78899999999999999999999987766444433321 00
Q ss_pred cccccCCCCCHhHHHHHHHhcccCCCCCCCH---HHHHcCccc
Q 044608 245 NLSALMPSASQDAISLFESLCSWDPSKRPTA---AEALQHPFF 284 (417)
Q Consensus 245 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta---~elL~hp~f 284 (417)
..+....+.++.+||.+||..||++|||+ +++++||||
T Consensus 210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 11223458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=312.99 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=194.6
Q ss_pred CCc-eecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCE
Q 044608 2 DKY-SGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNR 74 (417)
Q Consensus 2 ~~Y-~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 74 (417)
++| ++++.||+|+||+||++. ...++..||+|+++............+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 577 999999999999998764 4457889999999765433333445689999999999999999998765 346
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+.++.+....... .+++.+++.++.|++.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 89999999877665555443 3899999999999999999999999999999999999964 78999999999866543
Q ss_pred CC----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-hCCCCccchHHHH
Q 044608 154 PP----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGV-LGSPTMDSWADGL 228 (417)
Q Consensus 154 ~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~~ 228 (417)
.. .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... +..+... .+......+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-
Confidence 22 12234567799999986554 899999999999999999999998654321 1111100 000000000000
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.... ........++.++.+|+.+||..||++|||++++++
T Consensus 237 -----~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 -----LERG-------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -----hhcC-------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 001123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=305.87 Aligned_cols=242 Identities=24% Similarity=0.417 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
++||+|+||.||+|.+.. ++.||+|.+.............+|++++++++||||+++++++.+.+..|+||||+.++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999887 9999999987654443344556899999999999999999999999999999999977655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC---ccccCCc
Q 044608 88 QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY---TNYVGSR 163 (417)
Q Consensus 88 ~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~---~~~~gt~ 163 (417)
..........+++..+..++.+++.||.|||++|++||||||+|||++ ++.+||+|||++......... ....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 444433334689999999999999999999999999999999999996 478999999999765422111 1123356
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
.|+|||.+.+.. ++.++|+|||||++|+|++ |..||......+....+... ...
T Consensus 160 ~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~--------------------~~~---- 214 (251)
T cd05041 160 KWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG--------------------YRM---- 214 (251)
T ss_pred ccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC--------------------CCC----
Confidence 799999986554 8999999999999999998 89999887765544433210 000
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
......+.++.+||.+||..+|.+|||+.|+++
T Consensus 215 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 112346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=307.02 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=199.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.++|++.+.||+|+||.||+|.+. .+..||+|.+...... .....+|++++++++||||+++++++.+...+++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 368999999999999999999875 4577999998764433 2345689999999999999999999999899999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--C
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~ 156 (417)
|+.++ +.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++..+..... .
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99765 55555444435689999999999999999999999999999999999996 58899999999886643211 1
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+.+..+....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------- 221 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY------------------- 221 (261)
T ss_pred hccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 1223456899999986554 8999999999999999998 999998877666655542110
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. ......+.++.+++.+||..||++|||++++++
T Consensus 222 -~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 222 -RM---------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 111335788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=307.87 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=196.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||.||+|.+. +++.||+|.+...... .....+|+.++++++||||+++++++. .+.+|++|||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 57999999999999999999854 5778999998754433 234568999999999999999999875 4568999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Cc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.++ +.+.+.......+++.++..++.|++.||.|||+.|++||||||+||++++ +.++|+|||++........ ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 9764 655555444456899999999999999999999999999999999999965 7899999999976653221 12
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.... ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 162 ~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------- 220 (260)
T cd05067 162 GAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-------------------- 220 (260)
T ss_pred CCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC--------------------
Confidence 234567899999986544 8899999999999999998 999998877665554432110
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......+.++.+||.+||..||++|||++++++
T Consensus 221 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 R---------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred C---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=309.93 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=197.7
Q ss_pred CCceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|.+.+.||+|+||.||+|.+... ...||||...............+|+.+++.++||||+++++++.+ +..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4789999999999999999987554 347999988765433334455689999999999999999999876 457899
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC-
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY- 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~- 156 (417)
|||+.++.+..+.......+++..+..++.||+.||.|||++|++|+||||+|||++. +.+||+|||++.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 9999876555554444446899999999999999999999999999999999999965 78999999998765443221
Q ss_pred -ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 -TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 -~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
+...++..|+|||.+... .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------------- 224 (270)
T cd05056 165 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG------------------- 224 (270)
T ss_pred cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 122345679999988554 48999999999999999986 99999888776655443210
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .....+.++.++.+||.+||..||++|||+.+++..
T Consensus 225 -~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 225 -E---------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -C---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001234578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=312.90 Aligned_cols=239 Identities=16% Similarity=0.255 Sum_probs=188.7
Q ss_pred ceecccCceEEEEEEECCCCcE-------EEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 8 KELGRGAFGRVFQAFDEHTGEA-------VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~-------vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+.||+|+||.||+|.++.++.. ||+|.+..... .......+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 4699999999999998765544 88888754322 122334579999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C--------cEEEeecccccccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G--------IIKIADFGLAREIK 151 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~--------~vkL~DFg~a~~~~ 151 (417)
|+.++.+..+.......+++..+..++.||+.||.|||++||+||||||+|||+++ + .++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99887666555544456899999999999999999999999999999999999953 2 27999999987554
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.. ....++..|+|||++.+...++.++|||||||++|+|++| .+||.............
T Consensus 160 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd05078 160 PK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----------------- 219 (258)
T ss_pred Cc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-----------------
Confidence 32 3356888999999997656689999999999999999998 56776554433221110
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ..+....+.++.+||.+||+.||++|||++++++.
T Consensus 220 ---~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 ---DR-----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---cc-----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 01223456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=307.16 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=195.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..++ .+|+|.+...... .....+|+.+++.++||||+++++++.. +..|++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc--HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 57999999999999999999876654 5999988654322 2344679999999999999999998854 568899999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Cc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.+ ++.+.+.......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++........ ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 986 5666665444455899999999999999999999999999999999999964 7899999999976543221 12
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+... +
T Consensus 162 ~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------------~ 220 (260)
T cd05069 162 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG--------------------Y 220 (260)
T ss_pred CCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 234567899999886554 8999999999999999999 89999887766655443211 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......+..+.+||.+||..||++|||++++++
T Consensus 221 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 R---------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred C---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=305.13 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=199.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .....+|+++++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 57999999999999999999875 4778999988754333 23346799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Ccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~~ 158 (417)
+.++.+..+.......++++.++.++.|++.||.|||++|++|+||||+||++++ +.+||+|||++........ ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9887666555544456899999999999999999999999999999999999964 6899999999876543221 112
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||++.+.. ++.++|+|||||++|+|++ |..||......+....+... ...
T Consensus 161 ~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------~~~- 220 (256)
T cd05112 161 TKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG------------------FRL- 220 (256)
T ss_pred CccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC------------------CCC-
Confidence 23467899999986554 8999999999999999998 99999877765555443210 000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
......+.++.+|+.+||..||++|||+.|++++
T Consensus 221 ----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ----------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0112357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=306.13 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEECCCC---cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEHTG---EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++||+|+||.||+|....++ ..||+|.+.............+|+++++.++||||+++++++. .+.+++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 57999999999999876655 7899999986654433445568999999999999999999876 4568999999876
Q ss_pred C-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC-c---c
Q 044608 85 N-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY-T---N 158 (417)
Q Consensus 85 ~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~-~---~ 158 (417)
+ +.+.+.. . ..+++..+..++.|++.||.|||++|++|+||||+|||++ ++.+||+|||++......... . .
T Consensus 80 ~~L~~~l~~-~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKK-R-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHh-C-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 5 5555443 3 3589999999999999999999999999999999999996 478999999999866443221 1 1
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---------------------- 214 (257)
T cd05060 158 GRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---------------------- 214 (257)
T ss_pred ccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC----------------------
Confidence 12345799999986554 8999999999999999997 99999877765554443210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+ ......++..+.+||.+||..||++|||+.++++
T Consensus 215 ~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 215 ER-------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred Cc-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 1122456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=308.08 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=188.2
Q ss_pred ceecccCceEEEEEEECC--CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEH--TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~--~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
++||+|+||+||+|.... ....+|+|.+.............+|+.+++.++||||+++++.+.....+|+||||+.++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 479999999999996433 445788888765443333344568999999999999999999999999999999999876
Q ss_pred HHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC---Cc
Q 044608 86 LYQLMAARDR----KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YT 157 (417)
Q Consensus 86 l~~~~~~~~~----~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~---~~ 157 (417)
.+..+..... ..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 5554443321 23467888999999999999999999999999999999964 7899999999865332211 12
Q ss_pred cccCCccccCchhhhc------cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 158 NYVGSRWYRAPEILLQ------SELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
...++..|+|||++.. ...++.++|||||||++|||++ |..||....+.+.+..+.....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------------- 227 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD------------- 227 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-------------
Confidence 3345778999999743 2346889999999999999999 7899988776665554432110
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
...+ . ......++....+++..|+ .||++|||++|+++
T Consensus 228 -----~~~~---~---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 -----IKLP---K---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----ccCC---C---CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011 1 1223457888999999888 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=313.23 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=201.0
Q ss_pred CceecceecccCceEEEEEEEC---CCCcEEEEEEecccccC---hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
+|++.+.||+|+||.||++.+. .+++.||+|+++..... .......+|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999854 46789999998753221 1122345799999999 699999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||+.++.+....... ..+++..++.++.|++.||.|||+.|++|+||||.||+++ ++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999875444433332 4589999999999999999999999999999999999996 5789999999987654332
Q ss_pred C--CccccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 P--YTNYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 ~--~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
. .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 223 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR---------------- 223 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH----------------
Confidence 2 22346899999999975432 3678999999999999999999999654322111111100
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC---HHHHHcCccccccccC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT---AAEALQHPFFKRCFYA 290 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~~ 290 (417)
..... ......++.++.+||.+||+.||++||| +.++|+||||+...+.
T Consensus 224 --~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 224 --ILKSK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred --HHccC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 00000 1122346789999999999999999998 5778999999886543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.84 Aligned_cols=238 Identities=16% Similarity=0.221 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEECCC------------------------CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeee
Q 044608 9 ELGRGAFGRVFQAFDEHT------------------------GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~------------------------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 64 (417)
.||+|+||.||+|....+ ...|++|++...... ......+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD-IALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH-HHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999974322 235889988654321 2233457899999999999999
Q ss_pred eceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--------
Q 044608 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-------- 136 (417)
Q Consensus 65 l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-------- 136 (417)
+++++.+....++||||++++.++.+.......+++..+..++.||+.||+|||++||+||||||+|||+++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 999999999999999999988777776655567899999999999999999999999999999999999963
Q ss_pred CcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHh
Q 044608 137 GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 137 ~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~ 215 (417)
..+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+....+.
T Consensus 161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-- 235 (274)
T cd05076 161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-- 235 (274)
T ss_pred ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH--
Confidence 14899999988644322 23467888999999876556899999999999999985 6899998765443321110
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... .....++++.+||.+||+.||++|||+.++|++
T Consensus 236 ------------------~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 ------------------KKHR-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ------------------hccC-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0001 112345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=330.23 Aligned_cols=235 Identities=26% Similarity=0.496 Sum_probs=194.8
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
.++-||.|+.|-||+| +..++.||||.++.-. ..+|+.|++|+||||+.|.++|...-.+|||||||..+
T Consensus 128 ELeWlGSGaQGAVF~G--rl~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLG--RLHNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeee--eccCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3456999999999999 4568999999886421 25899999999999999999999999999999999866
Q ss_pred -HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCc
Q 044608 86 -LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSR 163 (417)
Q Consensus 86 -l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~ 163 (417)
|+..+.. . ..++......|..+|+.|+.|||.+.|||||||.-||||+ ++.|||+|||-++.+........++||.
T Consensus 198 qL~~VLka-~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 198 QLYEVLKA-G-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred cHHHHHhc-c-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 5554443 3 4588999999999999999999999999999999999996 6889999999999887776677889999
Q ss_pred cccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCc
Q 044608 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243 (417)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (417)
.|||||++.+.. .+.|+|||||||||||||||..||.+-....++.-+ |+
T Consensus 276 aWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----Gs------------------------- 325 (904)
T KOG4721|consen 276 AWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GS------------------------- 325 (904)
T ss_pred hhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEec----cC-------------------------
Confidence 999999996554 899999999999999999999999665432222111 11
Q ss_pred cccc-ccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 244 ANLS-ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 244 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
..+. ..+..+++.++-||+.||.-.|..||++.++|.|-
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 1111 12335677899999999999999999999999884
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.99 Aligned_cols=243 Identities=26% Similarity=0.360 Sum_probs=194.9
Q ss_pred ceecccCceEEEEEEECC-CCc--EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDEH-TGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.||+|++|.||+|.+.. .++ .||+|.+.............+|+.++++++||||+++++++.+ ..+++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998765 333 6999999876554334455689999999999999999999988 899999999976
Q ss_pred C-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC----Ccc
Q 044608 85 N-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP----YTN 158 (417)
Q Consensus 85 ~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~----~~~ 158 (417)
+ +.+.+..+....+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++..+..... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 5 55555443324689999999999999999999999999999999999996 58899999999987644221 112
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..++..|+|||.+.... ++.++|||||||++|+|++ |..||...+..+....+... ...
T Consensus 160 ~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------------~~~ 219 (257)
T cd05040 160 LKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-------------------GER 219 (257)
T ss_pred CCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------------CCc
Confidence 45678899999886544 8999999999999999998 99999888777666554320 000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......+.++.+++.+||..+|++|||+.++++
T Consensus 220 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 ---------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0111345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.01 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=196.7
Q ss_pred CCceecceecccCceEEEEEEECC----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~ 76 (417)
++|++.+.||+|+||.||+|.+.. ++..|++|.+.............+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 689999999999999999999876 3688999988755444444555789999999999999999998765 57789
Q ss_pred EEEeccCCCHH-HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 77 LVFECMECNLY-QLMAARDR------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 77 lv~E~~~~~l~-~~~~~~~~------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
+++||+.++.+ +.+..... ..+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999876544 44433211 3589999999999999999999999999999999999996 4789999999998
Q ss_pred cccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 149 EIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 149 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
.+..... .....++..|+|||++.+.. ++.++|||||||++|++++ |.+||...+..+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---------- 234 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---------- 234 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc----------
Confidence 6543221 12234577899999986554 8999999999999999998 9999988766554333211
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+.. .....+++++.+++.+||..||++|||+.++++
T Consensus 235 ----------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 ----------GYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ----------CCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.28 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=194.7
Q ss_pred CCceecceecccCceEEEEEEECCCCc----EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+.||+|+||.||+|.+..+|+ .||+|.+.............+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 578999999999999999999888876 46888886544333333456899999999999999999998754 4678
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
++||+.++ +.+.+. .....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 86 v~e~~~~g~l~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 86 VTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eehhcCCCCHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 99998865 554444 3334589999999999999999999999999999999999996 47899999999986643322
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+. .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~---------------- 226 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-K---------------- 226 (303)
T ss_pred ccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-C----------------
Confidence 22334577899999986554 8999999999999999997 899998765444322221 0
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... ...+..+.++.+++.+|+..||++|||++++++.
T Consensus 227 ---~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 ---GERL---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.27 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=187.3
Q ss_pred ceecccCceEEEEEEECC---CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE-eCCEEEEEEeccC
Q 044608 8 KELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ-NNNRLYLVFECME 83 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~~ 83 (417)
+.||+|+||.||+|.+.. .+..||||.+.............+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 345799998864333333344568999999999999999999765 4566899999988
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-----CCc
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-----PYT 157 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-----~~~ 157 (417)
++.+..+........++..+..++.||+.||.|||++|++||||||+|||+++ +.+||+|||++....... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 66555544444445688888999999999999999999999999999999964 789999999987553321 112
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+...
T Consensus 161 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--------------------- 218 (262)
T cd05058 161 GAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--------------------- 218 (262)
T ss_pred cCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---------------------
Confidence 335677899999986554 8999999999999999999 57788776655544333210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
..+ .....++..+.+++.+||..||++|||+.|+++.
T Consensus 219 ~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 219 RRL--------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 0112357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.58 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=188.3
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.||+|+||.||+|... .++..+|+|.++............+|+.+++.++||||+++++++.+...+++||||+.++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 47999999999999754 4567899999876554434445568999999999999999999999999999999999866
Q ss_pred HHH-HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC---Cc
Q 044608 86 LYQ-LMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YT 157 (417)
Q Consensus 86 l~~-~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~---~~ 157 (417)
.+. .+.... ....++..+..++.|++.||.|||++|++||||||+||+++. +.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 544 443321 124567788899999999999999999999999999999975 6899999999875433221 12
Q ss_pred cccCCccccCchhhhccC------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 158 NYVGSRWYRAPEILLQSE------LYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
...++..|+|||++.+.. .++.++|||||||++|||++ |..||......+........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------- 225 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE--------------- 225 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc---------------
Confidence 346788899999985321 25789999999999999996 99999877665543322110
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.....+ . .......+..+.+++.+|+ .||++|||++||+.
T Consensus 226 ---~~~~~~---~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 ---QQLKLP---K---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---ccCCCC---C---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000 0 1112346788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=307.49 Aligned_cols=243 Identities=29% Similarity=0.435 Sum_probs=192.3
Q ss_pred ceecccCceEEEEEEECCCC------cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 8 KELGRGAFGRVFQAFDEHTG------EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.||+|+||.||+|.++..+ +.+|+|.+.............+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999876544 689999887554333344556899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-----cEEEeecccccc
Q 044608 82 MECN-LYQLMAAR-----DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-----IIKIADFGLARE 149 (417)
Q Consensus 82 ~~~~-l~~~~~~~-----~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-----~vkL~DFg~a~~ 149 (417)
+.++ +.+.+... ....+++..+..++.||+.||.|||++|++|+||||+||++++ + .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9765 55554432 2234788999999999999999999999999999999999975 4 699999999876
Q ss_pred ccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 150 IKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 150 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
...... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------- 229 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG---------- 229 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----------
Confidence 543221 12334577899999986655 8999999999999999998 99999877766554433210
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......++.++.+||.+||..+|.+|||++++++
T Consensus 230 ----------~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ----------G---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------C---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 00112346789999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=327.80 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=199.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh-hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC-LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~-~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+..+...||+|.||+||+|+. -|. ||||+++......+.. .+.+|+.++++-+|.||+=|.+++..... .||..+
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~w--hGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRW--HGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred Hhhccceeccccccceeeccc--ccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 456788999999999999954 454 9999999776665543 34589999999999999999999988887 889999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccc---ccCCCCC
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLARE---IKSGPPY 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~---~~~~~~~ 156 (417)
|+|. |+..+.... ..|.....+.|++||++|+.|||.++|+|||||..||++.+ +.|||+|||+++. +......
T Consensus 469 CeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred ccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9987 555554443 56899999999999999999999999999999999999975 8999999999863 2233445
Q ss_pred ccccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
....|...|||||++. ....|++.+|||||||++|||++|..||...+...++..+-+.++
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l----------------- 610 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL----------------- 610 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-----------------
Confidence 5567888999999985 234589999999999999999999999995555444433322111
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........-....++++|+..|+..++++||+..+||.
T Consensus 611 --------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 --------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12223333456679999999999999999999999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.61 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=198.2
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||.|+||.||+|+.+.+ .+.|++|.+.............+|++++++++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 5799999999999999999997643 46799998865433322344568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccc
Q 044608 77 LVFECMECNLYQLMAARDR--------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLA 147 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~--------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a 147 (417)
+||||+.++.+..+..... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999998655444433322 1589999999999999999999999999999999999996 478999999998
Q ss_pred ccccCC--CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 148 REIKSG--PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 148 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
...... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--------- 234 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--------- 234 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC---------
Confidence 654322 2233446678899999986555 7899999999999999998 78899776655544333110
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... .....++..+.++|.+||+.||++|||+.|++++
T Consensus 235 ----------~~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ----------KLEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ----------CcCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 1123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=303.22 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=196.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.++|++.++||+|+||.||++.+. .+..+|+|.+..... ......+|+++++.++|+||+++++++.+ ...|++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 478999999999999999999754 456699998875422 23345679999999999999999999887 77899999
Q ss_pred ccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--C
Q 044608 81 CMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 81 ~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~ 156 (417)
|+++ ++.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++..+..... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9975 5666655444456788999999999999999999999999999999999964 7899999999876543221 1
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....++..|+|||++.... ++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------------------- 219 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------------------- 219 (260)
T ss_pred cCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--------------------
Confidence 2234567799999986544 8999999999999999998 99999887766655443210
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+. .......+.++.+++.+||+.||++|||+.++++
T Consensus 220 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 YR---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CC---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 0112456789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.30 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=192.1
Q ss_pred CCceecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (417)
++|++++.||+|+||.||+|. +..+++.||+|.+.... ........+|+++++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 479999999999999999997 45678999999987542 2222344689999999999999999998753 3568
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
++||||+.++.+..+.......+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 999999976544444443335589999999999999999999999999999999999996 4789999999998764432
Q ss_pred CC----ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCc-cchHHHHH
Q 044608 155 PY----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM-DSWADGLR 229 (417)
Q Consensus 155 ~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~-~~~~~~~~ 229 (417)
.. ....++..|+|||++.+.. ++.++|||||||++|||++|..++...... .... .+.... ......+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~ 236 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQGQMIVYHLI 236 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----cccccccccchHHHH
Confidence 21 1223455699999986554 899999999999999999998776543321 1111 111100 00000000
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........ ......++.++.+||.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000 1122457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=303.49 Aligned_cols=227 Identities=26% Similarity=0.404 Sum_probs=183.1
Q ss_pred cCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC-HHHHHH
Q 044608 13 GAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN-LYQLMA 91 (417)
Q Consensus 13 G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~-l~~~~~ 91 (417)
|.+|+||+|+++.+|+.||+|.+..... ..+|...+....||||+++++++.+.+.+|+||||+.++ +.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999976421 123555556667999999999999999999999999875 555554
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCccccCchh
Q 044608 92 ARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170 (417)
Q Consensus 92 ~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~ 170 (417)
.. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||.+...... .....++..|+|||.
T Consensus 78 ~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 78 KF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 43 3489999999999999999999999999999999999996 578999999988665433 233456788999998
Q ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccC
Q 044608 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALM 250 (417)
Q Consensus 171 l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (417)
+.... ++.++|+||+||++|+|++|..||........ .... ..+.
T Consensus 154 ~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------------~~~~-----------~~~~ 198 (237)
T cd05576 154 GGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------------THTT-----------LNIP 198 (237)
T ss_pred cCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------------cccc-----------cCCc
Confidence 85444 78999999999999999999988754321000 0000 0122
Q ss_pred CCCCHhHHHHHHHhcccCCCCCCCH-----HHHHcCccc
Q 044608 251 PSASQDAISLFESLCSWDPSKRPTA-----AEALQHPFF 284 (417)
Q Consensus 251 ~~~s~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f 284 (417)
+.+++++.+||.+||+.||++|+|+ +|+++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 4578999999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=303.65 Aligned_cols=250 Identities=28% Similarity=0.476 Sum_probs=199.5
Q ss_pred CceecceecccCceEEEEEEECC-CCcEEEEEEeccccc---------ChhhhhhHHHHHHHHh-cCCCCeeeeceEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYA---------SWEDCLNLREVKCLRK-LNHSNIVKLKELIQN 71 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~---------~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 71 (417)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .........|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58999999999999999999988 788999998863221 1112233578888875 799999999999999
Q ss_pred CCEEEEEEeccCCC-HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 72 NNRLYLVFECMECN-LYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 72 ~~~~~lv~E~~~~~-l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
.+..++||||+.++ +.+.+.. .....+++..++.++.|++.||.|||+ +|++|+||+|+|||++ ++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999875 4444322 233568999999999999999999996 7899999999999996 47899999999
Q ss_pred cccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 147 AREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 147 a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
+.............|+..|+|||.+.+.. ++.++|+||||+++|+|++|.+||...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 229 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV---------- 229 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc----------
Confidence 98765554455667899999999987654 8999999999999999999999998776555444332110
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ......++.++.+||.+||+.||++|||+.|+..+
T Consensus 230 -----------~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 -----------YE-------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------CC-------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00 00112467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=301.78 Aligned_cols=241 Identities=32% Similarity=0.480 Sum_probs=193.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||++. .+++.||+|.+.... ......+|+.+++.++||||+++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 579999999999999999984 578899999986532 223446899999999999999999998765 47999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.+ ++.+.+.......+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNS 157 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCC
Confidence 986 565555544444689999999999999999999999999999999999996 478999999998754332 1223
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...+..+....+... +..
T Consensus 158 ~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------------~~~ 216 (254)
T cd05083 158 KLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG--------------------YRM 216 (254)
T ss_pred CCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC--------------------CCC
Confidence 4467899999886554 8999999999999999997 99999887765544333210 000
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.....++.++.+||.+||+.+|++|||+++++.
T Consensus 217 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 ---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=306.80 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=186.4
Q ss_pred CCceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhh----------hhHHHHHHHHhcCCCCeeeeceE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDC----------LNLREVKCLRKLNHSNIVKLKEL 68 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~----------~~~~E~~~l~~l~hpnIv~l~~~ 68 (417)
++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998887 6778888654322111000 11233445566789999999987
Q ss_pred EEeCC----EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEee
Q 044608 69 IQNNN----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIAD 143 (417)
Q Consensus 69 ~~~~~----~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~D 143 (417)
+.... ..++++|++..++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.++|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 65443 44788888776666554432 3368899999999999999999999999999999999996 47899999
Q ss_pred ccccccccCC--------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 044608 144 FGLAREIKSG--------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGV 215 (417)
Q Consensus 144 Fg~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 215 (417)
||+|+.+... .......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..........
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~- 247 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK- 247 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH-
Confidence 9999765321 1122347999999999986554 89999999999999999999999988743222211110
Q ss_pred hCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 216 LGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 216 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+.......... ..+..+.++.+++..|+..||++||+++++++
T Consensus 248 ---------~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 ---------CDFIKRLHEGKI------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ---------HHHHHHhhhhhh------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000011110011 12345788999999999999999999999975
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=302.27 Aligned_cols=236 Identities=20% Similarity=0.285 Sum_probs=186.3
Q ss_pred ceecccCceEEEEEEECCCC----------cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 8 KELGRGAFGRVFQAFDEHTG----------EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g----------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+.||+|+||.||+|.+..++ ..+++|.+...... .....+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 47999999999999998777 35888877654322 3445689999999999999999999888 77899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-------cEEEeecccccc
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-------IIKIADFGLARE 149 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-------~vkL~DFg~a~~ 149 (417)
||||+.++.+..+.......+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999987666665544446899999999999999999999999999999999999964 3 599999999986
Q ss_pred ccCCCCCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+......
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------------- 220 (259)
T cd05037 158 VLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------------- 220 (259)
T ss_pred ccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--------------
Confidence 544 2234577889999998655 358999999999999999999 578886654322211110
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.... .....+.++.+||.+||..||.+|||+.++++
T Consensus 221 ------~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 ------DQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------cCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 00112378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.50 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=201.2
Q ss_pred CceecceecccCceEEEEEEECCCCc---E-EEEEEeccc--ccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGE---A-VAIKELKQR--YASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~---~-vaiK~i~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
+-.+.++||+|+||.||+|..+..+. . ||+|..+.. .........++|.+++++++|||||++||+..+..-+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44567999999999999998766432 3 899998852 22333445579999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~ 155 (417)
||||+|.|+.++...+.....++..+...++.+.+.||+|||+++++||||-..|+|++. +.+||+|||+++.-.....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 999999987666655555556899999999999999999999999999999999999987 5569999999875432211
Q ss_pred Cc-cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 156 YT-NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 156 ~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.. ...-...|+|||.+... .|+.++|||||||++||+++ |..||++.+..+...+|...
T Consensus 318 ~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------------------ 378 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------------------ 378 (474)
T ss_pred ccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc------------------
Confidence 11 11245679999999655 69999999999999999998 88899999998888877421
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.|.. ......+.++..++.+|+..||++|||+.++.+
T Consensus 379 -~~r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 -GYRM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -CccC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1111 112356778999999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.36 Aligned_cols=274 Identities=20% Similarity=0.257 Sum_probs=182.2
Q ss_pred CCCceecceecccCceEEEEEEECCC----CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceE------EE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHT----GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL------IQ 70 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~~ 70 (417)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +. ... +.++...+.+++.+... ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~--~~~--e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EI--WMN--ERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HH--HHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence 37899999999999999999999998 999999987643211 10 011 11222223333333222 24
Q ss_pred eCCEEEEEEeccCCCHHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCC
Q 044608 71 NNNRLYLVFECMECNLYQLMAARDRK-------------------LFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPEN 131 (417)
Q Consensus 71 ~~~~~~lv~E~~~~~l~~~~~~~~~~-------------------~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~N 131 (417)
....+++||||++++.+..+...... ...+..++.++.||+.||.|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 56789999999987644443332211 11234577899999999999999999999999999
Q ss_pred eeeeC--CcEEEeeccccccccCC--CCCccccCCccccCchhhhccC---------------------CCCchhhHHHH
Q 044608 132 LLVSQ--GIIKIADFGLAREIKSG--PPYTNYVGSRWYRAPEILLQSE---------------------LYSSKADMWAM 186 (417)
Q Consensus 132 ILl~~--~~vkL~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwSl 186 (417)
||+++ +.+||+|||+|+.+... ......++|+.|+|||.+.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99974 68999999999865432 2234578999999999764221 13456799999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcc
Q 044608 187 GAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCS 266 (417)
Q Consensus 187 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 266 (417)
||+||||+++..+ ..+....+..+....+.. ...|....... .... .............++.+||.+||+
T Consensus 366 GviL~el~~~~~~--~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~------~~~~-~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 366 GLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYD-LVAWRKLVEPR------ASPD-LRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHhCcCC--CchHHHHHHHHHHhcCCc-HHHHHHhhccc------cchh-hhhhhhhccccchHHHHHHHHHcc
Confidence 9999999986544 444444555444433321 22232211100 0000 000011122334567899999999
Q ss_pred cCCCCCCCHHHHHcCcccccccc
Q 044608 267 WDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 267 ~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
.||++|||++|+|+||||+....
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999999987543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.07 Aligned_cols=248 Identities=22% Similarity=0.286 Sum_probs=187.2
Q ss_pred ceecccCceEEEEEEECCC--CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHT--GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~--g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
++||+|+||+||++..... ...+++|.+.............+|+.+++.++||||+++++.+.+....|+||||+.++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 4699999999999975433 34567777765444334455678999999999999999999999999999999999865
Q ss_pred -HHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---CCCcc
Q 044608 86 -LYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG---PPYTN 158 (417)
Q Consensus 86 -l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~---~~~~~ 158 (417)
|.+.+.... ...+++..++.++.||+.||+|||++|++||||||+|||++ ++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 444544321 23467778899999999999999999999999999999996 578999999998643221 11234
Q ss_pred ccCCccccCchhhhcc------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 159 YVGSRWYRAPEILLQS------ELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.+++..|+|||++... ..++.++|||||||++|||++ |.+||...++.+.+..+.....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 226 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-------------- 226 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc--------------
Confidence 5788999999987431 135789999999999999997 5788987777666555432100
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
...+ .......+++.+.+++..|+ .||++|||++++++
T Consensus 227 ----~~~~------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 227 ----VKLF------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cccC------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 01222347889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.98 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=214.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEE-----eCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQ-----NNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~~~ 75 (417)
|.|++.+.||.|.+|.||+++++++++..|+|++....... ..+..|+++|+.+ .|||++.+|++|. .++.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 56899999999999999999999999999999987654433 3334689999988 6999999999985 46789
Q ss_pred EEEEeccCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 76 YLVFECMECNLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~-~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
|||||||+||...++.++ .+..+.|+.|..|++.++.||.+||.+.++|||||-.|||++ ++.|||+|||.+..+.+.
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999998866665543 356789999999999999999999999999999999999996 589999999999887764
Q ss_pred -CCCccccCCccccCchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 154 -PPYTNYVGSRWYRAPEILLQS----ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
...++.+|||+|||||++... ..|+..+|+||||++..||.-|.+|+-+..+...+..|
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---------------- 240 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---------------- 240 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC----------------
Confidence 445778999999999999543 34788999999999999999999999887766554443
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
|..+++.+. -+...+.++.+||..||.+|-++||+..++|+|||+++
T Consensus 241 ----------pRNPPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 241 ----------PRNPPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ----------CCCCCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 332332222 23456889999999999999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.56 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=192.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-EEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-RLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E 80 (417)
++|.-...||+|+||.||+|.-.. |..||||++....... ...+.+|++++.+++|||+|+++++|.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 456677899999999999997654 4899999887654431 233678999999999999999999999988 5999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCCeeee-CCcEEEeeccccccccC-CC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG---FFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GP 154 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g---i~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~ 154 (417)
||..+ |.+.+.......+++.....|+.+++.||+|||... |+||||||+|||+| +...||+|||+|..... ..
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 99865 545554433217899999999999999999999864 99999999999998 56899999999976554 33
Q ss_pred CCccc-cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 155 PYTNY-VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 155 ~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...+. .||.+|+|||.+..+. .+.++|||||||+|.||++|+.+........... ...|....-...
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~----------l~~w~~~~~~~~- 300 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS----------LVEWAKPLLEEG- 300 (361)
T ss_pred ceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCccccc----------HHHHHHHHHHCc-
Confidence 33333 8999999999986544 8999999999999999999998876543111100 111221111110
Q ss_pred hhccCCCCCccccc--ccCC-CCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 234 IKYQFPQLPRANLS--ALMP-SASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 234 ~~~~~~~~~~~~~~--~~~~-~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+.......+. .+.. ..-..+..+..+|++.+|.+||++.|+++
T Consensus 301 ---~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 ---KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ---chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111111111 1100 11234778889999999999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.31 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=206.3
Q ss_pred CceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+-+..++||+|+||+||+|+... ....||||.++.........++.||++++..|+|||||+|++++..++-+|+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 34678899999999999997433 2357999999887666566677899999999999999999999999999999
Q ss_pred EEeccC-CCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEEEee
Q 044608 78 VFECME-CNLYQLMAARD------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIAD 143 (417)
Q Consensus 78 v~E~~~-~~l~~~~~~~~------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vkL~D 143 (417)
|||||. |+|-+.+..+. ...++..+...++.||+.|++||-++.+|||||-..|+||.++ .|||+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence 999997 45666665442 1238899999999999999999999999999999999999876 699999
Q ss_pred ccccccccCCCCCc---cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCC
Q 044608 144 FGLAREIKSGPPYT---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSP 219 (417)
Q Consensus 144 Fg~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~ 219 (417)
||+++.+-+.+-+. ...-...||+||.+..++ |+.++||||+||+|||+++ |..||.+.++.+.++.|...
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g---- 721 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG---- 721 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC----
Confidence 99998765543322 223356799999998877 8999999999999999996 79999999999999888531
Q ss_pred CccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 220 TMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
.+-..+...+.++.+|+..|++.+|.+|||+.||
T Consensus 722 -------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 -------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred -------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1123345788999999999999999999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.43 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=192.5
Q ss_pred ceecceecccCceEEEEEEEC---CCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCC------
Q 044608 4 YSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNN------ 73 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 73 (417)
|.+.+.||+|+||.||+|... .++..||||++....... ......+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 788999999999999999854 367899999997654332 2334568999999999999999999886532
Q ss_pred EEEEEEeccCCCHHH-HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccc
Q 044608 74 RLYLVFECMECNLYQ-LMAAR----DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLA 147 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~-~~~~~----~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a 147 (417)
..++++||+.++.+. .+... ....+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347888998765443 33221 112478899999999999999999999999999999999996 478999999999
Q ss_pred ccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccc
Q 044608 148 REIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 148 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 223 (417)
....... ......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+....+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------- 231 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-------- 231 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 8654322 122334567899999986554 7899999999999999999 89999887765544433210
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ....+..+.++.+++.+||+.+|++|||+.+++++
T Consensus 232 -------------~~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 -------------NR--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -------------Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=300.17 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=195.0
Q ss_pred CCceecceecccCceEEEEEEEC----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (417)
++|++.+.||+|+||.||+|... .+++.||+|++.............+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 47899999999999999999854 35889999999865443233445689999999999999999999887 5689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~ 154 (417)
++||||+.++.+..+.......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999765444444443345899999999999999999999999999999999999964 789999999998765322
Q ss_pred CC----ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 PY----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ~~----~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.. ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||......... ..+......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~- 236 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQGQMIVTRLL- 236 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhcc-----ccccccccccHHHHH-
Confidence 21 1224456799999986554 899999999999999999999998654322110 000000000000000
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....... . .......+.++.+|+.+||..||++|||+.|+++
T Consensus 237 -~~~~~~~-~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 -ELLKEGE-R------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred -HHHHcCC-c------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 0 0112345688999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.12 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=202.7
Q ss_pred ceecceecccCceEEEEEEECCC-C----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHT-G----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~-g----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
-++.+.||+|+||.||.|.-... | ..||||.+.+.....+...+++|..+|++++|||||++++++.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 46778999999999999986553 2 249999998877777777888999999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccccccc
Q 044608 79 FECMECN-LYQLMAARD-----RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK 151 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~-----~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~ 151 (417)
+|||+|+ |+..+.... ...++..+...++.||+.|..||+++++|||||-..|+||+. ..|||+|||+|+.+.
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 9999876 555554431 456899999999999999999999999999999999999975 679999999999443
Q ss_pred CCCCCc---cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 152 SGPPYT---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 152 ~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
....+. ...-..-|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+......
T Consensus 854 ~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g------------ 920 (1025)
T KOG1095|consen 854 DKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG------------ 920 (1025)
T ss_pred hchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC------------
Confidence 322111 1122357999999976 459999999999999999997 78999999988887654321
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+ -..+..++..+.+++..|+..+|++||++..|++
T Consensus 921 ------gR-----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 ------GR-----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------Cc-----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 01 1123457788999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.84 Aligned_cols=268 Identities=22% Similarity=0.330 Sum_probs=184.0
Q ss_pred CCceecceecccCceEEEEEEEC----------------CCCcEEEEEEecccccChh-------------hhhhHHHHH
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE----------------HTGEAVAIKELKQRYASWE-------------DCLNLREVK 52 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~----------------~~g~~vaiK~i~~~~~~~~-------------~~~~~~E~~ 52 (417)
++|++.++||+|+||.||+|... ..++.||||.++....... ......|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999642 2456799999864321110 111234777
Q ss_pred HHHhcCCCCe-----eeeceEEEe--------CCEEEEEEeccCCCHHHHHHHhc-----------------------CC
Q 044608 53 CLRKLNHSNI-----VKLKELIQN--------NNRLYLVFECMECNLYQLMAARD-----------------------RK 96 (417)
Q Consensus 53 ~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~~l~~~~~~~~-----------------------~~ 96 (417)
++.+++|.++ ++++++|.. .+..++||||+.++.+..+.... ..
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7888876654 667776643 35689999999876444333211 01
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc--ccCCccccCchhhhc
Q 044608 97 LFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN--YVGSRWYRAPEILLQ 173 (417)
Q Consensus 97 ~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~--~~gt~~y~aPE~l~~ 173 (417)
.+++..++.++.||+.+|.|||++||+||||||+|||++ ++.+||+|||++........... ..+|+.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 245678899999999999999999999999999999996 47899999999976544333332 244899999999853
Q ss_pred cCC-------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 174 SEL-------------------YS--SKADMWAMGAIMAELFTFCP-LFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 174 ~~~-------------------~~--~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
... |+ .+.||||+|||+|+|++|.. ||.+........+.. ......|...
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~~---- 456 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRMY---- 456 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHhh----
Confidence 221 12 34799999999999999875 775432211111100 0000112110
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCC---CCCCCHHHHHcCccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDP---SKRPTAAEALQHPFFKR 286 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpta~elL~hp~f~~ 286 (417)
....+.+ ..++..+++++|||.+||..+| .+|+|++|+|+||||..
T Consensus 457 ~~~~~~~---------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 KGQKYDF---------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccCCCc---------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0111111 1345679999999999999876 68999999999999964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.48 Aligned_cols=278 Identities=28% Similarity=0.475 Sum_probs=213.6
Q ss_pred CCceecceecccCceEEEEEEECC---CCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+.|..+.+||+|+|++||++.+.. ..+.||+|.+..-.. -.++.+|+++|..+ .+.||+++.+++..++...+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 468899999999999999999887 788999999864322 23467899999999 59999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCC--
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSG-- 153 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~-- 153 (417)
||||++......+... ++..+++.|++.++.||.++|.+||+||||||.|+|.+. ++-.|+|||+|......
T Consensus 113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999987766665532 678999999999999999999999999999999999975 78999999999721100
Q ss_pred -------------C----------------C--------------CccccCCccccCchhhhccCCCCchhhHHHHHHHH
Q 044608 154 -------------P----------------P--------------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIM 190 (417)
Q Consensus 154 -------------~----------------~--------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 190 (417)
. + .....||++|+|||++..-...++++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 01235999999999998877789999999999999
Q ss_pred HHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCccchHHHHHH-----------HhhhhccCCCC-----C---c--ccccc
Q 044608 191 AELFTFCPLF-PGASEADQMYKICGVLGSPTMDSWADGLRQ-----------ARAIKYQFPQL-----P---R--ANLSA 248 (417)
Q Consensus 191 ~ell~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-----------~~~~~~~~~~~-----~---~--~~~~~ 248 (417)
.-++++..|| ...++.+.+..|+..+|............. .......|... . . .....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999998775 555667777777777765333221111100 00001111111 0 0 11222
Q ss_pred cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 249 LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 249 ~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....++..+.||+.+||..||.+|.||+|+|+||||..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 23345668999999999999999999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=278.77 Aligned_cols=242 Identities=42% Similarity=0.693 Sum_probs=195.9
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC-HHHHHHH
Q 044608 14 AFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAA 92 (417)
Q Consensus 14 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~-l~~~~~~ 92 (417)
+||.||+|.+..+|+.+|+|++.............+|++.+++++|+||+++++++......+++|||++++ +...+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999999999999999976544332345568999999999999999999999999999999999884 5544433
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccccCCccccCchhh
Q 044608 93 RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171 (417)
Q Consensus 93 ~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l 171 (417)
. ..+++..+..++.+++.+|.+||+.|++|+||+|.||++++ +.++|+|||.+.............++..|++||.+
T Consensus 81 -~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 -R-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred -c-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 3 22899999999999999999999999999999999999965 78999999999877665555667889999999998
Q ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCC
Q 044608 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMP 251 (417)
Q Consensus 172 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (417)
.+.. ++.++|+||||+++|+|++|..||......+........ . ... ......
T Consensus 159 ~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~---------------~~~--------~~~~~~ 211 (244)
T smart00220 159 LGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---P---------------KPP--------FPPPEW 211 (244)
T ss_pred ccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---c---------------CCC--------Cccccc
Confidence 6444 788999999999999999999999874333332222110 0 000 001111
Q ss_pred CCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 252 SASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 252 ~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
.++.++.+++.+||..||++|||+.++++||||
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.93 Aligned_cols=242 Identities=31% Similarity=0.508 Sum_probs=189.9
Q ss_pred ceecccCce-EEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFG-RVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
+.+|.|+-| .||+| ...|+.||||.+-... .....+|+..|+.- +|||||++|+.-.+....||+.|.|.++
T Consensus 515 eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRG--VYEGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred HHcccCCCCcEEEEE--eeCCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhh
Confidence 568999998 56999 4678999999885432 22345899999998 5999999999999999999999999999
Q ss_pred HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----C--cEEEeeccccccccCCCC--
Q 044608 86 LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----G--IIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 86 l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~--~vkL~DFg~a~~~~~~~~-- 155 (417)
|.+++... .......-..+.++.|+++||++||+.+|+||||||.||||+. + +++|+|||+++.+..+..
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99888763 1111111445788999999999999999999999999999953 3 589999999998865432
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....||-+|+|||++.... -+.++||||||||+|..++| ..||.+..+.+. .|.. |
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~--~--------------- 728 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILT--G--------------- 728 (903)
T ss_pred hcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhc--C---------------
Confidence 45668999999999997766 57799999999999998887 899977654332 1211 0
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
.+ .+..+.+....++.|||.+||++||..||||.++|.||||=
T Consensus 729 --~~--------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 729 --NY--------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred --cc--------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 11 11111122222899999999999999999999999999993
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.15 Aligned_cols=211 Identities=24% Similarity=0.418 Sum_probs=180.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
....+..||+|++|.|=+.++..+|...|+|.+.......+....++|+.+..+. .+|++|.||+.+.++..++|.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3455678999999999999999999999999999888877777888999987766 799999999999999999999999
Q ss_pred cCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 82 MECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|+-++-.+..+ ..+...+|..+-.++..++.||.|||++ .++|||+||+||||+ +|+||+||||.+..+.++-..+
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 98765444332 2346789999999999999999999987 899999999999997 6999999999999887776666
Q ss_pred cccCCccccCchhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH
Q 044608 158 NYVGSRWYRAPEILL---QSELYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKIC 213 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~ 213 (417)
...|.-.|||||.+. +...|+-++||||||+.+.||.+++.||+.- ++.+++..++
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 568899999999983 3336999999999999999999999998653 4556666554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=294.48 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=200.6
Q ss_pred eecceecccCceEEEEEEECCC--C--cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 5 SGFKELGRGAFGRVFQAFDEHT--G--EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~--g--~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+..++||.|.||.||.|..... | -.||||..+.+........++.|..++++++|||||++++++.+ ...|||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 3457899999999999975332 3 36999999987776666777899999999999999999999976 45799999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
.+..|-+..+.+++...++......|+.||+.||.|||++.+|||||-..|||++. ..|||+|||+++.+.....+...
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence 88766555555566677899999999999999999999999999999999999965 67999999999988776555444
Q ss_pred cC--CccccCchhhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 160 VG--SRWYRAPEILLQSELYSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 160 ~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.| ..-|||||.+.-.. ++.++|+|.|||.+||++ .|..||.+-.+.|.+..|.
T Consensus 551 ~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE----------------------- 606 (974)
T KOG4257|consen 551 RGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE----------------------- 606 (974)
T ss_pred ccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-----------------------
Confidence 44 34599999985544 899999999999999987 5899999887766654432
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
.......++.+++.+..|+.+|+..||.+||+..|+.
T Consensus 607 ------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 607 ------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1112345578899999999999999999999987764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=289.74 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=207.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
...+.++||+|.||.|.+|.- ..+..||+|.++..........+.+|+++|.+|+|||||+++++|...+.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 346789999999999999963 3468999999987766655567789999999999999999999999999999999999
Q ss_pred CCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc---
Q 044608 83 ECNLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT--- 157 (417)
Q Consensus 83 ~~~l~~-~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~--- 157 (417)
+++.+. .+...............++.||++|++||.+.++|||||.+.|+|++. .++||+|||+++.+-+++.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 876544 444443222344556669999999999999999999999999999975 799999999999776655432
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF--TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
..+-...|||+|.++.++ ++.++|+|+||+++||++ +...||...++++.....+..+..+.
T Consensus 698 r~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~--------------- 761 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG--------------- 761 (807)
T ss_pred ceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC---------------
Confidence 235577899999998777 899999999999999976 45789988888887777665443322
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
..-....++-+..++..||.+|+..|-++|||.+++ |-+|+
T Consensus 762 -------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 762 -------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred -------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 122223345678899999999999999999999999 44454
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=296.60 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=207.6
Q ss_pred CceecceecccCceEEEEEEECC-CCc--EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEH-TGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~-~g~--~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+..+.++||+|.||.|++|.... +|+ .||||.++..........+++|+.+|.+|+|||++++|++..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 45677899999999999998765 343 7999999876655555667899999999999999999999987 6778999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|.+.++ |++.+.+.....|-....-.|+.||+.|+.||.++++|||||-..|||+. ...|||||||+.+.+.....+.
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999865 66666654556788899999999999999999999999999999999994 5889999999999887766544
Q ss_pred ccc----CCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 158 NYV----GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 158 ~~~----gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.+. -...|+|||.|.... ++.++|+|++||++|||++ |..||.|.+..+++.+|-.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~------------------ 330 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA------------------ 330 (1039)
T ss_pred EecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc------------------
Confidence 322 245699999997665 8999999999999999997 5899999999988887631
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
...-...+.+++++.+++..|+..+|++|||+..|.+.-++
T Consensus 331 -----------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 331 -----------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -----------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 01112234678999999999999999999999988654443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.98 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=213.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+.+..+|.|+||.||+|+++.+++..|+|+++..-.. .-..+..|+-+++.++|||||.+++.|...+.++++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 6899999999999999999999999999999999864322 122234699999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
|+|+.++.+.... +.++|.++..+++..+.||.|||+.|=+|||||-.|||+++ |.+|++|||.+..+... .....+
T Consensus 94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 9999888877544 67999999999999999999999999999999999999965 89999999998766533 344678
Q ss_pred cCCccccCchhh--hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEIL--LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l--~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
.||++|||||+- .....|...+|||++|+...||--.++|.-.......++.+..- .++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-------------------~~q 233 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-------------------GFQ 233 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-------------------CCC
Confidence 999999999985 33445999999999999999999999886555555544443211 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
-|.. .-....++-+.+|++.+|.++|.+|||++.+|+|||...
T Consensus 234 pp~l------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 234 PPTL------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCcc------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111 111345788999999999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=289.57 Aligned_cols=198 Identities=31% Similarity=0.538 Sum_probs=171.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh---h----hHHHHHHHHhcC---CCCeeeeceEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC---L----NLREVKCLRKLN---HSNIVKLKELIQN 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~---~----~~~E~~~l~~l~---hpnIv~l~~~~~~ 71 (417)
.+|..++.||.|+||.|++|+++.+...|+||.|.+...-.+.. . .-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999999999999999998764322211 1 136999999998 9999999999999
Q ss_pred CCEEEEEEeccC-C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 72 NNRLYLVFECME-C-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 72 ~~~~~lv~E~~~-~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
++++||+||--+ | +|++.+..+ ..++|.+++.|++||+.|+++||+.||+|||||-||+.++ +|.+||+|||.|.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 999999999643 3 355555443 4589999999999999999999999999999999999996 6899999999998
Q ss_pred cccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 044608 149 EIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPG 202 (417)
Q Consensus 149 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 202 (417)
...++ ++..++||..|.|||++.+..+.+..-|||+||++||-+.....||..
T Consensus 719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76554 577889999999999998888888899999999999999998888853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=320.89 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=182.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
.|...+.||+|+||.||+|.++.+|..||+|.+...... ...|++.+++++|||||++++++.+.+..|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 456677899999999999999999999999998643221 135789999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCcc
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH---QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH---~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
+++.+..+.. .+++..+..++.||+.||+||| +.+|+||||||+||++++ +..++. ||........ ..
T Consensus 766 ~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~ 837 (968)
T PLN00113 766 EGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TK 837 (968)
T ss_pred CCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CC
Confidence 8776655543 2789999999999999999999 679999999999999975 455554 6655433221 23
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh-hcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI-KYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~-~~~ 237 (417)
..||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .....|.......... .+.
T Consensus 838 ~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 838 CFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVH-----------GSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCC-----------CcHHHHHHHhcCccchhhee
Confidence 47899999999986554 8999999999999999999999985432100 0001111100000000 000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+.... . .........++.+++.+|++.||++|||++|+++.
T Consensus 906 ~~~~~~-~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 906 DPSIRG-D-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccccC-C-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000 0 00001122467899999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.18 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=215.2
Q ss_pred eecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.|.++||.|.||.|++|+.+..|+ .||||.++..+.++....++.|..||-+++||||++|.++.....-+.||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 567889999999999999988874 79999999999888888899999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEEEeeccccccccCCCC--Ccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPP--YTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vkL~DFg~a~~~~~~~~--~~~ 158 (417)
|+.+.++...+.+.+.|+.-++..+++.|+.|++||-+.|+|||||-..|||++.+ .+|++|||+++.+.++.. +++
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt 791 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 791 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccc
Confidence 99887777777766789999999999999999999999999999999999999765 689999999998865542 222
Q ss_pred ccC--CccccCchhhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 159 YVG--SRWYRAPEILLQSELYSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 159 ~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
..| ...|.|||.+...+ ++.++|+||+|++|||.+ .|..||.+.++.|.++.|.. .
T Consensus 792 ~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~--------------------g 850 (996)
T KOG0196|consen 792 LGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ--------------------G 850 (996)
T ss_pred cCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHh--------------------c
Confidence 222 35799999997666 899999999999999966 68999999999999988853 3
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
|..|. +..++..+..|+..|+++|-..||+..+|+.+
T Consensus 851 yRLPp---------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 851 YRLPP---------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cCCCC---------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 33332 24578899999999999999999999999863
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=283.44 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=201.7
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
..+..+||-|.||.||.|..++..-.||||.++.+. .+...++.|..+|+.++|||+|+++++|..+--+|||.|||.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 345678999999999999999999999999998653 445566899999999999999999999999999999999985
Q ss_pred -CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEEEeeccccccccCCCCCccccC
Q 044608 84 -CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVG 161 (417)
Q Consensus 84 -~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vkL~DFg~a~~~~~~~~~~~~~g 161 (417)
|+|++++...++..++.-....++.||.+|++||..+++|||||-..|.|+.++ .||++|||+++....+ .++...|
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAG 425 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAG 425 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceecccC
Confidence 789999988777777777888899999999999999999999999999999865 5899999999976433 3333333
Q ss_pred ---CccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 162 ---SRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 162 ---t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..-|.|||-|.-+. ++.++|+|+|||+|||+.| |-.||++-+-...+..+.. .|.
T Consensus 426 AKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk--------------------gyR 484 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK--------------------GYR 484 (1157)
T ss_pred ccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc--------------------ccc
Confidence 44599999986544 8999999999999999986 6789999876554443321 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
. .-+.++++.+..|++.|++|+|.+||+.+|+-
T Consensus 485 M---------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 M---------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred c---------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1 12246889999999999999999999999883
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=256.56 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=194.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceE-EEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKEL-IQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~ 79 (417)
|.|.|.+.||+|.||.+-+|.|+.+...+++|.+....... ....+|...--.| -|.||+.-|++ |+..+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~--~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ--ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH--HHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 68999999999999999999999999999999998876553 3345677665556 48999999975 78888999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCC
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~ 155 (417)
||++.+ |...+.. ..+.|...+.++.|+++||.|||++++||||||.+||||- .-+|||||||+++..+....
T Consensus 102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 998755 4443322 3489999999999999999999999999999999999993 24799999999987655433
Q ss_pred CccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 YTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
... -+..|.+||++.. .-...+.+|+|.||+|+|.+++|++||......+.-+- .|.
T Consensus 179 ~~~--~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~-----------~~~------ 239 (378)
T KOG1345|consen 179 YLE--YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW-----------EWE------ 239 (378)
T ss_pred hhh--hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH-----------HHH------
Confidence 222 2456999998742 22356789999999999999999999975443222211 111
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCC---CCHHHHHcCcccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFK 285 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pta~elL~hp~f~ 285 (417)
.+.- .....+...+..+|+.+..++++-|..++++| -+++.-...-|..
T Consensus 240 ---~w~~--rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 240 ---QWLK--RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ---HHhc--ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 1111 11223445567789999999999999999999 5555555666653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=239.82 Aligned_cols=212 Identities=43% Similarity=0.689 Sum_probs=179.3
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHHHH
Q 044608 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQL 89 (417)
Q Consensus 10 LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~~~ 89 (417)
||+|.+|.||++.+..+|+.+++|++.............+|++.++.+.|++|+++++++......+++||++.|..+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999865443223445689999999999999999999999999999999999654444
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCCC-CCccccCCcccc
Q 044608 90 MAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGP-PYTNYVGSRWYR 166 (417)
Q Consensus 90 ~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~~-~~~~~~gt~~y~ 166 (417)
+.......+++..++.++.+++.+|.+||++|++|+||+|.||++++ +.++|+|||.+....... ......+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 44433235899999999999999999999999999999999999976 789999999998654432 133456788999
Q ss_pred CchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccc
Q 044608 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANL 246 (417)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (417)
+||.+.....++.+.|+|++|+++++|
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------------- 187 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------------- 187 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------------
Confidence 999986553588999999999999999
Q ss_pred cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 247 SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 247 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
..+.+++.+||+.||++|||++++++|+
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2356899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=279.69 Aligned_cols=246 Identities=30% Similarity=0.481 Sum_probs=195.6
Q ss_pred eecceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEE
Q 044608 5 SGFKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 76 (417)
.+.+.||+|+||.|++|.-.. ....||+|.++......+...+..|+++|+.+ .||||+.+++++...+.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 566799999999999996321 14579999998877776666778999999999 5999999999999999999
Q ss_pred EEEeccCC-CHHHHHHHhc------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEE
Q 044608 77 LVFECMEC-NLYQLMAARD------R--------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIK 140 (417)
Q Consensus 77 lv~E~~~~-~l~~~~~~~~------~--------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vk 140 (417)
+|+||+.. +|+..+..+. . ..++..+...+..||+.|++||+++.++||||-..|||++++ .+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 99999875 4665555433 0 238889999999999999999999999999999999999875 789
Q ss_pred EeeccccccccCCCCCcc--ccC--CccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHH
Q 044608 141 IADFGLAREIKSGPPYTN--YVG--SRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGAS-EADQMYKICG 214 (417)
Q Consensus 141 L~DFg~a~~~~~~~~~~~--~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~-~~~~~~~i~~ 214 (417)
|+|||+|+.......+.. ..| ...|||||.+.. ..|+.++||||+|++|||+++ |..||++-. ..+.+..+..
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE 537 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence 999999996655443321 222 234999999976 559999999999999999997 689998855 4444332211
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
......+..++.++.++++.|++.+|++||+..++.+
T Consensus 538 -----------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 538 -----------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred -----------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 0111223456899999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=261.06 Aligned_cols=259 Identities=27% Similarity=0.344 Sum_probs=179.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHh--cCCCCeeeeceEEEeCC----EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--LNHSNIVKLKELIQNNN----RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~ 75 (417)
+..++++.||+|.||.||+| +-+++.||||++... +......|.+|.+. ++|+||++|+++-+... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehh--hccCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34567889999999999999 566799999998643 22233456666554 68999999999876555 89
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCCeee-eCCcEEEeec
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN---------GFFHRDLKPENLLV-SQGIIKIADF 144 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~---------gi~HrDLKp~NILl-~~~~vkL~DF 144 (417)
+||+||-+.+ |.+++.. + ..+......++..+++||+|||+- .|+|||||..|||| +|.+.-|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~-n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-N--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHh-c--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999987655 5555543 3 379999999999999999999963 59999999999999 5689999999
Q ss_pred cccccccCCC---CCccccCCccccCchhhhccCCCC-----chhhHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHHHH
Q 044608 145 GLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYS-----SKADMWAMGAIMAELFTFCPLFPG-AS-EADQMYKICG 214 (417)
Q Consensus 145 g~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~ell~g~~pf~~-~~-~~~~~~~i~~ 214 (417)
|+|..+..+. .....+||..|||||+|.+.-... ...||||+|.|||||++.+..+.. .. +...-+ ..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf--e~ 438 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF--EA 438 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch--hH
Confidence 9998876432 233479999999999996543232 358999999999999998755531 11 111100 00
Q ss_pred hhC-CCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 215 VLG-SPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 215 ~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
.+| .|+.+......- .+...|.++..-... ..-..+++.+..|++.||+.|.||.=+
T Consensus 439 evG~hPt~e~mq~~VV----~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVV----RKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHH----hhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 111 122222111110 011112211111111 123468999999999999999997544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=270.63 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=197.4
Q ss_pred eecceecccCceEEEEEEECCCCc----EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+..++||.|+||+||+|.....|+ .||||++...........+++|+-+|.+|+|||++++++++.... +-||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 456889999999999998776665 688998876655555666789999999999999999999997765 889999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC-Ccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-~~~ 158 (417)
||.++.+....+.++..+.......|..||++|+.|||.++++||||-..|||+.. +++||.|||+++.+..... +..
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 99876444444445567899999999999999999999999999999999999965 8999999999998765433 222
Q ss_pred cc--CCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 159 YV--GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 159 ~~--gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.. -.+-|||=|.+.... |+.++||||+||.+|||+| |..|+.+.+..++-..+. ...
T Consensus 858 ~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----------------~ge--- 917 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----------------KGE--- 917 (1177)
T ss_pred cccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------ccc---
Confidence 22 245588988886555 9999999999999999885 889998887666543331 110
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
--..+|..+-++.-++.+||..|+..||+++++-.
T Consensus 918 ----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 ----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11234668899999999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=297.60 Aligned_cols=199 Identities=20% Similarity=0.258 Sum_probs=147.3
Q ss_pred HhcCC-CCeeeeceEE-------EeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 044608 55 RKLNH-SNIVKLKELI-------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126 (417)
Q Consensus 55 ~~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrD 126 (417)
+.++| .||++++++| .....++++|||++++|.+.+... ...+++.+++.++.||++||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 44556 5888888877 233568889999988888877543 35589999999999999999999999999999
Q ss_pred CCCCCeeeeC--------------------CcEEEeeccccccccCC-----------------CCCccccCCccccCch
Q 044608 127 LKPENLLVSQ--------------------GIIKIADFGLAREIKSG-----------------PPYTNYVGSRWYRAPE 169 (417)
Q Consensus 127 LKp~NILl~~--------------------~~vkL~DFg~a~~~~~~-----------------~~~~~~~gt~~y~aPE 169 (417)
|||+||||+. +.+||+|||+++..... ......+||++|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999942 34667777776532110 0011246899999999
Q ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCccccccc
Q 044608 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSAL 249 (417)
Q Consensus 170 ~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (417)
++.+.. |+.++|||||||+||||++|.+||.... ..+..+... ..+. .
T Consensus 186 ~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~---------------------~~~~--------~ 233 (793)
T PLN00181 186 EDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR---------------------VLPP--------Q 233 (793)
T ss_pred hhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh---------------------hcCh--------h
Confidence 987665 8999999999999999999988875321 111111100 0010 0
Q ss_pred CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 250 MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 250 ~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.....+++.+++.+||..||.+|||+.|+|+||||..
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0112456789999999999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=236.87 Aligned_cols=206 Identities=39% Similarity=0.599 Sum_probs=171.4
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
|.+.+.||.|++|.||++.+..+++.+|+|.+.............+|++.+++++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999999999999999865433233445689999999999999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC--CCcccc
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYTNYV 160 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~--~~~~~~ 160 (417)
++.+..+.......+++..+..++.+++.+|.+||++|++|+||+|.||++++ +.++|+|||++....... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 84444444333222799999999999999999999999999999999999975 789999999998765543 344567
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHH
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPG-ASEADQM 209 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~ 209 (417)
++..|++||.+.....++.++|+|+||+++|+|++|+.||.. .+....+
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~ 210 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL 210 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence 888999999874344477899999999999999999999977 4444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=243.05 Aligned_cols=244 Identities=28% Similarity=0.399 Sum_probs=175.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHh--cCCCCeeeeceEEEeC----CEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--LNHSNIVKLKELIQNN----NRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~----~~~~ 76 (417)
+..+++.||+|.||+||+| +.-|+.||||++.... +..-+||.+|++. |+|+||+.|++.-... ..+|
T Consensus 212 qI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeec--cccCCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 4568899999999999999 5669999999987531 2222466666665 6999999999875433 3689
Q ss_pred EEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCeeee-CCcEEEeeccc
Q 044608 77 LVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN--------GFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~--------gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
||.+|-+. +|++++.. ..++.+....++..+++||++||.. .|+|||||..|||+. +|.+-|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999875 56666554 3489999999999999999999943 599999999999995 68999999999
Q ss_pred cccccCC-----CCCccccCCccccCchhhhccC----CCC-chhhHHHHHHHHHHHHhC----------CCCCCCC---
Q 044608 147 AREIKSG-----PPYTNYVGSRWYRAPEILLQSE----LYS-SKADMWAMGAIMAELFTF----------CPLFPGA--- 203 (417)
Q Consensus 147 a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~----~~~-~~~DiwSlG~il~ell~g----------~~pf~~~--- 203 (417)
|....+. ...+..+||-.|||||+|...- .-+ ..+||||||.|+||++.. .+||.+-
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9765543 2346779999999999985331 111 247999999999998752 4777543
Q ss_pred -CHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCC--CCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 204 -SEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPS--ASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 204 -~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
...+.+.+++.. +...+.+...+.. .-..+-.+++.|+..||.-|.||--+.
T Consensus 443 DPs~eeMrkVVCv------------------------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 443 DPSFEEMRKVVCV------------------------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCHHHHhcceee------------------------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 223333333221 0001111111111 112466789999999999999987663
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=263.20 Aligned_cols=261 Identities=26% Similarity=0.354 Sum_probs=199.7
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEeccc----ccChhhh-hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQR----YASWEDC-LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~----~~~~~~~-~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.....+|.|++|.|+.+......+.++.|..... ....... .+..|+-+-..|.|||++.....+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3456899999999999988877777777765421 1111111 1345777788899999998888777766666669
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG----- 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~----- 153 (417)
||+.++++..+... ..++..++..+++||+.||+|||+.||.|||||++|++++. |.+||+|||.+..+...
T Consensus 401 E~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99998777766653 35899999999999999999999999999999999999975 69999999998765432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
......+|+..|+|||++.+..+....+||||.|++++.|.+|+.||......+.... .
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------------------~ 537 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------------------T 537 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------------------h
Confidence 2235578999999999998888666788999999999999999999977665444320 0
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
..+............+...++.+.+.+|.+||++||.+|.|+++|++.+||+...
T Consensus 538 ~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 538 NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0111111112222334445678899999999999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=216.75 Aligned_cols=166 Identities=20% Similarity=0.289 Sum_probs=123.6
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccccCC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
|+|.+.+..+ +..+++.+++.++.||+.||.|||+++ ||+|||+++ +.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 4566655543 356999999999999999999999999 999999964 67888 9998765432 23689
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
+.|+|||++.+.. |+.++|||||||++|||++|..||........ +..+...... ..+..
T Consensus 68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~~ 128 (176)
T smart00750 68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA------------------DDPRD 128 (176)
T ss_pred ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc------------------CCccc
Confidence 9999999997655 89999999999999999999999976544322 2222111000 00000
Q ss_pred CcccccccCCCCCH--hHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 242 PRANLSALMPSASQ--DAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 242 ~~~~~~~~~~~~s~--~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
......++. ++.+||.+||..||.+|||+.|+++|+|+..
T Consensus 129 -----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 129 -----RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -----cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 000112233 6999999999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=220.24 Aligned_cols=260 Identities=34% Similarity=0.527 Sum_probs=204.0
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCC-CeeeeceEEEeCCEEEEEEe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHS-NIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E 80 (417)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 8899999987655543 45557899999999988 79999999988888999999
Q ss_pred ccCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C-cEEEeeccccccccCCC--
Q 044608 81 CMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G-IIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~--~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~-~vkL~DFg~a~~~~~~~-- 154 (417)
++.++.+..+..... ..+++..+..++.|++.++.|+|+.|++||||||+||+++. + .++++|||++..+....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 998876665544432 25899999999999999999999999999999999999975 4 69999999997554432
Q ss_pred -----CCccccCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhCCCCccch
Q 044608 155 -----PYTNYVGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASE---ADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 155 -----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~ 224 (417)
.....+||..|+|||.+.+. ..++...|+||+|++++++++|..||..... .............+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence 34677899999999998763 4589999999999999999999999887764 33333332222211
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....... ..........+.+++.+++..+|..|.+..+...++|...
T Consensus 234 ------------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 234 ------------SLASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ------------ccccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 0000000 0000122367899999999999999999999999977654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=229.29 Aligned_cols=160 Identities=23% Similarity=0.324 Sum_probs=125.3
Q ss_pred CCCceecceecccCceEEEEEEECC-CCcEEEEEEeccccc----ChhhhhhHHHHHHHHhcCCCCeee-eceEEEeCCE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYA----SWEDCLNLREVKCLRKLNHSNIVK-LKELIQNNNR 74 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~ 74 (417)
+++|++.+.||+|+||+||+|+++. +++.||||++..... ........+|+++|++|+|+||+. +++ .+.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 4789999999999999999999876 788889998753311 112234568999999999999985 443 245
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCCeeee-CCcEEEeeccccccccC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL-KPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDL-Kp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.|+||||++|+.+.... . .. ...++.|++++|.|||++||+|||| ||+|||++ ++.+||+|||+|+.+..
T Consensus 93 ~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 93 DGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred cEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 79999999987665321 1 11 1468899999999999999999999 99999996 47899999999986543
Q ss_pred CC---------CCccccCCccccCchhhh
Q 044608 153 GP---------PYTNYVGSRWYRAPEILL 172 (417)
Q Consensus 153 ~~---------~~~~~~gt~~y~aPE~l~ 172 (417)
.. ..+..++++.|+|||.+.
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 22 124567888999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=218.49 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=190.8
Q ss_pred CceecceecccCceEEEEEEECCCC-cEEEEEEecccccChhhhhhHHHHHHHHhcCC----CCeeeeceEE-EeCCEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKELKQRYASWEDCLNLREVKCLRKLNH----SNIVKLKELI-QNNNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~ 76 (417)
+|.+.++||+|+||.||.|.+..++ +.+|+|+.......... ....|+.++..+.. +++..+++.. ..+..-|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988875 68999987654332222 44578899988863 6899999998 5788899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC------CcEEEeeccccc--
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ------GIIKIADFGLAR-- 148 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~------~~vkL~DFg~a~-- 148 (417)
+||+.++.+|.++......+.|+...+..++.|++.+|++||+.|++||||||+|+++.. ..+.|.|||+++
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 999999888888765555577999999999999999999999999999999999999953 359999999998
Q ss_pred cccCCC--------C-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Q 044608 149 EIKSGP--------P-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSP 219 (417)
Q Consensus 149 ~~~~~~--------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 219 (417)
.+.... . .....||..|.++.+..+.. .+.+.|+||++.++.+|+.|..||.+........++......
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~- 255 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK- 255 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh-
Confidence 321111 1 12355999999999987666 799999999999999999999999777644333332211000
Q ss_pred CccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 220 TMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.... ........+...+...+-..+...+|....+...
T Consensus 256 ----------------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 ----------------LLTD--------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ----------------hccc--------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0000 0122334566677666667888888887776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=241.86 Aligned_cols=241 Identities=31% Similarity=0.466 Sum_probs=195.4
Q ss_pred eecccCceEEEEEEE---CCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEeccC
Q 044608 9 ELGRGAFGRVFQAFD---EHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
.+|+|+||.|++++. ...|..||+|+.++....... .....|..++..++ ||.+|+++..|+.+..+++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998753 345788999998755332211 12245888888887 9999999999999999999999988
Q ss_pred CC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccC
Q 044608 84 CN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVG 161 (417)
Q Consensus 84 ~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~g 161 (417)
|+ +...+... ..+.+...+.+...++.+++++|+.||+|||+|++||+++ +|++++.|||+++..-..... ||
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---cc
Confidence 75 44444332 4589999999999999999999999999999999999996 699999999999876544332 99
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
|..|||||++. ....++|+||+|+++++|++|..||.+ +.+..|... ...
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-------------------~~~---- 205 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-------------------ELE---- 205 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-------------------ccC----
Confidence 99999999986 368899999999999999999999988 555555421 111
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCccccccccCC
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFYAP 291 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~ 291 (417)
.+...+.++.+++..|+..+|..|.- +.|+++|+||+...|..
T Consensus 206 -------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 206 -------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred -------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 12346889999999999999999965 58999999999877653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=215.14 Aligned_cols=249 Identities=18% Similarity=0.273 Sum_probs=192.8
Q ss_pred CCceecceecccCceEEEEEEECCCC-----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEE-EeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI-QNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~ 75 (417)
+|++....+-+|.||.||.|+.+... +.|-+|.++...........+.|--.+..+.|||+..+.++. ++....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 45677778899999999999765432 356777777766665566667898899999999999999986 456678
Q ss_pred EEEEeccC-CCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecccc
Q 044608 76 YLVFECME-CNLYQLMAAR------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLA 147 (417)
Q Consensus 76 ~lv~E~~~-~~l~~~~~~~------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a 147 (417)
++++.+++ |+|...+..- ....++.-+...++.|++.|++|||+.|++|.||-..|.+|++ =+|||+|=.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 88899887 4555555421 1234666778889999999999999999999999999999987 58999999999
Q ss_pred ccccCCCCCc---cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccc
Q 044608 148 REIKSGPPYT---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 148 ~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 223 (417)
+.+...+-.. .--...-||+||.+.+.. |+.++|+|||||+||||++ |+.|+..-++.+...-+..
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd--------- 513 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD--------- 513 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc---------
Confidence 8765443211 112245699999997655 9999999999999999986 7899988887776554431
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.|.. .-+-++++++..++.-|+..+|++||+.+|+..
T Consensus 514 -----------GyRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 -----------GYRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------ccee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111 122467899999999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=240.33 Aligned_cols=222 Identities=29% Similarity=0.444 Sum_probs=167.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+.+|.|..|+||-||.++|+.+.+.+|+|+-++.. ++|- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-------hhhc--cccccCCccee------------------
Confidence 47899999999999999999999999999995433221 1111 44444555555
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-------
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG------- 153 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~------- 153 (417)
|+....+.. . +.++.+. +.+++|||+-||+|||+||+|+||+ -|++|+.|||++....-.
T Consensus 136 --gDc~tllk~-~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 --GDCATLLKN-I-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred --chhhhhccc-C-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 333333321 1 2344333 7789999999999999999999996 599999999998632110
Q ss_pred ---------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 154 ---------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 154 ---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
-.-...||||.|+||||++... |+..+|+|+||+|+||.+.|+.||.++..++.+..++.-
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd--------- 273 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD--------- 273 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh---------
Confidence 0113469999999999997655 999999999999999999999999999999988776532
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCC---CCHHHHHcCccccccccC
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pta~elL~hp~f~~~~~~ 290 (417)
...+|+ -.....+|++++|.++|+.+|..| ..+-++.+|+||+...|.
T Consensus 274 ----------~i~wpE--------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 274 ----------DIEWPE--------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ----------hccccc--------cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 111221 123467899999999999999999 568889999999876554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=195.64 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=166.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.+|.++++||.|+||.+|.|.+..+|+.||||+-..... .-....|.++.+.|. ...|..+..++.+..+-.+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 579999999999999999999999999999998654322 223457999999996 4778888888888888899999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCC--
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~-- 154 (417)
.++-+|.++..-.. +.|+...+.-++-|++.-++|+|.++++||||||+|+|..- +.+.|+|||+|+.+.+..
T Consensus 92 LLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred ccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 98777666654333 45899999999999999999999999999999999999953 569999999998764322
Q ss_pred ------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 044608 155 ------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEAD 207 (417)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 207 (417)
.-....||..|.+--...+.. .+...|+=|+|.+|..+.-|..||.+.....
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 124568999999977766555 6788999999999999999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=195.35 Aligned_cols=141 Identities=23% Similarity=0.278 Sum_probs=110.2
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-------------------------hhhHHHHHHHHhcCCC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-------------------------CLNLREVKCLRKLNHS 60 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-------------------------~~~~~E~~~l~~l~hp 60 (417)
+.+.||+|+||.||+|.+. +|+.||+|+++........ ....+|++++.+|.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999987 8999999999754321111 1113499999999888
Q ss_pred CeeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCCeeeeCCcE
Q 044608 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM-HQNGFFHRDLKPENLLVSQGII 139 (417)
Q Consensus 61 nIv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~L-H~~gi~HrDLKp~NILl~~~~v 139 (417)
++.....+... + .+|||||++|+.+....... ..+++..+..++.|++.+|.+| |+.||+||||||+|||++++.+
T Consensus 80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v 156 (190)
T cd05147 80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKL 156 (190)
T ss_pred CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcE
Confidence 87544433222 2 38999999986543322222 4589999999999999999999 7999999999999999998999
Q ss_pred EEeeccccccc
Q 044608 140 KIADFGLAREI 150 (417)
Q Consensus 140 kL~DFg~a~~~ 150 (417)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=196.62 Aligned_cols=206 Identities=24% Similarity=0.338 Sum_probs=170.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|.+.++||+|+||.++.|.+.-+++.||||.-..+.. .-+...|....+.| ..++|...|.+...+.+-.||||.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 69999999999999999999999999999997544321 22334688888888 479999999988888888999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee------CCcEEEeeccccccccCCCC
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS------QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~------~~~vkL~DFg~a~~~~~~~~ 155 (417)
++-+|.++..-.. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||. .+.|.|+|||+|+.+.+...
T Consensus 106 LGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 LGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 8777766655444 5699999999999999999999999999999999999994 25699999999987754322
Q ss_pred --------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Q 044608 156 --------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---ADQMYKIC 213 (417)
Q Consensus 156 --------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~ 213 (417)
.....||..||+=-..++.+ .+...|+=|||.+++..|-|..||.|... .+-+.+|-
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 34567999999988777776 78999999999999999999999998753 34444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=228.60 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=181.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh---hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED---CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|...+.||.+.|=+|.+|++.. |. |+||++-+....... .+.++|++ ...+++||.+.+.-+......-|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 46778899999999999997643 55 999998665433322 23356777 66779999999998888888889999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccc--c--CCC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI--K--SGP 154 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~--~--~~~ 154 (417)
+|...+|++.+..+ ..+.+-+.+-|+.||+.||.-||..||+|+|||.|||||+. +-+.|+||..-+.. . +..
T Consensus 101 qyvkhnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHhhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 99999999988765 44788899999999999999999999999999999999976 88999999876422 1 222
Q ss_pred CCccccC----CccccCchhhhcc---------C-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh-hCC
Q 044608 155 PYTNYVG----SRWYRAPEILLQS---------E-LYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGV-LGS 218 (417)
Q Consensus 155 ~~~~~~g----t~~y~aPE~l~~~---------~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~g~ 218 (417)
.++.+.. -.+|.|||.+... . ..+++.||||+||+++||++ |+|||.-. .+++- -|.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr~~~ 251 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYRSGN 251 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHhccC
Confidence 2332322 3469999998531 1 25788999999999999986 68999421 11110 000
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+.-... +..+ -+..++.||..|++.||++|.+|++.|+.
T Consensus 252 --~~~~e~~------------------Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 --ADDPEQL------------------LEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --ccCHHHH------------------HHhC---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000 0111 13468999999999999999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=201.81 Aligned_cols=196 Identities=30% Similarity=0.404 Sum_probs=146.1
Q ss_pred CCCCeeeeceEEEe---------------------------CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHH
Q 044608 58 NHSNIVKLKELIQN---------------------------NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQV 110 (417)
Q Consensus 58 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi 110 (417)
+|||||++..+|.+ +..+|+||....+.|..++..+. .+....+-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence 59999999887743 24589999988888888887654 5777888899999
Q ss_pred HHHHHHHHHCCcccccCCCCCeeee--C-C--cEEEeeccccccccC-------CCCCccccCCccccCchhhhccC---
Q 044608 111 FQGLSYMHQNGFFHRDLKPENLLVS--Q-G--IIKIADFGLAREIKS-------GPPYTNYVGSRWYRAPEILLQSE--- 175 (417)
Q Consensus 111 ~~aL~~LH~~gi~HrDLKp~NILl~--~-~--~vkL~DFg~a~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~--- 175 (417)
++|+.|||+.||.|||||.+|||+. + + .+.|+|||.+-.-++ ........|....||||+.....
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999993 3 2 589999998743222 11223456888899999974321
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCC
Q 044608 176 --LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSA 253 (417)
Q Consensus 176 --~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (417)
..-.++|.|+.|.+.||++....||.+..+... + ...|+ ...+..+...+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~----------~r~Yq-----e~qLPalp~~v 482 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------D----------TRTYQ-----ESQLPALPSRV 482 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchhee-------------c----------hhhhh-----hhhCCCCcccC
Confidence 123579999999999999999999987432211 0 00122 12234455678
Q ss_pred CHhHHHHHHHhcccCCCCCCC---HHHHHcCccc
Q 044608 254 SQDAISLFESLCSWDPSKRPT---AAEALQHPFF 284 (417)
Q Consensus 254 s~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f 284 (417)
.+.+++|+..+|+.||++|++ |+.+|+-..|
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 899999999999999999998 4556654433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=193.27 Aligned_cols=170 Identities=15% Similarity=0.108 Sum_probs=128.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhh--h------hHHHHHHHHhcCCCCeeeeceEEEeC-
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDC--L------NLREVKCLRKLNHSNIVKLKELIQNN- 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~--~------~~~E~~~l~~l~hpnIv~l~~~~~~~- 72 (417)
++|.+++.||.|+||.||++.. ++..+|+|++.......+.. . ..+|+..+.+|.||+|..+.+++.+.
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5899999999999999999644 46789999997654433322 1 24789999999999999999987643
Q ss_pred -------CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeecc
Q 044608 73 -------NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFG 145 (417)
Q Consensus 73 -------~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg 145 (417)
+..+++|||++|..+..+. .+++. ...+|+.+|..||+.|++||||||+||+++++.++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECC
Confidence 3578999999987555442 13443 4569999999999999999999999999976449999999
Q ss_pred ccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHH
Q 044608 146 LAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELF 194 (417)
Q Consensus 146 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell 194 (417)
.+.......... .+++... |+.++|+||||+++..+.
T Consensus 180 ~~~~~~e~~a~d-----------~~vler~-y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKD-----------RIDLERH-YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHH-----------HHHHHhH-hcccccccceeEeehHHH
Confidence 886543221111 1233444 678999999999876554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=194.31 Aligned_cols=233 Identities=19% Similarity=0.260 Sum_probs=145.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hh-hhHHHHHHHHhcCC----------CCeeeeceEE--
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DC-LNLREVKCLRKLNH----------SNIVKLKELI-- 69 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~-~~~~E~~~l~~l~h----------pnIv~l~~~~-- 69 (417)
+...+.||.|+++.||.+.+..||+.+|+|+......... .. ...+|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3566789999999999999999999999999864332211 11 12233323322221 1222223322
Q ss_pred -------EeC---C-----EEEEEEeccCCCHHHHHH---HhcCCCCC--HHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 044608 70 -------QNN---N-----RLYLVFECMECNLYQLMA---ARDRKLFS--EPEIKAWLFQVFQGLSYMHQNGFFHRDLKP 129 (417)
Q Consensus 70 -------~~~---~-----~~~lv~E~~~~~l~~~~~---~~~~~~l~--e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp 129 (417)
... + +.+++|+-+.+++...+. ........ -.....+..|++..+++||+.|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 1 237788888888766533 33322111 222344568999999999999999999999
Q ss_pred CCeeee-CCcEEEeeccccccccCCCCCccccCCccccCchhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 044608 130 ENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS-------ELYSSKADMWAMGAIMAELFTFCPLFP 201 (417)
Q Consensus 130 ~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~ 201 (417)
+|+|++ +|.++|+||+.....+..... ...+..|.+||..... -.++.+.|.|+||+++|.|+||..||.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 999996 599999999987765443322 3446789999987442 237889999999999999999999997
Q ss_pred CCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCC
Q 044608 202 GASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR 272 (417)
Q Consensus 202 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 272 (417)
....... ....+..+. .+++.+++||+.||++||.+|
T Consensus 252 ~~~~~~~---------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEAD---------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGST---------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCcccc---------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 6532110 001334444 788999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=186.35 Aligned_cols=141 Identities=22% Similarity=0.224 Sum_probs=111.6
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChh-------------------------hhhhHHHHHHHHhcCCC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-------------------------DCLNLREVKCLRKLNHS 60 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-------------------------~~~~~~E~~~l~~l~hp 60 (417)
+.+.||+|+||.||+|.+. +|+.||||+++....... .....+|.+.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999987 899999999876432100 11124689999999999
Q ss_pred CeeeeceEEEeCCEEEEEEeccCCCH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeCCc
Q 044608 61 NIVKLKELIQNNNRLYLVFECMECNL-YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQGI 138 (417)
Q Consensus 61 nIv~l~~~~~~~~~~~lv~E~~~~~l-~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~~~ 138 (417)
+|.....+.... .|+||||++|+. ....... ..+++.++..++.|++.+|.+||+ +||+||||||+|||++++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~ 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGK 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCC
Confidence 886555544332 489999998863 3222222 347889999999999999999999 9999999999999999899
Q ss_pred EEEeecccccccc
Q 044608 139 IKIADFGLAREIK 151 (417)
Q Consensus 139 vkL~DFg~a~~~~ 151 (417)
++|+|||+|....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=211.25 Aligned_cols=174 Identities=31% Similarity=0.481 Sum_probs=126.1
Q ss_pred EEEEEeccCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc
Q 044608 75 LYLVFECMECNLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK 151 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~ 151 (417)
+||.|++|.-+.+.+++.+ .....+......++.|+..|++| +|.+|||+||.||+.. ++.+||.|||+.+...
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 5677777765544444432 22345667788999999999999 9999999999999995 4679999999998776
Q ss_pred CCC-------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccc
Q 044608 152 SGP-------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 152 ~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 223 (417)
... ..+..+||.+||+||.+.+.. |+.++||||||+||+||+. -...|..... +..+
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~----------- 472 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIAT---LTDI----------- 472 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhh-----------
Confidence 555 567789999999999997665 9999999999999999998 2222211110 0000
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+ ...+| +..+ .--++-.+|+.+||...|.+||++.+.--|.|.
T Consensus 473 --------r--~g~ip---~~~~-----~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 --------R--DGIIP---PEFL-----QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------h--cCCCC---hHHh-----hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 0 00111 0111 112456799999999999999988888778775
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=176.16 Aligned_cols=188 Identities=19% Similarity=0.105 Sum_probs=138.6
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh---hhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE---DCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+.+...|++|+||+|+.+. ..+..++.+.+........ .....+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 4567889999999999884 3677888777765432211 113458999999995 5889999886 4469999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCCeeee-CCcEEEeeccccccccCCCCC-
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL-KPENLLVS-QGIIKIADFGLAREIKSGPPY- 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDL-Kp~NILl~-~~~vkL~DFg~a~~~~~~~~~- 156 (417)
||+.|..+.... +.. ...++.|++.+|.+||++||+|||| ||+|||++ +|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~-------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 78 SYLAGAAMYQRP-------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eeecCccHHhhh-------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999987654321 111 2357889999999999999999999 79999996 578999999999855433311
Q ss_pred -------------ccccCCccccCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCH
Q 044608 157 -------------TNYVGSRWYRAPEILLQSELYS-SKADMWAMGAIMAELFTFCPLFPGASE 205 (417)
Q Consensus 157 -------------~~~~gt~~y~aPE~l~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~ 205 (417)
.-...++.|++|+.-.--...+ ...++++.|+-+|.++|+..++.+.++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0112588899998643222123 567888999999999999998866543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=170.82 Aligned_cols=136 Identities=22% Similarity=0.260 Sum_probs=102.9
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-----CCCCeeeeceEEEeCC---EE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-----NHSNIVKLKELIQNNN---RL 75 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~~ 75 (417)
+.-.+.||+|+||.||. +..++.. +||++...... ......+|+.+++.| +||||++++++++++. .+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34467899999999995 7777766 69988754322 233457899999999 6799999999999874 43
Q ss_pred E-EEEeccC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccCCCCCeeeeC-----CcEEEeeccc
Q 044608 76 Y-LVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGL-SYMHQNGFFHRDLKPENLLVSQ-----GIIKIADFGL 146 (417)
Q Consensus 76 ~-lv~E~~~--~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL-~~LH~~gi~HrDLKp~NILl~~-----~~vkL~DFg~ 146 (417)
+ +||||.+ ++.+..+..+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. +.++|+||+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 4 7899944 44444444433 36666 36688888888 9999999999999999999952 2799999554
Q ss_pred c
Q 044608 147 A 147 (417)
Q Consensus 147 a 147 (417)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=177.24 Aligned_cols=144 Identities=20% Similarity=0.212 Sum_probs=110.3
Q ss_pred ceecceecccCceEEEEEE-ECCCCcEEEEEEecccccCh-----------------------hhhhhHHHHHHHHhcCC
Q 044608 4 YSGFKELGRGAFGRVFQAF-DEHTGEAVAIKELKQRYASW-----------------------EDCLNLREVKCLRKLNH 59 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~-~~~~g~~vaiK~i~~~~~~~-----------------------~~~~~~~E~~~l~~l~h 59 (417)
|.+.+.||+|+||.||+|. +..+|+.||+|+++...... ......+|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7889999999999999998 77899999999987542110 00122479999999976
Q ss_pred CCeeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCCeeeeCCc
Q 044608 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG-FFHRDLKPENLLVSQGI 138 (417)
Q Consensus 60 pnIv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g-i~HrDLKp~NILl~~~~ 138 (417)
. ++.+..++... ..++||||++|+.+....... ..+.+.++..++.||+.+|.+||++| |+||||||+||+++++.
T Consensus 110 ~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~ 186 (237)
T smart00090 110 A-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGK 186 (237)
T ss_pred c-CCCCCeeeEec-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCC
Confidence 3 33333333332 358999999987554432222 34667778899999999999999999 99999999999999889
Q ss_pred EEEeeccccccc
Q 044608 139 IKIADFGLAREI 150 (417)
Q Consensus 139 vkL~DFg~a~~~ 150 (417)
++|+|||.|...
T Consensus 187 i~LiDFg~a~~~ 198 (237)
T smart00090 187 VVIIDVSQSVEL 198 (237)
T ss_pred EEEEEChhhhcc
Confidence 999999998753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=174.85 Aligned_cols=240 Identities=19% Similarity=0.248 Sum_probs=184.7
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
..++-+|.+...|+.|+| +..|..++.|+++-+..+.. ...+..|.-.|+-+.||||+.+++.+....++.++..||
T Consensus 192 lnl~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccc--cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345678899999999999 55677788898875543322 233346888899999999999999999999999999999
Q ss_pred CC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeCC---cEEEeeccccccccCCCCC
Q 044608 83 EC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQG---IIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 83 ~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~~---~vkL~DFg~a~~~~~~~~~ 156 (417)
.. +|+..+.....-..+..++..++.+|++|+.|||+.. |.--.|....++|+++ ++..+|--++....
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~----- 344 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV----- 344 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc-----
Confidence 85 5777776665556788899999999999999999874 4444688889999864 45555654443211
Q ss_pred ccccCCccccCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILLQSEL--YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...-.|.||+||.+..... .-.++|+|||+++++||.|...||...++.+.-.+|.-
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------------------- 403 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------------------- 403 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--------------------
Confidence 1133788999999865432 33578999999999999999999999988877666520
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
+ .-...++|++|.....|+.-|+..||.+||..+.++
T Consensus 404 e--------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 E--------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred c--------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1 111345689999999999999999999999987763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=196.85 Aligned_cols=189 Identities=22% Similarity=0.359 Sum_probs=152.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 78 (417)
+.|.|-++||+|+||+||.|.+.. |+.||+|+-+.... |+-+. -.+++.+|+ -+.|..+..++.-.+.-+||
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-WEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-eeeee---hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 578999999999999999999877 99999998765432 22211 234455555 34566677766667777899
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--------CcEEEeecccccc
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--------GIIKIADFGLARE 149 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--------~~vkL~DFg~a~~ 149 (417)
+||.++| |++++. ..+.+++..+..+..|++..++.||..+|||+||||+|+||.. -.++|+|||-|..
T Consensus 773 ~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999866 555544 4567999999999999999999999999999999999999942 2499999999854
Q ss_pred ---ccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 044608 150 ---IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCP 198 (417)
Q Consensus 150 ---~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~ 198 (417)
+.++..+...++|-.+-.+|...+.. ++..+|.|.|+.+++.||+|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 34556677888999999999886555 9999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-19 Score=159.64 Aligned_cols=136 Identities=20% Similarity=0.234 Sum_probs=111.3
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccCh-------hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-------EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++.||+|++|.||+|.. .|..+++|+........ ......+|+.++..+.|++|.....++.+.+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999976 77889999865432211 1123457999999999999988888887888899999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
||++|..+..+.... .. ....++.+++.+|.+||+.|++|+|++|.|||++++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 999887665554432 22 788999999999999999999999999999999988999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-22 Score=203.57 Aligned_cols=260 Identities=26% Similarity=0.335 Sum_probs=200.7
Q ss_pred CCceecceecccCceEEEEEEECC-CCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 78 (417)
..|.+.+.||+|+|+.|-.+.+.. +...+|.|.+..... ......+..|..+-+.+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 468899999999999999887644 344677776654321 111222235888888887 99999999999999999999
Q ss_pred EeccCCCHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCeeeeC-C-cEEEeeccccccccC-C
Q 044608 79 FECMECNLYQLMA-ARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFHRDLKPENLLVSQ-G-IIKIADFGLAREIKS-G 153 (417)
Q Consensus 79 ~E~~~~~l~~~~~-~~~~~~l~e~~i~~i~~qi~~aL~~LH-~~gi~HrDLKp~NILl~~-~-~vkL~DFg~a~~~~~-~ 153 (417)
++|..|+.+.... .......+...+..++.|+..+|.|+| ..++.||||||+|.+++. + .++++|||+|+.+.. .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9998776443333 333225788899999999999999999 999999999999999975 5 799999999987655 2
Q ss_pred ---CCCccccC-CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 154 ---PPYTNYVG-SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 154 ---~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
......+| ++.|+|||...+....+...|+||+|+++..+++|..|+......+..+. .|
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-----------~~----- 243 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-----------SW----- 243 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-----------ee-----
Confidence 22345688 99999999998766678999999999999999999999866554332110 01
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...........+..++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus 244 ---------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 244 ---------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---------cccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111111123345678899999999999999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.2e-19 Score=157.57 Aligned_cols=132 Identities=17% Similarity=0.211 Sum_probs=103.9
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEeccccc-Ch------hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SW------EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.||+|+||.||+|. .+|..+++|+...... .. ......+|+++++.+.|+++....-++.+.+..++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999997 4678899998654321 11 112335799999999998876666666667778999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREI 150 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~ 150 (417)
++|..+........ . .++.+++.+|.+||+.|++|+|++|.||+++++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH-----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 98876555443221 1 7899999999999999999999999999999899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=156.25 Aligned_cols=136 Identities=22% Similarity=0.240 Sum_probs=104.6
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChh---------------------hhhhHHHHHHHHhcCCCC-
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE---------------------DCLNLREVKCLRKLNHSN- 61 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---------------------~~~~~~E~~~l~~l~hpn- 61 (417)
|.+.+.||+|+||.||+|.+. +|+.||||++........ .....+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999874 799999998764321100 011346899999998874
Q ss_pred -eeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcE
Q 044608 62 -IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGII 139 (417)
Q Consensus 62 -Iv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~v 139 (417)
+...++ ....++||||++|..+..+.. ......++.+|+.++.++|+.||+||||||+||+++ ++.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 344333 345589999999876654321 135667889999999999999999999999999997 5789
Q ss_pred EEeecccccccc
Q 044608 140 KIADFGLAREIK 151 (417)
Q Consensus 140 kL~DFg~a~~~~ 151 (417)
+|+|||++..+.
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=176.38 Aligned_cols=135 Identities=18% Similarity=0.175 Sum_probs=106.7
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEec-ccccCh------hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASW------EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~-~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
|...+.||+|+||+||++... +..+++|+.. +..... ......+|+++++.++|++|+..+.++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 456789999999999999754 3445555432 211111 1223468999999999999998888777777889
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
+||||++|+.+..... ....++.+++.+|.+||+.|++||||||+|||++++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence 9999998876655432 346789999999999999999999999999999889999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=151.94 Aligned_cols=137 Identities=26% Similarity=0.326 Sum_probs=98.6
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhh-----------------------hHHHHHHHHhcCCCC-
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-----------------------NLREVKCLRKLNHSN- 61 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~-----------------------~~~E~~~l~~l~hpn- 61 (417)
+.+.||+|+||.||+|.+. +|+.||||++........... ...|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999876 799999999875322211110 024666666665443
Q ss_pred -eeeeceEEEeCCEEEEEEeccCCCHH--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeCC
Q 044608 62 -IVKLKELIQNNNRLYLVFECMECNLY--QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQG 137 (417)
Q Consensus 62 -Iv~l~~~~~~~~~~~lv~E~~~~~l~--~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~~ 137 (417)
+.+.+++ ...++||||++++.. ..+.... .. .+++.++.+++.++.++|. .||+|+||||+||+++++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~ 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDG 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECC
Confidence 3444433 235899999998321 1111111 11 6788999999999999999 999999999999999988
Q ss_pred cEEEeecccccccc
Q 044608 138 IIKIADFGLAREIK 151 (417)
Q Consensus 138 ~vkL~DFg~a~~~~ 151 (417)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=163.78 Aligned_cols=203 Identities=21% Similarity=0.316 Sum_probs=151.5
Q ss_pred HHhcCCCCeeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccCCCCCe
Q 044608 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF-FHRDLKPENL 132 (417)
Q Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi-~HrDLKp~NI 132 (417)
|+.+.|.|+.++++.+.++...++|.+||..+.+.++.......++.--...++++|+.||.|||.--| +|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457899999999999999999999999998877777766655667888888999999999999998866 9999999999
Q ss_pred eeeCC-cEEEeeccccccccCC---CCCccccCCccccCchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 044608 133 LVSQG-IIKIADFGLAREIKSG---PPYTNYVGSRWYRAPEILLQSE------LYSSKADMWAMGAIMAELFTFCPLFPG 202 (417)
Q Consensus 133 Ll~~~-~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~ 202 (417)
+++.. .+||+|||+....... .......-..-|.|||.+.... ..+.+.||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99865 7999999998765421 1111222345699999986532 146679999999999999999999976
Q ss_pred CCH----HHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 203 ASE----ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 203 ~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
... .+.+..+.. .+.. ...+.+.... ...+++..++..|+..+|..||+++++
T Consensus 161 ~~~~~~~~eii~~~~~-~~~~---------------------~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKK-GGSN---------------------PFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred ccccCChHHHHHHHHh-cCCC---------------------CcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHH
Confidence 432 223333221 0110 0011111111 344589999999999999999999998
Q ss_pred H
Q 044608 279 L 279 (417)
Q Consensus 279 L 279 (417)
-
T Consensus 218 ~ 218 (484)
T KOG1023|consen 218 R 218 (484)
T ss_pred H
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.8e-17 Score=162.24 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=194.8
Q ss_pred Cceecceecc--cCceEEEEEEE--CCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEE
Q 044608 3 KYSGFKELGR--GAFGRVFQAFD--EHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~--G~~g~V~~a~~--~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 76 (417)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ........+|+...++++ |+|.++.+..++..+.+|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567788999 99999999988 88999999998543322 122334467888888885 999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccccCCCCCeeee-C-CcEEEeeccccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ----GLSYMHQNGFFHRDLKPENLLVS-Q-GIIKIADFGLAREI 150 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~----aL~~LH~~gi~HrDLKp~NILl~-~-~~vkL~DFg~a~~~ 150 (417)
+-.|+++..+....... ...+++..++..+.+..+ ||.++|+++++|-|+||.||++. + ...+++|||+...+
T Consensus 195 iqtE~~~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeccccchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 99999886666655433 345899999999999999 99999999999999999999995 4 56899999999887
Q ss_pred cCCCCC------ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHhhCCCCcc
Q 044608 151 KSGPPY------TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA--SEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 151 ~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~g~~~~~ 222 (417)
.+..-. ...-|...|++||++.+ .++.+.|+++||.+..+-.++..++... +.+.++..
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----------- 340 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----------- 340 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-----------
Confidence 665421 12257778999998743 3899999999999999988886555332 22111111
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...-.++....+.++...+..|++.||-.|+++..++.|++...
T Consensus 341 --------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 --------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred --------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 00112334456777778999999999999999999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=134.00 Aligned_cols=131 Identities=27% Similarity=0.275 Sum_probs=108.6
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC--CCeeeeceEEEeCCEEEEEEeccC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH--SNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
+++.||.|.++.||++.+.. ..+++|....... .....+|+.+++.+.| .++++++.++...+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 56889999999999998643 7899999866533 2344579999999976 589999998888889999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN---GFFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~---gi~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
|..+..+ +......++.+++.+|.+||.. +++|+||+|+||++++ +.++++|||.+..
T Consensus 77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7655322 4566677899999999999985 7999999999999986 8899999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.4e-16 Score=143.50 Aligned_cols=134 Identities=17% Similarity=0.234 Sum_probs=97.5
Q ss_pred ceec-ccCceEEEEEEECCCCcEEEEEEecccc----------c--ChhhhhhHHHHHHHHhcCCCCe--eeeceEEEeC
Q 044608 8 KELG-RGAFGRVFQAFDEHTGEAVAIKELKQRY----------A--SWEDCLNLREVKCLRKLNHSNI--VKLKELIQNN 72 (417)
Q Consensus 8 ~~LG-~G~~g~V~~a~~~~~g~~vaiK~i~~~~----------~--~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~ 72 (417)
..|| .|+.|+||.+.. .+..+++|.+.... . ........+|++++..|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 888888988854 47889999875311 0 1122334689999999998875 6666664332
Q ss_pred -C---EEEEEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 73 -N---RLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 73 -~---~~~lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
. ..++|||+++| ..+..+... ..+++.. +.+|+.+|.+||++||+||||||+|||++ ++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 23599999986 444444433 2355543 57899999999999999999999999997 47899999998
Q ss_pred ccc
Q 044608 147 ARE 149 (417)
Q Consensus 147 a~~ 149 (417)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-17 Score=171.00 Aligned_cols=269 Identities=22% Similarity=0.232 Sum_probs=199.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-Chhhh-hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDC-LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~-~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|.+.+++-+-.|+++.++.+.-..+|...++|+...... ..... ....+-.++-.-.+|-++.....+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 677888899999999999998888898888886643211 00011 1112333333345677777766666777899999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-----
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG----- 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~----- 153 (417)
+|.+++.+....... .+.+++-.+.++..+..++++||...+.|||++|.|+|+. +++.++.|||......-.
T Consensus 884 ~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred HHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999765333333333 4578888999999999999999999999999999999995 689999999844321100
Q ss_pred ---------------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 044608 154 ---------------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA 206 (417)
Q Consensus 154 ---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 206 (417)
......+||+.|.+||.+.+.. .+..+|+|++|++++|.++|.+||......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0112357999999999998776 789999999999999999999999998887
Q ss_pred HHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHH---HHHcCcc
Q 044608 207 DQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA---EALQHPF 283 (417)
Q Consensus 207 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~---elL~hp~ 283 (417)
.....|... ...+.......+.++++++.++|..+|.+|.++. ++-.|+|
T Consensus 1042 ~~f~ni~~~---------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1042 QIFENILNR---------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred hhhhccccC---------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 776555321 1111222345688999999999999999998877 9999999
Q ss_pred ccccccCCCCCCCCCC
Q 044608 284 FKRCFYAPPHIRSTPA 299 (417)
Q Consensus 284 f~~~~~~~~~~~~~~~ 299 (417)
|+...|..........
T Consensus 1095 ~~~~~~~~l~~q~~~~ 1110 (1205)
T KOG0606|consen 1095 FQDVDWENLALQKAEF 1110 (1205)
T ss_pred cCCCCccccccccCcc
Confidence 9998877655544433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.2e-15 Score=147.11 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=186.3
Q ss_pred CCceecceecccCceEEEEEEEC-CCCcEEEEEEecccccCh-hhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-HTGEAVAIKELKQRYASW-EDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
.+|-.+..||.|.|+.|+.+.-+ .++-.|++|...+..... .+...+.|+-+...+ .|.+++..+..+....+.|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 46788999999999999988755 577899999887655443 333346788888877 499999999988888888899
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~~~~ 156 (417)
.||++++...+-..- ...+++...+.+..|++.++.++|+..++|+|+||+||++.+ +..++.|||..+.+.-..
T Consensus 345 ~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-- 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-- 421 (524)
T ss_pred hhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec--
Confidence 999987655544322 234789999999999999999999999999999999999976 678999999886422111
Q ss_pred ccccCCcccc-CchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYR-APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~-aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+.-++. ..|++.....+..+.|++|||.-+++.++|.+.-........+
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-------------------------- 475 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-------------------------- 475 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee--------------------------
Confidence 1122333444 4677767777899999999999999999987654332211110
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
........+..+.++..+.+.+...|+..|+.+.++..|.=|.
T Consensus 476 -------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 -------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111122344557889999999999999999999999887664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-14 Score=148.18 Aligned_cols=142 Identities=26% Similarity=0.370 Sum_probs=94.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--------------------------------h-hh----
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--------------------------------E-DC---- 45 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--------------------------------~-~~---- 45 (417)
.|+. +.||.|++|.||+|+.+.+|+.||||+++...... + ..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 78999999999999998889999999997432110 0 00
Q ss_pred --hhHHHHHHHHhc----CCCCeeeeceEEEe-CCEEEEEEeccCCCHHHHHHH--hcC---CCCCHHHHHHHHHHHHHH
Q 044608 46 --LNLREVKCLRKL----NHSNIVKLKELIQN-NNRLYLVFECMECNLYQLMAA--RDR---KLFSEPEIKAWLFQVFQG 113 (417)
Q Consensus 46 --~~~~E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~~l~~~~~~--~~~---~~l~e~~i~~i~~qi~~a 113 (417)
...+|...+.++ .+.+.+.+-.+|.+ .+..+|||||++|..+..+.. ..+ ..+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 112344333333 23344444444433 445679999999875554321 111 1245555666666665
Q ss_pred HHHHHHCCcccccCCCCCeeeeC-C----cEEEeeccccccccC
Q 044608 114 LSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREIKS 152 (417)
Q Consensus 114 L~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~~~ 152 (417)
..|++|+|+||.||+++. | +++++|||++..+..
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 589999999999999964 5 899999999876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-13 Score=121.50 Aligned_cols=138 Identities=17% Similarity=0.179 Sum_probs=100.6
Q ss_pred cceecccCceEEEEEEECC------CCcEEEEEEecccc---------c--C----------hhhhhh----HHHHHHHH
Q 044608 7 FKELGRGAFGRVFQAFDEH------TGEAVAIKELKQRY---------A--S----------WEDCLN----LREVKCLR 55 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~------~g~~vaiK~i~~~~---------~--~----------~~~~~~----~~E~~~l~ 55 (417)
...||.|.-+.||.|.... .+..+|||+.+... . + ...... .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999997543 35799999874211 0 0 001111 27999999
Q ss_pred hcCC--CCeeeeceEEEeCCEEEEEEeccCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCC
Q 044608 56 KLNH--SNIVKLKELIQNNNRLYLVFECMECNLY-QLMAARDRKLFSEPEIKAWLFQVFQGLSYM-HQNGFFHRDLKPEN 131 (417)
Q Consensus 56 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~~l~-~~~~~~~~~~l~e~~i~~i~~qi~~aL~~L-H~~gi~HrDLKp~N 131 (417)
+|.. -++.+++++ ..-+|||||++++.+ ...... ..+++.++..+..+++.+|..| |+.|++|+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9853 455555654 455889999987522 111211 2356677788899999999999 89999999999999
Q ss_pred eeeeCCcEEEeeccccccc
Q 044608 132 LLVSQGIIKIADFGLAREI 150 (417)
Q Consensus 132 ILl~~~~vkL~DFg~a~~~ 150 (417)
||++++.+.|+|||.|...
T Consensus 156 IL~~~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHDGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEECCcEEEEECCCceeC
Confidence 9999999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=120.76 Aligned_cols=127 Identities=17% Similarity=0.122 Sum_probs=94.8
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEeccCCC
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
++.|+.|.++.||++... +..|++|+....... .....+|+.+++.+.+.++ .+++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 567899999999999754 788999987654321 1233579999999865554 3454443 33357999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccccCCCCCeeeeCCcEEEeeccccc
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF-----FHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi-----~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
.+... ......++.+++.+|..||+.++ +|+|++|.||+++++.++|+|||.+.
T Consensus 77 ~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 54321 01123456899999999999985 99999999999998899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.1e-13 Score=132.95 Aligned_cols=182 Identities=22% Similarity=0.308 Sum_probs=131.8
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
|++ ...+-++.+..-.|..+.++..|.+.+.+.... .......+-++.|+.|+||||+++++.++..+.+|||.|-+.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 444 333333343222466788899999998876544 222334578899999999999999999999999999999753
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-Ccccc
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-YTNYV 160 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH-~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-~~~~~ 160 (417)
.+-..+.. ++...+..-++||+.||.||| +++++|++|.-..|+++ .|..||++|.++........ .....
T Consensus 93 -Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 93 -PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred -cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch
Confidence 23333322 346778888999999999997 67899999999999997 59999999998865433221 12222
Q ss_pred CCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC
Q 044608 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196 (417)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g 196 (417)
---.|..|+.+... +...|.|-|||++++++.|
T Consensus 167 ~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 23346777765222 2567999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-13 Score=136.34 Aligned_cols=140 Identities=26% Similarity=0.296 Sum_probs=91.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChh---------------------------------------hhhhH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE---------------------------------------DCLNL 48 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~---------------------------------------~~~~~ 48 (417)
+.||.|++|.||+|+.+ +|+.||||+.+......- +....
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999864 799999999864321100 00112
Q ss_pred HHHHHHHhc----CCCCeeeeceEE-EeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 044608 49 REVKCLRKL----NHSNIVKLKELI-QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ-GLSYMHQNGF 122 (417)
Q Consensus 49 ~E~~~l~~l----~hpnIv~l~~~~-~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~-aL~~LH~~gi 122 (417)
+|...+.++ .|.+-+.+-.+| ...+..++||||++|..+..+........+ ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 455555554 233333333333 223456899999998765544332211122 2345555555 4788999999
Q ss_pred ccccCCCCCeeee-CCcEEEeecccccccc
Q 044608 123 FHRDLKPENLLVS-QGIIKIADFGLAREIK 151 (417)
Q Consensus 123 ~HrDLKp~NILl~-~~~vkL~DFg~a~~~~ 151 (417)
+|+|+||.||+++ +|.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999995 5789999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-12 Score=109.86 Aligned_cols=132 Identities=23% Similarity=0.271 Sum_probs=100.2
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEE-ecccccChhhh------hhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKE-LKQRYASWEDC------LNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~-i~~~~~~~~~~------~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
..+++|+-+.+|.+. .-|..+++|. +.+.+...+.. +..+|..++.++.--.|...+=++.+.+.-.|+||
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 468899999999983 3455677774 44444433222 22579999999876666555555667777889999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
|++|.++....... .-.++..+-.-+.-||.+||+|+||.++||+++++.+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 99999887655433 14566677777889999999999999999999999999999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-11 Score=119.28 Aligned_cols=213 Identities=21% Similarity=0.273 Sum_probs=155.7
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE----eCCEEEEEEeccCC--CHH
Q 044608 14 AFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ----NNNRLYLVFECMEC--NLY 87 (417)
Q Consensus 14 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~~--~l~ 87 (417)
-..+.|+|....+|..|++|+++....... .....-++.++++.|+|||++.++|. ....+++|++|.++ .|+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 345789999999999999999943221111 11124688999999999999999986 34578999999875 366
Q ss_pred HHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-cEEEeeccccccccCC
Q 044608 88 QLMAAR-------------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSG 153 (417)
Q Consensus 88 ~~~~~~-------------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~-~vkL~DFg~a~~~~~~ 153 (417)
+..... .+...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.. +|+|...|....+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 655422 12347889999999999999999999999999999999999876 8999988877665444
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
+ + |-+.. -.+-|.=.||.+++.|.+|+.- +........
T Consensus 447 ~------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s------------------------ 485 (655)
T KOG3741|consen 447 P------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS------------------------ 485 (655)
T ss_pred C------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH------------------------
Confidence 3 0 11211 2246888999999999999643 211111111
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+..+.+.+|.|+.++|.-+...++++ -++.+++.|
T Consensus 486 ------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 486 ------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 012223467899999999999999987 788888865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-13 Score=127.52 Aligned_cols=201 Identities=20% Similarity=0.291 Sum_probs=135.9
Q ss_pred HHHhcCCCCeeeeceEEEeC-----CEEEEEEeccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 044608 53 CLRKLNHSNIVKLKELIQNN-----NRLYLVFECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQN--GF 122 (417)
Q Consensus 53 ~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~--gi 122 (417)
-|-.+.|-|||+++.++.+. ....++.|||..+.+....+ +....+.....++|+-||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34456799999999987654 45789999998664443332 2335678889999999999999999988 49
Q ss_pred ccccCCCCCeeee-CCcEEEeeccccccccC-----CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC
Q 044608 123 FHRDLKPENLLVS-QGIIKIADFGLAREIKS-----GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196 (417)
Q Consensus 123 ~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g 196 (417)
+|+++..+-|++. +|-||+.--........ ........+-++|.|||.=...+ .+.++|||++|+-..+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHh
Confidence 9999999999996 46677653332211111 01112235678999999643333 57789999999999999887
Q ss_pred CCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH
Q 044608 197 CPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA 275 (417)
Q Consensus 197 ~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 275 (417)
..- -.+.+..+.-..|..+. . ..-..--.++|.+||.-.|..||++
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i------------------------------~---~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVI------------------------------I---GLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred eeccCCCcceeehhhhhhhhe------------------------------e---eccCccccCcCcccccCCCCCCcch
Confidence 643 22222211111111100 0 0001123468899999999999999
Q ss_pred HHHHcCcccccc
Q 044608 276 AEALQHPFFKRC 287 (417)
Q Consensus 276 ~elL~hp~f~~~ 287 (417)
.++|.||.+-++
T Consensus 326 r~llfHpllfeV 337 (458)
T KOG1266|consen 326 RLLLFHPLLFEV 337 (458)
T ss_pred hhhhcCceeeec
Confidence 999999987654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-11 Score=105.87 Aligned_cols=142 Identities=20% Similarity=0.254 Sum_probs=106.1
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEe-cccccChh------hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWE------DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i-~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
.+..|-+|+-+.|+++ ...|+.++||.= .+.+.-.. ..+...|++.|.++.--.|.-..-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4667889999999999 677999888853 33332221 22335799999998765666555667777777899
Q ss_pred EeccCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-C-Cc--EEEeecccccc
Q 044608 79 FECMEC--NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-Q-GI--IKIADFGLARE 149 (417)
Q Consensus 79 ~E~~~~--~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~-~~--vkL~DFg~a~~ 149 (417)
|||++| ...+.+...............++..|-+.+.-||.++|+|+||..+||++. + +. +.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999998 555666554433333344488999999999999999999999999999994 2 33 58999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.4e-11 Score=106.74 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=99.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC--CeeeeceEEEeC---CEEEEEEec
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS--NIVKLKELIQNN---NRLYLVFEC 81 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~---~~~~lv~E~ 81 (417)
++.||.|.++.||++.... |+.|++|...............+|+++++.+.+. .+.+++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999997643 6889999876543321223446899999999763 456677666543 366899999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ------------------------------------------ 119 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~------------------------------------------ 119 (417)
++|..+...... ..+++++...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988644332211 235666666777777777777763
Q ss_pred --------------CCcccccCCCCCeeeeC--C-cEEEeecccccc
Q 044608 120 --------------NGFFHRDLKPENLLVSQ--G-IIKIADFGLARE 149 (417)
Q Consensus 120 --------------~gi~HrDLKp~NILl~~--~-~vkL~DFg~a~~ 149 (417)
..++|+|++|.||++++ + .+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24689999999999976 3 478999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.4e-10 Score=99.61 Aligned_cols=126 Identities=29% Similarity=0.429 Sum_probs=82.2
Q ss_pred EEEEEEECCCCcEEEEEEecccccC----------------------hh---hhhhHHHHHHHHhcCCC--CeeeeceEE
Q 044608 17 RVFQAFDEHTGEAVAIKELKQRYAS----------------------WE---DCLNLREVKCLRKLNHS--NIVKLKELI 69 (417)
Q Consensus 17 ~V~~a~~~~~g~~vaiK~i~~~~~~----------------------~~---~~~~~~E~~~l~~l~hp--nIv~l~~~~ 69 (417)
.||.|.. ..|..+|+|+.+..... +. .....+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899976 45789999987432100 00 11124799999999765 45666644
Q ss_pred EeCCEEEEEEeccC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccccCCCCCeeeeCCcEEEeeccc
Q 044608 70 QNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY-MHQNGFFHRDLKPENLLVSQGIIKIADFGL 146 (417)
Q Consensus 70 ~~~~~~~lv~E~~~--~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~-LH~~gi~HrDLKp~NILl~~~~vkL~DFg~ 146 (417)
+. -+|||||++ |..+..+.... ++.+....++.+++..+.. +|+.||+|+||.+.|||++++.+.|+|||.
T Consensus 79 -~~--~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~q 152 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQ 152 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTT
T ss_pred -eC--CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCc
Confidence 22 369999998 65554444322 2345667788888885555 579999999999999999999999999998
Q ss_pred cccc
Q 044608 147 AREI 150 (417)
Q Consensus 147 a~~~ 150 (417)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 8654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.1e-09 Score=99.67 Aligned_cols=133 Identities=14% Similarity=0.070 Sum_probs=90.1
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccCh----------hhhhhHHHHHHHHhcCCCCe--eeeceEEEe-----CCEEE
Q 044608 14 AFGRVFQAFDEHTGEAVAIKELKQRYASW----------EDCLNLREVKCLRKLNHSNI--VKLKELIQN-----NNRLY 76 (417)
Q Consensus 14 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~----------~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~~~~~ 76 (417)
....|.++ ...|+.|.||......... ......+|...+.+|..-+| ..++.+++. ...-+
T Consensus 34 ~~rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 33445555 3357889999764322100 00024578888888854333 333444443 23568
Q ss_pred EEEeccCCC-HHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--------CcEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAA-RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--------GIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~-~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--------~~vkL~DFg~ 146 (417)
||+|++++. .+..+.. ......++.....++.+|+..+.-||++||+|+|+++.|||+++ ..+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999874 3444332 22234567788899999999999999999999999999999963 4699999998
Q ss_pred cc
Q 044608 147 AR 148 (417)
Q Consensus 147 a~ 148 (417)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 75
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-09 Score=100.01 Aligned_cols=256 Identities=14% Similarity=0.106 Sum_probs=153.2
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeec----eEE--EeC-CEEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLK----ELI--QNN-NRLYL 77 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~----~~~--~~~-~~~~l 77 (417)
..+.||+|+-+.+|-.- .-+ ..+.|++...-..... ..+..|... .||-+-.-+ ... -+. ..+-+
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~-d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVR-DQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecc--hhh-chhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 35679999999999762 222 3455887755332211 122333333 465433211 111 122 23667
Q ss_pred EEeccCCC--HHHHHH----HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 78 VFECMECN--LYQLMA----ARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 78 v~E~~~~~--l~~~~~----~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
+|..+.|. ....+. .+....+...-.....+.|+.+...||..|.+-+|++++|+|+++ +.|.|.|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88877653 222111 112234566778889999999999999999999999999999965 78999987665555
Q ss_pred cCCCCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.++..+.-.+|.+.|.+||.-.- .-.-+...|.|.||+++++|+.| +.||.+-..... -+.+....+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p~E~~Ia 240 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNPLETDIA 240 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCcchhhhh
Confidence 56666666789999999997531 11246678999999999999987 999976431000 0000000000
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhccc--CCCCCCCHHH
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW--DPSKRPTAAE 277 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rpta~e 277 (417)
.+. +... ...-+...+...+.-+.-+.+++..|+.+|+.. ++.-|||++.
T Consensus 241 ~g~-f~ya-~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGR-FAYA-SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cce-eeec-hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 000 0000 001111112222222334678899999999953 4668999754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.6e-10 Score=116.95 Aligned_cols=152 Identities=19% Similarity=0.302 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHC-CcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--C---c-----cccCCccccCchhhhccCC
Q 044608 109 QVFQGLSYMHQN-GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--Y---T-----NYVGSRWYRAPEILLQSEL 176 (417)
Q Consensus 109 qi~~aL~~LH~~-gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~---~-----~~~gt~~y~aPE~l~~~~~ 176 (417)
++..||.|+|.. ++||++|.|++|.++. +..||+.|+++........ + . -..-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999965 9999999999999975 7899999999865544211 1 1 1123566999999976 44
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCH
Q 044608 177 YSSKADMWAMGAIMAELF-TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQ 255 (417)
Q Consensus 177 ~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 255 (417)
.+.++|+||+||++|.+. .|...|.+.+.......-... .......+...+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~--------------------------~~~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL--------------------------LNAGAFGYSNNLPS 239 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc--------------------------cccccccccccCcH
Confidence 799999999999999999 667777665443332221100 01111223356889
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 256 DAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 256 ~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++++=|.++|..|+..||++.+++..|||+..
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 99999999999999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.9e-11 Score=118.90 Aligned_cols=245 Identities=15% Similarity=0.115 Sum_probs=173.3
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC-eeeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN-IVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~ 82 (417)
|......++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+...++.|+++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 455677899999999999877766655 6766543 11224899999999999 777777777888899999998
Q ss_pred CCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCCCccccC
Q 044608 83 ECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVG 161 (417)
Q Consensus 83 ~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~~~~~~g 161 (417)
.++ ............+.+-+...+.+.-+.+|+++|+--=+|+| |||.+++..|..||+....+......++..+
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~ 392 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIG 392 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCC
Confidence 765 11111111112345556677778888899999998778999 9999999999999999988877666677899
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
|+.++|||+...+. +..+.|.|++|+-..++.-|.+|-..... .... .|... .
T Consensus 393 ~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~----~g~~p-------------------~- 445 (829)
T KOG0576|consen 393 TPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPM----IGNGP-------------------N- 445 (829)
T ss_pred CCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--ccCC----CCCCC-------------------C-
Confidence 99999999986655 88999999999887788888777644110 0000 00000 0
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+..-..+...+-.++...||..-|..|++...++.|.+|..|
T Consensus 446 -s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 446 -SPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred -ccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 000000000001111257788999999999999999999999876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-08 Score=93.31 Aligned_cols=133 Identities=25% Similarity=0.304 Sum_probs=98.0
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEeccc------------------ccCh---hhhhhHHHHHHHHhcCCC--C
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQR------------------YASW---EDCLNLREVKCLRKLNHS--N 61 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~------------------~~~~---~~~~~~~E~~~l~~l~hp--n 61 (417)
.+...||-|.-|.||.|.+. .|..+|||.-+.. ..++ ......+|.++|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46688999999999999865 6889999964211 1111 111224799999999655 6
Q ss_pred eeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEE
Q 044608 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIK 140 (417)
Q Consensus 62 Iv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vk 140 (417)
|.+.++. +.-.+|||+++|-.+..+. ++.+....++..|++-+.-+-..||+|+|+.+-||++++ |.+.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 6666653 5668999999986443221 245566677777888777777999999999999999975 6999
Q ss_pred Eeeccccc
Q 044608 141 IADFGLAR 148 (417)
Q Consensus 141 L~DFg~a~ 148 (417)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99997554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.9e-08 Score=88.34 Aligned_cols=124 Identities=19% Similarity=0.243 Sum_probs=85.3
Q ss_pred CCCcEEEEEEecccccC------hhhhhhHHHHHHHHhcCCCC--eeeeceEEEeC----CEEEEEEeccCCC-HHHHHH
Q 044608 25 HTGEAVAIKELKQRYAS------WEDCLNLREVKCLRKLNHSN--IVKLKELIQNN----NRLYLVFECMECN-LYQLMA 91 (417)
Q Consensus 25 ~~g~~vaiK~i~~~~~~------~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~E~~~~~-l~~~~~ 91 (417)
..++.|-+|........ .......+|...+..|..-+ +.+.+.+.+.. ..-++|+|++++. .+..+.
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 34566777754322111 12233457888888875433 34445554432 2458999999874 444444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC----cEEEeecccccc
Q 044608 92 ARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG----IIKIADFGLARE 149 (417)
Q Consensus 92 ~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~----~vkL~DFg~a~~ 149 (417)
..... .+......++.+++..+.-||++||+|+|+++.|||++.+ .+.|+||+-+..
T Consensus 110 ~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred Hhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 43212 6778889999999999999999999999999999999764 499999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=85.31 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=88.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhh--------hHHHHHHHHhcC---CCCeeeeceEEE-
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL--------NLREVKCLRKLN---HSNIVKLKELIQ- 70 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~--------~~~E~~~l~~l~---hpnIv~l~~~~~- 70 (417)
+|.+++.+-......|.+. .-.|+.+++|..+....-.+... ..+++..+.++. .-.+..++-+.+
T Consensus 32 ~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 5777777777777777666 45678899998765432222111 123444444442 333334333322
Q ss_pred ----eCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccc
Q 044608 71 ----NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGL 146 (417)
Q Consensus 71 ----~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~ 146 (417)
-....+++|||++|-.+..+.. +++ .+...|.+++.-||+.|++|+|.+|.|++++++.++++||+.
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~ 180 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQG 180 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcc
Confidence 2345578999999965433321 233 244567788999999999999999999999999999999986
Q ss_pred cc
Q 044608 147 AR 148 (417)
Q Consensus 147 a~ 148 (417)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-07 Score=81.34 Aligned_cols=136 Identities=19% Similarity=0.215 Sum_probs=94.3
Q ss_pred cccCceEEEEEEECCCCcEEEEEEeccc-cc----ChhhhhhHHHHHHHHhcCCCC--eeeeceEEE---eC--CEEEEE
Q 044608 11 GRGAFGRVFQAFDEHTGEAVAIKELKQR-YA----SWEDCLNLREVKCLRKLNHSN--IVKLKELIQ---NN--NRLYLV 78 (417)
Q Consensus 11 G~G~~g~V~~a~~~~~g~~vaiK~i~~~-~~----~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~---~~--~~~~lv 78 (417)
|+|+-+.|++.. ..|+.|-+|.-... .. ......+.+|+..|..|..-+ +.++. ++. .+ ..-+||
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 568899999874 34557888876421 11 112234468999998885332 44444 222 22 245799
Q ss_pred EeccCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCc--EEEeecccccc
Q 044608 79 FECMEC--NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGI--IKIADFGLARE 149 (417)
Q Consensus 79 ~E~~~~--~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~--vkL~DFg~a~~ 149 (417)
+|-++| +|.+.+....-...++.....++.+|+..+.-||+.|+.|+|+.+.|||++ +|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997774 344444333223457788889999999999999999999999999999996 566 99999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.8e-07 Score=83.71 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=94.8
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhh-------------------h----hhHHHHHHHHhcCCC--C
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-------------------C----LNLREVKCLRKLNHS--N 61 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-------------------~----~~~~E~~~l~~l~hp--n 61 (417)
...|+.|.-+.||+|.. ..+..+|+|+.+........ . -..+|+..|+++..- .
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999964 56889999998643221111 0 013588888887533 3
Q ss_pred eeeeceEEEeCCEEEEEEeccCCCHHH--HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeCCc
Q 044608 62 IVKLKELIQNNNRLYLVFECMECNLYQ--LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQGI 138 (417)
Q Consensus 62 Iv~l~~~~~~~~~~~lv~E~~~~~l~~--~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~~~ 138 (417)
+.+.+.+.. -.|||||++....- .+.. -.+...++..+..++++.+.-|-. .|+||+||..-|||+.+|.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~ 204 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGE 204 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCe
Confidence 445555432 36899998754111 1111 123344788888999999988887 8999999999999999999
Q ss_pred EEEeecccccccc
Q 044608 139 IKIADFGLAREIK 151 (417)
Q Consensus 139 vkL~DFg~a~~~~ 151 (417)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999886543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=80.71 Aligned_cols=134 Identities=16% Similarity=0.173 Sum_probs=82.8
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeeceEEEeCCEEEEEEeccCCC
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
..||.|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++.++.+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 25568889876533 2233468999999986433 467788888888889999999985
Q ss_pred H-H---------------HHHHH----hcC---CCCCHHH-HHHHHHH----------HHHH-HHHHH----HCCccccc
Q 044608 86 L-Y---------------QLMAA----RDR---KLFSEPE-IKAWLFQ----------VFQG-LSYMH----QNGFFHRD 126 (417)
Q Consensus 86 l-~---------------~~~~~----~~~---~~l~e~~-i~~i~~q----------i~~a-L~~LH----~~gi~HrD 126 (417)
. . ..+.. -+. ....... ...+..+ +... ..+|. ...++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1 1 11111 010 0011111 0111100 1111 12222 12478999
Q ss_pred CCCCCeeeeCCcEEEeeccccc
Q 044608 127 LKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 127 LKp~NILl~~~~vkL~DFg~a~ 148 (417)
+.|.||+++++.+.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCCcEEEechhcC
Confidence 9999999987669999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=92.26 Aligned_cols=141 Identities=23% Similarity=0.379 Sum_probs=86.6
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccCh---------------------------------------hhhhhH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW---------------------------------------EDCLNL 48 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~---------------------------------------~~~~~~ 48 (417)
.-|+.++-|.||+|+-+. |+.||||+.+....+. .+.+..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 357899999999998654 9999999875321100 001112
Q ss_pred HHHHHHHhcC-----CCCeeeeceEE-EeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 044608 49 REVKCLRKLN-----HSNIVKLKELI-QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122 (417)
Q Consensus 49 ~E~~~l~~l~-----hpnIv~l~~~~-~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi 122 (417)
+|...+.++. .|+| ++=.+| +-.+.-.|+|||++|--.+.+.......++...+.....++. +.-+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 4555555542 3333 333333 334566899999998544433222223355444433322221 233334899
Q ss_pred ccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 123 FHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 123 ~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
+|.|.+|.||++. +|++.+.|||+...+.+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999996 58999999999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.9e-06 Score=77.52 Aligned_cols=137 Identities=22% Similarity=0.242 Sum_probs=78.2
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC--CeeeeceEE---EeCCEEEEEEec
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS--NIVKLKELI---QNNNRLYLVFEC 81 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~---~~~~~~~lv~E~ 81 (417)
++.|+.|..+.||++.... ..+++|..... .......+|..+++.|... -+.+++... ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5689999999999997655 48999987654 2233445788888888533 345666543 234457999999
Q ss_pred cCCCHHHH---------HH--------H--hc---CCCCCHHH------HHH---------------HHHHHHH-HHHHH
Q 044608 82 MECNLYQL---------MA--------A--RD---RKLFSEPE------IKA---------------WLFQVFQ-GLSYM 117 (417)
Q Consensus 82 ~~~~l~~~---------~~--------~--~~---~~~l~e~~------i~~---------------i~~qi~~-aL~~L 117 (417)
++|..+.. +. . .. ...+.... ... ....+.. .++.+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 98864433 00 0 00 00001000 000 0111222 23333
Q ss_pred HH-------CCcccccCCCCCeeee--CCcEEEeeccccc
Q 044608 118 HQ-------NGFFHRDLKPENLLVS--QGIIKIADFGLAR 148 (417)
Q Consensus 118 H~-------~gi~HrDLKp~NILl~--~~~vkL~DFg~a~ 148 (417)
++ ..++|+|+.|.|||++ ++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 4699999999999998 5777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.5e-06 Score=91.64 Aligned_cols=196 Identities=18% Similarity=0.216 Sum_probs=131.7
Q ss_pred HHHHHHHhcCCCCeeeeceEEEeCCEEEEE----EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 044608 49 REVKCLRKLNHSNIVKLKELIQNNNRLYLV----FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124 (417)
Q Consensus 49 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv----~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~H 124 (417)
.|++.+.++.|+|++.++.+-.......++ -|++....+....+.. ...+....+.+..++++||.|+|+....|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 477788888999999998875433222233 3455543333333332 45788999999999999999999996655
Q ss_pred ccCCCCCe---eee-CCcEEEe--eccccccccCCCCCccccCCccccCchhhhccCCCCch--hhHHHHHHHHHHHHhC
Q 044608 125 RDLKPENL---LVS-QGIIKIA--DFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSK--ADMWAMGAIMAELFTF 196 (417)
Q Consensus 125 rDLKp~NI---Ll~-~~~vkL~--DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~--~DiwSlG~il~ell~g 196 (417)
.-|...-. ..+ ++.+.++ ||+.+..+..........-+..+.++|....+. +..+ .|+|++|.++..+..|
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHHHhhhhhc
Confidence 54444311 111 3456666 999888776555444445677788999875443 3443 6999999999999887
Q ss_pred CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCH-hHHHHHHHhcccCCCCCCCH
Q 044608 197 CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQ-DAISLFESLCSWDPSKRPTA 275 (417)
Q Consensus 197 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~Rpta 275 (417)
..+-..... ...+.+..+. +..+++.+|+..|+++|+++
T Consensus 389 ~~i~~~~~~----------------------------------------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 389 EDISEKSAV----------------------------------------PVSLLDVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred Ccccccccc----------------------------------------hhhhhccccchhhhhhhhhhcchhhhhccch
Confidence 654211110 0111122222 67889999999999999999
Q ss_pred HHHHcCccccc
Q 044608 276 AEALQHPFFKR 286 (417)
Q Consensus 276 ~elL~hp~f~~ 286 (417)
.+++.|+|.+.
T Consensus 429 ~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 429 LELLTHPFLRF 439 (1351)
T ss_pred hhhhhchhccc
Confidence 99999999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.3e-06 Score=90.35 Aligned_cols=80 Identities=18% Similarity=0.238 Sum_probs=56.6
Q ss_pred ecceecccCceEEEEEEECCCC--cEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCe--eeeceEEEeC---CEEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTG--EAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNI--VKLKELIQNN---NRLYL 77 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g--~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~l 77 (417)
.++.|+.|.+..+|+......+ ..+++|+..............+|+++|+.|. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3567899999999998654432 4678887654322222334568999999995 6765 7777777664 46789
Q ss_pred EEeccCCC
Q 044608 78 VFECMECN 85 (417)
Q Consensus 78 v~E~~~~~ 85 (417)
||||++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=73.93 Aligned_cols=74 Identities=14% Similarity=0.100 Sum_probs=50.7
Q ss_pred eecccCc-eEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEeccCCCH
Q 044608 9 ELGRGAF-GRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFECMECNL 86 (417)
Q Consensus 9 ~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~~l 86 (417)
.|-.|.+ +.||++.. .+..+.+|...... .....+|+++++.+. +--+.+++++....+..++|||+++|..
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3445555 78999954 34678888775432 223457899988884 3345677777777777899999998864
Q ss_pred HH
Q 044608 87 YQ 88 (417)
Q Consensus 87 ~~ 88 (417)
+.
T Consensus 79 l~ 80 (244)
T cd05150 79 AA 80 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.3e-06 Score=70.73 Aligned_cols=127 Identities=20% Similarity=0.225 Sum_probs=88.6
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCee-eeceEEEeCCEEEEEEeccCC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV-KLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~ 84 (417)
+.+.||+|.+|.||++. ..|..+|+|+-+.+.. ......|.++|..+..-++- ++|.+-++ ++.|||++|
T Consensus 26 v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 26 VEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhcccccEEEEee--ccCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 45789999999999994 5577899997654432 33345799999999876653 44444333 355999999
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC--CCeeeeCCcEEEeecccccc
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKP--ENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp--~NILl~~~~vkL~DFg~a~~ 149 (417)
-.+...... .+ +.-+..+++.---|-..||-|..|.- .||++.++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 544433221 12 22234566666667788999999874 47777888999999999974
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1e-05 Score=82.28 Aligned_cols=138 Identities=22% Similarity=0.292 Sum_probs=84.5
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChh------------------------------------hhhhHHHH
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE------------------------------------DCLNLREV 51 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~------------------------------------~~~~~~E~ 51 (417)
+.||.-+.|.||+|+.+. |+.||||+-+......- +-+..+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 458999999999998766 99999998754311110 00011233
Q ss_pred HHHHh----cCCCC---eeeeceEEEe-CCEEEEEEeccCCC---HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 044608 52 KCLRK----LNHSN---IVKLKELIQN-NNRLYLVFECMECN---LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120 (417)
Q Consensus 52 ~~l~~----l~hpn---Iv~l~~~~~~-~~~~~lv~E~~~~~---l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~ 120 (417)
+...+ +.|-+ =|.+=.+|.+ ...-.|+||||+|. .++.+.+. .++...+...+.+... +-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHHhc
Confidence 32222 23444 1223333332 34568999999984 44444433 3566655444333322 233356
Q ss_pred CcccccCCCCCeeee-----CCcEEEeecccccccc
Q 044608 121 GFFHRDLKPENLLVS-----QGIIKIADFGLAREIK 151 (417)
Q Consensus 121 gi~HrDLKp~NILl~-----~~~vkL~DFg~a~~~~ 151 (417)
|++|+|=+|.||++. +..+.+.|||+...+.
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999997 3579999999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.2e-05 Score=68.81 Aligned_cols=126 Identities=22% Similarity=0.267 Sum_probs=85.1
Q ss_pred CCceecceecccCc-eEEEEEEECCCCcEEEEEEecc---ccc-------C-hhh---------hhhHHHHHH---HHhc
Q 044608 2 DKYSGFKELGRGAF-GRVFQAFDEHTGEAVAIKELKQ---RYA-------S-WED---------CLNLREVKC---LRKL 57 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~---~~~-------~-~~~---------~~~~~E~~~---l~~l 57 (417)
++++.++.||.|.- |.||++. -.|+.||+|+... ... . .+. .-+..|-+. |+.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46789999999999 9999994 5688999999321 000 0 000 011245554 4445
Q ss_pred CCCCe--eeeceEEEeC------------------CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 044608 58 NHSNI--VKLKELIQNN------------------NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117 (417)
Q Consensus 58 ~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~L 117 (417)
++.++ |+++++..-. ...-||.||..... .++... +.+|++-+..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHH
Confidence 56667 9999986321 12357888766543 133333 45677778899
Q ss_pred HHCCcccccCCCCCeeeeCCcEEEeecccc
Q 044608 118 HQNGFFHRDLKPENLLVSQGIIKIADFGLA 147 (417)
Q Consensus 118 H~~gi~HrDLKp~NILl~~~~vkL~DFg~a 147 (417)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc----CCEEEecccC
Confidence 9999999999999986 4588999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=9.2e-05 Score=66.25 Aligned_cols=128 Identities=21% Similarity=0.270 Sum_probs=88.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccc---------------cChhhhhhHHHHHHHHhcC------CCCeeee
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY---------------ASWEDCLNLREVKCLRKLN------HSNIVKL 65 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~---------------~~~~~~~~~~E~~~l~~l~------hpnIv~l 65 (417)
...||+|+.-.||.- . .....+||++.... .........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999965 3 34567899987654 0111223346766666665 7899999
Q ss_pred ceEEEeCCEEEEEEecc---CCC---HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---C
Q 044608 66 KELIQNNNRLYLVFECM---ECN---LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---Q 136 (417)
Q Consensus 66 ~~~~~~~~~~~lv~E~~---~~~---l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~ 136 (417)
+++.+++..+-+|+|.+ +|+ .+..+... ..+++ . +...+-+-.+||-+.+|+.+||+|.||++. +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99999999999999965 232 34444433 33565 3 334445556788999999999999999994 2
Q ss_pred C--cEEEee
Q 044608 137 G--IIKIAD 143 (417)
Q Consensus 137 ~--~vkL~D 143 (417)
+ .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.1e-05 Score=71.77 Aligned_cols=141 Identities=21% Similarity=0.227 Sum_probs=97.8
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccc---------cChh------------hh----hhHHHHHHHHhcCCC
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY---------ASWE------------DC----LNLREVKCLRKLNHS 60 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~---------~~~~------------~~----~~~~E~~~l~~l~hp 60 (417)
+-.+|..|.-+.||.|.. ..|..+|||+++... ...+ .. ....|+.-|.+|+.-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456789999999999974 568889999875321 1110 00 112588888888765
Q ss_pred CeeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCCeeeeCCcE
Q 044608 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFHRDLKPENLLVSQGII 139 (417)
Q Consensus 61 nIv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH-~~gi~HrDLKp~NILl~~~~v 139 (417)
.|...--+... .-.|||++++.+.+-.-.-+ ...++...+..+-.|++.-+.-|- .+++||.||.=-|+|+.+|.+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKL 303 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEE
Confidence 54332222221 23689999875533321111 134788889998888888887775 569999999999999999999
Q ss_pred EEeeccccccc
Q 044608 140 KIADFGLAREI 150 (417)
Q Consensus 140 kL~DFg~a~~~ 150 (417)
.|+|.+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999877543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.3e-05 Score=69.40 Aligned_cols=71 Identities=11% Similarity=0.133 Sum_probs=42.7
Q ss_pred cceecccCce-EEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC---CeeeeceEEEeC---CEEEEEE
Q 044608 7 FKELGRGAFG-RVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS---NIVKLKELIQNN---NRLYLVF 79 (417)
Q Consensus 7 ~~~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~ 79 (417)
++.|+.|+.. .||+. +..+++|...... ......+|.+++..|... -+.++++..... ...+++|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567877776 59986 3457888755422 123456799999888532 233333332221 2458899
Q ss_pred eccCCC
Q 044608 80 ECMECN 85 (417)
Q Consensus 80 E~~~~~ 85 (417)
++++|.
T Consensus 74 ~~i~G~ 79 (235)
T cd05155 74 RWLEGE 79 (235)
T ss_pred EeecCC
Confidence 998874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00028 Score=69.92 Aligned_cols=76 Identities=18% Similarity=0.190 Sum_probs=52.2
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEeccccc------ChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA------SWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~------~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l 77 (417)
.+.||.|.+..||++.+...++.++||.-..... .....+...|.+.|+.+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999998865446899998542110 112233456888888863 3457777776 4456789
Q ss_pred EEeccCC
Q 044608 78 VFECMEC 84 (417)
Q Consensus 78 v~E~~~~ 84 (417)
|||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00012 Score=68.34 Aligned_cols=134 Identities=19% Similarity=0.229 Sum_probs=77.1
Q ss_pred eecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEeccCCCHH
Q 044608 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFECMECNLY 87 (417)
Q Consensus 9 ~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~~l~ 87 (417)
.+..|-...+|+.. .+++.+++|......... .....+|..+++.+..-.+ .+++... .+ ++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~--~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--EH--WLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--CC--EEEEEeccCccc
Confidence 45678888999985 557789999765432111 1123579999998864333 3333332 22 689999987532
Q ss_pred H-----------HHH----HhcC-----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcccccCCC
Q 044608 88 Q-----------LMA----ARDR-----KLFSE-PEIKAWLFQV---------FQGLSYMHQ--------NGFFHRDLKP 129 (417)
Q Consensus 88 ~-----------~~~----~~~~-----~~l~e-~~i~~i~~qi---------~~aL~~LH~--------~gi~HrDLKp 129 (417)
. .+. +-+. ..++. ..+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 2 111 1111 11111 1222322222 111222221 2589999999
Q ss_pred CCeeeeCCcEEEeecccccc
Q 044608 130 ENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 130 ~NILl~~~~vkL~DFg~a~~ 149 (417)
.||+++++.+.|+||+.|..
T Consensus 156 ~Nil~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQGLKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCCCEEEeccccCc
Confidence 99999877799999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00074 Score=65.23 Aligned_cols=29 Identities=31% Similarity=0.449 Sum_probs=25.7
Q ss_pred CCcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 120 NGFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
.|++|+|++|.|||++++.+ -|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 48999999999999988775 799999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0003 Score=64.68 Aligned_cols=73 Identities=19% Similarity=0.255 Sum_probs=47.0
Q ss_pred cceecccCceEEEEEEECC-CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC-eeeeceEEEeCCEEEEEEeccCC
Q 044608 7 FKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN-IVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++.|..|-...+|++.... .++.|++|+....... .....+|+.+++.+...+ ..+++..+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 4678889999999996433 3578999976543211 122347899999885433 344444332 2 379999887
Q ss_pred C
Q 044608 85 N 85 (417)
Q Consensus 85 ~ 85 (417)
.
T Consensus 77 ~ 77 (235)
T cd05157 77 R 77 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00044 Score=67.17 Aligned_cols=75 Identities=16% Similarity=0.179 Sum_probs=48.9
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEeccc------ccChhhhhhHHHHHHHHhcC--CC-CeeeeceEEEeCCEEEEE
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR------YASWEDCLNLREVKCLRKLN--HS-NIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~------~~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv 78 (417)
++||.|....||++.+...++.++||.-..- .......+...|.+.|+... .| ++.++|.+ +.+...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 4689999999999997544468999975311 11222233346888887764 34 45555544 55556789
Q ss_pred EeccCC
Q 044608 79 FECMEC 84 (417)
Q Consensus 79 ~E~~~~ 84 (417)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 998753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0019 Score=62.13 Aligned_cols=137 Identities=15% Similarity=0.090 Sum_probs=77.5
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeeceE------EEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLKEL------IQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv 78 (417)
++.++.|....+|++.. ++..+++|+...... ......|++++..|...+ +.+++.. ....+..+++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 56688888889999853 344688897755321 112335677777774222 3343331 2235677899
Q ss_pred EeccCCCHH-----HH---H----HHhc--CCCCC--------HHH-----HH----------HHHHHHHHHHHHHHH--
Q 044608 79 FECMECNLY-----QL---M----AARD--RKLFS--------EPE-----IK----------AWLFQVFQGLSYMHQ-- 119 (417)
Q Consensus 79 ~E~~~~~l~-----~~---~----~~~~--~~~l~--------e~~-----i~----------~i~~qi~~aL~~LH~-- 119 (417)
|||++|... .. + ..-+ ...++ ... .. .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 999887321 11 1 0000 00010 000 00 011123334555542
Q ss_pred -----CCcccccCCCCCeeeeCCc-EEEeeccccc
Q 044608 120 -----NGFFHRDLKPENLLVSQGI-IKIADFGLAR 148 (417)
Q Consensus 120 -----~gi~HrDLKp~NILl~~~~-vkL~DFg~a~ 148 (417)
.+++|+|+++.||+++++. +.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5899999999999998765 5899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=1.3e-05 Score=88.24 Aligned_cols=208 Identities=13% Similarity=-0.004 Sum_probs=135.5
Q ss_pred HHHHHHHHhcCCCCeeeeceEEEe--CCEEEEEEeccCCC-HHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 044608 48 LREVKCLRKLNHSNIVKLKELIQN--NNRLYLVFECMECN-LYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNG- 121 (417)
Q Consensus 48 ~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~~-l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~g- 121 (417)
+.|...+++..|+++...+.-... ....|..++|+.++ +...+.+.. ...+.+.-+-....+.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 446666777889998876654432 33457888887655 555554322 123444555555666577777777542
Q ss_pred ----cccccCCCCCeeee-CCcEEEeeccccccc-cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh
Q 044608 122 ----FFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT 195 (417)
Q Consensus 122 ----i~HrDLKp~NILl~-~~~vkL~DFg~a~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~ 195 (417)
-+|++||+-|.+|. +-.+|++++|+.+.. .........++++.|+++++...-. ++.++|+|..|+.+|++.-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhc
Confidence 68999999999995 567999999999833 3334456678899999999875544 7788999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH
Q 044608 196 FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA 275 (417)
Q Consensus 196 g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 275 (417)
|.++|-.. ...+... .. .+... ..+.--.+.++-.....+|-+.-..||.-
T Consensus 1436 ~n~~fi~f-----lq~~Lkg---ii------------------dn~tf---~sIe~l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1436 GNAYFIFF-----LQPALKG---II------------------DNHTF---FSIEKLKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred ccHHHHHH-----HHHHHcC---cc------------------ccccc---ccccccCCCcccHHHHHHHHHHhhhcchh
Confidence 98887322 1111110 00 00000 00111123445555666677777889999
Q ss_pred HHHHcCcccc
Q 044608 276 AEALQHPFFK 285 (417)
Q Consensus 276 ~elL~hp~f~ 285 (417)
...+.-+.|-
T Consensus 1487 ~isls~d~~a 1496 (2724)
T KOG1826|consen 1487 YISLSRDHFA 1496 (2724)
T ss_pred hhhccccccc
Confidence 8888877764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00083 Score=64.08 Aligned_cols=136 Identities=14% Similarity=0.096 Sum_probs=79.3
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeece------EEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLKE------LIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~------~~~~~~~~~lv 78 (417)
++.|..|....+|++.. .+..+++|+.... . ......|+.++..|.+-+ +.+++. +...++..++|
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~--~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S--AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC--C--hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 55678888889999853 3457999987641 1 223446888888774322 444443 22345667899
Q ss_pred EeccCCCHHH--------HHHH----hc--CCCCC--------HHHHH------------HHHHHHHHHHHHHHH-----
Q 044608 79 FECMECNLYQ--------LMAA----RD--RKLFS--------EPEIK------------AWLFQVFQGLSYMHQ----- 119 (417)
Q Consensus 79 ~E~~~~~l~~--------~~~~----~~--~~~l~--------e~~i~------------~i~~qi~~aL~~LH~----- 119 (417)
+++++|.... .+.+ -+ ...+. ..... .....+..++.++.+
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9999874321 1100 00 00000 00000 011112334444443
Q ss_pred --CCcccccCCCCCeeeeCCc-EEEeeccccc
Q 044608 120 --NGFFHRDLKPENLLVSQGI-IKIADFGLAR 148 (417)
Q Consensus 120 --~gi~HrDLKp~NILl~~~~-vkL~DFg~a~ 148 (417)
.+++|+|+.|.|||++++. +.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4799999999999998766 4799999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.001 Score=63.68 Aligned_cols=73 Identities=16% Similarity=0.149 Sum_probs=47.0
Q ss_pred cceecccCceEEEEEEECC------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEH------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVF 79 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~ 79 (417)
++.|..|-...||++.... +++.|++|+...... ......+|++++..+..-++ .+++.++.. .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4567788888999996543 257899998765322 12334578888888854333 345555432 2578
Q ss_pred eccCCC
Q 044608 80 ECMECN 85 (417)
Q Consensus 80 E~~~~~ 85 (417)
||++|.
T Consensus 77 e~i~G~ 82 (302)
T cd05156 77 EFIPSR 82 (302)
T ss_pred heeCCC
Confidence 888764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0014 Score=64.57 Aligned_cols=75 Identities=20% Similarity=0.206 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccc-----cChhhhhhHHHHHHHHhcC--CC-CeeeeceEEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY-----ASWEDCLNLREVKCLRKLN--HS-NIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~-----~~~~~~~~~~E~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv 78 (417)
.+.||.|.-.-||++.+...++.|+||.-..-. ......+...|.+.|+.+. .| ++.++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578999999999999875446789999753111 1122334456888888774 34 45556654 45556788
Q ss_pred EeccC
Q 044608 79 FECME 83 (417)
Q Consensus 79 ~E~~~ 83 (417)
||++.
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00083 Score=67.18 Aligned_cols=174 Identities=20% Similarity=0.304 Sum_probs=110.8
Q ss_pred hhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 044608 45 CLNLREVKCLRKLNHSNIVKLKELIQN-NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123 (417)
Q Consensus 45 ~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~ 123 (417)
..++-...+++.+.|+|....+++-.. .....+|||+++-++.+....+... ... ++ +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~---~~s-------~~-----------~ 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLK---DES-------LL-----------A 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccc---hhh-------hc-----------c
Confidence 344567889999999999999887653 3568899999988888776554311 111 11 2
Q ss_pred cccCCCCCeeeeCCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 044608 124 HRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA 203 (417)
Q Consensus 124 HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 203 (417)
|+=+ +- +.++++| .+++.. |-. .++++||||+|.++.++..|...+...
T Consensus 86 ~~~~-~~------~~~~~td-~~~t~~-----------------~~~------~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 86 HGVL-HL------NIIYITD-HFLTKY-----------------PSP------IGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cccc-ee------hhhhccc-cccccC-----------------CCC------CCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 3211 11 2233444 111110 110 124999999999999999999888877
Q ss_pred CHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 204 SEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 204 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
...+....|......+ ..... +.....+. -.+.....++..+|+...|..||...++.+++-
T Consensus 135 ~~s~~l~~i~k~~~~d-~~~~~--~a~e~~~~---------------~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDD-QELLS--TAMEHLIQ---------------LLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHhccCc-hhHHH--HHHHHHHH---------------HhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 7777776665442221 11100 00000111 124566789999999999999999999999999
Q ss_pred ccccc
Q 044608 284 FKRCF 288 (417)
Q Consensus 284 f~~~~ 288 (417)
|.++.
T Consensus 197 ~~ev~ 201 (725)
T KOG1093|consen 197 FTEVY 201 (725)
T ss_pred HHHHH
Confidence 98763
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0013 Score=58.48 Aligned_cols=96 Identities=20% Similarity=0.199 Sum_probs=74.0
Q ss_pred HHHHHHHhcCC-CCeeeeceEEEeCCEEEEEEeccCCC-HHH---HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 044608 49 REVKCLRKLNH-SNIVKLKELIQNNNRLYLVFECMECN-LYQ---LMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ---N 120 (417)
Q Consensus 49 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~~-l~~---~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~---~ 120 (417)
.|.-+++.+.+ +++.+++|+|-. ++|.||...+ ++. .+... ...+......++.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999976 699999999832 5588988743 321 11111 225889999999999999999998 4
Q ss_pred CcccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 121 GFFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 121 gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
.+.-.|++++|+-+++ +++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5777899999999975 79999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0069 Score=58.11 Aligned_cols=29 Identities=28% Similarity=0.560 Sum_probs=26.1
Q ss_pred CCcccccCCCCCeeeeCCcEEEeeccccc
Q 044608 120 NGFFHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
.+++|+|+.+.||+++++.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 57899999999999988889999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00045 Score=65.39 Aligned_cols=132 Identities=17% Similarity=0.243 Sum_probs=90.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEeccc------------------ccChh---hhhhHHHHHHHHhcCC-CC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQR------------------YASWE---DCLNLREVKCLRKLNH-SN 61 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~------------------~~~~~---~~~~~~E~~~l~~l~h-pn 61 (417)
|.+...||-|.-+.||.+-+ ..|...++|.-+.. ..+|- .-...+|+..|+.|.. -.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45778999999999999975 45888999853211 01111 1112478888888853 22
Q ss_pred -eeeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcE
Q 044608 62 -IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGII 139 (417)
Q Consensus 62 -Iv~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~v 139 (417)
|.+.+ +.+..++|||++.|-.+..+.. ...+..+...++.-+.-|-..|+||+|..=-||++. ++.+
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 33333 3466789999988754433221 123445566677777889999999999999999997 5789
Q ss_pred EEeecccc
Q 044608 140 KIADFGLA 147 (417)
Q Consensus 140 kL~DFg~a 147 (417)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.013 Score=56.25 Aligned_cols=144 Identities=17% Similarity=0.204 Sum_probs=78.6
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEecc-cccChhhhhhHHHHHHHHhcCCC--CeeeeceEEEeCC--EEEEEE
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQ-RYASWEDCLNLREVKCLRKLNHS--NIVKLKELIQNNN--RLYLVF 79 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~-~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~~--~~~lv~ 79 (417)
.+++.+-.|..-.+|..... ++.+++. ... ...........+|+.+++.+.-- -+...++++.++. ..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455544555566666433 7888888 332 22222233345788888887532 2334455555544 669999
Q ss_pred eccCCCH----------H-HHHH--------Hhc----------C--CCCCHHHHHHHHHHH--------------HHHH
Q 044608 80 ECMECNL----------Y-QLMA--------ARD----------R--KLFSEPEIKAWLFQV--------------FQGL 114 (417)
Q Consensus 80 E~~~~~l----------~-~~~~--------~~~----------~--~~l~e~~i~~i~~qi--------------~~aL 114 (417)
+|++|.. . .... .-+ . ..+...++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9988720 0 0000 000 0 001112222222222 1223
Q ss_pred HHHHHC--------CcccccCCCCCeeeeCC-cEEEeecccccccc
Q 044608 115 SYMHQN--------GFFHRDLKPENLLVSQG-IIKIADFGLAREIK 151 (417)
Q Consensus 115 ~~LH~~--------gi~HrDLKp~NILl~~~-~vkL~DFg~a~~~~ 151 (417)
.+|+.+ .++|+|+.+.||+++++ .+-|+||+++..-+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 444433 48999999999999764 58899999987533
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.018 Score=57.18 Aligned_cols=75 Identities=16% Similarity=0.186 Sum_probs=50.3
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEeccccc----C--hhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA----S--WEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----~--~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~ 76 (417)
..+.||.|....||+..+. +..|+||.-..... + ....+...|.+.|+.+. -.++.+++.+++ +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3567999999999999763 45699997652111 1 12233345777777664 247788888776 3457
Q ss_pred EEEeccCC
Q 044608 77 LVFECMEC 84 (417)
Q Consensus 77 lv~E~~~~ 84 (417)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.013 Score=57.23 Aligned_cols=137 Identities=19% Similarity=0.234 Sum_probs=77.7
Q ss_pred ecceecccCceEEEEEEECC----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEe
Q 044608 6 GFKELGRGAFGRVFQAFDEH----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E 80 (417)
-++.|-.|-.-.+|++.... +++.|++|+..... . .......|..+++.+..-++ .++++.+..+ .|.|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 34456568888999986322 34789999876532 1 11223579999998864443 3555655332 4788
Q ss_pred ccCCCHHH-----------HHHH----hcCC-------CCCHHHHHHHHHHHH-----------------HHHHHH----
Q 044608 81 CMECNLYQ-----------LMAA----RDRK-------LFSEPEIKAWLFQVF-----------------QGLSYM---- 117 (417)
Q Consensus 81 ~~~~~l~~-----------~~~~----~~~~-------~l~e~~i~~i~~qi~-----------------~aL~~L---- 117 (417)
|+++..+. .+.. -+.. ......+..+..++. ..+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 87764221 1110 0110 011223333332221 111111
Q ss_pred H----HCCcccccCCCCCeeeeC--CcEEEeeccccc
Q 044608 118 H----QNGFFHRDLKPENLLVSQ--GIIKIADFGLAR 148 (417)
Q Consensus 118 H----~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~ 148 (417)
. ...++|+|+++.|||+++ +.+.|+||..|.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999974 569999999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=57.31 Aligned_cols=73 Identities=11% Similarity=0.172 Sum_probs=45.4
Q ss_pred cceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 82 (417)
++.|..|-...+|++..... +..|++|+...... ......+|..+++.+..-++ .++++++. ++ +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence 45566688889999864432 34799998764321 12223479999999865444 45565553 22 478887
Q ss_pred CCC
Q 044608 83 ECN 85 (417)
Q Consensus 83 ~~~ 85 (417)
+|.
T Consensus 93 ~g~ 95 (330)
T PLN02421 93 NAR 95 (330)
T ss_pred cCC
Confidence 764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.019 Score=54.31 Aligned_cols=29 Identities=24% Similarity=0.452 Sum_probs=24.6
Q ss_pred CcccccCCCCCeeeeC-Cc-EEEeecccccc
Q 044608 121 GFFHRDLKPENLLVSQ-GI-IKIADFGLARE 149 (417)
Q Consensus 121 gi~HrDLKp~NILl~~-~~-vkL~DFg~a~~ 149 (417)
.++|+|++|.|||+++ +. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987 65 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.065 Score=51.53 Aligned_cols=29 Identities=17% Similarity=0.086 Sum_probs=25.5
Q ss_pred CcccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 121 GFFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 121 gi~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
+++|+|+.+.|||+++ +.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 7999999999999965 6799999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.011 Score=57.12 Aligned_cols=72 Identities=25% Similarity=0.422 Sum_probs=55.7
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
..+.|++|++-++.+. .+ +.-..+++..++.+.+..+.-+..+ ..-|||+.-.||||++|.|-|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeec
Confidence 3466888887544432 22 1235578888888888888777766 57899999999999999999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.024 Score=56.22 Aligned_cols=29 Identities=34% Similarity=0.287 Sum_probs=25.9
Q ss_pred CCcccccCCCCCeeeeCCcEEEeeccccc
Q 044608 120 NGFFHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
...+|.||-+.|||.+++.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEecccc
Confidence 46799999999999988899999998774
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.026 Score=54.03 Aligned_cols=103 Identities=10% Similarity=0.056 Sum_probs=68.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC---CCeeeeceEEEe---CCEEEEEEe
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH---SNIVKLKELIQN---NNRLYLVFE 80 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~---~~~~~lv~E 80 (417)
.+.||.|..+.||.... ++..+.+|..+... ......+|...|+.|.. -.+.++++++.+ .+..+||||
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 45799999999999843 22347778743311 12344679999998853 357777877654 366899999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~ 120 (417)
+++|...... ..+......+..+++.+|.-||+.
T Consensus 94 ~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9998643321 123444556667777888888864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.44 Score=46.16 Aligned_cols=69 Identities=20% Similarity=0.149 Sum_probs=40.3
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeec---e--EEEeCCEEEEEEeccCCC
Q 044608 14 AFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLK---E--LIQNNNRLYLVFECMECN 85 (417)
Q Consensus 14 ~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~~~ 85 (417)
.-..||++.. .+|..|++|+.+.... ....+..|++.+..|.... ++... + +...++..+.++++++|.
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 3456888853 3466799998764332 2334456777777763211 22211 1 233456778899988764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.21 Score=55.89 Aligned_cols=30 Identities=33% Similarity=0.448 Sum_probs=25.1
Q ss_pred CCcccccCCCCCeeeeCC---cEE-Eeecccccc
Q 044608 120 NGFFHRDLKPENLLVSQG---IIK-IADFGLARE 149 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~~---~vk-L~DFg~a~~ 149 (417)
.+++|.|+++.|||++.+ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 479999999999999754 565 999998753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.2 Score=50.64 Aligned_cols=74 Identities=9% Similarity=0.094 Sum_probs=45.4
Q ss_pred ecceecccCceEEEEEEECCC--------CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCee-eeceEEEeCCEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHT--------GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV-KLKELIQNNNRLY 76 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~--------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~ 76 (417)
-++.|..|-.-.+|++..... ++.|.+++....... -.....|..+++.+..-+|- ++++.+. + +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~--lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE--LYNPISEFEVYKTMSKYRIAPQLLNTFS-G---G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc--eeCHHHHHHHHHHHHHCCCCCceEEEeC-C---C
Confidence 456677788888999864421 567999987553221 12334688888888644443 4555553 2 3
Q ss_pred EEEeccCCC
Q 044608 77 LVFECMECN 85 (417)
Q Consensus 77 lv~E~~~~~ 85 (417)
.|.||++|.
T Consensus 183 ~I~efi~g~ 191 (442)
T PTZ00296 183 RIEEWLYGD 191 (442)
T ss_pred EEEEeeCCc
Confidence 467887764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.059 Score=51.50 Aligned_cols=60 Identities=25% Similarity=0.253 Sum_probs=35.1
Q ss_pred EEEEEeccCCCHH--HH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCCCCeee
Q 044608 75 LYLVFECMECNLY--QL-MAARDRKLFSEPEIKAWLFQVFQGLSYMH----QNGFFHRDLKPENLLV 134 (417)
Q Consensus 75 ~~lv~E~~~~~l~--~~-~~~~~~~~l~e~~i~~i~~qi~~aL~~LH----~~gi~HrDLKp~NILl 134 (417)
-.+|+....|+.- .. .....+-.--.+-++.++.||+.-.-.+- ..+++|-||||+|||+
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi 316 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI 316 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE
Confidence 3577876655321 11 11111111123457778888866543342 2369999999999999
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.61 Score=44.34 Aligned_cols=75 Identities=13% Similarity=0.191 Sum_probs=46.4
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEEEEEec
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+-.+.|+-|....+|+.. .+++.+.+|+-.... ......|..-|+.|. --.+.+++.+....+.-||||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 345678999999999985 778899999876322 223346888888873 34577888888777777999999
Q ss_pred cCCC
Q 044608 82 MECN 85 (417)
Q Consensus 82 ~~~~ 85 (417)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 7644
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.037 Score=48.94 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=25.8
Q ss_pred CcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 121 GFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 121 gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
-.+|+|+.|.||+++++.++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASGLRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCCEEEEeCCcccC
Confidence 36999999999999887899999998863
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.06 Score=51.66 Aligned_cols=74 Identities=20% Similarity=0.309 Sum_probs=42.7
Q ss_pred EEEEeccCCCHHH--HHHHhcCCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccccCCCCCeeeeCC-----------
Q 044608 76 YLVFECMECNLYQ--LMAARDRKL-FSEPEIKAWLFQVFQGLSYMH----QNGFFHRDLKPENLLVSQG----------- 137 (417)
Q Consensus 76 ~lv~E~~~~~l~~--~~~~~~~~~-l~e~~i~~i~~qi~~aL~~LH----~~gi~HrDLKp~NILl~~~----------- 137 (417)
.+||....|+.-. .......+. .-.+-++.++.||+.-.--+- ..+.+|-||||+|||+-+.
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 5788876554221 111111111 123456677777754331132 3479999999999999221
Q ss_pred --------cEEEeecccccc
Q 044608 138 --------IIKIADFGLARE 149 (417)
Q Consensus 138 --------~vkL~DFg~a~~ 149 (417)
..+|.||.+|..
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEEecccceeeecccCHHHh
Confidence 267888888864
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.092 Score=49.43 Aligned_cols=44 Identities=27% Similarity=0.347 Sum_probs=33.3
Q ss_pred HHHHHHHHHHHHHHC--CcccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 106 WLFQVFQGLSYMHQN--GFFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 106 i~~qi~~aL~~LH~~--gi~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
.+..+-.++.-.+.. =++|+|+.|+|+|.++ |.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 444444444444444 4899999999999988 9999999998863
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 417 | ||||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-61 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-61 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-61 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-61 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-61 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-61 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-61 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-61 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-61 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-61 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-61 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-61 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-61 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-61 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-61 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-60 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-60 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-60 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-60 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-60 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-60 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-60 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-60 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-60 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-60 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-60 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-60 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-60 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-60 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-60 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-60 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-60 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-60 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-60 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-59 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-51 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-51 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-51 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-50 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-50 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-50 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-50 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-49 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-48 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-47 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-47 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-47 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-47 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-47 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-47 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-47 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-47 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-47 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-47 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-46 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-46 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-46 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-46 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-46 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-46 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-46 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-46 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-46 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-46 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-46 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-46 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-46 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-46 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-46 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-46 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-46 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-46 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-46 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-46 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-45 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-45 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-45 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-45 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-45 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-44 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-44 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-44 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-44 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-44 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-44 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-44 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-44 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-44 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-44 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-44 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-44 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-44 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-44 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-44 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-44 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-44 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-44 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-44 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-44 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-44 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-44 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-44 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-44 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-44 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-44 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-44 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-44 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-44 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-44 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-44 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-44 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-44 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-44 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-44 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-44 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-44 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-44 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-44 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-44 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-44 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-44 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-44 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-44 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-44 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-44 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-44 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-44 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-44 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-44 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-44 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-44 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-44 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-44 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-44 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-44 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-44 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-44 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-44 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-44 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-44 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-43 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-43 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-43 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-43 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-43 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-43 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-43 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-43 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-43 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-43 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-43 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-43 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-43 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-43 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-43 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-43 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-43 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-43 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-43 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-43 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-43 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-43 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-43 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-43 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-43 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-43 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-42 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-42 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-42 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-42 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-41 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-41 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-41 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-41 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-40 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-39 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-39 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-39 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-38 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-38 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-38 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-37 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-36 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-36 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-36 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-36 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-36 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-36 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-36 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-35 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-35 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-35 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-35 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-35 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-35 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-35 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-35 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-35 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-35 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-35 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-35 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-35 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-35 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-35 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-35 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-34 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-34 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-34 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-34 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-34 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-34 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-33 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-33 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-33 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-32 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-31 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-31 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-30 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-30 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-29 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-28 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-28 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-28 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-28 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-27 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-27 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-27 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-27 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-27 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-27 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-27 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-27 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-27 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-27 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-27 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-27 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-27 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-27 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-27 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-27 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-27 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-26 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-26 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-26 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-26 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-26 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-26 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-26 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-26 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-26 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-25 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-25 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-25 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-25 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-25 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-25 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-25 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-25 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-25 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-25 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-25 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-25 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-24 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-24 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-24 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-24 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-24 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-24 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-24 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-23 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-23 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-23 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-23 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-22 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-22 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-22 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-21 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-21 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-21 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-21 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-21 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-21 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-21 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-21 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-21 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-21 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-21 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-21 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-21 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-21 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-20 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-20 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-20 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-20 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 |
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 374 bits (964), Expect = e-129
Identities = 92/289 (31%), Positives = 151/289 (52%), Gaps = 5/289 (1%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNH 59
M+KY ++G G++G VF+ + TG+ VAIK+ + LRE++ L++L H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
N+V L E+ + RL+LVFE + + + ++ E +K+ +Q Q +++ H+
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSELY 177
+ HRD+KPEN+L++ +IK+ DFG AR + Y + V +RWYR+PE+L+ Y
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
D+WA+G + AEL + PL+PG S+ DQ+Y I LG +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 238 FPQ-LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
P L P+ S A+ L + DP++R T + L HP+F+
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-125
Identities = 99/289 (34%), Positives = 152/289 (52%), Gaps = 5/289 (1%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNH 59
M+KY +G G++G V + ++ TG VAIK+ + +RE+K L++L H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
N+V L E+ + R YLVFE ++ + + ++ +LFQ+ G+ + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSELY 177
+ HRD+KPEN+LVS G++K+ DFG AR + + G Y + V +RWYRAPE+L+ Y
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
D+WA+G ++ E+F PLFPG S+ DQ+Y I LG+ + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 238 FPQL-PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
P++ R L P S+ I L + DP KRP AE L H FF+
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-116
Identities = 98/294 (33%), Positives = 165/294 (56%), Gaps = 18/294 (6%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
Y+ K +G G+FG V+QA +GE VAIK++ Q + RE++ +RKL+H NI
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 109
Query: 63 VKLKELI------QNNNRLYLVFECMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGL 114
V+L+ ++ L LV + + +Y++ +R ++ +K +++Q+F+ L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 115 SYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+Y+H G HRD+KP+NLL+ ++K+ DFG A+++ G P +Y+ SR+YRAPE++
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 229
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ Y+S D+W+ G ++AEL P+FPG S DQ+ +I VLG+PT + +
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--MNPN 287
Query: 233 AIKYQFPQLPRANLS-ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+++FPQ+ + P +AI+L L + P+ R T EA H FF
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-116
Identities = 104/296 (35%), Positives = 162/296 (54%), Gaps = 19/296 (6%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
Y+ K +G G+FG VFQA + E VAIK++ Q + RE++ +R + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-----DKRFKNRELQIMRIVKHP 92
Query: 61 NIVKLKELI------QNNNRLYLVFECMECNLYQLMA--ARDRKLFSEPEIKAWLFQVFQ 112
N+V LK ++ L LV E + +Y+ A+ ++ IK +++Q+ +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 113 GLSYMHQNGFFHRDLKPENLLV--SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
L+Y+H G HRD+KP+NLL+ G++K+ DFG A+ + +G P +Y+ SR+YRAPE+
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ + Y++ D+W+ G +MAEL PLFPG S DQ+ +I VLG+P+ +
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN-- 270
Query: 231 ARAIKYQFPQLPRANLS-ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
++++FPQ+ S P DAI L L + PS R TA EAL HPFF
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-115
Identities = 111/337 (32%), Positives = 175/337 (51%), Gaps = 10/337 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLN---LREVKCLRK 56
+Y LG G F V++A D++T + VAIK++K + +D +N LRE+K L++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
L+H NI+ L + + + + LVF+ ME +L ++ + IKA++ QGL Y
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 127
Query: 117 MHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQS 174
+HQ+ HRDLKP NLL+ G++K+ADFGLA+ S YT+ V +RWYRAPE+L +
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+Y DMWA+G I+AEL P PG S+ DQ+ +I LG+PT + W +
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP-DMCSLPDY 246
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY-APPH 293
F P L + +A D + L + L ++P R TA +AL+ +F P
Sbjct: 247 V-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305
Query: 294 IRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGAR 330
P T + + + ++R + +Q +
Sbjct: 306 QLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-114
Identities = 109/329 (33%), Positives = 170/329 (51%), Gaps = 8/329 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M+ Y +LG G + V++ + T VA+KE++ + C +REV L+ L H+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
NIV L ++I L LVFE ++ +L Q + + + +K +LFQ+ +GL+Y H+
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 121 GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPEILLQSELY 177
HRDLKP+NLL++ +G +K+ADFGLAR KS P Y N V + WYR P+ILL S Y
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S++ DMW +G I E+ T PLFPG++ +Q++ I +LG+PT ++W L Y
Sbjct: 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRST 297
+P+ L + P D L L ++ R +A +A++HPFF I
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS---LGERIHKL 295
Query: 298 PAVATTTANQPAAATRGMLKQRRQQQQQQ 326
P + A + + +
Sbjct: 296 PDTTSIFALKEIQLQKEASLRSAHHHHHH 324
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-114
Identities = 104/290 (35%), Positives = 167/290 (57%), Gaps = 10/290 (3%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKL 57
M+KY G +++G G +G V++A + GE A+K++ R ++ + +RE+ L++L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI--RLEKEDEGIPSTTIREISILKEL 57
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
HSNIVKL ++I RL LVFE ++ +L +L+ K++L Q+ G++Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYC 116
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSE 175
H HRDLKP+NLL++ +G +KIADFGLAR YT+ + + WYRAP++L+ S+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
YS+ D+W++G I AE+ PLFPG SEADQ+ +I +LG+P +W + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP-NVTELPKYD 235
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
F + + + I L + DP++R TA +AL+H +FK
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-111
Identities = 108/300 (36%), Positives = 181/300 (60%), Gaps = 14/300 (4%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKL 57
M+KY +++G G +G V++A D G VA+K + R + ++ + +RE+ L++L
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI--RLDAEDEGIPSTAIREISLLKEL 76
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+H NIV L ++I + L LVFE ME +L +++ + + +IK +L+Q+ +G+++
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHC 135
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSE 175
HQ+ HRDLKP+NLL++ G +K+ADFGLAR YT+ V + WYRAP++L+ S+
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
YS+ D+W++G I AE+ T PLFPG ++ DQ+ KI +LG+P W +++ K
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP-QVQELPLWK 254
Query: 236 -YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHI 294
F + S+++P Q+ I L ++ +DP+KR +A +A+ HP+FK P I
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL---DPQI 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-110
Identities = 104/300 (34%), Positives = 156/300 (52%), Gaps = 21/300 (7%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN------LREVKCL 54
+Y E+G GA+G V++A D H+G VA+K + R + +REV L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALL 65
Query: 55 RKLN---HSNIVKLKELIQNNN-----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAW 106
R+L H N+V+L ++ + ++ LVFE ++ +L + IK
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
+ Q +GL ++H N HRDLKPEN+LV+ G +K+ADFGLAR T V + WY
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
RAPE+LLQS Y++ DMW++G I AE+F PLF G SEADQ+ KI ++G P D W
Sbjct: 186 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ FP + +++P + L + +++P KR +A ALQH +
Sbjct: 245 -RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-110
Identities = 103/292 (35%), Positives = 166/292 (56%), Gaps = 12/292 (4%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKL 57
M KY +++G G +G VF+A + T E VA+K + R ++ + LRE+ L++L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKEL 58
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H NIV+L +++ ++ +L LVFE + +L + + +K++LFQ+ +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFC 117
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSE 175
H HRDLKP+NLL++ G +K+A+FGLAR Y+ V + WYR P++L ++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 176 LYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
LYS+ DMW+ G I AEL PLFPG DQ+ +I +LG+PT + W + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SMTKLPDY 236
Query: 235 KYQFPQLPRA-NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
K +P P +L ++P + L ++L +P +R +A EALQHP+F
Sbjct: 237 K-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 322 bits (829), Expect = e-109
Identities = 94/300 (31%), Positives = 160/300 (53%), Gaps = 20/300 (6%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED---CLNLREVKCLRKL 57
++ ++LG G + V++ ++ TG VA+KE+K E+ +RE+ +++L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKEL 60
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLM----AARDRKLFSEPEIKAWLFQVFQG 113
H NIV+L ++I N+L LVFE M+ +L + M + +K + +Q+ QG
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 114 LSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPEI 170
L++ H+N HRDLKP+NLL++ +G +K+ DFGLAR P +++ V + WYRAP++
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFSSEVVTLWYRAPDV 179
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
L+ S YS+ D+W+ G I+AE+ T PLFPG ++ +Q+ I ++G+P W + +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP-SVTK 238
Query: 231 ARAIKYQFPQLPRANLS-----ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q P +L + + L +P R +A +AL HP+F
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-109
Identities = 111/296 (37%), Positives = 167/296 (56%), Gaps = 16/296 (5%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKL 57
+D+Y +LG G +G V++A D T E VAIK + R E+ + +REV L++L
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKEL 90
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H NI++LK +I +N+RL+L+FE E +L + M S IK++L+Q+ G+++
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 118 HQNGFFHRDLKPENLLVS------QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEI 170
H HRDLKP+NLL+S ++KI DFGLAR +T+ + + WYR PEI
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
LL S YS+ D+W++ I AE+ PLFPG SE DQ++KI VLG P +W G+
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-GVTA 267
Query: 231 ARAIKYQFPQLPRANLSALMPSA-SQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
K FP+ L ++ + + + L ++ DP KR +A AL+HP+F
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-106
Identities = 102/298 (34%), Positives = 158/298 (53%), Gaps = 19/298 (6%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDE-HTGEAVAIKELKQRYASWEDCLN---LREVKCLRK 56
+Y E+G GA+G+VF+A D + G VA+K + R + E+ + +REV LR
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRH 67
Query: 57 LN---HSNIVKLKELIQ-----NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLF 108
L H N+V+L ++ +L LVFE ++ +L + IK +F
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRA 167
Q+ +GL ++H + HRDLKP+N+LV+ G IK+ADFGLAR T+ V + WYRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
PE+LLQS Y++ D+W++G I AE+F PLF G+S+ DQ+ KI V+G P + W
Sbjct: 188 PEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-R 245
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ F + + + L +++P+KR +A AL HP+F+
Sbjct: 246 DVALP--RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-104
Identities = 103/346 (29%), Positives = 165/346 (47%), Gaps = 29/346 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKL 57
+ KY ++G+G FG VF+A TG+ VA+K K + ++ LRE+K L+ L
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLL 73
Query: 58 NHSNIVKLKELI--------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQ 109
H N+V L E+ + +YLVF+ E +L L++ K F+ EIK +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQM 132
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI-----KSGPPYTNYVGSR 163
+ GL Y+H+N HRD+K N+L++ G++K+ADFGLAR YTN V +
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
WYR PE+LL Y D+W G IMAE++T P+ G +E Q+ I + GS T +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQD--AISLFESLCSWDPSKRPTAAEALQH 281
W + K + + + + + + +D A+ L + L DP++R + +AL H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 282 PFFKRCFYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQ 327
FF P ++ + + + RR+
Sbjct: 313 DFFWSDPM-PSDLKGML------STHLTSMFEYLAPPRRKHHHHHH 351
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 88/304 (28%), Positives = 150/304 (49%), Gaps = 25/304 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQ--RYASWEDCLNLREVKCLRKLN 58
MD++ + G+G FG V ++ TG +VAIK++ Q R+ + E L+ ++ L L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQDLAVLH 77
Query: 59 HSNIVKLKELIQNNNR-------LYLVFECMECNLYQLM--AARDRKLFSEPEIKAWLFQ 109
H NIV+L+ L +V E + L++ R + IK +LFQ
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 110 VFQGLSYMHQN--GFFHRDLKPENLLV--SQGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
+ + + +H HRD+KP N+LV + G +K+ DFG A+++ P Y+ SR+Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
RAPE++ ++ Y++ D+W++G I AE+ P+F G + A Q+++I VLG P+ +
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257
Query: 226 DGLRQARAIKYQFPQLPRANLS----ALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
L + S +++A L +L + P +R EAL H
Sbjct: 258 -KLNPSHTDVD-LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315
Query: 282 PFFK 285
P+F
Sbjct: 316 PYFD 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-99
Identities = 92/329 (27%), Positives = 156/329 (47%), Gaps = 54/329 (16%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQ--RYASWEDCLNLREVKCLRKLN 58
KYS K LG G+FG V + FD +G+ A+K++ Q RY RE+ ++ L+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLD 58
Query: 59 HSNIVKLKELI--------------------------------------QNNNRLYLVFE 80
H NI+KL + N L ++ E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 81 CMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV--SQ 136
+ L++++ R + I +++Q+F+ + ++H G HRD+KP+NLLV
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 137 GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+K+ DFG A+++ P Y+ SR+YRAPE++L + Y+ D+W++G + EL
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 197 CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSAS-Q 255
PLF G + DQ+ +I ++G+PT + + + +FP L + ++P +
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMI-RMNPHYT-EVRFPTLKAKDWRKILPEGTPS 296
Query: 256 DAISLFESLCSWDPSKRPTAAEALQHPFF 284
AI L E + ++P R EA+ HPFF
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 2e-99
Identities = 90/303 (29%), Positives = 154/303 (50%), Gaps = 22/303 (7%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN----------LREV 51
Y+ + + G++G V D G VAIK + + LRE+
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 52 KCLRKLNHSNIVKLKELI-----QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAW 106
+ L +H NI+ L+++ ++LYLV E M +L Q++ + + S I+ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI-SPQHIQYF 139
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
++ + GL +H+ G HRDL P N+L+ I I DF LARE + T+YV RWY
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
RAPE+++Q + ++ DMW+ G +MAE+F LF G++ +Q+ KI V+G+P ++
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV- 258
Query: 226 DGLRQARAIKY---QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282
A Y +P +A++P+A A+ L + ++P +R + +AL+HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 283 FFK 285
+F+
Sbjct: 319 YFE 321
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 9e-99
Identities = 102/304 (33%), Positives = 162/304 (53%), Gaps = 24/304 (7%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
+ LG GA+G V A + TGE VAIK+++ + L LRE+K L+ H
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHE 69
Query: 61 NIVKLKELI-----QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
NI+ + + +N N +Y++ E M+ +L+++++ + S+ I+ +++Q + +
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQYFIYQTLRAVK 126
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY-----------TNYVGSR 163
+H + HRDLKP NLL+ S +K+ DFGLAR I +V +R
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
WYRAPE++L S YS D+W+ G I+AELF P+FPG Q+ I G++G+P D+
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 224 WADGLRQARAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ RA +Y P P A L + P + I L + + +DP+KR TA EAL+H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 282 PFFK 285
P+ +
Sbjct: 307 PYLQ 310
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 3e-98
Identities = 111/294 (37%), Positives = 154/294 (52%), Gaps = 17/294 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
Y +G GA+G V A D+ +GE VAIK+L + + S RE+ L+ + H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 61 NIVKLKELI------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ +N YLV M+ +L ++M FSE +I+ ++Q+ +GL
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM----GLKFSEEKIQYLVYQMLKGL 139
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRDLKP NL V +KI DFGLAR T YV +RWYRAPE++L
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILS 197
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ D+W++G IMAE+ T LF G DQ+ +I V G P + L A
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV-QKLNDKAA 256
Query: 234 IKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y PQ PR + + L P AS A L E + D KR TAA+AL HPFF+
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-97
Identities = 96/306 (31%), Positives = 146/306 (47%), Gaps = 26/306 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
+Y K LG G G VF A D + VAIK K + LRE+K +R+L+H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 61 NIVKLKELIQNNNR--------------LYLVFECMECNLYQLMAARDRKLFSEPEIKAW 106
NIVK+ E++ + +Y+V E ME +L ++ E + +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP---LLEEHARLF 125
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLVSQG--IIKIADFGLAREIKSGPPY----TNYV 160
++Q+ +GL Y+H HRDLKP NL ++ ++KI DFGLAR + + + +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 161 GSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPT 220
++WYR+P +LL Y+ DMWA G I AE+ T LF GA E +QM I +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 221 MDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ + L P L+ L+P S++A+ E + ++ P R TA EAL
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
Query: 281 HPFFKR 286
HP+
Sbjct: 306 HPYMSI 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 5e-97
Identities = 101/297 (34%), Positives = 162/297 (54%), Gaps = 18/297 (6%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
+Y+ +G GA+G V A+D VAIK++ + C LRE+K L + H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHE 85
Query: 61 NIVKLKELI-----QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
NI+ + ++I + +Y+V + ME +LY+L+ + S I +L+Q+ +GL
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLK 142
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAR----EIKSGPPYTNYVGSRWYRAPEI 170
Y+H HRDLKP NLL+ + +KI DFGLAR + T YV +RWYRAPEI
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+L S+ Y+ D+W++G I+AE+ + P+FPG DQ+ I G+LGSP+ + + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL-NCIIN 261
Query: 231 ARAIKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+A Y P + + L P+A A+ L + + +++P KR +AL HP+ +
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-96
Identities = 102/383 (26%), Positives = 171/383 (44%), Gaps = 50/383 (13%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEH--TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+Y G K +GRG +G V++A + + A+K+++ + RE+ LR+L H
Sbjct: 23 EYEGCK-VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHP 78
Query: 61 NIVKLKELI--QNNNRLYLVFECMECNLYQLM-------AARDRKLFSEPEIKAWLFQVF 111
N++ L+++ + +++L+F+ E +L+ ++ A + +K+ L+Q+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 112 QGLSYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKS-GPPYTNY---VGS 162
G+ Y+H N HRDLKP N+LV +G +KIAD G AR S P + V +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKIC 213
WYRAPE+LL + Y+ D+WA+G I AEL T P+F E DQ+ +I
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 214 GVLGSPTMDSWAD--GLRQARAIKYQFPQLPRAN------LSALMPSASQDAISLFESLC 265
V+G P W D + + + F + N + A L + L
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318
Query: 266 SWDPSKRPTAAEALQHPFFKR-------CFYAPPHIRSTPAVATTTANQPAAATRGMLKQ 318
+ DP KR T+ +A+Q P+F F T + +Q
Sbjct: 319 TMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKN--QQ 376
Query: 319 RRQQQQQQQGARMCADEASSNSQ 341
++Q G ++ SS++Q
Sbjct: 377 QQQGNNHTNGTGHPGNQDSSHTQ 399
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 6e-96
Identities = 82/303 (27%), Positives = 144/303 (47%), Gaps = 31/303 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK----QRYASWEDCLNLREVKCLRK 56
D Y ++LGRG + VF+A + E V +K LK ++ RE+K L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--------KREIKILEN 86
Query: 57 L-NHSNIVKLKELIQ--NNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
L NI+ L ++++ + LVFE + QL + ++ +I+ +++++ +
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILK 141
Query: 113 GLSYMHQNGFFHRDLKPENLLV--SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
L Y H G HRD+KP N+++ +++ D+GLA G Y V SR+++ PE+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 171 LLQSELYSSKADMWAMGAIMAEL-FTFCPLFPGASEADQMYKICGVLGSPTMDSWAD--G 227
L+ ++Y DMW++G ++A + F P F G DQ+ +I VLG+ + + D
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 228 LRQARAIKYQFPQLPRANLSALMPS-----ASQDAISLFESLCSWDPSKRPTAAEALQHP 282
+ + R + S S +A+ + L +D R TA EA++HP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 283 FFK 285
+F
Sbjct: 322 YFY 324
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 1e-94
Identities = 103/294 (35%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
Y + +G GA+G V A D TG VAIK+L + + S RE++ L+ + H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 61 NIVKLKELIQNNNR------LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ + YLV M +L +LM E I+ ++Q+ +GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGL 141
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRDLKP NL V +KI DFGLAR+ T YV +RWYRAPE++L
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILN 199
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ D+W++G IMAE+ T LF G+ DQ+ +I V G+P + L+ A
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV-QRLQSDEA 258
Query: 234 IKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y P+L + + ++++ +AS A++L E + D +R TA EAL HP+F+
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 2e-94
Identities = 100/294 (34%), Positives = 153/294 (52%), Gaps = 16/294 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
++Y +G GA+G V AFD TG VA+K+L + + S RE++ L+ + H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 61 NIVKLKELI------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ + N +YLV M +L ++ + ++ ++ ++Q+ +GL
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 145
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H HRDLKP NL V +KI DFGLAR T YV +RWYRAPEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAPEIMLN 203
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ D+W++G IMAEL T LFPG DQ+ I ++G+P + + A
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL-KKISSESA 262
Query: 234 IKY--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y Q+P+ N + + A+ A+ L E + D KR TAA+AL H +F
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 287 bits (735), Expect = 4e-93
Identities = 107/353 (30%), Positives = 167/353 (47%), Gaps = 71/353 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
D+Y +G G++G V +A+D+ VAIK++ + + DC LRE+ L +LNH
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 61 NIVKLKELI-----QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
++VK+ +++ + + LY+V E + + +L R +E IK L+ + G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF--RTPVYLTELHIKTLLYNLLVGVK 170
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPP------------------- 155
Y+H G HRDLKP N LV +K+ DFGLAR +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 156 ---------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC--------- 197
T +V +RWYRAPE++L E Y+ D+W++G I AEL
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 198 --PLFPGAS--------------------EADQMYKICGVLGSPTMDSWADGLRQARAIK 235
PLFPG+S DQ+ I +LG+P+ + + L + A +
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI-EALEKEDAKR 349
Query: 236 Y--QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
Y FP+ +L+ P++S DAI L + + ++P+KR T E L HPFFK
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 4e-90
Identities = 93/305 (30%), Positives = 140/305 (45%), Gaps = 25/305 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNH 59
+ +Y K +G GA G V A+D VAIK+L + + + RE+ ++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 60 SNIVKLKELIQNNNR------LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI+ L + +Y+V E M+ NL Q++ + + L+Q+ G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI----QMELDHERMSYLLYQMLCG 139
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y D+W++G IM E+ LFPG DQ K+ LG+P + R
Sbjct: 200 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 233 AIKYQFPQLPRANLSALMPSA------------SQDAISLFESLCSWDPSKRPTAAEALQ 280
P+ + L P + A L + D SKR + EALQ
Sbjct: 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318
Query: 281 HPFFK 285
HP+
Sbjct: 319 HPYIN 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 1e-89
Identities = 111/345 (32%), Positives = 168/345 (48%), Gaps = 63/345 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
D Y +GRG++G V+ A+D++T + VAIK++ + + DC LRE+ L +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 61 NIVKLKELIQNNNR-----LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
I++L +LI ++ LY+V E + +L +L + +E IK L+ + G +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF--KTPIFLTEEHIKTILYNLLLGEN 143
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY------------------ 156
++H++G HRDLKP N L+ +K+ DFGLAR I S
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 157 -----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-----------PLF 200
T++V +RWYRAPE++L E Y+ D+W+ G I AEL PLF
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 201 PGASEA-----------------DQMYKICGVLGSPTMDSWADGLRQARAIKY--QFPQL 241
PG+S DQ+ I ++G+PT D + + IKY FP
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL-KNINKPEVIKYIKLFPHR 322
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
NL PS S D I+L ES+ ++P+KR T +AL HP+ K
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-89
Identities = 103/402 (25%), Positives = 166/402 (41%), Gaps = 33/402 (8%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLNHS 60
+Y K +G GA G V A+D VAIK+L + + + RE+ ++ +NH
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 61 NIVKLKELI------QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
NI+ L + + +YLV E M+ NL Q++ + + L+Q+ G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGI 177
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y D+W++G IM E+ LFPG DQ K+ LG+P + R
Sbjct: 238 MG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296
Query: 234 IKYQFPQLPRANLSALMPSA------------SQDAISLFESLCSWDPSKRPTAAEALQH 281
P+ L P + + A L + DP+KR + +ALQH
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 282 PFFKRCFYAPPHIRSTPAVATTTANQPAAATRGMLKQ-------RRQQQQQQQGARMCAD 334
P+ +Y P + + P T K+ +++ + +
Sbjct: 357 PYINV-WYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPS 415
Query: 335 EASSNSQMVGKLSPLDLIKQVQQKSVKQPKYSPAAEKKSPTS 376
+ + L P + + S Q S ++
Sbjct: 416 PSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASA 457
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-87
Identities = 98/329 (29%), Positives = 168/329 (51%), Gaps = 49/329 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCL-NLREVKCLRKLN-H 59
KY K+LG+GA+G V+++ D TGE VA+K++ + + D RE+ L +L+ H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 60 SNIVKLKELIQ--NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
NIV L +++ N+ +YLVF+ ME +L+ ++ A + ++Q+ + + Y+
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVVYQLIKVIKYL 125
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY-------------------- 156
H G HRD+KP N+L+ ++ +K+ADFGL+R +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 157 --TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214
T+YV +RWYRAPEILL S Y+ DMW++G I+ E+ P+FPG+S +Q+ +I G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 215 VLGSPTMDSWADGLRQARAIKY--QFPQLPRANLSAL----------------MPSASQD 256
V+ P+ + + ++ A + S +++
Sbjct: 246 VIDFPSNEDV-ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 257 AISLFESLCSWDPSKRPTAAEALQHPFFK 285
A+ L + L ++P+KR +A +AL+HPF
Sbjct: 305 ALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-71
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 37/289 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-N 58
+ LG G++G VF+ + G A+K + +D L EV K+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
H V+L++ + LYL E +L Q E ++ +L L+++H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 119 QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
G H D+KP N+ + G K+ DFGL E+ + G Y APE+L S Y
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--Y 232
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ AD++++G + E+ L G Q+ + Y
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-----------------------GYL 269
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
P+ S + S+ + DP R TA L P ++
Sbjct: 270 PPEFT--------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-71
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 48/301 (15%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH-- 59
YS K++G G +VFQ +E + AIK + A + + E+ L KL
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
I++L + + +Y+V EC +L + + +K E K++ + + + +HQ
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILLQS-- 174
+G H DLKP N L+ G++K+ DFG+A +++ + VG+ Y PE +
Sbjct: 146 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 175 --------ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWA 225
S K+D+W++G I+ + F ++ I
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------------ 253
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ +FP +D + + DP +R + E L HP+ +
Sbjct: 254 -----DPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 286 R 286
Sbjct: 298 I 298
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-71
Identities = 84/346 (24%), Positives = 143/346 (41%), Gaps = 36/346 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
M+KY +++G G+FG+ G IKE+ S ++ REV L + H
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 60 SNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
NIV+ +E + N LY+V + C +L++ + A+ LF E +I W Q+ L ++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 119 QNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
HRD+K +N L G +++ DFG+AR + S +G+ +Y +PEI +++
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKP 201
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y++K+D+WA+G ++ EL T F S + + KI
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---------------------SG 240
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF--YAPPHI 294
FP + S D SL L +P RP+ L+ F + + P +
Sbjct: 241 SFPPVS--------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 295 RSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNS 340
+ T + + Q A+ A+
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYG 338
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-71
Identities = 92/339 (27%), Positives = 152/339 (44%), Gaps = 51/339 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRY--ASWEDCLNLREVKCLRKL 57
+Y K +G+G+FG+V +A+D + VA+K ++ +R+ + E++ L L
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA------AEEIRILEHL 150
Query: 58 NH------SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
N++ + E N + + FE + NLY+L+ + FS P ++ + +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 112 QGLSYMHQNGFFHRDLKPENLLVSQG---IIKIADFGLAREIKSGPPYTNYVGSRWYRAP 168
Q L +H+N H DLKPEN+L+ Q IK+ DFG + Y+ SR+YRAP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAP 268
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSP--------- 219
E++L + Y DMW++G I+AEL T PL PG E DQ+ + +LG P
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 220 ------------------TMDSWADGLRQARAIKYQFPQLPRA-NLSALMPSASQDA-IS 259
T+ + L R+ + + P + + +
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 260 LFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTP 298
+ WDP+ R T +AL+HP+ +R PP T
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTS 426
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 5e-71
Identities = 73/315 (23%), Positives = 116/315 (36%), Gaps = 61/315 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ LG+GAFG+V +A + AIK+++ L EV L LNH
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL--SEVMLLASLNHQY 63
Query: 62 IVKLKELIQNNNR-------------LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWL 107
+V+ L++ E E LY L+ + + E
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRLF 122
Query: 108 FQVFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPY---------- 156
Q+ + LSY+H G HRDLKP N + +KI DFGLA+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 157 -----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211
T+ +G+ Y A E+L + Y+ K DM+++G I E+ P G + + K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNILKK 240
Query: 212 ICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK 271
+ R++ +FP + + + L DP+K
Sbjct: 241 L-------------------RSVSIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNK 274
Query: 272 RPTAAEALQHPFFKR 286
RP A L +
Sbjct: 275 RPGARTLLNSGWLPV 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-70
Identities = 69/357 (19%), Positives = 135/357 (37%), Gaps = 50/357 (14%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH-- 59
YS K++G G +VFQ +E + AIK + A + + E+ L KL
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
I++L + + +Y+V EC +L + + +K E K++ + + + +HQ
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILLQS-- 174
+G H DLKP N L+ G++K+ DFG+A +++ + VG+ Y PE +
Sbjct: 127 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 175 --------ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWA 225
S K+D+W++G I+ + F ++ I
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------------ 234
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ +FP +D + + DP +R + E L HP+ +
Sbjct: 235 -----DPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
Query: 286 RCFYAPPHIR--STPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNS 340
+ + +T + + + + + + + +SS +
Sbjct: 279 IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKT 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-70
Identities = 70/306 (22%), Positives = 117/306 (38%), Gaps = 31/306 (10%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ LG+GA VF+ + TG+ AIK + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 62 IVKLKELIQ--NNNRLYLVFECME-CN---LYQLMAARDRKL-FSEPEIKAWLFQVFQGL 114
IVKL + + L+ ME C LY ++ E E L V G+
Sbjct: 69 IVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 115 SYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+++ +NG HR++KP N++ Q + K+ DFG ARE++ + + G+ Y P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 170 IL-------LQSELYSSKADMWAMGAIMAELFT----FCPLFPGASEADQMYKICGVLGS 218
+ + Y + D+W++G T F P + MYKI + G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGK 243
Query: 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278
P+ + I + +LS + ++ D K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LQHPFF 284
Sbjct: 301 FAETSD 306
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-68
Identities = 93/303 (30%), Positives = 151/303 (49%), Gaps = 36/303 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
++Y+ LG+G+FG V + D T + A+K + + A +D + REV+ L+KL+H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI+KL E++++++ Y+V E L+ + R R FSE + + QVF G++YMH+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139
Query: 120 NGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ HRDLKPEN+L+ IKI DFGL+ + + +G+ +Y APE+L +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y K D+W+ G I+ L + P F G +E D + ++ K
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------------------ETGK 238
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
Y F + S DA L + ++ PS R TA + L+HP+ ++ P I
Sbjct: 239 YAFDLPQ-------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291
Query: 296 STP 298
P
Sbjct: 292 DLP 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-67
Identities = 101/334 (30%), Positives = 143/334 (42%), Gaps = 58/334 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRY--ASWEDCLNLREVKCLRKL 57
D+Y +G+G+FG+V +A+D E VAIK +K + + + EV+ L +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA------QIEVRLLELM 107
Query: 58 NH------SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
N IV LK N L LVFE + NLY L+ + + S + + Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 112 QGLSYMHQN--GFFHRDLKPENLLVSQG---IIKIADFGLAREIKSGPPYTNYVGSRWYR 166
L ++ H DLKPEN+L+ IKI DFG + + G Y+ SR+YR
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYR 225
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM----- 221
+PE+LL Y DMW++G I+ E+ T PLF GA+E DQM KI VLG P
Sbjct: 226 SPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 222 --------DSWADG---------------------LRQARAIKYQFPQLPRANLSALMPS 252
+ DG L ++ P RA S +
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 253 ASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
L + +DP R ALQH FFK+
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-67
Identities = 71/356 (19%), Positives = 130/356 (36%), Gaps = 51/356 (14%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH-- 59
YS K++G G +VFQ +E + AIK + A + + E+ L KL
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
I++L + + +Y+V EC +L + + +K E K++ + + + +HQ
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 120 NGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILLQS-- 174
+G H DLKP N L+ G++K+ DFG+A +++ + VG+ Y PE +
Sbjct: 174 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 175 --------ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWA 225
S K+D+W++G I+ + F ++ I
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------- 282
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ +FP +D + + DP +R + E L HP+ +
Sbjct: 283 ------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 286 RCFYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQ 341
+ T G+ + + + S NS
Sbjct: 326 I---QTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-67
Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 43/299 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH 59
+ Y +G G++GR + + G+ + KEL + + L EV LR+L H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 60 SNIVKLKELIQ--NNNRLYLVFE-CMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGL 114
NIV+ + I N LY+V E C +L ++ ++R+ E + + Q+ L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 115 SYMHQNGFF-----HRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRA 167
H+ HRDLKP N L + +K+ DFGLAR + + +VG+ +Y +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
PE + Y+ K+D+W++G ++ EL P F S+ + KI
Sbjct: 185 PEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------------- 229
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ +F ++P S + + + + RP+ E L++P
Sbjct: 230 -------EGKFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-67
Identities = 86/303 (28%), Positives = 139/303 (45%), Gaps = 36/303 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
+ Y K+LG GA+G V D+ T AIK +++ S L EV L+ L+H
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI+KL + ++ YLV E L+ + R + F+E + + QV G++Y+H+
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHK 154
Query: 120 NGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ HRDLKPENLL+ +IKI DFGL+ ++ +G+ +Y APE+L +
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK- 213
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y K D+W++G I+ L P F G ++ + + K+ K
Sbjct: 214 -YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------------------EKGK 253
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
Y F + S+ A L + + +D +R +A +AL+HP+ K
Sbjct: 254 YTFDSPE-------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGI 306
Query: 296 STP 298
P
Sbjct: 307 ELP 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-67
Identities = 95/292 (32%), Positives = 147/292 (50%), Gaps = 37/292 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLNH 59
D+Y G + LG+G+FG V D+ TG+ A+K + K++ D +L REV+ L++L+H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 60 SNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
NI+KL E ++ YLV E L+ + +R R FSE + + QV G++YMH
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMH 143
Query: 119 QNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
+N HRDLKPENLL+ I+I DFGL+ ++ + +G+ +Y APE+L +
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y K D+W+ G I+ L + CP F GA+E D + K+
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------------------EKG 242
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
KY F S+ A L + ++ PS R +A +AL H + +
Sbjct: 243 KYTFELPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-67
Identities = 90/290 (31%), Positives = 147/290 (50%), Gaps = 36/290 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
++Y+ LG+G+FG V + D T + A+K + + A +D + REV+ L+KL+H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI+KL E++++++ Y+V E L+ + R R FSE + + QVF G++YMH+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139
Query: 120 NGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ HRDLKPEN+L+ IKI DFGL+ + + +G+ +Y APE+L +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y K D+W+ G I+ L + P F G +E D + ++ K
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------------------ETGK 238
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y F + S DA L + ++ PS R TA + L+HP+ +
Sbjct: 239 YAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-67
Identities = 91/290 (31%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
D Y +ELG+GAF V + + TG A K + + S D L RE + RKL H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV+L + IQ + YLVF+ L++ + AR+ +SE + + Q+ + ++Y H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHS 123
Query: 120 NGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
NG HR+LKPENLL++ +K+ADFGLA E+ + + G+ Y +PE+L + +
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 182
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
YS D+WA G I+ L P F + +I +A
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------------KAGA 223
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y +P S + + +A SL +S+ + +P KR TA +AL+ P+
Sbjct: 224 YDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-66
Identities = 71/305 (23%), Positives = 113/305 (37%), Gaps = 60/305 (19%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNH 59
+ + +G G FG+VF+A G+ IK + E REVK L KL+H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAE--REVKALAKLDH 63
Query: 60 SNIVKLKE----------------LIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPE 102
NIV L++ E C + L Q + R + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 103 IKAWLFQVFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNYVG 161
Q+ +G+ Y+H +RDLKP N LV +KI DFGL +K+ T G
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221
+ Y +PE + S+ Y + D++A+G I+AEL + A E + +
Sbjct: 184 TLRYMSPEQI-SSQDYGKEVDLYALGLILAEL---LHVCDTAFETSKFFT---------- 229
Query: 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ + + +L + L S P RP +E L+
Sbjct: 230 -------------DLRDGIIS--------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268
Query: 282 PFFKR 286
+
Sbjct: 269 LTVWK 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-66
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNHS 60
D + ++LG GAFG V + +G IK + K R + + E++ L+ L+H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI-EAEIEVLKSLDHP 80
Query: 61 NIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKL--FSEPEIKAWLFQVFQGLSYM 117
NI+K+ E+ ++ + +Y+V E E L + + + + SE + + Q+ L+Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 118 HQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
H H+DLKPEN+L IKI DFGLA KS TN G+ Y APE+ +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
+ K D+W+ G +M L T C F G S + K
Sbjct: 201 D--VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-------------------TY 239
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ + R + A+ L + + + DP +RP+AA+ L H +FK
Sbjct: 240 KEPNYAVECR--------PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-66
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 36/297 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
Y+ +GRG++G V A + T A K++ + + D +E++ ++ L+H N
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLDHPN 67
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I++L E ++N +YLV E L++ + + F E + + V ++Y H+
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL 125
Query: 121 GFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
HRDLKPEN L +K+ DFGLA K G VG+ +Y +P++L
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-- 183
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y + D W+ G +M L P F ++++ M KI R +
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------------------REGTF 224
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPH 293
FP + S A SL L + P +R T+ +AL+H +F++ + P
Sbjct: 225 TFP-------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-66
Identities = 70/303 (23%), Positives = 117/303 (38%), Gaps = 31/303 (10%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ LG+GA VF+ + TG+ AIK + +RE + L+KLNH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 62 IVKLKELIQ--NNNRLYLVFECME-CN---LYQLMAARDRKL-FSEPEIKAWLFQVFQGL 114
IVKL + + L+ ME C LY ++ E E L V G+
Sbjct: 69 IVKLFAIEEETTTRHKVLI---MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 115 SYMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+++ +NG HR++KP N++ Q + K+ DFG ARE++ + + G+ Y P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 170 IL-------LQSELYSSKADMWAMGAIMAELFT----FCPLFPGASEADQMYKICGVLGS 218
+ + Y + D+W++G T F P + MYKI + G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGK 243
Query: 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278
P+ + I + +LS + ++ D K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LQH 281
Sbjct: 301 FAE 303
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 2e-65
Identities = 91/342 (26%), Positives = 146/342 (42%), Gaps = 43/342 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLN------LREVKCL 54
D+Y K LG GA G V AF+ T + VAIK + K+++A E++ L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55 RKLNHSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQG 113
+KLNH I+K+K + Y+V E ME L+ + R E K + +Q+
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLA 126
Query: 114 LSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+ Y+H+NG HRDLKPEN+L+S +IKI DFG ++ + G+ Y APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 170 ILLQSEL--YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
+L+ Y+ D W++G I+ + P F +
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---------------- 230
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
Q + KY F + S+ A+ L + L DP R T EAL+HP+ +
Sbjct: 231 --QITSGKYNFI-------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281
Query: 288 FYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGA 329
+ + + P + ++R ++ + +GA
Sbjct: 282 -DMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 40/295 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
D Y +ELG G F V + + TG+ A K +K+R S REV LR+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ H NI+ L ++ +N + L+ E + L+ +A ++ +E E +L Q+ G+
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVH 122
Query: 116 YMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
Y+H H DLKPEN+++ IK+ DFG+A +I++G + N G+ + APEI
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ E +ADMW++G I L + F G ++ + + I
Sbjct: 183 VNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------------ 223
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
A+ Y F + S+ A L DP +R T A++L+H + K
Sbjct: 224 -SAVNYDFD-------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-65
Identities = 86/335 (25%), Positives = 140/335 (41%), Gaps = 64/335 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKELK--QRY--ASWEDCLNLREVKCLRK 56
+Y LG GAFG+V + D G VA+K +K RY A+ E++ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA------RSEIQVLEH 67
Query: 57 LNH------SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQV 110
LN V++ E +++ + +VFE + + Y + F I+ +Q+
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 111 FQGLSYMHQNGFFHRDLKPEN-LLVSQGI-------------------IKIADFGLAREI 150
+ ++++H N H DLKPEN L V IK+ DFG A
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 151 KSGPPYTNYVGSRWYRAPEILLQSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQM 209
++ V +R YRAPE++L L +S D+W++G I+ E + +FP + +
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVIL--ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 210 YKICGVLGSPTMDSWADGLRQARAIKY------QFPQLPRA---------NLSALMPSAS 254
+ +LG +++ R KY + + A L M S
Sbjct: 244 AMMERILGPLPKHM----IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 255 QD---AISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ L + + +DP+KR T EAL+HPFF
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 39/309 (12%)
Query: 2 DKYS-GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH 59
+ Y KELGRG F V Q + TG+ A K LK+R + + E+ L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 60 S-NIVKLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
++ L E+ +N + + L+ E E ++ L ++ SE ++ + Q+ +G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGE--IFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 116 YMHQNGFFHRDLKPENLLV----SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
Y+HQN H DLKP+N+L+ G IKI DFG++R+I +G+ Y APEIL
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+ ++ DMW +G I L T F G + I
Sbjct: 206 NY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------------------- 245
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
+ + S SQ A +SL +P KRPTA L H + ++ +
Sbjct: 246 SQVNVDYS-------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
Query: 292 PHIRSTPAV 300
+
Sbjct: 299 LFHPEETSS 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-65
Identities = 70/319 (21%), Positives = 116/319 (36%), Gaps = 60/319 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+ + + LGRG FG VF+A ++ AIK ++ +REVK L KL H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 61 NIVKLKELIQNNNR------------LYLVFE-CMECNLYQLMAARDRKLFSE-PEIKAW 106
IV+ N LY+ + C + NL M R E
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS------------- 152
Q+ + + ++H G HRDLKP N+ + ++K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKI 212
+T VG++ Y +PE + YS K D++++G I+ EL P + +
Sbjct: 184 YARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDV 240
Query: 213 CGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR 272
+FP L + + + S P +R
Sbjct: 241 R---------------------NLKFPPLF--------TQKYPCEYVMVQDMLSPSPMER 271
Query: 273 PTAAEALQHPFFKRCFYAP 291
P A +++ F+ +
Sbjct: 272 PEAINIIENAVFEDLDFPG 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-65
Identities = 73/340 (21%), Positives = 137/340 (40%), Gaps = 70/340 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRY--ASWEDCLNLREVKCLRKL 57
+ + +++G G FGRV + A+K ++ ++Y ++ E L+K+
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA------KIEADILKKI 88
Query: 58 NH-----SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
+ +NIVK + + L+FE + +LY+++ + F +IK + ++ +
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 113 GLSYMHQNGFFHRDLKPEN-LLVSQGI-------------------------IKIADFGL 146
L+Y+ + H DLKPEN LL IK+ DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 147 AREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA 206
A + + + +R YRAPE++L + +DMW+ G ++AEL+T LF
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 207 DQMYKICGVLGSPTMD---------------------SWADGLRQARAIKYQFPQLPRAN 245
+ + + ++ + +W + +IK+ LP
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 246 LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ + S+ DP+ RP+ AE L+H F +
Sbjct: 326 IIKH-----ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-64
Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 40/312 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
D Y +ELG G F V + ++ TG A K +K+R + REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ H N++ L ++ +N + L+ E + L+ +A ++ SE E +++ Q+ G++
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVN 129
Query: 116 YMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
Y+H H DLKPEN+++ IK+ DFGLA EI+ G + N G+ + APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ E +ADMW++G I L + F G ++ + + I
Sbjct: 190 VNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------------ 230
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290
++ Y F S+ A L + KR T EAL+HP+
Sbjct: 231 -TSVSYDFD-------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282
Query: 291 PPHIRSTPAVAT 302
+R V
Sbjct: 283 QAMVRRESVVNL 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-64
Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 47/302 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLN-----------LR 49
+ Y ++LG GA+G V +++ AIK + K ++ +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 50 EVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLF 108
E+ L+ L+H NI+KL ++ ++ YLV E E L++ + R + F E + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMK 153
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRW 164
Q+ G+ Y+H++ HRD+KPEN+L+ IKI DFGL+ + +G+ +
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 165 YRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224
Y APE+L + Y+ K D+W+ G IM L P F G ++ D + K+
Sbjct: 214 YIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV------------ 259
Query: 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
KY F + S +A L + + ++D +KR TA EAL +
Sbjct: 260 -------EKGKYYFDFND-------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305
Query: 285 KR 286
K+
Sbjct: 306 KK 307
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-64
Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 40/312 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
D Y +ELG G F V + ++ TG A K +K+R REV L++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ H N++ L E+ +N + L+ E + L+ +A ++ +E E +L Q+ G+
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVY 128
Query: 116 YMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
Y+H H DLKPEN+++ + IKI DFGLA +I G + N G+ + APEI
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ E +ADMW++G I L + F G ++ + + +
Sbjct: 189 VNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------------ 229
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290
A+ Y+F + S A L DP KR T ++LQHP+ K
Sbjct: 230 -SAVNYEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
Query: 291 PPHIRSTPAVAT 302
R AV
Sbjct: 282 QALSRKASAVNM 293
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-64
Identities = 81/353 (22%), Positives = 141/353 (39%), Gaps = 67/353 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKELK--QRY--ASWEDCLNLREVKCLRK 56
++Y LG G FG+V + D G VA+K ++ +Y A+ E+ L+K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA------RLEINVLKK 72
Query: 57 LNH------SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQV 110
+ V + + + + + FE + N ++ + + + + P ++ +Q+
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 111 FQGLSYMHQNGFFHRDLKPENLLVSQGI--------------------IKIADFGLAREI 150
L ++H+N H DLKPEN+L I++ADFG A
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190
Query: 151 KSGPPYTNYVGSRWYRAPEILLQSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQM 209
+T V +R YR PE++L EL ++ D+W++G I+ E + LF + +
Sbjct: 191 FDHEHHTTIVATRHYRPPEVIL--ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 210 YKICGVLGSPTMDSWADGLRQARAIKY------QFPQLPRAN---------LSALMPSAS 254
+ +LG + + R KY + + L + M S
Sbjct: 249 VMMEKILGPIPSHM----IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 255 QD---AISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTT 304
+ L + +DP++R T AEAL HPFF P RS +
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL---TPEERSFHTSRNPS 354
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-64
Identities = 85/312 (27%), Positives = 135/312 (43%), Gaps = 40/312 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
D Y +ELG G F V + ++ TG A K +K+R + REV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ H NI+ L ++ +N + L+ E + L+ +A ++ SE E +++ Q+ G++
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVN 129
Query: 116 YMHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
Y+H H DLKPEN+++ IK+ DFGLA EI+ G + N G+ + APEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ E +ADMW++G I L + F G ++ + + I
Sbjct: 190 VNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------------------ 230
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290
A+ Y F S+ A L + KR T EAL+HP+
Sbjct: 231 -TAVSYDFD-------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282
Query: 291 PPHIRSTPAVAT 302
+R V
Sbjct: 283 QAMVRRESVVNL 294
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-64
Identities = 91/290 (31%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
D Y +ELG+GAF V + + TG A K + + S D L RE + RKL H
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV+L + IQ + YLVF+ + L++ + AR+ +SE + + Q+ + ++Y H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHS 146
Query: 120 NGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
NG HR+LKPENLL++ +K+ADFGLA E+ + + G+ Y +PE+L +
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD- 205
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
YS D+WA G I+ L P F + +I +A
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------------------KAGA 246
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Y +P S + + +A SL +S+ + +P KR TA +AL+ P+
Sbjct: 247 YDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-63
Identities = 69/291 (23%), Positives = 128/291 (43%), Gaps = 38/291 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+KY ++LGRG FG V + + + + K +K + +E+ L H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK--KEISILNIARHRN 62
Query: 62 IVKLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
I+ L E ++ L ++FE + + +++ + + +E EI +++ QV + L ++H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD--IFERINTSAFE-LNEREIVSYVHQVCEALQFLH 119
Query: 119 QNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ H D++PEN++ IKI +FG AR++K G + + Y APE+ +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-D 178
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
+ S+ DMW++G ++ L + F + + I +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------------------MNAE 219
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
Y F S +A+ + L + R TA+EALQHP+ K+
Sbjct: 220 YTFD-------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 1e-63
Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 45/296 (15%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSN 61
+ LG GA G + VA+K + S+ D REV+ LR+ + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPN 79
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+++ ++ Y+ E L + + +D E L Q GL+++H
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 122 FFHRDLKPENLLV------SQGIIKIADFGLAREIKSGPPY----TNYVGSRWYRAPEIL 171
HRDLKP N+L+ + I+DFGL +++ G + G+ + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 172 LQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+ E + D+++ G + + + G S Q + G
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG--------------- 243
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
L A L E + + DP KRP+A L+HPFF
Sbjct: 244 -----ACSLDCLHPE------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 85/298 (28%), Positives = 129/298 (43%), Gaps = 42/298 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-------REVKCL 54
D+Y K LG GA G V AF+ T + VAI+ + +R + E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 55 RKLNHSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQG 113
+KLNH I+K+K + Y+V E ME L+ + R E K + +Q+
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLA 251
Query: 114 LSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+ Y+H+NG HRDLKPEN+L+S +IKI DFG ++ + G+ Y APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 170 ILLQSEL--YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
+L+ Y+ D W++G I+ + P F +
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---------------- 355
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
Q + KY F S+ A+ L + L DP R T EAL+HP+ +
Sbjct: 356 --QITSGKYNFIPEV-------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-63
Identities = 81/337 (24%), Positives = 127/337 (37%), Gaps = 78/337 (23%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL---KQRYASWEDCLNL-REVKCLRKL 57
KY +G+G++G V A + T AIK + K R + +D + EV+ ++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 58 NHSNIVKLKELIQNNNRLYLVFECME---------------------------------- 83
+H NI +L E+ ++ + LV E
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 84 -----CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--- 135
+ E I + Q+F L Y+H G HRD+KPEN L S
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 136 QGIIKIADFGLAREIKSGPP-----YTNYVGSRWYRAPEIL-LQSELYSSKADMWAMGAI 189
IK+ DFGL++E T G+ ++ APE+L +E Y K D W+ G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 190 MAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSAL 249
+ L FPG ++AD + ++ K F +
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQV-------------------LNKKLCFE-------NPN 299
Query: 250 MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
S A L +L + + +R A ALQHP+ +
Sbjct: 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-63
Identities = 79/370 (21%), Positives = 144/370 (38%), Gaps = 44/370 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D Y +ELG GAFG V + ++ TG K + Y + + E+ + +L+H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHPK 109
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
++ L + ++ + L+ E + L+ +AA D K SE E+ ++ Q +GL +MH++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH 168
Query: 121 GFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
H D+KPEN++ +KI DFGLA ++ + + APEI+ + E
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPV 227
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
DMWA+G + L + F G + + + + + ++
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------------------KRCDWE 268
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRST 297
F S S +A ++L +P KR T +AL+HP+ K +
Sbjct: 269 FD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 321
Query: 298 PAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSPLDLI---KQ 354
+ ++ Q A+ +S + D K+
Sbjct: 322 SRYNKIRQK--------IKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 373
Query: 355 VQQKSVKQPK 364
+ +P
Sbjct: 374 AVPRFKLRPS 383
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-63
Identities = 68/298 (22%), Positives = 127/298 (42%), Gaps = 34/298 (11%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
+ + K++GRG F V++A G VA+K+++ ++E+ L++LN
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGLS 115
H N++K +N L +V E +L +++ + ++L E + + Q+ L
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 116 YMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQ 173
+MH HRD+KP N + + G++K+ D GL R S + VG+ +Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IH 209
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ K+D+W++G ++ E+ F G + +Y +C +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLC-----------------KKI 250
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
+ +P LP + S++ L + DP KRP A
Sbjct: 251 EQCDYPPLPSDHY-------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-63
Identities = 83/289 (28%), Positives = 127/289 (43%), Gaps = 36/289 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ + LG GAF VF TG+ A+K +K+ A + L E+ L+K+ H N
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-ENEIAVLKKIKHEN 67
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IV L+++ ++ YLV + L+ + R ++E + + QV + Y+H+N
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN 125
Query: 121 GFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
G HRDLKPENLL I I DFGL++ ++G + G+ Y APE+L Q +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KP 183
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
YS D W++G I L P F +E+ KI + Y
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-------------------KEGYY 224
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+F S+ A L DP++R T +AL HP+
Sbjct: 225 EFESPFW-------DDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-62
Identities = 74/310 (23%), Positives = 121/310 (39%), Gaps = 60/310 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-NH 59
++ +++G G FG VF+ G AIK K+ A D N LREV L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 60 SNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSY 116
S++V+ ++ + + E C +L ++ R F E E+K L QV +GL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 117 MHQNGFFHRDLKPENLLVSQ--------------------GIIKIADFGLAREIKSGPPY 156
+H H D+KP N+ +S+ + KI D G I S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQ 188
Query: 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL 216
G + A E+L ++ + KAD++A+ + PL DQ ++I
Sbjct: 189 V-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIR--- 241
Query: 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA 276
+ + P++P SQ+ L + + DP +RP+A
Sbjct: 242 ------------------QGRLPRIP--------QVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 277 EALQHPFFKR 286
++H
Sbjct: 276 ALVKHSVLLS 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 83/301 (27%), Positives = 126/301 (41%), Gaps = 44/301 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL---KQRYASWEDCLNL-----REVKC 53
+ Y + LGRG V + + T + A+K + S E+ L +EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 54 LRKLN-HSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVF 111
LRK++ H NI++LK+ + N +LVF+ M+ L+ + + SE E + + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 134
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
+ + +H+ HRDLKPEN+L+ IK+ DFG + ++ G G+ Y APEI
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 LLQSEL-----YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
+ S Y + DMW+ G IM L P F + + I
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------------- 241
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ YQF S S L P KR TA EAL HPFF+
Sbjct: 242 ------MSGNYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
Query: 286 R 286
+
Sbjct: 289 Q 289
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 9e-62
Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 35/290 (12%)
Query: 2 DKYS--GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH 59
Y+ + LG G FG+V + + TG +A K +K R ++ + E+ + +L+H
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDH 145
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+N+++L + ++ N + LV E ++ L+ + +E + ++ Q+ +G+ +MH
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMH 204
Query: 119 QNGFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
Q H DLKPEN+L IKI DFGLAR K G+ + APE++ +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-D 263
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
S DMW++G I L + F G ++A+ + I A +
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI-------------------LACR 304
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ S++A L + S R +A+EAL+HP+
Sbjct: 305 WDLE-------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-61
Identities = 73/315 (23%), Positives = 122/315 (38%), Gaps = 60/315 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
+ K LG G+ G V G VA+K + + E+K L + +H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHP 69
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAAR-----DRKLFSEPEIKAWLFQVFQGLS 115
N+++ + LY+ E NL L+ ++ + KL E + L Q+ G++
Sbjct: 70 NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 116 YMHQNGFFHRDLKPENLLVS--------------QGIIKIADFGLAREIKSG-----PPY 156
++H HRDLKP+N+LVS I I+DFGL +++ SG
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 157 TNYVGSRWYRAPEILLQSEL------YSSKADMWAMGAIMAELFTFCPLFPGASEADQMY 210
N G+ +RAPE+L +S + D+++MG + + + P + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGDKYSRES 248
Query: 211 KICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS 270
I + ++ S +A L + DP
Sbjct: 249 NI-------------------IRGIFSLDEMK----CLHDRSLIAEATDLISQMIDHDPL 285
Query: 271 KRPTAAEALQHPFFK 285
KRPTA + L+HP F
Sbjct: 286 KRPTAMKVLRHPLFW 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-61
Identities = 86/330 (26%), Positives = 137/330 (41%), Gaps = 56/330 (16%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRY--ASWEDCLNLREVKCLRKLN 58
+Y ++LG G F V+ A D VA+K ++ + Y A+ E+K L+++N
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA------EDEIKLLQRVN 73
Query: 59 -----------HSNIVKLKE--LIQNNNR--LYLVFECMECNLYQLMAARDRKLFSEPEI 103
++I+KL + + N + +VFE + NL L+ + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 104 KAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-------QGIIKIADFGLAREIKSGPP 155
K Q+ GL YMH+ G H D+KPEN+L+ IKIAD G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEH 191
Query: 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS------EADQM 209
YTN + +R YR+PE+LL + + AD+W+ ++ EL T LF + D +
Sbjct: 192 YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 210 YKICGVLGSPTMDSWADGLR---------QARAIKYQFPQLPRANLSALMPSASQDAISL 260
+I +LG +G R I + P ++ S+D
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS-KLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 261 FESLCS----WDPSKRPTAAEALQHPFFKR 286
S DP KR A + HP+ K
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-61
Identities = 78/310 (25%), Positives = 127/310 (40%), Gaps = 50/310 (16%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL----REVKCLRKL 57
D Y + +G+G F V + + TG+ A+K + + L+ RE L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAAR--DRKLFSEPEIKAWLFQVFQGL 114
H +IV+L E ++ LY+VFE M+ +L + R ++SE ++ Q+ + L
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 115 SYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPE 169
Y H N HRD+KP +L++ +K+ FG+A ++ +SG VG+ + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKI--CGVLGSPTMDSWADG 227
++ + Y D+W G I ++ I G L P +
Sbjct: 204 VVKREP-YGKPVDVWGCGVI-------------------LF-ILLSGCL--PF---YGTK 237
Query: 228 LRQARAI---KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
R I KY+ S+ A L + DP++R T EAL HP+
Sbjct: 238 ERLFEGIIKGKYKMN-------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 285 KRCFYAPPHI 294
K I
Sbjct: 291 KERDRYAYKI 300
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-60
Identities = 90/294 (30%), Positives = 138/294 (46%), Gaps = 42/294 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
++Y F+ELG+GAF V + G+ A + + S D L RE + R L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 61 NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV+L + I YL+F+ L++ + AR+ +SE + + Q+ + + + HQ
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQ 128
Query: 120 NGFFHRDLKPENLLVS----QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQS 174
G HR+LKPENLL++ +K+ADFGLA E++ + + G+ Y +PE+L +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKI--CGVLGSPTMDSWADGLRQA- 231
Y D+WA G I +Y I G P D L Q
Sbjct: 189 P-YGKPVDLWACGVI-------------------LY-ILLVGY--PPFWDEDQHRLYQQI 225
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+A Y FP S + + +A L + + +PSKR TAAEAL+HP+
Sbjct: 226 KAGAYDFP-------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 1e-60
Identities = 75/364 (20%), Positives = 140/364 (38%), Gaps = 48/364 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNHS 60
D Y +ELG GAFG V + + TG A K + + E +E++ + L H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHP 214
Query: 61 NIVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+V L + +++N + +++E M L++ +A SE E ++ QV +GL +MH+
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 120 NGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
N + H DLKPEN++ + +K+ DFGL + G+ + APE+ + +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKP 332
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
DMW++G + L + F G ++ + + + ++ +
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------------------KSCDW 373
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRS 296
+ S+D L DP+ R T +AL+HP+ +
Sbjct: 374 NMD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 297 TPAV-------------ATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMV 343
+ A P R+ + Q+ D + + + +
Sbjct: 427 PSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFI 486
Query: 344 GKLS 347
K
Sbjct: 487 VKPY 490
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-59
Identities = 85/289 (29%), Positives = 128/289 (44%), Gaps = 36/289 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D + ELGRGA V++ + T + A+K LK+ + E+ L +L+H N
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVR--TEIGVLLRLSHPN 109
Query: 62 IVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I+KLKE+ + + LV E L+ + + +SE + + Q+ + ++Y+H+N
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHEN 167
Query: 121 GFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
G HRDLKPENLL + +KIADFGL++ ++ G+ Y APEIL
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA- 226
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y + DMW++G I L F M+ R+ +Y
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------------------RRILNCEY 268
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
F S S +A L L DP KR T +ALQHP+
Sbjct: 269 YFI-------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-59
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 43/300 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK-----ELKQRYASWEDCLN--LREVKCL 54
KY +GRG V + TG A+K + E+ RE L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 55 RKL-NHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
R++ H +I+ L + ++++ ++LVF+ M L+ + + SE E ++ + + +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLE 211
Query: 113 GLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
+S++H N HRDLKPEN+L+ I+++DFG + ++ G G+ Y APEIL
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 172 LQSEL-----YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
S Y + D+WA G I+ L P F + + I
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI-------------- 317
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+YQF S S L L DP R TA +ALQHPFF+R
Sbjct: 318 -----MEGQYQFS-------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 204 bits (519), Expect = 2e-59
Identities = 97/427 (22%), Positives = 168/427 (39%), Gaps = 43/427 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH 59
+ + LG G FG V + + TGE VAIK+ +Q S ++ E++ ++KLNH
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNH 71
Query: 60 SNIVKLKELIQN------NNRLYLVFECMEC-NLYQLMAARDRKL-FSEPEIKAWLFQVF 111
N+V +E+ N+ L E E +L + + + E I+ L +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 112 QGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRA 167
L Y+H+N HRDLKPEN+++ + I KI D G A+E+ G T +VG+ Y A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
PE+ L+ + Y+ D W+ G + E T F P P K+ +
Sbjct: 192 PEL-LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD-- 248
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK- 285
A+K+ +LS + + + W +R T + F+
Sbjct: 249 --DLTGAVKFSSVLPTPNHLS---GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
Query: 286 ---RCFYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQ-----QQQ---QGARMCAD 334
+ + + T LK QQ ++Q Q + + +
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALN 363
Query: 335 EASSNSQMVGKLSPLD--------LIKQVQQKSVKQPKYSPAAEKKSPTSINKDKIAQLN 386
A +Q V + +D + +K+V +P+ S A +S + + +D L
Sbjct: 364 SAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSIVLQDPKRPLT 423
Query: 387 LPHMMKT 393
H+ +
Sbjct: 424 YTHLRRV 430
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-59
Identities = 83/315 (26%), Positives = 130/315 (41%), Gaps = 59/315 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
+Y + LG+G F + F+ D T E A K + K + E+ R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H ++V ++N+ +++V E C +L +L R +EPE + +L Q+ G Y+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYL 131
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS---------GPPYTNYVGSRWYRA 167
H+N HRDLK NL + +KI DFGLA +++ G P NY+ A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP--NYI------A 183
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWAD 226
PE+ L + +S + D+W++G IM L P F S + Y +I
Sbjct: 184 PEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-------------- 227
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ +Y P + A SL + + DP+ RPT E L FF
Sbjct: 228 -----KKNEYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
Query: 287 CF---YAPPHIRSTP 298
+ P + P
Sbjct: 272 GYIPARLPITCLTIP 286
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 93/320 (29%), Positives = 139/320 (43%), Gaps = 39/320 (12%)
Query: 2 DKYSGFKE-LGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKL-N 58
D Y ++ LG GA RV + T + A+K + KQ REV+ L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQG 69
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H N+++L E + +R YLVFE M + R+ F+E E + V L ++
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILS--HIHKRRHFNELEASVVVQDVASALDFL 127
Query: 118 HQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNY--------VGSRWY 165
H G HRDLKPEN+L +KI DF L IK + GS Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 166 RAPEIL----LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221
APE++ ++ +Y + D+W++G I+ L + P F G +D CG
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-----CGWDRGEAC 242
Query: 222 DSWADGLRQA-RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ + L ++ + KY+FP S A L L D +R +AA+ LQ
Sbjct: 243 PACQNMLFESIQEGKYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
Query: 281 HPFFKRCFYAPPHIRSTPAV 300
HP+ + C AP + TP V
Sbjct: 296 HPWVQGC--APENTLPTPMV 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-58
Identities = 80/335 (23%), Positives = 137/335 (40%), Gaps = 36/335 (10%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D K LG G+F + + + +A A+K + +R + +E+ L+ H
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQ--KEITALKLCEGHP 66
Query: 61 NIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKL E+ + +LV E + L++ + +K FSE E + ++ +S+MH
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 120 NGFFHRDLKPENLLVS----QGIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQS 174
G HRDLKPENLL + IKI DFG AR P + Y APE+L Q+
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y D+W++G I+ + + F S T S + +++ +
Sbjct: 185 G-YDESCDLWSLGVILYTMLSGQVPFQSHDR------------SLTCTSAVEIMKKIKKG 231
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHI 294
+ F + SQ+A L + L + DP+KR + + + + +
Sbjct: 232 DFSFE-------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284
Query: 295 RSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGA 329
TP + + AA + + ++
Sbjct: 285 LMTPDI---LGSSGAAVHTCVKATFHAFNKYKREG 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-58
Identities = 83/340 (24%), Positives = 132/340 (38%), Gaps = 49/340 (14%)
Query: 2 DKYS-GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NH 59
D Y + LG G G+V + F TG+ A+K L +EV +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR--QEVDHHWQASGG 81
Query: 60 SNIVKLKELIQN----NNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
+IV + ++ +N L ++ ECM E L+ + R + F+E E + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGE--LFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 113 GLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAP 168
+ ++H + HRD+KPENLL + ++K+ DFG A+E T + +Y AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-PCYTPYYVAP 198
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
E+L E Y DMW++G IM L P F + +
Sbjct: 199 EVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---------------K 242
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288
R+ R +Y FP + S+DA L L DP++R T + + HP+ +
Sbjct: 243 RRIRLGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
Query: 289 YAPPHIRSTPAVATTTANQ----PAAATRGMLKQRRQQQQ 324
P T V + T + R Q
Sbjct: 296 VVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQ 335
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-58
Identities = 79/351 (22%), Positives = 137/351 (39%), Gaps = 54/351 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D Y +++G G++ + + T A+K + + D E++ L + H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPT--EEIEILLRYGQHP 76
Query: 61 NIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI+ LK++ + +Y+V E M+ L + + K FSE E A LF + + + Y+H
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA 134
Query: 120 NGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQ 173
G HRDLKP N+L I+I DFG A+++++ + + APE+L +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y + D+W++G ++ + T F + +I L + +
Sbjct: 195 QG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEI---------------LARIGS 237
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPH 293
K+ S S A L + DP +R TAA L+HP+ P +
Sbjct: 238 GKFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
Query: 294 IRSTPAVATTTANQPAAATRGM---------------LKQRRQQQQQQQGA 329
+ AA + L QRR ++ A
Sbjct: 291 QLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTA 341
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 65/313 (20%), Positives = 107/313 (34%), Gaps = 50/313 (15%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNHSN 61
Y ++LG G F V H G A+K + E+ RE R NH N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ--READMHRLFNHPN 87
Query: 62 IVKLKE----LIQNNNRLYLVFE-CMECNLYQLMAARDRK--LFSEPEIKAWLFQVFQGL 114
I++L + +L+ L+ + K +E +I L + +GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT----------NYVGSR 163
+H G+ HRDLKP N+L+ G + D G + + +
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 164 WYRAPEIL-LQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221
YRAPE+ +QS + + D+W++G ++ + + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-------------- 253
Query: 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
D + A + PQ PR S L S+ + DP +RP L
Sbjct: 254 ----DSVALAVQNQLSIPQSPR---------HSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 282 PFFKRCFYAPPHI 294
+ H
Sbjct: 301 LEALQPPAPGQHT 313
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-57
Identities = 85/375 (22%), Positives = 149/375 (39%), Gaps = 54/375 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D + LG G G+V Q F++ T E A+K L+ REV+ +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKAR--REVELHWRASQCP 115
Query: 61 NIVKLKELIQN----NNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+IV++ ++ +N L +V EC++ L+ + R + F+E E + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 116 YMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
Y+H HRD+KPENLL + I+K+ DFG A+E S T + +Y APE+L
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
E Y DMW++G IM L P F + +
Sbjct: 236 GP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------KTRI 279
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
R +Y+FP + S++ L +L +P++R T E + HP+ + P
Sbjct: 280 RMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
Query: 292 PHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSPLD- 350
T V K+R + +++ + + + K+
Sbjct: 333 QTPLHTSRVLK------------EDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 380
Query: 351 --LIKQVQQKSVKQP 363
L+K+ ++ +
Sbjct: 381 PLLLKRRKKARALEA 395
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 83/332 (25%), Positives = 134/332 (40%), Gaps = 57/332 (17%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
+Y + LG+G F + F+ D T E A K + K + E+ R L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H ++V ++N+ +++V E C +L +L R +EPE + +L Q+ G Y+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYL 157
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS---------GPPYTNYVGSRWYRA 167
H+N HRDLK NL + +KI DFGLA +++ G P NY+ A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP--NYI------A 209
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
PE+ L + +S + D+W++G IM L P F + + Y
Sbjct: 210 PEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETY----------------- 250
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
+ + +Y P + A SL + + DP+ RPT E L FF
Sbjct: 251 -LRIKKNEYSIP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 288 F---YAPPHIRSTPAVATTTANQPAAATRGML 316
+ P + P + + + R L
Sbjct: 299 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 38/299 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
++ + + LG+G FG V+ A ++ + +A+K L K + L REV+ L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H NI++L + R+YL+ E +Y+ + + F E ++ ++ LSY
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYC 125
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H HRD+KPENLL+ S G +KIADFG + S G+ Y PE+ ++ +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEM-IEGRM 183
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+ K D+W++G + E P F + + +I V ++
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EF 224
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
FP ++ A L L +PS+RP E L+HP+ P + +
Sbjct: 225 TFP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 272
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-57
Identities = 73/351 (20%), Positives = 124/351 (35%), Gaps = 55/351 (15%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL---KQRYASWEDCLNL----REVKC 53
KYS LG GAFG V+ A D+ + V +K + K W + L E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFE----CMECNLYQLMAARDRKLFSEPEIKAWLFQ 109
L ++ H+NI+K+ ++ +N LV E ++ L+ + R EP Q
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD--LFAFIDRHPR--LDEPLASYIFRQ 138
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAP 168
+ + Y+ HRD+K EN+++ IK+ DFG A ++ G + + G+ Y AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 169 EILLQSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
E+ L Y + +MW++G L+T + P
Sbjct: 199 EV-LMGNPYRGPELEMWSLGVT---LYTL---------------VFEEN--PF-----CE 232
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287
L + P S++ +SL L P +R T + + P+ +
Sbjct: 233 LEETVEAAIHPP-----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 288 FYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASS 338
+ + R Q +C E
Sbjct: 282 -VNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHH 331
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-56
Identities = 44/314 (14%), Positives = 82/314 (26%), Gaps = 58/314 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+ L G VF D E A+K + L +L + +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 66 KELIQ--------------------------NNNRLYLVFECMECNLYQLMAARDR---- 95
++ + L+ +L L + D
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 96 -KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153
+ Q+ + + + G H P+NL + G + + D K G
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVG 245
Query: 154 PPYTNYVGSRWYRAPEILLQSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKI 212
Y E L S ++ + W +G + ++ F + +
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 213 CGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR 272
L P DS F +P + I ++D +R
Sbjct: 306 RPSLRVPGTDSL------------AFGSCTP------LPDFVKTLIG---RFLNFDRRRR 344
Query: 273 PTAAEALQHPFFKR 286
EA++ P F +
Sbjct: 345 LLPLEAMETPEFLQ 358
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 38/286 (13%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
LG+G +G V+ D +AIKE+ +R + + L+ E+ + L H NIV+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGSF 88
Query: 70 QNNNRLYLVFE-CMECNLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
N + + E +L L+ ++ L +E I + Q+ +GL Y+H N HRD+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 128 KPENLLVS--QGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL-YSSKADM 183
K +N+L++ G++KI+DFG ++ + P T + G+ Y APEI+ + Y AD+
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 184 WAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242
W++G + E+ T P F E M+K+ G+ P++P
Sbjct: 209 WSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVH-------------------PEIP 248
Query: 243 RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
S S +A + F C DP KR A + L F K
Sbjct: 249 --------ESMSAEAKA-FILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-56
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 55/307 (17%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
++ + LG+G+F V++A HTG VAIK + K+ + EVK +L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H +I++L +++N +YLV E C + + + R + FSE E + ++ Q+ G+ Y+
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYL 128
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS---------GPPYTNYVGSRWYRA 167
H +G HRDL NLL+ IKIADFGLA ++K G P NY+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP--NYI------S 180
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWAD 226
PEI + ++D+W++G + L P F K+
Sbjct: 181 PEI-ATRSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKV-------------- 224
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
Y+ P S +A L L +P+ R + + L HPF R
Sbjct: 225 -----VLADYEMP-----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
Query: 287 CFYAPPH 293
Sbjct: 269 NSSTKSK 275
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 68/306 (22%), Positives = 120/306 (39%), Gaps = 56/306 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL----REVKCLR 55
+Y LG G FG V+ VAIK + K R + W + N EV L+
Sbjct: 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 56 KLNHS--NIVKLKELIQNNNRLYLVFE----CMECNLYQLMAARDRKLFSEPEIKAWLFQ 109
K++ +++L + + + L+ E + L+ + R E +++ +Q
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGA--LQEELARSFFWQ 157
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLV--SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRA 167
V + + + H G HRD+K EN+L+ ++G +K+ DFG +K YT++ G+R Y
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSP 216
Query: 168 PEILLQSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
PE ++ Y A +W++G + L+ +CG + P +
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGIL---LYDM---------------VCGDI--PF-----E 250
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ + F S + L + PS RPT E HP+ +
Sbjct: 251 HDEEIIRGQVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
Query: 287 CFYAPP 292
Sbjct: 300 VLLPQE 305
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 56/320 (17%), Positives = 120/320 (37%), Gaps = 57/320 (17%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL------KQRYASWEDCLNL------ 48
++ Y + L +G F ++ E + A+K+ K+R + + +
Sbjct: 30 INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 49 ----REVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDR------KL 97
E++ + + + + + +I N + +Y+++E ME ++ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 98 FSEPEIKAWLFQVFQGLSYMH-QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPP 155
IK + V SY+H + HRD+KP N+L+ G +K++DFG + +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 156 YTNYVGSRWYRAPEILLQSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMY-KIC 213
+ G+ + PE Y+ +K D+W++G + +F F +++ I
Sbjct: 208 KGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSA--------SQDAISLFESLC 265
++P L L S + I +
Sbjct: 267 TK-------------------NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL 307
Query: 266 SWDPSKRPTAAEALQHPFFK 285
+P++R T+ +AL+H +
Sbjct: 308 RKNPAERITSEDALKHEWLA 327
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-55
Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 40/305 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
+D + + LG+G FG V+ A ++ +A+K L K + L RE++ L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 59 HSNIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H NI+++ + R+YL+ E LY+ + R F E ++ ++ L Y
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYC 130
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H+ HRD+KPENLL+ +G +KIADFG + S T G+ Y PE+ ++ +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEM-IEGKT 188
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+ K D+W G + E P F S + +I V
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------------DL 229
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF--YAPPHI 294
+FP P S + L L + P +R ++HP+ K PP
Sbjct: 230 KFP-----------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
Query: 295 RSTPA 299
+ST +
Sbjct: 279 QSTQS 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 44/290 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLR-EVKCLRKLNHSNIVKL- 65
E+GRG+F V++ D T VA EL+ R + + + E + L+ L H NIV+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 66 ---KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ ++ + LV E M L + + K+ +++W Q+ +GL ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 122 FF--HRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
HRDLK +N+ ++ G +KI D GLA ++ +G+ + APE+ E Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY--EEKY 206
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
D++A G M E+ T + A Q+Y+ G
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGVK------------------ 247
Query: 238 FPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKR 286
P + ++ C + +R + + L H FF+
Sbjct: 248 -PASFDKVAIPEV----KE----IIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-54
Identities = 70/308 (22%), Positives = 115/308 (37%), Gaps = 58/308 (18%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL----REVKCLR 55
+Y LG+G FG VF VAIK + + R W + EV L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 56 KLN----HSNIVKLKELIQNNNRLYLVFE----CMECNLYQLMAARDRKLFSEPEIKAWL 107
K+ H +++L + + LV E + L+ + + E + +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD--LFDYITEKGP--LGEGPSRCFF 145
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
QV + + H G HRD+K EN+L+ +G K+ DFG + PYT++ G+R Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVY 204
Query: 166 RAPEILLQSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224
PE + Y A +W++G + L+ +CG + P
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGIL---LYDM---------------VCGDI--PF---- 239
Query: 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284
+ ++ + FP S D +L + PS RP+ E L P+
Sbjct: 240 -ERDQEILEAELHFP-----------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287
Query: 285 KRCFYAPP 292
+ P
Sbjct: 288 QTPAEDVP 295
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-54
Identities = 86/310 (27%), Positives = 132/310 (42%), Gaps = 61/310 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL------------------ 48
E+G+G++G V A++E+ A+K L K++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 49 ------REVKCLRKLNHSNIVKLKELIQ--NNNRLYLVFECMECNLYQLMAARDRKLFSE 100
+E+ L+KL+H N+VKL E++ N + LY+VFE + +M K SE
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTLKPLSE 136
Query: 101 PEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY-TN 158
+ + + + +G+ Y+H HRD+KP NLLV G IKIADFG++ E K +N
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 159 YVGSRWYRAPEILL-QSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL 216
VG+ + APE L +++S D+WAMG L+ F + G
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT---LYCF---------------VFGQC 238
Query: 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA 276
P MD L IK Q + P P ++D L + +P R
Sbjct: 239 --PFMDERIMCLH--SKIKSQALEFPDQ------PDIAEDLKDLITRMLDKNPESRIVVP 288
Query: 277 EALQHPFFKR 286
E HP+ R
Sbjct: 289 EIKLHPWVTR 298
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 8e-53
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 47/297 (15%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+ + +GRG+FG V + D+ TG A+K+++ + + E+ L+
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
IV L ++ + + E +E +L QL+ + E +L Q +GL Y+H
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 120 NGFFHRDLKPENLLVSQ--GIIKIADFGLAREI------KSGPPYTNYVGSRWYRAPEIL 171
H D+K +N+L+S + DFG A + KS G+ + APE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+ +K D+W+ +M + C + KI +
Sbjct: 229 MGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPP-------- 273
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P + PS + +P R +A E +
Sbjct: 274 -------PIRE------IPPSCAPLTAQ-AIQEGLRKEPVHRASAMELRRKVGKALQ 316
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 83/296 (28%), Positives = 127/296 (42%), Gaps = 37/296 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH 59
+ Y K +G+G F +V A TG VAIK + + + L REV+ ++ LNH
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
NIVKL E+I+ LYL+ E ++ + A R E E ++ Q+ + Y H
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCH 131
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
Q HRDLK ENLL+ + IKIADFG + E G + G+ Y APE L Q + Y
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE-LFQGKKY 190
Query: 178 S-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+ D+W++G I+ L + F G + + ++ G KY
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL------------RG-------KY 231
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
+ P S D +L + +P KR T + ++ +
Sbjct: 232 RIP-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-50
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 46/297 (15%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNH 59
++ + + LG GA+G V A + T EAVA+K + +R + + +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
N+VK + N YL E L+ + EP+ + + Q+ G+ Y+H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN---YVGSRWYRAPEILLQS 174
G HRD+KPENLL+ + +KI+DFGLA + G+ Y APE+ L+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKR 181
Query: 175 ELYS-SKADMWAMGAIMAELFT----FCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+ D+W+ G + L P + S++ Q Y
Sbjct: 182 REFHAEPVDVWSCGIV---LTAMLAGELP-WDQPSDSCQEYS------------------ 219
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ + P + ++L + +PS R T + + ++ +
Sbjct: 220 --DWKEKKTYLNPWKKI-------DSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 72/309 (23%), Positives = 119/309 (38%), Gaps = 60/309 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
D + LG G G+V Q F++ T E A+K L+ REV+ +
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKAR--REVELHWRASQCP 71
Query: 61 NIVKLKELIQN----NNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+IV++ ++ +N L +V EC++ L+ + R + F+E E + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 116 YMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
Y+H HRD+KPENLL + I+K+ DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT 171
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+ Y DMW++G IM L P F + +
Sbjct: 172 GEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------KTRI 214
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
R +Y+FP + S++ L +L +P++R T E + HP+ + P
Sbjct: 215 RMGQYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
Query: 292 PHIRSTPAV 300
T V
Sbjct: 268 QTPLHTSRV 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 70/327 (21%), Positives = 129/327 (39%), Gaps = 48/327 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLREVKCLRKLNH 59
++ + + LG GA+G V A + T EAVA+K + +R + + +E+ + LNH
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
N+VK + N YL E L+ + EP+ + + Q+ G+ Y+H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH 122
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN---YVGSRWYRAPEILLQS 174
G HRD+KPENLL+ + +KI+DFGLA + G+ Y APE+ L+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKR 181
Query: 175 ELYS-SKADMWAMGAIMAELFT----FCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+ D+W+ G + L P + S++ Q Y
Sbjct: 182 REFHAEPVDVWSCGIV---LTAMLAGELP-WDQPSDSCQEYS------------------ 219
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289
+ + P + ++L + +PS R T + + ++ +
Sbjct: 220 --DWKEKKTYLNPWKKI-------DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL- 269
Query: 290 APPHIRSTPAVATTTANQPAAATRGML 316
+ + + P+ ++ +
Sbjct: 270 -KKGAKRPRVTSGGVSESPSGFSKHIQ 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 74/312 (23%), Positives = 111/312 (35%), Gaps = 67/312 (21%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKE-LKQRYASWEDCLNLREVKCLRKL-NHS 60
+ + L G F V++A D +G A+K L + +EV ++KL H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII--QEVCFMKKLSGHP 86
Query: 61 NIVKL-------KELIQNNNRLYLVFECME-CN---LYQLMAARDRKLFSEPEIKAWLFQ 109
NIV+ KE +L+ E C + L R S + +Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLL--TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 110 VFQGLSYMHQNG--FFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT--------- 157
+ + +MH+ HRDLK ENLL+S QG IK+ DFG A I P Y+
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 158 ----NYVGSRWYRAPEI--LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211
+ YR PEI L + K D+WA+G I+ L F + +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLR 260
Query: 212 ICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK 271
I KY P + SL ++ +P +
Sbjct: 261 IVNG-------------------KYSIPP---------HDTQYTVFHSLIRAMLQVNPEE 292
Query: 272 RPTAAEALQHPF 283
R + AE +
Sbjct: 293 RLSIAEVVHQLQ 304
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-49
Identities = 71/310 (22%), Positives = 130/310 (41%), Gaps = 46/310 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLN--LREVKCLRKL 57
+ KY LG G++G+V + D T A+K L K++ + +E++ LR+L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 58 NHSNIVKLKELIQNNNR--LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
H N+++L +++ N + +Y+V E C + +++ + K F + + Q+ GL
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLA---REIKSGPPYTNYVGSRWYRAPEIL 171
Y+H G H+D+KP NLL+ + G +KI+ G+A + GS ++ PEI
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 172 LQSELYS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ +S K D+W+ G L+ G+ P L +
Sbjct: 184 NGLDTFSGFKVDIWSAGVT---LYNI---------------TTGLY--PFEGDNIYKLFE 223
Query: 231 --ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288
+ Y P L + + ++P+KR + + QH +F++
Sbjct: 224 NIGKG-SYAIP-----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
Query: 289 YAPPHIRSTP 298
PP P
Sbjct: 272 --PPAEAPVP 279
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 80/302 (26%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
+ Y LG G FG+V + TG VA+K L +Q+ S + + RE++ L+
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H +I+KL ++I ++V E + L+ + R E E + Q+ + Y
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYC 127
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H++ HRDLKPEN+L+ + KIADFGL+ + G GS Y APE+ + L
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV-ISGRL 186
Query: 177 YS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y+ + D+W+ G I L+ +CG L P D L + I+
Sbjct: 187 YAGPEVDIWSCGVI---LYAL---------------LCGTL--PFDDEHVPTLF--KKIR 224
Query: 236 ---YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
+ P ++ +L + DP KR T + +H +FK+ P
Sbjct: 225 GGVFYIP-----------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL--PS 271
Query: 293 HI 294
++
Sbjct: 272 YL 273
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 81/301 (26%), Positives = 132/301 (43%), Gaps = 41/301 (13%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLNHS 60
Y + LG G+FG+V A T + VA+K + +Q + + + RE+ L+ L H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+I+KL ++I + +V E L+ + + R +E E + + Q+ + Y H++
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH 127
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS- 178
HRDLKPENLL+ +KIADFGL+ + G GS Y APE+ + +LY+
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV-INGKLYAG 186
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-ARAIKYQ 237
+ D+W+ G + L+ + G L P D + L + + Y
Sbjct: 187 PEVDVWSCGIV---LYVM---------------LVGRL--PFDDEFIPNLFKKVNSCVYV 226
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRST 297
P S A SL + DP +R T E + P+F P ++R
Sbjct: 227 MP-----------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL--PDYLRPM 273
Query: 298 P 298
Sbjct: 274 E 274
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 89/371 (23%), Positives = 141/371 (38%), Gaps = 54/371 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNH 59
D+Y K++G G FG D+ T E VA+K +++ A E N+ RE+ R L H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRH 75
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC----NLYQLMAARDRKLFSEPEIKAWLF-QVFQGL 114
NIV+ KE+I L ++ ME LY+ + R FSE E + + F Q+ G+
Sbjct: 76 PNIVRFKEVILTPTHLAII---MEYASGGELYERICNAGR--FSEDEAR-FFFQQLLSGV 129
Query: 115 SYMHQNGFFHRDLKPENLLV---SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
SY H HRDLK EN L+ +KI DFG ++ + VG+ Y APE+L
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL---GSPTMDSWADGL 228
L+ E AD+W+ G L+ + G + +
Sbjct: 190 LRQEYDGKIADVWSCGVT---LYVM---------------LVGAYPFEDPEEPRDYRKTI 231
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288
++ ++KY P R S + L + DP+ R + E H +F +
Sbjct: 232 QRILSVKYSIPDDIR---------ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282
Query: 289 YAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQGARMCADEASSNSQMVGKLSP 348
P + + + + + R + M L
Sbjct: 283 --PADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVR----NRCLDDFMTDNLDL 336
Query: 349 LDLIKQVQQKS 359
D + +S
Sbjct: 337 DDDMDDFDSES 347
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 45/324 (13%), Positives = 94/324 (29%), Gaps = 82/324 (25%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLR-EVKCLRKL-------- 57
LG+ +A D+ TGE+ + ++ EV LR L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 58 -----------------NHSNIVKLKELIQNNNRL--YLVFECMECNLYQLM-----AAR 93
+++++ ++ L + ++ M+ NL +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 94 DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS 152
K QV + L+ +H G H L+P ++++ Q G + + F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 153 GPPYTNYVGSRWYRAPEILLQSEL----------YSSKADMWAMGAIMAELFTFCPLFPG 202
SR + PE+ + + D WA+G ++ ++
Sbjct: 259 ---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 203 ASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFE 262
+ I R + I Q +L E
Sbjct: 316 DAALGGSEWI---------------FRSCKNI-------------------PQPVRALLE 341
Query: 263 SLCSWDPSKRPTAAEALQHPFFKR 286
+ R +A++ P +++
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-48
Identities = 68/317 (21%), Positives = 113/317 (35%), Gaps = 32/317 (10%)
Query: 2 DKYSGFKELGRGA--FGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLN 58
Y +G+G V A + TGE V ++ + S E L E+ + N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 59 HSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H NIV + +N L++V M + L+ +E I L V + L Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 118 HQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS--------GPPYTNYVGSRWYRAP 168
H G+ HR +K ++L+S G + ++ + S V + +P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 169 EILLQSEL-YSSKADMWAMGAIMA-ELFTFCP----------LF------PGASEADQMY 210
E+L Q+ Y +K+D++++G I A EL L
Sbjct: 205 EVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 211 KICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPS 270
+ SP+ GL + P + + S E +P
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 271 KRPTAAEALQHPFFKRC 287
RP+A+ L H FFK+
Sbjct: 324 ARPSASTLLNHSFFKQI 340
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 60/358 (16%), Positives = 112/358 (31%), Gaps = 105/358 (29%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVA-------------------IKELKQR--- 38
+ + + +GRG FG VF+A ++ A +K L +
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 39 -----YASW------------------------------EDCLNLREVKCLRKLNHSNIV 63
+ +W +++ + + N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 64 KLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPE-IKAWLFQVFQGLSYMHQNG 121
+ LY+ + C + NL M R E Q+ + + ++H G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 122 FFHRDLKPEN-LLVSQGIIKIADFGLAREIKS-------------GPPYTNYVGSRWYRA 167
HRDLKP N ++K+ DFGL + +T VG++ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
PE + YS K D++++G I+ EL + +
Sbjct: 245 PEQ-IHGNNYSHKVDIFSLGLILFEL--LYSFSTQMERVRIITDVR-------------- 287
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+FP L + + + S P++RP A + +++ F+
Sbjct: 288 -------NLKFPLLF--------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-47
Identities = 45/309 (14%), Positives = 96/309 (31%), Gaps = 62/309 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
LG GAF +V++A D + +K K WE + + ++ L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKP 123
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC----NLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
+K N LV E N L K+ + + ++ ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQGI------------IKIADFGLAREIKSGPP---YT 157
+ +H H D+KP+N ++ G + + D G + ++K P +T
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL- 216
+ ++ E+L + ++ + D + + A + + + K G+
Sbjct: 244 AKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMK--VKNEGGECKPEGLFR 300
Query: 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA 276
P +D W + F + + +
Sbjct: 301 RLPHLDMWNE---------------------------------FFHVMLNIPDCHHLPSL 327
Query: 277 EALQHPFFK 285
+ L+ K
Sbjct: 328 DLLRQKLKK 336
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-47
Identities = 86/308 (27%), Positives = 135/308 (43%), Gaps = 50/308 (16%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNH 59
D Y + +G GA V A+ E VAIK L++ S ++ L +E++ + + +H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHH 72
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLM------AARDRKLFSEPEIKAWLFQVFQ 112
NIV + L+LV + + ++ ++ + E I L +V +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 113 GLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN------YVGSRWY 165
GL Y+H+NG HRD+K N+L+ G ++IADFG++ + +G T +VG+ +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 166 RAPEILLQSELYSSKADMWAMGAIMA-ELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224
APE++ Q Y KAD+W+ G I A EL T P P M
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFG-ITAIELATGAA--PYHKY-------------PPM--- 233
Query: 225 ADGLRQARAI----KYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEAL 279
+ + + P L M + SLC DP KRPTAAE L
Sbjct: 234 -------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 280 QHPFFKRC 287
+H FF++
Sbjct: 287 RHKFFQKA 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 81/299 (27%), Positives = 126/299 (42%), Gaps = 53/299 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL--REVKCLRKLNH 59
+S +E+G G+FG V+ A D E VAIK++ + +EV+ L+KL H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
N ++ + + +LV E + L+ + L E EI A QGL+Y+H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL-QEVEIAAVTHGALQGLAYLHS 172
Query: 120 NGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL--QSEL 176
+ HRD+K N LL G++K+ DFG A + P ++VG+ ++ APE++L
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQ 229
Query: 177 YSSKADMWAMG--AI-MAE----LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
Y K D+W++G I +AE LF + +Y I +S
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHI------AQNES------ 270
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P L + S + F C P RPT+ L+H F R
Sbjct: 271 ---------PALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 46/347 (13%), Positives = 91/347 (26%), Gaps = 82/347 (23%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNLR-EVKCLRKL-------- 57
LG+ +A D+ TGE+ + ++ EV LR L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 58 --------------NHSNIVKLKELIQNNNR-----LYLVFECMECNLYQLMAA-----R 93
K+ + + + ++ M+ NL
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 94 DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS 152
K QV + L+ +H G H L+P ++++ Q G + + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 153 G--PPYTNYVGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEA 206
P A +L L + D W +G + ++ +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 207 DQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCS 266
I F +P + + E
Sbjct: 324 GGSEWI-------------------------FRSCKN------IPQPVRALL---EGFLR 349
Query: 267 WDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPAVATTTANQPAAATR 313
+ R +A++ P +++ +R+ + A TR
Sbjct: 350 YPKEDRLLPLQAMETPEYEQ-------LRTELSAALPLYQTDGEPTR 389
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 42/304 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKEL-KQRYASWEDCLNL-REVKCLRKLN 58
+ Y LG G FG+V E TG VA+K L +Q+ S + + RE++ L+
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
H +I+KL ++I + +++V E + L+ + R E E + Q+ G+ Y
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYC 132
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H++ HRDLKPEN+L+ + KIADFGL+ + G GS Y APE+ + L
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV-ISGRL 191
Query: 177 YS-SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-ARAI 234
Y+ + D+W+ G I L+ +CG L P D L +
Sbjct: 192 YAGPEVDIWSSGVI---LYAL---------------LCGTL--PFDDDHVPTLFKKICDG 231
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHI 294
+ P + ISL + + DP KR T + +H +FK+ P ++
Sbjct: 232 IFYTP-----------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL--PKYL 278
Query: 295 RSTP 298
Sbjct: 279 FPED 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 55/299 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHS 60
KY+ F+++G+GA G V+ A D TG+ VAI+++ + E +N E+ +R+ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN--EILVMRENKNP 77
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV + + L++V E + +L ++ E +I A + Q L ++H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 120 NGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELY 177
N HRD+K +N LL G +K+ DFG +I + VG+ ++ APE++ + Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-Y 193
Query: 178 SSKADMWAMG--AI-MAE----LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
K D+W++G AI M E PL A +Y I T +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RA--LYLI------ATNGT------- 233
Query: 231 ARAIKYQFPQLP-RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P+L LSA+ F + C D KR +A E LQH F K
Sbjct: 234 --------PELQNPEKLSAIFRD--------FLNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN------LREVKCLRKLNHSN 61
K++G+G FG V + VAIK L + E + REV + LNH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IVKL L+ N +V E + C +LY + + + + + G+ YM
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQNQ 141
Query: 121 GFF--HRDLKPENLLVSQG------IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
HRDL+ N+ + K+ADFGL+++ + +G+ + APE +
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIG 199
Query: 173 -QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+ E Y+ KAD ++ I+ + T F S ++ I + +GLR
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIR--------EEGLR-- 248
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P +P L ++ E S DP KRP + ++
Sbjct: 249 -------PTIPEDCPPRL--------RNVIELCWSGDPKKRPHFSYIVKE 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 76/300 (25%), Positives = 116/300 (38%), Gaps = 64/300 (21%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K LG G+F V A + T AIK L++R + +V + +L+H
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKR-----HIIKENKVPYVTRERDVMSRLDHP 90
Query: 61 NIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
VKL Q++ +LY L + R F E + + ++ L Y
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSY--AKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEY 145
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN---YVGSRWYRAPEILL 172
+H G HRDLKPEN+L+ I+I DFG A+ + +VG+ Y +PE+ L
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-L 204
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADGLRQA 231
+ +D+WA+G I+ +L P F +E ++ KI
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKI------------------- 244
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT------AAEALQHPFFK 285
++Y FP A L E L D +KR HPFF+
Sbjct: 245 IKLEYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 80/341 (23%), Positives = 145/341 (42%), Gaps = 69/341 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNH 59
+ + ++LG G++G V++A + TG+ VAIK ++ ++ + E+ +++ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIK--EISIMQQCDS 83
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
++VK N L++V E ++ ++ R++ L +E EI L +GL Y+H
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-TEDEIATILQSTLKGLEYLH 142
Query: 119 QNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
HRD+K N LL ++G K+ADFG+A ++ N +G+ ++ APE++ +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG- 201
Query: 177 YSSKADMWAMG--AI-MAE----LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
Y+ AD+W++G AI MAE P+ ++ I PT
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMI------PTNPP------ 242
Query: 230 QARAIKYQFPQLP-RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P S F C P +R TA + LQHPF +
Sbjct: 243 ---------PTFRKPELWSDNFTD--------FVKQCLVKSPEQRATATQLLQHPFVRS- 284
Query: 288 FYAPPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQQQQG 328
A + + +R++ QQ+++G
Sbjct: 285 --AKGVSILRDLI---------NEAMDVKLKRQESQQREEG 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-44
Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 54/286 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+ +GRGAFG V +A + + VAIK+++ E + E++ L ++NH NIVKL
Sbjct: 14 EVVGRGAFGVVCKA--KWRAKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKL 66
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYMHQ---N 120
N + LV E E +LY ++ + ++ +W Q QG++Y+H
Sbjct: 67 YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 121 GFFHRDLKPENLLVSQG--IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRDLKP NLL+ G ++KI DFG A +I++ TN GS + APE+ + YS
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEV-FEGSNYS 181
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
K D+++ G I+ E+ T F M + +G R
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----------MWAVHNGTR--------- 222
Query: 239 PQLPR---ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P L + + +LM S DPS+RP+ E ++
Sbjct: 223 PPLIKNLPKPIESLM-----------TRCWSKDPSQRPSMEEIVKI 257
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 72/298 (24%), Positives = 130/298 (43%), Gaps = 53/298 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ ++G G+ G V A ++H+G VA+K + R + L EV +R H N
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFN 103
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V++ + L+++ E ++ L ++ + +E +I V Q L+Y+H
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 121 GFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSELYS 178
G HRD+K ++ LL G +K++DFG +I P VG+ ++ APE++ +S Y+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YA 219
Query: 179 SKADMWAMG--AI-MAE----LFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
++ D+W++G I M + F+ P+ +A M ++
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QA--MKRL------RDSPP-------- 258
Query: 232 RAIKYQFPQLP-RANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P+L +S ++ F DP +R TA E L HPF +
Sbjct: 259 -------PKLKNSHKVSPVLRD--------FLERMLVRDPQERATAQELLDHPFLLQT 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 42/296 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHS 60
+ + ELG GAFG+V++A ++ TG A K ++ + ED + E++ L +H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHP 76
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
IVKL ++ +L+++ E + +M DR L +EP+I+ Q+ + L+++H
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVVCRQMLEALNFLHS 135
Query: 120 NGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL- 176
HRDLK N L+ +G I++ADFG++ + + ++G+ ++ APE+++ +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 177 ---YSSKADMWAMGAIMA-ELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y KAD+W++G I E+ P + + KI D
Sbjct: 196 DTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI------AKSDP--------- 239
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P L PS F + +P RP+AA+ L+HPF
Sbjct: 240 ------PTLLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 21/304 (6%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
D + ELG G G VF+ + +G +A K + +RE++ L + N
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 61 NIVKLKELIQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
IV ++ + + E M+ L Q++ + E + V +GL+Y+ +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 120 NG-FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
HRD+KP N+LV S+G IK+ DFG++ ++ + +VG+R Y +PE LQ Y
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPER-LQGTHY 207
Query: 178 SSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
S ++D+W+MG + E+ P+ P ++ ++ C V G K+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 237 QFPQLPRANLSALM--------PSASQDAISL----FESLCSW-DPSKRPTAAEALQHPF 283
P + L+ P SL F + C +P++R + + H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 284 FKRC 287
KR
Sbjct: 328 IKRS 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIK--ELKQRYASWEDCLNLREVKCLRKLNH 59
+ ++ +++G+G+FG VF+ D T + VAIK +L++ ED +E+ L + +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDS 79
Query: 60 SNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+ K + +L+++ E + + L+ E +I L ++ +GL Y+H
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH 136
Query: 119 QNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQSEL 176
HRD+K N LL G +K+ADFG+A ++ N +VG+ ++ APE++ QS
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA- 195
Query: 177 YSSKADMWAMGAIMA-ELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y SKAD+W++G I A EL P ++ I P +
Sbjct: 196 YDSKADIWSLG-ITAIELARGEPPHSELHPMKVLFLI------PKNNP------------ 236
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRC 287
P L N S + F C + +PS RPTA E L+H F R
Sbjct: 237 ---PTL-EGNYSKPLKE--------FVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 57/289 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+ LG+G FG+ + TGE + +KEL + E+ L+EVK +R L H N++K
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
++ + RL + E ++ L ++ + D + + ++ + G++Y+H H
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 125 RDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY---------------VGSRWYRAP 168
RDL N LV + +ADFGLAR + VG+ ++ AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
E+ + Y K D+++ G ++ E+ P + + L
Sbjct: 192 EM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLNVRGFL 240
Query: 229 RQARAIKYQFPQLPR---ANLSALMPSASQDAISLFESLCSWDPSKRPT 274
P + + C DP KRP+
Sbjct: 241 D---------RYCPPNCPPSFFPIT-----------VRCCDLDPEKRPS 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
+ + +G G +G+V++ TG+ AIK + E+ E+ L+K +H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--EINMLKKYSHHR 81
Query: 61 NIVKL------KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI K +++L+LV E ++ L+ E I ++ +G
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 114 LSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEIL 171
LS++HQ+ HRD+K +N LL +K+ DFG++ ++ N ++G+ ++ APE++
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 172 LQSEL----YSSKADMWAMGAIMA-ELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
E Y K+D+W++G I A E+ P ++ I P +
Sbjct: 202 ACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI------PRNPA--- 251
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFK 285
P+L S S F C + S+RP + ++HPF +
Sbjct: 252 ------------PRLKSKKWSKKFQS--------FIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 286 R 286
Sbjct: 292 D 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 57/293 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQ-RYASWEDCLN--LREVKCLRKLNHSNIVK 64
+ +G G FG+V++A G+ VA+K + + +E K L H NI+
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L+ + L LV E L +++ +++ + W Q+ +G++Y+H
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRI-PPDILVNWAVQIARGMNYLHDEAIV 127
Query: 124 ---HRDLKPENLLVSQG---------IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
HRDLK N+L+ Q I+KI DFGLARE + G+ + APE+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEV- 185
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+++ ++S +D+W+ G ++ EL T F G Y + + L
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-----------MNKLA-- 232
Query: 232 RAIKYQFPQLPR---ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+P + LM E + DP RP+ L
Sbjct: 233 -------LPIPSTCPEPFAKLM-----------EDCWNPDPHSRPSFTNILDQ 267
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+++G G+FG V +A E G VA+K L ++ + +N LREV +++L H NIV
Sbjct: 43 EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLF 99
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKL-FSEPEIKAWLFQVFQGLSYMHQNG-- 121
+ L +V E + +LY+L+ + E + + V +G++Y+H
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY-TNYVGSRWYRAPEILLQSELYSS 179
HR+LK NLLV + +K+ DFGL+R S + G+ + APE+ L+ E +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV-LRDEPSNE 218
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K+D+++ G I+ EL T + + A + + R
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-----------FKCKR---------L 258
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
++PR + ++ E + +P KRP+ A +
Sbjct: 259 EIPRNLNPQV--------AAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 79/335 (23%), Positives = 134/335 (40%), Gaps = 39/335 (11%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK-CLRKLNH 59
+ E+GRGA+G V + + +G+ +A+K ++ E L ++ +R +
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 60 SNIVKLKELIQNNNRLYLVFECME---CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
IV+ + ++ E M Y+ + + + E + + L++
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 117 MHQNG-FFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
+ +N HRD+KP N+L+ G IK+ DFG++ ++ T G R Y APE + S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 175 EL---YSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
Y ++D+W++G + EL T P S DQ+ ++ V G P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDP----------- 247
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRCFY 289
PQL ++ S I+ F +LC + D SKRP E L+HPF Y
Sbjct: 248 --------PQLS----NSEEREFSPSFIN-FVNLCLTKDESKRPKYKELLKHPFILM--Y 292
Query: 290 APPHIRSTPAVATTTANQPAAATRGMLKQRRQQQQ 324
+ V PA + M
Sbjct: 293 EERAVEVACYVCKILDQMPATPSSPMYVDHHHHHH 327
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 60/295 (20%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
+ +G+G+FG+V T + A+K + + + C+ EV+ ++ L H
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQIMQGLEHP 75
Query: 61 NIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+V L Q+ +++V + + Y L + F E +K ++ ++ L Y
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLL--LGGDLRYHL---QQNVHFKEETVKLFICELVMALDY 130
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
+ HRD+KP+N+L+ G + I DF +A + T G++ Y APE+ +
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 176 L--YSSKADMWAMGAIMAELFTFCPLFPGASEAD--QMYKICGVLGSPTMDSWADGLRQA 231
YS D W++G EL + S ++
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-------------------- 230
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ-HPFFK 285
+ P + SQ+ +SL + L +P +R + +Q P+
Sbjct: 231 -TFETTVVTYP--------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 50/291 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+ +G+G FG+V+ GE VAI+ + + ED L REV R+ H N+V
Sbjct: 39 ELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLF 94
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ L ++ + LY ++ L + + ++ +G+ Y+H G H
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL-DVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 125 RDLKPENLLVSQGIIKIADFGLAREIKSGP------PYTNYVGSRWYRAPEIL------- 171
+DLK +N+ G + I DFGL G + APEI+
Sbjct: 154 KDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 172 -LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+S +D++A+G I EL F ++++ G++
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------------GTGMK- 260
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P L + + + + +++ +RPT + +
Sbjct: 261 --------PNLSQIGMGKEI-------SDILLFCWAFEQEERPTFTKLMDM 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-41
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 39/276 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+ +G G+FG V++ + G+ VA+K L + L EV LRK H NI+
Sbjct: 30 QRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
L +V + E +LY + A + K ++ Q +G+ Y+H H
Sbjct: 86 MGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 125 RDLKPENLLVSQ-GIIKIADFGLAREIK---SGPPYTNYVGSRWYRAPEILLQSEL--YS 178
RDLK N+ + + +KI DFGLA E + GS + APE++ + YS
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
++D++A G ++ EL T + + DQ I ++G R +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG-----------RGSL------ 243
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT 274
+LS + + + L +RP+
Sbjct: 244 ----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 74/301 (24%), Positives = 113/301 (37%), Gaps = 58/301 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K +GRGAF V + TG+ A+K + + D L EV C L +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNK-----WDMLKRGEVSCFREERDVLVNGDRR 121
Query: 61 NIVKLKELIQNNNRLYLVFECM---ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
I +L Q+ N LYLV E + L L + + + +L ++ + +
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDL-LTLLS--KFGERIPAEMARFYLAEIVMAIDSV 178
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTN-YVGSRWYRAPEILLQS 174
H+ G+ HRD+KP+N+L+ G I++ADFG + G + VG+ Y +PEIL
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 175 EL------YSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADG 227
Y + D WA+G E+F F S + Y KI
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYGKIV-------------- 283
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFF 284
P + ++A + L P R A + HPFF
Sbjct: 284 ---HYKEHLSLPLVD--------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331
Query: 285 K 285
Sbjct: 332 F 332
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKL- 57
++ E+G G G+V++ TG +A+K++ R + ++ L ++ + K
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSH 81
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ IV+ N +++ E M +L E + + + L Y+
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYL 140
Query: 118 H-QNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSE 175
++G HRD+KP N+L+ +G IK+ DFG++ + G Y APE + +
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 176 L----YSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
Y +AD+W++G + EL T P ++ + + K+ + P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEP----------- 247
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
P LP S D S + + D KRP + L+H F KR
Sbjct: 248 --------PLLPGH------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 81/295 (27%), Positives = 129/295 (43%), Gaps = 60/295 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K LG G+FGRV + +G A+K L + + + L++++ L+ +N
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 61 NIVKLKELIQNNNRLYLVFECMECN---LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+VKL+ ++N+ LY+V E ++ + R FSEP + + Q+ Y+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEY--VAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
H +RDLKPENLL+ QG I++ DFG A+ +K G +T G+ APEI+L
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEALAPEIILSKG- 214
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADGLRQARAIK 235
Y+ D WA+G ++ E+ P F A + Q+Y KI + K
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIV-------------------SGK 254
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+FP S D L +L D +KR + H +F
Sbjct: 255 VRFP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 80/307 (26%), Positives = 122/307 (39%), Gaps = 59/307 (19%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC------- 53
D + F+ LGRG FG VF + TG+ A K+L + + + +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK-----KRLKKRKGYQGAMVEKKI 238
Query: 54 LRKLNHSNIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDR-KLFSEPEIKAWLF 108
L K++ IV L + L LV M N Y + + F EP +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIM--NGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYR 166
Q+ GL ++HQ +RDLKPEN+L+ G ++I+D GLA E+K+G T Y G+ +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA---DQMYKICGVLGSPTMDS 223
APE+LL E Y D +A+G + E+ F E ++
Sbjct: 357 APELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------- 402
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL 279
+ + Q P S + E+L DP KR + + L
Sbjct: 403 --------QRVLEQAVTYPD--------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446
Query: 280 -QHPFFK 285
HP F+
Sbjct: 447 RTHPLFR 453
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 50/296 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K +GRGAFG V ++ + A+K L + + L E C L +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNK-----WEMLKRAETACFREERDVLVNGDSK 134
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
I L Q++N LYLV + +L L++ + E + +L ++ + +HQ
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTN-YVGSRWYRAPEILLQSEL 176
+ HRD+KP+N+L+ G I++ADFG + ++ G ++ VG+ Y +PEIL E
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 177 ----YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y + D W++G M E+ F S + KI
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-----------------NH 296
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFK 285
++QFP S++A L L R + +HPFF
Sbjct: 297 KERFQFPTQV--------TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 49/302 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR-YASWEDCLNLREVKCLRKLNHSNIVKL- 65
+ +G+G FG V++ + GE VA+K R SW E+ L H NI+
Sbjct: 48 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENILGFI 102
Query: 66 ---KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ +L+LV + E +L+ + +R + + GL+++H
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 122 FF--------HRDLKPENLLV-SQGIIKIADFGLAREIKSGP-----PYTNYVGSRWYRA 167
HRDLK +N+LV G IAD GLA S + VG++ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 168 PEIL-----LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222
PE+L ++ +AD++AMG + E+ C + + Y D
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-----DLVPSD 274
Query: 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCS--W--DPSKRPTAAEA 278
+ +R+ + P +P S +A+ + + W + + R TA
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQ-------SCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 279 LQ 280
+
Sbjct: 328 KK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 41/297 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK-CLRKLNH 59
D ELGRGA+G V + +G+ +A+K ++ S E L ++ +R ++
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYM 117
V + +++ E M+ +L + + E + + + L ++
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 118 HQNG-FFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL---L 172
H HRD+KP N+L++ G +K+ DFG++ + G + Y APE + L
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 173 QSELYSSKADMWAMGAIMAELFT--FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+ YS K+D+W++G M EL F P + Q+ ++ V
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRF-PYDSWGTPFQQLKQV--VEEPS----------- 231
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW-DPSKRPTAAEALQHPFFKR 286
PQLP SA F S C + +RPT E +QHPFF
Sbjct: 232 --------PQLPADKFSAEFVD--------FTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-40
Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 61/297 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K LG+G FG+V ++ TG A+K L++ E + EV L+ H
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 61 NIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ LK Q ++RL V ME N + L R+R F+E + + ++ L
Sbjct: 66 FLTALKYAFQTHDRLCFV---MEYANGGELFFHLS--RERV-FTEERARFYGAEIVSALE 119
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H +RD+K ENL++ G IKI DFGL +E I G + G+ Y APE+L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
++ Y D W +G +M E+ F +++++
Sbjct: 180 ND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFE---------------------L 216
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL-QHPFFK 285
I + + PR + S +A SL L DP +R P+ A+ + +H FF
Sbjct: 217 ILMEEIRFPR--------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 42/297 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
+ + ++ LG+G FG V TG+ A K+L+++ L E + L K+N
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
+V L + + L LV M N + + + F E + ++ GL
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGL 299
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
+H+ +RDLKPEN+L+ G I+I+D GLA + G VG+ Y APE++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y+ D WA+G ++ E+ F + + ++ R
Sbjct: 360 ER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------------------ERL 400
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+K + S A SL L DP++R +A E +HP FK
Sbjct: 401 VKEVPEEYSE--------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-40
Identities = 74/296 (25%), Positives = 116/296 (39%), Gaps = 54/296 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K +GRGAFG V + T + A+K L + + + + + N
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-----FEMIKRSDSAFFWEERDIMAFANSP 129
Query: 61 NIVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
+V+L Q++ LY+V E M +L LM+ D E + + +V L +H
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHS 186
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTN-YVGSRWYRAPEILLQ--- 173
GF HRD+KP+N+L+ G +K+ADFG + K G + VG+ Y +PE+L
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADGLRQAR 232
Y + D W++G + E+ F S Y KI
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIM-----------------NH 288
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFK 285
FP S++A +L + + D R E +H FFK
Sbjct: 289 KNSLTFPD---------DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 73/297 (24%), Positives = 122/297 (41%), Gaps = 64/297 (21%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
+ LG G+FGRV H G A+K LK+ E + L++V+ L + H
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 61 NIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
I+++ Q+ +++++ + L R + F P K + +V L Y
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDY--IEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEY 121
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAPEILLQS 174
+H +RDLKPEN+L+ G IKI DFG A+ + T G+ Y APE+ + +
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEV-VST 177
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY-KICGVLGSPTMDSWADGLRQARA 233
+ Y+ D W+ G ++ E+ F ++ + Y KI
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKIL-------------------N 217
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
+ +FP P ++D L L + D S+R + HP+FK
Sbjct: 218 AELRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 58/292 (19%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR--------KLNHSN 61
LG+G+FG+VF A + T + AIK LK+ + L +V+C H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 62 IVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+ + Q L+ V ME N +Y + + F + ++ GL +
Sbjct: 80 LTHMFCTFQTKENLFFV---MEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 133
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQS 174
+H G +RDLK +N+L+ G IKIADFG+ +E + + G+ Y APEILL
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+ Y+ D W+ G ++ E+ F G E ++++ +I
Sbjct: 194 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELF---------------------HSI 230
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ-HPFFK 285
+ P PR ++A L L +P KR ++ HP F+
Sbjct: 231 RMDNPFYPR--------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 71/298 (23%), Positives = 109/298 (36%), Gaps = 41/298 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELK-QRYASWEDCLNLREVKCLRKLNHSNIVKL- 65
K++G+G +G V+ + GE VA+K ASW E+ + H NI+
Sbjct: 43 KQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEASW---FRETEIYQTVLMRHENILGFI 97
Query: 66 ---KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ + +LYL+ + E +LY + + + GL ++H
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 122 FF--------HRDLKPENLLV-SQGIIKIADFGLAREIKSGP-----PYTNYVGSRWYRA 167
F HRDLK +N+LV G IAD GLA + S P VG++ Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 168 PEIL-----LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222
PE+L ADM++ G I+ E+ C E Y D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH-----DLVPSD 269
Query: 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ +R+ IK P P S L + +P+ R TA +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQ---MGKLMTECWAHNPASRLTALRVKK 324
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 61/297 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC--------LRKLNH 59
K +G+G+FG+V A + A+K L++ + L +E K L+ + H
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQK-----KAILKKKEEKHIMSERNVLLKNVKH 98
Query: 60 SNIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
+V L Q ++LY V ++ N Y L R+R F EP + + ++ L
Sbjct: 99 PFLVGLHFSFQTADKLYFV---LDYINGGELFYHL--QRERC-FLEPRARFYAAEIASAL 152
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILL 172
Y+H +RDLKPEN+L+ SQG I + DFGL +E I+ + + G+ Y APE+L
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ Y D W +GA++ E+ P F + +MY
Sbjct: 213 KQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYD--------------------- 249
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQHPFFK 285
I + QL P+ + A L E L D +KR E H FF
Sbjct: 250 NILNKPLQLK--------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 65/298 (21%), Positives = 109/298 (36%), Gaps = 41/298 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR-YASWEDCLNLREVKCLRKLNHSNIVKL- 65
+ +G+G +G V++ GE VA+K R SW E+ L H NI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSW---FRETELYNTVMLRHENILGFI 68
Query: 66 ---KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
++ +L+L+ E +LY + + + GL+++H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 122 FF--------HRDLKPENLLV-SQGIIKIADFGLAREIKSGP-----PYTNYVGSRWYRA 167
F HRDLK +N+LV G IAD GLA VG++ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 168 PEIL-----LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222
PE+L + + D+WA G ++ E+ + + D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY-----DVVPND 240
Query: 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ +R+ + Q P +P S ++ L + +PS R TA +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMKECWYQNPSARLTALRIKK 295
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 62/307 (20%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC------- 53
M+ +S + +GRG FG V+ TG+ A+K L + + +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETLALNERIM 242
Query: 54 LRKLNHSN---IVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAW 106
L ++ + IV + ++L + + M N Y L +FSE +++ +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM--NGGDLHYHL---SQHGVFSEADMRFY 297
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWY 165
++ GL +MH +RDLKP N+L+ G ++I+D GLA + P+ VG+ Y
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGY 356
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEAD--QMYKICGVLGSPTMDS 223
APE+L + Y S AD +++G ++ +L F D ++
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------- 403
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEAL 279
R +LP S S + SL E L D ++R A+ +
Sbjct: 404 --------RMTLTMAVELP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447
Query: 280 -QHPFFK 285
+ PFF+
Sbjct: 448 KESPFFR 454
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 63/300 (21%)
Query: 8 KELGRGAFGRVFQA---FDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKL 57
+ LG+G +G+VFQ +TG+ A+K LK+ N ++ L ++
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTAHTKAERNILEEV 78
Query: 58 NHSNIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQ 112
H IV L Q +LYL+ +E + QL R+ F E +L ++
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLI---LEYLSGGELFMQL--EREGI-FMEDTACFYLAEISM 132
Query: 113 GLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEI 170
L ++HQ G +RDLKPEN+++ QG +K+ DFGL +E I G + G+ Y APEI
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
L++S ++ D W++GA+M ++ T P F G + +
Sbjct: 193 LMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTI-------------------- 230
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFK 285
I LP P +Q+A L + L + + R P A +Q HPFF+
Sbjct: 231 -DKILKCKLNLP--------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-39
Identities = 67/292 (22%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG+G FG V ++TGE VA+K+L+ RE++ L+ L H NIV
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF-EREIEILKSLQHDNIV 74
Query: 64 KLKELIQNNNR--LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K K + + R L L+ E + +L + ++ ++ + Q+ +G+ Y+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYLGTK 133
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS-------RWYRAPEILL 172
+ HRDL N+LV ++ +KI DFGL + + + + WY APE L
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWY-APESLT 190
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKIC----GVLGSPTMDSWADGL 228
+S+ +S +D+W+ G ++ ELFT+ ++ ++ +
Sbjct: 191 ESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 229 RQARAIKYQFPQLPR-----ANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
R LPR + +M + C + + ++RP+
Sbjct: 250 R-----------LPRPDGCPDEIYMIM------------TECWNNNVNQRPS 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 50/284 (17%), Positives = 99/284 (34%), Gaps = 45/284 (15%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVKLK 66
+L G +++ G + +K LK R S + E LR +H N++ +
Sbjct: 16 TKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 67 --ELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH--QNG 121
L+ M +LY ++ + + + + + +G++++H +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGS-RWYRAPEILL--QSELY 177
L ++++ + +I+ + +S + + W APE L +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWV-APEALQKKPEDTN 188
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
ADMW+ ++ EL T F S + K+ +GLR
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA-----------LEGLR-------- 229
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P +P P S L + + DP+KRP +
Sbjct: 230 -PTIP--------PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 62/298 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR--------KLNH 59
LG+G+FG+V + + T E A+K LK+ + + +V+C
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKP 80
Query: 60 SNIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
+ +L Q +RLY V ME N +Y + + + F EP + ++ GL
Sbjct: 81 PFLTQLHSCFQTMDRLYFV---MEYVNGGDLMYHIQ--QVGR-FKEPHAVFYAAEIAIGL 134
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILL 172
++ G +RDLK +N+++ S+G IKIADFG+ +E I G + G+ Y APEI+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y D WA G ++ E+ F G E D+++ +
Sbjct: 195 YQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELF---------------------Q 231
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFK 285
+I P+ S S++A+++ + L + P KR P ++ H FF+
Sbjct: 232 SIMEHNVAYPK--------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG+G FG V ++TGE VA+K+L+ RE++ L+ L H NIV
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF-EREIEILKSLQHDNIV 105
Query: 64 KLKELIQNNNR--LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K K + + R L L+ E + +L + ++ ++ + Q+ +G+ Y+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYLGTK 164
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS-------RWYRAPEILL 172
+ HRDL N+LV ++ +KI DFGL + + Y Y WY APE L
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWY-APESLT 221
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKIC----GVLGSPTMDSWADGL 228
+S+ +S +D+W+ G ++ ELFT+ ++ ++ +
Sbjct: 222 ESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 229 RQARAIKYQFPQLPR-----ANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
R LPR + +M + C + + ++RP+
Sbjct: 281 R-----------LPRPDGCPDEIYMIM------------TECWNNNVNQRPS 309
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 61/298 (20%)
Query: 8 KELGRGAFGRVFQA---FDEHTGEAVAIKELK-----QRYASWEDCLNLREVKCLRKLNH 59
K LG+G+FG+VF + A+K LK R R++ L ++NH
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDI--LVEVNH 85
Query: 60 SNIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
IVKL Q +LYL+ ++ +L +++ F+E ++K +L ++ L
Sbjct: 86 PFIVKLHYAFQTEGKLYLI---LDFLRGGDLFTRL--SKEVM-FTEEDVKFYLAELALAL 139
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILL 172
++H G +RDLKPEN+L+ +G IK+ DFGL++E I ++ G+ Y APE++
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ ++ AD W+ G +M E+ T F G +
Sbjct: 200 RRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETM---------------------T 236
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFK 285
I +P S +A SL L +P+ R P E ++ H FF
Sbjct: 237 MILKAKLGMP--------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 63/299 (21%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR--------KLNH 59
+ LG+G+FG+V A + TG+ A+K LK+ + L +V+C NH
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRILSLARNH 83
Query: 60 SNIVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
+ +L Q +RL+ V ME N ++ + + R+ F E + + ++ L
Sbjct: 84 PFLTQLFCCFQTPDRLFFV---MEFVNGGDLMFHIQ--KSRR-FDEARARFYAAEIISAL 137
Query: 115 SYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILL 172
++H G +RDLK +N+L+ +G K+ADFG+ +E I +G + G+ Y APEIL
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ Y D WAMG ++ E+ F +E D ++
Sbjct: 198 EML-YGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLF---------------------E 234
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEA--LQHPFFK 285
AI P +DA + +S + +P+ R E L+HPFFK
Sbjct: 235 AILNDEVVYPT--------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG G FG+V ++TGE VA+K LK +E++ LR L H NIV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 64 KLKELIQNNNR--LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K K + + + L+ E + +L + + K+ + + + Q+ +G+ Y+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI-NLKQQLKYAVQICKGMDYLGSR 145
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS-------RWYRAPEILL 172
+ HRDL N+LV S+ +KI DFGL + I++ Y Y WY APE L+
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFWY-APECLM 202
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
QS+ + +D+W+ G + EL T+C L + + R
Sbjct: 203 QSK-FYIASDVWSFGVTLHELLTYC----------DSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 233 AIKY--QFPQLPR-----ANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+ + +LP + LM C + PS R +
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLM------------RKCWEFQPSNRTS 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 82/325 (25%), Positives = 128/325 (39%), Gaps = 56/325 (17%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
+LG+G FG V ++TG VA+K+L+ + RE++ L+ L+ IV
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF-QREIQILKALHSDFIV 87
Query: 64 KLKELIQNNNR--LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K + + R L LV E + L + +L + + Q+ +G+ Y+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYSSQICKGMEYLGSR 146
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS-------RWYRAPEILL 172
HRDL N+LV S+ +KIADFGLA+ + Y YV WY APE L
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--YVVREPGQSPIFWY-APESLS 203
Query: 173 QSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKICGVLGSP-TMDSWADGLR 229
+ +S ++D+W+ G ++ ELFT+C P A M V ++ +G R
Sbjct: 204 DNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 230 QARAIKYQFPQLPR-----ANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPF 283
LP A + LM LC + P RP+ + P
Sbjct: 263 -----------LPAPPACPAEVHELM------------KLCWAPSPQDRPSFSAL--GPQ 297
Query: 284 FKRCFYAPPHIRSTPAVATTTANQP 308
+ T A +
Sbjct: 298 LDMLWSGSRGCE-THAFTAHPEGKH 321
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+LG G +G V++ + VA+K LK+ E+ L+E ++++ H N+V+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPNLVQLLG 76
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ Y++ E M NL + +R+ S + Q+ + Y+ + F HRD
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L N LV ++K+ADFGL+R + YT + G+ +W APE L + +S K+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWT-APESLAYN-KFSIKS 193
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA G ++ E+ T+ P +PG + + R R P
Sbjct: 194 DVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL------------EKDYRMER------P 234
Query: 240 QLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+ + LM C W+PS RP+
Sbjct: 235 EGCPEKVYELM------------RACWQWNPSDRPS 258
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 45/280 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+++GRG FG VF VA+K ++ L+E + L++ +H NIV+L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ +Y+V E ++ + + +L + + G+ Y+ HRD
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 127 LKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS-----RWYRAPEILLQSELYSSK 180
L N LV++ ++KI+DFG++RE G Y G +W APE L YSS+
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWT-APEALNYG-RYSSE 295
Query: 181 ADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+D+W+ G ++ E F+ P +P S + G R
Sbjct: 296 SDVWSFGILLWETFSLGASP-YPNLSNQQTREFVE------------KGGRLPC------ 336
Query: 239 PQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAE 277
P+L + LM C +++P +RP+ +
Sbjct: 337 PELCPDAVFRLM------------EQCWAYEPGQRPSFST 364
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 56/295 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKLNHS 60
K LG+G FG+V ++ TG A+K LK+ E + EV L+ H
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMA--ARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+ LK Q ++RL V E N +L +R+R FSE + + ++ L Y+H
Sbjct: 209 FLTALKYSFQTHDRLCFVMEY--ANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLH 265
Query: 119 -QNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQSE 175
+ +RDLK ENL++ G IKI DFGL +E IK G + G+ Y APE+L ++
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y D W +G +M E+ F +++++ I
Sbjct: 326 -YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFE---------------------LIL 362
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PT-AAEALQHPFFK 285
+ + PR + +A SL L DP +R A E +QH FF
Sbjct: 363 MEEIRFPR--------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 43/299 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR-YASWEDCLNLREVKCLRKLNHSNIVKL- 65
+ RG FG V++A + E VA+K + SW+ N EV L + H NI++
Sbjct: 30 EVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENILQFI 84
Query: 66 ---KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
K + L+L+ E +L + + S E+ + +GL+Y+H++
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 122 FF----------HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRA 167
HRD+K +N+L+ + IADFGLA + ++G VG+R Y A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 168 PEIL----LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
PE+L + DM+AMG ++ EL + C G + + + P+++
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSW--DPSKRPTAAEALQ 280
+++ K + P L + + I C W D R +A +
Sbjct: 262 ----MQEVVVHKKKRPVLRDYWQKHAGMAMLCETI----EEC-WDHDAEARLSAGCVGE 311
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 75/365 (20%), Positives = 127/365 (34%), Gaps = 86/365 (23%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRYASWEDCLNLREVKCLRKLNH 59
+Y ++LG G F V+ ++D + VA+K +K + Y L E++ L+ + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRN 92
Query: 60 SN--------IVKLKE--LIQ--NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL 107
S+ +V+L + I N + +VFE + +L + + + + P +K +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 108 FQVFQGLSYMH-QNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYVG----- 161
QV QGL Y+H + H D+KPEN+L+S I G
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 162 ------------------------------SRW-------------YRAPEILLQSELYS 178
+ W YR+ E+L+ S Y+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YN 271
Query: 179 SKADMWAMGAIMAELFTFCPLFPG------ASEADQMYKICGVLGSPTMDSWADG----- 227
+ AD+W+ + EL T LF + D + I +LG G
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 228 -------LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
L+ +K + + P KR TAAE L+
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
Query: 281 HPFFK 285
HP+
Sbjct: 392 HPWLN 396
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 47/276 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+E+G G FG V + + + VAIK +++ S ED + E + + KL+H +V+L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFI--EEAEVMMKLSHPKLVQLYG 70
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ + LV E ME L + + + + V +G++Y+ + HRD
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L N LV +IK++DFG+ R + YT+ G+ +W +PE+ S YSSK+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWA-SPEVFSFSR-YSSKS 186
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+W+ G +M E+F+ P + S ++ + I + G R + P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI------------STGFRLYK------P 227
Query: 240 QLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+L ++ +M + C P RP
Sbjct: 228 RLASTHVYQIM------------NHCWRERPEDRPA 251
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 54/291 (18%)
Query: 8 KELGRGAFGRVFQA----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
++LG G FG+V ++ TGE VA+K LK +E+ LR L H +I+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 64 KLKELIQNNNR--LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
K K ++ L LV E + +L + + ++ + Q+ +G++Y+H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSI-GLAQLLLFAQQICEGMAYLHAQ 153
Query: 121 GFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS-------RWYRAPEILL 172
+ HRDL N+L+ ++KI DFGLA+ + G Y Y WY APE L
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFWY-APECLK 210
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKIC---GVLGSPTMDSWADGLR 229
+ + + +D+W+ G + EL T C + + G R
Sbjct: 211 EYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 230 QARAIKYQFPQLPR-----ANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
LPR A + LM C + S RPT
Sbjct: 270 -----------LPRPDKCPAEVYHLM------------KNCWETEASFRPT 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 45/276 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+LG G +G V++ + VA+K LK+ E+ L +E ++++ H N+V+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL--KEAAVMKEIKHPNLVQLLG 283
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ Y++ E M NL + +R+ S + Q+ + Y+ + F HR+
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L N LV ++K+ADFGL+R + YT + G+ +W APE L + +S K+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWT-APESLAYN-KFSIKS 400
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+WA G ++ E+ T+ P +PG + + R R P
Sbjct: 401 DVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL------------EKDYRMER------P 441
Query: 240 QLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+ + LM + C W+PS RP+
Sbjct: 442 EGCPEKVYELMRA------------CWQWNPSDRPS 465
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 52/298 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--------LNH 59
+ +GRG++ +V + T A+K +K+ E + ++ ++ NH
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+V L Q +RL+ V E N ++ + R RK E + + ++ L+
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQ--RQRK-LPEEHARFYSAEISLALN 124
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H+ G +RDLK +N+L+ S+G IK+ D+G+ +E ++ G + + G+ Y APEIL
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
E Y D WA+G +M E+ F +D + +
Sbjct: 185 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------------NTEDYLFQV 230
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQ-HPFFK 285
I + ++PR S S A S+ +S + DP +R T +Q HPFF+
Sbjct: 231 ILEKQIRIPR--------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 60/298 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR--------KLNH 59
LG+G+FG+V + + T E A+K LK+ + + +V+C
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKP 401
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ +L Q +RLY V E N +Y + + F EP + ++ GL
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLF 456
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQ 173
++ G +RDLK +N+++ S+G IKIADFG+ +E I G + G+ Y APEI+
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
Y D WA G ++ E+ F G E D+++ ++
Sbjct: 517 QP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELF---------------------QS 553
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HPFFKR 286
I P+ S S++A+++ + L + P KR P ++ H FF+
Sbjct: 554 IMEHNVAYPK--------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 53/277 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ +G+G FG V ++ G VA+K +K A+ + L E + +L HSN+V+L
Sbjct: 27 QTIGKGEFGDVMLG--DYRGNKVAVKCIKND-ATAQAFL--AEASVMTQLRHSNLVQLLG 81
Query: 68 LI-QNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+I + LY+V E M +L + +R R + + + V + + Y+ N F HR
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141
Query: 126 DLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSK 180
DL N+LVS + K++DFGL +E + +W APE L + +S+K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWT-APEALREK-KFSTK 194
Query: 181 ADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+D+W+ G ++ E+++F P +P D + ++ G +
Sbjct: 195 SDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRV------------EKGYKMDA------ 235
Query: 239 PQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
P + +M C D + RP+
Sbjct: 236 PDGCPPAVYEVM------------KNCWHLDAAMRPS 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 61/303 (20%)
Query: 8 KELGRGAFGRVFQA---FDEHTGEAVAIKELKQRYASWEDCLNLREVKC-------LRKL 57
K LG GA+G+VF TG+ A+K LK+ + + + L +
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHI 115
Query: 58 NHSN-IVKLKELIQNNNRLYLVFECME-CN----LYQLMAARDRKLFSEPEIKAWLFQVF 111
S +V L Q +L+L+ ++ N L R+ F+E E++ ++ ++
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLI---LDYINGGELFTHL---SQRERFTEHEVQIYVGEIV 169
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTN-YVGSRWYRAP 168
L ++H+ G +RD+K EN+L+ S G + + DFGL++E + + G+ Y AP
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 169 EILLQSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227
+I+ + + D W++G +M EL T F E + +I
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-------------- 275
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR----PTAAEALQ-HP 282
R I P P S A L + L DP KR P A+ ++ H
Sbjct: 276 ----RRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 283 FFK 285
FF+
Sbjct: 324 FFQ 326
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 50/305 (16%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K LG GAFG V++ E VAIKEL++ + + L E + +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L I + + L+ + M L + + + W Q+ +G++Y+
Sbjct: 81 RL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
HRDL N+LV + +KI DFGLA+ + + + G +W A E +L Y
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRI-Y 196
Query: 178 SSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
+ ++D+W+ G + EL TF P + G ++ + G R +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL------------EKGERLPQ--- 240
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRCFYAPPHI 294
P + ++ +M C D RP E L F + P
Sbjct: 241 ---PPICTIDVYMIM------------RKCWMIDADSRPKFRE-LII-EFSKMARDPQRY 283
Query: 295 RSTPA 299
Sbjct: 284 LVIQG 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+LG+G FG V+ T VAIK LK S E L +E + ++KL H +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLRHEKLVQLYA 246
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y+V E M +L + K P++ Q+ G++Y+ + + HRD
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L+ N+LV + K+ADFGLAR I+ YT G+ +W APE L ++ K+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT-APEAALYG-RFTIKS 362
Query: 182 DMWAMGAIMAELFTFCPL-FPGASEADQMYKI 212
D+W+ G ++ EL T + +PG + + ++
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 74/298 (24%), Positives = 131/298 (43%), Gaps = 52/298 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--------LNH 59
+ +GRG++ +V + T A++ +K+ E + ++ ++ NH
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 60 SNIVKLKELIQNNNRLYLVFECMECN----LYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+V L Q +RL+ V E N ++ + R RK E + + ++ L+
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQ--RQRK-LPEEHARFYSAEISLALN 167
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLARE-IKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H+ G +RDLK +N+L+ S+G IK+ D+G+ +E ++ G + + G+ Y APEIL
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
E Y D WA+G +M E+ F +D + +
Sbjct: 228 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------------NTEDYLFQV 273
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQ-HPFFK 285
I + ++PR S S A S+ +S + DP +R T +Q HPFF+
Sbjct: 274 ILEKQIRIPR--------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 19/196 (9%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ +G+G FG V ++ G VA+K +K A+ + L E + +L HSN+V+L
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIKND-ATAQAFL--AEASVMTQLRHSNLVQLLG 253
Query: 68 LI-QNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+I + LY+V E M +L + +R R + + + V + + Y+ N F HR
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 126 DLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSK 180
DL N+LVS + K++DFGL +E + +W APE L + +S+K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWT-APEALREK-KFSTK 366
Query: 181 ADMWAMGAIMAELFTF 196
+D+W+ G ++ E+++F
Sbjct: 367 SDVWSFGILLWEIYSF 382
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
K+LG G FG V+ A + VA+K +K S E L E ++ L H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL--AEANVMKTLQHDKLVKLHA 250
Query: 68 LIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y++ E M +L + + + P++ + Q+ +G++++ Q + HRD
Sbjct: 251 VVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L+ N+LVS + KIADFGLAR I+ YT G+ +W APE + ++ K+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWT-APEAINFG-SFTIKS 366
Query: 182 DMWAMGAIMAELFTFCPL-FPGASEADQMYKI 212
D+W+ G ++ E+ T+ + +PG S + + +
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 8 KELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVK 64
KELG G FG V + + + + VA+K LK L E +++L++ IV+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 65 LKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+ + + LV E E L + + + + + I + QV G+ Y+ ++ F
Sbjct: 83 MIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPP-YTNYVGS----RWYRAPEILLQSELY 177
HRDL N+L+ +Q KI+DFGL++ +++ Y +WY APE + + +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYK-F 197
Query: 178 SSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
SSK+D+W+ G +M E F++ P + G ++ +
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAML 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 51/308 (16%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
K +G G G V G+ VAIK LK Y + L E + + +H NI++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L+ ++ +V E ME +L + D + + ++ L V G+ Y+ G+
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF-TIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSEL 176
HRDL N+LV S + K++DFGL+R ++ P Y + RW APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APEAIAFRT- 230
Query: 177 YSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+SS +D+W+ G +M E+ + P + + D + + +G R
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV------------EEGYRLPA-- 275
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRCFYAPPH 293
P L LM C D ++RP ++ + +P
Sbjct: 276 ----PMGCPHALHQLM------------LDCWHKDRAQRPRFSQ-IVS-VLDALIRSPES 317
Query: 294 IRSTPAVA 301
+R+T V+
Sbjct: 318 LRATATVS 325
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
KELG G FG V + VAIK +K+ S ++ + E K + L+H +V+L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFI--EEAKVMMNLSHEKLVQLYG 86
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
+ ++++ E M L + + ++ V + + Y+ F HRD
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L N LV+ QG++K++DFGL+R + YT+ VGS RW PE+L+ S+ +SSK+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWS-PPEVLMYSK-FSSKS 202
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
D+WA G +M E+++ P + + ++ I
Sbjct: 203 DIWAFGVLMWEIYSLGKMP-YERFTNSETAEHI 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 49/277 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGE-AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
KELG G FG V + G+ VA+K +K+ S ++ +E + + KL+H +VK
Sbjct: 14 KELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSEDEFF--QEAQTMMKLSHPKLVKFY 69
Query: 67 ELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ +Y+V E + L + + + L ++ + V +G++++ + F HR
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL-EPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 126 DLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSK 180
DL N LV +K++DFG+ R + Y + VG+ +W APE+ + YSSK
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWS-APEVFHYFK-YSSK 185
Query: 181 ADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
+D+WA G +M E+F+ P + + ++ + K+ + G R R
Sbjct: 186 SDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV------------SQGHRLYR------ 226
Query: 239 PQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
P L + +M C P KRPT
Sbjct: 227 PHLASDTIYQIM------------YSCWHELPEKRPT 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNI 62
++LG G+FG V + +VA+K LK S + ++ +REV + L+H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 63 VKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
++L + + +V E +L + + + QV +G+ Y+
Sbjct: 84 IRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGYLESKR 141
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPP-YTNYVGS----RWYRAPEILLQSE 175
F HRDL NLL+ ++ ++KI DFGL R + Y W APE L
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLKTRT 200
Query: 176 LYSSKADMWAMGAIMAELFTF 196
+S +D W G + E+FT+
Sbjct: 201 -FSHASDTWMFGVTLWEMFTY 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 47/276 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ LG G FG V+ + + VA+K LKQ S + L E +++L H +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL--AEANLMKQLQHQRLVRLYA 75
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y++ E ME +L + + ++ Q+ +G++++ + + HRD
Sbjct: 76 VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L+ N+LVS KIADFGLAR I+ YT G+ +W APE + ++ K+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWT-APEAINYG-TFTIKS 191
Query: 182 DMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
D+W+ G ++ E+ T P +PG + + + + G R R P
Sbjct: 192 DVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL------------ERGYRMVR------P 232
Query: 240 QLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
L LM LC P RPT
Sbjct: 233 DNCPEELYQLM------------RLCWKERPEDRPT 256
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIV 63
K LG G FG V + ++ T VA+K +K +S + L E C++ +H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 64 KL-----KELIQNNNRLYLVFECMEC-NLYQ-LMAARDR---KLFSEPEIKAWLFQVFQG 113
+L + Q + ++ M+ +L+ L+ +R K + ++ + G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 114 LSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS----RWYRAP 168
+ Y+ F HRDL N ++ + +ADFGL+++I SG Y + +W A
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-AI 218
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWAD 226
E L +Y+SK+D+WA G M E+ T P +PG + +
Sbjct: 219 ESLADR-VYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYL------------LH 264
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAE 277
G R + P+ L +M C DP RPT +
Sbjct: 265 GHRLKQ------PEDCLDELYEIM------------YSCWRTDPLDRPTFSV 298
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 56/293 (19%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIV 63
+ LG+G FG V +A ++ + VA+K LK + D LRE C+++ +H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 64 KL------KELIQNNNRLYLVFECMEC-NLYQ-LMAAR---DRKLFSEPEIKAWLFQVFQ 112
KL ++ M+ +L+ L+A+R + + ++ +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS----RWYRA 167
G+ Y+ F HRDL N ++++ + +ADFGL+R+I SG Y S +W A
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-A 207
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWA 225
E L + LY+ +D+WA G M E+ T P + G A+ +
Sbjct: 208 LESLADN-LYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYL------------I 253
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAE 277
G R + P + LM C S DP +RP+
Sbjct: 254 GGNRLKQ------PPECMEEVYDLM------------YQCWSADPKQRPSFTC 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+LG+G FG V+ T VAIK LK S E L +E + ++KL H +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLRHEKLVQLYA 329
Query: 68 LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRD 126
++ +Y+V E M +L + K P++ Q+ G++Y+ + + HRD
Sbjct: 330 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 127 LKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYSSKA 181
L+ N+LV + K+ADFGLAR I+ YT G+ +W APE L ++ K+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT-APEAALYG-RFTIKS 445
Query: 182 DMWAMGAIMAELFTFCPL-FPGASEADQMYKI 212
D+W+ G ++ EL T + +PG + + ++
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 68/315 (21%), Positives = 119/315 (37%), Gaps = 50/315 (15%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K LG GAFG V++ E VAIKEL++ + + L E + +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L I + + L+ + M L + + + W Q+ +G++Y+
Sbjct: 81 RL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
HRDL N+LV + +KI DFGLA+ + + + G +W A E +L +Y
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHR-IY 196
Query: 178 SSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
+ ++D+W+ G + EL TF P + G ++ + G R +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL------------EKGERLPQ--- 240
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEALQHPFFKRCFYAPPHI 294
P + ++ +M C D RP E L F + P
Sbjct: 241 ---PPICTIDVYMIMVK------------CWMIDADSRPKFRE-LII-EFSKMARDPQRY 283
Query: 295 RSTPAVATTTANQPA 309
P
Sbjct: 284 LVIQGDERMHLPSPT 298
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 44/287 (15%), Positives = 101/287 (35%), Gaps = 58/287 (20%)
Query: 8 KELGRGAFGRVFQAFDEHTGEA-------VAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+ LG+G F ++F+ G+ V +K L + + ++ + + KL+H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-FEAASMMSKLSHK 72
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
++V + + LV E ++ +L + + + Q+ + ++ +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCI-NILWKLEVAKQLAAAMHFLEE 131
Query: 120 NGFFHRDLKPENLLVSQ---------GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
N H ++ +N+L+ + IK++D G++ + + W PE
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPEC 188
Query: 171 LLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
+ + + D W+ G + E+ + P ++ D
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY------------EDR- 234
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPT 274
+Q P A L+ L+ + C ++P RP+
Sbjct: 235 -------HQLPAPKAAELANLI------------NNCMDYEPDHRPS 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K LG G FG V + E V IK ++ + + + L+H++IV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L + + L LV + + +L + L + W Q+ +G+ Y+ ++G
Sbjct: 79 RL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGAL-GPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
HR+L N+L+ S +++ADFG+A + Y + +W A E + + Y
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIHFGK-Y 194
Query: 178 SSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
+ ++D+W+ G + EL TF P + G A+ +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLL 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 9 ELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLK 66
ELG G FG V Q + VAIK LKQ + +RE + + +L++ IV+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 67 ELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ Q L LV E L++ + + ++ + L QV G+ Y+ + F HR
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 126 DLKPENLLV-SQGIIKIADFGLAREIKSGPP-YTNYVGS----RWYRAPEILLQSELYSS 179
DL N+L+ ++ KI+DFGL++ + + YT +WY APE + + +SS
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRK-FSS 192
Query: 180 KADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
++D+W+ G M E ++ P + + M I
Sbjct: 193 RSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
K +G G FG V + + +VAIK LK Y + L E + + +H NI++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L+ ++ + + +V E ME +L + D + + ++ L + G+ Y+ G+
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-TVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSEL 176
HRDL N+L+ S + K++DFGL R ++ P Y RW +PE + +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWT-SPEAIAYRK- 226
Query: 177 YSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
++S +D+W+ G ++ E+ ++ P + S D + +
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 71/311 (22%), Positives = 115/311 (36%), Gaps = 56/311 (18%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQR-YASWEDCLNLREVKCLRKLNHSNIVKL- 65
+ +GRG +G V++ VA+K ++ +N + + + + H NI +
Sbjct: 19 ELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNF---INEKNIYRVPLMEHDNIARFI 73
Query: 66 ----KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+ LV E +L + + V +GL+Y+H
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 121 GFF---------HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY---------TNYVG 161
HRDL N+LV + G I+DFGL+ + + VG
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 162 SRWYRAPEIL------LQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEAD-QMYKIC 213
+ Y APE+L E + DM+A+G I E+F C LFPG S + QM
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250
Query: 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCS--W--DP 269
V PT + ++ + + Q P+ P A + A+ + W D
Sbjct: 251 EVGNHPTFED----MQVLVSREKQRPKFPEAWKE------NSLAVRSLKETIEDCWDQDA 300
Query: 270 SKRPTAAEALQ 280
R TA A +
Sbjct: 301 EARLTAQXAEE 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 8 KELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K +G G FG V++ VAIK LK Y + L E + + +H NI+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 64 KLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+L+ +I + ++ E ME L + + +D + S ++ L + G+ Y+ +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEF-SVLQLVGMLRGIAAGMKYLANMNY 168
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSE 175
HRDL N+LV S + K++DFGL+R ++ P Y S RW APE + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWT-APEAISYRK 226
Query: 176 LYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
++S +D+W+ G +M E+ T+ P + S + M I
Sbjct: 227 -FTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ +GRG FG V+ ++ A+K L + E L E ++ +H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 65 LKELI-QNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
L + ++ +V M+ +L + + ++ + QV +G+ Y+ F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKF 149
Query: 123 FHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSE 175
HRDL N ++ + +K+ADFGLAR++ Y+ + + +W A E L
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQ- 207
Query: 176 LYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
+++K+D+W+ G ++ EL T P +P + D +
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 8 KELGRGAFGRVFQAFDEHTGEA---VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ +G+G FG V+ + AIK L + + LRE +R LNH N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 65 LKEL-IQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
L + + +++ M +L Q + + R + ++ ++ QV +G+ Y+ + F
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYLAEQKF 145
Query: 123 FHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSE 175
HRDL N ++ + +K+ADFGLAR+I Y+ +W A E L
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQTY- 203
Query: 176 LYSSKADMWAMGAIMAELFTF 196
+++K+D+W+ G ++ EL T
Sbjct: 204 RFTTKSDVWSFGVLLWELLTR 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 66/314 (21%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+ELG GAFG+VF A VA+K LK + + RE + L L H +
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEH 78
Query: 62 IVKLKELIQNNNRLYLVFECME---------------CNLYQLMAARDRKLFSEPEIKAW 106
IVK + + + L +VFE M+ L + + ++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS--- 162
Q+ G+ Y+ F HRDL N LV ++KI DFG++R++ S Y +
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 163 -RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKICGVLGSP 219
RW PE ++ +++++D+W+ G I+ E+FT+ P + S + + I
Sbjct: 199 IRWM-PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP-WFQLSNTEVIECI------- 248
Query: 220 TMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEA 278
G R P++ + +M C +P +R E
Sbjct: 249 -----TQGRVLER------PRVCPKEVYDVM------------LGCWQREPQQRLNIKEI 285
Query: 279 LQHPFFKRCFYAPP 292
+ A P
Sbjct: 286 --YKILHALGKATP 297
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 8 KELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65
ELG G FG V Q + VAIK LKQ + +RE + + +L++ IV+L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 66 KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ Q L LV E L++ + + ++ + L QV G+ Y+ + F H
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 125 RDLKPENLLV-SQGIIKIADFGLAREIKSGPP-YTNYVGS----RWYRAPEILLQSELYS 178
R+L N+L+ ++ KI+DFGL++ + + YT +WY APE + + +S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRK-FS 517
Query: 179 SKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
S++D+W+ G M E ++ P + + M I
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 17/216 (7%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ +G G FG V Q AVAIK K + L+E +R+ +H +IVK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L +I N ++++ E L + R L + + +Q+ L+Y+ F
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLSTALAYLESKRFV 138
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELYS 178
HRD+ N+LV S +K+ DFGL+R ++ Y +W APE + ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWM-APESINFRR-FT 195
Query: 179 SKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
S +D+W G M E+ P F G D + +I
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+ELG+G+FG V++ + VAIK + + AS + + L E +++ N +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHH 89
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAAR-------DRKLFSEPEIKAWLFQVFQ 112
+V+L ++ ++ E M +L L + R S ++ ++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS----RWYRA 167
G++Y++ N F HRDL N +V++ +KI DFG+ R+I Y RW +
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-S 208
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGAS 204
PE L ++++ +D+W+ G ++ E+ T P + G S
Sbjct: 209 PESLKDG-VFTTYSDVWSFGVVLWEIATLAEQP-YQGLS 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL 65
+LG G V+ A D VAIK + E+ L REV +L+H NIV +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 66 KELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
++ + ++ YLV E +E L + + S + Q+ G+ + H H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 125 RDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-YTNYV-GSRWYRAPEILLQSELYSSKA 181
RD+KP+N+L+ +KI DFG+A+ + TN+V G+ Y +PE + E
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEATDECT 193
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
D++++G ++ E+ P F G + K I+ P +
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNGETAVSIAIK---------------------HIQDSVPNV 232
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279
+ + Q ++ D + R + +
Sbjct: 233 T----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ +GRG FG V+ ++ A+K L + E L E ++ +H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 65 LKELI-QNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
L + ++ +V M+ +L + + ++ + QV +G+ ++ F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKF 213
Query: 123 FHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS------RWYRAPEILLQSE 175
HRDL N ++ + +K+ADFGLAR++ + + + +W A E L
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQ- 271
Query: 176 LYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
+++K+D+W+ G ++ EL T P +P + D +
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 309
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-31
Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 8 KELGRGAFGRVFQAF---DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ LG G FG V++ + VA+K K+ + E ++ L+H +IVK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 65 LKELIQNNNRLYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
L +I+ +++ E + L ++ + + Q+ + ++Y+
Sbjct: 78 LIGIIEEE-PTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESINC 134
Query: 123 FHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS----RWYRAPEILLQSELY 177
HRD+ N+LV S +K+ DFGL+R I+ Y + +W +PE + +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWM-SPESINFRR-F 191
Query: 178 SSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKI 212
++ +D+W M E+ +F P F D + +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVL 227
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 81/313 (25%), Positives = 123/313 (39%), Gaps = 65/313 (20%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
ELG GAFG+VF A E VA+K LK+ AS + RE + L L H +
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQH 104
Query: 62 IVKLKELIQNNNRLYLVFECME--------------CNLYQLMAARDRKLFSEPEIKAWL 107
IV+ + L +VFE M L ++ A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS---- 162
QV G+ Y+ F HRDL N LV QG ++KI DFG++R+I S Y +
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKICGVLGSPT 220
RW PE +L +++++D+W+ G ++ E+FT+ P + S + + I
Sbjct: 225 RWM-PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP-WYQLSNTEAIDCI-------- 273
Query: 221 MDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTAAEAL 279
G R P+ + A+M C +P +R + +
Sbjct: 274 ----TQGRELER------PRACPPEVYAIMRG------------CWQREPQQRHSIKDV- 310
Query: 280 QHPFFKRCFYAPP 292
H + APP
Sbjct: 311 -HARLQALAQAPP 322
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+ELG FG+V++ +AVAIK LK + A E +L H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPN 73
Query: 62 IVKLKELIQNNNRLYLVFECME---------------CNLYQLMAARDRKLFSEPEIKAW 106
+V L ++ + L ++F + P+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 107 LFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS--- 162
+ Q+ G+ Y+ + H+DL N+LV +KI+D GL RE+ + Y S
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 163 -RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC 197
RW APE ++ +S +D+W+ G ++ E+F++
Sbjct: 194 IRWM-APEAIMYG-KFSIDSDIWSYGVVLWEVFSYG 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 8 KELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK 64
+ +G G FG V Q AVAIK K + L+E +R+ +H +IVK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 65 LKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L +I N ++++ E L + R L + + +Q+ L+Y+ F
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSL-DLASLILYAYQLSTALAYLESKRFV 513
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGS---RWYRAPEILLQSELYSS 179
HRD+ N+LV S +K+ DFGL+R ++ Y G +W APE + ++S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APES-INFRRFTS 571
Query: 180 KADMWAMGAIMAELFTF 196
+D+W G M E+
Sbjct: 572 ASDVWMFGVCMWEILMH 588
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+ LG GAFG V++ ++ + VA+K L + S +D L+ L E + K NH N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQN 94
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAAR----DRKLFSEPEIKAWLFQVFQGLS 115
IV+ + + +++ E M +L L R + ++ + G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 116 YMHQNGFFHRDLKPENLLVSQG----IIKIADFGLAREIKSGPPYTNYVGS----RWYRA 167
Y+ +N F HRD+ N L++ + KI DFG+AR+I Y + +W
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM-P 213
Query: 168 PEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKI 212
PE ++ +++SK D W+ G ++ E+F+ P +P S + + +
Sbjct: 214 PEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFV 258
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 38/236 (16%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-NHS 60
K LGRGAFG+V +A T VA+K LK+ A+ + + E+K L + +H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHIGHHL 91
Query: 61 NIVKLKEL---IQNNNRLYLVFECMEC-NLYQ-LMAAR-------------DRKLFSEPE 102
N+V L L + L ++ E + NL L + R + +
Sbjct: 92 NVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 103 IKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVG 161
+ + FQV +G+ ++ HRDL N+L+S+ ++KI DFGLAR+I P Y
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 162 S----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYK 211
+ +W APE + +Y+ ++D+W+ G ++ E+F+ P +PG ++ +
Sbjct: 210 ARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+ LG GAFG V++ ++ + VA+K L + S +D L+ L E + K NH N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQN 135
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAAR----DRKLFSEPEIKAWLFQVFQGLS 115
IV+ + + +++ E M +L L R + ++ + G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 116 YMHQNGFFHRDLKPENLLVSQG----IIKIADFGLAREIKSGPPYTNYVGS------RWY 165
Y+ +N F HRD+ N L++ + KI DFG+AR+I Y G +W
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVKWM 253
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFC--PLFPGASEADQMYKI 212
PE ++ +++SK D W+ G ++ E+F+ P +P S + + +
Sbjct: 254 -PPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEVLEFV 299
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
+++G GAFGRVFQA VA+K LK+ AS + + RE + + ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPN 111
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAARDRKLFSEPEIKAWL------------ 107
IVKL + + L+FE M +L + L + + S
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 108 ---------FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT 157
QV G++Y+ + F HRDL N LV + ++KIADFGL+R I S Y
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 158 NYVGS----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC 197
RW PE + + Y++++D+WA G ++ E+F++
Sbjct: 232 ADGNDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIFSYG 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSN 61
K LG G FG+V +A VA+K LK+ AS + + L E L+++NH +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASPSELRDLLSEFNVLKQVNHPH 87
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAARDRKLFSEPEIKAWL------------ 107
++KL + L L+ E + +L L +R +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 108 ---------FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT 157
+Q+ QG+ Y+ + HRDL N+LV++G +KI+DFGL+R++ Y
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 158 NYVGS----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+W A E L +Y++++D+W+ G ++ E+ T
Sbjct: 208 KRSQGRIPVKWM-AIESLFDH-IYTTQSDVWSFGVLLWEIVTL 248
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 35/235 (14%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-NHS 60
K LG GAFG+V +A VA+K LK A + + E+K L L NH
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLSYLGNHM 87
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NL----------------YQLMAARDRKLFSEPEI 103
NIV L ++ E +L + D ++
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 104 KAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS 162
++ +QV +G++++ HRDL N+L++ G I KI DFGLAR+IK+ Y +
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 163 ----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYK 211
+W APE + +Y+ ++D+W+ G + ELF+ P +PG + YK
Sbjct: 208 RLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYK 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 41/316 (12%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL-- 65
LG G V A D VA+K L+ A RE + LNH IV +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 66 --KELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGF 122
+ Y+V E ++ L ++ + + Q L++ HQNG
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGI 137
Query: 123 FHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YTNYV-GSRWYRAPEILLQSELY 177
HRD+KP N+++S +K+ DFG+AR I T V G+ Y +PE + +
Sbjct: 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSV 196
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+++D++++G ++ E+ T P F G S ++ YQ
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTGDS--------------------------PVSVAYQ 230
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRST 297
+ SA S D ++ + +P R A ++ + PP
Sbjct: 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290
Query: 298 PAVATTTANQPAAATR 313
A T+ +AA
Sbjct: 291 LTDAERTSLLSSAAGN 306
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLKE 67
+GRG G V++A D VA+K + + +S RE + +L ++V + +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 68 LIQNNNRLYLVFECME----CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+ + +LY+ M +L ++ + + P A + Q+ L H G
Sbjct: 102 FGEIDGQLYVD---MRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGAT 156
Query: 124 HRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT---NYVGSRWYRAPEILLQSELYSS 179
HRD+KPEN+LVS + DFG+A + T N VG+ +Y APE +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPE-RFSESHATY 214
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYK 211
+AD++A+ ++ E T P + G + M
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLS-VMGA 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLN-LREVKCLRKL-NHS 60
K LG GAFG+V +A G+ VA+K LK A ++ + E+K + L H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELKIMSHLGQHE 110
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NL------------YQLMAARDRKLFSEPEIKAWL 107
NIV L + + ++ E +L A S ++ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS---- 162
QV QG++++ HRD+ N+L++ G + KI DFGLAR+I + Y +
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYK 211
+W APE + +Y+ ++D+W+ G ++ E+F+ P +PG + YK
Sbjct: 231 KWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYK 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 10 LGRGAFGRVFQAFDEH-TGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKL- 65
+ G G ++ A D + G V +K L ++ + + E + L ++ H +IV++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 66 ----KELIQNNNRLYLVFECME----CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+ Y+V ME +L + + E A+L ++ LSY+
Sbjct: 146 NFVEHTDRHGDPVGYIV---MEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 118 HQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPPYTNYV-GSRWYRAPEILLQSEL 176
H G + DLKPEN+++++ +K+ D G I S Y+ G+ ++APEI+
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS----FGYLYGTPGFQAPEIVRTGP- 253
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEAD 207
+ D++ +G +A L P G
Sbjct: 254 -TVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 8 KELGRGAFGRVFQA-------FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-N 58
K LG GAFG+V A VA+K LK A+ +D + + E++ ++ +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK 99
Query: 59 HSNIVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAAR-------------DRKLFSEPEI 103
H NI+ L + LY++ E NL + L A R + + ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 104 KAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS 162
+ +Q+ +G+ Y+ HRDL N+LV++ ++KIADFGLAR+I + Y
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 163 ----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+W APE L +Y+ ++D+W+ G +M E+FT
Sbjct: 220 RLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 66/302 (21%)
Query: 8 KELGRGAFGRVFQA-------FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-N 58
K LG G FG+V A VA+K LK A+ +D + + E++ ++ +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK 145
Query: 59 HSNIVKLKELIQNNNRLYLVFECMEC-NLYQ-LMAAR-------------DRKLFSEPEI 103
H NI+ L + LY++ E NL + L A R + + ++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 104 KAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS 162
+ +Q+ +G+ Y+ HRDL N+LV++ ++KIADFGLAR+I + Y
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 163 ----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYKICGVL 216
+W APE L +Y+ ++D+W+ G +M E+FT P +PG + +
Sbjct: 266 RLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL---- 318
Query: 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLC-SWDPSKRPTA 275
+G R + P L +M C PS+RPT
Sbjct: 319 --------KEGHRMDK------PANCTNELYMMM------------RDCWHAVPSQRPTF 352
Query: 276 AE 277
+
Sbjct: 353 KQ 354
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 8 KELGRGAFGRVFQA-------FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-N 58
K LG GAFG+V A + VA+K LK A+ +D + + E++ ++ +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGK 133
Query: 59 HSNIVKLKELIQNNNRLYLVFECME---------------CNLYQLMAARDRKLFSEPEI 103
H NI+ L + LY++ E + + S ++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 104 KAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS 162
+ +QV +G+ Y+ HRDL N+LV++ ++KIADFGLAR+I Y
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 163 ----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
+W APE L +Y+ ++D+W+ G ++ E+FT
Sbjct: 254 RLPVKWM-APEALFDR-IYTHQSDVWSFGVLLWEIFTL 289
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 40/240 (16%)
Query: 8 KELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-NHS 60
K LG GAFG+V A VA+K LK+ A + + E+K + +L +H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHE 109
Query: 61 NIVKLKELIQNNNRLYLVFECMEC----------------------NLYQLMAARDRKLF 98
NIV L + +YL+FE N +L D +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 99 SEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYT 157
+ ++ + +QV +G+ ++ HRDL N+LV+ G ++KI DFGLAR+I S Y
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 158 NYVGS----RWYRAPEILLQSELYSSKADMWAMGAIMAELFTF--CPLFPGASEADQMYK 211
+ +W APE L + +Y+ K+D+W+ G ++ E+F+ P +PG YK
Sbjct: 230 VRGNARLPVKWM-APESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFYK 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASWEDCLN-LREVKCLRKL-NHSNIV 63
+G G FG+V +A + G AIK +K+ YAS +D + E++ L KL +H NI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 64 KLKELIQNNNRLYLVFECME---------------CNLYQLMAARDRKLFSEPEIKAWLF 108
L ++ LYL E + +A S ++ +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 109 QVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPYTNYVGS----R 163
V +G+ Y+ Q F HRDL N+LV + + KIADFGL+R + Y R
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVR 206
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
W A E L S +Y++ +D+W+ G ++ E+ +
Sbjct: 207 WM-AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 36/311 (11%), Positives = 77/311 (24%), Gaps = 68/311 (21%)
Query: 9 ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNHSNIVKLK 66
G + +QA D VA+ + + +D L L L +++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 67 ELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+++ +V E + +L ++ S + + H+ G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALS 153
Query: 126 DLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMW 184
P + VS G + +A + + D+
Sbjct: 154 IDHPSRVRVSIDGDVVLAYPA-------------------TMPDA--------NPQDDIR 186
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
+GA + L P A + A +
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGL-----------------------APAERDTAGQPI 223
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAA--EALQHPFFKRCFYAPPHIRSTPAVAT 302
+ + ++ D R + +Q A T +
Sbjct: 224 EPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ--------ATAVADRTEVLGP 275
Query: 303 TTANQPAAATR 313
+AA R
Sbjct: 276 IDEAPVSAAPR 286
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS- 60
++Y +++G G+FG ++ D GE VAIK + + E K + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGV 65
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL---FQVFQGLSYM 117
I ++ + +V E + +L L RK FS +K L Q+ + Y+
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FS---LKTVLLLADQMISRIEYI 121
Query: 118 HQNGFFHRDLKPENLLVSQG----IIKIADFGLAREIKSGP-----PYT---NYVGSRWY 165
H F HRD+KP+N L+ G ++ I DFGLA++ + PY N G+ Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 166 RAPEILLQSELYSSKADMWAMG 187
+ L E S + D+ ++G
Sbjct: 182 ASINTHLGIEQ-SRRDDLESLG 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 26/212 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHS 60
Y + +G G+FG +F+ + + VAIK +R + E + + L +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 66
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL---FQVFQGLSYM 117
I + Q LV + + +L L+ RK FS +K Q+ + +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FS---VKTVAMAAKQMLARVQSI 122
Query: 118 HQNGFFHRDLKPENLLVSQG------IIKIADFGLAREIKSGP-----PYT---NYVGSR 163
H+ +RD+KP+N L+ + +I + DFG+ + + PY N G+
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFT 195
Y + L E S + D+ A+G +
Sbjct: 183 RYMSINTHLGREQ-SRRDDLEALGHVFMYFLR 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSN 61
+ K++G G FG + + +T E VAIK + E + ++L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDG 66
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL---FQVFQGLSYMH 118
I ++ +V E + +L L DR FS +K L Q+ + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-FS---LKTVLMIAIQLISRMEYVH 122
Query: 119 QNGFFHRDLKPENLLVSQG------IIKIADFGLARE 149
+RD+KPEN L+ + +I I DF LA+E
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 86.1 bits (212), Expect = 8e-19
Identities = 44/271 (16%), Positives = 82/271 (30%), Gaps = 63/271 (23%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAI-----KELKQRYASWEDCLNLREVKCLRK 56
+K +++G G FG VFQ +HT A+ I +L L E+ ++
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 57 L---------NHSNIVKLKEL------------------------------IQNNNRLYL 77
L + L + +++L++
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLV-S 135
V E + + KL S K+ L Q+ L+ + F HRDL N+L+
Sbjct: 140 VLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 136 QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT 195
+ K+ + P V Y + + ++
Sbjct: 198 TSLKKLHYTLNGKSSTI-PSCGLQVSIIDYTLSRL------------ERDGIVVFCDVSM 244
Query: 196 FCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
LF G + D + I ++ + W +
Sbjct: 245 DEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS- 60
+K+ +++G G+FG ++ + T E VAIK + + L E K R L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGT 63
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I ++ + LV + + +L L RK S + Q+ + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSK 122
Query: 121 GFFHRDLKPENLLVSQG----IIKIADFGLARE 149
F HRD+KP+N L+ G + I DFGLA++
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 21/163 (12%)
Query: 8 KELGRGAFGRVFQAFDEHTG--------EAVAIK-ELKQRYASWEDCLNLREVKCLRKLN 58
R G +++A T + ++K + K E R K L+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 59 HSNIVKLKEL---------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQ 109
+ L + + +LV + +L + + + SE + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLVSQG---IIKIADFGLARE 149
+ L ++H+N + H ++ EN+ V + +A +G A
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 40/201 (19%)
Query: 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG-IIK 140
+ + + + + + FQV +G+ ++ HRDL N+L+S+ ++K
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 141 IADFGLAREIKSGPPYTNYVGSR----WYRAPEILLQSELYSSKADMWAMGAIMAELFTF 196
I DFGLAR+I P Y +R W APE + +Y+ ++D+W+ G ++ E+F+
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWEIFSL 291
Query: 197 --CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSAS 254
P +PG ++ + +G R P + M
Sbjct: 292 GASP-YPGVKIDEEFCRR-----------LKEGTRMRA------PDYTTPEMYQTM---- 329
Query: 255 QDAISLFESLC-SWDPSKRPT 274
C +PS+RPT
Sbjct: 330 --------LDCWHGEPSQRPT 342
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 35/138 (25%), Positives = 54/138 (39%), Gaps = 16/138 (11%)
Query: 8 KELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSN 61
K LGRGAFG+V +A T VA+K LK+ E + E+K L + +H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 62 IVKLKEL-IQNNNRLYLVFECMEC-NLYQ-LMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+V L + L ++ E + NL L + R E + + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-------NEFVPYKTKGARFRQGKD 140
Query: 119 QNGFFHRDLKPENLLVSQ 136
G DLK ++
Sbjct: 141 YVGAIPVDLKRRLDSITS 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 34/167 (20%), Positives = 67/167 (40%), Gaps = 32/167 (19%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN---LREVKCLRKLNHSNIVK 64
K++G G FG ++ AF + E A +K Y N E+K +++ + +K
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-----NGPLFSELKFYQRVAKKDCIK 97
Query: 65 LKELIQNNNRL-------------------YLVFECMECNLYQLMAARDRKLFSEPEIKA 105
+ + L ++V E + +L ++ F + +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKIS--GQNGTFKKSTVLQ 155
Query: 106 WLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG---IIKIADFGLARE 149
++ L Y+H+N + H D+K NLL+ + +AD+GL+
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 49/218 (22%)
Query: 6 GFKE---LGRGAFGRVFQAFDEHTGEAVAIKELK----QRYASWEDCLNLREVKCLRKLN 58
F +G G FG+V++ G VA+K Q + E++ L
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEF-----ETEIETLSFCR 93
Query: 59 HSNIVKL----KELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWL------ 107
H ++V L E N + L+++ ME NL R L+ +
Sbjct: 94 HPHLVSLIGFCDE---RNEMI-LIYKYMENGNL-------KRHLYGSDLPTMSMSWEQRL 142
Query: 108 ---FQVFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPY------T 157
+GL Y+H HRD+K N LL + KI DFG++ K G T
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLST 199
Query: 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT 195
G+ Y PE ++ L + K+D+++ G ++ E+
Sbjct: 200 VVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLC 236
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 59/218 (27%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--------WEDCLNLREVKCLRKLNHSN 61
+G G FG V++ + VA+K+L + +E+K + K H N
Sbjct: 39 MGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQF-----DQEIKVMAKCQHEN 91
Query: 62 IVKLKEL---IQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKA--W------LFQ 109
+V+L L ++ LV+ M L +L W
Sbjct: 92 LVEL--LGFSSDGDDLC-LVYVYMPNGSL-------LDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 110 VFQGLSYMHQNGFFHRDLKPEN-LLVSQGIIKIADFGLAREIKSGPPY------TNYVGS 162
G++++H+N HRD+K N LL KI+DFGLA ++ + + VG+
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA---RASEKFAQTVMTSRIVGT 198
Query: 163 RWYRAPEILLQSELY-----SSKADMWAMGAIMAELFT 195
Y APE + K+D+++ G ++ E+ T
Sbjct: 199 TAYMAPE-------ALRGEITPKSDIYSFGVVLLEIIT 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 28/172 (16%), Positives = 61/172 (35%), Gaps = 39/172 (22%)
Query: 8 KELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
+G+G FG ++ A + +K E+K ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-----FTELKFYQRAAKPEQ 95
Query: 63 VKLKELIQNNNRL-------------------YLVFECMECNLYQLMAARDRKLFSEPEI 103
++ + L +++ + +L ++ A ++ FS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR-FS---R 151
Query: 104 KAWL---FQVFQGLSYMHQNGFFHRDLKPENLLVSQG---IIKIADFGLARE 149
K L ++ L Y+H++ + H D+K NLL++ + + D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL- 68
LGRG FG+V++ G VA+K LK+ + EV+ + H N+++L+
Sbjct: 38 LGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 69 IQNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWL-----FQVFQG----LSYMH 118
+ RL LV+ M + L PE + L ++ G L+Y+H
Sbjct: 97 MTPTERL-LVYPYMANGSV-------ASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 119 QNG---FFHRDLKPENLLVSQGII-KIADFGLAREIKSGPPYTNYV-----GSRWYRAPE 169
+ HRD+K N+L+ + + DFGLA K +V G+ + APE
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTAVRGTIGHIAPE 205
Query: 170 ILLQSELYSSKADMWAMGAIMAELFT 195
L + S K D++ G ++ EL T
Sbjct: 206 YLSTGKS-SEKTDVFGYGVMLLELIT 230
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 29/144 (20%), Positives = 50/144 (34%), Gaps = 8/144 (5%)
Query: 10 LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI 69
+G G VF + E +K K + S++ R+ L + E
Sbjct: 98 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE-F 155
Query: 70 QNNNRLY--LVFECMECNLYQL-MAARDRKLFSEPEI---KAWLFQVFQGLSYMHQNGFF 123
+ +L V + + M D K + L + + ++ + G
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 215
Query: 124 HRDLKPENLLVSQGIIKIADFGLA 147
H DL N+LVS+ I I DF +
Sbjct: 216 HGDLSQYNVLVSEEGIWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.57 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.5 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.47 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=488.96 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=206.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||+||+|+++.+|+.||||++++...... .....+|+++|++|+|||||+++++|++++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999976543322 23456899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||++|++++.+..+ +.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.........
T Consensus 92 mEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 92 IEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 999998888887654 4599999999999999999999999999999999999996 5899999999998877666667
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+.+||+.|||||++.+..+++.++|||||||++|+|++|++||.+.+..+.+..|... .+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-------------------~~~ 230 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-------------------VYT 230 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------CCC
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------------CCC
Confidence 7899999999999987765678999999999999999999999998887777766421 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
++..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 231 -----------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 -----------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 22457999999999999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-66 Score=494.83 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=223.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ........+|+++|++|+|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999976432 122334568999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---C
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG---P 154 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~---~ 154 (417)
||++|+ |.+.+... +.++|.+++.|+.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.+... .
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999875 55555443 4599999999999999999999999999999999999996 589999999999877532 3
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...+.|||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|...
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------------- 249 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------------- 249 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------
T ss_pred cccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 356789999999999997655 899999999999999999999999999988888887532
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHH------HHcCccccccccCCCC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE------ALQHPFFKRCFYAPPH 293 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~~~~~~~ 293 (417)
.+.+ +..+|+++++||.+||+.||++|||++| +++||||++..|....
T Consensus 250 ~~~~-----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 250 EYDF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp CCCC-----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred CCCC-----------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 2222 2357999999999999999999999987 5899999988775543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-66 Score=502.83 Aligned_cols=256 Identities=31% Similarity=0.564 Sum_probs=218.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
||+|+++++||+|+||+||+|+++.+|+.||||++++..... ......+|+++|++|+|||||+++++|++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999998654433 3345578999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CC
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PY 156 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~ 156 (417)
|||+|+ |.+.+..+....++|.+++.|+.||+.||+|||++||+||||||+||||+ +|.+||+|||+|+.+.... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999865 66666655556789999999999999999999999999999999999996 5899999999998765432 23
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
++.+||+.|||||++.+.. |+.++|||||||+||||++|.+||.+.+..+.+.+|...
T Consensus 183 ~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------------------- 240 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--------------------- 240 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------------------
T ss_pred cccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------------------
Confidence 4578999999999997654 899999999999999999999999999998888877532
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.++ .....+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 241 ~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 SFP--------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCC--------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 111 223568999999999999999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=496.39 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=221.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ......+|+++|++|+|||||+++++|++++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999999765433 234557899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
|+|+.+..+..+. .+++.+++.|+.||+.||+|||++||+||||||+||||+ +|.+||+|||+|+.+... ...++.
T Consensus 153 ~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9987666666553 499999999999999999999999999999999999996 589999999999877543 446678
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|..... +.
T Consensus 231 ~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~------------------- 289 (346)
T 4fih_A 231 VGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR------------------- 289 (346)
T ss_dssp CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-------------------
T ss_pred ccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC-------------------
Confidence 9999999999986554 89999999999999999999999999998888877653210 00
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+..+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 290 -------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 290 -------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 01123579999999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-65 Score=504.63 Aligned_cols=284 Identities=35% Similarity=0.620 Sum_probs=245.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe------CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN------NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 74 (417)
|+|+++++||+|+||+||+|+++.+|+.||||++++...... ....++|+++|+.|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999976544433 3345689999999999999999998764 367
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS- 152 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~- 152 (417)
+|||||||+|+|.+.+... +.+++.+++.|++||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9999999999888777543 5699999999999999999999999999999999999996 58999999999987643
Q ss_pred ----CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 153 ----GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 153 ----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
.....+.+||++|||||++.+...|+.++||||+|||+|||++|.+||.+.+..+++..|+...|.+....|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 2345678999999999999887778999999999999999999999999999999999999999999988776532
Q ss_pred H-HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 R-QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ........++......+..+++.+|++++|||.+||.+||++|||++|+|+||||++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 2 2223334566666677778889999999999999999999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-64 Score=498.80 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=222.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999999765333 234457999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
|+|+.+..+.... .+++.+++.|+.||+.||+|||++||+||||||+||||+ +|.+||+|||+|+.+... ....+.
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9987666666543 499999999999999999999999999999999999996 589999999999877543 456678
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+||++|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|..... +
T Consensus 308 ~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------------~ 365 (423)
T 4fie_A 308 VGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------------P 365 (423)
T ss_dssp EECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------------C
T ss_pred ccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------------------C
Confidence 9999999999986655 89999999999999999999999999998888877753210 0
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....+..+|+++++||.+||..||++|||++|+|+||||++.
T Consensus 366 ------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 366 ------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 011235689999999999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-64 Score=478.65 Aligned_cols=255 Identities=30% Similarity=0.479 Sum_probs=212.4
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||+||+|++. .+++.||||++++..... ......+|+++|++|+|||||+++++|++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 468899999997653322 22344689999999999999999999999999999
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GP 154 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~ 154 (417)
||||++|+ |.+.+... +.+++.+++.|+.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.... ..
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999876 55555443 4599999999999999999999999999999999999996 58999999999986543 34
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...+.+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------------- 241 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------------------- 241 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------
T ss_pred cccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-------------------
Confidence 456789999999999997655 899999999999999999999999999998888877531
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
... ++..+|+++++||.+||+.||++||| ++|+++||||+...|
T Consensus 242 ~~~-----------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 242 KLG-----------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCC-----------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 111 22457999999999999999999998 589999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-62 Score=465.50 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=208.3
Q ss_pred Cc-eecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe----CCEEE
Q 044608 3 KY-SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN----NNRLY 76 (417)
Q Consensus 3 ~Y-~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 76 (417)
+| ++.++||+|+||+||+|+++.++..||+|++........ ...+.+|+++|++|+|||||+++++|++ ++.+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 45 677889999999999999999999999999976544333 3445689999999999999999999975 35689
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeee--CCcEEEeeccccccccC
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVS--QGIIKIADFGLAREIKS 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~ 152 (417)
||||||+|+.+..+..+. ..+++..++.|+.||+.||+|||++| |+||||||+||||+ +|.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 999999876555544443 45899999999999999999999999 99999999999996 4799999999998543
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+.+||+.|||||++.+ . |+.++|||||||++|||++|.+||.+.+....+...... +
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~--------------- 245 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G--------------- 245 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T---------------
T ss_pred CCccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C---------------
Confidence 334567799999999998854 4 899999999999999999999999876655544433210 0
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ....+....++++++||.+||+.||++|||++|+|+||||++
T Consensus 246 -----~------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 -----V------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----C------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----C------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0 001122457899999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=474.24 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=211.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.|+|||||+++++|++++.+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 568899999999999999999999999999999976432 24799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC-cEEEeeccccccccCCCC----
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG-IIKIADFGLAREIKSGPP---- 155 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~-~vkL~DFg~a~~~~~~~~---- 155 (417)
++|+.+..+..+. +.+++.+++.|+.||+.||+|||++||+||||||+||||+ +| ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9876444444433 4599999999999999999999999999999999999996 45 699999999987654321
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
....+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|...
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------------ 271 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------------------ 271 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------------------
T ss_pred ecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------------------
Confidence 23468999999999997655 899999999999999999999999988776666665421
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH-------------HcCccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA-------------LQHPFFKR 286 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el-------------L~hp~f~~ 286 (417)
...+..+++.+|+++.+||.+||+.||.+|||+.|+ |+|||+++
T Consensus 272 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 272 ---------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ---------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ---------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 112234567889999999999999999999999998 57999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-62 Score=476.05 Aligned_cols=279 Identities=25% Similarity=0.416 Sum_probs=218.6
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
++|+++++||+|+||+||+|+++ .+++.||+|.+..... .....+|+++|+.+ +|||||+++++|++.+++|+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 57999999999999999999875 4678999999865422 23456899999998 69999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--CcEEEeeccccccccCC--
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSG-- 153 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--~~vkL~DFg~a~~~~~~-- 153 (417)
||||++|+.+..+. +.+++.+++.|+.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999865444443 23899999999999999999999999999999999999974 68999999999754322
Q ss_pred ---------------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCH
Q 044608 154 ---------------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLF-PGASE 205 (417)
Q Consensus 154 ---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~ 205 (417)
...++.+||++|+|||++.+...|+.++||||+|||+|||++|++|| .+.++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 12345689999999999987777999999999999999999999887 56778
Q ss_pred HHHHHHHHHhhCCCCccchHHH-------------------HHHHhhhhccCCCCCc-----ccccccCCCCCHhHHHHH
Q 044608 206 ADQMYKICGVLGSPTMDSWADG-------------------LRQARAIKYQFPQLPR-----ANLSALMPSASQDAISLF 261 (417)
Q Consensus 206 ~~~~~~i~~~~g~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~-----~~~~~~~~~~s~~~~~li 261 (417)
.+++..|...+|++....+... ...........|.... ......+..+|++++|||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 8999999998886543333221 1111111111221110 111223467899999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccccc
Q 044608 262 ESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 262 ~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++||++||++|+||+|+|+||||++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=453.51 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=193.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-------- 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 73 (417)
++|++++.||+|+||+||+|+++.+|+.||||+++............+|+++|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999976544444455679999999999999999999987654
Q ss_pred ----EEEEEEeccCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 74 ----RLYLVFECMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 74 ----~~~lv~E~~~~~l~~~~~~~~~--~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
.+|+||||+.|+.+..+..... ...++..++.|+.||++||+|||++||+||||||+|||++ +|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 4799999998765555444322 1245567899999999999999999999999999999996 58999999999
Q ss_pred cccccCCC-------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 044608 147 AREIKSGP-------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKIC 213 (417)
Q Consensus 147 a~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 213 (417)
|+.+.... ..+..+||+.|||||++.+.. |+.++|||||||++|||++ ||.+.. +....+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHH
Confidence 98765432 124568999999999997654 9999999999999999996 775432 2222222
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
... ...+| ..++..++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 239 ~~~------------------~~~~p--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 239 DVR------------------NLKFP--------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHH------------------TTCCC--------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHh------------------cCCCC--------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 111 11111 11223467889999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-60 Score=487.70 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=225.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|+|+++++||+|+||+||+|+++.+|+.||+|++...... ......+|+++|+.|+|||||+++++|++.+.+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 47899999999999999999999999999999999764322 23445689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC---CcEEEeeccccccccCCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~---~~vkL~DFg~a~~~~~~~~~ 156 (417)
||+|+ |++.+.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++. +.+||+|||+|+.+......
T Consensus 235 ~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 235 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred ecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 99876 5555543 3356999999999999999999999999999999999999963 78999999999988877777
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|.....
T Consensus 314 ~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------------------- 373 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------------- 373 (573)
T ss_dssp EEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-------------------
T ss_pred eeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-------------------
Confidence 7889999999999997655 89999999999999999999999999999988888754321
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.++ ...++.+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus 374 ~~~-------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 374 NMD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp CCC-------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred CCC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 111 123356899999999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=485.24 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=211.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhH---HHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNL---REVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
||+|++++.||+|+||+||+|+++.+|+.||||++++...... ..... +++.+++.++|||||+++++|++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 5899999999999999999999999999999999975432111 11222 346677788999999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
||||||+.|+ |...+.. . +.++|..++.|+.||+.||+|||++||+||||||+||||+ +|++||+|||+|+.+...
T Consensus 268 ylVmEy~~GGdL~~~l~~-~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-H-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-H-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEecCCCCcHHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999876 5555544 3 4599999999999999999999999999999999999996 589999999999877554
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA---DQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
. ..+.|||+.|||||++.++..|+.++||||||||+|||++|.+||.+.+.. +....+..
T Consensus 346 ~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---------------- 408 (689)
T 3v5w_A 346 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------- 408 (689)
T ss_dssp C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----------------
T ss_pred C-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----------------
Confidence 4 456799999999999976656999999999999999999999999765322 22222211
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
... .++..+|+++++||.+||+.||.+|++ ++||++||||+...|
T Consensus 409 ---~~~-----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 409 ---MAV-----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp ---CCC-----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ---CCC-----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 111 223568999999999999999999998 899999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=429.48 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=200.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.++||+|+||+||+|+.+ ..||||+++......+ ...+.+|++++++|+|||||++++++.+ +.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 57889999999999999999754 3599999975544433 3345689999999999999999998754 56899999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccC---CCCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS---GPPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~---~~~~ 156 (417)
||+|+.+..+.......+++.++..|+.||+.||+|||++||+||||||+||||++ +.+||+|||+|+.... ....
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99977555554444467999999999999999999999999999999999999975 6899999999986543 2334
Q ss_pred ccccCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+..+.+..+...
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~------------------- 252 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR------------------- 252 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-------------------
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-------------------
Confidence 567999999999999643 34899999999999999999999999987766655544321
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+. .+.+....+.+++++.+||.+||+.||++|||+.|++++
T Consensus 253 ~~~-----~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 GYA-----SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TCC-----CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCC-----CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 112234456789999999999999999999999988643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=430.85 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|.+.++||+|+||+||+|++. .++..||||+++... ......+.+|+++|++|+|||||++++++.+++.+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 47899999999999999999865 367899999997542 223345578999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEee
Q 044608 77 LVFECMECN-LYQLMAAR-----------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIAD 143 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~-----------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~D 143 (417)
||||||+++ |.+.+... ....+++.++..|+.||+.||.|||+++|+||||||+|||+++ +.+||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence 999999876 44444332 1246999999999999999999999999999999999999964 7899999
Q ss_pred ccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCC
Q 044608 144 FGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSP 219 (417)
Q Consensus 144 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~ 219 (417)
||+|+....... ....+||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+.+..+...
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~---- 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---- 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT----
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Confidence 999986544322 23357999999999997665 9999999999999999998 89999999988877766431
Q ss_pred CccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 220 TMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ...+..+++++.+||.+||+.||++|||++|+ |+|+++.
T Consensus 247 -----------------~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 247 -----------------RV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp -----------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred -----------------CC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 00 11234678999999999999999999999999 5677653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=429.59 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=207.8
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++++++++||+|+||+||+|... .+++.||||+++..........+.+|+.++++|+|||||++++++.+++.+|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46788999999999999999853 4678999999986554444455678999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEE
Q 044608 77 LVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIK 140 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vk 140 (417)
||||||+++ |.+.+..+. ...+++.++..|+.||+.||.|||+++|+||||||+||||++ +.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 999999876 545554321 235899999999999999999999999999999999999975 7899
Q ss_pred EeeccccccccCC---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 044608 141 IADFGLAREIKSG---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVL 216 (417)
Q Consensus 141 L~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~ 216 (417)
|+|||+|+.+... ...+..+||+.|||||++.+.. |+.++|||||||+||||+| |..||.+.+..+.+..|...
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~- 263 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR- 263 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999866433 2345578999999999997665 9999999999999999998 89999999988877666421
Q ss_pred CCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 217 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ....++.+++++.+||.+||+.||++|||+.||+++
T Consensus 264 --------------------~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 264 --------------------Q--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------C--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 011234678999999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=431.82 Aligned_cols=288 Identities=36% Similarity=0.654 Sum_probs=247.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|++|++++.||+|+||.||+|.+..+++.||+|++.............+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 68999999999999999999999999999999999765433333344579999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 99998888776543 5689999999999999999999999999999999999996 579999999999765432 33445
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...........+.+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 68899999999997766689999999999999999999999999999999999999999999999988777766667777
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
+......+....+.+++++.+||.+||+.||.+|||++|+|+||||.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 776666667777889999999999999999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=427.05 Aligned_cols=285 Identities=36% Similarity=0.688 Sum_probs=243.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|+++++||+|+||+||+|.+. +|+.||+|++....... ......+|++++++++||||+++++++.+++.+|+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 479999999999999999999985 59999999997543322 2234468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 99 e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 99 EFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp ECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred cCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 999998888776543 5689999999999999999999999999999999999996 589999999999876533 3345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+...++.+....|.............
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 56899999999999776668999999999999999999999999999999999999999999988887765544444444
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.......+....+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 44445556667778899999999999999999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=430.21 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=199.9
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|.+.++||+|+||+||+|+.+ .+++.||||+++... ......+.+|+++|++|+|||||++++++.+.+.+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35788899999999999999864 468899999997542 223345578999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEE
Q 044608 77 LVFECMECNLYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKI 141 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL 141 (417)
||||||+++.+..+.... ...+++.++..|+.||+.||.|||+++|+||||||+||||++ +.+||
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence 999999876555444322 245899999999999999999999999999999999999975 78999
Q ss_pred eeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhC
Q 044608 142 ADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLG 217 (417)
Q Consensus 142 ~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 217 (417)
+|||+|+.+.... ..+..+||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..|....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~- 277 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR- 277 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999998764432 234568999999999997655 8999999999999999998 899999998888777664310
Q ss_pred CCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 218 SPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ...+..+++++.+||.+||+.||++|||++||+++
T Consensus 278 -----------------~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 -----------------E-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -----------------C-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -----------------C-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0 11234678999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=416.81 Aligned_cols=284 Identities=35% Similarity=0.638 Sum_probs=240.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|++|++++.||+|+||+||+|.++.+|+.||+|++........ .....+|+.++++++||||+++++++.+++.+|+||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999976543322 244568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 81 e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp ECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred ecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 999999888877644 5699999999999999999999999999999999999996 579999999999876533 3345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....|...........+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 568999999999998776689999999999999999977555 8888889999999999999998888765433222111
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.. ......+....+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 240 PM-YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CC-CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cc-ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 11 11122334455678999999999999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=414.08 Aligned_cols=283 Identities=36% Similarity=0.692 Sum_probs=236.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|++|++++.||+|+||.||+|.+ .+|+.||+|++........ .....+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 68999999999999999999998 6799999999975433221 234468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp ECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 999998777765433 5689999999999999999999999999999999999996 589999999999866432 3344
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|....... .....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP-KYDPN 237 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-TCCTT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc-ccccc
Confidence 56899999999999776668999999999999999999999999999999999999999998888776543222 11122
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
++......+......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 3333344455666789999999999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=443.12 Aligned_cols=281 Identities=33% Similarity=0.560 Sum_probs=230.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++++.||+|+||+||+|.+..+|+.||||++........ .....+|+.+++.++||||++++++|... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 689999999999999999999999999999999976543332 33456899999999999999999999654 46
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+++++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 142 ~~lv~E~~~~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred EEEEEeCCCCCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 89999999999877663 3489999999999999999999999999999999999997 579999999999987776
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
...+..+||++|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+++.+|...+|.+..+.|.........
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 6677789999999999997765 899999999999999999999999999999999999999999987766554333333
Q ss_pred hhccCCCCCcccccccCCCC------------CHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 234 IKYQFPQLPRANLSALMPSA------------SQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~------------s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+......+...++.. ++++++||.+||..||++|||++|+|+||||+..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 33333333333333333322 6789999999999999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-55 Score=439.83 Aligned_cols=286 Identities=36% Similarity=0.650 Sum_probs=226.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEe-----CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQN-----NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~ 75 (417)
++|++++.||+|+||.||+|+++.+|+.||||++......... ....+|+++|+.|+||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999999999999999999765444332 345689999999999999999999843 3679
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~- 153 (417)
|+||||+++++...+... ..+++..++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|+.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999999998888777543 4599999999999999999999999999999999999996 479999999999866422
Q ss_pred ---------------------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-----------
Q 044608 154 ---------------------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT----------- 195 (417)
Q Consensus 154 ---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~----------- 195 (417)
...+..+||++|+|||++.....|+.++||||||||+|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 124556899999999988666669999999999999999998
Q ss_pred CCCCCCCCC--------------------HHHHHHHHHHhhCCCCccchHHHHH-HHhhhhccCCCCCcccccccCCCCC
Q 044608 196 FCPLFPGAS--------------------EADQMYKICGVLGSPTMDSWADGLR-QARAIKYQFPQLPRANLSALMPSAS 254 (417)
Q Consensus 196 g~~pf~~~~--------------------~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s 254 (417)
|.++|++.+ ..+++..|...+|.+..+.|..... ........++......+...++..+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788888765 3678889999999998876654322 1222333455666667777888999
Q ss_pred HhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 255 QDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 255 ~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
+++.+||.+||..||++|||++|+|+||||+...+
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 99999999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=416.11 Aligned_cols=282 Identities=37% Similarity=0.638 Sum_probs=239.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh----hhhhHHHHHHHHhc---CCCCeeeeceEEEeCC-
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE----DCLNLREVKCLRKL---NHSNIVKLKELIQNNN- 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~- 73 (417)
++|++++.||+|+||+||+|++..+|+.||+|++........ .....+|+.+++.+ +||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 689999999999999999999999999999999874432111 12334677777766 4999999999998765
Q ss_pred ----EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 74 ----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 74 ----~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
.+++||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 58999999999888887765555599999999999999999999999999999999999996 5789999999998
Q ss_pred cccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 149 EIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 149 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
...........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred ccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 877766677789999999999997665 8999999999999999999999999999999999999999998888886543
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... ...++......+....+.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 248 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 322 23344444555666778899999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=419.03 Aligned_cols=287 Identities=32% Similarity=0.638 Sum_probs=226.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.++|++++.||+|+||.||+|.++.+|+.||+|+++............+|++++++++||||+++++++.+++.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36899999999999999999999999999999999765433333445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-C
Q 044608 81 CMECNLYQLMAARD----RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-P 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~----~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~ 154 (417)
|+++++.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 99998888776543 13589999999999999999999999999999999999996 589999999999876533 3
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+....|........ .
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~ 242 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK-Y 242 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT-C
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh-c
Confidence 345668999999999997766689999999999999999999999999999999999999999988887765432221 1
Q ss_pred hccCCCCCcccc-----cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 235 KYQFPQLPRANL-----SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 235 ~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
...++......+ ......++.++.+||.+||+.||++|||++|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 111111111111 122346889999999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=416.10 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=222.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++++.||+|+||.||+|.+..+|+.||||++........ .....+|+++++.++||||+++++++.+.+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999976544332 334568999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 999765 55555544 3489999999999999999999999999999999999996 5789999999998877666677
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... .+.
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------------~~~ 232 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------------------KYR 232 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CCC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCC
Confidence 7899999999999987775568999999999999999999999999887777666421 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+..+|+++.+||.+||..||.+|||++|+|+||||+...
T Consensus 233 -----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 233 -----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp -----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred -----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 1234789999999999999999999999999999998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=427.88 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=205.0
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhhhhhHHHHHHHHhcCC-CCeeeeceEEEe-CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKLKELIQN-NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~-~~~ 74 (417)
|+|++.++||+|+||+||+|.+..+ ++.||||+++......+.....+|+++|.+++| ||||+++++|.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 5799999999999999999987654 468999999876555455566789999999976 899999999865 467
Q ss_pred EEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCc
Q 044608 75 LYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGI 138 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~ 138 (417)
+|||||||+++ |.+.+.... ...+++.++..|+.||+.||+|||+++|+||||||+|||++ ++.
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence 89999999876 444444321 23589999999999999999999999999999999999996 578
Q ss_pred EEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 044608 139 IKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICG 214 (417)
Q Consensus 139 vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 214 (417)
+||+|||+|+.+..... .+..+||+.|||||++.+.. |+.++|||||||+||||+| |..||.+.+..+.+.++..
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999987654432 24567999999999997655 9999999999999999998 8999998765444433321
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ... ...+..+++++.+||.+||+.||++|||+.||++|
T Consensus 303 ~-------------------g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 E-------------------GTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp H-------------------TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-------------------CCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1 000 11234578999999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=420.13 Aligned_cols=288 Identities=38% Similarity=0.671 Sum_probs=231.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++++.||+|+||+||+|++..+|+.||||+++....... .....+|++++++++||||+++++++.+++.+|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4789999999999999999999999999999999975543322 234468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC------CcEEEeeccccccccCC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ------GIIKIADFGLAREIKSG 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~------~~vkL~DFg~a~~~~~~ 153 (417)
||+++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 113 e~~~~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 113 EYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp ECCSEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 99999888777654 34899999999999999999999999999999999999942 35999999999876532
Q ss_pred -CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 154 -PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|........
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 3345568899999999997766689999999999999999999999999999999999999999888877765332211
Q ss_pred hhhccCCCCCcccccc-cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCC
Q 044608 233 AIKYQFPQLPRANLSA-LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 291 (417)
....++......+.. +...+++++.+||.+||+.||++|||++|+|+||||+...+.|
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 271 -WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp -CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred -hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 111222222222221 1223789999999999999999999999999999999876544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=428.92 Aligned_cols=287 Identities=37% Similarity=0.648 Sum_probs=236.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 75 (417)
++|++++.||+|+||.||+|+++.+|+.||||++........ .....+|+++|+.++||||+++++++... +.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 689999999999999999999999999999999976544332 23456899999999999999999999766 679
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+......
T Consensus 106 ~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999999998888776543 45899999999999999999999999999999999999964 789999999998765432
Q ss_pred -----------------------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-----------CCCCC
Q 044608 155 -----------------------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-----------FCPLF 200 (417)
Q Consensus 155 -----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-----------g~~pf 200 (417)
..+..+||++|+|||++.....|+.++||||||||+|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 24677999999999998666669999999999999999998 56777
Q ss_pred CCCC-----------------HHHHHHHHHHhhCCCCccchHHHHH-HHhhhhccCCCCCcccccccCCCCCHhHHHHHH
Q 044608 201 PGAS-----------------EADQMYKICGVLGSPTMDSWADGLR-QARAIKYQFPQLPRANLSALMPSASQDAISLFE 262 (417)
Q Consensus 201 ~~~~-----------------~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 262 (417)
.+.+ ..+++..|...+|.+..+.+..... ........++......+...++.+++++.+||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 6654 4788999999999998876654211 112222334555555666777889999999999
Q ss_pred HhcccCCCCCCCHHHHHcCccccccccC
Q 044608 263 SLCSWDPSKRPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 263 ~~L~~dP~~Rpta~elL~hp~f~~~~~~ 290 (417)
+||..||++|||++|+|+||||+...+.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=421.67 Aligned_cols=283 Identities=35% Similarity=0.671 Sum_probs=219.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcC-CCCeeeeceEEEeCC--EEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLN-HSNIVKLKELIQNNN--RLY 76 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~ 76 (417)
+++|++++.||+|+||.||+|.++.+|+.||||++........ .....+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 3689999999999999999999999999999999975543332 334568999999997 999999999998554 799
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC---
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS--- 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~--- 152 (417)
+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 9999999887777654 3589999999999999999999999999999999999996 57899999999986532
Q ss_pred -------------------CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 044608 153 -------------------GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKIC 213 (417)
Q Consensus 153 -------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 213 (417)
....+..+||++|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..|.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1224557899999999999876669999999999999999999999999999999999999
Q ss_pred HhhCCCCccchHHHHH-----HHhhhhccCCCCCcccccc-------------cCCCCCHhHHHHHHHhcccCCCCCCCH
Q 044608 214 GVLGSPTMDSWADGLR-----QARAIKYQFPQLPRANLSA-------------LMPSASQDAISLFESLCSWDPSKRPTA 275 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-------------~~~~~s~~~~~li~~~L~~dP~~Rpta 275 (417)
..+|.|..+.+..... ......... ......... ....+++++.+||.+||+.||++|||+
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKV-EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHC-C-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccc-cccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 9999887665432100 000000000 000000001 123679999999999999999999999
Q ss_pred HHHHcCcccccc
Q 044608 276 AEALQHPFFKRC 287 (417)
Q Consensus 276 ~elL~hp~f~~~ 287 (417)
+|+|+||||+..
T Consensus 324 ~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 324 NDALKHPFVSIF 335 (388)
T ss_dssp HHHTTSTTTTTT
T ss_pred HHHhCCHHHHHh
Confidence 999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=418.58 Aligned_cols=258 Identities=31% Similarity=0.471 Sum_probs=220.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|+++.+|+.||+|++++..... ......+|+.+++.++||||++++++|.+.+.+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 57999999999999999999999999999999997654322 1234568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C----cEEEeecccccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREIK 151 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~~ 151 (417)
+||||+.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++....
T Consensus 92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999765444444333 56999999999999999999999999999999999999954 4 69999999999887
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
........+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|....
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------- 234 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS--------------- 234 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC---------------
T ss_pred CCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------
Confidence 766677789999999999986554 8999999999999999999999999998888877765321
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.++ ...++.+|+++++||.+||..||.+|||++|+|+||||+..
T Consensus 235 ----~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 235 ----YDFD-------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ----CCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ----CCCC-------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 1111 12335679999999999999999999999999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=418.47 Aligned_cols=284 Identities=37% Similarity=0.678 Sum_probs=235.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh----hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE----DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+|+++++.++||||+++++++.+.+.+|+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 689999999999999999999999999999999975432211 1234689999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~ 155 (417)
||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+... ..
T Consensus 90 v~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 90 VFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred EEEcCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 999999977766654 335689999999999999999999999999999999999996 579999999999876543 34
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|.+........
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~- 247 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV- 247 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC-
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc-
Confidence 4567899999999999776668999999999999999999999999999999999999999999888887643322211
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+...+...+......++.++.+||.+||..||++|||++|+|+||||++..
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 248 -TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp -CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred -cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 1222233344556678899999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=420.52 Aligned_cols=279 Identities=32% Similarity=0.599 Sum_probs=236.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe----------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN---------- 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---------- 71 (417)
++|++++.||+|+||.||+|.+..+|+.||||++...... ..+|+++++.++||||++++++|..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 6899999999999999999999999999999998654221 2379999999999999999999843
Q ss_pred ----------------------------CCEEEEEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 044608 72 ----------------------------NNRLYLVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121 (417)
Q Consensus 72 ----------------------------~~~~~lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~g 121 (417)
...+++||||+++++.+.+.. .....+++..++.++.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 345899999999887766653 33466999999999999999999999999
Q ss_pred cccccCCCCCeeee--CCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 044608 122 FFHRDLKPENLLVS--QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL 199 (417)
Q Consensus 122 i~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p 199 (417)
|+||||||+|||++ ++.+||+|||+|..+.........+||+.|+|||++.+...++.++|||||||++|+|++|.+|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 99999999999996 5789999999999877766667788999999999997766689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccc-cCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 200 FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSA-LMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 200 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
|.+.+..+.+..+...+|.+..+.|..... ......++......+.. +....++++.+||.+||..||.+|||+.|+
T Consensus 242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNP--HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCT--TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhCc--ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999999999999999999998877654322 12233344444444433 344589999999999999999999999999
Q ss_pred HcCcccccc
Q 044608 279 LQHPFFKRC 287 (417)
Q Consensus 279 L~hp~f~~~ 287 (417)
|+||||+..
T Consensus 320 l~hp~f~~~ 328 (383)
T 3eb0_A 320 MAHPFFDHL 328 (383)
T ss_dssp HTSGGGHHH
T ss_pred hcCHHHHHH
Confidence 999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=414.05 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=218.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||+||+|+++.+|+.||+|++++... ........+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976421 12223446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~~ 156 (417)
|||+.|+.+.....+. ..+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||++.... .....
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 9999876444444333 4589999999999999999999999999999999999996 5899999999998643 33445
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|... ..
T Consensus 163 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 222 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EI 222 (337)
T ss_dssp CCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CC
T ss_pred cccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------CC
Confidence 6779999999999986554 899999999999999999999999998877776665421 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
. +...+++++.+||.+||+.||.+|| |++|+++||||+...|
T Consensus 223 ~-----------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 223 R-----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp C-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred C-----------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 1 2245799999999999999999999 9999999999987644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=418.73 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=213.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||+||+|+++.+|+.||||++++..... ......+|..+++.+ +||||++++++|.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999997643211 123346899999998 79999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
||||+.|+.+.....+. ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|.... ....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 99999876444444333 4599999999999999999999999999999999999996 5899999999998543 3344
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|... .
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------------------~ 240 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------------------E 240 (353)
T ss_dssp -----CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------C
T ss_pred ccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------C
Confidence 55678999999999987655 899999999999999999999999999988888777531 1
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH------HHHHcCcccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA------AEALQHPFFKRCFY 289 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~~~ 289 (417)
.. +...+++++.+||.+||+.||.+|||+ +|+++||||+...|
T Consensus 241 ~~-----------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 241 VV-----------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp CC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred CC-----------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 11 223578999999999999999999999 99999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=425.03 Aligned_cols=279 Identities=35% Similarity=0.646 Sum_probs=235.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC------CEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN------NRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~ 76 (417)
+|++++.||+|+||.||+|+++.+|+.||||++..... ...+|+++++.|+||||++++++|... ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 69999999999999999999999999999999865421 223799999999999999999988532 2477
Q ss_pred EEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-C-CcEEEeeccccccccC
Q 044608 77 LVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-Q-GIIKIADFGLAREIKS 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~-~~vkL~DFg~a~~~~~ 152 (417)
+||||++++++..+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+++.+..
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9999999987776543 3346699999999999999999999999999999999999998 3 4689999999998766
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.......+||++|+|||++.+...|+.++||||||||+|||++|.+||.+.+..+++.+|...+|.+..+.|..... .
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~--~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP--N 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--C
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--h
Confidence 66666779999999999997765699999999999999999999999999999999999999999998877765321 1
Q ss_pred hhhccCCCCCcccccc-cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 233 AIKYQFPQLPRANLSA-LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
...+.++......+.. +.+.+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 2233444443333333 3457899999999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=412.44 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=222.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 378999999999999999999999999999999987542 233445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCCCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|++|+.+..........+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 9987644444444445699999999999999999999999999999999999996 5789999999999877666666
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 162 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------- 223 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----------------- 223 (321)
T ss_dssp EEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred cccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-----------------
Confidence 778999999999986654 89999999999999999999999999988887777654321111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...++.+|.++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 224 ---------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 12234679999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=416.14 Aligned_cols=282 Identities=36% Similarity=0.622 Sum_probs=233.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++++.||+|+||.||+|.+..+|+.||||++........ .....+|+++++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 589999999999999999999999999999999976543332 23456899999999999999999999765 35
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+++++.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred EEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 699999996666665543 3489999999999999999999999999999999999997 57899999999987543
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH-HHh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-QAR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~ 232 (417)
..+..+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..|....|.+..+.+..... ...
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 345678999999999998756699999999999999999999999999999999999999999988765543211 112
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
......+......+..+++.+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 22234566666677788889999999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=419.41 Aligned_cols=280 Identities=37% Similarity=0.638 Sum_probs=236.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC------EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN------RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~ 75 (417)
.+|++++.||+|+||.||+|++..+++ ||+|++..... ...+|+++++.++||||++++++|...+ .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 369999999999999999999988776 88887754321 1237999999999999999999986543 38
Q ss_pred EEEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeecccccccc
Q 044608 76 YLVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIK 151 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~ 151 (417)
|+||||++++++..+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 89999999988776553 2345699999999999999999999999999999999999997 5789999999999877
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
........+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..|...+|.+..+.+.... .
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~--~ 271 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN--P 271 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--G
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC--h
Confidence 66666778999999999999776669999999999999999999999999999999999999999999888765532 2
Q ss_pred hhhhccCCCCCcccccc-cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 232 RAIKYQFPQLPRANLSA-LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
......++......+.. +.+.+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 22334455544444444 33458999999999999999999999999999999987644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=402.32 Aligned_cols=286 Identities=32% Similarity=0.585 Sum_probs=229.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+|++++++++||||+++++++.+.+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 6899999999999999999999999999999999876544332 233468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 999999887776544 5589999999999999999999999999999999999997 588999999999876533 3345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...++......+.............
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 66899999999999876668999999999999999999999999999999999888887776544332211111111111
Q ss_pred CCCC-CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQL-PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+.. ....+....+.++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 1111 1122333456789999999999999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=410.99 Aligned_cols=283 Identities=35% Similarity=0.663 Sum_probs=240.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (417)
++|++++.||+|+||.||+|.+..+++.||||++.............+|++++++++||||+++++++... ..+|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 48999999999999999999999999999999997543333334557899999999999999999999765 4789
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~- 154 (417)
+||||+++++.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 107 iv~e~~~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEcccCcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 9999999988777654 34899999999999999999999999999999999999964 789999999998664332
Q ss_pred ---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH-
Q 044608 155 ---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ- 230 (417)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~- 230 (417)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.+..+.|......
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 2345689999999999877766899999999999999999999999999999999999999999887766442211
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
........+......+..+.+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 112233445445556667778899999999999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=417.48 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=217.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+|+.||+|++........ .....+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999975432211 22446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||++|++++.+.... .+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..........
T Consensus 88 ~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp ECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 9999888988887654 4899999999999999999999999999999999999975 789999999998877766667
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------------------- 220 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------------------- 220 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------------------------
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------------
Confidence 7899999999999976664588999999999999999999999765432111000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..........+|+++.+||++||+.||.+|||++|+++||||+..
T Consensus 221 -----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 -----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 011112334579999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=410.76 Aligned_cols=286 Identities=34% Similarity=0.572 Sum_probs=232.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe--------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN-------- 71 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 71 (417)
+++|++++.||+|+||.||+|+++.+|+.||+|++........ .....+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999999999999999865543222 2344689999999999999999999987
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
.+.+|+||||+++++...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 45789999999998888876544 4589999999999999999999999999999999999997 589999999999865
Q ss_pred cC-----CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KS-----GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+......|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 42 2334556899999999999776668999999999999999999999999999999999999999988877766
Q ss_pred HHHHHHhhhhccCCCCCcccccccC--CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALM--PSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....................+.... ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 5432221111111111000000000 0137889999999999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=398.26 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=216.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 58999999999999999999999999999999997554332 33456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
+.++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ......
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 9876655555443 489999999999999999999999999999999999996 589999999999876543 334566
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.... . +
T Consensus 177 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~--------------------~ 234 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T--------------------P 234 (297)
T ss_dssp CSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S--------------------C
T ss_pred cCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C--------------------C
Confidence 8999999999987655 8999999999999999999999999988877766554221 0 0
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ......++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 235 ~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 235 E------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp C------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred C------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 0 0112357899999999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=418.39 Aligned_cols=284 Identities=31% Similarity=0.563 Sum_probs=214.6
Q ss_pred Ccee-cceecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEE
Q 044608 3 KYSG-FKELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYL 77 (417)
Q Consensus 3 ~Y~~-~~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (417)
.|++ .++||+|+||.||+|+++ .+++.||||++...... ....+|+.+|++|+||||++++++|.+ ...+|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4676 457999999999999966 57899999999754332 234689999999999999999999964 778999
Q ss_pred EEeccCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee----e-CCcEEEeecc
Q 044608 78 VFECMECNLYQLMAARD-------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV----S-QGIIKIADFG 145 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~-------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl----~-~~~vkL~DFg 145 (417)
||||+++++++.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 99999999888776432 1248999999999999999999999999999999999999 3 3689999999
Q ss_pred ccccccCC----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q 044608 146 LAREIKSG----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKI 212 (417)
Q Consensus 146 ~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i 212 (417)
+|+.+... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+++..|
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99876532 2345578999999999998766699999999999999999999999987765 4889999
Q ss_pred HHhhCCCCccchHHHHHHHhhhhc--c-----CCCCC-cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 213 CGVLGSPTMDSWADGLRQARAIKY--Q-----FPQLP-RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 213 ~~~~g~~~~~~~~~~~~~~~~~~~--~-----~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
+..+|.+....|............ . +.... ...+.......++++.+||.+||..||.+|||++|+|+||||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 999999999888765322111100 0 00000 001111223457899999999999999999999999999999
Q ss_pred ccccc
Q 044608 285 KRCFY 289 (417)
Q Consensus 285 ~~~~~ 289 (417)
++...
T Consensus 338 ~~~~~ 342 (405)
T 3rgf_A 338 LEDPL 342 (405)
T ss_dssp TSSSC
T ss_pred ccCCC
Confidence 87543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=415.67 Aligned_cols=266 Identities=24% Similarity=0.430 Sum_probs=211.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||+||+|+++.+++.||+|++++....... ....+|..++.++ +||||++++++|.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46899999999999999999999999999999999865433222 2345799999887 89999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccc-ccCCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLARE-IKSGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~-~~~~~~ 155 (417)
||||+.|+.+.....+. ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+. ......
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 99999876544444433 4589999999999999999999999999999999999996 58999999999986 334455
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+....+.... ..............
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~----------~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----------NTEDYLFQVILEKQ 278 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------------CCHHHHHHHHHHCC
T ss_pred cccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccch----------hhHHHHHHHHhccc
Confidence 66789999999999997655 89999999999999999999999975432111000 00000000011111
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH------HHHHcCcccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA------AEALQHPFFKRCFY 289 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~~~ 289 (417)
. .++..+|.++++||++||+.||.+|||+ +|+++||||+...|
T Consensus 279 ~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 279 I-----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp C-----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred c-----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 1 1234679999999999999999999995 89999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=414.66 Aligned_cols=282 Identities=33% Similarity=0.552 Sum_probs=218.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN------ 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 73 (417)
+++|++++.||+|+||.||+|.+..+|+.||||++........ .....+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3689999999999999999999999999999999976543332 234468999999999999999999997665
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+|+||||+++++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 889999999998887764 3489999999999999999999999999999999999997 57999999999987766
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...+|.+..+.|........
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ----------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred ccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 55556678999999999997654 89999999999999999999999999999999999998888876655443222221
Q ss_pred hhhccCCCCCcccccccCCC------------CCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPS------------ASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~------------~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+......+....+. .+.++++||.+||..||.+|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 11112222211111111111 25789999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=414.64 Aligned_cols=281 Identities=36% Similarity=0.642 Sum_probs=222.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
++|++++.||+|+||.||+|.+..+|+.||||++....... ......+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 68999999999999999999999999999999997654332 233456899999999999999999999754 56
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+|||+++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 109 ~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 899999997776665543 4589999999999999999999999999999999999996 478999999999865432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH-HHh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-QAR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~ 232 (417)
....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..|...+|.+..+.+..... ...
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred --CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 45568999999999997756699999999999999999999999999999999999999999987765543221 111
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+..+...+...++..++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 2223345555666777788899999999999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=419.87 Aligned_cols=257 Identities=33% Similarity=0.542 Sum_probs=217.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.+++.|+||||+++++++.+.+.+|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 47999999999999999999999999999999997654332 23345689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCC-C
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSG-P 154 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~-~ 154 (417)
|+.|+ |.+.+..+ ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .
T Consensus 91 ~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99875 55555543 4599999999999999999999999999999999999996 367999999999876543 3
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------------- 228 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG------------------- 228 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------------------
T ss_pred eeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------------------
Confidence 345678999999999986654 899999999999999999999999999888877766532
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+.++ ...++.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 229 ~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 229 AYDFP-------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp CCCCC-------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred CCCCC-------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 12221 12235679999999999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=410.19 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=217.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||.||+|+++.+|+.||||++++... ........+|..++..+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999999999999999999976432 11223345799999887 99999999999999999999
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GP 154 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~ 154 (417)
||||+.|+ |.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||++..... ..
T Consensus 96 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999875 54444433 3589999999999999999999999999999999999996 58999999999986432 33
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|...
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------------- 233 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------------- 233 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------
T ss_pred cccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 456679999999999997655 899999999999999999999999998888777666421
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHH-HHHcCcccccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA-EALQHPFFKRCFY 289 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~~~ 289 (417)
.. .+...+++++.+||.+||..||++|||+. |+++||||+...|
T Consensus 234 ~~-----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 234 NP-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp CC-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred CC-----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 11 12235789999999999999999999998 9999999988654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=407.65 Aligned_cols=285 Identities=30% Similarity=0.485 Sum_probs=224.6
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR------ 74 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------ 74 (417)
+++|++.+.||+|+||.||+|.++.+|+.||||++...... .....+|++.+..++||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 47999999999999999999999999999999998654222 2233578888899999999999999976433
Q ss_pred -EEEEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCCeeee--CCcEEEeecccc
Q 044608 75 -LYLVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMH--QNGFFHRDLKPENLLVS--QGIIKIADFGLA 147 (417)
Q Consensus 75 -~~lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH--~~gi~HrDLKp~NILl~--~~~vkL~DFg~a 147 (417)
+++||||+++++...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 899999999988776553 23456899999999999999999999 99999999999999997 578999999999
Q ss_pred ccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 148 REIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 148 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
............+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..+.|...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 98777666667789999999999977666899999999999999999999999999999999999999998887666543
Q ss_pred HHHHhhhhccCCCCCcccccc----cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSA----LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
...... ..+.......+.. .....++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTD--VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCC--GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhh--ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 211111 1111111112222 22346789999999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=410.43 Aligned_cols=256 Identities=34% Similarity=0.567 Sum_probs=218.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++......... ....+|+.+++.|+||||+++++++.+.+.+|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999999999999999999865444332 345689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.|+ +.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++........
T Consensus 109 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 109 LVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99875 5455443 245899999999999999999999999999999999999953 3599999999988776666
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+... .
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~ 246 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------------A 246 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------C
T ss_pred cccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------------------C
Confidence 67789999999999986654 899999999999999999999999998887777666432 1
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+.++. ..+..+++++.+||.+||..||++|||+.|+|+||||+.
T Consensus 247 ~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 247 YDYPS-------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CCCCT-------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCc-------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11111 112357899999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=404.13 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=218.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||+||+|+++.+|+.||+|++++.... .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 47899999999999999999999999999999999764321 1223345799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++...... ..
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY 161 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cc
Confidence 9999876444444433 4589999999999999999999999999999999999996 589999999999875442 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...+|... ..
T Consensus 162 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------------------~~- 220 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------------EL- 220 (318)
T ss_dssp CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------------CC-
T ss_pred cccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CC-
Confidence 568999999999986654 899999999999999999999999998888777766431 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
.+.+.+++++.+||.+||..||++|+ |++|+++||||+...|.
T Consensus 221 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 221 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 12245789999999999999999999 99999999999976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=417.63 Aligned_cols=263 Identities=26% Similarity=0.354 Sum_probs=220.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|+++.+++.||+|++++.... .......+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999999753211 11223458999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~ 156 (417)
||+.|+.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|....... ..
T Consensus 149 E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp CCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999776554444443 489999999999999999999999999999999999996 5899999999998765433 23
Q ss_pred ccccCCccccCchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 157 TNYVGSRWYRAPEILLQSE---LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.+.+||+.|+|||++.+.. .|+.++|||||||++|||++|.+||.+.+..+.+.+|....
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------------- 289 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK----------------- 289 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----------------
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-----------------
Confidence 4678999999999986543 27899999999999999999999999999888888775321
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCccccccccCCC
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~~~ 292 (417)
....+|. ...+|.++++||.+||..+|.+ |+|++|+++||||+...|...
T Consensus 290 ~~~~~p~---------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 290 NSLTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp HHCCCCT---------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred ccccCCC---------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 1122221 1357999999999999999988 999999999999998766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=402.52 Aligned_cols=257 Identities=31% Similarity=0.464 Sum_probs=218.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++....... ......+|+.++++++||||+++++++.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46999999999999999999999999999999997653321 1234568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C----cEEEeecccccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREIK 151 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~~ 151 (417)
+||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999775444444333 56899999999999999999999999999999999999964 4 69999999998877
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------- 234 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-------------- 234 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC--------------
T ss_pred CCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC--------------
Confidence 666667778999999999986554 89999999999999999999999999888777766643211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.++ ...++.++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 235 -----~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 235 -----EFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp -----CCC-------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred -----CcC-------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 111 1223467899999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=420.02 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=222.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|+++++||+|+||+||+|+++.+++.||+|++++.... .......+|+.++..++||||++++++|.+.+.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999999753221 11223468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~ 156 (417)
||+.|+.+..+..+....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|........ .
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99977655554444345699999999999999999999999999999999999997 58999999999976654332 3
Q ss_pred ccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...+||+.|+|||++.. ...|+.++|||||||++|||++|.+||.+.+..+.+.+|....
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 297 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK---------------- 297 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----------------
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----------------
Confidence 44689999999999862 3458999999999999999999999999999888888775311
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCC--CCCHHHHHcCccccccccCCC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSK--RPTAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~~~ 292 (417)
..+.+|. ....+|+++++||++||+.+|++ |++++|+++||||+...|...
T Consensus 298 -~~~~~p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 298 -ERFQFPT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -HHCCCCS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -ccccCCc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 1122222 23468999999999999998888 999999999999998776554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=403.84 Aligned_cols=285 Identities=34% Similarity=0.623 Sum_probs=232.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++++.||+|+||.||+|++..+|+.||+|++........ .....+|++++++++||||+++++++.+.+.+|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 5789999999999999999999999999999999876544433 233458999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||++++++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 999999888776544 4589999999999999999999999999999999999996 578999999999765442 3345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+.............
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 56899999999999776568999999999999999999999999999999999998888876655443332222222222
Q ss_pred CCCC-CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQL-PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+.. .........+.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2222 122334455678999999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=415.28 Aligned_cols=282 Identities=32% Similarity=0.574 Sum_probs=228.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc------CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL------NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~~~~~ 75 (417)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+|+.+++.+ +|+||+++++++...+.+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 579999999999999999999999999999999975421 123345688888777 578999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-Cc--EEEeeccccccccC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GI--IKIADFGLAREIKS 152 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~--vkL~DFg~a~~~~~ 152 (417)
|+||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|||+|.....
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999999999998888766566999999999999999999999999999999999999974 44 99999999976443
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+...+|.+....+........
T Consensus 255 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 255 --RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 334568999999999997665 89999999999999999999999999999999999999999887665433221111
Q ss_pred hhhc-cCCC----------------------------CCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 233 AIKY-QFPQ----------------------------LPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 233 ~~~~-~~~~----------------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.+.. .++. ........+....++++.+||.+||++||++|||++|+|+|||
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 1000 0000 0000011122345889999999999999999999999999999
Q ss_pred ccccc
Q 044608 284 FKRCF 288 (417)
Q Consensus 284 f~~~~ 288 (417)
|++..
T Consensus 412 ~~~~~ 416 (429)
T 3kvw_A 412 LRRRL 416 (429)
T ss_dssp TC---
T ss_pred hccCC
Confidence 98754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=407.29 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=217.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||+||+|+++.+|+.||+|++++... ........+|..++..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 5799999999999999999999999999999999976432 11223346799999988 79999999999999999999
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGP 154 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~ 154 (417)
||||+.|+ |.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++.... ...
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 99999875 55444433 3589999999999999999999999999999999999996 5899999999998643 334
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....|...
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------------- 236 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------------- 236 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------
T ss_pred ccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 456679999999999986655 899999999999999999999999999888877776531
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccccC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFYA 290 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 290 (417)
... +...+++++.+||.+||..||.+|| +++|+++||||+...|.
T Consensus 237 ~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 NVA-----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp CCC-----------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred CCC-----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 111 2246799999999999999999999 47999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=404.43 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=211.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||.||+|+++.+|+.||+|++++...... .....+|+.+++++ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999986543322 23345899999988 89999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
||||+.|+.+.....+. ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++.... ....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 99999875444444333 4589999999999999999999999999999999999996 5899999999998643 3344
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHhhCCCCccchHH
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---------ADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~ 226 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||..... ......+.
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~------------- 232 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------------- 232 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-------------
T ss_pred ccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-------------
Confidence 56679999999999997654 89999999999999999999999975321 11111111
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH------HHHHcCcccccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA------AEALQHPFFKRCFY 289 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~~~ 289 (417)
.... .+...++.++.+||.+||+.||.+|||+ +|+++||||+...|
T Consensus 233 ------~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 233 ------EKQI-----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ------HCCC-----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ------cCCC-----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 1111 1234679999999999999999999995 89999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=413.70 Aligned_cols=265 Identities=26% Similarity=0.369 Sum_probs=218.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||+||+|+++.+|+.||+|++++..... ......+|+.++..++||||++++++|.+.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997532211 1223468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--Y 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~ 156 (417)
||+.|+.+..+..+.+..+++..++.++.||+.||+|||++||+||||||+|||++. |++||+|||++........ .
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999765444444443346999999999999999999999999999999999999974 8999999999987654432 2
Q ss_pred ccccCCccccCchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 157 TNYVGSRWYRAPEILLQ------SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
...+||+.|+|||++.. ...|+.++|||||||++|||++|.+||.+.+..+.+.+|....
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------- 286 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-------------- 286 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------------
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Confidence 35689999999999863 3458999999999999999999999999999888887775310
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCC---CCHHHHHcCccccccccCCC
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKR---PTAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pta~elL~hp~f~~~~~~~~ 292 (417)
....+| .....+|+++++||++||. ||.+| +|++|+++||||+...|...
T Consensus 287 ---~~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 287 ---EHLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ---HHCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ---cCcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 011111 1224689999999999999 99998 59999999999998776654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=406.25 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=217.6
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46899999999999999999999999999999999754321 1223446899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.|+ |.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++...... .
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 9999765 55555443 3589999999999999999999999999999999999996 589999999999876543 3
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....|... ..
T Consensus 196 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 255 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------------KV 255 (350)
T ss_dssp CCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CC
T ss_pred ccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------------------CC
Confidence 4568999999999987654 899999999999999999999999999888777766431 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
.+...++.++.+||.+||+.||.+||+ ++|+++||||+...|
T Consensus 256 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 122457899999999999999999998 999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=402.74 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=210.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+++|++++.||+|+||.||+|+++.+++.||+|++.............+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 57999999999999999999999999999999999755443334455789999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC---CCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG---PPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~---~~~ 156 (417)
|+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++..+... ...
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9987544333332 245899999999999999999999999999999999999975 89999999999765422 234
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+............ ..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------------~~ 226 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------------KT 226 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT------------------CT
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc------------------cc
Confidence 567899999999999877656889999999999999999999998766533222211100 00
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ......+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 227 ~---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 Y---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp T---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred c---------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 0 01123578999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=409.92 Aligned_cols=258 Identities=22% Similarity=0.393 Sum_probs=216.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||.||+|.++.+|+.||+|++.+... ........+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999975431 11223446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++..+.......
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 9999877555555443 5699999999999999999999999999999999999996 5899999999999887777777
Q ss_pred cccCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 158 NYVGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEA---DQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
..+||+.|+|||++.. ...|+.++|||||||++|+|++|..||.+.+.. +....+..
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------------ 234 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------------------ 234 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------------------
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------------------
Confidence 8899999999999864 234899999999999999999999999754432 22222110
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-HHHHHcCcccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-AAEALQHPFFKRCFY 289 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~elL~hp~f~~~~~ 289 (417)
.. ..+...++.++.+||.+||+.||.+||+ ++++++||||+...|
T Consensus 235 -~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 235 -TV-----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -CC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -cc-----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 01 1223467899999999999999999998 999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=408.99 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=220.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+|+.+++.|+||||+++++++.+.+.+|+||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 589999999999999999999999999999999976432 2233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
+.|+.+..........+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 987655444443445689999999999999999999999999999999999995 25799999999998766655566
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... .+.+
T Consensus 210 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------~~~~ 269 (387)
T 1kob_A 210 TTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------------DWEF 269 (387)
T ss_dssp ECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------------------CCCC
T ss_pred eccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------CCCC
Confidence 78999999999986554 899999999999999999999999998887777665431 1111
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+ ...+..+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 270 ~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 270 D-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp C-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred C-------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1 12335679999999999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=402.77 Aligned_cols=279 Identities=24% Similarity=0.414 Sum_probs=225.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----CCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----HSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~~~~~ 76 (417)
++|+++++||+|+||.||+|++..+++.||||++.... .......+|+.+++.+. ||||+++++++...+.+|
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 68999999999999999999999999999999997432 12233357999999996 999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---------------------
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--------------------- 135 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--------------------- 135 (417)
+||||++++|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999977888887766555699999999999999999999999999999999999995
Q ss_pred -----CCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 044608 136 -----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMY 210 (417)
Q Consensus 136 -----~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 210 (417)
++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 568999999999864432 34568999999999997665 8999999999999999999999999999999999
Q ss_pred HHHHhhCCCCccchHHHHHHHhhhhc-------cCCCCCcc---------cccccCCCCCHhHHHHHHHhcccCCCCCCC
Q 044608 211 KICGVLGSPTMDSWADGLRQARAIKY-------QFPQLPRA---------NLSALMPSASQDAISLFESLCSWDPSKRPT 274 (417)
Q Consensus 211 ~i~~~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 274 (417)
.+....+......+............ .+|..... ....+....++++.+||.+||+.||++|||
T Consensus 270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 349 (360)
T 3llt_A 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349 (360)
T ss_dssp HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence 88888777665544332211111000 01110000 000111123578899999999999999999
Q ss_pred HHHHHcCcccc
Q 044608 275 AAEALQHPFFK 285 (417)
Q Consensus 275 a~elL~hp~f~ 285 (417)
++|+|+||||+
T Consensus 350 a~elL~hp~f~ 360 (360)
T 3llt_A 350 PAELLKHKFLE 360 (360)
T ss_dssp HHHHTTSGGGC
T ss_pred HHHHhcCcccC
Confidence 99999999995
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=405.87 Aligned_cols=258 Identities=31% Similarity=0.442 Sum_probs=199.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|+++.+|+.||+|++...... .....+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 6899999999999999999999999999999999754332 23346899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C--cEEEeeccccccccCCCCCc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G--IIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~--~vkL~DFg~a~~~~~~~~~~ 157 (417)
+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++.........
T Consensus 98 ~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 98 ASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp CCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 9765 55554443 35899999999999999999999999999999999999964 3 49999999998655555556
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.........+.. ......+.
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------------~~~~~~~~ 240 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---------------RILSVKYS 240 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---------------HHHTTCCC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---------------HHhcCCCC
Confidence 678999999999997776445559999999999999999999987654322222211 11111222
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++. ...+++++.+||.+||+.||++|||++|+|+||||.+.
T Consensus 241 ~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 IPD---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 221 12578999999999999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=395.13 Aligned_cols=284 Identities=36% Similarity=0.620 Sum_probs=238.0
Q ss_pred CCceecceecccCceEEEEEEEC-CCCcEEEEEEecccccChh-hhhhHHHHHHHHhc---CCCCeeeeceEEE-----e
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-HTGEAVAIKELKQRYASWE-DCLNLREVKCLRKL---NHSNIVKLKELIQ-----N 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~ 71 (417)
++|++++.||+|+||.||+|.+. .+|+.||+|++........ .....+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 58999999999999999999995 6789999999975433221 22345777777766 8999999999987 5
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
...+++||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 6789999999999888887765555699999999999999999999999999999999999996 589999999999876
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|......
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 6554555678999999999987655 899999999999999999999999999999999999999998888777653322
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
.. ..+.......+..+.+.++.++.+||.+||..||.+|||+.|+|+||||+....
T Consensus 250 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 250 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 11 122223334455667789999999999999999999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=400.47 Aligned_cols=284 Identities=35% Similarity=0.641 Sum_probs=233.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-----CEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN-----NRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 76 (417)
++|++.+.||+|+||.||+|.+..+|+.||||++.............+|++++++++||||+++++++... ..+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 68999999999999999999999999999999997543333334456899999999999999999987654 6799
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~- 154 (417)
+||||+++++.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 91 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 9999999887776654 3489999999999999999999999999999999999996 4789999999998654321
Q ss_pred ----------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 155 ----------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 155 ----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+.....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1234589999999999876666899999999999999999999999999999999999988888764432
Q ss_pred HHHHHH--HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 225 ADGLRQ--ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 225 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
...... ........+..+...+....+.+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 221111 1111122333344455666778999999999999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=402.03 Aligned_cols=284 Identities=31% Similarity=0.577 Sum_probs=227.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh----------hhhhHHHHHHHHhcCCCCeeeeceEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE----------DCLNLREVKCLRKLNHSNIVKLKELIQN 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----------~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 71 (417)
++|++.+.||+|+||.||+|.+.. |+.||||++........ .....+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 689999999999999999999865 99999999865433211 1344689999999999999999999854
Q ss_pred -----CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecc
Q 044608 72 -----NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFG 145 (417)
Q Consensus 72 -----~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg 145 (417)
...+|+||||++|++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 34789999999998888877543 5689999999999999999999999999999999999997 5889999999
Q ss_pred ccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 146 LAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 146 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
++............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence 99876666556677899999999999775668999999999999999999999999999999999999999988776544
Q ss_pred HHHH--HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLR--QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.... ............+...+....+..++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 3211 1111222233334445556677889999999999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=403.80 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=211.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc----ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA----SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ........+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 469999999999999999999999999999999864321 1123345689999999999999999999999999999
Q ss_pred EEeccCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccccccc
Q 044608 78 VFECMECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGLAREI 150 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~a~~~ 150 (417)
||||++|+ |.+.+..+ ....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999865 55555443 2345899999999999999999999999999999999999963 3 4999999999876
Q ss_pred cCCCC-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 151 KSGPP-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 151 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
..... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. .+....+....
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~------------- 248 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK------------- 248 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC-------------
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC-------------
Confidence 55432 44568999999999987654 8999999999999999999999998753 33333332211
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.++ ...++.++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 249 ------~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 249 ------YKMN-------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------CCCC-------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------CCCC-------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1000 11224678999999999999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=407.17 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=212.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHH-HHhcCCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKC-LRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||+||+|+++.+++.||+|++++..... ......+|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999997654322 22233466666 567899999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
||||+.|+.+..+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+++... ....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 99999876444444333 4589999999999999999999999999999999999996 5899999999998643 3444
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|... .
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------------------~ 255 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------------------P 255 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-------------------C
T ss_pred cccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------------c
Confidence 56779999999999987654 899999999999999999999999998888877776531 0
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH----HHHHcCccccccccC
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA----AEALQHPFFKRCFYA 290 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~~~~ 290 (417)
..+.+.++.++.+||.+||+.||.+||++ .|+++||||+...|.
T Consensus 256 -----------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 256 -----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp -----------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred -----------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 11234689999999999999999999996 699999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=399.99 Aligned_cols=280 Identities=39% Similarity=0.639 Sum_probs=232.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE-----
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRL----- 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----- 75 (417)
++|.+.+.||+|+||.||+|.++.+|+.||||++........ .....+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 589999999999999999999999999999999986544332 23446899999999999999999999877654
Q ss_pred -EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 76 -YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 76 -~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
|+||||+.+++.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 122 ~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CEEEEECCCEEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEEEEccccccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 999999998776654 24489999999999999999999999999999999999997 578999999999865433
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH-HHh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-QAR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~ 232 (417)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....|.+..+.+..... ...
T Consensus 198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 198 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred --cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 34568999999999997756689999999999999999999999999999999999999888876654432211 111
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+......+....+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 1222344445556667778899999999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=417.27 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=209.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++++.||+|+||.||+|.++.+|+.||||++..... ........+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3679999999999999999999999999999999975432 12223346799999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
|||++++.+....... ..+++..++.++.||+.||+|||+ +||+||||||+|||++ ++.+||+|||+|.... ....
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 9999886554444433 458999999999999999999998 9999999999999996 5899999999998643 3344
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+..+....+... .
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------------~ 365 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------E 365 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------C
T ss_pred cccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-------------------C
Confidence 56679999999999986655 899999999999999999999999998887777665421 1
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.. +...+++++.+||.+||+.||.+|| |++|+|+||||+...+
T Consensus 366 ~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 366 IR-----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CC-----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 11 2245789999999999999999999 9999999999987644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=387.77 Aligned_cols=256 Identities=32% Similarity=0.501 Sum_probs=210.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.++.++..||+|++.............+|++++++++||||+++++++.+.+.+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57999999999999999999999999999999998765444445567899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCC
Q 044608 82 MECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 82 ~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~ 154 (417)
++++ +.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 9874 66555432 235699999999999999999999999999999999999994 2579999999998776666
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 182 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------------- 240 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK------------------- 240 (285)
T ss_dssp -----CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------
T ss_pred cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-------------------
Confidence 6667789999999999853 3899999999999999999999999988876665544211
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+ ........+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 241 ---~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 241 ---EP-----NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---CC-----CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---Cc-----ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 011112347899999999999999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=400.33 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=209.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+... ...+|++++.++ +||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 479999999999999999999999999999999976532 234788899888 79999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-----CcEEEeeccccccccCC-
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-----GIIKIADFGLAREIKSG- 153 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-----~~vkL~DFg~a~~~~~~- 153 (417)
|+.|+ +.+.+.. . ..+++..++.++.||+.||.|||++||+||||||+|||+.+ +.+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~-~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 97 LMKGGELLDKILR-Q-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCSCBHHHHHHT-C-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCCcHHHHHHH-c-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99875 5555543 3 45999999999999999999999999999999999999842 24999999999876543
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA---SEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+. ...+....+..
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---------------- 237 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---------------- 237 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----------------
T ss_pred CceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----------------
Confidence 3445678999999999987654 899999999999999999999999863 33444444321
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+.++ ...++.+|+++++||++||..||++|||++|+|+||||...
T Consensus 238 ---~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 238 ---GKFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ---CCCCCC-------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ---CCcccC-------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 111111 12345689999999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=393.51 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=208.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-------------------------hhhhhHHHHHHHH
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-------------------------EDCLNLREVKCLR 55 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-------------------------~~~~~~~E~~~l~ 55 (417)
+++|++.+.||+|+||.||+|.+..+|+.||||++....... ......+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999997543211 1123468999999
Q ss_pred hcCCCCeeeeceEEEe--CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 56 KLNHSNIVKLKELIQN--NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 56 ~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
+++||||+++++++.+ .+.+|+||||++++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999987 678999999998765544332 346899999999999999999999999999999999999
Q ss_pred ee-CCcEEEeeccccccccCCC-CCccccCCccccCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 044608 134 VS-QGIIKIADFGLAREIKSGP-PYTNYVGSRWYRAPEILLQSEL--YSSKADMWAMGAIMAELFTFCPLFPGASEADQM 209 (417)
Q Consensus 134 l~-~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 209 (417)
++ ++.+||+|||++....... .....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 96 5799999999998765432 2345689999999999865432 478899999999999999999999888766555
Q ss_pred HHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 210 YKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 210 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+... ...++ ..+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 250 ~~~~~~-------------------~~~~~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 250 SKIKSQ-------------------ALEFP---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHC-------------------CCCCC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHhcc-------------------cCCCC---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 444211 11111 12467899999999999999999999999999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=403.55 Aligned_cols=287 Identities=22% Similarity=0.284 Sum_probs=212.6
Q ss_pred CCceecceeccc--CceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRG--AFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G--~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++++.||+| +||.||+|+++.+|+.||||++......... ....+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 589999999999 9999999999999999999999866544333 3345799999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--- 153 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--- 153 (417)
|||+.++ +.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999865 44555444345699999999999999999999999999999999999997 589999999988644221
Q ss_pred -----CCCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCcc-----
Q 044608 154 -----PPYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD----- 222 (417)
Q Consensus 154 -----~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~----- 222 (417)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....-....+
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence 112335899999999999763 458999999999999999999999999877666554433211000000
Q ss_pred --ch---------HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 223 --SW---------ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 223 --~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+ ..............+.............+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00 0000000000000011111112234566899999999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=381.57 Aligned_cols=257 Identities=35% Similarity=0.564 Sum_probs=219.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.++.+|+.||+|++......... ....+|+.++++++||||+++++++.+.+..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 6899999999999999999999999999999999765544333 344689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++........
T Consensus 86 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 86 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99875 55555544 45899999999999999999999999999999999999953 3499999999988776666
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------------- 223 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA------------------- 223 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------------
T ss_pred ccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc-------------------
Confidence 66778999999999987655 8999999999999999999999999988877766654321
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.++ ......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 224 ~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 224 YDYP-------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp CCCC-------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ccCC-------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 1111 11224678999999999999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=397.15 Aligned_cols=266 Identities=24% Similarity=0.262 Sum_probs=187.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC----EEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN----RLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 77 (417)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+.+|+|||||++++++.+.+ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4688999999999999999976 68999999997542 22222235666777899999999999997654 6899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN--------GFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~--------gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
||||++++.+..+..+. .++++.+..++.|++.||.|||++ ||+||||||+||||+ ++.+||+|||+|+
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999976555555443 489999999999999999999987 999999999999997 5799999999998
Q ss_pred cccCCCC-----CccccCCccccCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Q 044608 149 EIKSGPP-----YTNYVGSRWYRAPEILLQSE-----LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 149 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
....... ....+||+.|||||++.+.. .|+.++|||||||+||||++|.+||......+..+.- ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~----~~ 232 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD----LV 232 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT----TS
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh----cc
Confidence 7654322 23468999999999986532 2678999999999999999998887543321100000 00
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+............ ......|..+.. ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVV-CEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHH-TTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHH-hcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000000000000 000001111100 0011234578999999999999999999999763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=392.57 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=205.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|+++++||+|+||+||+|+++.+|+.||||++........ ....+.|+..+.++ +||||+++++++.+.+.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999876544332 23335666666655 8999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||+++++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...........
T Consensus 137 e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp ECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred eccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 999888888777654 5699999999999999999999999999999999999996 57899999999988766665666
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
..||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+. +.. ..
T Consensus 216 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~---------------------~~- 268 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ---------------------GY- 268 (311)
T ss_dssp CCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT---------------------TC-
T ss_pred cCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc---------------------cC-
Confidence 789999999999865 389999999999999999999777655332221 100 00
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....+...+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 269 ------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 ------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 001223467899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=416.53 Aligned_cols=256 Identities=34% Similarity=0.569 Sum_probs=217.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||+||+|.++.+|+.||||++..... ........+|++++++++||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 479999999999999999999999999999999965432 2223445689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.....
T Consensus 102 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99865 55655554 4589999999999999999999999999999999999994 35799999999988777666
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 244 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------------- 244 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-------------
T ss_pred cCCCcCCCCCCCHHHhCC-C-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-------------
Confidence 677899999999999864 3 8999999999999999999999999999888877765422111111
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+..+|+++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 -------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 -------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 123578999999999999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=394.08 Aligned_cols=255 Identities=32% Similarity=0.544 Sum_probs=207.5
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccCh---hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASW---EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
++|++++.||+|+||.||+|++. .+|+.||+|++++..... ......+|+.+++.++||||+++++++.+.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 68999999999999999999985 689999999998653221 223345799999999999999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS- 152 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~- 152 (417)
|+||||+.|+ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999865 55555433 4589999999999999999999999999999999999996 58999999999975433
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----------------- 236 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----------------- 236 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----------------
T ss_pred CccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 23345668999999999986654 899999999999999999999999998887777666431
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.. .+.+.++.++.+||.+||..||.+|| |++|+++||||+...+
T Consensus 237 --~~-----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 237 --KL-----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp --CC-----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred --CC-----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 11 12245789999999999999999999 8999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=415.68 Aligned_cols=256 Identities=29% Similarity=0.418 Sum_probs=219.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|++..+|+.||||++....... ......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997543211 123446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.|+.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence 999976544444333 34589999999999999999999999999999999999996 4789999999999877666667
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+...++... .+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 234 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-------------------IFY 234 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-------------------CCC
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------CcC
Confidence 7899999999999977665688999999999999999999999988877776666421 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 235 -----------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -----------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 123578999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.57 Aligned_cols=255 Identities=33% Similarity=0.482 Sum_probs=197.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.++.+++.||||+++... ......+|++++++++||||+++++++.+.+.+|+||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 46999999999999999999999999999999997543 223345799999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCCCCc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
+.++.+....... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 9875444433333 4589999999999999999999999999999999999996 5789999999998776655556
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEAD-QMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+ ....+... .+
T Consensus 209 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~-------------------~~ 268 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-------------------EY 268 (349)
T ss_dssp ----CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-------------------CC
T ss_pred cccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-------------------CC
Confidence 778999999999987654 8999999999999999999999998766554 33333211 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+ .....+.++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 269 ~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 269 YF-------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp CC-------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred cc-------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 11 122345689999999999999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=402.94 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=210.3
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCCC-
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMECN- 85 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~~- 85 (417)
.+.||+|+||.||+|.+..+|+.||+|+++.... .......+|++++++|+||||+++++++.+.+.+|+||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 5689999999999999999999999999976432 23344568999999999999999999999999999999999865
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCCCccccCC
Q 044608 86 LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTNYVGS 162 (417)
Q Consensus 86 l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~~~~~~gt 162 (417)
|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||++..+.........+||
T Consensus 173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 251 (373)
T 2x4f_A 173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251 (373)
T ss_dssp EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence 55555443 34589999999999999999999999999999999999993 368999999999987766666677899
Q ss_pred ccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCC
Q 044608 163 RWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLP 242 (417)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (417)
+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...... ++
T Consensus 252 ~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~--- 308 (373)
T 2x4f_A 252 PEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-------------------LE--- 308 (373)
T ss_dssp CTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------------------SC---
T ss_pred CcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------------CC---
Confidence 999999998654 4899999999999999999999999999988887777542111 11
Q ss_pred cccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 243 RANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 243 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...++.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 309 ----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ----DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12234679999999999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=390.26 Aligned_cols=282 Identities=34% Similarity=0.571 Sum_probs=223.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE-----------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ----------- 70 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----------- 70 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 68999999999999999999999999999999987542 222334568999999999999999999873
Q ss_pred ---eCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeecc
Q 044608 71 ---NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFG 145 (417)
Q Consensus 71 ---~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg 145 (417)
+.+.+|+||||++|++.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccCCCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 447899999999987776653 24589999999999999999999999999999999999996 3589999999
Q ss_pred ccccccCC----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 146 LAREIKSG----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 146 ~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 99866432 22345578999999999877566899999999999999999999999999999998888877666555
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+.................+...+....+.++.++.+||.+||+.||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 554443222111111111112233455667899999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=390.41 Aligned_cols=258 Identities=31% Similarity=0.453 Sum_probs=218.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|+++.+|+.||+|++....... ......+|+.++++++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46999999999999999999999999999999997653322 1234568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C----cEEEeecccccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREIK 151 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~~ 151 (417)
+||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999765444444433 45899999999999999999999999999999999999964 4 69999999998877
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------- 235 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-------------- 235 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--------------
T ss_pred ccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--------------
Confidence 666667778999999999986554 89999999999999999999999999888777766643211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+ .......++.++.+||.+||..||++|||++|+|+||||+..
T Consensus 236 -----~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 236 -----DF-------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -----CC-------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -----cc-------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 11 012234678999999999999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=415.83 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=216.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC------------hhhhhhHHHHHHHHhcCCCCeeeeceEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS------------WEDCLNLREVKCLRKLNHSNIVKLKELI 69 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 69 (417)
++|+++++||+|+||+||+|.++.+++.||+|++...... .......+|+.++++|+||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 5899999999999999999999999999999999764322 1123446899999999999999999999
Q ss_pred EeCCEEEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeec
Q 044608 70 QNNNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADF 144 (417)
Q Consensus 70 ~~~~~~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DF 144 (417)
.+...+|+||||+.|+ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999875 55666554 44899999999999999999999999999999999999964 3 6999999
Q ss_pred cccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 145 GLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 145 g~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
|++............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 267 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD---- 267 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 99998877666777899999999999853 389999999999999999999999999998888777754211111
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+..+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 268 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 268 ----------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ----------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ----------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 11224679999999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=382.08 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=218.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..++..||+|++....... .....+|++++++++||||+++++++.+.+.+|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 47999999999999999999999999999999997654332 33456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee---e-CCcEEEeeccccccccCCCCC
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV---S-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl---~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++.........
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9875 54555443 448999999999999999999999999999999999999 3 468999999999887776666
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 166 ~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 227 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP---------------- 227 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred hccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 777899999999998543 89999999999999999999999999888777766643211111
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
......+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 228 ----------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred ----------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 111235789999999999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=392.12 Aligned_cols=279 Identities=28% Similarity=0.534 Sum_probs=220.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEe--CCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQN--NNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv 78 (417)
++|++++.||+|+||.||+|++..+++.||+|+++... .....+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 57999999999999999999999999999999987432 234568999999997 9999999999998 6789999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC-cEEEeeccccccccCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG-IIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~-~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.........
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 99998876665543 289999999999999999999999999999999999997 45 7999999999887776666
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCccchHHHHHHHh--h
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLF-PGASEADQMYKICGVLGSPTMDSWADGLRQAR--A 233 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~--~ 233 (417)
...+||+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+....+.+....+........ .
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 77899999999999977566999999999999999999999888 45566777777766665433222211100000 0
Q ss_pred hhccCCCCCcccccc-----cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 234 IKYQFPQLPRANLSA-----LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
............+.. ....+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 000000000111111 1123789999999999999999999999999999998753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=415.05 Aligned_cols=256 Identities=33% Similarity=0.568 Sum_probs=215.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||+||+|+++.++..||+|++....... ......+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 36999999999999999999999999999999997653222 23345689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++........
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99875 55655544 44899999999999999999999999999999999999953 4599999999988877666
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 195 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 257 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD--------------- 257 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 777899999999999853 389999999999999999999999999998888777654221111
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+..+|+++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 258 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 258 -----------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -----------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11234679999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=416.58 Aligned_cols=256 Identities=36% Similarity=0.598 Sum_probs=219.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|+++.+|+.||||++...... .......+|+.++++++||||+++++++.+.+.+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999754322 22344568999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCC
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~ 154 (417)
||+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 106 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 106 EVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999765 55555433 4589999999999999999999999999999999999993 4689999999998877766
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 248 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL------------- 248 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-------------
T ss_pred ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Confidence 6677789999999999865 3899999999999999999999999999988887777542211111
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+..+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 249 -------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 249 -------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp -------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred -------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 1123578999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=401.38 Aligned_cols=280 Identities=28% Similarity=0.431 Sum_probs=222.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC--------CCCeeeeceEEE---
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN--------HSNIVKLKELIQ--- 70 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~~--- 70 (417)
++|+++++||+|+||.||+|++..+++.||||++.... .......+|+.+++.+. ||||++++++|.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 68999999999999999999999999999999997532 22334468999999985 788999999987
Q ss_pred -eCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeCC-----------
Q 044608 71 -NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQG----------- 137 (417)
Q Consensus 71 -~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~~----------- 137 (417)
+...+|+||||+++++++.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 56689999999999999998877656799999999999999999999999 99999999999999643
Q ss_pred ---------------------------------------cEEEeeccccccccCCCCCccccCCccccCchhhhccCCCC
Q 044608 138 ---------------------------------------IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178 (417)
Q Consensus 138 ---------------------------------------~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 178 (417)
.+||+|||++...... ....+||+.|+|||++.+.. ++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-CC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-CC
Confidence 6999999999876543 45568999999999997665 89
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc-----CCCCCcccc-
Q 044608 179 SKADMWAMGAIMAELFTFCPLFPGAS------EADQMYKICGVLGSPTMDSWADGLRQARAIKYQ-----FPQLPRANL- 246 (417)
Q Consensus 179 ~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~- 246 (417)
.++|||||||++|+|++|..||.+.+ ..+.+..+...+|.+....+............. ........+
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 99999999999999999999998765 567778888888877655443221111000000 000000000
Q ss_pred ------cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 247 ------SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 247 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.......+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0011223567899999999999999999999999999963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=391.90 Aligned_cols=280 Identities=39% Similarity=0.641 Sum_probs=229.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCE------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNR------ 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------ 74 (417)
++|.+.+.||+|+||.||+|+++.+|+.||||++........ .....+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 589999999999999999999999999999999976544332 2344689999999999999999999987654
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+++++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CEEEEECCSEEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred EEEEeccccCCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 59999999987665442 3489999999999999999999999999999999999997 478999999999865432
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH-h
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA-R 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~ 232 (417)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....|.+..+.+....... .
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 3456899999999998775668999999999999999999999999999999999999888887655443321111 1
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+......+....+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1112233344445556677899999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=403.96 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=198.2
Q ss_pred CCceec-ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHH-hcCCCCeeeeceEEEe----CCEE
Q 044608 2 DKYSGF-KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLR-KLNHSNIVKLKELIQN----NNRL 75 (417)
Q Consensus 2 ~~Y~~~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~----~~~~ 75 (417)
++|.+. +.||+|+||+||+|.++.+|+.||||++... ....+|+.++. .++||||++++++|.. ...+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 578887 6899999999999999999999999998642 22357888874 4589999999999876 6679
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccc
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREI 150 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~ 150 (417)
|+||||+.|+ |.+.+..+....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999875 66555544334699999999999999999999999999999999999996 468999999999877
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhCCCCccchHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEAD----QMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~g~~~~~~~~~ 226 (417)
.........+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+..... ....+.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~------------- 280 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------------- 280 (400)
T ss_dssp C-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-------------
T ss_pred CCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-------------
Confidence 666666778999999999998654 48999999999999999999999998765321 111111
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+.++. ..+..++.++.+||++||+.||++|||++|+|+||||...
T Consensus 281 ------~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 281 ------MGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------HTCCCCCT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------cCcccCCC-------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 11222221 1234689999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=426.40 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=220.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++++.||+|+||.||+|+++.+++.||||++++... ........+|..++..+ +||||++++++|++.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999999976422 12223346799999988 79999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc-CCCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK-SGPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~-~~~~ 155 (417)
||||+.|+.+....... ..+++..++.|+.||+.||+|||++||+||||||+||||+ ++.+||+|||+|+... ....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 99999876444444433 4599999999999999999999999999999999999996 5899999999998643 3444
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|... .
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~ 558 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------------N 558 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-------------------C
T ss_pred cccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-------------------C
Confidence 56789999999999996555 899999999999999999999999999988888777521 1
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHcCccccccccCC
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTA-----AEALQHPFFKRCFYAP 291 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~~~~~ 291 (417)
. .+...+++++.+||++||+.||++|+++ +||++||||+...|..
T Consensus 559 ~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 559 V-----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp C-----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred C-----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 1 1234689999999999999999999997 9999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=391.54 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=215.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|++++.||+|+||.||+|++..+|+.||||++........ .....+|++++++++||||+++++++.+.+..|+|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 48999999999999999999999999999999975433222 2345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.|++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++...... ...
T Consensus 135 ~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~ 210 (348)
T 1u5q_A 135 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSF 210 (348)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCC
T ss_pred cCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Ccc
Confidence 99998888776544 56899999999999999999999999999999999999975 89999999999865432 356
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+..+.+..+... .
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------------------~ 269 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------------E 269 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------------------C
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------------C
Confidence 89999999999853 345899999999999999999999999988877766655421 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+. .....+++++.+||.+||+.||++|||++++|+||||..
T Consensus 270 ~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 SPA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCC-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 010 112357899999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=417.28 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=215.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .......+|+++|+.++||||++++++|.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999999754221 12233468999999999999999999999999999999
Q ss_pred eccCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECNLY-QLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~l~-~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.|+.+ ..+.......+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++..........
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 343 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence 99987644 444443334599999999999999999999999999999999999997 4899999999998877666666
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE----ADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
..+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+. .+....+..
T Consensus 344 ~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~------------------- 403 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------------- 403 (576)
T ss_dssp CCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------------------
T ss_pred ccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------------------
Confidence 779999999999997654 89999999999999999999999987642 222222210
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.. ..+...+|+++++||.+||+.||.+|| |++|+++||||+...|
T Consensus 404 ~~-----------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 404 VP-----------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred cc-----------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 01 112346899999999999999999999 8999999999997643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=394.32 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=188.6
Q ss_pred CCceec---ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGF---KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~---~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 77 (417)
++|++. +.||+|+||.||+|.++.+|+.||+|++.... .....+|+.+++.+. ||||+++++++.+...+|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 357775 78999999999999999999999999997542 233458999999997 9999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccccccccCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGLAREIKSG 153 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~a~~~~~~ 153 (417)
||||++++.+....... ..+++.+++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999875444444333 56999999999999999999999999999999999999964 3 7999999999865433
Q ss_pred -CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhhCCCCccchH
Q 044608 154 -PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA-------DQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~g~~~~~~~~ 225 (417)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... +.+..+..
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~----------- 230 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK----------- 230 (325)
T ss_dssp ---------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-----------
T ss_pred CCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-----------
Confidence 3345678999999999986655 899999999999999999999999875432 22222211
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+.++ ...+..+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 231 --------~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 231 --------GDFSFE-------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp --------TCCCCC-------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred --------CCCCCC-------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 111111 11123578999999999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=396.75 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=209.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-------hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-------EDCLNLREVKCLRKLNHSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 74 (417)
++|++++.||+|+||.||+|+++.+|+.||||++....... ......+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 47999999999999999999999999999999997653221 12234579999999999999999999999999
Q ss_pred EEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 75 LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
+++||||+.++ .+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999988653 343333333 4599999999999999999999999999999999999996 47899999999998877
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||......
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------------- 236 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------------- 236 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------------
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------------
Confidence 766677889999999999987765689999999999999999999999652210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.... ......+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 237 -~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -VEAA---------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -TTTC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -Hhhc---------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0000 01123478999999999999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=390.49 Aligned_cols=261 Identities=32% Similarity=0.480 Sum_probs=214.0
Q ss_pred Cceec-ceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGF-KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|.+. +.||+|+||.||+|+++.+|+.||+|++........ .....+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 57777 889999999999999999999999999976543322 334568999999995 699999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCC
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGP 154 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~ 154 (417)
||+.++ +.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.......
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 999875 444443333466999999999999999999999999999999999999964 789999999999877666
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------- 252 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY--------------- 252 (327)
T ss_dssp -----CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------------
T ss_pred ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc---------------
Confidence 666778999999999986554 8999999999999999999999999988887776664322111
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYA 290 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 290 (417)
.......++.++.+||.+||+.||.+|||++|+|+||||+...+.
T Consensus 253 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 253 -----------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp -----------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred -----------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 112234678999999999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=381.70 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=211.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4789999999999999999999999999999999865432211 23346899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|||++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R 164 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-c
Confidence 9999875 54555443 3489999999999999999999999999999999999996 5899999999986554332 3
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~ 224 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EF 224 (279)
T ss_dssp ---CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------------CC
T ss_pred cccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-------------------CC
Confidence 4568999999999986554 899999999999999999999999988877766655321 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
. ....++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 225 ~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 T-----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp C-----------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred C-----------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 1 2234789999999999999999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=382.55 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=198.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhH-HHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~-~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++............. ++...++.++||||+++++++.+++..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999997654433333333 45555788899999999999999999999999
Q ss_pred ccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC
Q 044608 81 CMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~ 156 (417)
|++|++.+.+.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++. +.+||+|||++.........
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 999887766543 2345699999999999999999999998 9999999999999975 89999999999877666555
Q ss_pred ccccCCccccCchhh---hccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 157 TNYVGSRWYRAPEIL---LQSELYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
....||+.|+|||++ .....++.++|||||||++|+|++|..||... .....+..+..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 228 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE------------------ 228 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH------------------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc------------------
Confidence 566899999999997 34455899999999999999999999999864 33333333221
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...+. .....+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 229 ---~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 229 ---EPSPQ-------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---SCCCC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---cCCCC-------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 00111 112357899999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=383.55 Aligned_cols=272 Identities=31% Similarity=0.485 Sum_probs=201.2
Q ss_pred CCceec-ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGF-KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++. +.||+|+||.||+|.+..+++.||||++...... ......+|++++.++ +||||+++++++.+.+.+|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 579996 7899999999999999999999999999765322 234456899999985 7999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccccccccCC-
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGLAREIKSG- 153 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~a~~~~~~- 153 (417)
||++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999865 55555443 45899999999999999999999999999999999999964 3 3999999998765321
Q ss_pred -------CCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 154 -------PPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 154 -------~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....+...... .....
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~ 244 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG----EACPA 244 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--------CCHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc----ccchh
Confidence 12334579999999999864 1347899999999999999999999998764311000000 00000
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.............+.++ ......++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 00000000111111111 11224578999999999999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=395.70 Aligned_cols=281 Identities=35% Similarity=0.531 Sum_probs=223.6
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CC-----CeeeeceEEEeCCE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HS-----NIVKLKELIQNNNR 74 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~~~~ 74 (417)
+++|++.+.||+|+||+||+|+++.+++.||||+++.... ......+|+.+++.++ |+ +|+++++++...+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4789999999999999999999999999999999975321 1223356888888885 44 49999999999999
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCCeeee---CCcEEEeecccccc
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH--QNGFFHRDLKPENLLVS---QGIIKIADFGLARE 149 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH--~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~ 149 (417)
+|+||||+++++.+.+.......+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||++..
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999999999988887765566999999999999999999999 57999999999999994 36799999999987
Q ss_pred ccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
... .....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+....+.+....+.....
T Consensus 211 ~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 211 LGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred ccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 643 345678999999999997665 89999999999999999999999999999999999999888876554432111
Q ss_pred HHhhhhccCCCC-----------------CcccccccC-----------CC-------CCHhHHHHHHHhcccCCCCCCC
Q 044608 230 QARAIKYQFPQL-----------------PRANLSALM-----------PS-------ASQDAISLFESLCSWDPSKRPT 274 (417)
Q Consensus 230 ~~~~~~~~~~~~-----------------~~~~~~~~~-----------~~-------~s~~~~~li~~~L~~dP~~Rpt 274 (417)
... .....+.. ....+.... .+ .++++++||.+||+.||++|||
T Consensus 288 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 288 ARK-FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp HHH-HEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHH-HHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 000 00000000 000000000 00 0147899999999999999999
Q ss_pred HHHHHcCcccccc
Q 044608 275 AAEALQHPFFKRC 287 (417)
Q Consensus 275 a~elL~hp~f~~~ 287 (417)
++|+|+||||++.
T Consensus 367 a~e~L~hp~f~~~ 379 (382)
T 2vx3_A 367 PYYALQHSFFKKT 379 (382)
T ss_dssp HHHHTTSGGGCC-
T ss_pred HHHHhcCcccccC
Confidence 9999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=389.14 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=204.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCC--CCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNH--SNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv 78 (417)
++|++++.||+|+||.||+|.+ .+++.||||++......... ....+|+.++++++| |||+++++++.+.+.+|+|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4799999999999999999987 46899999999765444332 344689999999987 9999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCC---C
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGP---P 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~---~ 155 (417)
|||.++++.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||++....... .
T Consensus 88 ~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 88 MECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp ECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC--------
T ss_pred EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCccccccc
Confidence 998777788777653 45899999999999999999999999999999999999999999999999998765432 2
Q ss_pred CccccCCccccCchhhhc----------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCccch
Q 044608 156 YTNYVGSRWYRAPEILLQ----------SELYSSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~ 224 (417)
....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+.. .
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~------ 236 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---P------ 236 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---T------
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---C------
Confidence 345689999999999864 245899999999999999999999999775432 22222210 0
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.....+....+.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 -------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 237 -------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp -------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred -------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 0001122345789999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=391.04 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=215.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hh-----hhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WE-----DCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~-----~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|++.+.||+|+||.||+|.++.+|+.||||++...... .. .....+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 3699999999999999999999999999999998754321 11 12345899999999 8999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccccc
Q 044608 74 RLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIK 151 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~ 151 (417)
..|+||||++|+ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999875 54444433 4589999999999999999999999999999999999996 4799999999998887
Q ss_pred CCCCCccccCCccccCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQS-----ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 226 (417)
........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------ 325 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS------ 325 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 76666778999999999998632 2478999999999999999999999998887776666543211110
Q ss_pred HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...+...+.++.+||.+||+.||++|||++|+|+||||++
T Consensus 326 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 --------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp --------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred --------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1112457899999999999999999999999999999973
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=381.72 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=214.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc---ChhhhhhHHHHHHHHhcCCCCeeeeceEEE--eCCEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA---SWEDCLNLREVKCLRKLNHSNIVKLKELIQ--NNNRL 75 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 75 (417)
+++|++.+.||+|+||.||+|.+..+++.||+|+++.... ........+|++++++++||||+++++++. +.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4799999999999999999999999999999999975432 122344568999999999999999999984 45688
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~- 153 (417)
|+||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999999988777765566799999999999999999999999999999999999996 589999999999866432
Q ss_pred --CCCccccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 --PPYTNYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------------- 228 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------------- 228 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------------
Confidence 2234567999999999986533 3478999999999999999999999988876665554321
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+ .+...+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 229 ----~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 229 ----SY-----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ----CC-----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ----CC-----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 11 12245789999999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=395.85 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=205.8
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcC--CCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLN--HSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|++++.||+|+||.||+|.+.. ++.||||++........ .....+|+.++++|. ||||+++++++...+.+|+||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 59999999999999999999865 99999999976544332 334568999999996 599999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCC---CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGP---PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~---~~ 156 (417)
|+.+++|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||++..+.... ..
T Consensus 136 E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 ECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp ECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------
T ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccC
Confidence 97777777776553 35899999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccCCccccCchhhhc----------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCccchH
Q 044608 157 TNYVGSRWYRAPEILLQ----------SELYSSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~ 225 (417)
...+||+.|+|||++.+ ...++.++||||||||+|+|++|.+||.+.... ..+..+...
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---------- 283 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---------- 283 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT----------
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc----------
Confidence 45689999999999864 134899999999999999999999999875432 333322210
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... ..+....+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 284 ---------~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 ---------NHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ---------TSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---------ccc---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 000 11223457899999999999999999999999999999853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=382.79 Aligned_cols=252 Identities=27% Similarity=0.494 Sum_probs=213.5
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECME 83 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 83 (417)
|+..+.||+|+||.||+|+++.+|+.||||++...... ......+|+.++++++||||+++++++...+.+|+||||+.
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 77888999999999999999999999999999754332 23345689999999999999999999999999999999998
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccccC
Q 044608 84 CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNYVG 161 (417)
Q Consensus 84 ~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~~g 161 (417)
++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ......+|
T Consensus 126 ~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 126 GGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp SCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 8766666543 4589999999999999999999999999999999999997 589999999999876543 23456689
Q ss_pred CccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCC
Q 044608 162 SRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241 (417)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 241 (417)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.... .+..
T Consensus 204 t~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------~~~~ 261 (321)
T 2c30_A 204 TPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---------------------PPKL 261 (321)
T ss_dssp CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------------CCCC
T ss_pred CccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------------CCCc
Confidence 99999999986554 8999999999999999999999999888777665553210 0000
Q ss_pred CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 242 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.....+++++.+||.+||+.||++|||++|+|+||||..
T Consensus 262 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 262 ------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 011246889999999999999999999999999999976
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=410.60 Aligned_cols=257 Identities=30% Similarity=0.424 Sum_probs=213.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|+++.+|+.||+|++.+..... ......+|++++++++||||++++++|.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997543221 1233468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 80 ECMECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 80 E~~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
||+.|+.+....... ...+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||++..+.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999876554444332 34699999999999999999999999999999999999996 58999999999987765443
Q ss_pred -CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCccchHHHHHH
Q 044608 156 -YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE----ADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 156 -~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+. .+....+..
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~---------------- 407 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE---------------- 407 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----------------
T ss_pred ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----------------
Confidence 34569999999999997654 89999999999999999999999987642 333333221
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
.. ..+...+++++.+||.+||+.||.+||+ ++++++||||+...|
T Consensus 408 ---~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 408 ---QA-----------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ---CC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ---cc-----------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 01 1123467999999999999999999996 589999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=383.92 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=200.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-------- 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 73 (417)
++|++++.||+|+||.||+|+++.+|+.||||++.............+|++++++|+||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 579999999999999999999999999999999986554444455678999999999999999999986543
Q ss_pred -------------------------------------------------EEEEEEeccCCCHHHHHHHhcC--CCCCHHH
Q 044608 74 -------------------------------------------------RLYLVFECMECNLYQLMAARDR--KLFSEPE 102 (417)
Q Consensus 74 -------------------------------------------------~~~lv~E~~~~~l~~~~~~~~~--~~l~e~~ 102 (417)
.+|+||||++++.+..+..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999998865555444322 2346667
Q ss_pred HHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-------------CCccccCCccccCc
Q 044608 103 IKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-------------PYTNYVGSRWYRAP 168 (417)
Q Consensus 103 i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-------------~~~~~~gt~~y~aP 168 (417)
++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .....+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999999999999999999999997 5899999999998765432 23446799999999
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccc
Q 044608 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSA 248 (417)
Q Consensus 169 E~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (417)
|++.+.. ++.++|||||||++|+|++|..|+.. ....+..... ..+ ..
T Consensus 246 E~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~------------------~~~--------~~ 293 (332)
T 3qd2_B 246 EQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRN------------------LKF--------PL 293 (332)
T ss_dssp HHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHT------------------TCC--------CH
T ss_pred HHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhc------------------cCC--------Cc
Confidence 9987655 89999999999999999998776521 1111111000 000 11
Q ss_pred cCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 249 LMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 249 ~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.....++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11234678899999999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=375.40 Aligned_cols=257 Identities=32% Similarity=0.520 Sum_probs=212.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|++..+|+.||+|+++...... ......+|+.++++++||||+++++++.+.+.+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 47999999999999999999999999999999997653321 1334568999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C----cEEEeeccccccc
Q 044608 77 LVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREI 150 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~ 150 (417)
+||||+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999765 55554433 45899999999999999999999999999999999999964 3 7999999999877
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 227 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN-------------- 227 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------
T ss_pred cCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc--------------
Confidence 6665566678999999999986554 8999999999999999999999999988777666553211
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.+ .....+.++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 228 -----~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 228 -----YDF-------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp -----CCC-------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -----cCC-------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 100 112234678999999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=402.35 Aligned_cols=258 Identities=32% Similarity=0.499 Sum_probs=199.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-------hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-------WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 74 (417)
++|++.+.||+|+||.||+|.++.+++.||+|++...... .......+|+.+|++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 6899999999999999999999999999999999754321 11123468999999999999999999985 456
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccc
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREI 150 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~ 150 (417)
+|+||||+.++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||++...
T Consensus 214 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred eEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 8999999987644333322 356899999999999999999999999999999999999953 35999999999987
Q ss_pred cCCCCCccccCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
.........+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+......+.....
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-------------- 358 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-------------- 358 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH--------------
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh--------------
Confidence 76666677899999999999853 34578999999999999999999999987543322222111
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...+. .....+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 359 ----~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 359 ----SGKYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----TTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----cCCCC-------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 00110 112233567999999999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=374.86 Aligned_cols=259 Identities=31% Similarity=0.462 Sum_probs=217.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc---C-----hhhhhhHHHHHHHHhcC-CCCeeeeceEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA---S-----WEDCLNLREVKCLRKLN-HSNIVKLKELIQN 71 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~---~-----~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 71 (417)
.++|++.+.||+|+||.||+|.++.+|+.||+|++..... . .......+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975431 1 11223458999999995 9999999999999
Q ss_pred CCEEEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccccc
Q 044608 72 NNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLARE 149 (417)
Q Consensus 72 ~~~~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~ 149 (417)
.+.+|+||||++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999865 55555443 4589999999999999999999999999999999999996 47899999999988
Q ss_pred ccCCCCCccccCCccccCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQ-----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
..........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 245 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-------- 245 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC--------
Confidence 776666677789999999999852 3447899999999999999999999999888777666554321
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.++. ...+.++.++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 246 -----------~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 246 -----------YQFGS-------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -----------CCCCT-------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -----------cccCc-------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 11110 1123568999999999999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=378.72 Aligned_cols=256 Identities=30% Similarity=0.452 Sum_probs=190.3
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999999999999999997543211 123446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~ 156 (417)
|||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ...
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 999987655555555446689999999999999999999999999999999999996 578999999999876532 223
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+. ...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------------~~~- 228 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------------LAD- 228 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------------SSC-
T ss_pred eeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------------hcc-
Confidence 4567999999999986554 8999999999999999999999998765433322110 000
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......++.++.+||.+||..||++|||++++|+||||+..
T Consensus 229 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 ----------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ----------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 01234578999999999999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=384.51 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=215.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999765432 22334468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccC-CCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS-GPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~-~~~~~ 157 (417)
||++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..... .....
T Consensus 121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 999876544444433 45899999999999999999999999999999999999974 7899999999987653 23345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+... .+
T Consensus 200 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~~- 258 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------------EY- 258 (335)
T ss_dssp CCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------------CC-
T ss_pred ccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------------------CC-
Confidence 568999999999987654 899999999999999999999999988776665544311 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.+...+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 259 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 259 ----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 12235789999999999999999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=382.19 Aligned_cols=279 Identities=27% Similarity=0.461 Sum_probs=222.3
Q ss_pred CCceecceecccCceEEEEEEE-CCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC------CeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS------NIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~~ 74 (417)
++|++++.||+|+||.||+|.+ ..+|+.||+|+++... .......+|+++++.++|+ +|+++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 6899999999999999999998 5689999999997532 2223445799999988765 49999999999999
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-------------------
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS------------------- 135 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~------------------- 135 (417)
+|+||||+++++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999988898888776555789999999999999999999999999999999999995
Q ss_pred -CCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 136 -QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 136 -~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp SCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred cCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 346999999999864432 34568999999999987655 89999999999999999999999999999888888887
Q ss_pred hhCCCCccchHHHHH----------------HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 215 VLGSPTMDSWADGLR----------------QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
..+......+..... ........... ...........++++.+||.+||..||.+|||++|+
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP--LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC--GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc--hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 777655433322110 00000000000 000011112345789999999999999999999999
Q ss_pred HcCcccccc
Q 044608 279 LQHPFFKRC 287 (417)
Q Consensus 279 L~hp~f~~~ 287 (417)
|+||||+..
T Consensus 327 l~hp~f~~~ 335 (339)
T 1z57_A 327 LKHPFFDLL 335 (339)
T ss_dssp TTSGGGGGG
T ss_pred hcCHHHHHH
Confidence 999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=374.40 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=205.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998754221 1122446899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.++ +.+.+... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 9999764 55555443 3489999999999999999999999999999999999997 478999999999877665555
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
....||+.|+|||++.+....+.++|||||||++|+|++|..||......+....+... ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~ 228 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-------------------VF 228 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CC
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------------cc
Confidence 66789999999999876654578999999999999999999999888776655544211 01
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....++.++.+||.+||+.||.+|||++|+++||||++.
T Consensus 229 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 -----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 1223568899999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=388.53 Aligned_cols=260 Identities=29% Similarity=0.412 Sum_probs=210.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccc----cChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY----ASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .........+|++++++++||||+++++++.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 47999999999999999999999999999999987542 12233445689999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHh---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Q 044608 78 VFECMECNLYQLMAAR---------------------------------------DRKLFSEPEIKAWLFQVFQGLSYMH 118 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~---------------------------------------~~~~l~e~~i~~i~~qi~~aL~~LH 118 (417)
||||++|+.+..+... ....+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999987655444321 0112467889999999999999999
Q ss_pred HCCcccccCCCCCeeeeC-C--cEEEeeccccccccCCC-----CCccccCCccccCchhhhcc-CCCCchhhHHHHHHH
Q 044608 119 QNGFFHRDLKPENLLVSQ-G--IIKIADFGLAREIKSGP-----PYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAI 189 (417)
Q Consensus 119 ~~gi~HrDLKp~NILl~~-~--~vkL~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~i 189 (417)
++||+||||||+|||++. + .+||+|||++..+.... ......||+.|+|||++.+. ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 999999999999999963 4 79999999998653321 23456899999999998642 458999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCC
Q 044608 190 MAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDP 269 (417)
Q Consensus 190 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 269 (417)
+|+|++|..||.+.+..+....+........ ......+++++.+||.+||+.||
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFE--------------------------NPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT--------------------------SGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccC--------------------------CcccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999988887776653211100 01113468999999999999999
Q ss_pred CCCCCHHHHHcCcccccc
Q 044608 270 SKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 270 ~~Rpta~elL~hp~f~~~ 287 (417)
.+|||+.|+|+||||++.
T Consensus 320 ~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 320 DERFDAMRALQHPWISQF 337 (345)
T ss_dssp TTSCCHHHHHHSHHHHTT
T ss_pred hHCCCHHHHhcChhhccC
Confidence 999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=375.79 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=211.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.++.+++.||+|++.............+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999999999999999997654444445557899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC---CCCc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG---PPYT 157 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~---~~~~ 157 (417)
++++.+...... ...+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... ....
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 987543333322 245899999999999999999999999999999999999974 88999999999765422 2245
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+............. ....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~~~ 227 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------------KKTY 227 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT------------------TCTT
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh------------------cccc
Confidence 5689999999999976665688999999999999999999999876543222111100 0000
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 228 ---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 01123578999999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=372.66 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=206.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc-ChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA-SWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|.+..+++.||+|++..... ........+|+..+..+ +||||+++++++.+.+.+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 479999999999999999999999999999999986533 33344557899999999 9999999999999999999999
Q ss_pred eccCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--------------------
Q 044608 80 ECMEC-NLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-------------------- 136 (417)
Q Consensus 80 E~~~~-~l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-------------------- 136 (417)
||+++ +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99977 5555554432 255899999999999999999999999999999999999962
Q ss_pred CcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 044608 137 GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVL 216 (417)
Q Consensus 137 ~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 216 (417)
..+||+|||++....... ...||+.|+|||++.+...++.++|||||||++|+|++|.+++....... .+.
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~--- 241 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR--- 241 (289)
T ss_dssp CCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHH---
T ss_pred eEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHH---
Confidence 269999999998765432 34699999999999776567789999999999999999998875543221 111
Q ss_pred CCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 217 GSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 217 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.. ....+...+++++.+||.+||..||++|||+.|+|+||||+.
T Consensus 242 ------------------~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 242 ------------------QG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp ------------------TT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred ------------------cC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 00 112233568999999999999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=374.54 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=214.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+|+++++.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999986542211 123446899999999999999999999999999999
Q ss_pred EeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC
Q 044608 79 FECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.+ ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... ..
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CB
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-cc
Confidence 999976 565555544 3489999999999999999999999999999999999996 589999999998765443 23
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+... ..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~~ 229 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------------DL 229 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------CC
T ss_pred ccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------------cc
Confidence 4568999999999987654 899999999999999999999999988877766555321 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+.+.++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 230 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 -----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1224578999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=373.81 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=214.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57999999999999999999999999999999997654322 2334468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~ 157 (417)
||++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .....
T Consensus 95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 999876554444433 4589999999999999999999999999999999999997 47899999999987653 23345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
...||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+... ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~- 232 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------------EY- 232 (294)
T ss_dssp CCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------CC-
T ss_pred cccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------------cC-
Confidence 568999999999986554 899999999999999999999999988876665544210 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+...+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 233 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 233 ----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ----------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 1224578999999999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=383.12 Aligned_cols=279 Identities=25% Similarity=0.461 Sum_probs=223.2
Q ss_pred CCceecceecccCceEEEEEEECCCC-cEEEEEEecccccChhhhhhHHHHHHHHhcCCCC------eeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN------IVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~~~ 74 (417)
++|++++.||+|+||.||+|.+..++ +.||+|+++... .......+|+.+++.++|++ ++.+++++...+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 68999999999999999999998877 689999997532 22334457999999987665 9999999999999
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee-------------------e
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-------------------S 135 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl-------------------~ 135 (417)
+|+||||+++++++.+.......+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 999999999999998887665679999999999999999999999999999999999999 2
Q ss_pred -CCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 136 -QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 136 -~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp SCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 468999999999864433 34568999999999997655 89999999999999999999999999999888888888
Q ss_pred hhCCCCccchHHHHH----------------HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 215 VLGSPTMDSWADGLR----------------QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
..+..+...+..... .........+.. ..........+.++.+||.+||+.||++|||++|+
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL--KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG--GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc--cccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 777665433322110 000000000000 00000111235689999999999999999999999
Q ss_pred HcCcccccc
Q 044608 279 LQHPFFKRC 287 (417)
Q Consensus 279 L~hp~f~~~ 287 (417)
|+||||+..
T Consensus 332 l~hp~f~~~ 340 (355)
T 2eu9_A 332 LLHPFFAGL 340 (355)
T ss_dssp TTSGGGGGC
T ss_pred hcChhhcCC
Confidence 999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=377.32 Aligned_cols=255 Identities=33% Similarity=0.528 Sum_probs=212.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4799999999999999999999999999999999754322 223456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee---e-CCcEEEeeccccccccCCCCC
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV---S-QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl---~-~~~vkL~DFg~a~~~~~~~~~ 156 (417)
++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++...... ..
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence 9764 55555544 358999999999999999999999999999999999999 3 468999999998754432 33
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.... +
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------------~ 224 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-------------------Y 224 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-------------------C
T ss_pred ccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------------C
Confidence 4567999999999986554 8999999999999999999999999988777766654321 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.++ ....+.+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 225 ~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 225 EFE-------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCC-------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCC-------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 111 12335678999999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=384.73 Aligned_cols=277 Identities=22% Similarity=0.313 Sum_probs=209.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--EEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN--RLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.+..+|+.||||++.............+|++++++++||||+++++++...+ .+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 479999999999999999999999999999999976543333344568999999999999999999998765 889999
Q ss_pred eccCCCHH-HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee----eC-CcEEEeeccccccccC
Q 044608 80 ECMECNLY-QLMAARD-RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV----SQ-GIIKIADFGLAREIKS 152 (417)
Q Consensus 80 E~~~~~l~-~~~~~~~-~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl----~~-~~vkL~DFg~a~~~~~ 152 (417)
||+.++.+ +.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +. +.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99986544 4444322 2238999999999999999999999999999999999998 32 4699999999998877
Q ss_pred CCCCccccCCccccCchhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhCCCCc
Q 044608 153 GPPYTNYVGSRWYRAPEILLQ-------SELYSSKADMWAMGAIMAELFTFCPLFPGASE----ADQMYKICGVLGSPTM 221 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~~~~ 221 (417)
.......+||+.|+|||++.. ...++.++|||||||++|||++|..||..... .+.+..+.........
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 766677889999999999863 34589999999999999999999999975432 3444444332111111
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
..+... ....+.+.... .....+...++..+.+||.+||+.||++|||++|+|+||=
T Consensus 249 ~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 249 SGVQKA----ENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp EEEECS----TTCCEEEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred hhhhcc----cCCccccCccC-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 110000 00000000000 0001122335668999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=381.93 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=208.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcCCCCeeeeceEEEeCC----EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLNHSNIVKLKELIQNNN----RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~ 75 (417)
++|++.+.||+|+||.||+|++..+++.||+|++......... ....+|++++++++||||+++++++.... .+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999999999999999999865433222 23468999999999999999999987654 45
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||++|+.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 9999999865444444333 4589999999999999999999999999999999999996 5789999999998664332
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------------- 236 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------------- 236 (311)
T ss_dssp -----------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------------
Confidence 223457999999999987654 89999999999999999999999999888776655432110
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccccCCC
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 292 (417)
.........++.++.+||.+||+.||++||++.++|.|+|++.....++
T Consensus 237 -------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 237 -------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp -------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred -------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 0112234568999999999999999999999999999999986544443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=374.79 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=209.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 589999999999999999999999999999999976432 23446899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
++++.+..+.......+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... ......
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence 988655554443446699999999999999999999999999999999999996 589999999999766543 233456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+.... .+
T Consensus 186 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~ 243 (314)
T 3com_A 186 IGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP---------------------PP 243 (314)
T ss_dssp CSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---------------------CC
T ss_pred CCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC---------------------Cc
Confidence 8999999999986554 8999999999999999999999998887666554432110 00
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
. ......++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 ~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 T------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp C------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred c------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 01123468899999999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=386.23 Aligned_cols=277 Identities=22% Similarity=0.335 Sum_probs=211.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++.............+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57999999999999999999999999999999998664444444567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
++++.+..+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 190 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF 190 (360)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCC
Confidence 9875444444333 3589999999999999999999996 999999999999996 589999999999755332 23456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC-CCccchHH------------
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS-PTMDSWAD------------ 226 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~-~~~~~~~~------------ 226 (417)
+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...... .....+..
T Consensus 191 ~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 8999999999987654 899999999999999999999999988766554332111111 00000000
Q ss_pred -------HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 227 -------GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
............+. ......++.++.+||.+||+.||++|||++|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPP------KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCC------CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCcccchhhhhHHhccCCC------CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000000000000 01113478999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.95 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=216.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|++..+++.||+|++.............+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 47999999999999999999999999999999997665444445567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~~~ 159 (417)
++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .....
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 988655555543 4589999999999999999999999999999999999996 4789999999998765432 33456
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
.||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+...
T Consensus 180 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------------ 234 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN------------------------ 234 (303)
T ss_dssp CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------------------
T ss_pred CCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC------------------------
Confidence 8999999999986654 899999999999999999999999888776655443210
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
....+...++.++.+||.+||+.||.+|||++|+|+||||..
T Consensus 235 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 235 -----NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -----CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -----CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 011223467899999999999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=384.55 Aligned_cols=282 Identities=28% Similarity=0.414 Sum_probs=219.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----------CCCeeeeceEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----------HSNIVKLKELIQ 70 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~ 70 (417)
++|++++.||+|+||.||+|.+..+|+.||||++..... ......+|+.++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 689999999999999999999999999999999975321 2233457999998886 899999999998
Q ss_pred eCC----EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeeeC-------Cc
Q 044608 71 NNN----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVSQ-------GI 138 (417)
Q Consensus 71 ~~~----~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~~-------~~ 138 (417)
..+ .+++||||+++++.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++. +.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 654 78999999977888887765556699999999999999999999998 9999999999999941 26
Q ss_pred EEEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Q 044608 139 IKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS------EADQMYKI 212 (417)
Q Consensus 139 vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i 212 (417)
+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..+.+..+
T Consensus 177 ~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 999999999876543 34568999999999997655 8999999999999999999999998765 56677778
Q ss_pred HHhhCCCCccchHHHHHHHhhhhc-----cCCCCCccc-------ccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 213 CGVLGSPTMDSWADGLRQARAIKY-----QFPQLPRAN-------LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 213 ~~~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
...+|..+...+............ ......... ...+....+.++.+||.+||+.||++|||++|+|+
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 888887665443322111000000 000000000 00112235678999999999999999999999999
Q ss_pred Cccccccc
Q 044608 281 HPFFKRCF 288 (417)
Q Consensus 281 hp~f~~~~ 288 (417)
||||++..
T Consensus 334 hp~f~~~~ 341 (373)
T 1q8y_A 334 HPWLKDTL 341 (373)
T ss_dssp CGGGTTCT
T ss_pred Chhhhccc
Confidence 99998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=369.06 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=206.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe----CCEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN----NNRLYL 77 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~l 77 (417)
.|++.+.||+|+||.||+|.+..++..||+|++........ .....+|+.+++.++||||+++++++.. ...+|+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 48899999999999999999999999999999986544433 3344689999999999999999999875 466899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeee--CCcEEEeeccccccccCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVS--QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~ 153 (417)
||||++++.+..+.... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999875444444433 45899999999999999999999999 99999999999996 478999999999754433
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+..............
T Consensus 186 -~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------------- 245 (290)
T 1t4h_A 186 -FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG----------------- 245 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-----------------
T ss_pred -ccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-----------------
Confidence 3345689999999998753 3 8999999999999999999999998866554443322100
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..........++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 246 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 246 ----------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0001122346789999999999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=377.99 Aligned_cols=265 Identities=28% Similarity=0.428 Sum_probs=192.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+|+.++++++||||+++++++...+..|+||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 68999999999999999999999999999999987554333334456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 82 MECN-LYQLMAAR------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 82 ~~~~-l~~~~~~~------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+.++ +.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9765 44444321 234589999999999999999999999999999999999996 589999999998765432
Q ss_pred C------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 154 P------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 154 ~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
. ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.........
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 243 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND----------- 243 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-----------
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-----------
Confidence 1 12345799999999998764558999999999999999999999998877655443332110
Q ss_pred HHHHhhhhccCCCC-CcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 228 LRQARAIKYQFPQL-PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 228 ~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+.. ...........++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 244 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 ----------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ----------CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ----------CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0000 0011123345688999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=374.34 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=209.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 5899999999999999999999999999999998754322 233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~~~ 159 (417)
++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... .......
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 988766665554446699999999999999999999999999999999999997 58999999998754321 1222345
Q ss_pred cCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.||+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 238 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD------------------- 238 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------------
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-------------------
Confidence 7999999999984 34458999999999999999999999999888776655543210
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+. ......++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 239 --~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 239 --PPT------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp --CCC------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred --Ccc------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 000 01123468899999999999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=371.18 Aligned_cols=256 Identities=35% Similarity=0.589 Sum_probs=216.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||.||+|.+..+++.||+|++...... .......+|++++++++||||+++++++.+.+.+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 4799999999999999999999999999999999755432 223445689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccccccccCCCC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~~~~~~~ 155 (417)
|+.++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++........
T Consensus 102 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99765 55555544 34899999999999999999999999999999999999953 3699999999987766655
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.....||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 180 ~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 238 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK------------------- 238 (287)
T ss_dssp CSCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------
T ss_pred cccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 566679999999999854 3 8999999999999999999999999988777666554311
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+.++ ......++.++.+||.+||..||++|||++|+|+||||++.
T Consensus 239 ~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 239 YAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CCCC-------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCC-------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1110 01124578999999999999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=387.21 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=206.4
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccC---hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 74 (417)
++|++++.||+|+||.||+|++. .+|+.||||+++..... .......+|+++++.+ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 58999999999754321 1122335799999999 69999999999999999
Q ss_pred EEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 75 LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
+|+||||++++ |.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999875 55555443 3589999999999999999999999999999999999996 57999999999986543
Q ss_pred C--CCCccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 153 G--PPYTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 153 ~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+...
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------- 277 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------------- 277 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--------------
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH--------------
Confidence 2 223456899999999998753 34789999999999999999999999754322111111110
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
..... ..+...++..+.+||.+||..||.+|| |++|+++||||+...+
T Consensus 278 ----~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 278 ----ILKSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ----HHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----HhccC--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 00000 122356789999999999999999999 9999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=380.96 Aligned_cols=257 Identities=33% Similarity=0.533 Sum_probs=204.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-------hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-------WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 74 (417)
++|++.+.||+|+||.||+|.+..+++.||||++...... .......+|++++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4799999999999999999999999999999999754321 11123468999999999999999999997765
Q ss_pred EEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeecccccc
Q 044608 75 LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGLARE 149 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~a~~ 149 (417)
+|+||||+.++ +.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999875 5554433 246899999999999999999999999999999999999963 3 499999999987
Q ss_pred ccCCCCCccccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
..........+||+.|+|||++. +...++.++|||||||++|+|++|..||........+.....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 233 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT------------- 233 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH-------------
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH-------------
Confidence 65544444567999999999984 244589999999999999999999999976543322211110
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...+. ........++.++.+||.+||..||++|||++|+|+||||+.
T Consensus 234 -----~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 234 -----SGKYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----HTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----hCccc-------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 00000 112233567899999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=397.28 Aligned_cols=246 Identities=17% Similarity=0.225 Sum_probs=196.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHH---HHHHhcCCCCeeeec-------eEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREV---KCLRKLNHSNIVKLK-------ELI 69 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~---~~l~~l~hpnIv~l~-------~~~ 69 (417)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ........+|+ ++++.++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 469999999999999999999999999999999975422 22234456899 555566899999998 777
Q ss_pred EeCCE-----------------EEEEEeccCCCHHHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcccc
Q 044608 70 QNNNR-----------------LYLVFECMECNLYQLMAARDRKLFSE-------PEIKAWLFQVFQGLSYMHQNGFFHR 125 (417)
Q Consensus 70 ~~~~~-----------------~~lv~E~~~~~l~~~~~~~~~~~l~e-------~~i~~i~~qi~~aL~~LH~~gi~Hr 125 (417)
++.+. .|+||||++|+|.+.+..... +++ ..++.++.||+.||+|||++||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 76543 899999998888887765432 444 7888899999999999999999999
Q ss_pred cCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCccccCchhhhcc----------CCCCchhhHHHHHHHHHHHH
Q 044608 126 DLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS----------ELYSSKADMWAMGAIMAELF 194 (417)
Q Consensus 126 DLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell 194 (417)
||||+|||++ ++.+||+|||+|..... .....+| +.|+|||++.+. ..++.++|||||||++|||+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999996 58999999999986433 3445678 999999999765 24899999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC
Q 044608 195 TFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT 274 (417)
Q Consensus 195 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 274 (417)
+|..||.+.+..+.... +....+.+++++.+||.+||+.||++|||
T Consensus 308 tg~~Pf~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 308 CADLPITKDAALGGSEW----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HSSCCC------CCSGG----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HCCCCCcccccccchhh----------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 99999976543221111 11122567999999999999999999999
Q ss_pred HHHHHcCccccc
Q 044608 275 AAEALQHPFFKR 286 (417)
Q Consensus 275 a~elL~hp~f~~ 286 (417)
+.|+|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=372.33 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=193.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhH-HHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~-~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+++|++++.||+|+||.||+|.++.+|+.||||++............+ ++..+++.++||||+++++++.+.+.+|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999999999999997654333333333 4555788889999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||++ +++..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||++..........
T Consensus 104 e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 104 ELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp CCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred eccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence 9995 444455444446699999999999999999999996 999999999999996 5799999999998776655555
Q ss_pred cccCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 158 NYVGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
...||+.|+|||++. ....++.++|||||||++|+|++|..||... ...+.+..+...
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------------- 245 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE----------------- 245 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-----------------
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-----------------
Confidence 678999999999985 2345889999999999999999999999874 344444433211
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
..+. ......+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 246 ----~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 246 ----EPPL------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ----CCCC------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ----CCCC------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0000 01123578999999999999999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=370.86 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=205.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEe------CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQN------NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------~~~ 74 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+|+.+++++ +||||+++++++.. .+.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 6899999999999999999999999999999998754322 33456899999999 79999999999987 568
Q ss_pred EEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 75 LYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
+|+||||++++ +.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999874 55555544335689999999999999999999999999999999999996 57899999999986653
Q ss_pred C-CCCccccCCccccCchhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 153 G-PPYTNYVGSRWYRAPEILLQ----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
. ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 249 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------------ 249 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------
Confidence 3 22345689999999999852 345899999999999999999999999888876665544321
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+ ......++.++.+||.+||..||.+|||++|+|+||||+.
T Consensus 250 ---------~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 250 ---------PAP-------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp ---------CCC-------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred ---------ccc-------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 000 1112457899999999999999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=367.10 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=206.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++++.||+|+||.||+|.+..+++.||+|++........ .....+|+.++++++||||+++++++.+.+.+|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 589999999999999999999999999999999865433222 234468999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CC
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PY 156 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~ 156 (417)
||++|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 999876544444433 4589999999999999999999999999999999999996 5789999999998765432 23
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+...+....
T Consensus 170 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--------------------- 227 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--------------------- 227 (294)
T ss_dssp -----CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS---------------------
T ss_pred CccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc---------------------
Confidence 4467999999999987655 899999999999999999999999998876655443210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
.. ........+.+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 228 ~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 228 SV----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CC----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred cC----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 01 1111234467899999999999999999999777777777654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=373.25 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=190.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHH-HHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVK-CLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.++|++++.||+|+||.||+|.++.+|+.||||++.............+|+. +++.++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3689999999999999999999999999999999986544333444455665 677789999999999999999999999
Q ss_pred eccCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 80 ECMECNLYQLMAA---RDRKLFSEPEIKAWLFQVFQGLSYMHQN-GFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 80 E~~~~~l~~~~~~---~~~~~l~e~~i~~i~~qi~~aL~~LH~~-gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
||+++++.+.+.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++ ++.+||+|||++.......
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 9999987766653 2246689999999999999999999999 999999999999996 5789999999998776555
Q ss_pred CCccccCCccccCchhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 PYTNYVGSRWYRAPEILL---QSELYSSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------------ 242 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------------------ 242 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC------------------
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH------------------
Confidence 555568999999999983 2344899999999999999999999999765432 111000
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.....+. ........+++++.+||.+||+.||++|||+.|+++||||...
T Consensus 243 ---~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 243 ---VKGDPPQ----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ---CCSCCCC----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---hcCCCCC----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 0000000 0112234678999999999999999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=373.72 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=206.9
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.+..+|+ .||||+++............+|+.++++++||||+++++++.+.+.+|+|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 579999999999999999999987665 49999998665444455567899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 999987655555544445699999999999999999999999999999999999996 47899999999987654322
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---------------- 271 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---------------- 271 (325)
T ss_dssp EECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------------
T ss_pred eeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------------
Confidence 22345678899999997655 8999999999999999999 999999988877766653210
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......+++++.+||.+||..||.+|||+.|+++
T Consensus 272 ----~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ----R---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----C---------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 1122467899999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=364.11 Aligned_cols=256 Identities=27% Similarity=0.485 Sum_probs=211.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (417)
+++|++++.||+|+||.||+|.++.+|+.||+|++....... ......+|+.++++++||||+++++++.+ ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999999999999999997654333 23345689999999999999999998854 678999
Q ss_pred EEeccCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCCeeee-CCcEEEeeccccc
Q 044608 78 VFECMEC-NLYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNG-----FFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 78 v~E~~~~-~l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~g-----i~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
||||+++ +|.+.+... ....+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999987 565555432 2345899999999999999999999999 99999999999997 5789999999998
Q ss_pred cccCCCC-CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 149 EIKSGPP-YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 149 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------------ 231 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------------ 231 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred eeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc------------
Confidence 6544321 23457899999999987654 899999999999999999999999988876666555321
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.. ..+...++.++.+||.+||..||.+|||++|+|+|+|+..
T Consensus 232 ---------~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 ---------KF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------cc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 01 1223467899999999999999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=380.81 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=210.3
Q ss_pred CCceecceecccCceEEEEEE-----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|. +..+++.||||+++............+|+.++++++||||+++++++.+....|
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 579999999999999999999 556788999999976544444455678999999999999999999999999999
Q ss_pred EEEeccCC-CHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccc
Q 044608 77 LVFECMEC-NLYQLMAARDR-----KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~-~l~~~~~~~~~-----~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~ 146 (417)
+||||+.+ +|.+.+..... ..+++.+++.++.||+.||.|||++||+||||||+|||++. | .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999976 45555554321 35899999999999999999999999999999999999962 2 599999999
Q ss_pred cccccC---CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKS---GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
++.... ........||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~------ 303 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG------ 303 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 975432 22334567899999999987665 8999999999999999998 999999988877766654210
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.......++.++.+||.+||+.||.+|||++|+++|.++..
T Consensus 304 -----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 -----------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 01122457889999999999999999999999999988743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=378.65 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=205.8
Q ss_pred CCceecceecccCceEEEEEEEC-------CCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-------HTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|++.+.||+|+||.||+|.+. .++..||+|+++............+|+.+++.+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57999999999999999999864 345689999998664444444567899999999 8999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|+||||+.++ |.+.+.... ...+++.+++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 999999999875 555544332 13479999999999999999999999999999999999996 58
Q ss_pred cEEEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++..+.... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 99999999998665432 233456789999999987655 8999999999999999999 999999887666554442
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. . .......++.++.+||.+||+.||.+|||+.|++++
T Consensus 320 ~~---------------------~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 EG---------------------H--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TT---------------------C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---------------------C--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 0 011234678999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=361.20 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=204.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|.....||+|+||.||+|.+..+++.||+|.+..... .......+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 456666799999999999999999999999999976532 2233456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccccCC-CCC
Q 044608 82 MECNLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREIKSG-PPY 156 (417)
Q Consensus 82 ~~~~l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~~-~~~ 156 (417)
+.++.+..+.... ...+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++...... ...
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9765444444433 23467999999999999999999999999999999999997 578999999999876543 223
Q ss_pred ccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQM-YKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
....||+.|+|||++.+. ..++.++|||||||++|+|++|..||......... ....
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------------- 239 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--------------------- 239 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH---------------------
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc---------------------
Confidence 456899999999998654 33789999999999999999999999765433221 1110
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.... ...+...+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 240 ~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 240 MFKV-------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHCC-------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cccc-------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0000 012334678999999999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=383.53 Aligned_cols=261 Identities=15% Similarity=0.186 Sum_probs=189.3
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--hhhhhHHHHHHHHhc--CCCCeeeec-------eEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--EDCLNLREVKCLRKL--NHSNIVKLK-------ELIQN 71 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l--~hpnIv~l~-------~~~~~ 71 (417)
+|++.+.||+|+||.||+|.++.+|+.||||++....... ......+|+.+++.| +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4899999999999999999999999999999998754322 222334674444444 799987755 55554
Q ss_pred C-----------------CEEEEEEeccCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCcccccCC
Q 044608 72 N-----------------NRLYLVFECMECNLYQLMAARDRKLFSEPEI------KAWLFQVFQGLSYMHQNGFFHRDLK 128 (417)
Q Consensus 72 ~-----------------~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i------~~i~~qi~~aL~~LH~~gi~HrDLK 128 (417)
. ..+|+||||++|+|.+.+.... ..+.+..+ ..++.||+.||.|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3 3489999999988888877653 23455555 6777999999999999999999999
Q ss_pred CCCeeee-CCcEEEeeccccccccCCCCCccccCCccccCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 044608 129 PENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ-SELYSSKADMWAMGAIMAELFTFCPLFPGASEA 206 (417)
Q Consensus 129 p~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 206 (417)
|+|||++ ++.+||+|||+|....... ....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred HHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence 9999996 4799999999998654322 24567799999999965 134899999999999999999999999876431
Q ss_pred HHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 207 DQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 207 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.. ..|. ........ .........+.+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 300 ~~-------------~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 300 IK-------------GSWK-------RPSLRVPG-TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CT-------------TCCC-------BCCTTSCC-CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cc-------------cchh-------hhhhhhcc-ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 10 0000 00000000 001111123578999999999999999999999999999999986
Q ss_pred c
Q 044608 287 C 287 (417)
Q Consensus 287 ~ 287 (417)
.
T Consensus 359 ~ 359 (371)
T 3q60_A 359 L 359 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=378.64 Aligned_cols=272 Identities=19% Similarity=0.340 Sum_probs=211.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh----------------hhhHHHHHHHHhcCCCCeee
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED----------------CLNLREVKCLRKLNHSNIVK 64 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~----------------~~~~~E~~~l~~l~hpnIv~ 64 (417)
+++|++++.||+|+||.||+|.+ +|+.||+|++......... ....+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999998 8999999999754322111 44568999999999999999
Q ss_pred eceEEEeCCEEEEEEeccCCC-HHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-
Q 044608 65 LKELIQNNNRLYLVFECMECN-LYQL------MAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS- 135 (417)
Q Consensus 65 l~~~~~~~~~~~lv~E~~~~~-l~~~------~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~- 135 (417)
+++++.+.+.+|+||||++++ |.+. +.......+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 999999999999999999885 4433 332224679999999999999999999999 9999999999999996
Q ss_pred CCcEEEeeccccccccCCCCCccccCCccccCchhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q 044608 136 QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS-KADMWAMGAIMAELFTFCPLFPGASE-ADQMYKIC 213 (417)
Q Consensus 136 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~ 213 (417)
++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+... .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 578999999999876443 3455689999999999876634666 99999999999999999999988776 55554443
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
........ .+. .................++.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 267 ~~~~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 267 TKNIEYPL-DRN----------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp SCCCCCCC-SSS----------SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccCcCCcc-chh----------hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 21100000 000 000000011112223568999999999999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=368.52 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=188.9
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEeccccc-ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE--
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYA-SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRL-- 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-- 75 (417)
++|++.+.||+|+||.||+|.+..++. .||+|+++.... ........+|++++++++||||+++++++.+....
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999887775 899999976543 23334556899999999999999999999877665
Q ss_pred ----EEEEeccCCC-HHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeecc
Q 044608 76 ----YLVFECMECN-LYQLMAARD----RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFG 145 (417)
Q Consensus 76 ----~lv~E~~~~~-l~~~~~~~~----~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg 145 (417)
++||||+.++ +.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 9999999875 544444332 125899999999999999999999999999999999999974 789999999
Q ss_pred ccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 146 LAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 146 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----- 256 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN----- 256 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred ccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-----
Confidence 9986644322 22345688999999987655 8999999999999999999 999999888766665543210
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-------HHHHHcCcccccccc
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-------AAEALQHPFFKRCFY 289 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------a~elL~hp~f~~~~~ 289 (417)
.....+.+++++.+||.+||+.||++||| ++++++|+|+.....
T Consensus 257 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 257 ------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred ------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 01223567899999999999999999999 788889999987533
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=357.57 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=207.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+. +++.||+|++....... ....+|++++++++||||+++++++.+.+.+|+||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH--HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 58999999999999999999987 47789999998654433 3456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~~~~ 158 (417)
++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 988766555555556789999999999999999999999999999999999996 478999999999865432 12334
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 167 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~--------------------- 224 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------------------- 224 (269)
T ss_dssp TTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------------------
T ss_pred cccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc---------------------
Confidence 56788999999987655 8999999999999999999 999999988877766653210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .......++++.+||.+||+.||++|||+.|+++|
T Consensus 225 -~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 -R-------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -c-------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 11123468999999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=365.86 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=204.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+|++++++++||||+++++++.+.+.+++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 68999999999999999999999999999999886432 22334456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCCC----
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY---- 156 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~~---- 156 (417)
+.++.+..+.......+++.++..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9886666555554567999999999999999999999999999999999999974 78999999999865433221
Q ss_pred -----------ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 157 -----------TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 157 -----------~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......... .....
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~~~~ 237 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLNVR 237 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SBCHH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hhhhh
Confidence 2568999999999987654 8999999999999999999999987543211000 00000
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.. .. ....+.+++++.+||.+||+.||++|||++|+++ |+..
T Consensus 238 ~~------~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 238 GF------LD-----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp HH------HH-----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred cc------cc-----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 00 00 1123567889999999999999999999999987 5543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=374.48 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=180.7
Q ss_pred CCceecc-eecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe----CCEEE
Q 044608 2 DKYSGFK-ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN----NNRLY 76 (417)
Q Consensus 2 ~~Y~~~~-~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 76 (417)
++|.+++ .||+|+||.||+|.++.+|+.||||++.... ....+....++.++||||+++++++.. ...+|
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 6899976 5999999999999999999999999986531 111223344677899999999999976 55689
Q ss_pred EEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeecccccccc
Q 044608 77 LVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIK 151 (417)
Q Consensus 77 lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~ 151 (417)
+||||++| +|.+.+..+....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999987 566666554445699999999999999999999999999999999999996 3459999999998654
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.. ..
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------------~~ 245 (336)
T 3fhr_A 183 QN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---------------RI 245 (336)
T ss_dssp ----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred cc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---------------hh
Confidence 33 334568899999999986544 89999999999999999999999977654433211110 00
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
....+.++ ......+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 246 ~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 246 RLGQYGFP-------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----CCC-------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hccccccC-------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00111111 112346799999999999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=368.95 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=207.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhcC--CCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKLN--HSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~ 74 (417)
++|++.+.||+|+||.||+|++..+|+.||||++....... ......+|+.++++++ ||||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 58999999999999999999999999999999997653322 1123357999999996 5999999999999999
Q ss_pred EEEEEeccC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccccc
Q 044608 75 LYLVFECME--CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAREI 150 (417)
Q Consensus 75 ~~lv~E~~~--~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~~~ 150 (417)
+++|||++. +++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999987 4566666554 4589999999999999999999999999999999999997 478999999999876
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +..
T Consensus 201 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~---------------- 257 (320)
T 3a99_A 201 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR---------------- 257 (320)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----------------
T ss_pred ccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc----------------
Confidence 543 344568999999999997776568899999999999999999999965321 100
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ..+...+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 258 ---~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 258 ---GQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ---CC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---cc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 00 01224678999999999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=364.08 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=197.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe----------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN---------- 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---------- 71 (417)
++|++++.||+|+||.||+|++..+|+.||||++.... .......+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 47999999999999999999999999999999996432 223345689999999999999999998865
Q ss_pred ---CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeecccc
Q 044608 72 ---NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLA 147 (417)
Q Consensus 72 ---~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a 147 (417)
.+.+|+||||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 4678999999987544444444445688999999999999999999999999999999999996 578999999999
Q ss_pred ccccCC---------------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q 044608 148 REIKSG---------------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYK 211 (417)
Q Consensus 148 ~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~ 211 (417)
...... .......||+.|+|||++.+...++.++|||||||++|+|++ ||.... ..+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 865421 223456799999999999766568999999999999999998 554322 2222222
Q ss_pred HHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 212 ICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 212 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+. .....++ ..+....+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 241 ~~-------------------~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 241 LR-------------------SVSIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HH-------------------STTCCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred cc-------------------ccccccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 21 1111111 1233456788999999999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=364.61 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=202.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcC--CCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLN--HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++++.||+|+||.||+|.+. +++.||+|++........ .....+|+.++++++ ||||+++++++.+.+.+|+|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46999999999999999999985 489999999976544332 234468999999997 59999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCC---
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~--- 155 (417)
||+.++++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++........
T Consensus 107 ~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 107 MECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp ECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC---------
T ss_pred EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCcccccc
Confidence 998777787777654 458999999999999999999999999999999999999999999999999986644321
Q ss_pred CccccCCccccCchhhhcc----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhCCCCccch
Q 044608 156 YTNYVGSRWYRAPEILLQS----------ELYSSKADMWAMGAIMAELFTFCPLFPGASEA-DQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~ 224 (417)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------- 255 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--------- 255 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT---------
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc---------
Confidence 2345799999999998641 35889999999999999999999999765432 222222100
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ....+....+.++.+||.+||..||.+|||++|+|+||||+.
T Consensus 256 ----------~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 256 ----------N---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp ----------T---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ----------c---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 0 001122345789999999999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=364.82 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=200.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||+||+|.+ +|+.||+|++......... ....+|++++++++||||+++++++.+.+.+++|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 5799999999999999999976 5889999999765544332 345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC-CcEEEeeccccccccCC-C
Q 044608 81 CMECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-P 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~--~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~ 154 (417)
|+.++.+..+..... ..+++..++.++.||+.||.|||++| |+||||||+|||+++ +.+||+|||++...... .
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 998764444443321 13899999999999999999999999 999999999999975 68999999999755433 2
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~----------------- 256 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----------------- 256 (309)
T ss_dssp -------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-----------------
T ss_pred ccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence 234568999999999987655 89999999999999999999999999887766655421100
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc--Cccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFFKR 286 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~~ 286 (417)
.......+++++.+||.+||+.||.+|||++|+++ +++++.
T Consensus 257 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 -----------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01233567899999999999999999999999987 566654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=363.92 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=201.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+|+.++++| +||||+++++++.+.+..|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 589999999999999999999999999999999875432 22346899999999 99999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-Cc-----EEEeeccccccccCCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GI-----IKIADFGLAREIKSGP 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~-----vkL~DFg~a~~~~~~~ 154 (417)
|++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|||++..+....
T Consensus 86 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9966666666543 456999999999999999999999999999999999999964 44 9999999998764432
Q ss_pred C--------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhCCCCccc
Q 044608 155 P--------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---ADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 155 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~ 223 (417)
. ....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+. .+.+..+...
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-------- 235 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-------- 235 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH--------
T ss_pred CCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh--------
Confidence 2 24678999999999987655 89999999999999999999999988543 2333333211
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....+ ........+ ++.+||.+||+.||.+|||++++++
T Consensus 236 -----------~~~~~------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 -----------KRATP------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------HHHSC------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------hccCC------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01000 111122234 9999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=359.59 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=194.4
Q ss_pred CCceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.+..+ +..||+|++.............+|+.++++++||||+++++++. .+..|+|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 5799999999999999999998764 45799999876543333445578999999999999999999984 5678999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccc
Confidence 999987555444444445689999999999999999999999999999999999996 68999999999987654322
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~------------------- 233 (281)
T 1mp8_A 174 ASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------------- 233 (281)
T ss_dssp -----CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------------------
T ss_pred cccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-------------------
Confidence 23346788999999986555 8999999999999999996 99999988776666554311
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
......+.+++++.+||.+||+.||++|||+.|++++
T Consensus 234 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 234 ----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012335678999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=369.65 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=206.3
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|.+. .+++.||+|+++............+|+.++++++||||+++++++.+.+.+|
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 58999999999999999999987 4568999999986544333445578999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 77 LVFECMECN-LYQLMAARD----------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~----------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
+||||++++ |.+.+.... ...+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 206 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence 999999875 555544321 146899999999999999999999999999999999999
Q ss_pred ee-CCcEEEeeccccccccCC---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 044608 134 VS-QGIIKIADFGLAREIKSG---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQ 208 (417)
Q Consensus 134 l~-~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 208 (417)
++ ++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 96 478999999999765432 2233457899999999987655 8999999999999999999 9999999887776
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...+... ........++.++.+||.+||+.||++|||+.+++++
T Consensus 286 ~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 IYYVRDG-----------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCC-----------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6555321 0112234678999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=374.65 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=203.4
Q ss_pred CCceecceecccCceEEEEEE-----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC-E
Q 044608 2 DKYSGFKELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN-R 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~-~ 74 (417)
++|++.+.||+|+||.||+|. +..+++.||||+++............+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 689999999999999999998 66778999999998654444445567899999999 7899999999998755 4
Q ss_pred EEEEEeccCCC-HHHHHHHhcC----------------------------------------------------------
Q 044608 75 LYLVFECMECN-LYQLMAARDR---------------------------------------------------------- 95 (417)
Q Consensus 75 ~~lv~E~~~~~-l~~~~~~~~~---------------------------------------------------------- 95 (417)
+++||||+.++ |.+.+.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 89999999875 4444433221
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---CccccCCccc
Q 044608 96 ------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP---YTNYVGSRWY 165 (417)
Q Consensus 96 ------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y 165 (417)
..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ .....||+.|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 1289999999999999999999999999999999999996 58899999999986644322 3345789999
Q ss_pred cCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcc
Q 044608 166 RAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244 (417)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (417)
+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+........
T Consensus 262 ~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------------- 313 (359)
T 3vhe_A 262 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------------------------- 313 (359)
T ss_dssp CCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---------------------------
T ss_pred EChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC---------------------------
Confidence 9999987655 8999999999999999998 9999988765444433321100
Q ss_pred cccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 245 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......+++++.+||.+||+.||.+|||++|+++|
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 011224578999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=372.62 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=208.0
Q ss_pred CCceecceecccCceEEEEEEECCC-------CcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-------GEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|++.+.||+|+||.||+|.+..+ +..||+|+++............+|+++++++ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 5799999999999999999987543 3579999998765444445567899999999 9999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|+||||+.++ |.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 999999999875 555554432 13589999999999999999999999999999999999997 58
Q ss_pred cEEEeeccccccccCC---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSG---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999999876543 2234456789999999987654 8999999999999999999 999999988776665543
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .......+++++.+||.+||+.||++|||++|++++
T Consensus 308 ~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGH-----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTC-----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 210 011224678999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=353.96 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=204.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.++ ++..||+|++....... ....+|++++++++||||+++++++.+.+.+|+||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH--HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 58999999999999999999876 56789999998654433 3456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--Ccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--YTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~~~ 158 (417)
++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ ...
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 987644444444335589999999999999999999999999999999999996 57899999999986644322 223
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 165 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------------- 222 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--------------------- 222 (268)
T ss_dssp CCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---------------------
T ss_pred CCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---------------------
Confidence 45677899999987655 8999999999999999998 999999888777665553210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++++.+||.+||+.||++|||+.|+++|
T Consensus 223 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 --------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011123468899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=375.50 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=204.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.++.+++.||+|+++............+|++++++++||||+++++++.+.+.+|+||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 47899999999999999999999999999999997654333334556899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---C
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP---Y 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~---~ 156 (417)
++++ +.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........ .
T Consensus 194 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 194 VQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 9865 5555544 334589999999999999999999999999999999999997 58899999999986443211 1
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....+++.|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 273 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------------------- 331 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-------------------- 331 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT--------------------
T ss_pred CCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 1223577899999987655 8999999999999999998 99999998876655444210
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. ......+++++.+||.+||+.||++|||++++++
T Consensus 332 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 GR---------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 1122357889999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=364.48 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=199.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----hhhhhHHHHHHHHhc----CCCCeeeeceEEEeC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----EDCLNLREVKCLRKL----NHSNIVKLKELIQNN 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----~~~~~~~E~~~l~~l----~hpnIv~l~~~~~~~ 72 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.+++++ +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 58999999999999999999999999999999997543321 122335799999999 899999999999999
Q ss_pred CEEEEEEec-cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee--CCcEEEeeccccc
Q 044608 73 NRLYLVFEC-MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS--QGIIKIADFGLAR 148 (417)
Q Consensus 73 ~~~~lv~E~-~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~--~~~vkL~DFg~a~ 148 (417)
+..++|||+ +.+ ++.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred CeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 999999998 554 566655543 3589999999999999999999999999999999999997 4789999999998
Q ss_pred cccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 149 EIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 149 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +..
T Consensus 189 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-------------- 247 (312)
T 2iwi_A 189 LLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-------------- 247 (312)
T ss_dssp ECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--------------
T ss_pred hcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--------------
Confidence 76543 345668999999999987766556799999999999999999999965321 110
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... .+...++.++.+||.+||..||++|||++|+|+||||+..
T Consensus 248 -----~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 248 -----AEL-----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -----TCC-----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -----hcc-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 011 1234678999999999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=367.42 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcE----EEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEA----VAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~----vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||.||+|.+..+++. ||+|.+.............+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 6899999999999999999999988876 67776654332222234458999999999999999999986 456889
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP- 154 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~- 154 (417)
||||+.++ +.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999865 5555543 335689999999999999999999999999999999999996 5899999999998765432
Q ss_pred --CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 --PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---------------- 233 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---------------- 233 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT----------------
T ss_pred cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC----------------
Confidence 234557888999999997655 8999999999999999999 99999987766555444211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
........++.++.+||.+||..||.+|||+.|+++|
T Consensus 234 -------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 -------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011123467789999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=362.62 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=205.6
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.+ +.+++.||+|++.............+|++++++++||||+++++++.+.+.+|
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 5799999999999999999987 34568999999986544444445578999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 77 LVFECMECN-LYQLMAARDR----------------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~----------------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
+||||+.++ |.+.+..... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 999999865 5555443221 23899999999999999999999999999999999999
Q ss_pred eeC-CcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 044608 134 VSQ-GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQ 208 (417)
Q Consensus 134 l~~-~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 208 (417)
+++ +.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 974 7899999999986644322 23456789999999987654 8999999999999999999 9999988876555
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...+... ........+++++.+||.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTG-----------------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTT-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcC-----------------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4443210 0012234678999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=365.31 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=194.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEE----EEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAV----AIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~v----aiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||+||+|++..+|+.+ |+|.+.............+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57999999999999999999998888765 7777654433333445578999999999999999999998765 678
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~- 155 (417)
|+||+.++.+..........+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 8888876544444444446699999999999999999999999999999999999996 58999999999986654322
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----------------- 235 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----------------- 235 (327)
T ss_dssp ------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----------------
T ss_pred ccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-----------------
Confidence 23345688999999997655 8999999999999999999 99999887765554433211
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ....+..+.++.+||.+||+.||.+|||+.|++++
T Consensus 236 ---~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 ---ER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---CC---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---CC---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 11234578899999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.50 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=203.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+. ++..||+|++....... ....+|++++++++||||+++++++.+.+.+|+||||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH--HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 58999999999999999999876 57789999998654433 3456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC--CCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG--PPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~--~~~~~ 158 (417)
+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++...... .....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9776444444443356999999999999999999999999999999999999964 78999999999865432 12233
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 181 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------------------- 239 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------------------- 239 (283)
T ss_dssp TTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------------------
T ss_pred CccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------------------
Confidence 46788999999997665 8999999999999999998 9999999888777666542110
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......++++.+||.+||+.||.+|||++|+++|
T Consensus 240 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ---------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123468899999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=352.25 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=193.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh---hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW---EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+++|++.+.||+|+||.||+|.+. |+.||+|++....... ......+|+++++.++||||+++++++.+.+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 478999999999999999999874 8999999987543322 12334689999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCCeeee---------CCcEEEeecc
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG---FFHRDLKPENLLVS---------QGIIKIADFG 145 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g---i~HrDLKp~NILl~---------~~~vkL~DFg 145 (417)
||||++++.+..+... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999988766666543 45899999999999999999999999 89999999999995 4679999999
Q ss_pred ccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 146 LAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 146 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
++........ ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 229 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN---------- 229 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----------
T ss_pred cccccccccc-cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----------
Confidence 9986654433 3458999999999987655 899999999999999999999999988876665544211
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. .......+++++.+||.+||+.||.+|||+.|+++|
T Consensus 230 ---------~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 ---------KL---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------CC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CC---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 00 011234678999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=352.20 Aligned_cols=249 Identities=19% Similarity=0.231 Sum_probs=204.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+|+.+++.+ +|+||+++++++.+....|+|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 589999999999999999999999999999999865432 23346899999999 79999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-Cc-----EEEeeccccccccCCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GI-----IKIADFGLAREIKSGP 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~-----vkL~DFg~a~~~~~~~ 154 (417)
|++++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecCCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 9966666666543 356899999999999999999999999999999999999953 33 9999999998765432
Q ss_pred --------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhhCCCCccc
Q 044608 155 --------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS---EADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 155 --------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~g~~~~~~ 223 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------- 237 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK------- 237 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-------
T ss_pred ccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-------
Confidence 234567999999999986655 8999999999999999999999998853 333333332110
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ........+.+++++.+||.+||+.||++|||++++++
T Consensus 238 ------------~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 ------------Q------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------H------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------c------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0 11123334568999999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.10 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=206.1
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+ ..+++.||+|+++............+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5799999999999999999984 5678899999998654434445567899999999 999999999999999999
Q ss_pred EEEEeccCC-CHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 76 YLVFECMEC-NLYQLMAARDR----------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 76 ~lv~E~~~~-~l~~~~~~~~~----------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
++||||+++ +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 999999987 45555544321 1489999999999999999999999999999999999997 47
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 899999999987655433 23446788999999987655 8999999999999999998 999998877555444432
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .. ......++.++.+||.+||+.||.+|||++|++++
T Consensus 262 ~~~-------------------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 262 KEG-------------------FR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHT-------------------CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccC-------------------CC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 210 00 01124578999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=364.37 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=202.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEE--EEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAV--AIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~v--aiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|+++.+|..+ |+|.+.............+|+++++++ +||||+++++++.+.+.+|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999999988865 999987544333344556899999999 899999999999999999999
Q ss_pred EeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEe
Q 044608 79 FECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIA 142 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~ 142 (417)
|||++++ |.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 9999765 555544321 236899999999999999999999999999999999999964 789999
Q ss_pred eccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 143 DFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 143 DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~------ 257 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 257 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT------
T ss_pred ccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC------
Confidence 999997554444444556789999999986654 8999999999999999998 99999988876655443210
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .......+++++.+||.+||..||.+|||++|++++
T Consensus 258 --------------~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 --------------Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp --------------C---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 011224578999999999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.72 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=202.7
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+ ..++..||+|++.............+|+.+++++ +||||+++++++.+.+.+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 5789999999999999999997 3466789999998654444445567899999999 899999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 76 YLVFECMECN-LYQLMAARDR---------------------KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~---------------------~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
|+||||++++ |.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 9999999775 5555543321 23789999999999999999999999999999999999
Q ss_pred ee-CCcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 044608 134 VS-QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQ 208 (417)
Q Consensus 134 l~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 208 (417)
++ ++.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 97 47899999999986654432 23446788999999987655 8999999999999999998 9999988775554
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
+..+.... .. ......+++++.+||.+||+.||.+|||+.|+++|-.
T Consensus 284 ~~~~~~~~-------------------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 284 FYKLIQNG-------------------FK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHTT-------------------CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcC-------------------CC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 44433210 00 1122457899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=353.37 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=206.5
Q ss_pred CCceecc-eecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFK-ELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~-~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|.+.+ .||+|+||.||+|.+. .++..||+|+++............+|++++++++||||+++++++ ..+.+++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4688887 9999999999999854 468889999998754433444557899999999999999999999 45668999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 999988655555544446699999999999999999999999999999999999996 58899999999987643322
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~----------------- 229 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----------------- 229 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----------------
T ss_pred eccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-----------------
Confidence 23345789999999986555 8999999999999999998 99999988877666554321
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
......+.+++++.+||.+||+.||++|||+.++++|.+
T Consensus 230 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 230 ------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 001223568899999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=362.82 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=209.9
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++.+.||+|+||.||+|.++ .+++.||+|++.............+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 57999999999999999999876 4678999999986544444445678999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAARD--------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~--------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~ 146 (417)
+||||+.++ |.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 999999864 555554321 134799999999999999999999999999999999999974 7999999999
Q ss_pred cccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
+........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------- 256 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG------- 256 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-------
T ss_pred ccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-------
Confidence 986543321 23346789999999987655 8999999999999999999 89999988877666554321
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC------cccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH------PFFKRC 287 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h------p~f~~~ 287 (417)
........++.++.+||.+||+.||.+|||+.|+++| ++|+..
T Consensus 257 ----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 257 ----------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred ----------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 0112234678999999999999999999999999976 566543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.02 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=204.8
Q ss_pred CCceecceecccCceEEEEEE-----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF-----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~-----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|. +..+++.||+|++.............+|+.++++++||||+++++++.+.+.+|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 589999999999999999998 566888999999975544444455678999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeeccc
Q 044608 77 LVFECMECN-LYQLMAARDR-----KLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~-----~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~ 146 (417)
+||||++++ |.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 999999764 5555544321 34899999999999999999999999999999999999962 3599999999
Q ss_pred cccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------ 262 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG------ 262 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC------
Confidence 97553322 223457899999999987655 8999999999999999998 999999888776665543210
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
.......++.++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 263 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 -----------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0112245789999999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=359.85 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=195.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEE----EEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAV----AIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~v----aiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||.||+|.+..+++.| |+|.+.............+|+.+++.++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 68999999999999999999999888765 6666654433334445678999999999999999999998766 677
Q ss_pred EEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 78 VFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
|+||+.++ +.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 94 v~~~~~~g~L~~~l~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EECCCSSCBHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEecCCCcHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 88887765 555554 4446699999999999999999999999999999999999996 58999999999986643322
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---------------- 235 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---------------- 235 (327)
T ss_dssp -------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------------
T ss_pred cccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------------
Confidence 23345788999999997655 8999999999999999999 99999888766554443211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .....+.++.++.+||.+||..||.+|||+.|+++
T Consensus 236 ----~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 ----E---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----C---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----C---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 01123457889999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.93 Aligned_cols=275 Identities=23% Similarity=0.324 Sum_probs=205.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--EEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN--RLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~ 79 (417)
++|++.+.||+|+||.||+|++..+|+.||||++.............+|++++++++||||+++++++.+.+ .+|+||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 479999999999999999999999999999999976543333344568999999999999999999998765 789999
Q ss_pred eccCCCHHHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee----eC-CcEEEeeccccccccC
Q 044608 80 ECMECNLYQLMAAR-D-RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV----SQ-GIIKIADFGLAREIKS 152 (417)
Q Consensus 80 E~~~~~l~~~~~~~-~-~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl----~~-~~vkL~DFg~a~~~~~ 152 (417)
||+.|+.+..+... . ...+++..++.++.||+.||.|||++||+||||||+|||+ ++ +.+||+|||++.....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 99987544444332 2 2238999999999999999999999999999999999998 32 4699999999988776
Q ss_pred CCCCccccCCccccCchhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhhCCCCc
Q 044608 153 GPPYTNYVGSRWYRAPEILLQS-------ELYSSKADMWAMGAIMAELFTFCPLFPGAS----EADQMYKICGVLGSPTM 221 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~g~~~~ 221 (417)
.......+||+.|+|||++.+. ..++.++|||||||++|||++|..||.... ..+.+.++... .+ .
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--~p-~ 245 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KP-S 245 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS--CC-T
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC--CC-c
Confidence 6666677899999999998641 347889999999999999999999997532 34445544432 11 1
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
..|..... .....+.+.... .....+...++..+.+||.+||..||++|||++|++++
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~-~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 246 GAISGVQK-AENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCCEEEEC-STTCCEEEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchhhee-ccCCCcccCccC-CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11110000 000000000000 00011222345678999999999999999999998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=347.07 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=205.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 57999999999999999999986 67889999998654433 3456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~~~~ 158 (417)
++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .....
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 987655554444446689999999999999999999999999999999999996 578999999999865432 12234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 165 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~--------------------- 222 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF--------------------- 222 (267)
T ss_dssp TTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------------------
T ss_pred ccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence 46788999999987655 8999999999999999999 899999888777665553210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .......+.++.+||.+||+.||++|||+.|++++
T Consensus 223 -~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 -R-------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -c-------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01123468899999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=355.31 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+|+.++++++||||+++++++.+.+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999976543222 23446899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--C
Q 044608 79 FECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--P 154 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~ 154 (417)
|||++++ +.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...... .
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999875 55544433 4589999999999999999999999999999999999996 588999999999765443 2
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------------- 249 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-------------------- 249 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS--------------------
T ss_pred cccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc--------------------
Confidence 234567999999999986554 89999999999999999999999988765432222210
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-CHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-TAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-ta~elL~ 280 (417)
. ........+.++.++.+||.+||+.||++|| |++++++
T Consensus 250 --~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 --A-----IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --C-----CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --C-----CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0 0112234467889999999999999999999 7887765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=354.91 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=197.4
Q ss_pred CCceecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (417)
++|++++.||+|+||.||+|+ +..+++.||+|++.... ........+|++++++++||||+++++++.. ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 589999999999999999998 67789999999987542 2222345689999999999999999999854 4568
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
++||||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 999999977544444444445589999999999999999999999999999999999996 5889999999998765432
Q ss_pred C----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 P----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
. .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||...... .. ...+......+... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~~~~~~~-~~ 241 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQGQMIVF-HL 241 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCCTHHHHH-HH
T ss_pred ceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccccchhHH-HH
Confidence 1 23346788899999997665 899999999999999999999998654321 11 11122221111110 00
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........ .......+++++.+||.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccC-------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00001000 11223567899999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.72 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=195.0
Q ss_pred CCceecceecccCceEEEEEEEC---CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE---HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~---~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|+++ .++..||||+++............+|+.++++++||||+++++++.+.+.+|+|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999876 467789999998654444445567899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||++++.+..+.......+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 999987655555555445699999999999999999999999999999999999996 47899999999987654321
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~----------------- 266 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----------------- 266 (373)
T ss_dssp ---------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-----------------
T ss_pred eeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 12234577899999987655 8999999999999999997 99999988877666554311
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+.. .....++.++.+||.+||+.||.+|||++|+++
T Consensus 267 ---~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 ---YRL---------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---EEC---------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCC---------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 111 112356889999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=352.84 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=204.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe----------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN---------- 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---------- 71 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 36999999999999999999999999999999997542 234589999999999999999999865
Q ss_pred ------CCEEEEEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEee
Q 044608 72 ------NNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIAD 143 (417)
Q Consensus 72 ------~~~~~lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~D 143 (417)
...+|+||||+++ +|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 4568999999987 566666555446699999999999999999999999999999999999996 57899999
Q ss_pred ccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccc
Q 044608 144 FGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223 (417)
Q Consensus 144 Fg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 223 (417)
||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+.
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~---------- 232 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR---------- 232 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----------
T ss_pred chhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----------
Confidence 99998877665566678999999999987654 8999999999999999999998873211 1111110
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ..+...++.++.+||.+||+.||.+|||+.|+++|.+.-.
T Consensus 233 -----------~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 -----------D-----------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------T-----------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------c-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0 0112457889999999999999999999999999988754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=376.97 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=194.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
+|.+.+.||+|+||+||. ....+|+.||||++..... ....+|+++|+++ +|||||++++++.+.+.+|+||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 588999999999999763 3456899999999965322 2235899999999 799999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CC--cEEEeeccccccccCC--
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QG--IIKIADFGLAREIKSG-- 153 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~--~vkL~DFg~a~~~~~~-- 153 (417)
++|++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+|......
T Consensus 100 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9988887776543 3456667889999999999999999999999999999994 22 5889999999876543
Q ss_pred --CCCccccCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 154 --PPYTNYVGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
......+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||...........+ +...
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~----~~~~-------- 246 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----GACS-------- 246 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----TCCC--------
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----ccCC--------
Confidence 23345689999999999864 3347889999999999999999 99999765543322111 1000
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.+. .......+..+.+||.+||+.||.+|||++|+|+||||...
T Consensus 247 ---------~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 ---------LDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------CTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------ccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000 00011235678999999999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=356.68 Aligned_cols=245 Identities=15% Similarity=0.227 Sum_probs=198.7
Q ss_pred CCceecceecccCceEEEEEEECCCC-------cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-------EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 74 (417)
++|++.+.||+|+||.||+|++..++ ..||+|++...... ......+|+.++++++||||+++++++.+.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-YSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG-GHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 68999999999999999999998877 47999998754322 23345689999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-Cc--------EEEeecc
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GI--------IKIADFG 145 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~--------vkL~DFg 145 (417)
.|+||||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 99999999865444444444455899999999999999999999999999999999999964 44 9999999
Q ss_pred ccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccch
Q 044608 146 LAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSW 224 (417)
Q Consensus 146 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 224 (417)
++...... ....||+.|+|||++.+...++.++|||||||++|+|++| .+||..............
T Consensus 167 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---------- 233 (289)
T 4fvq_A 167 ISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---------- 233 (289)
T ss_dssp SCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----------
T ss_pred ccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc----------
Confidence 98754332 3346899999999997755689999999999999999995 556655554433322110
Q ss_pred HHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 225 ADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. .......+.++.+||.+||+.||.+|||++|+++|
T Consensus 234 ----------~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 ----------R-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----------T-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------c-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 11223457889999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=359.87 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=204.8
Q ss_pred CCceecceecccCceEEEEEEEC-------CCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-------HTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-------~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
++|++.+.||+|+||.||+|.+. .++..||+|+++............+|+++++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 58999999999999999999976 467789999998654444444557899999999 8999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 74 RLYLVFECMECN-LYQLMAARD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
.+|+||||+.++ |.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 999999999875 554444322 12489999999999999999999999999999999999996 58
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 899999999986654322 23446788999999987655 8999999999999999999 999999888776655543
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .......++.++.+||.+||+.||.+|||+.|++++
T Consensus 274 ~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGH-----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 210 011234678999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.14 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=200.0
Q ss_pred CCceecceecccCceEEEEEEECCCC----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+.||+|+||.||+|.++.++ ..||+|+++............+|+.++++++||||+++++++.+.+.+|+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 57899999999999999999877654 35999999865544444456789999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~- 155 (417)
||||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 9999988655555544446699999999999999999999999999999999999997 47899999999987654321
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--------------- 267 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--------------- 267 (333)
T ss_dssp -------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------------
T ss_pred ccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---------------
Confidence 12335688999999986554 8999999999999999998 999999888776665553210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. .....++.++.+||.+||+.||++|||+.+++++
T Consensus 268 -----~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 -----RL---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -----CC---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----cC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1123578999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=352.54 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=200.5
Q ss_pred CCceecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN--NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 75 (417)
++|++++.||+|+||.||+|+ +..+++.||+|++.............+|+++++.++||||+++++++.+. +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 368999999999999999998 67789999999998654333334556899999999999999999999876 678
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
++||||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 999999987555444434445699999999999999999999999999999999999995 6889999999998765443
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......||..|+|||++.+.. ++.++|||||||++|+|++|..|+.... .. +....+...........
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~~~~~~~~-- 252 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHGQMTVTRL-- 252 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCGGGHHHHH--
T ss_pred cceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCcccccCHHHH--
Confidence 234457889999999987665 7899999999999999999999864321 11 11111221111111100
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........ .....+.+++++.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00111100 11233568899999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=350.51 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=199.7
Q ss_pred CCceecceecccCceEEEEEEECC---CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.+.. ++..||+|++.............+|+.+++.++||||+++++++.++ ..|+|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 589999999999999999998643 34569999998664444445567899999999999999999998754 56899
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--C
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--P 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~ 155 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 170 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence 999987655544444445689999999999999999999999999999999999996 5889999999998665432 2
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+....
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~------------------ 231 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD------------------ 231 (281)
T ss_dssp --CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC------------------
T ss_pred cccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC------------------
Confidence 23456788999999986554 8999999999999999998 999998776655544432110
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ......+++++.+||.+||..||++|||+.|++++
T Consensus 232 --~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 --R---------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --C---------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0 11224578999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=352.45 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=206.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.++.++..||+|++..... ......+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 579999999999999999999999999999999975432 234456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--Cc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
+.+ ++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ ..
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 985 566666554556699999999999999999999999999999999999996 47899999999986654322 23
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+... .
T Consensus 171 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------------------~ 229 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------------Y 229 (288)
T ss_dssp TEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------------------C
T ss_pred CCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc--------------------C
Confidence 345688899999987655 8999999999999999999 99999887765554443210 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......+++++.+||.+||..||.+|||++|+++
T Consensus 230 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 01122467899999999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=350.44 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=198.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh------hhhHHHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED------CLNLREVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~------~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++......... ....+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6899999999999999999999999999999998754332211 33468999999999999999999997666
Q ss_pred EEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC-Cc-----EEEeeccc
Q 044608 76 YLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ-GI-----IKIADFGL 146 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~-~~-----vkL~DFg~ 146 (417)
++||||+.++ +.+.+.. ....+++..++.++.||+.||.|||++| |+||||||+|||++. +. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6899999865 5555544 3456999999999999999999999999 999999999999963 43 99999999
Q ss_pred cccccCCCCCccccCCccccCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhCCCCccc
Q 044608 147 AREIKSGPPYTNYVGSRWYRAPEILLQ-SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ--MYKICGVLGSPTMDS 223 (417)
Q Consensus 147 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~ 223 (417)
+..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+..+. ...+..
T Consensus 176 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 244 (287)
T 4f0f_A 176 SQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--------- 244 (287)
T ss_dssp CBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH---------
T ss_pred cccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc---------
Confidence 975433 3445689999999999842 33478999999999999999999999987654332 221110
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... .......+++++.+||.+||+.||.+|||++|+++
T Consensus 245 ------------~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 ------------EGL-------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ------------SCC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------cCC-------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 01233567899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=357.50 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC-E
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN-R 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~-~ 74 (417)
++|++.+.||+|+||.||+|.+ ..+++.||+|++.............+|+.+++++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999984 4678999999998665444444567899999999 7999999999987654 5
Q ss_pred EEEEEeccCCCHHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCc
Q 044608 75 LYLVFECMECNLYQLMAARDRK---------------LFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGI 138 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~---------------~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~ 138 (417)
+|+||||+.++.+..+...... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 8999999987544444433322 289999999999999999999999999999999999996 588
Q ss_pred EEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 044608 139 IKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICG 214 (417)
Q Consensus 139 vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~ 214 (417)
+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+.....
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 99999999986654332 23456789999999987655 8999999999999999998 9999988764443333221
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .......+++++.+||.+||+.||.+|||+.|+++|
T Consensus 266 ~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGT----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCc----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 011224578999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.74 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=191.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+. ..||+|+++........ ....+|++++++++||||++++++. ....+++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 58999999999999999999754 35999999765544332 3446899999999999999999954 5667899999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC---CCCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS---GPPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~---~~~~ 156 (417)
|+.++.+..........+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9987655555444446699999999999999999999999999999999999996 57899999999975543 2334
Q ss_pred ccccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
....||+.|+|||++. ....++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------- 242 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS----------------- 242 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-----------------
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-----------------
Confidence 4567999999999985 234478899999999999999999999988776665544432100
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....+......+++++.+||.+||..||.+|||++|+++
T Consensus 243 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 243 -------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011223344567899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=358.89 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=205.3
Q ss_pred CCceecceecccCceEEEEEEECCCCc-----EEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|.+..+++ .||+|++.............+|+.+++.+ +||||+++++++.+.+.+
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 579999999999999999999987765 79999997654444445567899999999 899999999999999999
Q ss_pred EEEEeccCC-CHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEE
Q 044608 76 YLVFECMEC-NLYQLMAARD------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKI 141 (417)
Q Consensus 76 ~lv~E~~~~-~l~~~~~~~~------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL 141 (417)
|+||||+++ +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 999999987 5655554432 245899999999999999999999999999999999999974 78999
Q ss_pred eeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhC
Q 044608 142 ADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLG 217 (417)
Q Consensus 142 ~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g 217 (417)
+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 283 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG- 283 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT-
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC-
Confidence 99999986644332 23346788999999987655 8999999999999999998 999998876555544433210
Q ss_pred CCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 218 SPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. .......+.++.+||.+||+.||.+|||+.|++++
T Consensus 284 ------------------~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 284 ------------------YQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp ------------------CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.87 Aligned_cols=264 Identities=25% Similarity=0.283 Sum_probs=195.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC----EEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN----RLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 77 (417)
++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++.+.. .+|+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 57999999999999999999765 7999999996542 22333456999999999999999999998744 5799
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccccCCCCCeeeeC-CcEEEeeccc
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN----------GFFHRDLKPENLLVSQ-GIIKIADFGL 146 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~----------gi~HrDLKp~NILl~~-~~vkL~DFg~ 146 (417)
||||+.++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+|||+++ +.+||+|||+
T Consensus 100 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999875554444443 389999999999999999999999 9999999999999975 7899999999
Q ss_pred cccccCCC---CCccccCCccccCchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Q 044608 147 AREIKSGP---PYTNYVGSRWYRAPEILLQS----ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSP 219 (417)
Q Consensus 147 a~~~~~~~---~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~ 219 (417)
+..+.... .....+||+.|+|||++.+. ..++.++|||||||++|||++|..||.+..............+.+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97665432 23446899999999998653 235678999999999999999999998754322111111111111
Q ss_pred CccchHHHHHHHhhhhccCCCCCcccccccC--CCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 220 TMDSWADGLRQARAIKYQFPQLPRANLSALM--PSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
....+.... ......+ .+...+ ...+.++.+||.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~----~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 258 SLEDMQEVV----VHKKKRP-----VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CHHHHHHHH----TTSCCCC-----CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhhhh----hcccCCC-----CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111110 0000001 111111 123456999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=344.88 Aligned_cols=246 Identities=18% Similarity=0.237 Sum_probs=202.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeC--CEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNN--NRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 77 (417)
+++|++.+.||+|+||.||+|.+. |+.||+|++........ .....+|+.++++++||||+++++++.+. +.+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 368999999999999999999874 88999999986544333 33456899999999999999999999887 78899
Q ss_pred EEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC-CcEEEeeccccccccCC
Q 044608 78 VFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG 153 (417)
Q Consensus 78 v~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~ 153 (417)
||||+++ +|.+.+.......+++..++.++.||+.||.|||++| |+||||||+|||+++ +.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999986 4555554433335899999999999999999999999 999999999999975 6899999988754332
Q ss_pred CCCccccCCccccCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 154 PPYTNYVGSRWYRAPEILLQSE--LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------- 227 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG--------------- 227 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC---------------
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC---------------
Confidence 3457899999999987543 23448999999999999999999999888777655543210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........+++++.+||.+||+.||++|||++|+++
T Consensus 228 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 228 -------------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001223567899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=347.06 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=200.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceE-EEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL-IQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~-~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+|+.+++.++|++++..+.. +...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 6899999999999999999999999999999998754322 234689999999998886666554 467888999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee----eCCcEEEeeccccccccCCCC-
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV----SQGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl----~~~~vkL~DFg~a~~~~~~~~- 155 (417)
|+++++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ .++.+||+|||++........
T Consensus 86 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ecCCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9966676666533 3569999999999999999999999999999999999999 357899999999987654322
Q ss_pred -------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhCCCCccchH
Q 044608 156 -------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---ADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 156 -------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~ 225 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+. .+.+..+...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 233 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------- 233 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----------
T ss_pred cccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----------
Confidence 34568999999999987655 89999999999999999999999987432 1222222110
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.... ........+++++.+||.+||+.||++|||++++++
T Consensus 234 ---------~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 ---------KMST------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------HHHS------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------ccCC------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0111 112233567899999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=346.56 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=198.7
Q ss_pred CCceecc-eecccCceEEEEE--EECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFK-ELGRGAFGRVFQA--FDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~-~LG~G~~g~V~~a--~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++.+ .||+|+||.||+| .+..+++.||+|+++....... .....+|+++++.++||||+++++++ ..+.+|+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4688888 9999999999999 4566789999999976543322 34456899999999999999999999 5677899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~- 155 (417)
||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999866444444443 4589999999999999999999999999999999999996 58899999999987654322
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------- 236 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------------- 236 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------------
T ss_pred ccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 22345678999999987655 8999999999999999999 99999998876665544311
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. .......+++++.+||.+||+.||.+|||+.++++
T Consensus 237 -----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 237 -----E--------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----C--------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----C--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 01223467899999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=362.94 Aligned_cols=258 Identities=16% Similarity=0.204 Sum_probs=194.1
Q ss_pred CCceecceecccCceEEEEEEECCC-----CcEEEEEEecccccChhh----------hhhHHHHHHHHhcCCCCeeeec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-----GEAVAIKELKQRYASWED----------CLNLREVKCLRKLNHSNIVKLK 66 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-----g~~vaiK~i~~~~~~~~~----------~~~~~E~~~l~~l~hpnIv~l~ 66 (417)
++|++.+.||+|+||.||+|.+..+ ++.||||++......... .....|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998775 588999998754321110 1123466677788999999999
Q ss_pred eEEEeC----CEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcE
Q 044608 67 ELIQNN----NRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGII 139 (417)
Q Consensus 67 ~~~~~~----~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~v 139 (417)
+++... ..+|+||||++++|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 56899999995556555544 446699999999999999999999999999999999999996 4789
Q ss_pred EEeeccccccccCCC--------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 044608 140 KIADFGLAREIKSGP--------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYK 211 (417)
Q Consensus 140 kL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 211 (417)
||+|||+++.+.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 999999997654321 123456999999999987655 89999999999999999999999986433222222
Q ss_pred HHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 212 ICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 212 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
............+ ....+ ....++.++.+||..||..||.+|||++++++
T Consensus 273 ~~~~~~~~~~~~~---------~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASL---------MDKCF----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHH---------HHHHS----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHH---------HHHhc----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110000000000 00000 01467899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.92 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=197.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceE-EEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKEL-IQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~-~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|++..+++.||+|++...... ....+|+++++.++|++++..+.. +.+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 5899999999999999999999999999999987644322 234689999999998887766655 477889999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee---e-CCcEEEeeccccccccCCC--
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV---S-QGIIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl---~-~~~vkL~DFg~a~~~~~~~-- 154 (417)
|+++++.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++.......
T Consensus 86 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 86 LLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCCCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 9966666666543 3569999999999999999999999999999999999999 3 4789999999998765432
Q ss_pred ------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCccchH
Q 044608 155 ------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA---DQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~ 225 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. ..+..+...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 233 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------- 233 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----------
T ss_pred ccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----------
Confidence 223568999999999987655 899999999999999999999999875432 111111110
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... .........+++++.+||.+||+.||++|||++++++
T Consensus 234 ---------~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 ---------KMS------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------HHH------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------ccc------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 010 1112333567899999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=348.89 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=198.1
Q ss_pred CceecceecccCceEEEEEEECCCC---cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEE-EeCCEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTG---EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELI-QNNNRLYLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv 78 (417)
+|++.+.||+|+||.||+|.+..++ ..||+|.+.............+|+.++++++||||+++++++ ..++..|+|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 6899999999999999999876543 468999987654444445567899999999999999999985 456788999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC----
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG---- 153 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~---- 153 (417)
|||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhc
Confidence 9999886555555444566899999999999999999999999999999999999975 78999999999865432
Q ss_pred -CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 154 -PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.......||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~--------------- 249 (298)
T 3f66_A 186 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------------- 249 (298)
T ss_dssp C-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC---------------
T ss_pred cccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC---------------
Confidence 2233456788999999987655 8999999999999999999 678888777655554443110
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......++.++.+||.+||+.||.+|||+.|+++
T Consensus 250 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 250 --------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01112356889999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=370.44 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=190.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEEEec
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
.|.+.+.||+|+||+||.+ ...+|+.||||++.... .....+|+.+++++ +||||+++++++.+.+.+|+||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4566788999999999875 45679999999986542 22346899999986 899999999999999999999999
Q ss_pred cCCCHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC--------------CcEEEe
Q 044608 82 MECNLYQLMAARDRK-----LFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ--------------GIIKIA 142 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~-----~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~--------------~~vkL~ 142 (417)
++|+|.+.+...... ..++..++.++.||+.||.|||++||+||||||+|||++. +.+||+
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 998777776543211 1133346789999999999999999999999999999963 379999
Q ss_pred eccccccccCCCC-----CccccCCccccCchhhhc------cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 044608 143 DFGLAREIKSGPP-----YTNYVGSRWYRAPEILLQ------SELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMY 210 (417)
Q Consensus 143 DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~ 210 (417)
|||++........ ....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||.+....+.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 9999987654321 234689999999999865 2458999999999999999999 9999976654331
Q ss_pred HHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 211 KICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 211 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+... .+..+.... .....+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 249 ~i~~~-------------------~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 249 NIIRG-------------------IFSLDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHT-------------------CCCCCCCTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHhcC-------------------CCCcccccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 22110 111111100 001234678999999999999999999999999999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=346.37 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=198.4
Q ss_pred CceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEE-EEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRL-YLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lv 78 (417)
.|.+.+.||+|+||.||+|.+..++. .||+|++.............+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 36677999999999999998765554 79999997654433444556899999999999999999999876655 999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC----
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG---- 153 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~---- 153 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9998765444444444466899999999999999999999999999999999999975 68999999999755332
Q ss_pred -CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 154 -PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------------- 245 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--------------- 245 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---------------
T ss_pred cccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---------------
Confidence 2334567899999999986554 8999999999999999999 566676666555544432110
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......+++++.+||.+||+.||.+|||++++++
T Consensus 246 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 --------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01122457899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=356.75 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=184.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEE--------eCC
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQ--------NNN 73 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--------~~~ 73 (417)
+|++.+.||+|+||.||+|++..+|+.||+|++..... .......+|+.+++++. ||||+++++++. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 79999999999999999999999999999999865422 22334568999999996 999999999984 345
Q ss_pred EEEEEEeccCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 74 RLYLVFECMECNLYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~-~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
.+++||||++|++.+.+... ....+++..++.++.||+.||.|||++| |+||||||+|||+++ +.+||+|||++..
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 68999999999888877652 3356999999999999999999999999 999999999999975 7999999999987
Q ss_pred ccCCCCC-------------ccccCCccccCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 150 IKSGPPY-------------TNYVGSRWYRAPEILL--QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 150 ~~~~~~~-------------~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
....... ...+||+.|+|||++. ....++.++|||||||++|+|++|..||.+.........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--- 264 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--- 264 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC---
Confidence 6543221 1456999999999983 334488999999999999999999999976543322111
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
.+.. ......+.++.+||.+||+.||.+|||++|+++|-+
T Consensus 265 --------------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 --------------------KYSI---------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------------CCC---------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred --------------------cccC---------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0111 112345778999999999999999999999999854
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=354.90 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=201.5
Q ss_pred CCceecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE--eCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ--NNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 75 (417)
++|++++.||+|+||.||+|+ +..+++.||+|++..... .......+|++++++++||||+++++++. +.+.+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 589999999999999999998 577899999999976432 22334568999999999999999999886 56779
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 999999976644444444334589999999999999999999999999999999999995 6899999999998765432
Q ss_pred ----CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCc-cchHHHHH
Q 044608 155 ----PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTM-DSWADGLR 229 (417)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~-~~~~~~~~ 229 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......... ...... ........
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCERDVPALSRLLE 255 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC----CCHHHHHHH
T ss_pred ccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----cccccccccHHHHHH
Confidence 233456899999999987655 8999999999999999999999997643321111 000000 00001110
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ..... .....+.+++++.+||.+||+.||.+|||++|++++
T Consensus 256 ~---~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 L---LEEGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp H---HHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H---hhccc-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01100 112235689999999999999999999999999654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=358.97 Aligned_cols=252 Identities=12% Similarity=0.151 Sum_probs=197.4
Q ss_pred CCceecceecccCceEEEEEEECCC--------CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeee---------
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT--------GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVK--------- 64 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~--------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 64 (417)
++|++.+.||+|+||.||+|++..+ ++.||+|++... ....+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5899999999999999999999884 889999998754 23468999999999999988
Q ss_pred ------eceEEEe-CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC
Q 044608 65 ------LKELIQN-NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG 137 (417)
Q Consensus 65 ------l~~~~~~-~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~ 137 (417)
+++++.. .+.+|+||||++++|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 5677766 788999999996667777665434569999999999999999999999999999999999999864
Q ss_pred ---cEEEeeccccccccCCC--------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-H
Q 044608 138 ---IIKIADFGLAREIKSGP--------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-E 205 (417)
Q Consensus 138 ---~vkL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~ 205 (417)
.+||+|||++..+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 79999999997654321 123458999999999987654 8999999999999999999999998764 2
Q ss_pred HHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 206 ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 206 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+.+....... ....+.. .........+++++.+||.+||..||++|||++++++
T Consensus 275 ~~~~~~~~~~~------------------~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 275 TEDIMKQKQKF------------------VDKPGPF--VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHH------------------HHSCCCE--ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhc------------------cCChhhh--hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 33222221100 0000000 0000112356899999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=357.41 Aligned_cols=269 Identities=24% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+ .+|+.||+|++.............+|+++++.++||||+++++++.+.+..++||||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 108 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence 6899999999999999999974 468999999998654443333457899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCCeeeeC-CcEEEeeccccccccCC-
Q 044608 82 MECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQN---GFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG- 153 (417)
Q Consensus 82 ~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~---gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~- 153 (417)
+.++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+++ +.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188 (326)
T ss_dssp CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence 9876554444332 23489999999999999999999999 9999999999999975 68999999999866433
Q ss_pred -CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 154 -PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .......|......
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~-- 257 (326)
T 3uim_A 189 THVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLK-- 257 (326)
T ss_dssp SCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT--------SCSBHHHHHTTTTS--
T ss_pred ccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccc--------cchhHHHHHHHHhh--
Confidence 2234456999999999987665 89999999999999999999999952110000 00000000000000
Q ss_pred hhhccCCCCCccc-ccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 233 AIKYQFPQLPRAN-LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
........... .....+..+.++.+||.+||+.||.+|||+.|+++|-.-
T Consensus 258 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 --EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp --SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred --chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000000000 011122335789999999999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.81 Aligned_cols=252 Identities=26% Similarity=0.469 Sum_probs=190.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+|+.++++++||||+++++++.+.+.+++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36899999999999999999999999999999999753222 2233456899999999999999999999999999999
Q ss_pred EeccCCC-HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 79 FECMECN-LYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 79 ~E~~~~~-l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
|||++++ +.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999875 4444432 2345689999999999999999999999999999999999997 5899999999997654432
Q ss_pred -CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 -PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE--ADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... .+....+.
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 251 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------------------ 251 (310)
T ss_dssp --------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH------------------
T ss_pred ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh------------------
Confidence 234457999999999986654 89999999999999999999999976532 22222211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...++.. ....++.++.+||.+||..||.+|||+++++++
T Consensus 252 ---~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 252 ---QCDYPPL-------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ---TTCSCCC-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---cccCCCC-------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111111 124578999999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=367.13 Aligned_cols=242 Identities=26% Similarity=0.437 Sum_probs=199.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-EEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-RLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+. |+.||||+++... ......+|+.++++++||||+++++++.+.. .+|+|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 57999999999999999999764 7899999997643 2334568999999999999999999987665 7999999
Q ss_pred ccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+.+ +|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ..
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~ 345 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT 345 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cC
Confidence 9976 566666655544579999999999999999999999999999999999997 5789999999998654332 23
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+... +.
T Consensus 346 ~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------------~~ 404 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------YK 404 (450)
T ss_dssp -CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT--------------------CC
T ss_pred CCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------CC
Confidence 46789999999997655 8999999999999999998 99999887766555444211 00
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
......+++++.+||.+||..||.+|||+.++++
T Consensus 405 ---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123467899999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=374.62 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=206.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||.||+|.++.++..||||+++..... .....+|+.++++|+||||+++++++.+.+.+|+||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4688999999999999999999999999999999765433 33456899999999999999999999999999999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
+.+ +|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ...
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 985 466666554445689999999999999999999999999999999999996 5789999999998764332 123
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+++.|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+... +
T Consensus 378 ~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------------~ 436 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------------Y 436 (495)
T ss_dssp TCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------------------C
T ss_pred CCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 345678999999987655 8999999999999999999 99999988765554433210 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......+++++.+||.+||+.||++|||+.++++
T Consensus 437 ~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0 1123467899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.56 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=192.6
Q ss_pred CCceecceecccCceEEEEEEECC---CCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC----
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN---- 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 73 (417)
++|++.+.||+|+||.||+|.+.. ++..||+|+++....... .....+|+.++++++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 479999999999999999998765 566899999976544333 234568999999999999999999998755
Q ss_pred -EEEEEEeccCCC-HHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccc
Q 044608 74 -RLYLVFECMECN-LYQLMAA----RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGL 146 (417)
Q Consensus 74 -~~~lv~E~~~~~-l~~~~~~----~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~ 146 (417)
..|+||||+.++ +.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 359999999875 4444432 12356899999999999999999999999999999999999975 7899999999
Q ss_pred cccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
+....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------ 266 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH------ 266 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------
T ss_pred ceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC------
Confidence 98664432 223446788999999986554 8999999999999999999 899998887766555443110
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.......+++++.+||.+||..||.+|||+.+++++
T Consensus 267 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 -----------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011224678999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.36 Aligned_cols=238 Identities=29% Similarity=0.460 Sum_probs=187.0
Q ss_pred CCCceec-ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHH-HhcCCCCeeeeceEEEe----CCE
Q 044608 1 MDKYSGF-KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCL-RKLNHSNIVKLKELIQN----NNR 74 (417)
Q Consensus 1 ~~~Y~~~-~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~ 74 (417)
+++|.++ +.||+|+||.||+|.++.+|+.||+|++... ....+|+.++ +.++||||+++++++.+ ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3678888 7799999999999999999999999998642 2335788888 66699999999999987 778
Q ss_pred EEEEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeecccccc
Q 044608 75 LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLARE 149 (417)
Q Consensus 75 ~~lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~ 149 (417)
+|+||||+.+ +|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999987 566666555445699999999999999999999999999999999999996 46799999999865
Q ss_pred ccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
... ..++.++|||||||++|+|++|..||.+....+....+.
T Consensus 170 ~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------------- 211 (299)
T 3m2w_A 170 TTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------------- 211 (299)
T ss_dssp CTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----------------
T ss_pred ccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----------------
Confidence 321 237889999999999999999999997765433211100
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
.................+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 212 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 ------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ------CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ------HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000000001112246799999999999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.36 Aligned_cols=255 Identities=16% Similarity=0.206 Sum_probs=192.3
Q ss_pred CCceecceecccCceEEEEEEECC---CCcEEEEEEecccccChh----------hhhhHHHHHHHHhcCCCCeeeeceE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH---TGEAVAIKELKQRYASWE----------DCLNLREVKCLRKLNHSNIVKLKEL 68 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~---~g~~vaiK~i~~~~~~~~----------~~~~~~E~~~l~~l~hpnIv~l~~~ 68 (417)
++|++.+.||+|+||.||+|.+.. ++..||+|++........ .....+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 788999999875432111 1123478889999999999999999
Q ss_pred EEe----CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C--cEEE
Q 044608 69 IQN----NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G--IIKI 141 (417)
Q Consensus 69 ~~~----~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~--~vkL 141 (417)
+.+ ...+|+||||++++|.+.+.... .+++.+++.++.||+.||.|||++||+||||||+|||++. + .+||
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 988 78899999999555665554332 5899999999999999999999999999999999999974 4 8999
Q ss_pred eeccccccccCCC--------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 044608 142 ADFGLAREIKSGP--------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKI 212 (417)
Q Consensus 142 ~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i 212 (417)
+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999997654321 124568999999999987654 8999999999999999999999996532 22211111
Q ss_pred HHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCC--CCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 213 CGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMP--SASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 213 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .....+ ..+....+ .++.++.+||.+||..||++|||++++++.
T Consensus 274 ~~~------------------~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTN------------------LLDELP----QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHH------------------HHHTTT----HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHh------------------hccccc----HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 110 000000 01111112 678999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=358.20 Aligned_cols=265 Identities=19% Similarity=0.266 Sum_probs=201.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. +|+.||+|++...... ......+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 68999999999999999999864 6899999988765332 234456899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC---C
Q 044608 82 MECNLYQLMAARD---RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG---P 154 (417)
Q Consensus 82 ~~~~l~~~~~~~~---~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~---~ 154 (417)
++++.+..+.... ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++...... .
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9875444333222 124899999999999999999999999999999999999974 78999999999764432 2
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+ .|.... ..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~~~----~~ 261 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----------EWAVES----HN 261 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH----------HHTHHH----HT
T ss_pred cccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH----------HHhhhc----cc
Confidence 234456899999999987665 899999999999999999999999765432211110 010000 00
Q ss_pred hccCCCCCcc-cccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcc
Q 044608 235 KYQFPQLPRA-NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283 (417)
Q Consensus 235 ~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~ 283 (417)
...+...... ......+..+.++.+||.+||+.||++|||+.|+++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0011111111 111222345678999999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=365.58 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=200.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC-CCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E 80 (417)
++|+++++||+|+||.||+|.+..+++.||||++...... ....+|+++++.|.| ++|..+..++...+..|||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 6899999999999999999999999999999988654322 234689999999987 556666677788899999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeee----eCCcEEEeeccccccccCCCC-
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV----SQGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl----~~~~vkL~DFg~a~~~~~~~~- 155 (417)
|++++|.+.+... ...+++..++.|+.||+.||.|||++||+||||||+|||| .++.+||+|||++..+.....
T Consensus 84 ~~g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9966677666543 3569999999999999999999999999999999999999 357899999999987654322
Q ss_pred -------CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhCCCCccchH
Q 044608 156 -------YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASE---ADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 156 -------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~~ 225 (417)
....+||+.|+|||++.+.. ++.++|||||||+||||++|..||.+... .+.+..+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH---------
T ss_pred cccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc---------
Confidence 23568999999999987655 89999999999999999999999987553 23333322110
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL 279 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL 279 (417)
. ...+..+...++.++.+||.+||..||++||++++|+
T Consensus 233 ----------~------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~ 270 (483)
T 3sv0_A 233 ----------V------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK 270 (483)
T ss_dssp ----------H------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred ----------c------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 0 0111223346789999999999999999999999886
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=351.20 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=200.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
.++|++.+.||+|+||.||+|.+.. .||+|+++....... .....+|+.++++++||||+++++++.+.+.+++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3689999999999999999998754 499999875433222 223457999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccC------C
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKS------G 153 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~------~ 153 (417)
||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++..... .
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------C
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccccc
Confidence 9998765555555444568999999999999999999999999999999999999999999999999875432 1
Q ss_pred CCCccccCCccccCchhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 154 PPYTNYVGSRWYRAPEILLQ--------SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....+....+...
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 258 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG---------- 258 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT----------
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC----------
Confidence 22344569999999999864 234789999999999999999999999988877666554321
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..+. .....++.++.+||.+||..||.+|||++++++
T Consensus 259 -----------~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 -----------MKPN-------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -----------CCCC-------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -----------CCCC-------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0010 011246889999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=390.70 Aligned_cols=280 Identities=26% Similarity=0.356 Sum_probs=207.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe------CCE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN------NNR 74 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 74 (417)
+++|++.+.||+|+||.||+|.+..+|+.||||++.............+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999998765444444455789999999999999999998765 677
Q ss_pred EEEEEeccCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C---cEEEeeccccc
Q 044608 75 LYLVFECMECNLYQLMAARD--RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G---IIKIADFGLAR 148 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~--~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~---~vkL~DFg~a~ 148 (417)
.|+||||+.|+.+..+.... ...+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 89999999775444444332 225899999999999999999999999999999999999974 3 38999999999
Q ss_pred cccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 149 EIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 149 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
...........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..............+......+.
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~--- 248 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD--- 248 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC---
T ss_pred ccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh---
Confidence 887766667789999999999986554 8999999999999999999999998765433211100000000000000
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.......+... ......+.+.+++++.+||.+||.+||++|||++|+|+||||+..
T Consensus 249 --~l~g~~~~~~~-lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 249 --DLTGAVKFSSV-LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp --CCSSSCCCCSS-SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred --hhccccccccc-cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 00000111110 011122334467899999999999999999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=359.88 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=191.6
Q ss_pred CceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE-eCCEEEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ-NNNRLYLV 78 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv 78 (417)
+|++.+.||+|+||.||+|.+..+ +..||+|.++............+|+.++++++||||+++++++. ..+..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477889999999999999987543 24689999876544444555678999999999999999999864 45688999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC---
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--- 154 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~--- 154 (417)
|||+.++.+..+.......+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999876555555544466899999999999999999999999999999999999974 789999999998654322
Q ss_pred --CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 155 --PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
......+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---------------- 312 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---------------- 312 (373)
T ss_dssp --------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT----------------
T ss_pred ccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC----------------
Confidence 123446788999999987655 8999999999999999999 78899877655544433210
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. ......++.++.+||.+||..||++|||+.|++++
T Consensus 313 -----~~--------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 -----RR--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01124578899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=349.53 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred Cc-eecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEE
Q 044608 3 KY-SGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN--NNRL 75 (417)
Q Consensus 3 ~Y-~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 75 (417)
+| ++++.||+|+||+||++. +..+|+.||+|+++............+|++++++++||||+++++++.+ ...+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 55 999999999999997774 4558899999999876444444556789999999999999999999987 4689
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~ 154 (417)
++||||++++.+..+.... .+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999876555555443 3899999999999999999999999999999999999975 789999999998765543
Q ss_pred C----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 P----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... . .+.... .+ .....
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~---~~~~~~-~~-~~~~~ 260 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--L---IGIAQG-QM-TVLRL 260 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--H---HCSCCH-HH-HHHHH
T ss_pred cccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--h---hccccc-ch-hHHHH
Confidence 2 33456889999999997655 789999999999999999999999754322110 0 000000 00 00000
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........ .......++.++.+||.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGE-------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccc-------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00111100 11223567899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.38 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=201.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. ++..||||+++..... .....+|+.++++|+||||+++++++. .+.+|+||||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc--HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 47899999999999999999886 4678999999865432 344578999999999999999999986 5678999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC--CCCc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG--PPYT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~--~~~~ 157 (417)
+.++ |.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..... ....
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 9764 66655544333589999999999999999999999999999999999997 478999999999865432 1123
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+|..|+|||++.... ++.++|||||||++|||++ |..||.+.+..+....+... +
T Consensus 344 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------------~ 402 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------------------Y 402 (454)
T ss_dssp SSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT--------------------C
T ss_pred CCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 345688999999997655 8999999999999999999 99999998887776655321 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..+ ....+++++.+||.+||..||++|||++++++
T Consensus 403 ~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 RMP---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 111 12457899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=342.94 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=192.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeC-CEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNN-NRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E 80 (417)
++|++.+.||+|+||.||+|.+ +|+.||+|+++... ......+|++++++++||||+++++++.+. +.+|+|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 6899999999999999999976 48899999997543 233456899999999999999999987544 57899999
Q ss_pred ccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 81 CMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 81 ~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
|+++ ++.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 173 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DT 173 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cC
Confidence 9987 566666554333479999999999999999999999999999999999996 5789999999997654432 23
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 174 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---------------------- 230 (278)
T 1byg_A 174 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------------- 230 (278)
T ss_dssp --CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------------------
T ss_pred CCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------------------
Confidence 46789999999987654 8999999999999999998 99999887765554443210
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........+++++.+||.+||+.||++|||+.|+++
T Consensus 231 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 -------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001223467899999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=343.74 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=192.2
Q ss_pred CCceecceecccCceEEEEEEECC-CCc--EEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-TGE--AVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-~g~--~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|.+.. +++ .||+|+++..... .......+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 579999999999999999998643 343 6999998755322 23344568999999999999999999998765 88
Q ss_pred EEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 77 LVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
+||||+.++ +.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 999999864 55555543 35589999999999999999999999999999999999995 6889999999998765432
Q ss_pred C----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 155 P----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 155 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------------- 240 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------------- 240 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------------
T ss_pred cchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--------------
Confidence 2 23446788999999987654 7999999999999999999 99999998877766555321
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... ......++.++.+||.+||..||.+|||+.++++
T Consensus 241 -----~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----GER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----CCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 1122467899999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=339.27 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=200.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++++.||+|+||.||+|.+. ++..||+|++...... .....+|+++++.++||||+++++++.+ +..|+||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 57999999999999999999875 5678999999765433 3345689999999999999999999864 558999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC--CCc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
+.++ |.+.+.......+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||++....... ...
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9765 555443332235899999999999999999999999999999999999975 789999999998765432 123
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 169 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------- 227 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-------------------- 227 (279)
T ss_dssp TCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------------
T ss_pred CCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc--------------------
Confidence 345788999999986554 8999999999999999999 999999888776665543210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......++.++.+||.+||..||++|||++++++
T Consensus 228 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 R---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 1122457899999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=375.28 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=201.2
Q ss_pred Cceecc-eecccCceEEEEEEEC--CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 3 KYSGFK-ELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 3 ~Y~~~~-~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
+|.+.+ +||+|+||.||+|.++ .++..||||+++............+|+++|++++|||||++++++.+ +.+|+||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 345555 7999999999999775 35667999999876444444556789999999999999999999976 5689999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC---
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--- 155 (417)
||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99988766555544456699999999999999999999999999999999999996 58899999999987643322
Q ss_pred -CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhh
Q 044608 156 -YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233 (417)
Q Consensus 156 -~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 233 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------------- 556 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------------- 556 (613)
T ss_dssp -------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-----------------
T ss_pred eccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 12234568899999997655 8999999999999999998 999999988877666553210
Q ss_pred hhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHH---cCcccc
Q 044608 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEAL---QHPFFK 285 (417)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL---~hp~f~ 285 (417)
.....+.+++++.+||.+||..||++|||+++++ ++.|+.
T Consensus 557 ------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 557 ------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112346789999999999999999999999984 455543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=350.12 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=194.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEE----eCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQ----NNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~l 77 (417)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+|+++++.++||||+++++++. ....+|+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 47999999999999999999999999999999986532 222334568999999999999999999987 3457899
Q ss_pred EEeccCCC-HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 78 VFECMECN-LYQLMAAR--DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~~--~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
||||+.++ |.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999875 55554432 345689999999999999999999999999999999999996 589999999998754321
Q ss_pred CC----------CccccCCccccCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCC
Q 044608 154 PP----------YTNYVGSRWYRAPEILLQSE--LYSSKADMWAMGAIMAELFTFCPLFPGASEAD-QMYKICGVLGSPT 220 (417)
Q Consensus 154 ~~----------~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~ 220 (417)
.. .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||....... ......
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------- 260 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV------- 260 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-------
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-------
Confidence 11 12346799999999985432 26889999999999999999999994311000 000000
Q ss_pred ccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 221 MDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
......+ ..+.++.++.+||.+||+.||.+|||++|++++
T Consensus 261 ------------~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 261 ------------QNQLSIP---------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------HCC--CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------hccCCCC---------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0011111 124678999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=347.31 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=189.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHh--cCCCCeeeeceEEEe----CCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--LNHSNIVKLKELIQN----NNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~----~~~~ 75 (417)
++|++++.||+|+||.||+|.+ +|+.||+|++.... .....+|.+++.. ++||||+++++++.+ ...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 5899999999999999999976 68999999986532 2233457777766 799999999998654 3568
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH--------QNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH--------~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
|+||||++++.+..+... ..+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999987655444433 45899999999999999999999 99999999999999997 57899999999
Q ss_pred cccccCCCC-----CccccCCccccCchhhhccC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCH-
Q 044608 147 AREIKSGPP-----YTNYVGSRWYRAPEILLQSE-----LYSSKADMWAMGAIMAELFTF----------CPLFPGASE- 205 (417)
Q Consensus 147 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g----------~~pf~~~~~- 205 (417)
+........ ....+||+.|+|||++.+.. .++.++|||||||++|||++| ..||.....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 976544322 23458999999999986553 244799999999999999999 888865321
Q ss_pred ---HHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 206 ---ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 206 ---~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.+.+..+.. .....+..+. .......+.++.+||.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~-------------------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 240 DPSFEDMRKVVC-------------------VDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCCHHHHHHHHT-------------------TSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcchhhhhHHHh-------------------ccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 122222111 0111111111 1111234678999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=362.71 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=199.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||.||+|.+.. +..||||+++..... .....+|++++++|+||||+++++++.+ +.+|+||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 468999999999999999999875 456999999865433 2345689999999999999999999876 678999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
+.++ |.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ...
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 9864 55555443335689999999999999999999999999999999999996 4789999999998664322 122
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+|..|+|||++.... ++.++|||||||++|||++ |..||.+....+....+... +
T Consensus 340 ~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------------~ 398 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------------------Y 398 (452)
T ss_dssp ---CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------------------C
T ss_pred CCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 345678999999987655 8999999999999999999 99999998877766555321 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc--Ccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFFK 285 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~ 285 (417)
.. ...+.+++++.+||.+||+.||++|||++++++ +.+|.
T Consensus 399 ~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 RM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11 122467899999999999999999999999986 34443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.37 Aligned_cols=242 Identities=14% Similarity=0.189 Sum_probs=190.1
Q ss_pred CCceecceecccCceEEEEE-----EECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a-----~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~ 73 (417)
++|.+.+.||+|+||.||+| .+..+++.||+|++.... .....+|+++++.+. |+||+++++++...+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 46999999999999999999 467789999999997542 223456888888886 999999999999999
Q ss_pred EEEEEEeccCCC-HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC------------C
Q 044608 74 RLYLVFECMECN-LYQLMAAR---DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ------------G 137 (417)
Q Consensus 74 ~~~lv~E~~~~~-l~~~~~~~---~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~------------~ 137 (417)
..|+||||++++ |.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 999999999865 55554432 2356999999999999999999999999999999999999954 7
Q ss_pred cEEEeecccccccc---CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 044608 138 IIKIADFGLAREIK---SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214 (417)
Q Consensus 138 ~vkL~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 214 (417)
.+||+|||+|..+. ........+||+.|+|||++.+.. |+.++|||||||++|||++|..||......
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~-------- 291 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG-------- 291 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT--------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC--------
Confidence 89999999996543 333455678999999999997665 899999999999999999999999543210
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
.+.... .+.. ...++.+.+++..||+.+|.+|++..+.|.+.
T Consensus 292 --------------------~~~~~~----~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 --------------------ECKPEG----LFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --------------------EEEECS----CCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --------------------ceeech----hccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000000 0001 12467899999999999999996655555443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=341.34 Aligned_cols=241 Identities=32% Similarity=0.460 Sum_probs=186.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||.||+|.+. ++.||+|++... .......+|++++++++||||+++++++.+ ..|+||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 58999999999999999999764 789999998643 223445689999999999999999998864 47899999
Q ss_pred cCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCCCCeeeeC-Cc-EEEeeccccccccCCC
Q 044608 82 MECNLYQLMAARDR--KLFSEPEIKAWLFQVFQGLSYMHQ---NGFFHRDLKPENLLVSQ-GI-IKIADFGLAREIKSGP 154 (417)
Q Consensus 82 ~~~~l~~~~~~~~~--~~l~e~~i~~i~~qi~~aL~~LH~---~gi~HrDLKp~NILl~~-~~-vkL~DFg~a~~~~~~~ 154 (417)
++++.+..+..... ..+++..+..++.||+.||.|||+ +||+||||||+|||+++ +. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 98754444443322 247899999999999999999999 89999999999999965 54 899999999765432
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA--DQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------------- 218 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH------------------- 218 (307)
T ss_dssp ------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-------------------
T ss_pred -cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-------------------
Confidence 23457999999999987654 899999999999999999999999764322 1111111
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .......++.++.+||.+||+.||++|||++|++++
T Consensus 219 --~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 219 --NGT--------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp --TTC--------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --cCC--------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 000 012234678999999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=340.55 Aligned_cols=264 Identities=22% Similarity=0.359 Sum_probs=200.2
Q ss_pred CCceecceecccCceEEEEEE----ECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC--EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAF----DEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN--RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~----~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~ 75 (417)
++|++++.||+|+||.||+|. +..+|+.||+|++.... ........+|++++++++||||+++++++...+ .+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 469999999999999999998 56789999999997642 333345568999999999999999999986544 78
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
++||||++++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999987544444444445689999999999999999999999999999999999996 5899999999998765443
Q ss_pred C----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 155 P----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 155 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
. .....++..|+|||++.+.. ++.++|||||||++|+|++|..||..... .. ....+......+... ..
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~~~~~~~-~~ 272 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQMIVF-HL 272 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCCTHHHHH-HH
T ss_pred cccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccchhhhHH-HH
Confidence 2 23346788899999987655 89999999999999999999999864321 11 111222222111100 00
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
........ .......++.++.+||.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCC-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00001000 01123567899999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=362.51 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=186.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccC-------hhhhhhHHHHHHHHhcC---------CCCeeee
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-------WEDCLNLREVKCLRKLN---------HSNIVKL 65 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~-------~~~~~~~~E~~~l~~l~---------hpnIv~l 65 (417)
++|++++.||+|+||+||+|++ +|+.||||++...... .......+|+.+++.|+ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999987 7899999999865321 11234468999998886 6666665
Q ss_pred ceE-----------------EEe-------------CCEEEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 044608 66 KEL-----------------IQN-------------NNRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGL 114 (417)
Q Consensus 66 ~~~-----------------~~~-------------~~~~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL 114 (417)
+++ |.+ .+.+|+||||+.++ +++.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 554 333 78899999999776 6666532 4589999999999999999
Q ss_pred HHHH-HCCcccccCCCCCeeeeC-C--------------------cEEEeeccccccccCCCCCccccCCccccCchhhh
Q 044608 115 SYMH-QNGFFHRDLKPENLLVSQ-G--------------------IIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172 (417)
Q Consensus 115 ~~LH-~~gi~HrDLKp~NILl~~-~--------------------~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~ 172 (417)
.||| ++||+||||||+|||++. + .+||+|||+|+..... ..+||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 999999999999999964 4 8999999999876543 458999999999986
Q ss_pred ccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccC
Q 044608 173 QSELYSSKADMWAMGAI-MAELFTFCPLFPGASEAD-QMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALM 250 (417)
Q Consensus 173 ~~~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (417)
+.. +.++||||||++ .+++++|..||.+..... ....+... ..+. ........
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~ 305 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ--------------------MTFK---TKCNTPAM 305 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT--------------------CCCS---SCCCSHHH
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh--------------------hccC---cccchhhh
Confidence 543 889999998777 788999999984321101 11111100 0111 11111223
Q ss_pred CCCCHhHHHHHHHhcccCCCCCCCHHHHH-cCcccc
Q 044608 251 PSASQDAISLFESLCSWDPSKRPTAAEAL-QHPFFK 285 (417)
Q Consensus 251 ~~~s~~~~~li~~~L~~dP~~Rpta~elL-~hp~f~ 285 (417)
+.+|+++++||.+||+.| |++|+| +||||+
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 356889999999999987 999999 999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.44 Aligned_cols=275 Identities=24% Similarity=0.324 Sum_probs=188.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-----CCEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN-----NNRL 75 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~ 75 (417)
+++|++++.||+|+||.||+|.+ +++.||||++..... .......|+..+..++||||+++++.+.. ...+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 57999999999999999999965 689999999975321 11222234444556899999999986542 3367
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCCeeeeC-CcEEEeecc
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN---------GFFHRDLKPENLLVSQ-GIIKIADFG 145 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~---------gi~HrDLKp~NILl~~-~~vkL~DFg 145 (417)
|+||||++++.+..+.... ..++..++.++.||+.||.|||++ ||+||||||+|||+++ +.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999775544444443 358999999999999999999999 9999999999999975 799999999
Q ss_pred ccccccCC---------CCCccccCCccccCchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHH
Q 044608 146 LAREIKSG---------PPYTNYVGSRWYRAPEILLQS------ELYSSKADMWAMGAIMAELFTFCPLF-PGASEADQM 209 (417)
Q Consensus 146 ~a~~~~~~---------~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~ 209 (417)
++..+... ......+||+.|+|||++.+. ..++.++|||||||++|||++|..|| .+....+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99866432 122355799999999998652 23678899999999999999996554 433321111
Q ss_pred HHHHHhhCC-CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH------HcCc
Q 044608 210 YKICGVLGS-PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA------LQHP 282 (417)
Q Consensus 210 ~~i~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el------L~hp 282 (417)
..+....+. +....+.. ........+..+. . ......+++++.+||.+||..||++|||++|+ +-++
T Consensus 246 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQV----LVSREKQRPKFPE-A-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHH----HHTTSCCCCCCCT-T-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHh----hhcccccCCCCCc-c-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 011111111 11111100 0000011111100 0 00011245689999999999999999999999 4577
Q ss_pred ccccc
Q 044608 283 FFKRC 287 (417)
Q Consensus 283 ~f~~~ 287 (417)
|-++.
T Consensus 320 ~~~~~ 324 (336)
T 3g2f_A 320 WERNK 324 (336)
T ss_dssp CCC--
T ss_pred HHhcc
Confidence 77664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.13 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=194.4
Q ss_pred ceecccCceEEEEEE--ECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~--~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++||+|+||.||+|. ++.+++.||||+++....... .....+|++++++|+|||||++++++.+ +.+++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 479999999999994 456778999999986544322 3445789999999999999999999975 458899999987
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC----Cccc
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP----YTNY 159 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~----~~~~ 159 (417)
+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 6555444433 5689999999999999999999999999999999999996 57899999999987654322 2334
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 533 ~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---------------------- 589 (635)
T 4fl3_A 533 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------------------- 589 (635)
T ss_dssp --CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------------
T ss_pred CCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence 5788999999996655 8999999999999999998 999999998877666553210
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.......+++++.+||.+||..||++|||++++++
T Consensus 590 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01123467899999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=366.83 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=202.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||.||+|.+.. +..||||+++..... .....+|+++|++|+||||+++++++.+ +.+||||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 468999999999999999999875 467999999865433 2345789999999999999999999876 678999999
Q ss_pred cCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 82 MEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
+.+ +|.+.+.......+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...... ...
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 986 466665544335689999999999999999999999999999999999996 4789999999998654321 123
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...++..|+|||++.... ++.++|||||||++|||++ |..||.+....+.+..+... +
T Consensus 423 ~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~--------------------~ 481 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------------------Y 481 (535)
T ss_dssp STTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT--------------------C
T ss_pred CCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 345788999999987655 8999999999999999999 99999998877766555321 1
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. .....++.++.+||.+||..||++|||+++|++
T Consensus 482 ~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 482 RM---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 122467899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=363.21 Aligned_cols=247 Identities=17% Similarity=0.195 Sum_probs=189.5
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCC-CCeee---------------
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNH-SNIVK--------------- 64 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~h-pnIv~--------------- 64 (417)
.|.+.+.||+|+||.||+|.+..+|+.||||++........ .....+|+.+++.+.| .|+..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 37788999999999999999999999999999874332221 2334589999999977 32111
Q ss_pred ------eceEEEe-----CCEEEEEEeccCCCHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 044608 65 ------LKELIQN-----NNRLYLVFECMECNLYQLMAA-----RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLK 128 (417)
Q Consensus 65 ------l~~~~~~-----~~~~~lv~E~~~~~l~~~~~~-----~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLK 128 (417)
+..++.. ...++++|+++.+++.+.+.. .....+++..+..++.||+.||+|||++||+|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 1111121 234788999988888877642 123447788899999999999999999999999999
Q ss_pred CCCeeee-CCcEEEeeccccccccCCCCCccccCCccccCchhhh---------ccCCCCchhhHHHHHHHHHHHHhCCC
Q 044608 129 PENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL---------QSELYSSKADMWAMGAIMAELFTFCP 198 (417)
Q Consensus 129 p~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwSlG~il~ell~g~~ 198 (417)
|+|||++ ++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||++|+.
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999997 478999999998865443 455678 9999999984 33347889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 044608 199 LFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA 278 (417)
Q Consensus 199 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 278 (417)
||.+.+..+... ..+ .....+++++.+||.+||+.||++|||+.|+
T Consensus 316 Pf~~~~~~~~~~-------------------------~~~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 316 PNTDDAALGGSE-------------------------WIF---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp CCCTTGGGSCSG-------------------------GGG---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcchhhhHH-------------------------HHH---------hhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 997754322111 001 1123578999999999999999999999999
Q ss_pred HcCccccc
Q 044608 279 LQHPFFKR 286 (417)
Q Consensus 279 L~hp~f~~ 286 (417)
|+||||+.
T Consensus 362 l~~~~~~~ 369 (413)
T 3dzo_A 362 METPEYEQ 369 (413)
T ss_dssp TTSHHHHH
T ss_pred HhCHHHHH
Confidence 99999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=340.71 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=196.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEeccccc---ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA---SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
|...+.||+|+||.||+|.+ +++.||+|++..... ........+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999975 688999999875432 1223345689999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--
Q 044608 81 CMECN-LYQLMAAR-DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~-~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~-- 155 (417)
|+.++ +.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99765 55555432 2346899999999999999999999999999999999999975 7899999999986544221
Q ss_pred -CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 -YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 -~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....||+.|+|||++.+ . ++.++|||||||++|+|++|.+||.+....+....+........ ..+.+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~-------- 259 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIED-------- 259 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHH--------
T ss_pred cccccCCCcCcCChHHhcC-C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhh--------
Confidence 234579999999998854 3 79999999999999999999999987654332222221110000 00000
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+ . ...+.......+.++.+||.+||+.||.+|||+++++++
T Consensus 260 -~-~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 -Y-I----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -H-S----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -h-c----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0 001111122345779999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.20 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=201.9
Q ss_pred CCceecceecccCceEEEEEEECCC---CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~---g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||.||+|.+..+ +..||+|.++............+|+.++++++||||+++++++. .+.+|+|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 4789999999999999999998654 45799999876544333445678999999999999999999985 4568999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 548 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCccee
Confidence 999987655555444445689999999999999999999999999999999999996 68999999999987654322
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~------------------ 609 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------------------ 609 (656)
T ss_dssp -----CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC------------------
T ss_pred ccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 23346788999999987654 8999999999999999997 999999988877766654210
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.....+.+++++.+||.+||..||.+|||+.|+++
T Consensus 610 -----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 610 -----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123567899999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=343.78 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=186.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhc--CCCCeeeeceEEEeC----CEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL--NHSNIVKLKELIQNN----NRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~----~~~ 75 (417)
++|++++.||+|+||.||+|.+. |+.||+|++.... .....+|.+++..+ +||||+++++++.+. ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 47999999999999999999875 8999999986432 22234556665554 899999999999887 789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCCeeee-CCcEEEeeccc
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN--------GFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~--------gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
|+||||+.++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999875444444433 489999999999999999999999 999999999999996 57999999999
Q ss_pred cccccCCCC-----CccccCCccccCchhhhccCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCCCCH
Q 044608 147 AREIKSGPP-----YTNYVGSRWYRAPEILLQSELYSS------KADMWAMGAIMAELFTF----------CPLFPGASE 205 (417)
Q Consensus 147 a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~------~~DiwSlG~il~ell~g----------~~pf~~~~~ 205 (417)
+..+..... ....+||+.|+|||++.+.. ++. ++|||||||++|||++| ..||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 976544322 23568999999999986554 344 49999999999999999 566644321
Q ss_pred ----HHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 206 ----ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 206 ----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+....+. ......+..+. ......+++++.+||.+||+.||.+|||++|+++|
T Consensus 268 ~~~~~~~~~~~~-------------------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIV-------------------CIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHH-------------------TTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHH-------------------hhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11111111 00000111100 00112356789999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.72 Aligned_cols=250 Identities=26% Similarity=0.307 Sum_probs=191.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHh--cCCCCeeeeceEEEeCC----EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK--LNHSNIVKLKELIQNNN----RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~ 75 (417)
++|++.+.||+|+||.||+|.+ +|+.||||++.... .....+|++++.. ++||||+++++++.... .+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 4799999999999999999987 58999999986532 2334578888888 78999999999998876 89
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCCeeee-CCcEEEeeccc
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH--------QNGFFHRDLKPENLLVS-QGIIKIADFGL 146 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH--------~~gi~HrDLKp~NILl~-~~~vkL~DFg~ 146 (417)
|+||||+.++.+..+... ..+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999987544444443 34899999999999999999999 89999999999999996 57899999999
Q ss_pred cccccCCC-----CCccccCCccccCchhhhccCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCCCH-
Q 044608 147 AREIKSGP-----PYTNYVGSRWYRAPEILLQSEL-----YSSKADMWAMGAIMAELFTF----------CPLFPGASE- 205 (417)
Q Consensus 147 a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~ell~g----------~~pf~~~~~- 205 (417)
+....... .....+||+.|+|||++.+... ++.++|||||||++|+|++| ..||.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 98665443 2345689999999999865432 23689999999999999999 678865421
Q ss_pred ---HHHHHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 206 ---ADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 206 ---~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.+.+...... ....+..+. .......+..+.+||.+||+.||++|||+.|+++|
T Consensus 274 ~~~~~~~~~~~~~-------------------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCE-------------------QKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTT-------------------SCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHH-------------------HHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1111111100 000011000 00112234679999999999999999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=372.27 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=197.7
Q ss_pred CCceecceecccCceEEEEEEECC-CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCE-----E
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNR-----L 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----~ 75 (417)
++|++.+.||+|+||.||+|.+.. +|+.||||++.............+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999976 7899999998754333333445689999999999999999999987665 7
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~ 155 (417)
||||||++|+.+...... .+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||++......
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC--
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC--
Confidence 999999987755544332 589999999999999999999999999999999999999999999999999876543
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
...+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....
T Consensus 235 -~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------------- 282 (681)
T 2pzi_A 235 -GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------------- 282 (681)
T ss_dssp -SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------------------
T ss_pred -CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------------------
Confidence 456899999999998654 489999999999999999999998642100
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
..+. ... ....++++.+||.+||+.||++|||+.+++.|+|+.
T Consensus 283 -~~~~--~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 -GLPE--DDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -SCCT--TCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -cccc--ccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000 000 012357899999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=325.81 Aligned_cols=226 Identities=14% Similarity=0.056 Sum_probs=181.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
++|++.+.||+|+||.||+|.+..+|+.||||++........ .....+|+.++.+++||||+++++++.+.+.+|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 589999999999999999999999999999999986544322 234568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCcc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
||++|+.+..+... + ..+.++..++.||+.||.|||++||+||||||+|||++ +|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 99987655555533 2 46678899999999999999999999999999999997 5789998554
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
|++ .++.++|||||||++|+|++|..||.+.+..+.+.. ....
T Consensus 175 ------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------------------~~~~ 217 (286)
T 3uqc_A 175 ------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------------------AERD 217 (286)
T ss_dssp ------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------------------CCBC
T ss_pred ------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------------------HHHH
Confidence 233 278999999999999999999999987653221100 0000
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
............+.+++++.+||.+||+.||++| |+.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0111122234556789999999999999999999 99999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.36 Aligned_cols=186 Identities=18% Similarity=0.108 Sum_probs=130.3
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccC---------hhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEE
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS---------WEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~---------~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 77 (417)
...+.|+.|.+..++....|+.||+|++.+.... .......+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3467788888888888889999999999754211 1122345899999999 69999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~ 155 (417)
||||++|+.+..++... +.+++. .|+.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 99999998666666554 456764 4789999999999999999999999999996 589999999999876543 44
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL 199 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p 199 (417)
..+.+||+.|+|||++.+. +..++|+||+|+++++|.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 5667999999999998653 67889999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=260.19 Aligned_cols=183 Identities=17% Similarity=0.154 Sum_probs=139.4
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChh-------hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-------DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
..+.||+|+||.||+| ...++.+++|.......... .....+|++++++++||||+++..++.+.+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 55688899998754322211 12246899999999999999777766677888999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccccccccCCCC---
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGLAREIKSGPP--- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~~~~~~~--- 155 (417)
|||++|+.+..+... +..++.||+.||.|||++||+||||||+|||+++ .+||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCcccccc
Confidence 999986544444322 6689999999999999999999999999999999 999999999987654322
Q ss_pred -----CccccCCccccCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 044608 156 -----YTNYVGSRWYRAPEILLQS-ELYSSKADMWAMGAIMAELFTFCPLF 200 (417)
Q Consensus 156 -----~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf 200 (417)
....+||+.|+|||++... ..|+..+|+||..+-..+-..++.+|
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2356899999999998641 23788899999998888877776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=217.11 Aligned_cols=144 Identities=21% Similarity=0.169 Sum_probs=114.5
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----------------hhhhhHHHHHHHHhcCCCCeeeec
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----------------EDCLNLREVKCLRKLNHSNIVKLK 66 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----------------~~~~~~~E~~~l~~l~hpnIv~l~ 66 (417)
|.+.+.||+|+||.||+|.+ .+|+.||+|+++...... ......+|+.++++++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 45669999999999999999 889999999996432211 1233468999999999 5 7777
Q ss_pred eEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccc
Q 044608 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGL 146 (417)
Q Consensus 67 ~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~ 146 (417)
+++.. +..|+||||++|+.+..+ .......++.||+.||.|||++||+||||||+|||++++.+||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHHc--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCC
Confidence 76655 456999999987544332 113456799999999999999999999999999999988999999999
Q ss_pred cccccCCCCCccccCCccccCchhhh
Q 044608 147 AREIKSGPPYTNYVGSRWYRAPEILL 172 (417)
Q Consensus 147 a~~~~~~~~~~~~~gt~~y~aPE~l~ 172 (417)
|.. +..|+|||++.
T Consensus 239 a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE------------VGEEGWREILE 252 (282)
T ss_dssp CEE------------TTSTTHHHHHH
T ss_pred CeE------------CCCCCHHHHHH
Confidence 863 55689999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=189.16 Aligned_cols=138 Identities=14% Similarity=0.184 Sum_probs=105.5
Q ss_pred ceecceecccCceEEEEEEECCCCcE--EEEEEecccccCh-----------------------hhhhhHHHHHHHHhcC
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASW-----------------------EDCLNLREVKCLRKLN 58 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~--vaiK~i~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 58 (417)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+|+.+|..|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778999 9999875432110 0113458999999998
Q ss_pred CCCe--eeeceEEEeCCEEEEEEeccCC-C----HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCC
Q 044608 59 HSNI--VKLKELIQNNNRLYLVFECMEC-N----LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH-QNGFFHRDLKPE 130 (417)
Q Consensus 59 hpnI--v~l~~~~~~~~~~~lv~E~~~~-~----l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH-~~gi~HrDLKp~ 130 (417)
|++| ..+++. +..+|||||+++ + .+...... .++..+..++.||+.||.||| ++||+||||||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 8865 333332 346899999953 1 33332211 245678899999999999999 999999999999
Q ss_pred CeeeeCCcEEEeeccccccc
Q 044608 131 NLLVSQGIIKIADFGLAREI 150 (417)
Q Consensus 131 NILl~~~~vkL~DFg~a~~~ 150 (417)
|||+++ .++|+|||+|...
T Consensus 201 NILl~~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID-KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS-SEEECCCTTCEET
T ss_pred HEEEcC-cEEEEECcccccC
Confidence 999988 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-19 Score=172.67 Aligned_cols=136 Identities=16% Similarity=0.218 Sum_probs=96.8
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-------------hh--------hhhHHHHHHHHhcCCCCe
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-------------ED--------CLNLREVKCLRKLNHSNI 62 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-------------~~--------~~~~~E~~~l~~l~hpnI 62 (417)
|.+.+.||.|+||.||+|.+. +|+.||||+++...... .. ....+|...|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999874 69999999876421110 00 001246777777755444
Q ss_pred eeeceEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCC-----
Q 044608 63 VKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQG----- 137 (417)
Q Consensus 63 v~l~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~----- 137 (417)
.-..-+.... .+|||||++|..+..+ ...+....++.||+.+|.+||++|||||||||.|||++++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3222222222 2799999988654322 2234566789999999999999999999999999999643
Q ss_pred ------cEEEeecccccc
Q 044608 138 ------IIKIADFGLARE 149 (417)
Q Consensus 138 ------~vkL~DFg~a~~ 149 (417)
.+.|+||+-+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 389999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-13 Score=126.35 Aligned_cols=138 Identities=18% Similarity=0.196 Sum_probs=109.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+.|++...+|.|+++.||++.. .+..+++|+....... ......+|+.+++.|. +..+.++++++.+.+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 6799999999999999999964 3688999998754221 1234568999999994 6778899999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ----------------------------------------- 119 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~----------------------------------------- 119 (417)
|++|..+.... .+......++.++..+|..||+
T Consensus 91 ~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99997655431 1223345788999999999998
Q ss_pred ------------------CCcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 120 ------------------NGFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 120 ------------------~gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
.+++|+|++|.|||++++.+ .|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 45899999999999988765 699999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=7e-12 Score=115.48 Aligned_cols=132 Identities=13% Similarity=0.055 Sum_probs=96.1
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E 80 (417)
.|.+....+.|..+.||++.. .+|..+++|+..... .....+|+.+++.|.+.+ +.+++.++.+.+..|+|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 455544445666799999953 567789999876531 123457999999986444 5668888888888999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--------------------------------------- 121 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--------------------------------------- 121 (417)
|++|..+. . . ..+ ...++.++...|..||+..
T Consensus 96 ~i~G~~l~-~---~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL-S---S--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT-T---S--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC-c---C--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99986553 1 1 112 2256677777777777643
Q ss_pred -------------------cccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 122 -------------------FFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 122 -------------------i~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
++|+|++|.|||++++.+ .|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 999999999999988765 599999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=117.90 Aligned_cols=140 Identities=15% Similarity=0.210 Sum_probs=102.7
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEec--ccccChhhhhhHHHHHHHHhcC--CCCeeeeceEEEeC---CEEEE
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELK--QRYASWEDCLNLREVKCLRKLN--HSNIVKLKELIQNN---NRLYL 77 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~--~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~l 77 (417)
..++.|+.|.++.||++.. .+..+++|+.. ............+|+.+++.|. +..+.+++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467899999999999964 35678999876 3322222345568999999997 45578888888776 45799
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-------------------------------------- 119 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-------------------------------------- 119 (417)
||||++|..+.. .....+++.+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999864421 111236788889999999999999997
Q ss_pred --------------------CCcccccCCCCCeeeeCC--c-EEEeecccccc
Q 044608 120 --------------------NGFFHRDLKPENLLVSQG--I-IKIADFGLARE 149 (417)
Q Consensus 120 --------------------~gi~HrDLKp~NILl~~~--~-vkL~DFg~a~~ 149 (417)
.+++|+|++|.|||++++ . +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 368999999999999743 3 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.3e-10 Score=110.09 Aligned_cols=183 Identities=14% Similarity=0.119 Sum_probs=117.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCC--eeeeceEEEeCC---EEEEEEe
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSN--IVKLKELIQNNN---RLYLVFE 80 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~E 80 (417)
++.++.|.+..||++. ..+++|+.... .......+|+.+|+.|. +.. +.+++....+.+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999872 56899986533 22344568999999884 333 334443333332 3488999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ----------------------------------------- 119 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~----------------------------------------- 119 (417)
+++|..+..... ..++.++...++.++...|..||+
T Consensus 97 ~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999864432221 226788888888999999998886
Q ss_pred -----------------CCcccccCCCCCeeeeC--Cc-EEEeeccccccccCCCCCccccCCccccCchhh---hcc-C
Q 044608 120 -----------------NGFFHRDLKPENLLVSQ--GI-IKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL---LQS-E 175 (417)
Q Consensus 120 -----------------~gi~HrDLKp~NILl~~--~~-vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l---~~~-~ 175 (417)
..++|+|++|.||++++ +. +.|+||+.+..-..............-..|+.. ... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999986 44 789999998753221111110000000223221 110 0
Q ss_pred C---------CCchhhHHHHHHHHHHHHhCCCCC
Q 044608 176 L---------YSSKADMWAMGAIMAELFTFCPLF 200 (417)
Q Consensus 176 ~---------~~~~~DiwSlG~il~ell~g~~pf 200 (417)
. ...-.+.|++|.++|.+.+|.++|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 112268999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3e-07 Score=87.09 Aligned_cols=132 Identities=15% Similarity=0.165 Sum_probs=90.4
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC---CeeeeceEEE-eCCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS---NIVKLKELIQ-NNNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~E~~ 82 (417)
++.++.|....||+. |..+++|+.... .......+|+.+|+.|.+. .|.+++.+.. ..+..|+|||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456889999999998 567899985321 1233456899999999753 2455566554 345678999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN------------------------------------------ 120 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~------------------------------------------ 120 (417)
+|..+....- ..++..+...+..++...|..||+.
T Consensus 96 ~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9875443211 1245555555566666666655542
Q ss_pred ------------------CcccccCCCCCeeeeC----CcE-EEeecccccc
Q 044608 121 ------------------GFFHRDLKPENLLVSQ----GII-KIADFGLARE 149 (417)
Q Consensus 121 ------------------gi~HrDLKp~NILl~~----~~v-kL~DFg~a~~ 149 (417)
.++|+|++|.|||+++ +.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999976 665 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=9e-07 Score=81.74 Aligned_cols=131 Identities=15% Similarity=0.138 Sum_probs=93.3
Q ss_pred eecccCce-EEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEeccCCCH
Q 044608 9 ELGRGAFG-RVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFECMECNL 86 (417)
Q Consensus 9 ~LG~G~~g-~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~~l 86 (417)
.+..|..+ .||+......+..+++|+-... ......+|...|+.|. +--|.+++.++.+.+..|+|||+++|..
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34556665 6999887777888999986532 2334567999999884 2236778888899999999999999875
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 044608 87 YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN---------------------------------------------- 120 (417)
Q Consensus 87 ~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~---------------------------------------------- 120 (417)
+....... ......+..++...|.-||+.
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 54433221 123344566666666666631
Q ss_pred ------------CcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 121 ------------GFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 121 ------------gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
.++|+|+.+.|||++++.+ -|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1689999999999988765 599999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=3.8e-07 Score=89.46 Aligned_cols=77 Identities=17% Similarity=0.191 Sum_probs=49.0
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEeccccc------ChhhhhhHHHHHHHHhcCC--CC-eeeeceEEEeCCEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA------SWEDCLNLREVKCLRKLNH--SN-IVKLKELIQNNNRLY 76 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~------~~~~~~~~~E~~~l~~l~h--pn-Iv~l~~~~~~~~~~~ 76 (417)
.++.||.|.++.||++....+++.|++|....... .........|.++++.+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997666678999998653211 0112233578999988742 33 4455543 445568
Q ss_pred EEEeccCC
Q 044608 77 LVFECMEC 84 (417)
Q Consensus 77 lv~E~~~~ 84 (417)
+|||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.9e-07 Score=85.72 Aligned_cols=79 Identities=4% Similarity=0.040 Sum_probs=52.2
Q ss_pred ccee-cccCceEEEEEEECC------CCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcC-C--CCeeeeceEEEeC--
Q 044608 7 FKEL-GRGAFGRVFQAFDEH------TGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLN-H--SNIVKLKELIQNN-- 72 (417)
Q Consensus 7 ~~~L-G~G~~g~V~~a~~~~------~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~-- 72 (417)
++.| +.|....+|++.... ++..+++|+...... ........+|+.+++.|. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 889999999886430 266899997654320 001233457888888884 2 3467777776655
Q ss_pred -CEEEEEEeccCCC
Q 044608 73 -NRLYLVFECMECN 85 (417)
Q Consensus 73 -~~~~lv~E~~~~~ 85 (417)
+..|+|||+++|.
T Consensus 105 ~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 105 LGTPFFLMDYVEGV 118 (357)
T ss_dssp TSSCEEEEECCCCB
T ss_pred cCCceEEEEecCCC
Confidence 3568999999873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=2e-05 Score=74.90 Aligned_cols=72 Identities=15% Similarity=0.221 Sum_probs=40.6
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----CCCeeeec-e--EEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----HSNIVKLK-E--LIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~-~--~~~~~~~~~lv 78 (417)
++.|+.|..+.||++... +..+++|+.... . .....|+.+++.|. .|.++... + +..+.+..+++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~--~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---E--KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---H--HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---H--HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 345666788999999653 345999988752 1 11223555555542 24444311 1 23457788999
Q ss_pred EeccCCC
Q 044608 79 FECMECN 85 (417)
Q Consensus 79 ~E~~~~~ 85 (417)
|+|++|.
T Consensus 110 ~~~i~G~ 116 (346)
T 2q83_A 110 YDWIEGR 116 (346)
T ss_dssp EECCCCB
T ss_pred EEeecCc
Confidence 9999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-05 Score=73.12 Aligned_cols=136 Identities=15% Similarity=0.109 Sum_probs=76.2
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEecc
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~ 82 (417)
+.-++.|+.|....+|++ ..+++|+....... .....+|+.+++.+..-++ .+++.+ +.+.-++|+||+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 444678999999999999 55889987643211 1223468888877743233 344443 343347899999
Q ss_pred -CCCHHH------------HH----HHhcC--CCC----C-HHHHHHHHHH--------------HHHHHHHHH----H-
Q 044608 83 -ECNLYQ------------LM----AARDR--KLF----S-EPEIKAWLFQ--------------VFQGLSYMH----Q- 119 (417)
Q Consensus 83 -~~~l~~------------~~----~~~~~--~~l----~-e~~i~~i~~q--------------i~~aL~~LH----~- 119 (417)
+|..+. .+ .+-+. ..+ . ...+..+... +...+..+. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 653211 00 00000 001 0 1112222111 111111111 1
Q ss_pred ---CCcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 120 ---NGFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 120 ---~gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
..++|+|+.+.||+.+++.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEEECCCCEEEEecccccC
Confidence 248999999999997788899999998763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=8.5e-05 Score=73.24 Aligned_cols=32 Identities=19% Similarity=0.315 Sum_probs=27.8
Q ss_pred HHCCcccccCCCCCeeeeCCcEEEeecccccc
Q 044608 118 HQNGFFHRDLKPENLLVSQGIIKIADFGLARE 149 (417)
Q Consensus 118 H~~gi~HrDLKp~NILl~~~~vkL~DFg~a~~ 149 (417)
+...++|+|++|.|||++++.++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 35679999999999999876699999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00031 Score=66.35 Aligned_cols=74 Identities=15% Similarity=0.157 Sum_probs=57.0
Q ss_pred ecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC---CCCeeeeceEEEeCCEEEEEEecc
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN---HSNIVKLKELIQNNNRLYLVFECM 82 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~ 82 (417)
-++.|+.|.+..+|+... .+..+++|+.... ......+|...|+.|. ...+.+++.+....+..|+||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 346799999999999964 4678999987543 1334457888888883 356888888888888999999999
Q ss_pred CCC
Q 044608 83 ECN 85 (417)
Q Consensus 83 ~~~ 85 (417)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00064 Score=60.10 Aligned_cols=95 Identities=14% Similarity=0.073 Sum_probs=58.2
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccccCCcc
Q 044608 87 YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRW 164 (417)
Q Consensus 87 ~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~~gt~~ 164 (417)
+..+....+.+++|+++|.++.|.+.+|.-+-. +.-..+=+-|..|++. +|.|-+.+ +.+. .....
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~ 102 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEPP 102 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccccC
Confidence 444444455789999999999999999877632 1212333446778874 57777664 2111 12334
Q ss_pred ccCchhhhccCCCCchhhHHHHHHHHHHHHh
Q 044608 165 YRAPEILLQSELYSSKADMWAMGAIMAELFT 195 (417)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~ 195 (417)
+.+||... ...+.+.=|||||+++|.-+-
T Consensus 103 ~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 103 PVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred CCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 67888752 225788899999999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00023 Score=68.76 Aligned_cols=136 Identities=14% Similarity=0.175 Sum_probs=74.5
Q ss_pred cceecccCceEEEEEEECC--------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC-eeeeceEEEeCCEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEH--------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN-IVKLKELIQNNNRLYL 77 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~--------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~l 77 (417)
++.|+.|....+|++.... .+..+++|+...... .......|..+++.|...+ +.+++..+ .+ ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 4568888889999997543 136789998754321 1112346888888885333 34666544 23 67
Q ss_pred EEeccCCCHH-----------HHH----HHhc--------CCCCC-----HHHHHHHHHH--------------------
Q 044608 78 VFECMECNLY-----------QLM----AARD--------RKLFS-----EPEIKAWLFQ-------------------- 109 (417)
Q Consensus 78 v~E~~~~~l~-----------~~~----~~~~--------~~~l~-----e~~i~~i~~q-------------------- 109 (417)
||||++|..+ ..+ .+-+ ...++ ...+..+..+
T Consensus 112 v~e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (369)
T 3c5i_A 112 IEEWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKE 191 (369)
T ss_dssp EEECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHH
T ss_pred EEEEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHH
Confidence 9999886311 111 0000 00111 0112222211
Q ss_pred HHHHHHHHHH----------CCcccccCCCCCeeeeCCcEEEeeccccc
Q 044608 110 VFQGLSYMHQ----------NGFFHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 110 i~~aL~~LH~----------~gi~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
+-..+.+|.. .+++|+|+++.|||++++.+.|+||+.+.
T Consensus 192 ~~~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 192 SDKFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp HHHHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred HHHHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 1122334432 25899999999999988889999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00097 Score=63.23 Aligned_cols=30 Identities=33% Similarity=0.444 Sum_probs=26.1
Q ss_pred CCcccccCCCCCeeeeC-----CcEEEeecccccc
Q 044608 120 NGFFHRDLKPENLLVSQ-----GIIKIADFGLARE 149 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~-----~~vkL~DFg~a~~ 149 (417)
..++|+|+.+.|||+++ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 47999999999999975 5799999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0026 Score=59.79 Aligned_cols=137 Identities=15% Similarity=0.142 Sum_probs=75.3
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----CCCeeeec-e--EEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----HSNIVKLK-E--LIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~-~--~~~~~~~~~lv 78 (417)
++.|+.|....+|++... +..+++|+...... ......|+.+++.|. -|.++... + +....+..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 456778988999999643 33688998875311 122345777777763 23333221 1 12345678999
Q ss_pred EeccCCCHH-----H----------HHHHhcCC---C----CCHHHHHHH---------------HHHHHHHHHHHHH--
Q 044608 79 FECMECNLY-----Q----------LMAARDRK---L----FSEPEIKAW---------------LFQVFQGLSYMHQ-- 119 (417)
Q Consensus 79 ~E~~~~~l~-----~----------~~~~~~~~---~----l~e~~i~~i---------------~~qi~~aL~~LH~-- 119 (417)
|+|++|... . .+...... . ......... ...+...++.+.+
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999987321 0 11111100 0 111100000 0113445555553
Q ss_pred -----CCcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 120 -----NGFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 120 -----~gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
.+++|+|+++.|||++++.+ .|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 37999999999999988765 799999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0015 Score=60.61 Aligned_cols=74 Identities=18% Similarity=0.161 Sum_probs=49.3
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCC---CeeeeceEEEeCCEEEEEEec
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS---NIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~~~~~lv~E~ 81 (417)
.-++.+|.|..+.||++.. .+|+.|++|+....... ......+|+..|+.|..- -+.+++.+ +. -++||||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred EEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 4567899999999999974 56889999986543222 122345799999988432 23344433 22 2689998
Q ss_pred cCC
Q 044608 82 MEC 84 (417)
Q Consensus 82 ~~~ 84 (417)
+++
T Consensus 92 l~~ 94 (288)
T 3f7w_A 92 VDE 94 (288)
T ss_dssp CCC
T ss_pred ecc
Confidence 865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0015 Score=64.52 Aligned_cols=71 Identities=11% Similarity=0.080 Sum_probs=47.5
Q ss_pred cceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv 78 (417)
++.|+.|....||++.... .+..+++|+..... . .....+|..+++.|...++ .++++.+. + .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 4678889999999997643 25789999884321 1 1233478988888853333 56666553 2 278
Q ss_pred EeccCC
Q 044608 79 FECMEC 84 (417)
Q Consensus 79 ~E~~~~ 84 (417)
+||++|
T Consensus 151 ~e~l~G 156 (429)
T 1nw1_A 151 EEYIPS 156 (429)
T ss_dssp ECCCCE
T ss_pred EEEeCC
Confidence 999876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0041 Score=61.84 Aligned_cols=72 Identities=19% Similarity=0.131 Sum_probs=47.3
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEeccCC
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++.|+.|....+|++.....+..|++|+....... .....+|..+++.|...++ .++++++ .+. +||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCC
Confidence 46788899999999976544578999987543211 1122479999999975544 5666666 232 49999876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=60.22 Aligned_cols=136 Identities=15% Similarity=0.114 Sum_probs=76.7
Q ss_pred ceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC--eeeeceE-----EEeCCEEEEEEe
Q 044608 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN--IVKLKEL-----IQNNNRLYLVFE 80 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~-----~~~~~~~~lv~E 80 (417)
..|+ |....||++.. .+|+.+++|+....... ......|..+++.|.... +.+++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889998843 34667999998643222 223346888877774212 3444432 334567789999
Q ss_pred ccCCCHH--------HH-------HHHhc-C------CCCCHHHH----------------------HHHHHHHHHHHHH
Q 044608 81 CMECNLY--------QL-------MAARD-R------KLFSEPEI----------------------KAWLFQVFQGLSY 116 (417)
Q Consensus 81 ~~~~~l~--------~~-------~~~~~-~------~~l~e~~i----------------------~~i~~qi~~aL~~ 116 (417)
+++|... .. +.... . ..++.... ...+..++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 9987311 11 11100 0 01111110 1111222222222
Q ss_pred H----HHCCcccccCCCCCeeeeCCcEEEeeccccc
Q 044608 117 M----HQNGFFHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 117 L----H~~gi~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
+ ....++|+|+++.|||+++ .+.|+||+.+.
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDAR 222 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred HhhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCC
Confidence 2 2346899999999999985 89999998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0012 Score=64.15 Aligned_cols=136 Identities=13% Similarity=0.090 Sum_probs=78.7
Q ss_pred cceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 78 (417)
++.|..|....+|++.... .++.|++|+...... ......+|..+++.|. +.-..++++++.+ . +|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cE
Confidence 3567778888999997542 357899998643221 1233458999998884 3223566665543 2 89
Q ss_pred EeccCCCHH-----------HHHH----HhcC------CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 044608 79 FECMECNLY-----------QLMA----ARDR------KLFS--EPEIKAWLFQVFQ-------------------GLSY 116 (417)
Q Consensus 79 ~E~~~~~l~-----------~~~~----~~~~------~~l~--e~~i~~i~~qi~~-------------------aL~~ 116 (417)
|||++|..+ ..+. +-.. +... ..++..|..++-. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999886321 1111 1111 1111 3566666655432 2333
Q ss_pred HH----H----CCcccccCCCCCeeeeC-----CcEEEeeccccc
Q 044608 117 MH----Q----NGFFHRDLKPENLLVSQ-----GIIKIADFGLAR 148 (417)
Q Consensus 117 LH----~----~gi~HrDLKp~NILl~~-----~~vkL~DFg~a~ 148 (417)
|. . ..++|+|+.+.|||+++ +.+.|+||..|.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 33 2 25899999999999975 489999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.019 Score=54.59 Aligned_cols=30 Identities=27% Similarity=0.312 Sum_probs=26.0
Q ss_pred CCcccccCCCCCeeeeC-CcEEEeecccccc
Q 044608 120 NGFFHRDLKPENLLVSQ-GIIKIADFGLARE 149 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~ 149 (417)
..++|+|+.+.||++++ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 36999999999999974 6899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.08 Score=51.90 Aligned_cols=73 Identities=10% Similarity=0.002 Sum_probs=46.9
Q ss_pred cceecccCceEEEEEEECCC-------CcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHT-------GEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~-------g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 78 (417)
++.|..|....+|++..... +..|++++..... .......+|..+++.|. +.-..++++.+ .+ ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 45677888899999976521 5789999865432 11122357888888884 32234555433 33 678
Q ss_pred EeccCCC
Q 044608 79 FECMECN 85 (417)
Q Consensus 79 ~E~~~~~ 85 (417)
|||++|.
T Consensus 149 ~efI~G~ 155 (424)
T 3mes_A 149 EEFIDGE 155 (424)
T ss_dssp EECCCSE
T ss_pred EEEeCCc
Confidence 9999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.47 E-value=0.071 Score=52.97 Aligned_cols=62 Identities=10% Similarity=-0.015 Sum_probs=18.2
Q ss_pred ecceecccCceEEEEEEECCCCcEEEE------EEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEE
Q 044608 6 GFKELGRGAFGRVFQAFDEHTGEAVAI------KELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQ 70 (417)
Q Consensus 6 ~~~~LG~G~~g~V~~a~~~~~g~~vai------K~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~ 70 (417)
+.+.|| ||.||++........||+ |..+......+ .....+|..+++.++|||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456777 999999977655567888 66654332222 223457888999999999999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 417 | ||||
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-85 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-80 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-79 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-78 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-77 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-76 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-76 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-76 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-74 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-74 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-73 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-73 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-73 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-72 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-71 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-70 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-69 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-66 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-61 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-60 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-59 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-55 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-54 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-27 |
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (667), Expect = 1e-85
Identities = 121/298 (40%), Positives = 181/298 (60%), Gaps = 4/298 (1%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
M+ + +++G G +G V++A ++ TGE VA+K+++ + +RE+ L++LNH
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIVKL ++I N+LYLVFE + +L + M A P IK++LFQ+ QGL++ H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 120 NGFFHRDLKPENLLVS-QGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELY 177
+ HRDLKP+NLL++ +G IK+ADFGLAR YT+ V + WYRAPEILL + Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S+ D+W++G I AE+ T LFPG SE DQ+++I LG+P W G+ K
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW-PGVTSMPDYKPS 239
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIR 295
FP+ R + S ++P +D SL + +DP+KR +A AL HPFF+ PH+R
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-80
Identities = 105/284 (36%), Positives = 160/284 (56%), Gaps = 9/284 (3%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED----CLNLREVKCLRKLNHSNIV 63
LG G F V++A D++T + VAIK++K + S LRE+K L++L+H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
L + + + + LVF+ ME +L ++ + + + IKA++ QGL Y+HQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGP-PYTNYVGSRWYRAPEILLQSELYSSKA 181
HRDLKP NLL+ G++K+ADFGLA+ S YT+ V +RWYRAPE+L + +Y
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 182 DMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQL 241
DMWA+G I+AEL P PG S+ DQ+ +I LG+PT + W D + F
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT--FKSF 240
Query: 242 PRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
P L + +A D + L + L ++P R TA +AL+ +F
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 3e-79
Identities = 67/302 (22%), Positives = 123/302 (40%), Gaps = 19/302 (6%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D + ELG G G VF+ + +G +A K + +RE++ L + N
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-N 120
IV ++ + + E M+ + + ++ E + V +GL+Y+ + +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PEQILGKVSIAVIKGLTYLREKH 124
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSS 179
HRD+KP N+LV S+G IK+ DFG++ ++ + +VG+R Y +PE L + YS
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH-YSV 182
Query: 180 KADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
++D+W+MG + E+ P ++ ++ C V G Y
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 239 PQLPRANLSALMPSA-------------SQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
P + L+ S + +P++R + + H F K
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 286 RC 287
R
Sbjct: 303 RS 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 5e-79
Identities = 98/293 (33%), Positives = 166/293 (56%), Gaps = 18/293 (6%)
Query: 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
Y+ K +G G+FG V+QA +GE VAIK++ Q + RE++ +RKL+H NIV
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 76
Query: 64 KLKELI------QNNNRLYLVFECMECNLYQLM--AARDRKLFSEPEIKAWLFQVFQGLS 115
+L+ ++ L LV + + +Y++ +R ++ +K +++Q+F+ L+
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 116 YMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRD+KP+NLL+ ++K+ DFG A+++ G P +Y+ SR+YRAPE++
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
+ Y+S D+W+ G ++AEL P+FPG S DQ+ +I VLG+PT + +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPNY 254
Query: 234 IKYQFPQLPRANLSALM-PSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+++FPQ+ + + P +AI+L L + P+ R T EA H FF
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 8e-78
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 34/296 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D + ELG GAFG+V++A ++ T A K + + + + E+ L +H N
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPN 70
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IVKL + N L+++ E + + +E +I+ Q L+Y+H N
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 122 FFHRDLKPENLLV-SQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILL----QSE 175
HRDLK N+L G IK+ADFG++ + ++ +++G+ ++ APE+++ +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
Y KAD+W++G + E+ P + + KI K
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------------------AK 229
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAP 291
+ P L + S + + + R T ++ LQHPF P
Sbjct: 230 SEPPTLAQ------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 239 bits (609), Expect = 4e-77
Identities = 102/288 (35%), Positives = 163/288 (56%), Gaps = 6/288 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
M+KY G +++G G +G V++A + + GE A+K+++ +RE+ L++L H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
SNIVKL ++I RL LVFE ++ +L +L+ + L K++L Q+ G++Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL-ESVTAKSFLLQLLNGIAYCHD 118
Query: 120 NGFFHRDLKP-ENLLVSQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELY 177
HRDLKP L+ +G +KIADFGLAR YT+ + + WYRAP++L+ S+ Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S+ D+W++G I AE+ PLFPG SEADQ+ +I +LG+P +W + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP-N 237
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
F + + + I L + DP++R TA +AL+H +FK
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 5e-77
Identities = 98/302 (32%), Positives = 154/302 (50%), Gaps = 18/302 (5%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
+ KY ++G+G FG VF+A TG+ VA+K++ + LRE+K L+ L H
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 60 SNIVKLKELIQ--------NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
N+V L E+ + +YLVF+ E +L L++ K F+ EIK + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLL 127
Query: 112 QGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-----PYTNYVGSRWY 165
GL Y+H+N HRD+K N+L+++ G++K+ADFGLAR YTN V + WY
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 166 RAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
R PE+LL Y D+W G IMAE++T P+ G +E Q+ I + GS T + W
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPS--ASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ K + + + + + + A+ L + L DP++R + +AL H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 284 FK 285
F
Sbjct: 308 FW 309
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 1e-76
Identities = 100/296 (33%), Positives = 158/296 (53%), Gaps = 14/296 (4%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+Y+ +G GA+G V A+D VAIK++ LRE+K L + H N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 62 IVKLKELIQ-----NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
I+ + ++I+ +YLV M +LY+L+ + S I +L+Q+ +GL Y
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKY 124
Query: 117 MHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY----TNYVGSRWYRAPEIL 171
+H HRDLKP NLL++ +KI DFGLAR + T YV +RWYRAPEI+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-Q 230
L S+ Y+ D+W++G I+AE+ + P+FPG DQ+ I G+LGSP+ + + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
AR P + + L P+A A+ L + + +++P KR +AL HP+ ++
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 239 bits (611), Expect = 1e-76
Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 32/302 (10%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
+D Y +ELG GAFG V + + TG A K + + S ++ + +E++ + L H
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHP 83
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V L + +++N + +++E M A + SE E ++ QV +GL +MH+N
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 121 GFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
+ H DLKPEN++ + +K+ DFGL + G+ + APE+ + +
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPV 202
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
DMW++G + L + F G ++ + + + + ++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------- 249
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRST 297
S+D L DP+ R T +AL+HP+ AP
Sbjct: 250 -------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP-GNAPGRDSQI 295
Query: 298 PA 299
P+
Sbjct: 296 PS 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 2e-76
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 36/288 (12%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
++ + + LG+G FG V+ A ++ + +A+K L + + REV+ L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
H NI++L + R+YL+ E + K F E ++ ++ LSY H
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 123
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
HRD+KPENLL+ S G +KIADFG + S T G+ Y PE+ ++ ++
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEM-IEGRMH 181
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
K D+W++G + E P F + + +I +++
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------------------RVEFT 222
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
FP ++ A L L +PS+RP E L+HP+
Sbjct: 223 FP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-74
Identities = 103/295 (34%), Positives = 159/295 (53%), Gaps = 15/295 (5%)
Query: 2 DKYSGFKELGRGAFGRVFQAFD-EHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKL-- 57
+Y E+G GA+G+VF+A D ++ G VA+K ++ + L+ +REV LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 58 -NHSNIVKLKELI-----QNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVF 111
H N+V+L ++ +L LVFE ++ +L + IK +FQ+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
+GL ++H + HRDLKP+N+LV S G IK+ADFGLAR T+ V + WYRAPE+
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
LLQS Y++ D+W++G I AE+F PLF G+S+ DQ+ KI V+G P + W R
Sbjct: 187 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP---RD 242
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ F + + + L +++P+KR +A AL HP+F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 233 bits (595), Expect = 4e-74
Identities = 79/341 (23%), Positives = 138/341 (40%), Gaps = 44/341 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D Y +ELG GAFG V + ++ TG K + Y + + E+ + +L+H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHPK 87
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
++ L + ++ + L+ E + L+ +AA D K+ SE E+ ++ Q +GL +MH++
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-SEAEVINYMRQACEGLKHMHEH 146
Query: 121 GFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
H D+KPEN++ +KI DFGLA ++ + + APEI+ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-V 205
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
DMWA+G + L + F G + + + + D++
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------- 252
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHI--- 294
S S +A ++L +P KR T +AL+HP+ K
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
Query: 295 --------RSTPAVATTTANQPAAATRGMLKQRRQQQQQQQ 327
+ A A QPA R+ + Q+
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 340
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 7e-74
Identities = 103/293 (35%), Positives = 159/293 (54%), Gaps = 14/293 (4%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHS 60
Y + +G GA+G V A D TG VAIK+L + + S RE++ L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 61 NIVKL------KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L E + + YLV M +L +LM + E I+ ++Q+ +GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---KHEKLGEDRIQFLVYQMLKGL 134
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H G HRDLKP NL V++ +KI DFGLAR+ S T YV +RWYRAPE++L
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILN 192
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD-GLRQAR 232
Y+ D+W++G IMAE+ T LF G+ DQ+ +I V G+P + +A+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
P+L + + ++++ +AS A++L E + D +R TA EAL HP+F+
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 7e-74
Identities = 68/289 (23%), Positives = 116/289 (40%), Gaps = 32/289 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ + + LG GA+G V A + T EAVA+K + + A +E+ + LNH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+VK + N YL E EP+ + + Q+ G+ Y+H G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELY 177
HRD+KPENLL+ + +KI+DFGLA + G+ Y APE+L + E +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ D+W+ G ++ + + S++ Q Y K +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------------------WKEK 222
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
L ++L + +PS R T + + ++ +
Sbjct: 223 KTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (589), Expect = 1e-73
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 37/290 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNH 59
+S +E+G G+FG V+ A D E VAIK++ + ++EV+ L+KL H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
N ++ + + +LV E + L+ +K E EI A QGL+Y+H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL--QSEL 176
+ HRD+K N+L+ G++K+ DFG A + P ++VG+ ++ APE++L
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQ 190
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y K D+W++G EL P + +Y I +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---------------------AQN 229
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
+ P L + S+ + +S P RPT+ L+H F R
Sbjct: 230 ESPALQSGHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-73
Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 8/296 (2%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
M KY +++G G +G VF+A + T E VA+K ++ + LRE+ L++L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NIV+L +++ ++ +L LVFE + +L + +K++LFQ+ +GL + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREI-KSGPPYTNYVGSRWYRAPEILLQSELY 177
HRDLKP+NLL+ G +K+A+FGLAR Y+ V + WYR P++L ++LY
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 178 SSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
S+ DMW+ G I AEL PLFPG DQ+ +I +LG+PT + W + Y
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
+L ++P + L ++L +P +R +A EALQHP+F + PP
Sbjct: 240 PMYPATT-SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD--FCPP 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-73
Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 36/304 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
KY+ F+++G+GA G V+ A D TG+ VAI+++ + ++ + + E+ +R+ + N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPN 78
Query: 62 IVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
IV + + L++V E + L E +I A + Q L ++H N
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 122 FFHRDLKPENLLVSQ-GIIKIADFGLAREIK-SGPPYTNYVGSRWYRAPEILLQSELYSS 179
HRD+K +N+L+ G +K+ DFG +I + VG+ ++ APE++ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGP 195
Query: 180 KADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
K D+W++G + E+ P + + +Y I G+P + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNP--------------- 239
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRSTPA 299
S D KR +A E LQH F K A P TP
Sbjct: 240 -----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI---AKPLSSLTPL 285
Query: 300 VATT 303
+A
Sbjct: 286 IAAA 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 226 bits (578), Expect = 2e-72
Identities = 80/301 (26%), Positives = 124/301 (41%), Gaps = 44/301 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--------LREVKC 53
+ Y + LGRG V + + T + A+K + L+EV
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 54 LRKLN-HSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVF 111
LRK++ H NI++LK+ + N +LVF+ M+ L+ + ++ SE E + + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 120
Query: 112 QGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEI 170
+ + +H+ HRDLKPEN+L+ IK+ DFG + ++ G G+ Y APEI
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 171 LLQSEL-----YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225
+ S Y + DMW+ G IM L P F + + I
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM------------ 228
Query: 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ YQF + S L P KR TA EAL HPFF+
Sbjct: 229 -------SGNYQFGSPEWDDY-------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
Query: 286 R 286
+
Sbjct: 275 Q 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 223 bits (570), Expect = 7e-71
Identities = 83/289 (28%), Positives = 122/289 (42%), Gaps = 34/289 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
D Y LG GAF V A D+ T + VAIK + ++ ++ E+ L K+ H N
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
IV L ++ ++ LYL+ + + L+ + ++ ++E + +FQV + Y+H
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 121 GFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSEL 176
G HRDLKPENLL I I+DFGL++ G + G+ Y APE+L Q
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP- 185
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
YS D W++G I L P F ++A +I W
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW------------ 233
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
S A L DP KR T +ALQHP+
Sbjct: 234 --------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 223 bits (570), Expect = 1e-70
Identities = 81/299 (27%), Positives = 142/299 (47%), Gaps = 23/299 (7%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-H 59
D Y ++LGRG + VF+A + E V +K LK RE+K L L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGG 89
Query: 60 SNIVKLKELIQN--NNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
NI+ L +++++ + LVFE + QL + ++ +I+ +++++ + L Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144
Query: 117 MHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
H G HRD+KP N+++ +++ D+GLA G Y V SR+++ PE+L+
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 175 ELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
++Y DMW++G ++A + P F G DQ+ +I VLG+ + + D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 234 IKYQ-------FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
++ + R S S +A+ + L +D R TA EA++HP+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 6e-70
Identities = 100/294 (34%), Positives = 154/294 (52%), Gaps = 14/294 (4%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHS 60
++Y +G GA+G V AFD TG VA+K+L + + S RE++ L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 61 NIVKLKELIQ------NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
N++ L ++ N +YLV M +L ++ + ++ ++ ++Q+ +GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGL 134
Query: 115 SYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQ 173
Y+H HRDLKP NL V++ +KI DFGLAR T YV +RWYRAPEI+L
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLN 192
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL-RQAR 232
Y+ D+W++G IMAEL T LFPG DQ+ I ++G+P + AR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
Q+P+ N + + A+ A+ L E + D KR TAA+AL H +F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-69
Identities = 70/289 (24%), Positives = 133/289 (46%), Gaps = 34/289 (11%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+KY ++LGRG FG V + + + + K +K + + L +E+ L H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRN 62
Query: 62 IVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I+ L E ++ L ++FE + ++++ + +L +E EI +++ QV + L ++H +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-NEREIVSYVHQVCEALQFLHSH 121
Query: 121 GFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
H D++PEN++ IKI +FG AR++K G + + Y APE+ Q ++
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-QHDVV 180
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S+ DMW++G ++ L + F + + I + +++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------- 227
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
S +A+ + L + R TA+EALQHP+ K+
Sbjct: 228 -------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 9e-69
Identities = 71/295 (24%), Positives = 131/295 (44%), Gaps = 43/295 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHS 60
+ Y +G G++GR + + G+ + KEL + E + + EV LR+L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 61 NIVKLKELI--QNNNRLYLVFECMEC-NLYQLM--AARDRKLFSEPEIKAWLFQVFQGLS 115
NIV+ + I + N LY+V E E +L ++ ++R+ E + + Q+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 116 YMHQ-----NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN-YVGSRWYRAP 168
H+ + HRDLKP N+ + + +K+ DFGLAR + + +VG+ +Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
E + + Y+ K+D+W++G ++ EL P F S+ + KI
Sbjct: 184 EQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--------------- 227
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPF 283
+ +F ++P S + + + + RP+ E L++P
Sbjct: 228 ------EGKFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-68
Identities = 96/318 (30%), Positives = 149/318 (46%), Gaps = 26/318 (8%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNH 59
+ +Y K +G GA G V A+D VAIK+L + + + RE+ ++ +NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 60 SNIVKLKEL------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
NI+ L + ++ +YLV E M+ NL Q++ + + L+Q+ G
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCG 131
Query: 114 LSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ ++H G HRDLKP N++V S +KI DFGLAR + T YV +R+YRAPE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
Y D+W++G IM E+ LFPG DQ K+ LG+P + R
Sbjct: 192 GMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 233 AIKYQFPQLPRANLSALMPSA------------SQDAISLFESLCSWDPSKRPTAAEALQ 280
P+ L P + + A L + DP+KR + +ALQ
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 281 HPFFKRCFYAPPHIRSTP 298
HP+ +Y P + + P
Sbjct: 311 HPYINV-WYDPAEVEAPP 327
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-67
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHSNIVKLK 66
E+GRG+F V++ D T VA EL+ R + + E + L+ L H NIV+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 67 ELIQ----NNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG- 121
+ + + LV E M + + K+ +++W Q+ +GL ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTY-LKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 122 -FFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYS 178
HRDLK +N+ ++ G +KI D GLA +K +G+ + APE+ + Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK--YD 190
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
D++A G M E+ T + A Q+Y+ +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------VTSGV 229
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
A + + E + +R + + L H FF+
Sbjct: 230 KPAS------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-67
Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 40/302 (13%)
Query: 1 MDKYSGFKE-LGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-N 58
+D Y + LG G G+V Q F++ T E A+K L+ + REV+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQ 63
Query: 59 HSNIVKLKELIQN----NNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQG 113
+IV++ ++ +N L +V EC++ L+ + R + F+E E + + +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 114 LSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE 169
+ Y+H HRD+KPENLL + I+K+ DFG A+E S T + +Y APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 170 ILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229
+L + Y DMW++G IM L P F +
Sbjct: 184 VLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------KT 227
Query: 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289
+ R +Y+FP + + S++ L +L +P++R T E + HP+ +
Sbjct: 228 RIRMGQYEFPNPEWSEV-------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
Query: 290 AP 291
P
Sbjct: 281 VP 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-66
Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 44/296 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNH 59
+ + K LG G+F V A + T AIK L++R+ E+ + RE + +L+H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 60 SNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
VKL Q++ +LY + + F E + + ++ L Y+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHG 126
Query: 120 NGFFHRDLKPENLLVSQ-GIIKIADFGLAREIK---SGPPYTNYVGSRWYRAPEILLQSE 175
G HRDLKPEN+L+++ I+I DFG A+ + ++VG+ Y +PE+L +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 176 LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235
+D+WA+G I+ +L P F +E KI ++
Sbjct: 187 -ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------------------KLE 226
Query: 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA------LQHPFFK 285
Y FP A L E L D +KR E HPFF+
Sbjct: 227 YDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 9e-66
Identities = 81/294 (27%), Positives = 125/294 (42%), Gaps = 38/294 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
D Y +ELG G F V + ++ TG A K +K+R REV L++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
+ H N++ L E+ +N + L+ E + A L E E +L Q+ G+ Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT-EEEATEFLKQILNGVYY 128
Query: 117 MHQNGFFHRDLKPENLLVS-----QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEIL 171
+H H DLKPEN+++ + IKI DFGLA +I G + N G+ + APEI
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI- 187
Query: 172 LQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
+ E +ADMW++G I L + F G ++ + + + V + +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF------- 240
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ S A L DP KR T ++LQHP+ K
Sbjct: 241 -------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-63
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 46/293 (15%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN-----LREVKCLRK 56
+Y LG G FG V+ VAIK +++ S L EV L+K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 57 LN--HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGL 114
++ S +++L + + + L+ E E +R E +++ +QV + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 115 SYMHQNGFFHRDLKPENLLVSQ--GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILL 172
+ H G HRD+K EN+L+ G +K+ DFG +K YT++ G+R Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIR 182
Query: 173 QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232
+ A +W++G ++ ++ F E +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----------------------- 219
Query: 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
+ F S + L + PS RPT E HP+ +
Sbjct: 220 --QVFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 201 bits (511), Expect = 2e-61
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 40/296 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-----REVKCLR 55
M+ +S + +GRG FG V+ TG+ A+K L ++ + L + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 56 KLNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
+ IV + ++L + + M +FSE +++ + ++ GL
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLE 121
Query: 116 YMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQS 174
+MH +RDLKP N+L+ G ++I+D GLA + P+ + G+ Y APE+L +
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 180
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
Y S AD +++G ++ +L F D+ R +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----------------RMTLTM 224
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFK 285
+ P S S + SL E L D ++R A E + PFF+
Sbjct: 225 AVELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCL-RKL 57
++ + K LG+G+FG+VF A + T + AIK LK+ +D + + E + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
H + + Q L+ V E + +L + + F + ++ GL +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQF 118
Query: 117 MHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSG-PPYTNYVGSRWYRAPEILLQS 174
+H G +RDLK +N+L+ G IKIADFG+ +E G + G+ Y APEILL
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 175 ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+ Y+ D W+ G ++ E+ F G E + +I
Sbjct: 179 K-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------------------HSI 215
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA-EALQHPFFK 285
+ P PR ++A L L +P KR + QHP F+
Sbjct: 216 RMDNPFYPR--------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 1e-59
Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 42/293 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
+ + + LG G+FGRV H G A+K LK+ + E L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
H I+++ Q+ +++++ + +E + + ++ F P K + +V L Y+H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH 121
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
+RDLKPEN+L+ G IKI DFG A+ + G+ Y APE+ + ++ Y
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV-VSTKPY 178
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ D W+ G ++ E+ F ++ KI + +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------------------NAELR 219
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
FP P ++D L L + D S+R + HP+FK
Sbjct: 220 FP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-59
Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 37/288 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNL-REVKCLRKLNHS 60
+ + + +G G+FG V++ VA+K L + + EV LRK H
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 61 NIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ 119
NI+ +L +V + E +LY + + K F ++ Q QG+ Y+H
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA 122
Query: 120 NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILL--Q 173
HRDLK N+ + +KI DFGLA GS + APE++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
YS ++D++A G ++ EL T + + DQ+ + G
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------------ 224
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
Y P L + + + + L +RP + L
Sbjct: 225 -GYLSPDLSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-59
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 41/294 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
M+ + K LG+G FG+V ++ TG A+K L++ +D + + E + L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
H + LK Q ++RL V E +R+R F+E + + ++ L Y+H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS-GPPYTNYVGSRWYRAPEILLQSEL 176
+RD+K ENL++ G IKI DFGL +E S G + G+ Y APE+L ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND- 181
Query: 177 YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
Y D W +G +M E+ F I +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EI 222
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFK 285
+FP + S +A SL L DP +R A E ++H FF
Sbjct: 223 RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHS 60
M + + +G+G FG V ++ G VA+K +K + L E + +L HS
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHS 60
Query: 61 NIVKLKE-LIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
N+V+L +++ LY+V E M +L + +R R + + + V + + Y+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 119 QNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
N F HRDL N+LVS+ + K++DFGL +E S + APE L + + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK-F 177
Query: 178 SSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
S+K+D+W+ G ++ E+++F +P D + ++ + K
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------------------KGYKM 219
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P + ++ D + RP+ + +
Sbjct: 220 DAP-----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (461), Expect = 3e-55
Identities = 62/295 (21%), Positives = 109/295 (36%), Gaps = 39/295 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLNH 59
D+Y + LG G V A D VA+K L+ A RE + LNH
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 60 SNIVKLKELIQNNN----RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLS 115
IV + + + Y+V E ++ + + + + + + Q L+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALN 125
Query: 116 YMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY----TNYVGSRWYRAPEI 170
+ HQNG HRD+KP N+++S +K+ DFG+AR I +G+ Y +PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 171 LLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+++D++++G ++ E+ T P F G S Y+ P
Sbjct: 186 ARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285
S D ++ + +P R A ++ +
Sbjct: 239 --------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 1e-54
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLN--LREVKCLRKLN 58
+D++ K LG G+FGRV + +G A+K L ++ + L E + L+ +N
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+VKL+ ++N+ LY+V E + R + FSEP + + Q+ Y+H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH 158
Query: 119 QNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELY 177
+RDLKPENLL+ QG I++ DFG A+ +K G+ APEI + S+ Y
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEI-ILSKGY 215
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
+ D WA+G ++ E+ P F KI + K +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-------------------SGKVR 256
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKR-----PTAAEALQHPFFK 285
FP S D L +L D +KR + H +F
Sbjct: 257 FP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (459), Expect = 6e-54
Identities = 80/331 (24%), Positives = 130/331 (39%), Gaps = 46/331 (13%)
Query: 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
+Y ++LG G F V+ A D VA+K ++ E E+K L+++N ++
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE--DEIKLLQRVNDADN 71
Query: 63 VKLKEL---------------IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWL 107
K + N + +VFE + NL L+ + + +K
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 108 FQVFQGLSYMH-QNGFFHRDLKPENLLVSQ-------GIIKIADFGLAREIKSGPPYTNY 159
Q+ GL YMH + G H D+KPEN+L+ IKIAD G A YTN
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNS 189
Query: 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS------EADQMYKIC 213
+ +R YR+PE+LL + + AD+W+ ++ EL T LF + D + +I
Sbjct: 190 IQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 214 GVLGSPTMDSWADG------------LRQARAIKYQFPQLPRANLSALMPSASQDAISLF 261
+LG +G LR +K+ + +++
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 262 ESLCSWDPSKRPTAAEALQHPFFKRCFYAPP 292
+ DP KR A + HP+ K
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-54
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 41/291 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ +LG+G FG V+ T VAIK LK S E L +E + ++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLRHEK 73
Query: 62 IVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V+L + + +Y+V E M +L + K P++ Q+ G++Y+ +
Sbjct: 74 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY--TNYVGSRWYRAPEILLQSELY 177
+ HRDL+ N+LV + K+ADFGLAR I+ + APE L +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 191
Query: 178 SSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+ K+D+W+ G ++ EL T +PG + + ++ R +
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------------------RGYRM 233
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFFK 285
P P + L +P +RPT +F
Sbjct: 234 PCP-----------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-53
Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 8 KELGRGAFGRVFQAF--DEHTGEAVAIKELKQRYASWEDCLN-LREVKCLRKLNHSNIVK 64
KELG G FG V + + + + VA+K LK L E +++L++ IV+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 65 LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFH 124
+ + + + LV E E ++R + + I + QV G+ Y+ ++ F H
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 125 RDLKPEN-LLVSQGIIKIADFGLAREIKSGPPY----TNYVGSRWYRAPEILLQSELYSS 179
RDL N LLV+Q KI+DFGL++ +++ Y T+ + APE + +SS
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSS 189
Query: 180 KADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
K+D+W+ G +M E F++ + G ++ + K +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---------------------KGER 228
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE---ALQHPFFK 285
P ++ L ++D RP A L++ ++
Sbjct: 229 MGCP--------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-53
Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+E+G G FG V + + VAIK +++ S ED + E + + KL+H +V+L
Sbjct: 11 QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI--EEAEVMMKLSHPKLVQLYG 67
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ + LVFE ME R LF+ + V +G++Y+ + HRDL
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 128 KPENLLVSQ-GIIKIADFGLAREIKSGPPYTNY--VGSRWYRAPEILLQSELYSSKADMW 184
N LV + +IK++DFG+ R + ++ + +PE+ S YSSK+D+W
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVW 186
Query: 185 AMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRA 244
+ G +M E+F+ + ++ + + + P+L
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVE-----------------DISTGFRLYKPRL--- 226
Query: 245 NLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
AS + P RP + L+
Sbjct: 227 --------ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-53
Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 37/278 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
KELG G FG V VAIK +K+ S ++ + E K + L+H +V+L
Sbjct: 10 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI--EEAKVMMNLSHEKLVQLYG 66
Query: 68 LIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDL 127
+ ++++ E M R F ++ V + + Y+ F HRDL
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 128 KPENLLV-SQGIIKIADFGLAREIKSGPPY--TNYVGSRWYRAPEILLQSELYSSKADMW 184
N LV QG++K++DFGL+R + + PE+ L +SSK+D+W
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV-LMYSKFSSKSDIW 185
Query: 185 AMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPR 243
A G +M E+++ + + ++ I + ++ P L
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIA------------------QGLRLYRPHL-- 225
Query: 244 ANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
AS+ ++ S +RPT L +
Sbjct: 226 ---------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 7e-53
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 42/289 (14%)
Query: 8 KELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKL 65
ELG G FG V Q + VAIK LKQ + +RE + + +L++ IV+L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 66 KELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHR 125
+ Q L LV E R+ + L QV G+ Y+ + F HR
Sbjct: 75 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 126 DLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNY----VGSRWYRAPEILLQSELYSSK 180
DL N+L+ ++ KI+DFGL++ + + Y + APE + +SS+
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSR 192
Query: 181 ADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239
+D+W+ G M E ++ + + M I + +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---------------------QGKRM 231
Query: 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE---ALQHPFFK 285
+ P P + +L + RP ++ ++
Sbjct: 232 ECP--------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-53
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 41/290 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ + LG G FG V+ + + VA+K LKQ S + L E +++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFL--AEANLMKQLQHQR 69
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V+L + +Y++ E ME +L + + ++ Q+ +G++++ +
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY--TNYVGSRWYRAPEILLQSELY 177
+ HRDL+ N+LV KIADFGLAR I+ + APE + +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTF 187
Query: 178 SSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236
+ K+D+W+ G ++ E+ T +PG + + + + R +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------------------ERGYRM 229
Query: 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFF 284
P + ++ L P RPT FF
Sbjct: 230 VRP-----------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 75/313 (23%), Positives = 129/313 (41%), Gaps = 62/313 (19%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLRK 56
+ K LG GAFG+V A + VA+K LK++ S E + E+K + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 57 L-NHSNIVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKL----------------- 97
L +H NIV L + +YL+FE +L + ++ K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 98 ----FSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS 152
+ ++ + +QV +G+ ++ HRDL N+LV+ ++KI DFGLAR+I S
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 153 GPPYT---NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQ 208
Y N + APE L + Y+ K+D+W+ G ++ E+F+ +PG
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWD 268
YK+ +G + P A+++ + +S ++D
Sbjct: 276 FYKL-----------IQNGFK---------MDQP--------FYATEEIYIIMQSCWAFD 307
Query: 269 PSKRPTAAEALQH 281
KRP+
Sbjct: 308 SRKRPSFPNLTSF 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-52
Identities = 57/303 (18%), Positives = 109/303 (35%), Gaps = 43/303 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
++Y +++G G+FG ++ D GE VAIK + + E K + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGV 63
Query: 62 IVK-LKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+ ++ + +V E + +L L RK FS + Q+ + Y+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSK 122
Query: 121 GFFHRDLKPENLLVSQ----GIIKIADFGLAREIKSG--------PPYTNYVGSRWYRAP 168
F HRD+KP+N L+ ++ I DFGLA++ + N G+ Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
L E S + D+ ++G ++ + G A + K
Sbjct: 183 NTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---------------- 225
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA---EALQHPFFK 285
+ K P + L + + S +P + + ++ F +
Sbjct: 226 ERISEKKMSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 286 RCF 288
+ F
Sbjct: 280 QGF 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-52
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 39/290 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHT---GEAVAIKELKQRYASWEDCLN--LREVKCLRK 56
++LG G+FG V + + +VA+K LK S + ++ +REV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSY 116
L+H N+++L ++ + +V E + + F + + QV +G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 117 MHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILL 172
+ F HRDL NLL++ + ++KI DFGL R + + + + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 173 QSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231
++ +S +D W G + E+FT+ + G + + ++KI
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------------------ 228
Query: 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ P+ QD ++ + P RPT
Sbjct: 229 -KEGERLPRPE---------DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (433), Expect = 6e-51
Identities = 53/302 (17%), Positives = 97/302 (32%), Gaps = 44/302 (14%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-S 60
Y + +G G+FG +F+ + + VAIK +R + E + + L +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 61
Query: 61 NIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
I + Q LV + + +L L+ RK FS + Q+ + +H+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEK 120
Query: 121 GFFHRDLKPENLLVSQ------GIIKIADFGLAREIKSGP--------PYTNYVGSRWYR 166
+RD+KP+N L+ + +I + DFG+ + + N G+ Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 167 APEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWAD 226
+ L E S + D+ A+G + + G A K
Sbjct: 181 SINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-------------- 225
Query: 227 GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286
I + P L L ++ + P F +
Sbjct: 226 -----ERIGEKKQSTP---LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSK 275
Query: 287 CF 288
Sbjct: 276 VL 277
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 9e-51
Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 35/283 (12%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN 61
+ +LG G +G V++ + VA+K LK+ E+ L+E ++++ H N
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIKHPN 74
Query: 62 IVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQN 120
+V+L + Y++ E M NL + +R+ S + Q+ + Y+ +
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 121 GFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPEILLQSELY 177
F HRDL N LV ++K+ADFGL+R + + + AP L +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP-ESLAYNKF 193
Query: 178 SSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237
S K+D+WA G ++ E+ T+ + Q+Y++ + + +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----------------EKDYRME 236
Query: 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
P + L + W+PS RP+ AE Q
Sbjct: 237 RP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-50
Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 45/316 (14%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFD---EHTGEAVAIKELKQRYASWEDCLN---LREVKCL 54
++ + K LG GA+G+VF TG+ A+K LK+ + E + L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 55 RKLNHS-NIVKLKELIQNNNRLYLVFE-CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQ 112
+ S +V L Q +L+L+ + L+ + R+ F+E E++ ++ ++
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVL 140
Query: 113 GLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYTNYVGSRWYRAPE 169
L ++H+ G +RD+K EN+L+ G + + DFGL++E + ++ G+ Y AP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 170 ILLQSEL-YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228
I+ + + D W++G +M EL T F E + +I
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------------- 244
Query: 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPF 283
+R I P P S A L + L DP KR A E +H F
Sbjct: 245 --SRRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294
Query: 284 FKRCFYAPPHIRSTPA 299
F++ + + PA
Sbjct: 295 FQKINWDDLAAKKVPA 310
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-50
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 39/297 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKE 67
+ +G+G FG V++ + GE VA+K R E+ L H NI+
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 68 LIQNNN----RLYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ--- 119
+N +L+LV + E +L+ + +R + + GL+++H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 120 -----NGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY-----TNYVGSRWYRAP 168
HRDLK +N+LV G IAD GLA S + VG++ Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 169 EILLQSEL-----YSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDS 223
E+L S +AD++AMG + E+ C + G E Q+ V P+++
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEE 240
Query: 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280
+ + + P +P S A + + + + R TA +
Sbjct: 241 MRKVVCEQK----LRPNIPNRWQS---CEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 7e-50
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 39/291 (13%)
Query: 1 MDKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKL 57
+ + +G G FG V + G+ VAIK LK Y + L E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
+H N++ L+ ++ + + ++ E ME ++ F+ ++ L + G+ Y+
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAPE-----IL 171
+ HRDL N+LV S + K++DFGL+R ++ Y + + P
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 172 LQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230
+Q ++S +D+W+ G +M E+ ++ + + D + I
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------------- 247
Query: 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
Q +LP L D + RP + +
Sbjct: 248 ------QDYRLPPP------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-50
Identities = 59/288 (20%), Positives = 104/288 (36%), Gaps = 38/288 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKL 57
++ K LG GAFG V++ GE VAIKEL++ + + L E + +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 58 NHSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYM 117
++ ++ +L + + + L + + W Q+ +G++Y+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL 127
Query: 118 HQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY---TNYVGSRWYRAPEILLQ 173
HRDL N+LV + +KI DFGLA+ + + + A E +
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-L 186
Query: 174 SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARA 233
+Y+ ++D+W+ G + EL TF A ++ I G R
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----------LEKGER---- 231
Query: 234 IKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
P P + D + D RP E +
Sbjct: 232 -----LPQP--------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-49
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 38/287 (13%)
Query: 2 DKYSGFKELGRGAFGRVFQAFD---EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN 58
++ + +G G FG V Q E+ AVAIK K + L+E +R+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
H +IVKL +I N ++++ E + + + + +Q+ L+Y+
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 119 QNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY--TNYVGSRWYRAPEILLQSE 175
F HRD+ N+LV S +K+ DFGL+R ++ Y + + APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 176 LYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
++S +D+W G M E+ F G D + +I
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------------------- 223
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ +P P+ SL ++DPS+RP E
Sbjct: 224 NGERLPMP--------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-49
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 40/298 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIV 63
K +G G FG V++ + + VAIK LK Y + L E + + +H NI+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 64 KLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFF 123
+L+ +I + ++ E ME FS ++ L + G+ Y+ +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132
Query: 124 HRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTN----YVGSRWYRAPEILLQSELYS 178
HRDL N+LV S + K++DFGL+R ++ P T + APE + ++
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI-SYRKFT 191
Query: 179 SKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238
S +D+W+ G +M E+ T+ ++ K DG R
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-----------INDGFR--------- 231
Query: 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFYAPPHIRS 296
P L + ++RP A+ + + AP +++
Sbjct: 232 LPTP--------MDCPSAIYQLMMQCWQQERARRPKFADIVS--ILDKLIRAPDSLKT 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 5e-48
Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 2 DKYSGFKELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
+ +++G GAFGRVFQA VA+K LK+ ++ RE + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLMAARDRKL------------------ 97
++ NIVKL + + L+FE M +L + + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 98 ----FSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKS 152
S E QV G++Y+ + F HRDL N LV ++KIADFGL+R I S
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 153 GPPY---TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQ 208
Y N + PE + + Y++++D+WA G ++ E+F++ + G + +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWD 268
+Y + N+ A + + +L S
Sbjct: 252 IYYVR-----------------------------DGNILACPENCPLELYNLMRLCWSKL 282
Query: 269 PSKRPTAAEALQ 280
P+ RP+ +
Sbjct: 283 PADRPSFCSIHR 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 7e-47
Identities = 66/294 (22%), Positives = 114/294 (38%), Gaps = 50/294 (17%)
Query: 8 KELGRGAFGRVFQAFDEHTGE--AVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVK 64
+G G FG+V +A + G AIK +K+ + + E++ L KL +H NI+
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 65 LKELIQNNNRLYLVFECME-CNLYQLM--------------AARDRKLFSEPEIKAWLFQ 109
L ++ LYL E NL + A S ++ +
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 110 VFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPYTNYVGSRWYRAP 168
V +G+ Y+ Q F HRDL N+LV + KIADFGL+R + T + A
Sbjct: 136 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 195
Query: 169 EILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADG 227
E L +Y++ +D+W+ G ++ E+ + + G + A+ K+
Sbjct: 196 ESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------------- 240
Query: 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ + + P + + L P +RP+ A+ L
Sbjct: 241 ----QGYRLEKP-----------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-46
Identities = 55/287 (19%), Positives = 109/287 (37%), Gaps = 42/287 (14%)
Query: 7 FKE-LGRGAFGRVFQAFD---EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI 62
F E +GRG FG V+ + A+K L + E L E ++ +H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 63 VKLKEL-IQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG 121
+ L + +++ +V M+ + + + ++ + QV +G+ ++
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 122 FFHRDLKPENLLVSQG-IIKIADFGLAREIKSGPPY-----TNYVGSRWYRAPEILLQSE 175
F HRDL N ++ + +K+ADFGLAR++ T + A E LQ++
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-LQTQ 209
Query: 176 LYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234
+++K+D+W+ G ++ EL T P +P + D + +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------------------L 248
Query: 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281
+ + P + RP+ +E +
Sbjct: 249 QGRRLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-46
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 57/307 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQA-----FDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
++ S K LG GAFG+V +A VA+K LK E + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 57 L-NHSNIVKLKELIQNNNRLYLVFECMEC-NLYQLM----------------AARDRKLF 98
L NH NIV L ++ E +L + D
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 99 SEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLV-SQGIIKIADFGLAREIKSGPPY- 156
++ ++ +QV +G++++ HRDL N+L+ I KI DFGLAR+IK+ Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 157 --TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKIC 213
N + APE + + +Y+ ++D+W+ G + ELF+ +PG + YK+
Sbjct: 203 VKGNARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM- 260
Query: 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP 273
+G R P A + + ++ DP KRP
Sbjct: 261 ----------IKEGFR---------MLSP--------EHAPAEMYDIMKTCWDADPLKRP 293
Query: 274 TAAEALQ 280
T + +Q
Sbjct: 294 TFKQIVQ 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-44
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 56/307 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
D+ K LGRGAFG+V +A T VA+K LK+ E + E+K L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 -LNHSNIVKLKE-LIQNNNRLYLVFECME-CNLYQLMAARD--------------RKLFS 99
+H N+V L + L ++ E + NL + ++ + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 100 EPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY-- 156
+ + FQV +G+ ++ HRDL N+L+S+ ++KI DFGLAR+I P Y
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 157 -TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICG 214
+ + APE + +Y+ ++D+W+ G ++ E+F+ +PG ++ +
Sbjct: 193 KGDARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 249
Query: 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT 274
+G R + P + + +PS+RPT
Sbjct: 250 ---------LKEGTR---------MRAP--------DYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 275 AAEALQH 281
+E ++H
Sbjct: 284 FSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-44
Identities = 58/309 (18%), Positives = 122/309 (39%), Gaps = 55/309 (17%)
Query: 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRK 56
+K + +ELG+G+FG V++ + VAIK + + + E L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 57 LNHSNIVKLKELIQNNNRLYLVFECME-CNLYQLMAARDRKL--------FSEPEIKAWL 107
N ++V+L ++ ++ E M +L + + + S ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 108 FQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPPY---TNYVGSR 163
++ G++Y++ N F HRDL N +V++ +KI DFG+ R+I Y +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 164 WYRAPEILLQSELYSSKADMWAMGAIMAELFTFC-PLFPGASEADQMYKICGVLGSPTMD 222
+ +PE L+ ++++ +D+W+ G ++ E+ T + G S + +
Sbjct: 200 RWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---------- 248
Query: 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ-- 280
++ P + L ++P RP+ E +
Sbjct: 249 -----------MEGGLLDKP--------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 281 ----HPFFK 285
P F+
Sbjct: 290 KEEMEPGFR 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-43
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 56/307 (18%)
Query: 2 DKYSGFKELGRGAFGRVFQAFDEHTGEA-------VAIKELKQRYASWEDCLNLREVKCL 54
D+ K LG GAFG+V A + VA+K LK + + E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 55 RKL-NHSNIVKLKELIQNNNRLYLVFECME-CNLYQLM--------------AARDRKLF 98
+ + H NI+ L + LY++ E NL + + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 99 SEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157
S ++ + +QV +G+ Y+ HRDL N+LV+ ++KIADFGLAR+I Y
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 158 N---YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICG 214
+ APE L +Y+ ++D+W+ G ++ E+FT ++++K+
Sbjct: 193 KTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL-- 249
Query: 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT 274
+G R P + + + + PS+RPT
Sbjct: 250 ---------LKEGHR---------MDKP--------SNCTNELYMMMRDCWHAVPSQRPT 283
Query: 275 AAEALQH 281
+ ++
Sbjct: 284 FKQLVED 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (261), Expect = 4e-27
Identities = 33/199 (16%), Positives = 64/199 (32%), Gaps = 27/199 (13%)
Query: 8 KELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS---------WEDCLNLREVKCLRKLN 58
K +G G VF + E +K K + S + D +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 59 HSNIVKLKELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMH 118
+ KL+ L ++Y L +L+ A++ L + + ++ +
Sbjct: 65 FRALQKLQGL--AVPKVYAWEG--NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 119 QNGFFHRDLKPENLLVSQGIIKIADFGLAREIK--SGPPYTN---YVGSRWYRAPEILLQ 173
G H DL N+LVS+ I I DF + E+ ++
Sbjct: 121 HRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT----- 175
Query: 174 SELYSSKADMWAMGAIMAE 192
Y ++ D+ + + +
Sbjct: 176 ---YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.36 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-64 Score=471.52 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=212.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|+|++++.||+|+||+||+|+++.+|+.||||++.............+|+++|++|+|||||++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 58999999999999999999999999999999999765443334456789999999999999999999999999999999
Q ss_pred ccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---CC
Q 044608 81 CMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG---PP 155 (417)
Q Consensus 81 ~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~---~~ 155 (417)
|++|+ |.+.+. . ...+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+... ..
T Consensus 84 y~~gg~L~~~l~-~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIE-P-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSB-T-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99875 544443 2 35699999999999999999999999999999999999996 589999999999876432 33
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.+..+||+.|+|||++.+...++.++|||||||++|||++|++||...+.............
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~------------------ 223 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------------------ 223 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC------------------
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Confidence 45678999999999998777567899999999999999999999987665443332221100
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
......+.+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 224 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 224 ---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 001112357899999999999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-63 Score=469.70 Aligned_cols=286 Identities=41% Similarity=0.735 Sum_probs=248.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
||+|+++++||+|+||+||+|.++.+|+.||||+++...... ......+|+++|++++|||||+++++|.+++++|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 799999999999999999999999999999999997543322 2334568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~~ 157 (417)
||+.++++..+.......+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.... .....
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 99999988888777667899999999999999999999999999999999999996 57899999999987654 34455
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+....|..... .......
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MPDYKPS 239 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-STTCCTT
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc-ccccccc
Confidence 678999999999988777789999999999999999999999999999999999999999988887765433 2233444
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++...........+.+|.++++||++||..||++|||++|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 55555566667778899999999999999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-63 Score=462.21 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=217.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
||+|++++.||+|+||+||+|+++.+|+.||+|++.+.... .......+|++++++++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999999754322 1223446899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||++|+.+..+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ...
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~ 162 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT 162 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence 9999876554444333 4589999999999999999999999999999999999997 589999999999866543 345
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+... .+.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------------~~~ 222 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EFT 222 (263)
T ss_dssp ETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------------CCC
T ss_pred ccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------CCC
Confidence 678999999999997654 899999999999999999999999999888877766421 111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
++..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 223 -----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 22457899999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=464.78 Aligned_cols=254 Identities=27% Similarity=0.471 Sum_probs=219.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++.+|+.||||+++...... .....+|+.++++++|||||+++++|.+++.+|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999999999999999997654332 34457899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
++|+.+..+.... .+++.+++.|+.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.+... ......
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9987666665543 499999999999999999999999999999999999996 589999999999876543 345667
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccCC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQFP 239 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 239 (417)
+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.... . +
T Consensus 177 ~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~--------------------~ 234 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T--------------------P 234 (293)
T ss_dssp CSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S--------------------C
T ss_pred ccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-C--------------------C
Confidence 8999999999997654 8999999999999999999999999998888777664321 0 0
Q ss_pred CCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 240 QLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 240 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
. ....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 235 ~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 E------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp C------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred C------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 0112357899999999999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-62 Score=467.75 Aligned_cols=280 Identities=38% Similarity=0.679 Sum_probs=237.4
Q ss_pred eecceecccCceEEEEEEECCCCcEEEEEEecccccChh----hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 5 SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE----DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 5 ~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+.++.||+|+||+||+|+++.+|+.||||+++....... .....+|+++|++++|||||+++++|.+++++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 467899999999999999999999999999975433221 1235689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC-CCCcc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-PPYTN 158 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-~~~~~ 158 (417)
|+.++++..+... ...+++.+++.+++||+.||+|||++||+||||||+|||++. +.+||+|||+|...... .....
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 9999887776543 466999999999999999999999999999999999999975 89999999999876543 33456
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|...+|.+....|.+........ .+
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~--~~ 237 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--TF 237 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC--CC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh--hh
Confidence 7899999999999877778999999999999999999999999999999999999999999988876644332221 22
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...+...+....+.+|+++++||.+||+.||++||||+|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 2333445566677899999999999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-62 Score=468.02 Aligned_cols=256 Identities=33% Similarity=0.535 Sum_probs=203.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|+|++++.||+|+||+||+|+++.+|+.||||++.+...........+|+++|++|+|||||+++++|.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 57999999999999999999999999999999998665444444456899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCCCC
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~~~ 156 (417)
++|+ |.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||+. ++.+||+|||+|+........
T Consensus 89 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 89 VSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred cCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9865 5555543 35699999999999999999999999999999999999994 478999999999887766666
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
.+.+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|... .+
T Consensus 167 ~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------------------~~ 226 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------------------EY 226 (307)
T ss_dssp ------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-------------------CC
T ss_pred eeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------CC
Confidence 7789999999999997654 899999999999999999999999999888887776532 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.++ ....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 227 ~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 227 EFD-------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CCC-------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCC-------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 111 1234578999999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-62 Score=472.11 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=224.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
||+|++++.||+|+||+||+|+++.+|+.||||++..... .......+|+++|++|+|||||+++++|.+++.+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999999999999999999976532 233445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCCCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|++|+.+..........+++.+++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 9987654444433345699999999999999999999999999999999999995 3689999999999887777777
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..|......
T Consensus 184 ~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------- 243 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN------------------- 243 (350)
T ss_dssp EECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------------
T ss_pred eecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 789999999999997655 899999999999999999999999999988888877643211
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
++ ....+.+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 244 ~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 244 MD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp SC-------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11 12234579999999999999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-62 Score=462.34 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=218.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|.|++++.||+|+||+||+|+++.+|+.||+|+++... ........+|+++|++|+|||||++++++.+++.+|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46999999999999999999999999999999997653 22334567899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~~~ 159 (417)
++|+.+..+..+....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...... ......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 998766665544446699999999999999999999999999999999999997 589999999999765432 223456
Q ss_pred cCCccccCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 160 VGSRWYRAPEILL----QSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 160 ~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
+||+.|+|||++. ....|+.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-------------------- 230 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------------- 230 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--------------------
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 8999999999984 2345899999999999999999999999998888777766531
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
..+. ......+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 231 -~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 -EPPT------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -CCCC------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -CCCC------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0010 1112457899999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-62 Score=462.10 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=217.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
|+|++++.||+|+||+||+|+++.+|+.||||++.+... ........+|++++++|+|||||+++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999975432 112234568999999999999999999999999999999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---C
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG---P 154 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~---~ 154 (417)
||++|+ |.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+... .
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999875 55554443 4599999999999999999999999999999999999996 579999999999876532 2
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|...
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------------- 225 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------------- 225 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------------------
T ss_pred ccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------------------
Confidence 345678999999999997655 899999999999999999999999999988887776521
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHH------HHcCccccccccCCC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAE------ALQHPFFKRCFYAPP 292 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~~~~~~ 292 (417)
.+.+ +..+|+++++||.+||+.||++|||++| +++||||+...|...
T Consensus 226 ~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 EYDF-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp CCCC-----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred CCCC-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 1112 2357999999999999999999999987 589999998766543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-61 Score=470.36 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=224.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|+|++++.||+|+||+||+|+++.+|+.||||+++.... .+.....+|+++|++|+|||||+++++|.+++.+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 679999999999999999999999999999999976532 2334556899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee---CCcEEEeeccccccccCCCCCcc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS---QGIIKIADFGLAREIKSGPPYTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~---~~~vkL~DFg~a~~~~~~~~~~~ 158 (417)
++|+.+..........+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+|..+........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 987655443333345699999999999999999999999999999999999996 47899999999998877777777
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|.... +.+
T Consensus 188 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~ 247 (352)
T d1koba_ 188 TTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------------------WEF 247 (352)
T ss_dssp ECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------------CCC
T ss_pred ccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------CCC
Confidence 89999999999987655 8999999999999999999999999999988887775421 111
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
+ ...++.+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 248 ~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 D-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp C-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred C-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1 12345789999999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-61 Score=465.86 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=221.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++|++++.||+|+||+||+|+++.+|+.||||++++... ........+|+.+|++++||||++++++|++.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 6899999999999999999999999999999999976532 11233456899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC-CCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS-GPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~-~~~~ 156 (417)
|||+.|+.+..+..+. ..++|..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.... ....
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 9999987555544444 4589999999999999999999999999999999999996 58999999999987644 4455
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....+... ..
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------------~~ 222 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------EI 222 (337)
T ss_dssp CCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CC
T ss_pred ccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-------------------CC
Confidence 6789999999999987655 899999999999999999999999999988877766421 11
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCccccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCF 288 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 288 (417)
. ++..+|+++++||.+||++||.+|+ |++|+++||||++..
T Consensus 223 ~-----------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 223 R-----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp C-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred C-----------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 1 2346899999999999999999999 499999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-62 Score=471.61 Aligned_cols=277 Identities=24% Similarity=0.366 Sum_probs=212.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
|+|+++++||+|+||+||+|+++.+|+.||+|+++............+|+.+|++|+|||||+++++|.+++++|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 68999999999999999999999999999999998765544455667999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
+.|+.+..+..+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++ +|.+||+|||+|..+.... .++.
T Consensus 86 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~ 163 (322)
T d1s9ja_ 86 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF 163 (322)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-C---
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-cccc
Confidence 9976555544443 458999999999999999999997 5999999999999996 5899999999998664432 3467
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCccchHH------------
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQ-MYKICGVLGSPTMDSWAD------------ 226 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~------------ 226 (417)
+||++|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+. ...+....|.........
T Consensus 164 ~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred cCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 9999999999997765 99999999999999999999999987654332 222222222211110000
Q ss_pred -------HHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 227 -------GLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 227 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
............+. .+ ....+|.+++|||.+||+.||.+|||++|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPP----KL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCC----CC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccchhHHHHHhhhhccCCc----cC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000000111000 00 012368999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-61 Score=455.49 Aligned_cols=259 Identities=31% Similarity=0.461 Sum_probs=220.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-----hhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-----DCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
|+|++++.||+|+||+||+|+++.+|+.||||++++...... .....+|+.+|++|+|||||+++++|++.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999999999999999975433221 234568999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C----cEEEeecccccccc
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G----IIKIADFGLAREIK 151 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~----~vkL~DFg~a~~~~ 151 (417)
+||||++|+.+..+.... +.+++..++.++.||+.||+|||++||+||||||+|||++. | .+||+|||+|....
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999876544444333 45999999999999999999999999999999999999953 3 59999999999887
Q ss_pred CCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 152 SGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
........+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..|....
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------------- 232 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN--------------- 232 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------------
T ss_pred CCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------
Confidence 77667778999999999999755 48999999999999999999999999999888887775321
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
+.+ .....+.+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 233 ----~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 233 ----YEF-------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp ----CCC-------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred ----CCC-------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 111 1223356899999999999999999999999999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-61 Score=457.70 Aligned_cols=282 Identities=36% Similarity=0.629 Sum_probs=240.2
Q ss_pred CCceecceecccCceEEEEEEECCC-CcEEEEEEecccccChh-hhhhHHHHHHHHhc---CCCCeeeeceEEEe-----
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHT-GEAVAIKELKQRYASWE-DCLNLREVKCLRKL---NHSNIVKLKELIQN----- 71 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~-g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l---~hpnIv~l~~~~~~----- 71 (417)
++|+++++||+|+||+||+|++..+ ++.||||+++....... .....+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999765 67899999976543322 22345788877766 79999999999863
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREI 150 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~ 150 (417)
...+|++|||++++++..........+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 35789999999999888777766678999999999999999999999999999999999999965 89999999999877
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.........+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|+..+|.+....|......
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 6666667789999999999997655 899999999999999999999999999999999999999999988887654332
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
.. ..+..........+...+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 246 ~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 246 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 22 2223333444556677899999999999999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-61 Score=453.18 Aligned_cols=283 Identities=36% Similarity=0.693 Sum_probs=242.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
||+|+++++||+|+||+||+|+++ +|+.||||+++...... ......+|+.+|++++|||||+++++|.+++..|++|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 799999999999999999999986 78999999997653322 1334568999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-CCCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG-PPYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~-~~~~ 157 (417)
||+.++++..+.... +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ....
T Consensus 80 e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp ECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 999999888876544 6699999999999999999999999999999999999996 589999999999876543 3344
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+|++.|+|||++.+...++.++|||||||++|||++|++||.+.++.+++.++....|.+....|........ ....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPN 237 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCTT
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh-cccc
Confidence 567999999999998777789999999999999999999999999999999999999999999888876544332 2333
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
+............+.+|+++.|||++||+.||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 4444455566777889999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-60 Score=455.56 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=217.7
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh--hhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED--CLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+|+++++||+|+||+||+|+++.+|+.||||+++........ ....+|+++|++|+|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999999999999999999765433222 345689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCccc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYTNY 159 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~~~ 159 (417)
|+.++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...... ...
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSF 171 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCC
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Ccc
Confidence 99998887665544 5699999999999999999999999999999999999997 479999999999865433 456
Q ss_pred cCCccccCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 160 VGSRWYRAPEILLQ--SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+||+.|+|||++.+ ...|+.++|||||||++|||++|..||.+.+..+.+..+... .
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~---------------------~ 230 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------------E 230 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------------------C
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---------------------C
Confidence 89999999999864 234899999999999999999999999999888877776531 1
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+. .....+|+++++||.+||+.||++|||++|+|+||||.+
T Consensus 231 ~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 SPA-------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CCC-------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCC-------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 111 112357899999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=451.00 Aligned_cols=254 Identities=27% Similarity=0.476 Sum_probs=204.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe--CCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN--NNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 77 (417)
.|+|++++.||+|+||+||+|+++.+|+.||+|++........ .....+|++++++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 3789999999999999999999999999999999986644332 3445689999999999999999999865 456899
Q ss_pred EEeccCCC-HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCCeeee-CCcEEEeeccccc
Q 044608 78 VFECMECN-LYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNG-----FFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 78 v~E~~~~~-l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~g-----i~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
||||++|+ |.+.+.. .....+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999876 4444432 23456999999999999999999999976 99999999999996 5899999999998
Q ss_pred cccCCC-CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH
Q 044608 149 EIKSGP-PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG 227 (417)
Q Consensus 149 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 227 (417)
.+.... .....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|...
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~------------ 229 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------------ 229 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------------
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence 775543 345678999999999996655 899999999999999999999999999888877766421
Q ss_pred HHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccc
Q 044608 228 LRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFF 284 (417)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f 284 (417)
. ...+...+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 230 ---------~--------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ---------K--------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------C--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 112234689999999999999999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-60 Score=455.82 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=221.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
|++|+++++||+|+||+||+|+++.+|+.||||++++.... .......+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57899999999999999999999999999999999754322 1223456899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+..... ..
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY 159 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cc
Confidence 9999988766666554 4589999999999999999999999999999999999996 589999999999876543 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
+.+||+.|+|||++.+.. |+.++|||||||++|+|++|..||.+.+..+.+.+|... ..
T Consensus 160 ~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------------~~- 218 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------------EL- 218 (316)
T ss_dssp CCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------------CC-
T ss_pred cccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-------------------CC-
Confidence 679999999999986554 899999999999999999999999999988888777531 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.+++.+|+++.+||.+||..||.+|+ |++|+|+||||++..|
T Consensus 219 ----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 219 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 12346799999999999999999996 9999999999988644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-60 Score=457.11 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=223.1
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
.|+|++++.||+|+||+||+|+++.+|+.||||+++... .+.....+|+++|+.++|||||+++++|++.+.+|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 489999999999999999999999999999999997653 233445689999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC---CcEEEeeccccccccCCCCCc
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ---GIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~---~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|++|+.+..........+++.+++.|+.||+.||+|||++||+||||||+|||++. +.+||+|||++..........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99876444444444446999999999999999999999999999999999999963 479999999999877666667
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..|........
T Consensus 162 ~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 223 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----------------- 223 (321)
T ss_dssp EEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred ccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 778999999999986655 89999999999999999999999999999888888764311111
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
...++.+|+++++||.+||..||.+|||++|+|+||||++
T Consensus 224 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1233568999999999999999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-60 Score=442.11 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=207.0
Q ss_pred Cc-eecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEe----CCEEE
Q 044608 3 KY-SGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQN----NNRLY 76 (417)
Q Consensus 3 ~Y-~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 76 (417)
+| ++.++||+|+||+||+|+++.+++.||+|++........ .....+|+++|++|+|||||+++++|++ ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45 677789999999999999999999999999976554433 3345689999999999999999999875 45689
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCCeeee--CCcEEEeeccccccccC
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNG--FFHRDLKPENLLVS--QGIIKIADFGLAREIKS 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~g--i~HrDLKp~NILl~--~~~vkL~DFg~a~~~~~ 152 (417)
+||||++++.+..+..+. ..+++..++.|+.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|+....
T Consensus 89 ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999886555544443 45899999999999999999999999 99999999999995 47899999999985433
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
......+||+.|+|||++.+ . |+.++|||||||++|||++|..||.+....+.+.+.... +.
T Consensus 168 -~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~-------------- 229 (270)
T d1t4ha_ 168 -SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GV-------------- 229 (270)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TC--------------
T ss_pred -CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CC--------------
Confidence 33456789999999998854 3 899999999999999999999999876655444332210 00
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
....+....++++.+||.+||+.||++|||++|+|+||||+
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 ------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ------------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00112235789999999999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-60 Score=458.46 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=219.0
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccC--hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYAS--WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
||+|++++.||+|+||+||+|+++.+|+.||||++.+.... .......+|+++|+.++|||||+++++|.+.+.+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 58999999999999999999999999999999999754321 1223456899999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
|||+.|+.+.....+. +.+++..++.|+.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+... ..
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW 196 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cc
Confidence 9999876544444333 4599999999999999999999999999999999999996 589999999999877543 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|... ..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------------~~- 255 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------------------KV- 255 (350)
T ss_dssp CCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------CC-
T ss_pred cccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-------------------CC-
Confidence 678999999999997655 899999999999999999999999999888887777531 11
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
..+..+|+++.+||++||..||.+|+ |++|+|+||||+...|
T Consensus 256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 12246799999999999999999994 9999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-59 Score=440.18 Aligned_cols=257 Identities=31% Similarity=0.473 Sum_probs=220.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh--------hhhhhHHHHHHHHhcC-CCCeeeeceEEEeC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW--------EDCLNLREVKCLRKLN-HSNIVKLKELIQNN 72 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~--------~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 72 (417)
|+|++++.||+|+||+||+|+++.+|+.||||++++..... ......+|+.++++|+ |||||+++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 79999999999999999999999999999999997653221 1123468999999997 99999999999999
Q ss_pred CEEEEEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 73 NRLYLVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 73 ~~~~lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
+.+||||||++|+ |.+.+..+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999865 55555443 4589999999999999999999999999999999999996 579999999999988
Q ss_pred cCCCCCccccCCccccCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQ-----SELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
.........+||+.|+|||++.+ ...++.++||||+||++|+|++|..||.+.+..+....|...
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~---------- 230 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG---------- 230 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC----------
Confidence 77666677899999999999853 234788999999999999999999999999988887777532
Q ss_pred HHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.+.++ ....+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 231 ---------~~~~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 231 ---------NYQFG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ---------CCCCC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ---------CCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 11111 1123468999999999999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-59 Score=458.77 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=212.8
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhH---HHHHHHHhcCCCCeeeeceEEEeCCEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNL---REVKCLRKLNHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~ 75 (417)
||+|++++.||+|+||+||+|+++.+|+.||||++.+...... ..... +|+++++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 7899999999999999999999999999999999975432211 11122 457777788999999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP 154 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~ 154 (417)
|+||||+.|+.+..+..+. ..+++..++.|+.||+.||.|||++||+||||||+|||++. |.+||+|||+|+.+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999876544444433 45899999999999999999999999999999999999964 899999999998776543
Q ss_pred CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 155 PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
....+||+.|+|||++.+...|+.++|||||||++|||++|..||.+.+..+....+...
T Consensus 162 -~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------------------- 221 (364)
T d1omwa3 162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------- 221 (364)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-------------------
T ss_pred -ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 355689999999999976666999999999999999999999999876543322211100
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHcCcccccccc
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPT-----AAEALQHPFFKRCFY 289 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 289 (417)
.. ....++..+|+++++||.+||+.||++||| |+|+++||||++..|
T Consensus 222 -~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 222 -LT-------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp -SS-------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred -cc-------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 00 011233468999999999999999999999 899999999987644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=452.00 Aligned_cols=278 Identities=35% Similarity=0.650 Sum_probs=236.4
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe------CCEEE
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN------NNRLY 76 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~ 76 (417)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+++|++|+||||++++++|.. ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 59999999999999999999999999999999975432 22379999999999999999999854 34689
Q ss_pred EEEeccCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC-cEEEeeccccccccC
Q 044608 77 LVFECMECNLYQLMAA--RDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG-IIKIADFGLAREIKS 152 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~--~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~-~vkL~DFg~a~~~~~ 152 (417)
+||||+++++...+.. .....+++.+++.|+.||+.||+|||++||+||||||+|||++ ++ .+||+|||++..+..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9999999887766543 3445699999999999999999999999999999999999997 44 799999999998877
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
.....+.+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..|...+|.+..+.|........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 77777789999999999988777799999999999999999999999999999999999999999998887766433222
Q ss_pred hhhccCCCCCcccc-cccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANL-SALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
...++......+ ....+..++++.+||.+||..||++||||.|+|+||||++.
T Consensus 256 --~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 256 --EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred --hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 222333322222 23456789999999999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-59 Score=448.35 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=216.9
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEeccccc--ChhhhhhHHHHHHHH-hcCCCCeeeeceEEEeCCEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYA--SWEDCLNLREVKCLR-KLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~--~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~l 77 (417)
||+|++++.||+|+||+||+|+++.+|+.||||++++... ........+|..++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 7999999999999999999999999999999999975432 112223356777665 6899999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccC-CCC
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKS-GPP 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~-~~~ 155 (417)
||||++|+.+..+.... ..+++.+++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 99999876555544443 45899999999999999999999999999999999999975 8999999999986654 344
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
.+..+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+...+|... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------------------~ 219 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------------------N 219 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------------C
T ss_pred ccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------C
Confidence 45678999999999997665 899999999999999999999999999988877776421 1
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHH-HHHcCccccccc
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA-EALQHPFFKRCF 288 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~~ 288 (417)
. .++..+|+++++||.+||+.||.+|||+. |+++||||++..
T Consensus 220 ~-----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 220 P-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp C-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred C-----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 1 12245799999999999999999999995 899999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=448.37 Aligned_cols=282 Identities=36% Similarity=0.617 Sum_probs=234.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-hhhhHHHHHHHHhcCCCCeeeeceEEEeCC------E
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-DCLNLREVKCLRKLNHSNIVKLKELIQNNN------R 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~ 74 (417)
++|+++++||+|+||+||+|+++.+|+.||||++++...... .....+|+++|+.|+|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 689999999999999999999999999999999986544433 234568999999999999999999997654 5
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+||||+++.+... ..+ ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|......
T Consensus 98 ~~lv~e~~~~~l~~~-~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKL-MKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CEEEEECCSEEHHHH-HHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEecccccHHHH-HHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 799999996555544 433 3499999999999999999999999999999999999996 589999999999876543
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH-Hh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ-AR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~ 232 (417)
.+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|...... ..
T Consensus 175 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred --cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 456789999999999987777899999999999999999999999999999999999999998877655442211 11
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCF 288 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~ 288 (417)
......+......+....+.+|++++|||.+||..||.+|||++|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 22334555566677778889999999999999999999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-58 Score=432.81 Aligned_cols=284 Identities=35% Similarity=0.636 Sum_probs=242.5
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 79 (417)
||+|+++++||+|+||+||+|+++.+|+.||||+++...... ......+|+.+|+.++||||++++++|.+.+.+++||
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 799999999999999999999999999999999997654332 2345569999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC-CCc
Q 044608 80 ECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP-PYT 157 (417)
Q Consensus 80 E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~-~~~ 157 (417)
|++.++++..+.... +.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||.|....... ...
T Consensus 81 ~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp ECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 999988887776544 6689999999999999999999999999999999999996 5899999999998775433 344
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+++.|+|||++.+...++.++|||||||++|||++|..| |.+.+..+.+.++....+.+....|...........+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 557889999999998777689999999999999999999876 6778888899999999999888887766544433332
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
.... .........+.+|+++.+||++||+.||.+||||+|+|+||||++
T Consensus 240 ~~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 2222 123444566788999999999999999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=450.52 Aligned_cols=258 Identities=30% Similarity=0.498 Sum_probs=209.7
Q ss_pred CCCceecc-eecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHh-cCCCCeeeeceEEEe----CCE
Q 044608 1 MDKYSGFK-ELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRK-LNHSNIVKLKELIQN----NNR 74 (417)
Q Consensus 1 ~~~Y~~~~-~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~----~~~ 74 (417)
+++|++++ .||+|+||+||+|+++.+|+.||||+++.. ....+|++++.+ ++|||||+++++|++ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 47899986 599999999999999999999999998643 234579998765 489999999999976 467
Q ss_pred EEEEEeccCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC----CcEEEeecccccc
Q 044608 75 LYLVFECMEC-NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ----GIIKIADFGLARE 149 (417)
Q Consensus 75 ~~lv~E~~~~-~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~----~~vkL~DFg~a~~ 149 (417)
+|+|||||+| +|.+.+..+....++|.+++.|+.||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 8999999986 4666665544457999999999999999999999999999999999999963 5799999999998
Q ss_pred ccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 150 IKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
..........+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------------- 229 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------------- 229 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-------------
T ss_pred ccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-------------
Confidence 87777777889999999999986655 8999999999999999999999998876555443332211
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
....+.+|. ...+.+|+++++||++||+.||++|||+.|+|+||||++.
T Consensus 230 --~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 --RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --CSCSSSCCT-------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred --hcCCCCCCC-------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 011112221 1123478999999999999999999999999999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=441.80 Aligned_cols=285 Identities=34% Similarity=0.579 Sum_probs=226.7
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEe--------
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQN-------- 71 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 71 (417)
+++|+++++||+|+||+||+|+++.+|+.||||++....... ......+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 479999999999999999999999999999999987543322 22345689999999999999999998854
Q ss_pred CCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccc
Q 044608 72 NNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREI 150 (417)
Q Consensus 72 ~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~ 150 (417)
++.+|+||||+.++++...... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999998888766543 35689999999999999999999999999999999999996 589999999999765
Q ss_pred cCC-----CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchH
Q 044608 151 KSG-----PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWA 225 (417)
Q Consensus 151 ~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 225 (417)
... ......+||++|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+....+....+.+..+.|.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 432 223456899999999999877679999999999999999999999999999999999999999888776654
Q ss_pred HHHHHHhhhhccCCCCCcccccccC--CCCCHhHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q 044608 226 DGLRQARAIKYQFPQLPRANLSALM--PSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKR 286 (417)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~ 286 (417)
........................+ ...+++++|||.+||+.||++|||++|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 4322211111111111111111100 124788999999999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=434.26 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=207.8
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh-----hhhhHHHHHHHHhcC--CCCeeeeceEEEeCCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE-----DCLNLREVKCLRKLN--HSNIVKLKELIQNNNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~-----~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~ 74 (417)
++|++.+.||+|+||+||+|+++.+|+.||||++++...... .....+|+.++++++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 589999999999999999999999999999999975433211 122358999999997 8999999999999999
Q ss_pred EEEEEeccCC-C-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-C-CcEEEeeccccccc
Q 044608 75 LYLVFECMEC-N-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-Q-GIIKIADFGLAREI 150 (417)
Q Consensus 75 ~~lv~E~~~~-~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~-~~vkL~DFg~a~~~ 150 (417)
+|+||||+.+ + +.+.+..+ ..+++.+++.++.||+.||+|||++||+||||||+|||++ + +.+||+|||+|...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999875 3 44444443 4599999999999999999999999999999999999997 3 68999999999865
Q ss_pred cCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 151 KSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
.. ...++.+||+.|+|||++.+...++.++|||||||++|||++|..||.+.+. +..
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~---------------- 218 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR---------------- 218 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----------------
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh----------------
Confidence 43 3456678999999999998777678889999999999999999999976321 110
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
... .+...+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 219 ---~~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 ---GQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ---CCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---ccc-----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 011 1224689999999999999999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=441.13 Aligned_cols=283 Identities=35% Similarity=0.651 Sum_probs=232.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC-----EEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN-----RLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 76 (417)
++|+++++||+|+||+||+|.++.+|+.||||++.+...........+|+++|++|+||||+++++++.... .+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 589999999999999999999999999999999976544434445678999999999999999999987543 467
Q ss_pred EEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCC--
Q 044608 77 LVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSG-- 153 (417)
Q Consensus 77 lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~-- 153 (417)
++|++++++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|......
T Consensus 88 l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 7777777777766643 24899999999999999999999999999999999999965 89999999999765432
Q ss_pred --CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHH-HHH
Q 044608 154 --PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADG-LRQ 230 (417)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~-~~~ 230 (417)
......+||+.|+|||++.....|+.++||||+||++|+|++|.+||.+.+..+....+...++.+........ ...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 23456789999999999877677899999999999999999999999999999999888888777665432221 111
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
........+......+....+.+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 222333455555566677788999999999999999999999999999999999865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=442.80 Aligned_cols=282 Identities=32% Similarity=0.539 Sum_probs=224.4
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEe------CC
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQN------NN 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~ 73 (417)
+++|+++++||+|+||+||+|+++.+|+.||||++......... ....+|+.+|++++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 37899999999999999999999999999999999876554433 345689999999999999999999963 47
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
++|+||||+.+++++.+. ..+++..++.+++||+.||.|||++||+||||||+|||++ ++.+|++|||+++....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 899999999999887663 4589999999999999999999999999999999999997 57899999999988777
Q ss_pred CCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 153 GPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
....+..+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+..+...++....+.+..+.|........
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 77777889999999999997654 89999999999999999999999999999999999999999887777765444433
Q ss_pred hhhccCCCCCccccccc------------CCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSAL------------MPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+.......... ....|+++++||++||..||++||||+|||+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 33333222222111111 12247789999999999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-57 Score=436.31 Aligned_cols=280 Identities=27% Similarity=0.529 Sum_probs=224.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEe--CCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQN--NNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv 78 (417)
|+|+++++||+|+||+||+|+++.+|+.||||+++... .....+|+++|++++ ||||++++++|.. ...+|+|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 68999999999999999999999999999999997532 234568999999995 9999999999985 4569999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC-cEEEeeccccccccCCCCC
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG-IIKIADFGLAREIKSGPPY 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~-~vkL~DFg~a~~~~~~~~~ 156 (417)
|||+.++.+..+ .+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|+........
T Consensus 111 ~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 999998765443 24599999999999999999999999999999999999997 34 6999999999988777777
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGA-SEADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
...+||+.|+|||++.+...|+.++||||+||++|+|++|..||... +..+....+...+|.+....|...........
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 88899999999999987777899999999999999999999998654 45667777777777654443332211111000
Q ss_pred c--cCCCCCccccc-----ccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccccc
Q 044608 236 Y--QFPQLPRANLS-----ALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRCFY 289 (417)
Q Consensus 236 ~--~~~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 289 (417)
+ ........... .....+|++++|||++||..||++|||++|+|+||||+.+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0 01111111111 112347899999999999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=434.20 Aligned_cols=281 Identities=36% Similarity=0.637 Sum_probs=228.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhh-hhhHHHHHHHHhcCCCCeeeeceEEEeC------CE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWED-CLNLREVKCLRKLNHSNIVKLKELIQNN------NR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 74 (417)
|+|+++++||+|+||+||+|+++.+|+.||||++.+....... ....+|+++|++|+|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 6899999999999999999999999999999999866544333 3456899999999999999999998633 33
Q ss_pred EEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC
Q 044608 75 LYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG 153 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~ 153 (417)
+|+++++.+|+|.+.+ .. +.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~-~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIV-KC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CEEEEECCSEEHHHHH-TT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEEeecCCchhhhc-cc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 5555555555555544 33 4599999999999999999999999999999999999996 58999999999976543
Q ss_pred CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH-HHh
Q 044608 154 PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR-QAR 232 (417)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~ 232 (417)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....|....+.+..+.+..... ...
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 234568999999999988777789999999999999999999999999999999999998888776554332111 112
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFKRC 287 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~ 287 (417)
......+..+...+......+|++++|||++||..||.+||||+|+|+||||++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 2223344445556667778899999999999999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-55 Score=415.50 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=203.9
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChh--hhhhHHHHHHHHhcCCCCeeeeceEEEeCC----EE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWE--DCLNLREVKCLRKLNHSNIVKLKELIQNNN----RL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~ 75 (417)
|+|++.+.||+|+||+||+|+++.+|+.||||+++....... .....+|+++++.++|||||++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 689999999999999999999999999999999986544322 234568999999999999999999997654 48
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC-
Q 044608 76 YLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~- 153 (417)
|+||||++|+.+....... +.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.++|+|||.+......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 9999999977555444433 4589999999999999999999999999999999999996 588999999998755432
Q ss_pred ---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 154 ---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 154 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.++....
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~-------------- 230 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED-------------- 230 (277)
T ss_dssp -------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------------
T ss_pred ccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC--------------
Confidence 2345678999999999986654 8999999999999999999999999999888777664311
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHPFFK 285 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp~f~ 285 (417)
........+.+|+++.+||.+||+.||.+||+..+.|.|+|.+
T Consensus 231 ------------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 ------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ------------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0111234467899999999999999999999544555567653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=418.74 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=200.2
Q ss_pred CCceecceecccCceEEEEEEECCCCc---EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE---AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~---~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||+||+|+++.+|+ .||||.+.............+|+++|++|+|||||++++++.+++.+|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 578999999999999999999987765 58899887655544445567999999999999999999999999999999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCC-
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPY- 156 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~- 156 (417)
|||++++.+..+.......+++.++..++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|+.+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 999998877666665556799999999999999999999999999999999999996 478999999999876543221
Q ss_pred -----ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHH
Q 044608 157 -----TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQ 230 (417)
Q Consensus 157 -----~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 230 (417)
....||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~--------------- 249 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD--------------- 249 (299)
T ss_dssp ----------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---------------
T ss_pred eeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 2245799999999987654 8999999999999999998 89999999888777666421
Q ss_pred HhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 231 ARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
... .....++.++.+||.+||+.||++|||++|++++
T Consensus 250 -----~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 -----YRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -----CCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----CCC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011 1224578999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=414.08 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=209.0
Q ss_pred CCceecc-eecccCceEEEEEEECCC--CcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFK-ELGRGAFGRVFQAFDEHT--GEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~-~LG~G~~g~V~~a~~~~~--g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|.+.+ +||+|+||+||+|.++.+ +..||||+++............+|+++|++|+|||||++++++.++ .+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 4577877 499999999999987654 4579999998655444445567999999999999999999999764 58999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP-- 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~-- 155 (417)
|||++++.+..+....+..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999998766665554456799999999999999999999999999999999999996 58999999999987654322
Q ss_pred --CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHh
Q 044608 156 --YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQAR 232 (417)
Q Consensus 156 --~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 232 (417)
....+||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....|...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~----------------- 228 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG----------------- 228 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----------------
T ss_pred ccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 23457899999999987665 8999999999999999998 89999998877776655321
Q ss_pred hhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH---HcCcccc
Q 044608 233 AIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA---LQHPFFK 285 (417)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el---L~hp~f~ 285 (417)
. ....++.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 229 ----~--------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 ----K--------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----C--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----C--------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0 012235688999999999999999999999888 6788874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=412.06 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 80 (417)
++|++.+.||+|+||+||+|+.+ ..||||+++...... ......+|+++|++++|||||++++++. .+.+|+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 58999999999999999999643 359999997554332 3344568999999999999999999864 456899999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCC---CCC
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSG---PPY 156 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~---~~~ 156 (417)
|++++.+..+.......+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+..... ...
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9987654444444445699999999999999999999999999999999999997 478999999999866432 234
Q ss_pred ccccCCccccCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 157 TNYVGSRWYRAPEILLQS--ELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
...+||+.|+|||++... ..|+.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~------------------ 225 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG------------------ 225 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT------------------
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC------------------
Confidence 567899999999998642 348999999999999999999999999887766655443211
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+. ...+......+++++.+||.+||+.||++|||++|++++
T Consensus 226 -~~-----~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 226 -YL-----SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -SC-----CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CC-----CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 122334556789999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-55 Score=415.40 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=204.5
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.++||+|+||+||+|+++.+|+.||||+++..... .....+|+++|++|+|||||+++++|.+++.+|+||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4788999999999999999999999999999999765443 33457899999999999999999999999999999999
Q ss_pred cCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC--Cc
Q 044608 82 MECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP--YT 157 (417)
Q Consensus 82 ~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~--~~ 157 (417)
++++ +...+.......+++..+..++.||+.||+|||++||+||||||+||||+ ++.+||+|||+|+....... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 9865 55555555556799999999999999999999999999999999999996 47899999999987654332 23
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPL-FPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+....+.. .+
T Consensus 175 ~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~--------------------~~ 233 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------------------DY 233 (287)
T ss_dssp TEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--------------------TC
T ss_pred cccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc--------------------CC
Confidence 345789999999997665 89999999999999999996555 555554443333211 00
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
. ......+++++.+||.+||+.||++|||++|+++
T Consensus 234 ~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 1223467899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=408.30 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=198.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++ +++.||||+++..... .....+|++++++++|||||++++++.+++.+|+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 58999999999999999999976 5678999999765433 33457899999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Ccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~~ 158 (417)
+.++.+..+.......+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+|+....... ...
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9887665555555567899999999999999999999999999999999999974 7899999999987654332 234
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..||+.|+|||++.+.. |+.++|||||||++|||++ |.+||...+..+.+..+.... .
T Consensus 162 ~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------------------~-- 220 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------------R-- 220 (263)
T ss_dssp ---CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------------------C--
T ss_pred eecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC------------------C--
Confidence 57899999999997665 8999999999999999998 578888877777766654210 0
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...+...++++.+||.+||+.||++|||++|+++|
T Consensus 221 ---------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ---------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01123468999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=423.02 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=204.4
Q ss_pred CCceecceecccCceEEEEEEECCCCc-----EEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE-----AVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~-----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
|+|++.++||+|+||+||+|+++.+++ .||+|.+.............+|+.+++++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999999876554 69999987655544445567899999998 899999999999999999
Q ss_pred EEEEeccCCC-HHHHHHHhc---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 76 YLVFECMECN-LYQLMAARD---------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 76 ~lv~E~~~~~-l~~~~~~~~---------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
|+||||++++ |.+.+..+. ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999876 444443322 124889999999999999999999999999999999999
Q ss_pred ee-CCcEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 044608 134 VS-QGIIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQ 208 (417)
Q Consensus 134 l~-~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~ 208 (417)
++ ++.+||+|||+|+....... ....+||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 97 57899999999987655433 23457899999999997665 8999999999999999997 8999998877666
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+.+++... +. ...+..+|+++++||.+||+.||++|||++||++|
T Consensus 276 ~~~~~~~~-------------------~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNG-------------------FK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTT-------------------CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcC-------------------CC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66654310 11 11234678999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=404.34 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=210.4
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++ ++..||||+++..... ....++|++++++++||||+++++++.+.+.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 68999999999999999999985 7889999999865443 33467999999999999999999999999999999999
Q ss_pred cCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCCC--Ccc
Q 044608 82 MECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGPP--YTN 158 (417)
Q Consensus 82 ~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~~--~~~ 158 (417)
+.++.+..+.......+++..++.++.||++||.|||++||+||||||+|||+++ +.+||+|||+|+....... ...
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9876555554444456899999999999999999999999999999999999975 7899999999986654322 334
Q ss_pred ccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhcc
Q 044608 159 YVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQ 237 (417)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (417)
..||+.|+|||++.+.. |+.++|||||||++|||++ |+.||.+.+..+....+.....
T Consensus 161 ~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-------------------- 219 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------------------- 219 (258)
T ss_dssp SCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------------------
T ss_pred cCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence 67899999999997665 8999999999999999998 8999999998887776643110
Q ss_pred CCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 238 FPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 238 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...+...++++.+||.+||+.||++|||++|+|+|
T Consensus 220 ---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ---------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01123567899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=408.00 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=198.4
Q ss_pred CCceecceecccCceEEEEEEECCCC---cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG---EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 78 (417)
++|++.+.||+|+||+||+|++..++ ..||||.++............+|++++++++|||||++++++. .+.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 68999999999999999999987654 4689998876544444455679999999999999999999985 4678999
Q ss_pred EeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--C
Q 044608 79 FECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--P 155 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~ 155 (417)
|||+.++.+..+.......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.... .
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~ 165 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCccee
Confidence 999987766555555556799999999999999999999999999999999999996 5899999999998765432 2
Q ss_pred CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhh
Q 044608 156 YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAI 234 (417)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 234 (417)
.+...||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 166 ~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~------------------- 225 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------------- 225 (273)
T ss_dssp -----CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------------------
T ss_pred ccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 34567899999999997655 8999999999999999997 89999998887777665421
Q ss_pred hccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 235 KYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
. ....++.+++++.+||.+||+.||++|||++|+++|
T Consensus 226 --~--------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 --E--------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --C--------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 012345789999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=406.37 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=197.9
Q ss_pred ceecccCceEEEEEEEC--CCCcEEEEEEecccccC-hhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEeccCC
Q 044608 8 KELGRGAFGRVFQAFDE--HTGEAVAIKELKQRYAS-WEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFECMEC 84 (417)
Q Consensus 8 ~~LG~G~~g~V~~a~~~--~~g~~vaiK~i~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 84 (417)
++||+|+||+||+|.++ .+++.||||+++....+ .......+|+++|++|+|||||+++++++++ .+|+||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999754 45678999999754333 2234557899999999999999999999754 57899999998
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC----Cccc
Q 044608 85 NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP----YTNY 159 (417)
Q Consensus 85 ~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~----~~~~ 159 (417)
+.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+..... ....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 7655555443 4589999999999999999999999999999999999996 58999999999987654322 2345
Q ss_pred cCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhccC
Q 044608 160 VGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKYQF 238 (417)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (417)
.||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....+... .
T Consensus 171 ~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~---------------------~- 227 (277)
T d1xbba_ 171 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------------------E- 227 (277)
T ss_dssp CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---------------------C-
T ss_pred CCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC---------------------C-
Confidence 7899999999997665 8999999999999999997 89999998887766655321 0
Q ss_pred CCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHH---HcCcccc
Q 044608 239 PQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEA---LQHPFFK 285 (417)
Q Consensus 239 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el---L~hp~f~ 285 (417)
....+..+++++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 228 -------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 -------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 011234678999999999999999999999998 5676653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=407.57 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=206.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|+++++||+|+||+||+|+++ ++..||||+++..... .....+|++++++++|||||++++++.+ +.+|+||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 57899999999999999999975 5788999999765433 2345799999999999999999998754 567999999
Q ss_pred cCCCHHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC--CCc
Q 044608 82 MECNLYQL-MAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~~l~~~-~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
++++.+.. +.......+++..+..++.||+.||.|||++||+||||||+||||++ +.+||+|||+|+.+.... ...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 98765544 43333345899999999999999999999999999999999999975 789999999998775432 234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...||+.|+|||++.+.. |+.++|||||||++|||+|| .+||...+..+.+..+... .
T Consensus 169 ~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~--------------------~ 227 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------------------Y 227 (272)
T ss_dssp TCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------------------C
T ss_pred ccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc--------------------C
Confidence 567899999999987655 89999999999999999995 6677777776666555321 0
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc--Cccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~~ 286 (417)
. ...+..+++++.+||.+||+.||++|||++|+++ |+||+.
T Consensus 228 ~---------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 R---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 1122467899999999999999999999999998 888864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=419.15 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=212.0
Q ss_pred CCCceecceecccCceEEEEEEE---CCCCcEEEEEEecccccC---hhhhhhHHHHHHHHhcCC-CCeeeeceEEEeCC
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFD---EHTGEAVAIKELKQRYAS---WEDCLNLREVKCLRKLNH-SNIVKLKELIQNNN 73 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~---~~~g~~vaiK~i~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~ 73 (417)
||+|+++++||+|+||+||+|.+ +.+|+.||||++++.... .......+|++++++++| |||+++++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 57899999999999999999987 447899999999754321 122344589999999977 89999999999999
Q ss_pred EEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccC
Q 044608 74 RLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKS 152 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~ 152 (417)
.+|++|||+.++.+....... ..+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|..+..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999876554444433 3479999999999999999999999999999999999997 58999999999986543
Q ss_pred C--CCCccccCCccccCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 153 G--PPYTNYVGSRWYRAPEILLQSE-LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 153 ~--~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
. .......|++.|+|||++.+.. .++.++|||||||+||+|++|..||.+.+..+....+....
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~------------- 248 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------- 248 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-------------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-------------
Confidence 2 2345578999999999996543 47889999999999999999999998877655544443211
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHcCcccccccc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRP-----TAAEALQHPFFKRCFY 289 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 289 (417)
.... ..++..+|+++.+||.+||+.||++|| |++|+|+||||+...+
T Consensus 249 ----~~~~---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 249 ----LKSE---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp ----HHCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----ccCC---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 0000 112346899999999999999999999 5999999999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=401.21 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=199.5
Q ss_pred CCceecceecccCceEEEEEEECCCC----cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG----EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g----~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
+.|++.+.||+|+||+||+|..+.++ ..||||+++............+|++++++|+|||||++++++.+.+.+++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 57999999999999999999877655 47999999766555445556799999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC-
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP- 155 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~- 155 (417)
||||+.++++..+.......+++.++..++.||+.||+|||++||+||||||+||||+ ++.+||+|||+|+.+.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999998876666655656799999999999999999999999999999999999997 47899999999987654322
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---------------- 229 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---------------- 229 (283)
T ss_dssp -------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------------
T ss_pred ceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc----------------
Confidence 23356899999999986654 89999999999999999985 5666666666555444211
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. ......++.++.+||.+||+.||++|||+.|+++
T Consensus 230 ----~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 ----FR---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----CC---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CC---------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 00 1122457889999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=406.02 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.7
Q ss_pred CCceecceecccCceEEEEEEECCCCc----EEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGE----AVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~----~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 77 (417)
++|++++.||+|+||+||+|.+..+|+ .||+|.++............+|++++++++|||||++++++.+++. ++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eE
Confidence 579999999999999999999998887 5788887654444344556799999999999999999999987655 55
Q ss_pred EEeccC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCC
Q 044608 78 VFECME-CNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPP 155 (417)
Q Consensus 78 v~E~~~-~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~ 155 (417)
+|||+. |++++.+... ...+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.......
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 666555 5566665544 46799999999999999999999999999999999999996 57899999999987654332
Q ss_pred ---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHH
Q 044608 156 ---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQA 231 (417)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 231 (417)
.....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~---------------- 229 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---------------- 229 (317)
T ss_dssp --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT----------------
T ss_pred cccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------------
Confidence 23456899999999997665 8999999999999999998 89999888766655444321
Q ss_pred hhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcCc
Q 044608 232 RAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQHP 282 (417)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~hp 282 (417)
.. ...++.+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 230 ----~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 230 ----ER---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ----CC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----CC---------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 00 112346789999999999999999999999999883
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=399.44 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=201.6
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEEEEEec
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLYLVFEC 81 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 81 (417)
++|++.+.||+|+||+||+|+++.+ +.||||+++..... .....+|+.++++++|||||++++++.+ +.+|+||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 6899999999999999999998765 56999999765443 3345789999999999999999999854 567899999
Q ss_pred cCCCH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC--CCc
Q 044608 82 MECNL-YQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP--PYT 157 (417)
Q Consensus 82 ~~~~l-~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~--~~~ 157 (417)
+.++. ...+.......+++.++..++.||+.||.|||++||+||||||+||||+ ++.+||+|||+|+.+.... ...
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 98774 4444444445699999999999999999999999999999999999997 4789999999998765432 234
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...||+.|+|||++.... ++.++|||||||++|||++| .+||.+....+.+..+....
T Consensus 173 ~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-------------------- 231 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------------- 231 (285)
T ss_dssp ---CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------------
T ss_pred cccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------------------
Confidence 467999999999997665 89999999999999999995 66677777766666553210
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc--Cccccc
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ--HPFFKR 286 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~~ 286 (417)
. ....+.+++++++||.+||+.||++|||++++++ |+||+.
T Consensus 232 ~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 R---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C---------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 0 1123567899999999999999999999999988 888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=398.57 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=192.9
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEe-CCE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQN-NNR 74 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-~~~ 74 (417)
++|+++++||+|+||+||+|.+.. +++.||||+++............+|..++.++ +|+||+.+++++.. +..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 679999999999999999998654 45789999998655544455556788888777 68999999998765 456
Q ss_pred EEEEEeccCCCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCc
Q 044608 75 LYLVFECMECNLYQLMAARD---------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGI 138 (417)
Q Consensus 75 ~~lv~E~~~~~l~~~~~~~~---------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~ 138 (417)
+++||||++++.+..+.... ...+++.++..++.||+.||.|||++||+||||||+||||+ ++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 89999999876444443321 23489999999999999999999999999999999999996 589
Q ss_pred EEEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHH
Q 044608 139 IKIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICG 214 (417)
Q Consensus 139 vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~ 214 (417)
+||+|||+|+...... .....+||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+..
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999998654432 234568999999999997655 89999999999999999986 578987765555444332
Q ss_pred hhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 215 VLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 215 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
.. . . ...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 252 ~~-------------------~-~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EG-------------------T-R--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HT-------------------C-C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC-------------------C-C--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 0 0 11234578999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=400.55 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=204.2
Q ss_pred CCceecceecccCceEEEEEEECCCCcE--EEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEEEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEA--VAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRLYLV 78 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~--vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 78 (417)
|+|++.++||+|+||+||+|+++.+|.. ||||.++............+|+++|+++ +|||||++++++.+++.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999988874 6778776544443444567999999999 799999999999999999999
Q ss_pred EeccCCCHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEe
Q 044608 79 FECMECNLYQLMAAR---------------DRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIA 142 (417)
Q Consensus 79 ~E~~~~~l~~~~~~~---------------~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~ 142 (417)
|||++++.+..+... ....+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 999987644444432 2356899999999999999999999999999999999999964 789999
Q ss_pred eccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCc
Q 044608 143 DFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTM 221 (417)
Q Consensus 143 DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~ 221 (417)
|||+|+............||..|+|||.+.+.. |+.++|||||||++|||++| .+||.+.+..+.+..+...
T Consensus 170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~------ 242 (309)
T d1fvra_ 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 242 (309)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT------
T ss_pred cccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc------
Confidence 999998766555555668999999999997665 89999999999999999996 5689888877766655321
Q ss_pred cchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 222 DSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+ ....+..+++++++||.+||+.||++|||++||++|
T Consensus 243 --------------~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 --------------Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --------------C---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------C---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 011234578999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-52 Score=395.88 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=205.9
Q ss_pred CCceecceecccCceEEEEEEEC-----CCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDE-----HTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~-----~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
|+|+++++||+|+||+||+|+.+ .+++.||||+++............+|+++|++++||||+++++++.+.+.++
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 57999999999999999999865 3567899999986654444555679999999999999999999999999999
Q ss_pred EEEeccCCC-HHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCee
Q 044608 77 LVFECMECN-LYQLMAARD----------------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLL 133 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~----------------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NIL 133 (417)
+||||+.++ +.+.+.... ...+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 999999865 454443221 124889999999999999999999999999999999999
Q ss_pred eeC-CcEEEeeccccccccCC---CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHH
Q 044608 134 VSQ-GIIKIADFGLAREIKSG---PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQ 208 (417)
Q Consensus 134 l~~-~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~ 208 (417)
++. +.+||+|||+|+...+. ...+..+||+.|+|||++.+.. |+.++|||||||++|||++| .+||.+.+..+.
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 974 78999999999865433 2234567899999999997665 89999999999999999998 478999988887
Q ss_pred HHHHHHhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 209 MYKICGVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 209 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
+..+... . ....+..+++++.+||.+||+.||++|||+.||++
T Consensus 252 ~~~v~~~---------------------~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 252 IYYVRDG---------------------N--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHTT---------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcC---------------------C--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7665421 0 11233467899999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=394.50 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=202.0
Q ss_pred CCceecceecccCceEEEEEEECCCC-------cEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCC
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTG-------EAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNN 73 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g-------~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 73 (417)
|+|++++.||+|+||.||+|++..++ ..||||+++............+|...+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 68999999999999999999876654 479999998766555555667899999888 7999999999999999
Q ss_pred EEEEEEeccCCCHHHHHHH-hc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-C
Q 044608 74 RLYLVFECMECNLYQLMAA-RD--------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-G 137 (417)
Q Consensus 74 ~~~lv~E~~~~~l~~~~~~-~~--------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~ 137 (417)
.+|+||||++++.+..+.. +. ...+++.+++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 9999999998764444443 21 235899999999999999999999999999999999999974 7
Q ss_pred cEEEeeccccccccCCC---CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGP---PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||+++...... .....+||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 99999999998765433 234568999999999997655 9999999999999999997 799999888766554442
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. .. ......+++++.+||.+||+.||++|||+.||++
T Consensus 252 ~~--------------------~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EG--------------------HR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TT--------------------CC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC--------------------CC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 11 00 1123467899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=391.15 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=192.9
Q ss_pred CCceecceecccCceEEEEEEECC-CC--cEEEEEEecccccCh--hhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-TG--EAVAIKELKQRYASW--EDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-~g--~~vaiK~i~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||.||+|+... ++ ..||||++++..... ......+|+++|++++|||||++++++.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 479999999999999999998643 33 368999987654322 22345799999999999999999999976 4678
Q ss_pred EEEeccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCC
Q 044608 77 LVFECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGP 154 (417)
Q Consensus 77 lv~E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~ 154 (417)
+||||++++ +.+.+..+ ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999865 45444444 35699999999999999999999999999999999999996 5789999999998765432
Q ss_pred C----CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHH
Q 044608 155 P----YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLR 229 (417)
Q Consensus 155 ~----~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 229 (417)
. .....||..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-------------- 230 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------------- 230 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------------
T ss_pred CcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--------------
Confidence 2 23456888999999997655 8999999999999999998 89999999998887776421
Q ss_pred HHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 230 QARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
... ....+.+++++.+||.+||..||++|||++||++
T Consensus 231 -----~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 -----GER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----CCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1223567899999999999999999999999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=387.53 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=195.2
Q ss_pred CCCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEEEEE
Q 044608 1 MDKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRLYLVF 79 (417)
Q Consensus 1 ~~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 79 (417)
+++|++++.||+|+||.||+|++ +|+.||||+++.... .....+|++++++++||||+++++++.+ .+.+|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 47899999999999999999987 478999999976432 2345689999999999999999998854 56689999
Q ss_pred eccCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CCcEEEeeccccccccCCCCCc
Q 044608 80 ECMECN-LYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QGIIKIADFGLAREIKSGPPYT 157 (417)
Q Consensus 80 E~~~~~-l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~~vkL~DFg~a~~~~~~~~~~ 157 (417)
||+.++ +.+.+..+....+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+|||+++..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cc
Confidence 999775 55555444434589999999999999999999999999999999999997 588999999999865443 34
Q ss_pred cccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCccchHHHHHHHhhhhc
Q 044608 158 NYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKICGVLGSPTMDSWADGLRQARAIKY 236 (417)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 236 (417)
...+|..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....|...
T Consensus 159 ~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------------- 216 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------------- 216 (262)
T ss_dssp ---CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------------
T ss_pred cccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------------
Confidence 457899999999997665 8999999999999999998 79999888777766655311
Q ss_pred cCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 237 QFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
....+.+.+++++.+||.+||+.||.+|||+.|++++
T Consensus 217 --------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 --------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0112334678999999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=388.13 Aligned_cols=250 Identities=29% Similarity=0.401 Sum_probs=206.5
Q ss_pred CCceecceecccCceEEEEEEE-----CCCCcEEEEEEecccccChhhhhhHHHHHHHHhc-CCCCeeeeceEEEeCCEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFD-----EHTGEAVAIKELKQRYASWEDCLNLREVKCLRKL-NHSNIVKLKELIQNNNRL 75 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~-----~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 75 (417)
++|++.+.||+|+||.||+|+. ..+++.||||+++............+|+.+++++ +|||||++++++.+.+.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5789999999999999999975 3567899999998765554555667899999999 699999999999999999
Q ss_pred EEEEeccCCCHHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee-CC
Q 044608 76 YLVFECMECNLYQLMAARD-----------------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS-QG 137 (417)
Q Consensus 76 ~lv~E~~~~~l~~~~~~~~-----------------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~-~~ 137 (417)
|+||||++++.+..+.... ...+++..+..|+.||+.||+|||++||+||||||+|||++ ++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 9999999876555444322 23589999999999999999999999999999999999997 57
Q ss_pred cEEEeeccccccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 044608 138 IIKIADFGLAREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFT-FCPLFPGASEADQMYKIC 213 (417)
Q Consensus 138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~ 213 (417)
.+||+|||+++....... ....+||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+.++.
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999987654332 23468899999999997655 8999999999999999998 678888877766665554
Q ss_pred HhhCCCCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
..- .+ .......++++.+||.+||+.||++|||++||++
T Consensus 262 ~~~---------------------~~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 262 KEG---------------------FR-------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHT---------------------CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcC---------------------CC-------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 210 00 0112357899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=385.31 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=204.3
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-eeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-VKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E 80 (417)
++|++++.||+|+||+||+|+++.+|+.||||++..... .....+|+++++.++|+|+ +.+..++.+++..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999875432 2334689999999987765 555666788899999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee----CCcEEEeeccccccccCCC--
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS----QGIIKIADFGLAREIKSGP-- 154 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~----~~~vkL~DFg~a~~~~~~~-- 154 (417)
|+++++...+.... ..+++..+..++.||+.||+|||++||+||||||+|||++ +..+||+|||+|+.+....
T Consensus 84 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 84 LLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99888877665544 5699999999999999999999999999999999999984 2469999999998765432
Q ss_pred ------CCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCccchHHHH
Q 044608 155 ------PYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGSPTMDSWADGL 228 (417)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 228 (417)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+....+....+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~------------ 229 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------ 229 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH------------
T ss_pred cceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh------------
Confidence 234568999999999987655 8999999999999999999999998877655444332110
Q ss_pred HHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHH---HHHcCccccc
Q 044608 229 RQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAA---EALQHPFFKR 286 (417)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~---elL~hp~f~~ 286 (417)
.... ........+.+++++.+||.+||+.||++|||++ ++|+|+|.+.
T Consensus 230 ----~~~~------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 ----EKKM------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ----HHHH------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----cccC------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0000 0112334467899999999999999999999987 4578887654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=389.63 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=210.6
Q ss_pred CCceecceecccCceEEEEEEECC-----CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCCEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEH-----TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNNRLY 76 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~-----~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 76 (417)
++|++++.||+|+||+||+|.++. +++.||||+++......+.....+|++++++++|||||++++++..++.++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 678999999999999999998753 357899999986554444455679999999999999999999999999999
Q ss_pred EEEeccCCCHHHH-HHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccc
Q 044608 77 LVFECMECNLYQL-MAARD--------RKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGL 146 (417)
Q Consensus 77 lv~E~~~~~l~~~-~~~~~--------~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~ 146 (417)
+||||+.++.+.. +.... ...+++..+..++.||+.||.|||+++|+||||||+|||+++ +.+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999998764444 43221 134688999999999999999999999999999999999975 6899999999
Q ss_pred cccccCCCC---CccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhhCCCCcc
Q 044608 147 AREIKSGPP---YTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTF-CPLFPGASEADQMYKICGVLGSPTMD 222 (417)
Q Consensus 147 a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~ 222 (417)
|+.+..... ....+||+.|+|||.+.+.. ++.++|||||||++|||++| .+||.+.+..+.+..+...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~------- 251 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG------- 251 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-------
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-------
Confidence 986644322 23457899999999997665 89999999999999999998 5889998888877766421
Q ss_pred chHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc------Cccccc
Q 044608 223 SWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ------HPFFKR 286 (417)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~------hp~f~~ 286 (417)
......+.+++++.+||.+||+.||++|||++||++ +|+|++
T Consensus 252 ----------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 252 ----------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ----------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 011223467899999999999999999999999997 666654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=379.19 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=195.9
Q ss_pred cceecccCceEEEEEEECCCC---cEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEe-CCEEEEEEecc
Q 044608 7 FKELGRGAFGRVFQAFDEHTG---EAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQN-NNRLYLVFECM 82 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g---~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~ 82 (417)
.++||+|+||+||+|++..++ ..||||+++............+|+++|++|+|||||++++++.+ ++.+++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 568999999999999986643 36999999765444444566799999999999999999999765 56899999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeC-CcEEEeeccccccccCCC-----CC
Q 044608 83 ECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQ-GIIKIADFGLAREIKSGP-----PY 156 (417)
Q Consensus 83 ~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~-~~vkL~DFg~a~~~~~~~-----~~ 156 (417)
+++.+..+.......+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++...... ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 988777766666567889999999999999999999999999999999999975 789999999998664332 22
Q ss_pred ccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhhCCCCccchHHHHHHHhhhh
Q 044608 157 TNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS-EADQMYKICGVLGSPTMDSWADGLRQARAIK 235 (417)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 235 (417)
....||+.|+|||++.... ++.++|||||||++|||++|..||.... ..+....+..
T Consensus 192 ~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--------------------- 249 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------------------- 249 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT---------------------
T ss_pred ccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---------------------
Confidence 3457899999999987665 8999999999999999999777765543 2232322211
Q ss_pred ccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 236 YQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
...+ ..++.+++++.+||.+||+.||++|||+.|+++|
T Consensus 250 g~~~--------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 250 GRRL--------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC--------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0001 1224578999999999999999999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-49 Score=384.64 Aligned_cols=280 Identities=28% Similarity=0.398 Sum_probs=211.6
Q ss_pred CceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-----------CCCeeeeceEEE-
Q 044608 3 KYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-----------HSNIVKLKELIQ- 70 (417)
Q Consensus 3 ~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~- 70 (417)
||+++++||+|+||+||+|+++.+|+.||||++++.... .....+|+++++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~--~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH--HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc--hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 699999999999999999999999999999999864321 223457888888875 578999999875
Q ss_pred -eCCEEEEEEeccCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCCeeeeC-C------cE
Q 044608 71 -NNNRLYLVFECMEC--NLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ-NGFFHRDLKPENLLVSQ-G------II 139 (417)
Q Consensus 71 -~~~~~~lv~E~~~~--~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~-~gi~HrDLKp~NILl~~-~------~v 139 (417)
.....+++|+++.+ +............+++..++.++.||+.||+|||+ .||+||||||+|||++. + .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 44667777776543 44555555556779999999999999999999998 89999999999999953 2 49
Q ss_pred EEeeccccccccCCCCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH
Q 044608 140 KIADFGLAREIKSGPPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGAS------EADQMYKIC 213 (417)
Q Consensus 140 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~ 213 (417)
||+|||.|...... ....+||+.|+|||++.+.. |+.++||||+||++++|++|+.||.... ..+.+..+.
T Consensus 172 kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeecccccccccc--cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 99999999865433 35668999999999987655 8999999999999999999999997553 345667777
Q ss_pred HhhCCCCccchHHHHHHHhhhhcc-----CCCCCccc-------ccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 214 GVLGSPTMDSWADGLRQARAIKYQ-----FPQLPRAN-------LSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 214 ~~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
..+|......+............. ........ ........+++++|||.+||.+||.+||||+|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 788887665554332211111110 00000000 001122356789999999999999999999999999
Q ss_pred cccccc
Q 044608 282 PFFKRC 287 (417)
Q Consensus 282 p~f~~~ 287 (417)
|||++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-49 Score=373.90 Aligned_cols=249 Identities=20% Similarity=0.245 Sum_probs=204.0
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC-CCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH-SNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E 80 (417)
++|+++++||+|+||+||+|+++.+|+.||||++..... .....+|++.++.|.| +||+.+++++.+....|+|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 589999999999999999999999999999999865432 2234579999999975 899999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeee------CCcEEEeeccccccccCC-
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVS------QGIIKIADFGLAREIKSG- 153 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~------~~~vkL~DFg~a~~~~~~- 153 (417)
|+++++.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecCCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9988887766543 45699999999999999999999999999999999999995 367999999999865432
Q ss_pred -------CCCccccCCccccCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCccc
Q 044608 154 -------PPYTNYVGSRWYRAPEILLQSELYSSKADMWAMGAIMAELFTFCPLFPGASEA---DQMYKICGVLGSPTMDS 223 (417)
Q Consensus 154 -------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~ 223 (417)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.... +...++...
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-------- 231 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-------- 231 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH--------
T ss_pred cccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc--------
Confidence 1234568999999999997655 899999999999999999999999865432 222232211
Q ss_pred hHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHc
Q 044608 224 WADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQ 280 (417)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~ 280 (417)
.. ......+.+.+++++.+|+..|+..+|++||+.+.+.+
T Consensus 232 -----------~~------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 -----------KQ------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------HH------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------cC------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 01123344667899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=370.60 Aligned_cols=266 Identities=25% Similarity=0.286 Sum_probs=186.7
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCeeeeceEEEeCC----EEEE
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNIVKLKELIQNNN----RLYL 77 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 77 (417)
.+|.+.++||+|+||.||+|+. +|+.||||+++.+. ........|+..+..++|||||++++++.+.+ .+|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4689999999999999999975 68999999997542 12222234555666789999999999987654 6899
Q ss_pred EEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccccCCCCCeeee-CCcEEEeeccccc
Q 044608 78 VFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ--------NGFFHRDLKPENLLVS-QGIIKIADFGLAR 148 (417)
Q Consensus 78 v~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~--------~gi~HrDLKp~NILl~-~~~vkL~DFg~a~ 148 (417)
||||+.++.+..+..+. .+++..+..++.|++.||.|||+ +||+||||||+||||+ ++.+||+|||++.
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999876555555543 48999999999999999999996 6999999999999996 5799999999998
Q ss_pred cccCCC-----CCccccCCccccCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Q 044608 149 EIKSGP-----PYTNYVGSRWYRAPEILLQSE-----LYSSKADMWAMGAIMAELFTFCPLFPGASEADQMYKICGVLGS 218 (417)
Q Consensus 149 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~ 218 (417)
...... .....+||+.|+|||++.+.. .++.++|||||||+||||++|.+||............. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-cccc
Confidence 765432 234568999999999986432 25778999999999999999998875433211000000 0000
Q ss_pred CCccchHHHHHHHhhhhccCCCCCcccccccCCCCCHhHHHHHHHhcccCCCCCCCHHHHHcC
Q 044608 219 PTMDSWADGLRQARAIKYQFPQLPRANLSALMPSASQDAISLFESLCSWDPSKRPTAAEALQH 281 (417)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~elL~h 281 (417)
+..... ..........|..+. .........++.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~----~~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEM----RKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHH----HHHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHH----HHHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000 000000000011110 00011233568999999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.8e-27 Score=207.63 Aligned_cols=163 Identities=20% Similarity=0.162 Sum_probs=121.3
Q ss_pred ceecceecccCceEEEEEEECCCCcEEEEEEecccccCh-----------------hhhhhHHHHHHHHhcCCCCeeeec
Q 044608 4 YSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASW-----------------EDCLNLREVKCLRKLNHSNIVKLK 66 (417)
Q Consensus 4 Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~-----------------~~~~~~~E~~~l~~l~hpnIv~l~ 66 (417)
|.+.++||+|+||+||+|++. +|+.||||+++...... ......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578899999999999999885 68999999875321110 011123688899999999999887
Q ss_pred eEEEeCCEEEEEEeccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCCeeeeCCcEEEeeccc
Q 044608 67 ELIQNNNRLYLVFECMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQNGFFHRDLKPENLLVSQGIIKIADFGL 146 (417)
Q Consensus 67 ~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~~gi~HrDLKp~NILl~~~~vkL~DFg~ 146 (417)
++. . .+++|||+++.... .+++..+..++.||+.+|.|||++||+||||||+|||++++.++|+|||+
T Consensus 81 ~~~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTT
T ss_pred Eec--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCC
Confidence 653 2 27999999876432 25666778899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccCc------hhhhccCCCCchhhHHHHHH
Q 044608 147 AREIKSGPPYTNYVGSRWYRAP------EILLQSELYSSKADMWAMGA 188 (417)
Q Consensus 147 a~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~~~~DiwSlG~ 188 (417)
|....... ...|... +.+ . +.|+.++|+||+.-
T Consensus 149 a~~~~~~~-------~~~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~ 187 (191)
T d1zara2 149 SVEVGEEG-------WREILERDVRNIITYF-S-RTYRTEKDINSAID 187 (191)
T ss_dssp CEETTSTT-------HHHHHHHHHHHHHHHH-H-HHHCCCCCHHHHHH
T ss_pred cccCCCCC-------cHHHHHHHHHHHHHHH-c-CCCCCcccHHHHHH
Confidence 97643221 1122211 111 2 23789999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.3e-07 Score=84.78 Aligned_cols=138 Identities=18% Similarity=0.211 Sum_probs=91.1
Q ss_pred CCceecceecccCceEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcC-CCCeeeeceEEEeCCEEEEEEe
Q 044608 2 DKYSGFKELGRGAFGRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLN-HSNIVKLKELIQNNNRLYLVFE 80 (417)
Q Consensus 2 ~~Y~~~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 80 (417)
+.|+..+..+-++.+.||+.. ..+..+++|........ ......+|...++.|. +=-+.+++.+..+++..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 567777766556667999884 55677888987644222 2223457888888874 3335677888888999999999
Q ss_pred ccCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 044608 81 CMECNLYQLMAARDRKLFSEPEIKAWLFQVFQGLSYMHQ----------------------------------------- 119 (417)
Q Consensus 81 ~~~~~l~~~~~~~~~~~l~e~~i~~i~~qi~~aL~~LH~----------------------------------------- 119 (417)
+++|..+..... +......+..++...|..||+
T Consensus 91 ~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred eccccccccccc------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 998865432211 111122233344444444442
Q ss_pred ------------C------CcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 120 ------------N------GFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 120 ------------~------gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
. .++|+|+.|.|||++++.+ -|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 2789999999999998776 599999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=1.5e-06 Score=82.74 Aligned_cols=76 Identities=18% Similarity=0.188 Sum_probs=48.0
Q ss_pred cceecccCceEEEEEEECCCCcEEEEEEecccc------cChhhhhhHHHHHHHHhcC-C--CCeeeeceEEEeCCEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEHTGEAVAIKELKQRY------ASWEDCLNLREVKCLRKLN-H--SNIVKLKELIQNNNRLYL 77 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~~g~~vaiK~i~~~~------~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~l 77 (417)
.+.||.|....||++.+..+++.|++|.-.... ......+..+|.+.|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567999999999999888888899999753210 1111223346888888773 2 345555544 4555678
Q ss_pred EEeccCC
Q 044608 78 VFECMEC 84 (417)
Q Consensus 78 v~E~~~~ 84 (417)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=2.9e-05 Score=68.49 Aligned_cols=72 Identities=13% Similarity=0.042 Sum_probs=50.1
Q ss_pred eecccCc-eEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCC--CCeeeeceEEEeCCEEEEEEeccCCC
Q 044608 9 ELGRGAF-GRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNH--SNIVKLKELIQNNNRLYLVFECMECN 85 (417)
Q Consensus 9 ~LG~G~~-g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~~ 85 (417)
.+..|.. +.||+... ..+..+++|...... .....+|...++.|.. -.+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 68999864 456678889765432 2234578888887743 23567788888888999999999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00019 Score=65.85 Aligned_cols=129 Identities=19% Similarity=0.184 Sum_probs=73.7
Q ss_pred eEEEEEEECCCCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCCe-----eeec--eEEEeCCEEEEEEeccCCCH--
Q 044608 16 GRVFQAFDEHTGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSNI-----VKLK--ELIQNNNRLYLVFECMECNL-- 86 (417)
Q Consensus 16 g~V~~a~~~~~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~--~~~~~~~~~~lv~E~~~~~l-- 86 (417)
-.||++.. .+|..|++|+.+....+ ...+..|...+..|..-+| +..- ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 47999964 56888999998765433 2334568888877742221 2211 23456778899999887621
Q ss_pred ---HHHHH----------Hh--c-----CCC-------------------CCHHHHHHHHHHHHHHHHHHHH-------C
Q 044608 87 ---YQLMA----------AR--D-----RKL-------------------FSEPEIKAWLFQVFQGLSYMHQ-------N 120 (417)
Q Consensus 87 ---~~~~~----------~~--~-----~~~-------------------l~e~~i~~i~~qi~~aL~~LH~-------~ 120 (417)
..... .. . +.. ++......+...+-..++.+.. .
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11110 00 0 001 1111111222222223333322 3
Q ss_pred CcccccCCCCCeeeeCCcEEEeeccccc
Q 044608 121 GFFHRDLKPENLLVSQGIIKIADFGLAR 148 (417)
Q Consensus 121 gi~HrDLKp~NILl~~~~vkL~DFg~a~ 148 (417)
+++|+|+.+.|||++++. .++||+.+.
T Consensus 193 ~liHgDlh~~NvL~~~~~-~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDGP-MFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSSE-EECCCTTCC
T ss_pred eeecCCCCcccEEEeCCc-eEEechhcc
Confidence 689999999999998765 489999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.89 E-value=0.00067 Score=63.84 Aligned_cols=71 Identities=11% Similarity=0.058 Sum_probs=48.0
Q ss_pred cceecccCceEEEEEEECC-------CCcEEEEEEecccccChhhhhhHHHHHHHHhcCCCC-eeeeceEEEeCCEEEEE
Q 044608 7 FKELGRGAFGRVFQAFDEH-------TGEAVAIKELKQRYASWEDCLNLREVKCLRKLNHSN-IVKLKELIQNNNRLYLV 78 (417)
Q Consensus 7 ~~~LG~G~~g~V~~a~~~~-------~g~~vaiK~i~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv 78 (417)
++.|+.|-.-.+|++.... .++.|.+++.... .. .....+|..+++.+.--+ ..++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4678889999999997653 3456777776532 11 233457999999885334 4577776643 578
Q ss_pred EeccCC
Q 044608 79 FECMEC 84 (417)
Q Consensus 79 ~E~~~~ 84 (417)
+||++|
T Consensus 120 ~efi~g 125 (395)
T d1nw1a_ 120 EEYIPS 125 (395)
T ss_dssp ECCCCE
T ss_pred EEEecc
Confidence 998876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.36 E-value=0.0046 Score=55.71 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=25.5
Q ss_pred CCcccccCCCCCeeeeCCcE-EEeeccccc
Q 044608 120 NGFFHRDLKPENLLVSQGII-KIADFGLAR 148 (417)
Q Consensus 120 ~gi~HrDLKp~NILl~~~~v-kL~DFg~a~ 148 (417)
.|++|+|+.++||+++++.+ -|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 47999999999999998765 799999875
|